acc12 final program w toc links
TRANSCRIPT
Final Program
www.accscientificsession.org/acc12
©2012 A
mer
ican
Col
lege
of C
ardi
olog
y A1
304
Join us for a whole new learning experience — in a whole new city — as we bring you the education that keeps you at the forefront of your profession and helps improve the quality of care for your patients.
www.accscientificsession.org
ACC.12 Final Program 1
TAB 1: General Information
General Meeting Information
Directory .......................................................... 27 – 28
Logistic Information ......................................... 29 – 37
Convention Center Map ............................................ 38
Poster Session Maps ........................................ 39 – 41
Hotel List and Map ........................................... 42 – 43
General Education Information ................................. 44 – 46
Disclosure of Financial Relationships ....................... 47 – 48
Scientific Session Descriptions ................................ 49 – 51
ACC.12 Expo
ACC.12 Expo Highlights .................................... 52 – 53
ACC.12 Exhibitor List ....................................... 54 – 56
ACC.12 Learning Destinations™ .............................. 57 – 59
Non-Accredited Educational Events ......................... 60 – 62
Independent CME/CNE-Certified Pre Conference & Evening Programs ................ 63 – 64
TAB 2: Your Road Map To ACC.12
Your Roadmap to ACC.12 ......................................... 65 – 69
Schedule-At-A-Glance ............................................. 70 – 71
Program-At-A-Glance
Daily Schedule ................................................. 72 – 86
Topic Schedule ............................................... 87 – 103
TAB 3: Friday, March 23 and Saturday, March 24
ACC.12 Educational Sessions Friday, March 23 ....... 105 – 106
ACC.12 Educational Sessions Satuday, March 24 ..... 107 – 131
Learning Destination™ Presentations ................... 131 – 132
TAB 4: Sunday, March 25
ACC.12 Educational Sessions ................................ 137 – 172
Learning Destination™ Presentations ................... 173 – 175
TAB 5: Monday, March 26
ACC.12 Educational Sessions ............................... 177 – 205
Learning Destination™ Presentations .................. 206 – 207
TAB 6: Tuesday, March 27
ACC.12 Educational Sessions ............................... 209 – 211
TAB 7: Author Index
Author Index ......................................................... 217 – 238
ACC.12
Table of ContentsWelcome to ACC.12 ................................................................................................................................................................... 3
ACC.12 Officials and Committees ................................................................................................................................................ 4
ACC.12 Acknowledgments .................................................................................................................................................. 6 – 10
ACC.12 Elite FIT Rising Star Acknowledgments .......................................................................................................................... 11
Grantor Acknowledgments ................................................................................................................................................. 12 – 15
ACCF Donor Recognition ................................................................................................................................................... 16 – 20
Access, Viewand PRINT!
ACC.11 Of�cials ACC.11 Acknowli2 Summit Of�ciai2 Summit Acknoi2 Summit Af�liaACC.11 Grantor A
©2012 American College of Cardiology. F1224
A M E R I C A N C O L L E G E o f C A R D I O L O G Y
Helping Cardiovascular Professionals Learn. Advance. Heal.
Join a network of CV professionals committed to quality cardiovascular care & advance your career:
- Physicians- Cardiovascular Administrators- Nurses- Physician Assistants- Cardiovascular Technicians- Pharmacists
Visit to join & discover the value of ACC membership!
ACC BOOTH #10027
ACC.12 Final Program 3
Welcome to Chicago for the American College of Cardiology’s 61st Annual Scientific Session and ACC-i2 with TCT: Innovation in Intervention.
This year’s program reflects the passion for science, education and peer-to-peer networking that ACC President David R. Holmes, Jr., MD, FACC, has brought to his administration. We’ve enriched ACC.12 to enhance your learning experience and provide you with a dynamic, individualized experience that meets all your learning needs.
Don’t miss:• The new daily schedule — focus on science each morning with late-breakers,
poster abstracts and new findings, and focus on practical clinical applications each afternoon with case-based sessions, review sessions, and MOC.
• The Legends of Cardiovascular Medicine — a series of five sessions featuring true legends in the field of cardiology.
• The Innovators of Cardiology — an all-new closing session which brings together top leaders in cardiology to discuss driving forces behind innovation and creativity.
• Your chance to earn up to 70 MOC points with the Maintenance of Certification sessions and the Competency-Based Learning System —helping you select the sessions that best fill your knowledge gaps in the Lifelong Learning Pathway.
• Collaborative efforts with subspecialty societies to create a “Family of Cardiology” with co-branded sessions and abstracts throughout the meeting.
• Cutting-edge technology including a new ACC.12 eMeeting Planner App (search ACC.12 in your app marketplace), and ACC.12 Online — live webcasts of 60 sessions plus an additional 18 on demand sessions from the Legends of CV Medicine and Core Curriculum series — available to attendees for free during the meeting!
To learn more about these sessions and additional features of ACC.12 check out Your Road Map to ACC.12 (page 65).
Can’t make it to all the sessions you want to attend? Purchase iScience, a comprehensive digital library of presentations from ACC.12. Order iScience on site in Chicago to save $1,000 or more — visit the iScience sales kiosk in Grand Concourse Lobby, Level 3 or ACC Central, Booth #10027.
Welcome to ACC.12
4 GO for ACC.12!
The College is most grateful to all program participants who have given freely of their time to participate in the 60th Annual Scientific Session.
President, 2011 – 2012David R. Holmes, Jr., MD, FACC
President-ElectWilliam A. Zoghbi, MD, FACC
Co-chairs, Annual Scientific Session Program CommitteeRick A. Nishimura, MD, FACCPatrick T. O’Gara, MD, FACC
Annual Scientific Session Program Committee
Karthikeyan Ananthasubramaniam,
MBBS, FACC
Alex J. Auseon, DO, FACC
Alison Bailey, MD, FACC
Christie M. Ballantyne, MD, FACC
R. Michael Benitez, MD, FACC
Lisa Bergersen, MD, MPH, FACC
Tandeep Bhatti, MD, FACC
Michael S. Blum, MD, FACC
Biykem Bozkurt, MD, PhD, FACC
John E. Brush, Jr., MD, FACC
Matthew J. Budoff, MD, FACC
Jean A. Connor, NP
Rhonda M. Cooper-DeHoff, PharmD,
FACC
Salvatore P. Costa, MD, FACC
Michael H. Crawford, MD, FACC
Mark G. Davies, MB, BCh, PhD, FACC
James A. de Lemos, MD, FACC
G. William Dec, Jr., MD, FACC
Akshay S. Desai, MD, FACC
Caroline Lloyd Doherty, MSN, CRNP,
AACC
Maurice Enriquez-Sarano, MD, FACC
John P. Erwin, III, MD, FACC
Derek V. Exner, MD, FACC
Barbara Fletcher, RN
Federico Gentile, MD, FACC
Maya E. Guglin, MD, FACC
Melanie T. Gura, RN, MSN, CNS, CCDS,
AACC
Stephen C. Hammill, MD, FACC
Jerome L. Hines, MD, PhD, FACC
Julia H. Indik, MD, PhD, FACC
Elizabeth A. Jackson, MD, FACC
Henri Justino, MD, CM, FACC
Joshua Kanter, MD
Sanjay Kaul, MBBS, FACC
Jerry D. Kennett, MD, FACC
Amit Khera, MD, MSc, FACC
Henry E. Kim, MD, MPH, FACC
Annapoorna Subhash Kini, MBBS,
FACC
Ajay J. Kirtane, MD, FACC
Neal S. Kleiman, MD, FACC
Eva M. Kline-Rogers, RN
Jeffrey T. Kuvin, MD, FACC
Richard A. Lange, MD, FACC
Michele Langenfeld, RN, MS
Gregory M. Lanza, MD, FACC
Christine E. Lawless, MD, FACC
Randall J. Lee, MD, PhD, FACC
Byron Kwock Lee, MD, FACC
Ms. Carolyn Lekavich, NP
Gregory D. Lewis, MD
Jane A. Linderbaum, MS, CNP, AACC
Bruce D. Lindsay, MD, FACC
Janet B. Long, MSN, ACNP
Thomas M. Maddox, MD, MSc, FACC
Frederick A. Masoudi, MD, MSPH,
FACC
Michael A. Mathier, MD, FACC
Doff B. McElhinney, MD
Dennis M. McNamara, MD, FACC
Edward J. McNulty, MD, FACC
Issam A. Mikati, MD, FACC
Todd D. Miller, MD, FACC
David A. Morrow, MD, MPH, FACC
Debabrata Mukherjee, MD, FACC
ACC.12
Officials and Committees
ACC.12 Final Program 5
Steve R. Ommen, MD, FACC
Narith Ou, PharmD
Ronald J. Oudiz, MD, FACC
Douglas L. Packer, MD, FACC
Hamang M. Patel, MD, FACC
Donna M. Polk, MD, MPH, FACC
Miguel A. Quinones, MD, FACC
Nalini Marie Rajamannan, MD, FACC
Sunil V. Rao, MD, FACC
George P. Rodgers, MD, FACC
Frances A. Rogers, NP
John S. Rumsfeld, MD, PhD, FACC
Thomas John Ryan, MD, FACC
Arwa Saidi, MB, BCh, FACC
Michael K. Schroyer, RN, AACC
Bindi K. Shah, MD, FACC
Prem Soman, MBBS, FACC
Paul Sorajja, MD, FACC
Anthony E. Steimle, MD, FACC
Karen K. Stout, MD, FACC
E. Murat Tuzcu, MD, FACC
Anne Marie Valente, MD, FACC
C. Michael Valentine, MD, FACC
Paul D. Varosy, MD, FACC
Hector O. Ventura, MD, FACC
Ralph J. Verdino, MD, FACC
Wanpen Vongpatanasin, MD, FACC
Mary Norine Walsh, MD, FACC
Andrew Wang, MD, FACC
Tracy Wang, MD, FACC
Suzanne J. Wingate, PhD, CRNP
Stephen D. Wiviott, MD, FACC
R. Scott Wright, MD, FACC
Robert W. Yeh, MD
ACC-i2 with TCT Program Executive Committee
E. Murat Tuzcu, MD, FACC, Chair
Gary S. Mintz, MD, FACC, Co-chair
George D. Dangas, MD, PhD, FACC
Howard C. Herrmann, MD, FACC
Martin B. Leon, MD, FACC
David J. Moliterno, MD, FACC
Gregg W. Stone, MD, FACC
Janet Fredal Wyman, MSN, NP, ACNS-
BC, AACC, Nurse Planner
ACC-i2 with TCT Program Committee
Karthikeyan Ananthasubramaniam,
MBBS, FACC
Dominick J. Angiolillo, MD, PhD, FACC
Raoul Bonan, MD, FACC
Sorin J. Brener, MD, FACC
Emmanouil S. Brilakis, MD, PhD, FACC
Nora Brown, M.S.N., R.N.
Douglas E. Drachman, MD, FACC
Caroline Lloyd Doherty, MSN, CRNP,
AACC
William Fuller Fearon, MD, FACC
Lee R. Goldberg, MD, MPH, FACC
James Aaron Grantham, MD, FACC
Rebecca T. Hahn, MD, FACC
Robert A. Harrington, MD, FACC
James Bernard Hermiller, Jr, MD, FACC
Michael R. Jaff, DO, FACC
Ik-Kyung Jang, MD, PhD, F.A.C.C
Allen Jeremias, MD, FACC
David E. Kandzari, MD, FACC
Samir R. Kapadia, MBBS, FACC
A. Pieter Kappetein, MD, PhD
Saibal Kar, MD, FACC
Dean J. Kereiakes, MD, FACC
Carey D. Kimmelstiel, MD, FACC
Ajay J. Kirtane, MD, FACC
Eva M. Kline-Rogers, RN, MS
Susheel K. Kodali, MD, FACC
Raghu Kolluri, MBBS, FACC
Michael J. Landzberg, MD, FACC
Michael J. Lim, MD, FACC
Jane A. Linderbaum, MS, CNP, AACC
Julie A. Logan, RN
Akiko Maehara, MD
Raj R. Makkar, MD, FACC
Tift Mann, III, MD, FACC
Roxana Mehran, MD, FACC
Venu Menon, MBBS, FACC
Jeffrey W. Moses, MD, FACC
Debabrata Mukherjee, MD, FACC
Hilary M. Nierenberg, NP
Masahiko Ochiai, MD, Ph.D, FACC
Sandra M. Oliver‐McNeil, NP, AACC
John A. Ormiston, MB, ChB, FACC
Sahil A. Parikh, MD, FACC
Nicolo Piazza, MD
Duane S. Pinto, MD, MPH, FACC
Abhiram Prasad, MD, FRCP, FACC
Sunil V. Rao, MD, FACC
Lisa A. Riggs, CNS, AACC
Charanjit S. Rihal, MD, FACC
Eric Roselli, MD
Timothy A. Sanborn, MD, FACC
Paul Schoenhagen, MD
Mehdi H. Shishehbor, DO, MPH
Frank E. Silvestry, MD, FACC
Lars G. Svensson, MBBCh, PhD, FACC
Jonathan M. Tobis, MD, FACC
Zoltan G. Turi, MD, FACC
Szilard Voros, MD, FACC
Christopher J. White, MD, FACC
Giora Weisz, MD, FACC
Mathew Williams, MD, FACC
Alan Zajarias, MD, MSc, FACC
Khaled M. Ziada, MD, FACC
ACC.12 • Officials and Committees
6 GO for ACC.12!
The ACC.12 and ACC-i2 with TCT Program Committees gratefully acknowledge the assistance of the following individuals as Abstract Reviewers and Chairs for the 61st Annual Scientific Session.
Suhny Abbara, MD
Aamer Abbas, MBBS, FACC
J. Dawn Abbott, MD, FACC
Alex Abou-Chebl, MD
Theodore P. Abraham, MBBS, FACC
Mazen S. Abu-Fadel, MD, FACC
Stephan Achenbach, MD, FACC
Michael John Ackerman, MD, PhD,
FACC
Evan C. Adelstein, MD, FACC
Ali Ahmed, MD, MPH
Karen P. Alexander, MD, FACC
Jeffrey D. Alexis, MD, FACC
Fernando Alfonso, MD, PhD
Imad A. Alhaddad, MBBS, FACC
Sana M. Al-Khatib, MD, FACC
Suhail Q. Allaqaband, MBBS, FACC
Larry A. Allen, MD, FACC
Mouaz H. Al-Mallah, MD, FACC
Carolyn A. Altman, MD, FACC
Aman M. Amanullah, MD, PhD, FACC
Zahid Amin, MBBS
Ezra A. Amsterdam, MD, FACC
Karthikeyan Ananthasubramaniam,
MBBS, FACC
H. Vernon Anderson, MD, FACC
Jeffrey L. Anderson, MD, FACC
Dominick J. Angiolillo, MD, PhD, FACC
Christopher P. Appleton, MD, FACC
Joseph R. Aragon, MD, FACC
Andrew E. Arai, MD
Juan M. Aranda, Jr., MD, FACC
Paul Wayne Armstrong, MD, FACC
William F. Armstrong, MD, FACC
Herbert D. Aronow, MD, FACC
James A. Arrighi, MD, FACC
Gerard P. Aurigemma, MD, FACC
Richard G. Bach, MD, FACC
Jayant Bagai, MBBS, FACC
Aaron L. Baggish, MD
Alison Bailey, MD, FACC
C. Noel Bairey Merz, MD, FACC
Christie M. Ballantyne, MD, FACC
Gerald Barbeau, MD, FACC
Gregory W. Barsness, MD, FACC
John R. Bartholomew, III, MD, FACC
Riyaz Bashir, MBBS, FACC
Jean-Pierre L. Bassand, MD, FACC
Eric R. Bates, MD, FACC
Timothy A. Beaver, MD, FACC
Jeffrey S. Berger, MD, FACC
Lisa Bergersen, MD, MPH, FACC
Daniel S. Berman, MD, FACC
Colin Berry, MB, ChB, FACC
John F. Beshai, MD, FACC
Patricia J. M. Best, MD, FACC
Deepak L. Bhatt, MD, MPH, FACC
Tandeep Bhatti, MD, FACC
Vera Bittner, MD, FACC
Ron Blankstein, MD, FACC
David A. Bluemke, MD, PhD
Kay Blum, NP, PhD
Elizabeth D. Blume, MD, FACC
Xu Bo
William E. Boden, MD, FACC
John P. Boehmer, MD, FACC
Eric Boersma, PhD
Raoul Bonan, MD, FACC
Robert O. Bonow, MD, MACC
Jeffrey S. Borer, MD, FACC
Barry Borlaug, MD, FACC
Robert C. Bourge, MD, FACC
Biykem Bozkurt, MD, PhD, FACC
Peter A. Brady, FACC
Somjot Singh Brar, MD, FACC
Sorin J. Brener, MD, FACC
Emmanouil S. Brilakis, MD, PhD, FACC
Ralph G. Brindis, MD, MPH, MACC
Jeffrey A. Brinker, MD, FACC
David L. Brown, MD, FACC
John E. Brush, Jr., MD, FACC
Randall M. Bryant, MD
Matthew J. Budoff, MD, FACC
Hector Bueno, MD, PhD
James A. Burke, MD, FACC
Javed Butler, MBBS, FACC
David Calhoun, MD
Hugh Calkins, MD, FACC
David S. Cannom, MD, FACC
Christopher P. Cannon, MD, FACC
Warren J. Cantor, MD
Davide Capodanno, MD
Joseph Patrick Carrozza, Jr., MD, FACC
Ivan P. Casserly, MD, FACC
Ricardo Castillo, MD, FACC
Bojan Cercek, MD, FACC
Paul Chan, MD, MSc
Panithaya Chareonthaitawee, MD,
FACC
Sandra L. Chase, PharmD
Farooq A. Chaudhry, MD, FACC
Jersey Chen, MD
Jie Cheng, FACC
Stanley J. Chetcuti, MD, FACC
Alaide Chieffo, MD
ACC.12
Acknowledgments
ACC.12 Final Program 7
Kenneth Chin, MBBS, FACC
Aram V. Chobanian, MD, FACC
George S. Chrysant, MD, FACC
Sumeet S. Chugh, MD, FACC
Joaquin E. Cigarroa, MD, FACC
Mehmet Cilingiroglu, MD, FACC
John G. F. Cleland, MD, FACC
David J. Cohen, MD
Mauricio G. Cohen, MD, FACC
Meryl S. Cohen, MD, FACC
Tyrone J. Collins, MD, FACC
John P. Cooke, MD, PhD
Joshua M. Cooper, MD, FACC
Leslie T. Cooper, MD, FACC
Salvatore P. Costa, MD, FACC
David Alan Cox, MD, FACC
Jesse W. Currier, MD, FACC
Jeptha P. Curtis, MD, FACC
Tillmann Cyrus, MD, FACC
George D. Dangas, MD, PhD, FACC
James P. Daubert, MD, FACC
Harold L. Dauerman, MD, FACC
Ravin Davidoff, MD, FACC
Charles J. Davidson, MD, FACC
Michael H. Davidson, MD, FACC
Mark G. Davies, MB, BCh, PhD, FACC
Robbert de Winter
Larry S. Dean, MD, FACC
G. William Dec, Jr., MD, FACC
Carole J. Decker, RN
Gregory J. Dehmer, MD, FACC
Ali E. Denktas, MD, FACC
David DeNofrio, MD, FACC
Akshay S. Desai, MD, FACC
Marcelo F. Di Carli, MD, FACC
Robert S. Dieter, MD, FACC
John P. DiMarco, MD, FACC
Alexios P. Dimas, MD, FACC
Germano DiSciascio, MD, FACC
Sanjay Dixit, MBBS, FACC
Caroline Lloyd Doherty, MSN, CRNP,
AACC
Hisham Dokainish, MD, FACC
James Douketis, MD
Douglas E. Drachman, MD, FACC
Mark H. Drazner, MD, FACC
Andre J. Duerinckx, FACC
Stephanie H. Dunlap, DO
Kim A. Eagle, MD, MACC
Robert T. Eberhardt, MD, FACC
Ramin Ebrahimi, MD, FACC
Andrew Jeffrey Einstein, MD, PhD,
FACC
Kenneth A. Ellenbogen, MD, FACC
Stephen G. Ellis, MD, FACC
Sammy Elmariah, MD
Andrew E. Epstein, MD, FACC
Raimund A Erbel, MD, FACC
N. A. Mark Estes, III, MD, FACC
Gregory A. Ewald, MD, FACC
Derek V. Exner, MD, FACC
Mitchell N. Faddis, MD, PhD, FACC
Thomas E. Fagan, MD, FACC
Peter S. Fail, MD, FACC
Bruno Farah, MD
Andrew Farb, MD, FACC
David P. Faxon, MD, FACC
William Fuller Fearon, MD, FACC
Frederick Feit, MD, FACC
Dmitriy N. Feldman, MD, FACC
Marc D. Feldman, MD, FACC
G. Michael Felker, MD, FACC
Keith C. Ferdinand, MD, FACC
Victor A. Ferrari, MD, FACC
Stephan D. Fihn, MD, MPH
Tim A. Fischell, MD, FACC
Scott D. Flamm, MD, FACC
Mark A. Fogel, MD, FACC
Gregg C. Fonarow, MD, FACC
Joanne M. Foody, MD, FACC
Paul Forfia, MD
Elyse Foster, MD, FACC
Wayne J. Franklin, MD, FACC
Robert P. Frantz, MD, FACC
James B. Froehlich, MD, MPH, FACC
Edward D. Frohlich, MD, FACC
Krishna K Gaddam, MD
Runlin Gao, MD, FACC
Lawrence A. Garcia, MD, FACC
Julius M. Gardin, MD, FACC
Marie D. Gerhard-Herman, MD, FACC
Anthony Gershlick, MD
Jalal K. Ghali, MD, FACC
Raymond J. Gibbons, MD, FACC
C. Michael Gibson, MD, FACC
Ian C. Gilchrist, MD, FACC
Anne M. Gillis, MD
Michael M. Givertz, MD, FACC
Michael Robert Gold, MD, PhD, FACC
Lee R. Goldberg, MD, MPH, FACC
Samuel Z. Goldhaber, MD, FACC
James A. Goldstein, MD, FACC
Sarah J. Goodlin, MD, FACC
Shaun G. Goodman, MD, FACC
Stephen S. Gottlieb, MD, FACC
Christopher B. Granger, MD, FACC
James Aaron Grantham, MD, FACC
Liliana R. Grinfeld, MD, FACC
Paul Michael Grossman, MD, FACC
Maya E. Guglin, MD, FACC
Rajiv Gulati, MD, FACC
Anuj Gupta, MD, FACC
Paul A. Gurbel, MD, FACC
Rory Hachamovitch, MD, FACC
David E. Haines, MD, FACC
Jonathan L. Halperin, MD, FACC
Kishore J. Harjai, MD, FACC
Robert A. Harrington, MD, FACC
Thomas H. Hauser, MD, FACC
Edward P. Havranek, MD, FACC
David L. Hayes, MD, FACC
Harvey S. Hecht, MD, FACC
ACC.12 • Acknowledgments
8 GO for ACC.12!
Paul A. Heidenreich, MD, FACC
Gary V. Heller, MD, PhD, FACC
Robert C. Hendel, MD, FACC
Timothy D. Henry, MD, FACC
James Bernard Hermiller, Jr., MD,
FACC
Adrian F. Hernandez, MD
Howard C. Herrmann, MD, FACC
William R. Hiatt, MD
Ziyad M. Hijazi, MBBS, MPH, FACC
Alan T. Hirsch, MD, FACC
Glenn A. Hirsch, MD, MHS, FACC
Kalon K. L. Ho, MD, FACC
Katherine J. Hoercher, RN
Udo Hoffmann, MD, MPH
Stefan H. Hohnloser, MD, FACC
Brian D. Hoit, MD, FACC
Thomas A. Holly, MD, FACC
David R. Holmes, Jr., MD, FACC
Ralf Holzer, MD
Shunichi Homma, MD, FACC
Susan D. Housholder-Hughes, NP,
AACC
Henry H. Hsia, MD, FACC
Eileen M. Hsich, MD, FACC
W. Gregory Hundley, MD, FACC
Judy W. Hung, MD
Mathew D. Hutchinson, MD, FACC
Adolph M. Hutter, Jr., MD, MACC
Julia H. Indik, MD, PhD, FACC
David Dunbar Ivy, MD, FACC
Warren M. Jackman, MD, FACC
Elizabeth A. Jackson, MD, FACC
Alice K. Jacobs, MD, FACC
Jeffrey P. Jacobs, MD, FACC
Farouc A. Jaffer, MD, PhD, FACC
Diwakar Jain, MD, FACC
Kenneth A. Jamerson, MD
Stefan K. James
Ik-Kyung Jang, MD, PhD, FACC
Allen Jeremias, MD, FACC
Robert H. Jones, MD, MACC
Ion S. Jovin, MD, FACC
Henri Justino, MD, CM, FACC
Jens J. Kaden, MD
Alan H. Kadish, MD, FACC
Mathew Samuel Kalarickal, MD
David E. Kandzari, MD, FACC
Samir R. Kapadia, MBBS, FACC
Aaron V. Kaplan, MD, FACC
Norman M. Kaplan, MD
Saibal Kar, MD, FACC
Ronald P. Karlsberg, MD, FACC
Andrew M. Kates, MD, FACC
Sanjay Kaul, MBBS, FACC
Dean J. Kereiakes, MD, FACC
Steven J. Keteyian, PhD
Amit Khera, MD, MSc, FACC
Henry E. Kim, MD, MPH, FACC
Carey D. Kimmelstiel, MD, FACC
Ajay J. Kirtane, MD, FACC
Kyle W. Klarich, MD, FACC
Neal S. Kleiman, MD, FACC
Lloyd W. Klein, MD, FACC
George J. Klein, MD
Paul Kligfield, MD, FACC
Eva M. Kline-Rogers, RN
Bradley P. Knight, MD, FACC
Todd M. Koelling, MD, FACC
Michael C. Kontos, MD, FACC
Smadar Kort, MD, FACC
Mikhail Kosiborod, MD, FACC
Jan Kovac, II, MD, FACC
Jason Ciril Kovacic, MBBS, PhD, FACC
Sandor J. Kovacs, Jr., MD, PhD, FACC
Christopher M. Kramer, MD, FACC
Richard A. Krasuski, MD, FACC
Jacqueline Kreutzer, MD, FACC
Eric V. Krieger, MD
Harlan M. Krumholz, MD, SM, FACC
Aaron D. Kugelmass, MD, FACC
Sudhir S. Kushwaha, MD, FACC
Fred M. Kusumoto, MD, FACC
Michael A. Kutcher, MD, FACC
Jeffrey T. Kuvin, MD, FACC
Raymond Y. K. Kwong, MD, FACC
Nasser M. Lakkis, MD, FACC
Omosalewa O. Lalude, MBBS, FACC
Rachel J. Lampert, MD, FACC
Roberto M. Lang, MD, FACC
Richard A. Lange, MD, FACC
Alexandra J. Lansky, MD, FACC
Gregory M. Lanza, MD, PhD, FACC
Warren K. Laskey, MD, FACC
Steven B. Laster, MD, FACC
Christine E. Lawless, MD, FACC
Martin B. Leon, MD, FACC
Amir Lerman, MD, FACC
John R. Lesser, MD, FACC
Wayne C. Levy, MD, FACC
Gregory D. Lewis, MD
Joao A. C. Lima, MD, FACC
David Lin, MD, FACC
A. Michael Lincoff, MD, FACC
Bruce D. Lindsay, MD, FACC
Mark S. Link, MD, FACC
Christopher F. Liu, MD, FACC
Margaret A. Lloyd, MD
Thomas M. Maddox, MD, MSc, FACC
Akiko Maehara, MD
Francesco Maisano, MD
David J. Malenka, MD, FACC
Calin V. Maniu, MD, FACC
Francis E. Marchlinski, MD, FACC
Frank I. Marcus, MD, FACC
David W. Markham, MD
Larry Markham, MD
David Joel Maron, MD, FACC
Randolph P. Martin, MD, FACC
Alice M. Mascette, MD, FACC
Frederick A. Masoudi, MD, MSPH,
FACC
Barry M. Massie, MD, FACC
Acknowledgments • ACC.12
ACC.12 Final Program 9
Paul J. Mather, MD, FACC
Verghese Mathew, MD, FACC
Mathew S. Maurer, MD
Robert D. McBane, II, MD, FACC
James K. McCord, MD
Doff B. McElhinney, MD
Dana P. McGlothlin, MD
Darren K. McGuire, MD, MHSc, FACC
Vallerie V. McLaughlin, MD, FACC
Dennis M. McNamara, MD, FACC
Robert L. McNamara, MD, MHS, FACC
David D. McPherson, MD, FACC
Jessica L Mega, MD
Julinda Mehilli
Roxana Mehran, MD, FACC
Shamir R. Mehta, MD, FACC
Bernhard Meier, MD, FACC
John C. Messenger, MD, FACC
David C. Metzger, MD, FACC
Alan B. Miller, MD, FACC
Fletcher A. Miller, Jr., MD, FACC
John M. Miller, MD, FACC
Gary S. Mintz, MD, FACC
Gregory J. Mishkel, MD, FACC
Suneet Mittal, MD, FACC
Emile R. Mohler, III, MD, FACC
David J. Moliterno, MD, FACC
Stephanie A. Moore, MD, FACC
David A. Morrow, MD, MPH, FACC
William R. Morrow, MD, FACC
Mauro Moscucci, MD, FACC
Jeffrey W. Moses, MD, FACC
Arthur J. Moss, MD, FACC
Joshua D. Moss, MD, FACC
Luis M. B. Moura, MD, PhD, FACC
Issam D. Moussa, MD, FACC
Debabrata Mukherjee, MD, FACC
David W. M. Muller, MBBS, FACC
Srinivas Murali, MBBS, FACC
Robert J. Myerburg, MD, FACC
Gerald V. Naccarelli, MD, FACC
Sherif F. Nagueh, MD, FACC
Srihari S. Naidu, MD, FACC
Vijay Nambi, MBBS, FACC
Navin C. Nanda, MD, FACC
Shawna D. Nesbitt, MD
David E. Newby, MD, PhD, FACC
Eugenia Nikolsky, MD, PhD, FACC
Steven E. Nissen, MD, MACC
Rick A. Nishimura, MD, FACC
Kevin D. O’Brien, MD
Patrick T. O’Gara, MD, FACC
Masahiko Ochiai, MD, PhD, FACC
Jae K. Oh, MD, FACC
Erik Magnus Ohman, MD, FACC
Jeffrey W. Olin, DO, FACC
Brian Olshansky, MD, FACC
Suzanne Oparil, MD, FACC
Catherine M. Otto, MD, FACC
Ronald J. Oudiz, MD, FACC
Ramdas G. Pai, MBBS, FACC
Tullio Palmerini, MD
Salpy V. Pamboukian, MD, FACC
Julio A. Panza, MD, FACC
Seung-Jung Park, MD, PhD
Myung H. Park, MD, FACC
Alan S. Pearlman, MD, FACC
Patricia A. Pellikka, MD, FACC
Carl J. Pepine, MD, MACC
Eduardo Perna, MD
Eric D. Peterson, MD, MPH, FACC
Harry R. Phillips, MD, FACC
Gregory Piazza, MD, FACC
Philippe Pibarot, DVM, PhD, FACC
Michael H. Picard, MD, FACC
Augusto Pichard, MD, FACC
Ileana L. Pina, MD, FACC
Edward Plow, PhD
Donna M. Polk, MD, MPH, FACC
Michael Poon, MD, FACC
Brian D. Powell, MD, FACC
Abhiram Prasad, MD, FRCP, FACC
Matthew J. Price, MD, FACC
Miguel A. Quinones, MD, FACC
Gilbert Raff, MD, FACC
Paolo Raggi, MD, FACC
Michael Ragosta, MD, FACC
Shahbudin H. Rahimtoola, MD, MACC
Navin Rajagopalan, MD, FACC
Sanjay Rajagopalan, MD, FACC
Nalini Marie Rajamannan, MD, FACC
C. Venkata S. Ram, MBBS, FACC
Ravi N. Ramani, MD
Jesus Eduardo Rame, MD
Sunil V. Rao, MD, FACC
Saif S. Rathore, MPH
Rita F. Redberg, MD, MSc, FACC
Bernhard Reimers
John F. Rhodes, Jr., MD, FACC
Vera H. Rigolin, MD, FACC
Michael P. Riley, MD, PhD
Michael J. Rinaldi, MD, FACC
Melissa R. Robinson, MD
Matthew T. Roe, MD, FACC
Joseph G. Rogers, MD, FACC
Anand Rohatgi, MD, FACC
Ivan Rokos, MD, FACC
Kerry L. Rosen, MD, FACC
Raphael Rosenhek, MD
Robert S. Rosenson, MD, FACC
Carlos E. Ruiz, MD, PhD, FACC
John S. Rumsfeld, MD, PhD, FACC
Jeremy N. Ruskin, MD, FACC
Stuart D. Russell, MD, FACC
Arwa Saidi, MB, BCh, FACC
Ernesto E. Salcedo, MD, FACC
Margaret M. Samyn, MD, FACC
Raul D. Santos, MD, DPhil
Lowell F. Satler, MD, FACC
William H. Sauer, MD, FACC
Sherry J. Saxonhouse, MD, FACC
Prof. Bruno Scheller
Nelson B. Schiller, MD, FACC
ACC.12 • Acknowledgments
10 GO for ACC.12!
Paul Schoenhagen, MD
Joachim Schofer
Benjamin M. Scirica, MD, MPH, FACC
Robert L. Scott, MD, PhD, FACC
Victor Serebruany, MD, PhD
Bindi K. Shah, MD, FACC
Pravin M. Shah, MD, MACC
Prediman K. Shah, MD, FACC
Esther Shao, MD, PhD
Samin K. Sharma, MBBS, FACC
Leslee J. Shaw, PhD, FACC
Mobeen Sheikh, MD, FACC
Richard J. Sheppard, MD, CM
Jerold S. Shinbane, MD, FACC
Mehdi H. Shishehbor, DO, MPH
Robert J. Siegel, MD, FACC
Horst Sievert, MD, FACC
Marc A. Silver, MD, FACC
Candice K. Silversides, MD
Daniel I. Simon, MD, FACC
Michael Hugh Sketch, Jr., MD, FACC
James N. Slater, MD, FACC
Christopher S. Snyder, MD
Scott D. Solomon, MD, FACC
Prem Soman, MBBS, FACC
Paul Sorajja, MD, FACC
David E. Sosnovik, MB, BCh, FACC
Laurence S. Sperling, MD, FACC
John A. Spertus, MD, MPH, FACC
Komandoor S. Srivathsan, MBBS, FACC
Bruce Sheldon Stambler, MD, FACC
Randall C. Starling, MD, MPH, FACC
Philippe Gabriel Steg, MD, FACC
James H. Stein, MD, FACC
Paul D. Stein, MD, FACC
Daniel Howard Steinberg, MD, FACC
Steven R. Steinhubl, MD, FACC
William J. Stewart, MD, FACC
Gregg W. Stone, MD, FACC
Neil J. Stone, MD, FACC
George A. Stouffer, MD, FACC
Karen K. Stout, MD, FACC
Takahiko Suzuki
Corrado Tamburino
Allen J. Taylor, MD, FACC
James E. Tcheng, MD, FACC
John R. Teerlink, MD, FACC
Jeffrey J. Teuteberg, MD
Paul D. Thompson, MD, FACC
Henry H. Ting, MD, FACC
Peter P. Toth, MD, PhD, FACC
Mark I. Travin, MD, FACC
Jennifer Tremmel, MD, FACC
Jeffrey C. Trost, MD, FACC
Robin J. Trupp, MSN, RN, ACNP
Etsuo Tsuchikane
Alexander G. Turpie, FACC
E. Murat Tuzcu, MD, FACC
Patricia A. Uber, PharmD
James E. Udelson, MD, FACC
Philip M. Urban, MD, FACC
Viola Vaccarino, MD, PhD
Alex S. Vahanian, MD
Anne Marie Valente, MD, FACC
Paul D. Varosy, MD, FACC
Hector O. Ventura, MD, FACC
Ralph J. Verdino, MD, FACC
Anil Verma, MD
Mladen I. Vidovich, MD, FACC
Todd C. Villines, MD, FACC
Salim S. Virani, MD
Renu Virmani, MD, FACC
Joseph A. Vita, MD, FACC
Pieter-Jan J. Vlaar
Szilard Voros, FACC
Ron Waksman, MD, FACC
Lars Wallentin, MD
Paul J. Wang, MD, FACC
Tracy Wang, MD, FACC
R. Parker Ward, MD, FACC
Michael A. Weber, MD, FACC
Mark W. I. Webster, MD
Bonnie H. Weiner, MD, FACC
Andrew R. Weintraub, MD, FACC
William S. Weintraub, MD, FACC
Raul Weiss, MD, FACC
Robert Matthew Weiss, MD
Neil J. Weissman, MD, FACC
Giora Weisz, MD
Francine K. Welty, MD, PhD, FACC
J. Marcus Wharton, MD
Grayson Wheatley, III, MD
Harvey D. White, DSc, FACC
Christopher J. White, MD, FACC
Harvey D. White, DSc, FACC
Susan E. Wiegers, MD, FACC
David J. Wilber, MD, FACC
Kim Allan Williams, Sr., MD, FACC
Peter Wilmshurst
Stephan Windecker, MD
Suzanne J. Wingate, PhD, CRNP
Michael D. Winniford, MD, FACC
Bernhard Witzenbichler, MD
Stephen D. Wiviott, MD, FACC
Wojciech Wojakowski
Shing-Chiu Wong, MD, FACC
Malissa Jane Wood, MD, FACC
Scott A. Wright, MD, FACC
Nina Wunderlich
Janet Fredal Wyman, MSN, NP,
ACNS-BC, AACC
Masahisa Yamane, MD, FACC
Phillip C. Yang, MD, FACC
Xiaoming Yang, MD, PhD
Robert W. Yeh, MD, FACC
Doron Zahger, MD
Alan Zajarias, MD, MSc, FACC
David Xiao-Ming Zhao, MD, FACC
Khaled M. Ziada, MD, FACC
Michael R. Zile, MD, FACC
Gilbert J. Zoghbi, MD, FACC
William A. Zoghbi, MD, FACC
ACC-i2 with TCT Affiliate Recognition:
VIVA 12: Vascular InterVentional
Advances
Acknowledgments • ACC.12
ACC.12 Final Program 11
Please join us in acknowledging the work of your peers. The following Fellows in Training have been selected as part of an elite group of FIT “rising stars,” based upon their top scoring abstract or case submission for ACC.12.
Ahmad Jeroudi
Ali Alizadehsovari
Amit Amin
Amit Noheria
Andrew Choi
Anita Radhakrishnan
Benjamin Galper
Brian Davidson
Christopher Statile
Dan Sorajja
Danny Eapen
Dawn Scantlebury
Dharam Kumbhani
Dongngan Truong
Eric Rome
Evan Brittain
Farbod Raiszadeh
Haseeb Jafri
Jeffrey Testani
JoEllyn Abraham
John Dodson
John Lee
Jose Vargas
Karim Sallam
Khurram Nasir
Kumar Dharmarajan
Kyle Ulveling
Louai Razzouk
Manoj Kesarwani
Marnie Taylor
Matthew Solomon
Max Liebo
Megan Coylewright
Meredith Brisco
Michael Blaha
Michael Burke
Morteza Farasat
Mosi Bennett
Murali Senapathi
Nada Shaban
Neha Yadav
Nitesh Sood
Nitin Mahajan
Omar Khalique
Paaladinesh Thavendiranathan
Philip Green
Poulina Uddin
Quinn Pack
Raymond Chan
Raymond Chan
Robert Mentz
Robert Tunks
Sameer Jamal
Samir Thadani
Sandeep Goyal
Seshu Rao
Sharath Subramanian
Shikhar Agarwal
Siddharth Wayangankar
Sreedevi Gondi
Stacey Clegg
Tarek Mousa
Tomas Neilan
Yasmin Hamirani
Zubin Eapen
ACC.12
Elite FIT Rising Star Acknowledgments
*Grantors as of February 27, 2012 ©2012 American College of Cardiology. A12269
ACC.12 GRANTOR ACKNOWLEDGMENTS*
ACUTE CORONARY SYNDROMES PATHWAY
ARRHYTHMIAS PATHWAY
DIAGNOSTIC TESTING AND IMAGING PATHWAY
HEART FAILURE PATHWAY
PREVENTION/GENERAL CARDIOLOGY PATHWAY
PULMONARY HYPERTENSION PATHWAY
VALVULAR PATHWAY
*Grantors as of February 27, 2012©2012 American College of Cardiology. A12270
ACC-i2 with TCT GRANTOR ACKNOWLEDGMENTS*
CHAMPIONING CARE FOR THE PATIENT WITH AORTIC STENOSIS
FIRST LINE OF DEFENSE: RISK FACTORS AND PREVENTION IN THE CARDIOLOGY PRACTICE
INNOVATIONS IN TRANSLATION: ACS
INNOVATIONS IN TRANSLATION: ATRIAL FIBRILLATIONJOINT SESSION OF THE HEART RHYTHM SOCIETY AND ACC
MULTIDISCIPLINARY APPROACH TO THE HIGH RISK AORTIC STENOSIS PATIENTJOINT SESSION OF AATS, STS AND ACC
*Grantors as of February 27, 2012 ©2012 American College of Cardiology. A12271
ACC.12 CLINICAL FOCUS SESSIONS GRANTOR ACKNOWLEDGMENTS*
*Grantors as of February 27, 2012©2012 American College of Cardiology. A12294
ACC.12 SESSION GRANTOR ACKNOWLEDMENTS*
THE ROLE OF THERAPEUTIC HYPOTHERMIA IN THE TREATMENT OF CARDIAC ARREST
SESSION #263 - SUNDAY, MARCH 25, 4:30 P.M. – 6:00 P.M.
SUPPORTED BY EDUCATIONAL GRANTS FROM:
ANTITHROMBOTIC THERAPIES FOR ATRIAL FIBRILLATION: THE CURRENT STATE OF THE ART
SESSION #747 - TUESDAY, MARCH 27, 8:00 A.M. – 9:30 A.M.
IN PARTNERSHIP WITH THE TEAM-A INITIATIVE
SUPPORTED BY AN EDUCATIONAL GRANT FROM:
BRISTOL-MYERS SQUIBB AND PFIZER, INC.
16 GO for ACC.12!
The American College of Cardiology Foundation proudly recognizes our 2011 donors whose generosity demonstrates the spirit of giving that enables the College to foster optimal cardiovascular care.
The following donors are recognized for their gifts to ACCF initiatives between January 1, 2011 and December 31, 2011.
Margarita Abbey, NPArnold Abrams, MDArnold Adicoff, MD, FACCAshok Agarwal, MD, FACCAnwar Ahmad, MBBS, FACCWalter Allison III, MDJoseph Alpert, MD, FACC &
Helle Mathiasen, PhDArthur Anderson, MD, FACCPaul Anderson, MD, FACCLewis Anthony, MD, FACCEmanuel Arbel, MD, FACCSurya Artham, MD, MPHJames Asaph, MD, FACCManisha Ashar, MD, FACCJohn Auseon, DO, FACCCatherine Avgeropoulou, MDDarla Bakersmith-Hess, MD, FACCAjay Bali, MBBS, FACCScott Baron, MD, FACCHabib Bassil, MD, FACCAsish Basu, MBBS, FACCJennifer Ray Beckman & Jon BeckmanJohn Beeble, MDLinda Bell & Douglas BellGeorge Beller, MD, MACC &
Emily CouricPachalla Bhat, MD, FACCKathleen Blake, MD, FACCBoris Bogomilov, MD, FACCMarc Bois, MD, FACCMichael Boland, MD, FACCJohn Bowers, MD, FACCAhmet Bozer, MD, FACCJoseph Branconi, MD, FACC
Alan Brenner, MD, FACCCraig BrennerDrs. Ralph and Claire BrindisAllison Brooks, NP, AACCCarman Brooks, MD, FACCNathan Brown, MD, FACCChristine Browning, MDPeter Bruno, MD, FACCJohn Brush, Jr., MD, FACCHoward Buckley, MD, FACCMarcia Buckley Bull, MD, FACCCalvert Busch, MD, FACCHomobono Calleja, MD, FACC &
Cecilia Calleja TaufiqueJames Calvin, MD, FACCJoanne Ceimo, MD, FACCBernard R. Chaitman, MD, FACCSandra Chase, PharmDLeonid Chernov, MD, FACCDevyani Chowdhury, MBBS, FACCLalji Chudasama, MD, FACCCarolyn ClarkLianna CollingePeter Correnti, Jr., DOThelma Cote’ PeperDaniel Courtade, MD, FACCWilliam Crafford, Jr., MD, FACCL. Bruce Cronk, MD, FACCDeborah Croy, NP, AACCIra Dauber, MD, FACCG. William Dec, Jr., MD, FACCAnand Deshmukh, MDRobert Deutscher, MD, FACCMichael DeVita, DO, FACCQuinton Dickerson, Jr., MD, FACC
Vincent Donlon, MHAW. Daniel Doty, MD, FACCPamela Douglas, MD, MACC &
Geoffrey Ginsburg, MD, PhD, FACCAndrew Drakonakis, MD, FACCDenis Drew, MD, FACCJoseph Drozda, Jr., MD, FACCEric Drummer, MD, FACCAngelos Economou, MD, FACCHaskell Ellison, MD, FACCGeorg Emlein, MD, FACCRaimund Erbel, MD, FACCJohn Erwin III, MD, FACCSteven Ettinger, MD, FACCKameel Farag, MD, FACCJames Fasules, MD, FACCMeredith Filson-Perry, RNJeffrey Fisher, MD, FACCMichael Flynn, MD, FACCKenneth Forman, MDRobert Francis, MD, FACCMilton Frank III, MDWilliam Frankl, MD, FACCRoberto Fred Santana, MD, FACCLeon Friedman, MD, FACCEugene Fu, MD, FACCJuan Fuselli, MDJoseph Gaeta, MD, FACCJulius Gardin, MD, FACC &
Susan GardinRichard Gerber, MD, FACCMichael Gewitz, MD, FACCMichael Girolami, MD, FACCJulian Gladstone, MD, FACCTyler Gluckman, MD, FACC
ACCF Charitable Benefactors
ACC.12 Final Program 17
Harry Goldberg, MD, FACCAlfredo Gonzalez, MD, FACCDavid Gooray, MD, FACCGabriel Gregoratos, MD, FACCJan Griffin, NPBhavdeep Gupta, MD, FACC &
Dolly GuptaEileen Handberg, PhD, ARNP, FACCBruce Handler, MD, FACCSyed Haq, MBBS, FACCMasood Haque, MD, FACCKishore Harjai, MD, FACCLawrence Harris, MD, FACCErhard Helmling, MDThomas Hennebry, MB, BCh, FACCShigeaki Hinohara, MD, FACCTetsuya Hirano, MD, PhD, FACCMurray Hoffman, MD, FACCDavid Holmes, Jr., MD, FACCMun Hong, MD, FACCDeepak Hooda, MDSusan Housholder-Hughes, NP, AACCVictor Howard, MD, FACCLarry Hurwitz, MD, FACCSaleem Husain, MD, FACCJohn Hutcherson, MD, FACCElisabeth Immanuel-Alexis, MBBS,
FACCDavid Jackson, MD, FACCLester Jacobson, MD, FACCMansoor Jelveh, MD, FACCThomas Johnson, MD, FACCZoe Jones, MD, FACCEdmundo Jordan-Morey, MD, FACCRobert KalmanAnna Kalynych, MD, FACCMurat Karatepe, MD, FACCSomeswarareddy Karri, MBBS, FACCJohn Kassotis, MD, FACCMaximiliaan Kaulbach, MD, FACCJulian Keil, PhD, FACCDennis Kelly, MD, FACCGabriel Khan, MD, FACCStephen Kiefer, MD, FACCWilliam Kimber, MD, FACCMarvin Kirsh, MD, FACCJay Kleiman, MD, FACC
Colette Kohler, MD, FACCRichard Kovacs, MD, FACC &
Roxanne KovacsFred Krainin, MD, FACCGerald Lackey, DO, PhD, FACCLawrence Laslett, MD, FACCFrancis Lau, MD, FACCRonald Lech, MD, PhD, FACCSidney Levitsky, MD, FACCRichard Lewis, MD, FACCShoa-Lin Lin, MD, FACCWilliam Lista, MD, FACCSteven Lloyd, MD, FACCJose Eugenio Lopez, MD, FACCLawrence Lubow, MD, FACCWalter Lucia, MDEugene Magnier, MD, PhD, FACCGeorge Maha, MDSabyasachi Mahapatra, MBBS, FACCTariq Malik, MBBS, FACCAmalendu Mandal, MD, FACCAndre Marquand, MD, FACCRaymond Massay, MBBS, DM, FACCAllan Mattern, MD, FACCManuel Mayor, MD, FACCGloria Mays, MD, FACCJohn McBride, MD, FACCJames McClurken, MD, FACCHerbert McDonald, MD, FACCMartin McGough, MD, FACCCharles McKay, MD, FACC &
Maleah Groover-McKayDaniel McMartin, MD, FACCJoseph Messer, MD, MACC &
Nancy L. KochDavid Messinger, MD, FACCKeith Miller, MD, PhD, FACCRonald Miller, MD, FACCMargo Minissian, ACNP-BC, MSN, CNSStephanie MitchellVijay Mittal, MD, FACCChitta Mohapatra, MD, FACCChristos Moschos, MD, FACCAshish MukherjeeNarayan Mulamalla, MD, FACCPramod Multani, MBBS, FACCStans Murad-Netto, MD, FACC
Maheswari Murugesan, NPMunir Nassar, MDRudolph Nisi, MD, FACCSteven Nissen, MD, MACCMichael Nocero, Jr., MD, MACCJacqueline Noonan, MD, FACCLester Nunnally, MD, FACCJohn Nwogu, MBBS, FACCPatrick O’Gara, MD, FACCPeter Odhiambo, MD, FACCWilliam Oetgen, MD, MBA, FACCLarry Osborn, MD, FACCYukio Ozawa, MD, FACCJohn Packard, MD, FACCVachaspathi Palakodeti, MBBS, FACCMadhava Pally, MBBS, FACCBipin Patadia, MBBS, FACCMrugesh B. PatelTimir Paul, MDPaul Piccini, MD, FACCDonna Polk, MD, MPH, FACCRichard Popp, MD, MACC & Janis PoppHerman Price, MD, FACCDavid Propert, MD, FACCWilliam Pryor, MD, FACCSatyavardhan Pulukurthy, MDJerome Radding, MD, FACCMartha Radford, MD, FACCAtul Ramachandran, MD, FACCNathaniel Reichek, MD, FACCJoseph Restivo, MD, FACCJames Reynolds, MD, FACCLarry Riedel, MDGaetan Ringuette, MD, FACCJanet Rippy, MD, FACC &
Fredrick HohltJose Rivera Del Rio, MD, FACCAbel Robertson, Jr., MD, PhD, FACCJerome Robinson, MD, FACCGeorge Rodgers, MD, FACC &
Leslie RodgersJoseph Romeo, MD, FACCFred Rose, MD, FACCJames Ross, MD, FACCDennis Rowe, MD, FACCJohn Rumsfeld, MD, PhD, FACCElayne Russek
ACCF Charitable Benefactors
18 GO for ACC.12!
Shelley Russek, PhD & David FarbSharon S. SadeghiniaJonathan Safren, MD, FACCBal Sahay, MBBS, FACCRosemarie Salerni, MD, FACCGeorge Sanders, MD, FACCJack Sanders, MD, FACCJoseph Saporito, MD, FACCBarry Saul II, MD, FACCWade Saunders III, MD, FACCJohn Schaeffer, MD, FACCGerold Schiebler, MD, FACCCarsten Schmalfuss, MD, FACCMark Schoenfeld, MD, FACCDouglas Schreck, MD, FACCJackie See, MD, FACCMarvin Segal, MD, FACCSamir Shah, MD, FACCJami Shakibi, MD, FACCAbdolhamid Sheikhzadeh, MD, FACCTianChu Shih, DO, FACCLeonard Silverman, MD, FACCSidney Smith, Jr., MD, FACC &
Lucy SmithSamuel Sobol, MD, FACCJames Spann, Jr., MD, FACCKurt Spriggs, DO, FACCJasbir Sra, MD, FACCBhaskaran Sreekumar, MD, FACCLawrence Staples, MD, FACC &
Marilyn StaplesEric Stern, MD, FACCW. Theodore Steudel, MD, FACCJames Stone, MD, PhD, FACCSiegfried Storz, MD, FACCRuth Strang, MD, FACCSamuel Suede, MD, FACCW. David Sullivan, MD, FACCMaria Arlene Sumido, RNJames Swan, MD, FACCAlexander Sytman, MD, FACCBurton Tabakin, MD, FACCKan Takayanagi, MD, PhD, FACCLinda Tavares, MS, RN, ACNP-BC,
AACCRichard Taylor
Madhusudan Thakur, MBBS, FACCGerasim Tikoff, MD, FACCPeter Tilkemeier, MD, FACCAlain Tocatjian, MD, FACCDorothy Tripodi, RNDeborah Tsunoda, NPE. Tuzcu, MD, FACCDavid Unterman, MD, FACCMucio Valenca, MD, FACCRomeo Vecht, MB, ChB, FACCRenu Virmani, MD, FACCRobert Vranian, MD, FACCEdwin Vyhmeister, MD, FACCStanley Wagner, MD, FACCStephen Wallenhaupt, MDHoward Walpole, Jr., MD, FACCJohn Wanamaker, MD, FACCHoward Warner, MD, FACCJames Warnock, Jr., MD, FACCIchiro Watanabe, MD, FACCSuzanne Waters, NPW. Douglas Weaver, MD, MACCJan Weber, MD, FACCHarry Weinrauch, MD, FACCMyron Weisfeldt, MD, FACC &
Linda WeisfeldtHarlan Weisman, MD, FACCArmisted L. WellfordEdward WestmarkDavid Wilber, MD, FACCJohn Williams, Jr., MD, MACC &
Jan WilliamsPatrick Williams, MD, FACCJohn Wilson, MDMichael Wolk, MD, MACCMaylene Wong, MD, FACCHarry Woske, MD, FACCMilford Wyman, MD, FACCVidya Yalamanchi, MBBS, FACCNoriaki Yamamoto, MDTakashi Yanaga, MD, FACCJames Yates, MD, FACCAlbert Zager, MD, FACC &
Marilouise ZagerIzhar Zahavi, MD, FACCAlex Zakharia, MD, FACC
Syamasundera Zampani, MD, FACCBujung Zen, MD, FACCDouglas Zipes, MD, MACC &
Joan ZipesNazih Zuhdi, MD, FACCAlan Zunamon, MD, FACCAssociation of Black Cardiologists, Inc.Baptist Memorial Medical GroupBlount Memorial Physician Group, Inc.California Cardiovascular Specialists Inc.California Pacific Medical CenterCardiology Consultants of NY, PCCardiology Services PSCCardiovascular Associates of
North Jersey, PCCardiovascular Care AssociatesCentral Coast Cardiology
A Medical CorporationDeTar Healthcare SystemDr. Jordan Cardiology Center, PSCEast Tennessee State UniversityEast Texas Cardiology, P.A.Easton Cardiovascular Associates, P.C.Fidelity Charitable Gift FundHeart Care Associates, P.S.C.Heart Center of Charlotte, PAHeartcare Associates of Bucks County, P.C.Imperial Valley Family Care Medical
Group A.P.C.Jefferson Medical AssociatesKitsap Cardiology Consultants, PLLCLearner’s Digest InternationalMidsouth Cardiovascular Center, PLLCMK & A CorporationNevada Heart & Vascular, LLPOcala Heart Clinic II LLCOcean Cardiovascular, LLCPartners HealthCarePittsburgh North CardiovascularSee Family Trust of MissouriSemma Medical PLLCSherman Heart Group, LLCThe Michael Wolk Heart Foundation, Inc.The Russek Foundation Inc.Virginia Cardiovascular Consultants PCWestern Slope Cardiology, P.C.
ACCF Charitable Benefactors
ACC.12 Final Program 19
Donor Honoree
Surya Artham, MD, MPH In honor of Carl J. Lavie, MD, FACC Allison Brooks, NP, AACC In honor of John Dent, MD, FACC Christine Browning, MD In honor of Anthony J. Minisi, MD, FACC Deborah Croy, NP, AACC In honor of John Dent, MD, FACC Pamela Douglas, MD, MACC In honor of Richard L. Popp, MD, MACC John Erwin III, MD, FACC In honor of Rick A. Nishimura, MD, FACC
Cardiovascular Leadership InstituteThe following donors have honored a mentor or leader who has helped paved the way for the next generation of cardiovascular professionals. Donations were made to the ACCF’s Cardiovascular Leadership Institute.
The following donors are recognized for their gifts to the ACCF’s Eugene Braunwald Clinical Investigator Award.
Hafil Abdulgani, MD, FACCJoseph Alpert, MD, FACCWilliam H. BarryGeorge Beller, MD, MACCRoger Blumenthal, MD, FACCChristoph Bode, MD, PhD, FACCAlfred Bove, MD, PhD, MACCLawrence Boxt, MD, FACCCraig BrennerRalph Brindis, MD, MPH, FACCMarcia Buckley Bull, MD, FACCHugh Calkins, MD, FACCJoanne Ceimo, MD, FACCBernard R. Chaitman, MD, FACCCraig Clark, MD, DO, FACCGary Francis, MD, FACCJulius Gardin, MD, FACCJoan Gnadt, MD, FACCLester Jacobson, MD, FACC
Robert Jones, MD, MACCFred Krainin, MD, FACCPeter Libby, MD, FACCSabyasachi Mahapatra, MBBS, FACCPeter McCullough, MD, MPH, FACC, FACP, FAHA, FCCPChitta Mohapatra, MD, FACCJacqueline Noonan, MD, FACCMartha Radford, MD, FACCTsuguya Sakamoto, MD, FACCJasvinder Sidhu, MD, FACCRenu Virmani, MD, FACCMyron Weisfeldt, MD, FACCHarlan Weisman, MD, FACCJohn Williams, Jr, MD, MACCJames Young, MD, FACCDouglas Zipes, MD, MACCLearner’s Digest InternationalPartners HealthCareAnonymous Donor
Eugene Braunwald Clinical Investigator Award Endowment
20 GO for ACC.12!
Steven Ettinger, MD, FACC In honor of Charles E. Chambers, MD, FACC Kameel Farag, MD, FACC Eugene Fu, MD, FACC In honor of Kennenth A. Ellenbogen, MD, FACC Jan Griffin, NP In honor of John Dent, MD, FACC Bhavdeep Gupta, MD, FACC In honor of Michael P. Savage, MD, FACC Kishore Harjai, MD, FACC In honor of Cynthia L. Grines, MD, FACC Kishore Harjai, MD, FACC In honor of Gregg W. Stone, MD, FACC Mun Hong, MD, FACC In honor of Kenneth M. Kent, MD, PhD, FACC Mun Hong, MD, FACC In honor of Martin B. Leon, MD, FACC Lester Jacobson, MD, FACC Robert Kalman In honor of Monte Malach, MD, FACC James McClurken, MD, FACC In honor of Anthony J. Atala, MD James McClurken, MD, FACC In honor of Randolph Chitwood, Jr., MD, FACC James McClurken, MD, FACC In honor of Daniel E. Forman, MD, FACC James McClurken, MD, FACC In honor of John G. Harold, MD, MACC James McClurken, MD, FACC In honor of Robert H. Jones, MD, MACC James McClurken, MD, FACC In honor of Aaron D. Kugelmass, MD, FACC James McClurken, MD, FACC In honor of Scott Millikan, MD, FACC James McClurken, MD, FACC In honor of Marc E. Shelton, MD, FACC Margo Minissian, ACNP-BC, MSN, CNS In memory of James T. Dove, MD, MACC Vijay Mittal, MD, FACC In honor of Ajay Acharya, MD, FACC Maheswari Murugesan, NP In honor of John Dent, MD, FACC Michael Nocero, Jr., MD, MACC In honor of Leonard S. Dreifus, MD, MACC Timir Paul, MD In honor of Paul W. McMullan, Jr., MD, FACC Donna Polk, MD, MPH, FACC In honor of C. Noel Bairey Merz David Propert, MD, FACC Nathaniel Reichek, MD, FACC In honor of Joseph K. Perloff, MD, FACC Janet Rippy Hohlt, MD, FACC TianChu Shih, DO, FACC In honor of Felix J. Rogers, DO, FACC Linda Tavares, MS, RN, ACNP-BC, AACC In honor of John Dent, MD, FACC Richard Taylor In honor of Paula J. Schrank Peter Tilkemeier, MD, FACC In honor of Alfred F. Parisi, MD, FACC Howard Walpole, Jr., MD, FACC In honor of Douglas C. Morris, MD, FACC Suzanne Waters, NP In honor of John Dent, MD, FACC John Wilson, MD In honor of Alan H. Gradman John Wilson, MD In honor of Jerome E. Granato John Wilson, MD In honor of Indu G. Poornima John Wilson, MD In honor of Venkatraman Srinivasan Alex Zakharia, MD, FACC Alan Zunamon, MD, FACC In honor of Hadi Dizadji, MD, FACC Ocala Heart Clinic II LLC In honor of Ajay Acharya, MD, FACC Pittsburgh North Cardiovascular In honor of Ram L. Dhawan, MD, FACC
If you would like to participate in any of the American College of Cardiology Foundation’s giving programs, please email [email protected].
Donor Honoree
Cardiovascular Leadership Institute
Get Your DailY Dose of Quality at aCC.12
©2012 American College of Cardiology. E1204
Learn more about ACC’s quality improvement programs and how you
can get involved during ACC.12
aCC Central (Booth #10027)
ExpEriEncE
Special attendee pricing expires March 27, 2012. *Savings vary with registration category
A12
199
©20
12 A
mer
ican
Col
lege
of C
ardi
olog
y
Order iScience today at the following locations:
• SouthBuilding,GrandConcourseLobby,Level3
• ACCCentral,Booth#10027,intheExhibitHall
Ororderonlineatwww.CMEonCall.com/accEnteryourbadgenumbertoreceivethe
attendeediscount.
Order iScience, the Acc.12 Meeting on Demand, during the meeting, and save over $1,000*!
iScienceisacomprehensivedigitallibraryofpresentationsfromACC.12andincludesover400hoursofeducationalcontent.ItisthemostconvenientwaytoexperiencealltheeducationfromACC.12andallowsyoutowatchpresenters’slideswhilelisteningtofully-synchronizedaudioasifyouwereactuallyattendingeachsession. Features of iScience include:
• Onlineaccesstocontentwithin24hours
• ConvenientUSBdrivewithaccesstotheentireiSciencelibraryforofflineviewing
• StreamingcontentforviewingoniPad®andiPhone®devices.
• DownloadablePDF’sofpresenterslidesforconvenientreferenceandnotetaking
• DownloadableMP3filesforconvenienton-the-goaudio
• Plus,youcanearnadditionalCMEcreditwithiScience
Stay up-to-date with NEW official magazines of the American College of Cardiology — CardioSource WorldNews and CardioSource InterventionalNews! These complimentary, monthly magazines are edgy, provocative and deliver point and counter point perspectives on the latest in cardiovascular research, medicine and technology. Learn the latest advances with:
• Perspectivesfromthoughtleaders
• Debatesonthekeycontroversiesinmedicine
• Practicalinsightsintocomplexclinicaldata—implicationsforyourpractice
Visit www.cswnews.org and www.csinewslive.org to access the electronic versions today.
Stop by ACC CentrAl, booth #10027 to leArn more! ©
2012
American
College
ofC
ardiolog
y.G1
212
Chris’s CornerWelcome to CardioSource World NewsPAGE 2
Jack In The BackCreating the futurePAGE 48
Number CheckInteresting stats and tidbits to ponderPAGE 36
Patient FocusHow you can help your patients with obesity
PAGE 42
IN THIS ISSUE:
CLINICAL NEWS
JANUARY 2012VOLUME 1 | ISSUE 1
www.cswnews.org
PREMIER ISSUEYour Source for News and Views from the World of Cardiology
CardioSource WorldNews
THE
ISFUTURENOWHow new anticoagulants will impact stroke prevention in AF — PAGE 20
Gregg C. Fonarow, MD on Home Monitoring—page 13 Suzanne Oparil, MD
on JNC 8—page 31Steven E. Nissen, MD on Politics vs. Science—page 46
46%Reduction in Incidence of MI
50% Reduction in Sudden Cardiac Deaths
Cardiology Countdown 3JACC in a Flash 8Journal Scan 9ACCEL Summaries 10Hot Topic 13Special Meeting Coverage 14
George’s Take
Life after COURAGE
PAGE 2
Jack In The Back
Problems with
PCI reimbursement
PAGE 48
Number Check
New data points from
NCDR databases
PAGE 36
Novel Techniques:
Grasping transradial
access
PAGE 42
IN THIS ISSUE:
CLINICAL NEWS
MARCH 2012 VOLUME 1 | ISSUE 1
www.cswnews.org
PREMIER ISSUE
Your Source for News and Views from the World of Cardiology
CardioSource InterventionalNews
Stents
in the Elderly—page 18
What ACOs Mean
for Intervention—page 23
The Issue of
Clopidogrel Resistance —page 36
JACC in a Flash 8
Journal Scan 9
Cardiology Countdown 12
ACCEL Intervention 14
Hot Topic 15
The New Frontier:
Will Change Everything
How the Development of TAVI
Save 15% off select educational products and courses purchased on site!
Visit ACC Central, Booth #10027!
©2012 American College of Cardiology. J1204
Make MULTAQ® your fi rst-choice AAD
Keeps patients in sinus rhythm longer and reduces symptomatic AFib recurrence 1
of fi rst AFib recurrence (symptomatic or asymptomatic)1
– Absolute difference in recurrence rate of about 11% at 1 year (P<0.001; primary endpoint)
– Majority of fi rst recurrences were symptomatic
of patients treated with MULTAQ were free of symptomatic AFib recurrence vs 54% of patients on placebo at 1 year (P<0.001; secondary endpoint)1
Decreases risk of patients being hospitalized for AFib events 2
in CV hospitalization or mortality, the combined primary endpoint (P<0.0001, entirely attributable to reduced CV hospitalizations, principally hospitalizations related to AFib)2
RRR25%
RRR*24%
62.3%
In tune with your patients’ needs
Visit MULTAQ.com/hcp for more information.
Indication
MULTAQ is an antiarrhythmic drug indicated to reduce the risk of hospitalization for atrial fi brillation (AFib) in patients in sinus rhythm with a history of paroxysmal or persistent AFib.
Important Update: Boxed WARNING, contraindications, and warnings have been revised due to label change.
Important Safety Information for MULTAQ–Boxed WARNING
WARNING: INCREASED RISK OF DEATH, STROKE AND HEART FAILURE IN PATIENTS WITH DECOMPENSATED HEART FAILURE OR PERMANENT ATRIAL FIBRILLATION
MULTAQ is contraindicated in patients with symptomatic heart failure with recent decompensation requiring hospitalization or NYHA Class IV heart failure. MULTAQ doubles the risk of death in these patients.
MULTAQ is contraindicated in patients in atrial fi brillation (AFib) who will not or cannot be cardioverted into normal sinus rhythm. In patients with permanent AFib, MULTAQ doubles the risk of death, stroke, and hospitalization for heart failure.
Please see additional Important Safety Information and brief summary of full Prescribing Information, including boxed WARNING, on following pages.
400-mg tablet bid,with morning and evening mealsThe absolute bioavailability of MULTAQ increases when administered with a full meal
• NO hospital initiation required 2
• NO loading dose 2
• NO titration 2
* Relative risk reduction (RRR) observed over the study period (median 22-month treatment and follow-up; minimum 12 months, maximum 30 months).2,3
Tune in at Booth #14000
General Information
Important Safety Information for MULTAQ®
WARNING:INCREASED RISK OF DEATH, STROKE AND HEART FAILURE IN PATIENTS WITH DECOMPENSATED HEART FAILURE OR PERMANENT ATRIAL FIBRILLATION
MULTAQ is contraindicated in patients with symptomatic heart failure with recent decompensation requiring hospitalization or NYHA Class IV heart failure. MULTAQ doubles the risk of death in these patients.
MULTAQ is contraindicated in patients in atrial fi brillation (AFib) who will not or cannot be cardioverted into normal sinus rhythm. In patients with permanent AFib, MULTAQ doubles the risk of death, stroke, and hospitalization for heart failure.
MULTAQ is also contraindicated in patients:
• With second- or third-degree atrioventricular (AV) block or sick sinus syndrome (except when used in conjunction with a functioning pacemaker), bradycardia <50 bpm, QTc Bazett interval ≥500 ms or PR interval >280 ms
• Who are or may become pregnant (Category X) or nursing. MULTAQ may cause fetal harm when administered to a pregnant woman
• With concomitant use of strong CYP 3A inhibitors, such as ketoconazole, itraconazole, voriconazole, cyclosporine, telithromycin, clarithromycin, nefazodone, ritonavir, or drugs or herbal products that prolong the QT interval and might increase the risk of Torsade de Pointes, such as phenothiazine antipsychotics, tricyclic antidepressants, certain oral macrolide antibiotics, and Class I and III antiarrhythmics
• With liver toxicity related to the previous use of amiodarone• With severe hepatic impairment
Cardiovascular Death in NYHA Class IV or Decompensated Heart FailureMULTAQ is contraindicated in patients with NYHA Class IV heart failure or symptomatic heart failure with recent decompensation requiring hospitalization because it doubles the risk of death.
Cardiovascular Death and Heart Failure in Permanent AFibMULTAQ doubles the risk of cardiovascular death (largely arrhythmic) and heart failure events in patients with permanent AFib. Patients treated with MULTAQ should undergo monitoring of cardiac rhythm no less often than every 3 months. Cardiovert patients who are in AFib (if clinically indicated) or discontinue MULTAQ. MULTAQ offers no benefi t in subjects in permanent AFib.
Increased Risk of Stroke in Permanent AFibIn a placebo-controlled study in patients with permanent atrial fi brillation, dronedarone was associated with an increased risk of stroke, particularly in the fi rst two weeks of therapy. MULTAQ should only be initiated in patients in sinus rhythm who are receiving appropriate antithrombotic therapy.
New Onset or Worsening Heart FailureNew onset or worsening of heart failure has been reported during treatment with MULTAQ in the postmarketing setting. In a placebo-controlled study in patients with permanent AFib, increased rates of heart failure were observed in patients with normal left ventricular function and no history of symptomatic heart failure, as well as those with a history of heart failure or left ventricular dysfunction. Advise patients to consult a physician if they develop signs or symptoms of heart failure, such as weight gain, dependent edema, or increasing shortness of breath. If heart failure develops or worsens and requires hospitalization, discontinue MULTAQ.
Liver InjuryHepatocellular liver injury, including acute liver failure requiring transplant, has been reported in patients treated with MULTAQ in the postmarketing setting. Advise patients treated with MULTAQ to report immediately symptoms suggesting hepatic injury (such as anorexia, nausea, vomiting, fever, malaise, fatigue, right upper quadrant pain, jaundice, dark urine, or itching). Consider obtaining periodic hepatic serum enzymes, especially during the fi rst 6 months of treatment. It is not known whether routine periodic monitoring of serum enzymes will prevent the development of severe liver injury. If hepatic injury is suspected, promptly discontinue MULTAQ and test serum enzymes, aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase, as well as serum bilirubin, to establish whether there is liver injury. If liver injury is found, institute appropriate treatment and investigate the probable cause. Do not restart MULTAQ in patients without another explanation for the observed liver injury.
Hypokalemia and Hypomagnesemia with Potassium-Depleting DiureticsHypokalemia and hypomagnesemia may occur with concomitant administration of potassium-depleting diuretics. Potassium levels should be within the normal range prior to administration of MULTAQ and maintained in the normal range during administration of MULTAQ.
QT Interval ProlongationMULTAQ induces a moderate (average of about 10 ms but much greater effects have been observed) QTc (Bazett) prolongation. If the QTc Bazett interval is ≥500 ms, discontinue MULTAQ.
Increase in CreatinineSmall increases in creatinine levels (about 0.1 mg/dL) following MULTAQ treatment initiation have been shown to be a result of inhibition of creatinine’s tubular secretion. The elevation has a rapid onset, reaches a plateau after 7 days and is reversible after discontinuation. Larger increases in creatinine after MULTAQ initiation have been reported in the postmarketing setting. Some cases also reported increases in blood urea nitrogen. In most cases, these effects appear to be reversible upon drug discontinuation. Monitor renal function periodically.
Women of Childbearing PotentialPremenopausal women who have not undergone a hysterectomy or oophorectomy must use effective contraception while using MULTAQ. Dronedarone caused fetal harm in animal studies at doses equivalent to recommended human doses. Counsel women of childbearing potential regarding appropriate contraceptive choices.
Drug-Drug Interactions• Treatment with Class I or III antiarrhythmics or drugs that are strong inhibitors
of CYP 3A must be stopped before starting MULTAQ (see Contraindications)• Patients should be instructed to avoid grapefruit juice beverages while
taking MULTAQ• Calcium channel blockers with depressant effects and beta-blockers could
increase the bradycardia effects of MULTAQ on conduction• Increased digoxin levels and gastrointestinal disorders have been observed
when MULTAQ was coadministered with digoxin. Digoxin can also potentiate the electrophysiologic effects of MULTAQ (such as decreased AV-node conduction); consider the need for continued digoxin therapy when prescribing MULTAQ. If digoxin treatment is continued, halve the dose of digoxin, monitor serum levels closely, and observe for toxicity
• Postmarketing cases of increased INR with or without bleeding events have been reported in warfarin-treated patients initiated with MULTAQ. Monitor INR after initiating MULTAQ in patients taking warfarin
• Statins: Follow statin label recommendations for use with CYP 3A and P-gP inhibitors such as MULTAQ
Adverse ReactionsIn studies, the most common adverse reactions observed with MULTAQ were diarrhea, nausea, abdominal pain, vomiting, and asthenia.
Please see brief summary of Prescribing Information, including boxed WARNING, on following pages.
References: 1. Singh BN, Connolly SJ, Crijns HJGM, et al; for the EURIDIS and ADONIS Investigators. Dronedarone for maintenance of sinus rhythm in atrial fi brillation or fl utter. N Engl J Med. 2007;357:987-999. 2. MULTAQ® (dronedarone) Prescribing Information. Sanofi -aventis U.S. LLC; 2011, Bridgewater, NJ. 3. Hohnloser SH, Crijns HJGM, van Eickels M, et al; for the ATHENA Investigators. Effect of dronedarone on cardiovascular events in atrial fi brillation. N Engl J Med. 2009;360:668-678.
US.DRO.11.12.032 December 2011 ©2011 sanofi -aventis U.S. LLC, A SANOFI COMPANY
Gene
ral I
nfor
mat
ion
MULTAQ® Rx Only(dronedarone) Tablets
Brief Summary of Prescribing Information
WARNING: INCREASED RISK OF DEATH, STROKE AND HEART FAILURE IN PATIENTSWITH DECOMPENSATED HEART FAILURE OR PERMANENT ATRIAL FIBRILLATION
In patients with symptomatic heart failure and recent decompensation requiringhospitalization or NYHA Class IV heart failure; MULTAQ doubles the risk of death. (14.3in the full prescribing information) MULTAQ is contraindicated in patients withsymptomatic heart failure with recent decompensation requiring hospitalization orNYHA Class IV heart failure. (4, 5.1)
In patients with permanent atrial fibrillation, MULTAQ doubles the risk of death, strokeand hospitalization for heart failure. (14.4 in the full prescribing information). MULTAQis contraindicated in patients in atrial fibrillation (AF) who will not or cannot becardioverted into normal sinus rhythm. (4, 5.2)
1 INDICATIONS AND USAGEMULTAQ® is indicated to reduce the risk of hospitalization for atrial fibrillation in patients in sinusrhythm with a history of paroxysmal or persistent atrial fibrillation (AF) [see Clinical Studies (14)in the full prescribing information].2 DOSAGE AND ADMINISTRATIONThe recommended dosage of MULTAQ is 400 mg twice daily in adults. MULTAQ should be takenas one tablet with the morning meal and one tablet with the evening meal.Treatment with Class I or III antiarrhythmics (e.g., amiodarone, flecainide, propafenone, quinidine,disopyramide, dofetilide, sotalol) or drugs that are strong inhibitors of CYP3A (e.g., ketoconazole)must be stopped before starting MULTAQ [see Contraindications (4)].4 CONTRAINDICATIONSMULTAQ is contraindicated in patients with:
• Permanent atrial fibrillation (patients in whom normal sinus rhythm will not or cannot berestored) [see Boxed Warning and Warnings and Precautions (5.2)]
• Symptomatic heart failure with recent decompensation requiring hospitalization or NYHA ClassIV symptoms [see Boxed Warning and Warnings and Precautions (5.1)]
• Second- or third-degree atrioventricular (AV) block, or sick sinus syndrome (except when usedin conjunction with a functioning pacemaker)
• Bradycardia <50 bpm• Concomitant use of strong CYP 3A inhibitors, such as ketoconazole, itraconazole, voricona-
zole, cyclosporine, telithromycin, clarithromycin, nefazodone, and ritonavir [see Drug Inter-actions (7.2)]
• Concomitant use of drugs or herbal products that prolong the QT interval and might increasethe risk of Torsade de Pointes, such as phenothiazine anti-psychotics, tricyclic antidepres-sants, certain oral macrolide antibiotics, and Class I and III antiarrhythmics
• Liver toxicity related to the previous use of amiodarone• QTc Bazett interval ≥500 ms or PR interval >280 ms• Severe hepatic impairment• Pregnancy (Category X): MULTAQ may cause fetal harm when administered to a pregnant
woman. MULTAQ is contraindicated in women who are or may become pregnant. If this drugis used during pregnancy, or if the patient becomes pregnant while taking this drug, the patientshould be apprised of the potential hazard to a fetus [see Use in Specific Populations (8.1)].
• Nursing mothers [see Use in Specific Populations (8.3)]5 WARNINGS AND PRECAUTIONS5.1 Cardiovascular Death in NYHA Class IV or Decompensated Heart FailureMULTAQ is contraindicated in patients with NYHA Class IV heart failure or symptomatic heartfailure with recent decompensation requiring hospitalization because it doubles the risk of death.5.2 Cardiovascular Death and Heart Failure in Permanent AFMULTAQ doubles the risk of cardiovascular death (largely arrhythmic) and heart failure events inpatients with permanent AF. Patients treated with dronedarone should undergo monitoring ofcardiac rhythm no less often than every 3 months. Cardiovert patients who are in atrial fibrillation(if clinically indicated) or discontinue MULTAQ. MULTAQ offers no benefit in subjects in permanentAF.5.3 Increased Risk of Stroke in Permanent AFIn a placebo-controlled study in patients with permanent atrial fibrillation, dronedarone wasassociated with an increased risk of stroke, particularly in the first two weeks of therapy [seeClinical Studies (14.4) in the full prescribing information]. MULTAQ should only be initiated inpatients in sinus rhythm who are receiving appropriate antithrombotic therapy [see Drug interac-tions (7.3)].5.4 New Onset or Worsening Heart FailureNew onset or worsening of heart failure has been reported during treatment with MULTAQ in thepostmarketing setting. In a placebo controlled study in patients with permanent AF increased ratesof heart failure were observed in patients with normal left ventricular function and no history ofsymptomatic heart failure, as well as those with a history of heart failure or left ventriculardysfunction.Advise patients to consult a physician if they develop signs or symptoms of heart failure, such asweight gain, dependent edema, or increasing shortness of breath. If heart failure develops orworsens and requires hospitalization, discontinue MULTAQ.5.5 Liver InjuryHepatocellular liver injury, including acute liver failure requiring transplant, has been reported inpatients treated with MULTAQ in the post-marketing setting. Advise patients treated with MULTAQto report immediately symptoms suggesting hepatic injury (such as anorexia, nausea, vomiting,fever, malaise, fatigue, right upper quadrant pain, jaundice, dark urine, or itching). Considerobtaining periodic hepatic serum enzymes, especially during the first 6 months of treatment, butit is not known whether routine periodic monitoring of serum enzymes will prevent the developmentof severe liver injury. If hepatic injury is suspected, promptly discontinue MULTAQ and test serumenzymes, aspartate aminotransferase (AST), alanine aminotransferase (ALT) and alkaline phos-phatase, as well as serum bilirubin, to establish whether there is liver injury. If liver injury is found,
institute appropriate treatment and investigate the probable cause. Do not restart MULTAQ inpatients without another explanation for the observed liver injury.5.6 Hypokalemia and Hypomagnesemia with Potassium-Depleting DiureticsHypokalemia or hypomagnesemia may occur with concomitant administration of potassium-depleting diuretics. Potassium levels should be within the normal range prior to administration ofMULTAQ and maintained in the normal range during administration of MULTAQ.5.7 QT Interval ProlongationDronedarone induces a moderate (average of about 10 ms but much greater effects have beenobserved) QTc (Bazett) prolongation [see Clinical Pharmacology (12.2) in the full prescribinginformation and Clinical Studies (14.1) in the full prescribing information]. If the QTc Bazett intervalis ≥500 ms, discontinue MULTAQ [see Contraindications (4)].5.8 Increase in Creatinine after Treatment InitiationSmall increases in creatinine levels (about 0.1 mg/dL) following dronedarone treatment initiationhave been shown to be a result of inhibition of creatinine’s tubular secretion. The elevation hasa rapid onset, reaches a plateau after 7 days and is reversible after discontinuation. Largerincreases in creatinine after dronedarone initiation have been reported in the postmarketing setting.Some cases also reported increases in blood urea nitrogen. In most cases, these effects appearto be reversible upon drug discontinuation. Monitor renal function periodically.5.9 Women of Childbearing PotentialPremenopausal women who have not undergone a hysterectomy or oophorectomy must useeffective contraception while using MULTAQ. Dronedarone caused fetal harm in animal studies atdoses equivalent to recommended human doses. Counsel women of childbearing potentialregarding appropriate contraceptive choices. [see Use in Specific Populations (8.1)].6 ADVERSE REACTIONSThe following safety concerns are described elsewhere in the label:
• New or worsening heart failure [see Warnings and Precautions (5.4)]• Liver Injury [see Warnings and Precautions (5.5)]• Hypokalemia and hypomagnesemia with potassium-depleting diuretics [see Warnings and
Precautions (5.6)]• QT prolongation [see Warnings and Precautions (5.7)]
6.1 Clinical Trials ExperienceThe safety evaluation of dronedarone 400 mg twice daily in patients with AF or AFL is based on5 placebo controlled studies, ATHENA, EURIDIS, ADONIS, ERATO and DAFNE. In these studies,a total of 6285 patients were randomized and treated, 3282 patients with MULTAQ 400 mg twicedaily, and 2875 with placebo. The mean exposure across studies was 12 months. In ATHENA, themaximum follow-up was 30 months.In clinical trials, premature discontinuation because of adverse reactions occurred in 11.8% of thedronedarone-treated patients and in 7.7% of the placebo-treated group. The most common reasonsfor discontinuation of therapy with MULTAQ were gastrointestinal disorders (3.2 % versus 1.8% inthe placebo group) and QT prolongation (1.5% versus 0.5% in the placebo group).The most frequent adverse reactions observed with MULTAQ 400 mg twice daily in the 5 studieswere diarrhea, nausea, abdominal pain, vomiting, and asthenia.Table 1 displays adverse reactions more common with dronedarone 400 mg twice daily than withplacebo in AF or AFL patients, presented by system organ class and by decreasing order offrequency. Adverse laboratory and ECG effects are presented separately in Table 2.
Table 1: Adverse Drug Reactions that Occurred in at Least 1% of Patients and WereMore Frequent than Placebo
Placebo Dronedarone 400mg twice daily
(N=2875) (N=3282)
Gastrointestinal
Diarrhea 6% 9%
Nausea 3% 5%
Abdominal pain 3% 4%
Vomiting 1% 2%
Dyspeptic signs and symptoms 1% 2%
General
Asthenic conditions 5% 7%
Cardiac
Bradycardia 1% 3%
Skin and subcutaneous tissue
Including rashes (generalized, macular,maculo-papular, erythematous), pruritus,eczema, dermatitis, dermatitis allergic
3% 5%
Photosensitivity reaction and dysgeusia have also been reported at an incidence less than 1% inpatients treated with MULTAQ.The following laboratory data/ECG parameters were reported with MULTAQ 400 mg twice daily.
Table 2: Laboratory data/ECG parameters not necessarily reported as adverse events
Placebo MULTAQ400 mg twice daily
(N=2875) (N=3282)
Early increases in creatinine ≥10% 21% 51%
(N=2237) (N=2701)
QTc prolonged 19% 28%
Assessment of demographic factors such as gender or age on the incidence of treatment-emergentadverse events did not suggest an excess of adverse events in any particular sub-group.6.2 Postmarketing ExperienceThe following adverse reactions have been identified during post-approval use of MULTAQ.Because these reactions are reported voluntarily from a population of an unknown size, it is notalways possible to reliably estimate their frequency or establish a causal relationship to drugexposure.Cardiac: New or worsening heart failure [see Warnings and Precautions (5.3)]Hepatic: Liver Injury [see Warnings and Precautions (5.5)]Respiratory: Postmarketing cases of interstitial lung disease including pneumonitis and pulmonaryfibrosis have been reported.7 DRUG INTERACTIONSDronedarone is metabolized primarily by CYP 3A and is a moderate inhibitor of CYP 3A and CYP2D6 [see Clinical Pharmacology (12.3) in the full prescribing information]. Dronedarone’s bloodlevels can therefore be affected by inhibitors and inducers of CYP 3A, and dronedarone caninteract with drugs that are substrates of CYP 3A and CYP 2D6.Dronedarone has no significant potential to inhibit CYP 1A2, CYP 2C9, CYP 2C19, CYP 2C8 andCYP 2B6. It has the potential to inhibit P-glycoprotein (P-gP) transport.Pharmacodynamic interactions can be expected with beta-blockers; calcium antagonists anddigoxin [see Drug Interactions (7.1)].In clinical trials, patients treated with dronedarone received concomitant medications includingbeta-blockers, digoxin, calcium antagonists (including those with heart rate-lowering effects),statins and oral anticoagulants.7.1 Pharmacodynamic InteractionsDrugs prolonging the QT interval (inducing Torsade de Pointes)Co-administration of drugs prolonging the QT interval (such as certain phenothiazines, tricyclicantidepressants, certain macrolide antibiotics, and Class I and III antiarrhythmics) is contraindi-cated because of the potential risk of Torsade de Pointes-type ventricular tachycardia [seeContraindications (4)].DigoxinDigoxin can potentiate the electrophysiologic effects of dronedarone (such as decreased AV-nodeconduction). In clinical trials, increased levels of digoxin were observed when dronedarone wasco-administered with digoxin. Gastrointestinal disorders were also increased.Because of the pharmacokinetic interaction [see Drug Interaction (7.3)] and possible pharmaco-dynamic interaction, consider the need for continued digoxin therapy. If digoxin treatment iscontinued, halve the dose of digoxin, monitor serum levels closely, and observe for toxicity.Calcium channel blockersCalcium channel blockers with depressant effects on the sinus and AV nodes could potentiatedronedarone’s effects on conduction.Give low doses of calcium channel blockers initially and increase only after ECG verification ofgood tolerability [see Drug Interactions (7.3)].Beta-blockersIn clinical trials, bradycardia was more frequently observed when dronedarone was given incombination with beta-blockers.Give low dose of beta-blockers initially, and increase only after ECG verification of good tolerability[see Drug Interactions (7.3)].7.2 Effects of Other Drugs on DronedaroneKetoconazole and other potent CYP 3A inhibitorsRepeated doses of ketoconazole, a strong CYP 3A inhibitor, resulted in a 17-fold increase indronedarone exposure and a 9-fold increase in Cmax. Concomitant use of ketoconazole as well asother potent CYP 3A inhibitors such as itraconazole, voriconazole, ritonavir, clarithromycin, andnefazodone is contraindicated [see Contraindications (4)].Grapefruit juiceGrapefruit juice, a moderate inhibitor of CYP 3A, resulted in a 3-fold increase in dronedaroneexposure and a 2.5-fold increase in Cmax. Therefore, patients should avoid grapefruit juicebeverages while taking MULTAQ.Rifampin and other CYP 3A inducersRifampin decreased dronedarone exposure by 80%. Avoid rifampin or other CYP 3A inducers suchas phenobarbital, carbamazepine, phenytoin, and St John’s wort with dronedarone because theydecrease its exposure significantly.Calcium channel blockersVerapamil and diltiazem are moderate CYP 3A inhibitors and increase dronedarone exposure byapproximately 1.4-to 1.7-fold [see Drug Interactions (7.1, 7.3)].PantoprazolePantoprazole, a drug that increases gastric pH, did not have a significant effect on dronedaronepharmacokinetics.7.3 Effects of Dronedarone on Other DrugsStatinsDronedarone increased simvastatin/simvastatin acid exposure by 4- and 2-fold, respectively.Because of multiple mechanisms of interaction with statins (CYPs and transporters), follow statinlabel recommendations for use with CYP 3A and P-gP inhibitors such as dronedarone.Calcium channel blockersDronedarone increases calcium channel blocker (verapamil, diltiazem or nifedipine) exposure by1.4- to 1.5-fold [see Drug Interactions (7.1)].Sirolimus, tacrolimus, and other CYP3A substrates with narrow therapeutic rangeDronedarone can increase plasma concentrations of tacrolimus, sirolimus, and other CYP 3Asubstrates with a narrow therapeutic range when given orally. Monitor plasma concentrations andadjust dosage appropriately.Beta-blockers and other CYP 2D6 substratesDronedarone increased propranolol exposure by approximately 1.3-fold following single doseadministration. Dronedarone increased metoprolol exposure by 1.6-fold following multiple doseadministration [see Drug Interaction (7.1)]. Other CYP 2D6 substrates, including other beta-blockers, tricyclic antidepressants, and selective serotonin reuptake inhibitors (SSRIs) may haveincreased exposure upon co-administration with dronedarone.P-glycoprotein substratesDigoxinDronedarone increased digoxin exposure by 2.5-fold by inhibiting the P-gP transporter [see DrugInteractions (7.1)].
DabigatranExposure to dabigatran is higher when it is administered with dronedarone than when it isadministered alone (1.7- to 2-fold).Other P-gP substrates are expected to have increased exposure when co-administered withdronedarone.Warfarin and losartan (CYP 2C9 substrates)LosartanNo interaction was observed between dronedarone and losartan.WarfarinWhen healthy subjects were administered dronedarone 600 mg twice daily, exposure to S-warfarinwas higher than when warfarin was administered alone (1.2-fold). Exposure to R-warfarin wasunchanged and there were no clinically significant increases in INR.More patients experienced clinically significant INR elevations (≥ 5) usually within 1 week afterstarting dronedarone vs. placebo in patients taking oral anticoagulants in ATHENA. However, noexcess risk of bleeding was observed in the dronedarone group.Postmarketing cases of increased INR with or without bleeding events have been reported inwarfarin-treated patients initiated on dronedarone. Monitor INR after initiating dronedarone inpatients taking warfarin.Theophylline (CYP 1A2 substrate)Dronedarone does not increase steady state theophylline exposure.Oral contraceptivesNo decreases in ethinylestradiol and levonorgestrel concentrations were observed in healthysubjects receiving dronedarone concomitantly with oral contraceptives.8 USE IN SPECIFIC POPULATIONS8.1 PregnancyPregnancy Category X [see Contraindications (4)]MULTAQ may cause fetal harm when administered to a pregnant woman. In animal studies,dronedarone was teratogenic in rats at the maximum recommended human dose (MRHD), and inrabbits at half the MRHD. If this drug is used during pregnancy or if the patient becomes pregnantwhile taking this drug, the patient should be apprised of the potential hazard to the fetus.When pregnant rats received dronedarone at oral doses greater than or equal to the MRHD (ona mg/m2 basis), fetuses had increased rates of external, visceral and skeletal malformations(cranioschisis, cleft palate, incomplete evagination of pineal body, brachygnathia, partially fusedcarotid arteries, truncus arteriosus, abnormal lobation of the liver, partially duplicated inferior venacava, brachydactyly, ectrodactylia, syndactylia, and anterior and/or posterior club feet). Whenpregnant rabbits received dronedarone, at a dose approximately half the MRHD (on a mg/m2
basis), fetuses had an increased rate of skeletal abnormalities (anomalous ribcage and vertebrae,pelvic asymmetry) at doses ≥20 mg/kg (the lowest dose tested and approximately half the MRHDon a mg/m2 basis).Actual animal doses: rat (≥80 mg/kg/day); rabbit (≥20 mg/kg)8.3 Nursing MothersIt is not known whether MULTAQ is excreted in human milk. Dronedarone and its metabolites areexcreted in rat milk. During a pre- and post-natal study in rats, maternal dronedarone administrationwas associated with minor reduced body-weight gain in the offspring. Because many drugs areexcreted in human milk and because of the potential for serious adverse reactions in nursinginfants from MULTAQ, discontinue nursing or discontinue the drug [see Contraindications (4)].8.4 Pediatric UseSafety and efficacy in children below the age of 18 years have not been established.8.5 Geriatric UseMore than 4500 patients with AF or AFL aged 65 years or above were included in the MULTAQclinical program (of whom more than 2000 patients were 75 years or older). Efficacy and safetywere similar in elderly and younger patients.8.6 Renal ImpairmentPatients with renal impairment were included in clinical studies. Because renal excretion ofdronedarone is minimal [see Clinical Pharmacology (12.3) in the full prescribing information], nodosing alteration is needed.8.7 Hepatic ImpairmentDronedarone is extensively metabolized by the liver. There is little clinical experience withmoderate hepatic impairment and none with severe impairment. No dosage adjustment isrecommended for moderate hepatic impairment [see Contraindications (4) and Clinical Pharma-cology (12.3) in the full prescribing information].10 OVERDOSAGEIn the event of overdosage, monitor the patient’s cardiac rhythm and blood pressure. Treatmentshould be supportive and based on symptoms.It is not known whether dronedarone or its metabolites can be removed by dialysis (hemodialysis,peritoneal dialysis or hemofiltration). There is no specific antidote available.
Issued December 2011
Manufactured by Sanofi Winthrop Industrie1, rue de la Vierge33440 Ambares, FranceIssue date: December 26, 2011
©sanofi-aventis, 2011All rights reserved.
MULTAQ is a trademark of sanofi-aventis.
The brands listed are the registered trademarks of their respective owners and are not trademarksof sanofi-aventis U.S. LLC.
sanofi-aventis U.S. LLCBridgewater, NJ 08807
DRO-BPLR-ACC-DEC11
MULTAQ®
(dronedarone) Tablets
ACC.12 Final Program 27
ABIM Information Desk . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Room S104b
ACC .12 Main Tent . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . North, Hall B
ACC Central . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A1, #10027
ACC Office . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Room S100a
ACCEL Office . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Room S100a
Business Center (FedEx Office) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Grand Concourse Lobby, Level 2 .5
CardioSmart Fun Run/Walk Kiosk . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Grand Concourse Lobby, Level 2 .5
Career Placement Center . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .North, Room N137
Coat Check . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . North, Hall B
South, West Transportation Lobby
Grand Concourse Level 1 near Hyatt
Convocation
Convocation Ceremony . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . North, Hall B
Convocation Office . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . North, Hall B
Convocation Hoods, Gowns & Photography . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . North, Hall B
Education Sessions & Information
E-Abstracts Self-Study Kiosks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Hall A1 near Posters
General Sessions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Levels 1, 4, 5
North, Levels 2, 4
Heart Songs Learning Lab . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Room S406 Lobby
Meet the Experts/Lunchtime/International Sessions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Levels 1, 4, 5
North, Levels 2, 4
Maintenance of Certification
MOC Education . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .South, Rooms S105a, S105d
MOC Lounge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Room S104b
MOC Simulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Room S104a
Poster Sessions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A2
Exhibitor Newsroom . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . North, Hall C
Expo . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Halls A1 & A2
ACC Central . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A1, #10027
CardioSmart Pavilion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A1
ExpoSuites . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Halls A1 & A2
Health IT Pavilion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A1
ACC.12
DirectoryAll activities are located in McCormick Place unless otherwise noted.
28 GO for ACC.12!
Interventional Pavilion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A1
Public Service Area . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A2
Publishers Showcase . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A1
First Aid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Grand Concourse Lobby, Level 2 .5
Heart Hubs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . North, Hall B
South, West Transportation Lobby
Housing Assistance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Registration, Lakeside, Level 3
Information Kiosks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Grand Concourse Lobby, Level 3
West Transportation Lobby
Interfaith Prayer Room . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . N136
iScience Sales Counters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Grand Concourse Lobby, Level 3
Learning Destinations
CardioSmart Forum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A2, CV Theater, #22097
CV Innovations Educational Forum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A2, CV Theater, #22097
Heart of Innovation Featured Learning Destination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A1, #1076
Industry-Expert Theater . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A1, #22042
Interactive Learning Labs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A1, #22027, #22035, #23027
Lounges
ACC Member Lounge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A1, #22063
CCA Community Lounge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .North, Room N138
Faculty Lounge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Room S100a
FIT Community Lounge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .North, Room N139
International Lounge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A2, #15097
Lost and Found . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .North, Room N128
Medical Meetings Information Units . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Grand Concourse Lobby, Level 2 .5
Newsroom . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . North, Hall C
Portfolio Pick-Up . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Registration, Lakeside, Level 3
West Transportation Lobby
Press Conference Room . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . North, Hall C
Registration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Lakeside, Level 3
Restaurants
Bistro ACC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A2, #1100
Windy City Café & Tech Hub . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A2, #22111
Restaurant Reservations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Grand Concourse Lobby, Level 3
Speaker Ready Room . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Room S100b
Speaker Registration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Room S100b
Directory • ACC.12
ACC.12 Final Program 29
About McCormick PlaceACC .12 takes place in McCormick Place Convention Center . The street address is 2301 S . Lake Shore Drive, Chicago, IL 60616 . Be sure to allow enough time to get where you want to be . It can take up to 15 minutes to walk between some locations within the center .
ABIM Information DeskMcCormick Place South, Room S104bTelephone: 312-791-6740
Saturday, March 24 7:30 a .m . – 6:00 p .m .Sunday, March 25 7:30 a .m . – 6:00 p .m .Monday, March 26 8:00 a .m . – 5:30 p .m .
ABIM staff will be available on site in Room S104b to answer your questions regarding the ABIM’s Maintenance of Certification program and process . You must be enrolled in ABIM’s MOC program in order to attend the ACCF Study Sessions . If you are not a current enrollee, please go to the “Physician Login” at ABIM’s website, www.abim.org, and follow the instructions to enroll . You may also enroll in the ABIM MOC program on site by visiting staff in room S104b, but please allow sufficient time to do this prior to the start of the session .
For your convenience, there will be computer terminals in the ACC MOC Center, Room S104b, for you to take the ABIM MOC test after the study session, if desired .
Regarding the study sessions, you must arrive no later than 15 minutes before the start of the session . At that time, all reserved seats will be released and non-ticket holders will be allowed to occupy vacant seats on a first-come, first-served basis .
ACC.12 eMeeting PlannerMake the most out of ACC .12 with instant access to sessions, abstracts, exhibitors, maps and more! Plus, get access to the ACC .12 twitter feed, download eBooks of the Final Program, Program-At-A-Glance and the JACC Abstract Supplement, and read the daily newspaper — CardioSourceNews from ACC.12 . Download the app on your mobile device (available for Apple®, Android® and Kindle Fire® devices) .
Apple Android
Search ACC.12 in your app store or browse to: http://ativ.me/acc
ACC.12 OnlineACC .12 Online features live webcasts of 60 sessions and on demand webcasts of an additional 18 sessions from the Legends of Cardiovascular Medicine and Core Curriculum series — available to all ACC .12 attendees for free for the duration of the meeting .
Sessions marked with the ACC .12 Online icon within the Program-At-A-Glance (starting on page 72) are available on ACC .12 Online . To access ACC .12 Online and see a complete schedule of webcasts, go to: http://acc12online.cardiosource.org, and login with your email address and passcode: ACCONLINE
ACC CentralMcCormick Place South, Hall A1, #10027
At ACC Central you’ll find comprehensive information on ACC’s quality initiatives; NCDR® registries and research; self-assessment tools; live courses; membership opportunities; and ways to ensure practice viability and protect patient access . In addition, don’t miss the exciting new products and services designed to help you translate science into practice .
ACC OfficeMcCormick Place South, Room S100aTelephone: 312-791-6720Fax: 312-791-6722
Saturday, March 24 7:00 a .m . – 6:00 p .m .Sunday, March 25 7:00 a .m . – 6:00 p .m .Monday, March 26 7:00 a .m . – 5:30 p .m .Tuesday, March 27 7:00 a .m . – 9:30 a .m .
ACC.12
General Meeting Information
30 GO for ACC.12!
ACCEL OfficeMcCormick Place South, Room S100aTelephone: 312-791-6726
Saturday, March 24 1:00 p .m . – 5:00 p .m .Sunday, March 25 8:00 a .m . – 5:00 p .m .Monday, March 26 8:00 a .m . – 5:00 p .m .Tuesday, March 27 8:00 a .m . – 3:00 p .m .
Business CenterMcCormick Place South, Grand Concourse Level 2.5Telephone: 312-949-2100
The FedEx Office Print & Ship Center in McCormick Place offers you virtually everything you need to meet your convention exhibiting needs — from packing and shipping to signage, copying and last-minute office supplies .
Hours:Friday – Monday 8:30 a .m . – 5:00 p .m .
Car RentalTelephone: 1-800-654-2240
The ACC has arranged rental car discounts through Hertz . You can call the above number or go to www.hertz.com to make your reservation . Conference ID is CV#044W0006 . The closest Hertz office is at the Hyatt Regency McCormick Place, office number 312-567-0380 .
Career Placement CenterMcCormick Place North, Room N137Telephone: 312-808-2970
Saturday, March 24 9:00 a .m . – 5:00 p .m .Sunday, March 25 9:00 a .m . – 5:00 p .m .Monday, March 26 9:00 a .m . – 5:00 p .m .
The ACC Cardiology Career Resource Center is the perfect venue for setting up interviews, posting jobs or résumés/CVs, and reviewing more than 300 positions listed on the College’s online job bank . The service is free to candidates and very economical for employers .
Certificate of Attendance and Claiming CME/CNE CreditThe online ACC .12/ACC-i2 with TCT CME/CNE Credit site will be available in real time for recording your session attendance and claiming credit . Please be sure to keep a
record of the session numbers you attended and know your badge number . You may enter your information at the conclusion of a session from any internet-enabled computer by visiting www.accscientificsession.org. Please allow time for the system to update if you registered the same day you are accessing the CME/CNE system .
Note: The CME/CNE system will give credit only for the total elapsed time spent in education sessions . Credit cannot be doubly awarded for sessions taking place concurrently .
ChildrenDuring Expo hours, children (defined as anyone under 18 years of age) will be permitted in the Expo Hall only if accompanied by an adult at all times . Children between 12 and 18 years of age are required to register for admission to the Exposition in the Family Member category at the posted rate . Under no circumstances will children be allowed in the Expo Hall during installation or dismantle periods . For reasons of insurance liability and safety, strollers and infant carriers are not permitted in the Expo Hall at any time . Infants must be held at all times . Because of limited seating capacity and the highly technical nature of the education program, children are not invited to attend presentations .
Coat CheckMcCormick Place North, Hall B; South, West Transportation Lobby; Grand Concourse Level 1 near Hyatt
Friday, March 23 7:00 a .m . – 6:30 p .m .Saturday, March 24 7:00 a .m . – 7:00 p .m .Sunday, March 25 7:00 a .m . – 7:00 p .m .Monday, March 26 7:00 a .m . – 10:00 p .m .Tuesday, March 27 7:00 a .m . – 12:30 p .m .
Attendees can check coats and/or luggage for $3 .00 per coat and $4 .00 per bag .
ConvocationConvocation CeremonyMcCormick Place North, Hall BMonday, March 26, 2012, 6:30 p.m.
The Convocation Ceremony, presided over by David R . Holmes, Jr ., President, MD, FACC, is one of the most exciting and prestigious events to take place during the Annual Scientific Session, honoring new Fellows (FACC), recognizing
General Meeting Information • ACC.12
ACC.12 Final Program 31
Associates of the American College of Cardiology (AACC), distinguished guests, and the induction of William A . Zoghbi, MD, FACC, as president of the College .
Convocation OfficeMcCormick Place North, Hall BSaturday, March 24 8:00 a .m . – 5:00 p .m .Sunday, March 25 8:00 a .m . – 5:00 p .m .Monday, March 26 8:00 a .m . – 3:00 p .m .Tuesday, March 27 9:00 a .m . – 11:00 a .m .
Convocation Hoods and GownsMcCormick Place North, Hall BSaturday, March 24 8:00 a .m . – 5:00 p .m .Sunday, March 25 8:00 a .m . – 5:00 p .m .Monday, March 26 8:00 a .m . – 9:00 p .m .
Collect academic attire and sign the Convocation Register .
Convocation Portrait PhotographyMcCormick Place North, Hall B
To schedule an appointment:Friday, March 23 11:00 a .m . – 4:00 p .m .Saturday, March 24 10:00 a .m . – Noon
Portraits may be posted and photographed on:Saturday, March 24 1:00 p .m . – 5:00 p .m .Sunday, March 25 10:00 a .m . – 5:00 p .m .Monday, March 26 10:00 a .m . – 6:00 p .m .
Education Sessions and InformationE-Abstracts Learning StationAccepted abstracts are also available as e-abstracts online and may be viewed from the dedicated terminals in the Poster Sessions area, Hall A1 . For 24/7 perusal of the e-abstracts, visit www.accscientificsession.org .
Heart Songs Learning LabMcCormick Place South, Room S406 Lobby
A unique audio-visual program to refresh cardiac auscultation skills by listening to heart sounds while viewing phonocardiograms, echoes and more on an iPod® Touch, iPad® or laptop computer . This clinical skills workshop provides attendees with a choice of three sessions — basic, advanced and expert levels . Plus, a video program that
combines 3D echo images with the auscultation findings on 4 common valvular abnormalities . In addition, you’re able to test your knowledge with pre- and post-tests .
MOC Education RoomMcCormick Place South, Rooms S105a, S105d
For the Maintenance of Certification (MOC) study sessions, preregistered attendees must arrive no later than 15 minutes before the start of the session . At that time, all reserved seats will be released and non-ticket holders will be allowed to occupy vacant seats on a first-come, first-served basis .
MOC LoungeMcCormick Place South, Room S104b
See also ABIM Information Desk above for additional information . Attendees may use the computer terminals in the Lounge to take the ABIM, ACCSAP or ABP tests after the conclusion of the sessions .
MOC Simulation RoomMcCormick Place South, Room S104a
ABIM offers an option for interventional cardiology diplomats to earn credit toward completion of the Self-Evaluation of Medical Knowledge requirement for Maintenance of Certification . Interventional Cardiology Simulations is the first-ever ABIM-developed lab-based simulation that provides an opportunity to perform cases that mirror what an interventional cardiologist would typically face in daily practice . Medical Simulation Corporation’s SimSuite® technology replicates a real-life catheterization lab suit . Physicians complete the Interventional Cardiology Simulations on-site in room S104a .
Poster SessionsMcCormick Place South, Hall ATelephone: 312-791-6768
Posters will be displayed from 9:30 a .m . – 4:30 p .m . on Saturday and Sunday; 9:30 a .m . – 2:00 p .m . on Monday . Presenters will be available Saturday through Monday from 9:30 a .m . – 10:30 a .m . and 11:00 a .m . – noon . Come during the presenter hours, meet the presenters and view the poster boards facilitated by poster discussants . Best poster awards will be awarded to one winner in each of the clinical pathways .
ACC.12 • General Meeting Information
32 GO for ACC.12!
Exhibitor NewsroomMcCormick Place North, Hall CTelephone: 312-808-2015Fax: 312-808-2016
Saturday, March 24 7:30 a .m . – 5:00 p .m .Sunday, March 25 7:30 a .m . – 5:00 p .m .Monday, March 26 7:30 a .m . – 5:00 p .m .Tuesday, March 27 7:30 a .m . – 5:00 p .m .
The Exhibitor Newsroom provides members of the media with access to information from exhibiting companies and their representatives . The fee is $350 on site . An ACC .12 exhibitor may register a maximum of four individuals to the Exhibitor Newsroom . Use of the Exhibitor Newsroom is limited to ACC .12 exhibiting companies . Persons who wish to substitute for an advance registrant must present a letter of authorization from the exhibiting company’s primary contact .
ExpoMcCormick Place South, Halls A1 & A2
A vital part of your ACC education can be found in the ACC .12 Expo, where more than 300 exhibiting companies and organizations showcase the latest advances in pharmaceuticals, imaging, devices, technologies and the services that you need to help you provide high-quality patient care .
Don’t miss these key specialty areas in the Expo:• ACC Central: South, Hall A1, #10027• CardioSmart Pavilion: South, Hall A1• ExpoSuites: South, Halls A1 & A2•Health IT Pavilion: South, Hall A1• Interventional Pavilion: South, Hall A1• Public Service Area: South, Hall A2• Publishers Showcase: South, Hall A1
Fire Safety InformationSeating capacity has been maximized in all session rooms according to local fire regulations . Standing in the aisles or against the walls is not permitted . If overcrowding occurs, staff/security personnel will close the session . Further admittance will not be allowed until the next speaker change . Noncompliance may subject the session to be shut down by the Fire Marshal .
Inside the Session Room:• Find seats as far forward as possible•Move to the center of the row and fill all seats so chairs
are available for additional attendees• Store materials under chairs to maximize seating• Take all personal effects when exiting; re-entry to an
overcrowded session room may not be allowed
Outside the Session Room:• Step back from the entrance• Form a line; the next attendee in line will be admitted
into the session and escorted to an available seat
If space does not permit you to attend a session, a recording of the session may be available for purchase at the iScience sales desk .
Orderly conduct is appreciated. Thank you for your cooperation!
First AidMcCormick Place South, First Aid Room, Level 2.5
Saturday, March 24 8:00 a .m . – 5:00 p .m .Sunday, March 25 8:00 a .m . – 5:00 p .m .Monday, March 26 8:00 a .m . – 8:00 p .m .Tuesday, March 27 8:00 a .m . – 5:00 p .m .
The first aid room in McCormick Place Convention Center will be operated and staffed by licensed medical professionals . The station will carry basic first aid supplies as well as over-the-counter medications available for distribution, oxygen and an AED .
Heart HubsMcCormick Place North, Hall BMcCormick Place South, West Transportation Lobby
Saturday, March 24 7:30 a .m . – 6:00 p .m .Sunday, March 25 7:30 a .m . – 6:00 p .m . Monday, March 26 7:30 a .m . – 5:30 p .m .Tuesday, March 27 7:30 a .m . – 11:45 a .m .
Relax with refreshments in a lounge setting while sessions from ACC .12 come to you on plasma screens . With two convenient locations in McCormick Place, this is the place to be for networking and news watching .
General Meeting Information • ACC.12
ACC.12 Final Program 33
Housing AssistanceMcCormick Place, Lakeside, Level 3Telephone: 312-949-3207
J . Spargo & Associates, Inc . staff is available to assist with hotel reservations at official ACC .12 hotels .
Information StationsMcCormick Place South, Grand Concourse Lobby, Level 2.5; Level 3, West Transportation Lobby
At locations throughout the convention center you will find Information Stations where you can
• Access the internet• Browse the education sessions• Plan, save and print your itinerary• Locate attendees, exhibitors and products• View the Exposition floor plan
ACC.12 Information Stations compliments of Forest Pharmaceuticals, Inc., Janssen Pharmaceuticals, Inc. and Merck & Co., Inc.
iScience Sales DeskMcCormick Place South, Grand Concourse Lobby, Level 3 and ACC Central, Hall A1, #10027
Saturday, March 24 7:00 a .m . – 6:00 p .m .Sunday, March 25 7:00 a .m . – 6:00 p .m .Monday, March 26 7:00 a .m . – 6:00 p .m .Tuesday, March 27 7:00 a .m . – Noon
iScience, the ACC .12 Meeting on Demand, is a comprehensive digital library of presentations from ACC .12 and includes over 400 hours of educational content . It is the most convenient way to experience all the education from ACC .12 and allows you to watch presenters’ slides while listening to fully-synchronized audio as if you were actually attending each session . Purchase on site in Chicago and save $1,000 or more!
Learning DestinationsMcCormick Place South, Halls A1 and A2
Learning Destinations™ are diverse, non-accredited, educationally focused areas that offer new and creative ways to expand your educational experience . We invite you to visit these dynamic learning environments, located in the Expo Hall .
• CardioSmart Forum: South, Hall A2, CV Theater, #22097• CV Innovations Educational Forum: South, Hall A2, CV
Theater, #22097•Heart of Innovation Featured Learning Destination:
South, Hall A1, #1076• Interactive Learning Labs: South, Hall A1, #22027,
#22035, #23027• Industry-Expert Theater: South, Hall A1, #22042
Please see the Learning Destinations section on page 57 for additional information .
Lost and FoundMcCormick Place North, Room 128Telephone: 312-670-5312
If you lose or find an item, please contact the ACC Office .
LoungesACC Member LoungeMcCormick Place South, Hall A1, #22063
The ACC Member Lounge is open to ACC members during all Expo hours . Take time with colleagues to network and relax, check emails and enjoy a cup of coffee in this inviting atmosphere .
CCA Community LoungeMcCormick Place North, Room N138
Friday, March 23 Noon – 5:00 p .m .Informal Session Noon – 5:00 p .m .
Saturday, March 24 8:00 a .m . – 5:00 p .m .Sunday, March 25 8:00 a .m . – 5:00 p .m .Monday, March 26 8:00 a .m . – 5:00 p .m .Tuesday, March 27 8:00 a .m . – 5:00 p .m .
Informal Session 2:00 p .m . – 5:00 p .m .
The ideal place to relax, check your email and touch base with your CCA peers .
ACC.12 • General Meeting Information
34 GO for ACC.12!
Faculty LoungeMcCormick Place South, Room S100aTelephone: 312-791-6715
Saturday, March 24 7:00 a .m . – 6:00 p .m .Sunday, March 25 7:00 a .m . – 6:00 p .m . Monday, March 26 7:00 a .m . – 5:30 p .m .Tuesday, March 27 7:00 a .m . – 9:30 a .m .
Invited faculty for ACC .12 will receive a white “Faculty” ribbon that will give them access to the Faculty Lounge . Services in the Lounge include computer/internet and printer access, work and meeting space, food service and a comfortable lounge atmosphere for private faculty networking .
FIT Community LoungeMcCormick Place North, Room N139
Saturday, March 24 8:00 a .m . – 5:00 p .m .Sunday, March 25 8:00 a .m . – 5:00 p .m .Monday, March 26 8:00 a .m . – 5:00 p .m .Tuesday, March 27 8:00 a .m . – 2:00 p .m .
The ideal place to relax, check your email and touch base with your FIT peers .
International LoungeMcCormick Place, Hall A1, #15097
Saturday, March 24 9:30 a .m . – 4:30 p .m .Sunday, March 25 9:30 a .m . – 4:30 p .m .Monday, March 26 9:30 a .m . – 2:00 p .m .
The lounge is open to all attendees practicing outside the United States, offering the opportunity to network with colleagues, learn about the multitude of international ACC initiatives and partnerships, and find information regarding international membership in the ACC .
Medical InformationDentist800-DENTIST or www.1800DENTIST.COM
HospitalsMercy Hospital2525 South Michigan AvenueChicago, IL 60616312-567-2000www.mercy-chicago.org
Rush-Presbyterian — St. Luke’s Medical Center1653 W . Congress Pkwy .Chicago, IL 60612312-942-5000www.rush.edu
Consult your hotel concierge for additional services and locations .
Medical Meetings InformationMcCormick Place, Grand Concourse Lobby, Level 2.5
Information about other national and international medical meetings is available . Distribution of literature is confined to the publication bins provided; posters are not permitted .
For news and updates about ACC .12 look for the daily editions of the CardioSource News from ACC.12 displayed on racks throughout McCormick Place .
Name BadgesYour badge serves as your passport to education sessions, the Exposition and to complimentary shuttle service . You must wear your name badge at all times . For security reasons, persons without badges will not be permitted access to attend events .
Badge Colors:Dark Blue Stripe ACC .12 Professional Registrants
Grey Stripe One Day Only Registrants
Purple Stripe Exhibitor Full Access (Expo Hall and all official ACC .12 Education sessions), Consultant
Yellow Stripe Exhibitor (Expo Hall only), Exhibitor Newsroom
Green Stripe ACC Staff and Official Contractors
Orange Stripe Exhibits Only, Family Member
Red Stripe Media
We recommend for your safety that you do not wear your name badge in public .
General Meeting Information • ACC.12
ACC.12 Final Program 35
NewsroomMcCormick Place North, Hall CTelephone: 312-808-2000
Saturday, March 24 7:30 a .m . – 5:00 p .m .Sunday, March 25 7:30 a .m . – 5:00 p .m .Monday, March 26 7:30 a .m . – 5:00 p .m .Tuesday, March 27 7:30 a .m . – 5:00 p .m .
Arrangements for interview and inquiries concerning news releases and news conferences should be directed to Beth Casteel in the Newsroom .
ParkingMcCormick Place parking rate is $19 for up to 16 hours and $30 from 16 to 24 hours . There are no in-and-out privileges . Overnight parking is available in Lot A only . Lost tickets will pay the $30 fee per day . Parking fees can be paid by cash or credit card; Visa, MasterCard and American Express are accepted .
Places of WorshipChicago has an extremely diverse population and visitors can find any number of religious institutions throughout the city for just about any faith . For a brief listing of places of worship, visit the Chicago Convention and Tourism Bureau website at www.choosechicago.com and search for places for worship on their home page .
Portfolio Pick-UpMcCormick Place, Lakeside, Level 3McCormick Place South, West Transportation Lobby
Once at the convention center, proceed to Registration or to the Portfolio Pickup Station located in the West Transportation Lobby to receive your portfolio bag and JACC ACC.12 Abstract Supple- ment . The Final Program will be included in the portfolio bag .
Poster Info BoothMcCormick Place South, Hall ATelephone: 312-791-6767
Poster presenters may check the U-Search computer kiosks throughout the poster hall to reconfirm poster board information and session presentation times . Poster Discussants and Best Poster Judges may check-in with staff to receive
ribbons and instructions . Staff are available to assist presenters with disclosure compliance information and materials .
Public TransportationCTA & METRATelephone: 312-836-7000
The Chicago Transit Authority (CTA) offers fast, direct train service from both airports to downtown Chicago, convenient bus and train lines to major attractions, simple fare cards and easy-to-use maps and brochures . For route, fare and schedule information, call any day from 5:00 a .m . – 1:00 a .m . (CT) . The CTA system map and Downtown Sightseeing Guide are available at all train stations, both airports, visitor information centers and hotels . You can also plan your trip online by visiting http://www.transitchicago.com.
RegistrationMcCormick Place Lakeside, Level 3Telephone: 312-949-3205
Friday, March 23 7:00 a .m . – 5:00 p .m .Saturday, March 24 7:00 a .m . – 6:00 p .m . Sunday, March 25 7:00 a .m . – 6:00 p .m .Monday, March 26 7:00 a .m . – 5:00 p .m .Tuesday, March 27 7:00 a .m . – Noon
Registration Cancellations, Substitutions and RefundsAs printed in the Registration Instructions, registration fees are non-refundable after Feb . 15, 2012 . Cancelled registrations are non-transferable .
Restaurant Reservations ServiceMcCormick Place, Grand Concourse Lobby, Level 3
Saturday, March 24 10:30 a .m . – 6:30 p .m . Sunday, March 25 10:30 a .m . – 6:30 p .m .Monday, March 26 10:30 a .m . – 6:30 p .m .Tuesday, March 27 10:00 a .m . – 1:00 p .m .
Representatives are available to recommend and to confirm reservations at any of the area’s restaurants .
ACC.12 • General Meeting Information
36 GO for ACC.12!
RestaurantsMcCormick Place South, Hall A2
Two restaurants satisfying a range of culinary tastes will be located in the Expo Hall . The restaurants each offer a large seating area where you can eat, network with colleagues and plan your schedule .
•Bistro ACC: An innovative dining option that is conveniently located at the back of the 4000 aisle . Assorted menu options include several fresh and healthy options, international cuisine and regional favorites . An all-inclusive lunch buffet costs $20 and includes your meal, beverages, dessert and tax . You can purchase lunch tickets in advance by going to www.bistroacc.com or visit the Bistro ACC ticket counter in the Grand Concourse just outside the Expo Hall .
•Windy City Café & Tech Hub: Join colleagues for a more upscale buffet-style dining experience at the Windy City Café & Tech Hub, located at the back of the 22000 aisle . The Windy City Café offers you a unique environment in which to relax and make plans for your continuing education and remaining time at ACC .12 . Charging stations will be available for your electronic devices — recharge your batteries and your phone’s batteries — all in one location!
Shuttle Bus ServiceShuttle service will operate daily from McCormick Place and the official hotels on a daily basis (except the Hyatt Regency McCormick Place, which is considered within walking distance) . Check the shuttle sign posted in the lobby of each hotel for additional information, changes, frequency of service and boarding locations .
Hours of OperationFriday, March 23 – Sunday, March 25Between hotels and McCormick Place6:00 a .m . – 6:45 p .m .*
Please note, on Sunday, March 25, there will be intermittent suspension of service and delays due to the Shamrock Shuffle 8K Race between the hours of 8 a.m. – noon. Please plan accordingly.
Monday, March 26, 2012Between hotels and McCormick Place6:00 a .m . – 10:00 p .m .*
Tuesday, March 27, 2012Between hotels and McCormick Place6:00 a .m . – 1:00 p .m .*
*Last motorcoach departs McCormick Place at this time . Last motorcoach departs the hotels approximately 90 minutes prior to this time . McCormick Place is the transfer point for all routes .
To make arrangements for a wheelchair-accessible shuttle, contact the shuttle supervisor at McCormick Place during shuttle hours .
Shuttle service information is current as of time of printing . Please check the route signs at McCormick Place and posted in the lobby of each hotel for updated information .
SmokingThe American College of Cardiology promotes a “No Smoking” policy . The use of tobacco products is strictly prohibited in the Convention Center and all hotel meeting rooms hosting ACC .12 events . Thank you for your compliance .
Speaker Ready RoomMcCormick Place South, Room S100bTelephone: 312-791-6728
Friday, March 23 7:00 a .m . – 5:00 p .m .Saturday, March 24 6:00 a .m . – 6:00 p .m .Sunday, March 25 6:00 a .m . – 6:00 p .m .Monday, March 26 6:00 a .m . – 5:30 p .m .Tuesday, March 27 6:00 a .m . – 10:00 a .m .
New this year: All invited faculty, including speakers, co-chairs and panelists, must check in at the Speaker Ready Room to confirm presentation times and review electronic files, even if they have uploaded their files in advance .
There will be one Speaker Ready Room to assist all presenters for both ACC .12 and ACC-i2 with TCT . We recommend presenters visit the Speaker Ready Room 24 hours before their presentation begins . However, presenters must go to the Speaker Ready Room at least 4 hours in advance to review and approve their presentations . Presenters who do not
General Meeting Information • ACC.12
ACC.12 Final Program 37
check-in sufficiently in advance of their presentation may give the scheduled talk, but may not have visuals .
Speaker RegistrationMcCormick Place South, Room S100b
Friday, March 23 7:00 a .m . – 5:00 p .m .Saturday, March 24 6:00 a .m . – 6:00 p .m .Sunday, March 25 6:00 a .m . – 6:00 p .m .Monday, March 26 6:00 a .m . – 5:30 p .m .Tuesday, March 27 6:00 a .m . – 10:00 a .m .
This is the location for all faculty registration . All advance-registered faculty should have received a white faculty ribbon with the badge in the mail; otherwise they may be picked up in this office .
TransportationHertz: 800-654-2240 Airport Shuttle: 888-284-3826
TaxisAmerican-United Taxi: 773-248-7600Checker Cab: 312-243-2537Yellow Cab: 312-829-4222Flash Cab: 773-561-1444
Taxis are plentiful and easy-to-hail in downtown, and offer a convenient way to get around the city . Taxis charge a base rate of $2 .25 for the first 1/9 mile, plus, 20¢ for each additional 1/9 mile . If a gas surcharge is in effect, a sign will be displayed inside the taxicab and a surcharge may apply . Tolls are an extra charge; taxis charge $1 for the first additional passenger over age 12 and under age 65 . Each additional passenger after first passenger, over 12 and under 65 is $ .50 . It is standard to tip the driver about 15 – 20% of the fare, plus $1 – 2 per bag if the driver helps you with luggage .
ACC.12 • General Meeting Information
38 GO for ACC.12!
ACC.12
McCormick Place Convention Center
ACC.12 Final Program 39
ACC.12
Poster Hall Map Saturday, March 24, 2012
40 GO for ACC.12!
ACC.12
Poster Hall Map Sunday, March 25, 2012
ACC.12 Final Program 41
ACC.12
Poster Hall Map Monday, March 26, 2012
42 GO for ACC.12!
Map Hotel Address Phone Fax
17 Allegro Chicago, A Kimpton Hotel 171 West Randolph Street Chicago, IL 60601 312-236-0123 312-236-0917
1 Amalfi Hotel Chicago 20 W Kinzie Street Chicago, IL 60654 312-395-9000 312-395-9001
18 Burnham, A Kimpton Hotel 1 West Washington Street Chicago, IL 60601 312-782-1111 312-762-3554
2 Chicago Marriott Downtown Magnificent Mile 540 North Michigan Avenue Chicago, IL 60611 312-836-0100 312-836-0100
3 Conrad Chicago 520 North Rush Street at Michigan Avenue Chicago, IL 60611 312-645-1500 312-645-1550
5 Courtyard by Marriott Magnificent Mile 165 East Ontario Street Chicago, IL 60611 312-573-0800 312-573-0573
4 Courtyard Chicago Downtown River North 30 East Hubbard Street Chicago, IL 60611 312-329-2500 312-329-0293
6 Dana Hotel and Spa 660 North State Street Chicago, IL 60654 312-202-6000 312-202-6033
7 Doubletree Chicago Magnificent Mile 300 East Ohio Street Chicago, IL 60611 312-787-6100 312-787-6259
9 Embassy Suites Chicago Downtown 600 North State Street Chicago, IL 60654 312-943-3800 312-943-7629
10 Embassy Suites Chicago Downtown Lakefront 511 North Columbus Drive Chicago, IL 60611 312-836-5900 312-839-5901
11 Fairfield Inn and Suites 216 East Ontario Street Chicago, IL 60611 312-787-3777 312-787-8714
13 Four Seasons 120 East Delaware Place Chicago, IL 60611 312-280-8800 312 280-1748
14 Hard Rock Hotel 230 North Michigan Avenue Chicago, IL 60601 312-345-1000 312-345-1012
15 Hilton Chicago 720 South Michigan Avenue Chicago, IL 60605 312-922-4400 312-922-5240
16 Holiday Inn Chicago Mart Plaza 350 West Mart Center Drive Chicago, IL 60654 312-836-5000 312-222-9508
19 Hotel Cass, A Holiday Inn Express 640 North Wabash Chicago, IL 60611 312-787-4030 312-787-1381
23 Hyatt Regency Chicago 151 East Wacker Drive Chicago, IL 60601 312-565-1234 312-239-4414
24 Hyatt Regency McCormick Place 2233 South Martin Luther King Drive Chicago, IL 60616 312-567-1234 312-528-4000
25 Inn of Chicago 162 East Ohio Street Chicago, IL 60611 312-787-3100 312-573-3136
26 InterContinental Chicago 505 North Michigan Avenue Chicago, IL 60611 312-944-4100 312-944-3050
28 JW Marriott 151 West Adams Street Chicago, IL 60604 312-660-8200 312-660-8201
20 Monaco Chicago, A Kimpton Hotel 225 North Wabash Avenue Chicago, IL 60601 312-960-8522 312-960-1883
29 Omni Chicago 676 North Michigan Avenue Chicago, IL 60611 312-944-6664 312-266-3017
30 Palmer House Hilton 17 East Monroe Street Chicago, IL 60603 312-726-7500 312-917-1707
21 Palomar Chicago, A Kimpton Hotel 505 North State Street Chicago, IL 60654 312-755-9703 312-755-9713
32 Renaissance Blackstone 636 South Michigan Avenue Chicago, IL 60605 312-447-0955 312-765-0545
33 Renaissance Chicago Hotel 1 West Wacker Drive Chicago, IL 60601 312-372-7200 312-372-0093
34 Residence Inn by Marriott Chicago Downtown River North 410 North Dearborn Street Chicago, IL 60610 312-494-9301 312-494-9302
35 Residence Inn by Marriott Magnificent Mile 201 East Walton Place Chicago, IL 60611 312-943-9800 312-943-8597
36 Ritz Carlton 160 East Pearson Street Chicago, IL 60611 312-266-1000 312-266-9498
22 Sax Chicago- A Thompson Hotel 333 North Dearborn Street Chicago, IL 60654 312-245-0333 312-923-2444
37 Sheraton Chicago Hotel and Towers 301 East North Water Street Chicago, IL 60611 312-464-1000 312-464-9140
38 Silversmith Hotel 10 South Wabash Avenue Chicago, IL 60603 312-795-6500 312-372-7320
39 Sofitel Chicago Water Tower 20 East Chestnut Street Chicago, IL 60611 312-324-4000 312-324-4025
40 Springhill Suites by Marriott Chicago Downtown River North 410 North Dearborn Street Chicago, IL 60654 312-644-4071 312-644-9302
41 Swissotel Chicago 323 East Wacker Drive Chicago, IL 60601 312-565-0565 312-268-8252
8 The Drake Hotel 140 East Walton Place Chicago, IL 60611 312-787-2200 312-787-1431
12 The Fairmont Chicago 200 North Columbia Drive Chicago, IL 60601 312-565-8000 312-856-1032
27 The James Hotel 55 East Ontario Chicago, IL 60611 312-337-1000 312-337-7217
31 The Peninsula Hotel 108 East Superior Street Chicago, IL 60611 312-337-2888 312-751-2888
42 theWit Hotel 201 North State Street Chicago, IL 60601 312-467-0200 312-673-8617
43 Westin Chicago River North 320 North Dearborn Street Chicago, IL 60654 312-744-1900 312-527-2650
44 Westin Michigan Avenue 909 North Michigan Avenue Chicago, IL 60611 312-943-7200 312-397-5580
45 Wyndham Chicago 633 North St . Clair Street Chicago, IL 60611 312-573-0300 312-274-0164
ACC.12
Hotels
ACC.12 Final Program 43
ACC.12
Hotel Map
44 GO for ACC.12!
Accreditation InformationStatement of Need Cardiovascular disease (CVD) is the leading cause of death in the United States . It is estimated that 83 million Americans have one or more forms of CVD and on average, more than 2,200 Americans die of this disease each day . Members of the health care team provide care for patients with cardiovascular health needs in a wide variety of environments affecting the lives of countless patients and families . As the overall care of the patient with CVD becomes more complex, it is imperative that the cardiovascular professional remain current on the diagnosis, treatment and management of these diseases .
As in the past, this program will offer needs-based educational programming, including the comprehensive review of current established practice patterns as well as state-of-the-art updates, techniques and translational research in the diagnosis and treatment of cardiovascular disease in areas such as women’s health, vascular and valvular disease, imaging modalities, interventional cardiology, congenital cardiology, electrophysiology, pulmonary hypertension, STEMI, and addressing comorbidities . Additionally, to address the ongoing needs of our members, emphasis on performance in practice, as related to Maintenance of Certification (MOC) and Maintenance of Licensure (MOL), will be a focus for those requiring this educational emphasis .
Program GoalsTwo global goals for the Annual Scientific Session communicate a commitment by the College to provide needs-based education that is independent of commercial interests and fosters change in learners’ knowledge, competence and performance to ultimately improve patient outcomes .
1 . KNOWLEDGE — To disseminate knowledge of optimal cardiovascular care, disease prevention and improvements in overall patient outcomes .
• Educational strategies for attaining this goal within specific learning pathways are to:
• Offer a core curriculum of cardiovascular and interventional education, including comprehensive reviews of established practice patterns as well as state-of-the-art techniques in the diagnosis and treatment of CVD
• Provide updates of available pharmaceuticals, medical devices and management strategies for cardiovascular patients
• Present basic and clinical research findings, independent of commercial interests, to increase the evidence base related to the care of patients with cardiovascular disease
• Disseminate information related to practice management, quality of care, ethical practices and non-clinical topics that contribute to desired patient outcomes
• Provide a forum for analyzing and critiquing new approaches to non-surgical management of patients with cardiovascular disease
• Create opportunities for knowledge exchange between general cardiologists and interventionalists, as well as cross-discipline areas of cardiology (e .g ., cardiovascular surgery)
2 . COMPETENCE — To foster the translation of evidence-based cardiovascular science and interventional concepts and techniques into daily clinical practice .
Educational strategies for attaining this goal within specific learning pathways are to:
• Offer education to satisfy, in part, requirements for MOC in cardiovascular and interventional medicine
ACC.12
General Education Information
ACC.12 Final Program 45
• Provide individualized training in clinical diagnostics and procedures, presented in self- paced and hands-on formats
• Promote professional exchanges between and within groups of cardiovascular care providers with similar clinical, geographic and/or educational interests
• Present best practices of cardiovascular specialists and related health care professionals working in multidisciplinary teams
• Create a forum for global collaboration and cooperation on issues in cardiovascular medicine to improve professional practices worldwide
ACC .12 program level objectives can be found on our website, www.accscientificsession.org, select Education, then Accreditation.
Target AudienceThe Annual Scientific Session is intended for all professionals involved in delivering cardiovascular care, with particular emphasis on physicians, scientists, nurse practitioners, clinical nurse specialists, physicians assistants, nurses, pharmacists and practice administrators . Medical students and trainees, technicians, dietitians and other health care professionals will also benefit .
AccreditationRequirements for successful completion and awarding of credit is attendance in sessions offering credit in their entirety and completion of the evaluation tool . Each participant should only claim the credit commensurate with the extent of their participation in each completed session .
While offering credits noted below, the program is not intended to provide extensive training or certification in the field .
Continuing Medical Education CreditThe American College of Cardiology Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians .
The ACCF designates the Annual Scientific Session (ACC .12) live educational activity for a maximum of 45 .75 AMA PRA Category 1 Credits™ .
Continuing Nurse Education CreditThe American College of Cardiology Foundation is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation .
The ACCF designates the Annual Scientific Session (ACC .12) educational activity for a maximum of 43 .25 continuing education hours .
Continuing Pharmacy Education CreditThe University of Florida College of Pharmacy is accredited by the Accreditation Council for Pharmacy
Education (ACPE) as a provider of continuing pharmacy education .
The ACPE Universal Program Numbers for ACC .12 can be found within the daily session listings starting on page 105 . This program has been designated as a Knowledge-Based Program and provides a maximum of 24 .75 contact hours of continuing education credit . Continuing education statements of credit will be mailed by the University of Florida College of Pharmacy in 4 – 6 weeks to participants who have attended the program and completed an activity evaluation form .
CME/CNE Credit SystemThe online ACC .12 CME/CNE Credit System will be available in real time for recording your session attendance and claiming credit . Please be sure to keep a record of the session numbers you attended and know your badge number. You may enter your information at the conclusion of a session through the ACC .12 eMeeting Planner or by visiting www.accscientificsession.org.
Note: The CME/CNE system will give credit only for the total elapsed time spent in education sessions . Credit can not be doubly awarded for sessions taking place concurrently . ACC .12 registrants in the following categories have access to the system: ACC Member, ACC International Associate, ACC Cardiac Care Team Member, ACC Cardiovascular Service Administrator Member, ACC FIT Member, ACC Emeritus Member, Nonmember Physician, Nonmember Trainee/Resident, Nonmember Nonphysician, Nonmember Government and One-Day . Those categories not eligible are Nonmember Administrator, Nonmedical, Exhibits, Exhibits Only and Family Member .
General Education Information • ACC.12
46 GO for ACC.12!
ACPE Credit ClaimingThis year for ACC .12, a maximum of 24 .75 contact hours of continuing education credit are available for pharmacists . In order to claim this credit, please complete the following steps:
• Log-in to the ACC .12 evaluation at www.accscientificsession.org and complete the overall evaluation
• After completing the overall evaluation, select the choice stating you are interested in claiming ACPE credits
•Open the link to claim credit in a separate window and fill in the appropriate information
• Continue with the ACC .12 evaluation to select your sessions and claim your certificate of attendance
• The ACPE credit claiming site will close in early May and continuing education statements of credit will be mailed by the University of Florida College of Pharmacy in 4 – 6 weeks to participants who have attended the program and completed an activity evaluation form
If you have any questions regarding this process, please contact Christina Chadwick at [email protected] .
DisclaimersThe American College of Cardiology Foundation does not warrant the completeness, accuracy or usefulness of any opinions, advices or other information provided through this activity . In no event will ACCF be liable for any decision made, or action take, in reliance upon the information provided through this activity .
Accredited status does not imply endorsement by the ACCF of any commercial products displayed in conjunction with the activity .
ACCF reserves the right to modify faculty and program without notice .
Abstracts of Original ContributionsMore than 2,100 oral and poster abstracts are scheduled to be presented at ACC .12 and ACC-i2 with TCT . The full text of the abstracts is contained in the supplement to the March 27, 2012 issue of JACC, which is distributed in print and CD format onsite in Chicago, and will be posted at onlinejacc.org, on Monday, March 26, 2012 . The abstracts will also be available as an e-book download and via the ACC .12
eMeeting Planner App . See additional information regarding download instructions, how to access these sites and online program planning at www.accscientificsession.org .
Learner Bill of RightsThe American College of Cardiology Foundation (ACCF) recognizes that you are a life-long learner who has chosen to engage in continuing medical education to identify or fill a gap in knowledge or skill; and to attain or enhance a desired competency . As part of ACCF’s duty to you as a learner, you have the right to expect that your continuing medical education experience with ACCF includes the following:
Content that:
• Promotes improvements or quality in healthcare • Is current, valid, reliable, accurate and evidence-based • Addresses the stated objectives or purpose • Is driven and based on independent survey and analysis
of learner needs, not commercial interests •Has been reviewed for bias and scientific rigor •Offers balanced presentations that are free of
commercial bias • Is vetted through a process that resolves any conflicts of
interest of planners and faculty • Is evaluated for its effectiveness in meeting the identified
educational need
A learning environment that:
• Is based on adult learning principles that support the use of various modalities
• Supports learners’ abilities to meet their individual needs • Respects and attends to any special needs of the
learners • Respects the diversity of groups of learners • Is free of promotional, commercial and/or sales activities
Disclosure of:
• Relevant financial relationships that planners, teachers and authors have with commercial interests related to the content of the activity
• Commercial support (funding or in-kind resources) of this activity
General Education Information • ACC.12
ACC.12 Final Program 47
Joint Conflict of Interest (COI) and Relationship with Industry (RWI) Policies of the American College of Cardiology Foundation (ACCF) and the Cardiovascular Research Foundation (CRF)ACCF/CRF require and collect disclosure of relationships with industry (RWI) from all individuals who are in a position to control or influence educational content . This is done annually in conjunction with all of ACC’s meetings and educational offerings for which CME/CNE/CPE is offered (including the annual ACC Scientific Session) and all of CRF’s meetings and educational offerings for which CME is offered (including TCT, CRF’s major annual educational event) . All individuals involved in directing, planning, and delivering educational content for ACCF and CRF (course directors, planning committee members, faculty, staff, etc) are required to submit RWI disclosures prior to participation; otherwise their participation in the event is precluded . If disclosure of RWI information is not already on file at the inception of a new activity, that information is collected at confirmation of individual participation . This information is also confirmed and updated prior to the development of each CME/CNE/CPE activity to ensure that the most up-to-date information is collected and available . Likewise, nonphysician staff are required to complete RWI Disclosure Declaration forms .
ACCF requires that all faculty disclose their intent to discuss any unlabeled/unapproved uses of drugs and/or devices during their presentations .
COI (RWI) DeclarationThe online Required Faculty Disclosure Declaration form requires each individual to identify financial relationships that he or she and/or his or her spouse or partner have had with any organization within the preceding 12 months or that is anticipated in the next 12 months that could be perceived as a relevant conflict of interest . Any individual who does not complete the form is not permitted to participate; this includes course director(s) and planners (who are then excluded from planning the activity) as well as faculty . For a live activity, each faculty is required to check in upon arrival; and faculty who have not completed their RWI declarations are not allowed to enter the CME/CNE/CPE activity . For enduring activities, the CME/CNE/CPE product is not
published, either online or in print, until all declarations are completed .
COI ResolutionDirector(s) and planning committee members are required to complete the COI Resolution form prior to content development . In the event that a conflict of interest exists, the activity content is reviewed by course director(s), planning committee members, CME/CNE/CPE committee members, or designees who do not have conflicts of interest .
Speakers, Presenters, Moderators, Panelists and Live Case Operators who have declared a COI or RWI are required to complete a COI Resolution form online to agree that their conflict(s) will be resolved by any mechanisms recommended by ACCF/CRF including one or more of the following:
1 . Confirming that no patient care recommendations will be made to the learners regarding the use of drugs or devices from companies with which they have a financial relationship
2 . Confirming that if patient recommendations will be made to the learners regarding the use of drugs or devices from companies with which they have a financial relationship, the conflict will need to be resolved (see next paragraph)
3 . Submitting an alternate resolution of the conflict that is then reviewed by the CME/CNE/CPE Committee, course director(s) and/or planning committee, and if acceptable, approved
4 . Recommending an alternate speaker
5 . Agreeing to divest themselves of the financial relationship
Upon receipt of the COI Resolution form, the course director(s), planning committee members, or CME/CNE/CPE committee members or their designees review each COI Resolution form to determine the course of action, if any, necessary to resolve the conflict . Possible conflict resolution mechanisms, based on the educational design of the program, include using a variety of approaches including, but not limited to:
ACC.12
Disclosure of Financial Relationships
48 GO for ACC.12!
1 . Prior knowledge of speakers’ presentation history (for example, in the past has the individual participated in unbiased presentations, discussions, published literature, etc .)
2 . Knowledge of content and its relevance to the financial relationships
3 . Interview with speakers
4 . Slide peer review
5 . Abstract peer review
6 . Replacing the presenter
For ACCF and TCT annual scientific sessions where presentations number in the thousands, a committee is formed to review all faculty financial relationships to determine whether slide review is necessary; if so, slides are reviewed prior to presentation and, when necessary, changes are recommended and implemented up to and including presenter replacement .
Effective July 2010, in response to an ACCME/ANCC update, sessions with industry employee speakers are allowed to be certified under the following circumstances:
1 . If the content of the session DOES NOT relate to the business lines and products of the industry employer
2 . The presentation is about the scientific or discovery process itself
3 . The presentation is about products that have not yet entered the clinical arena (including products that are under investigation) at the level of biology or physics — but not about products
4 . Presentation slides are submitted at least 2 weeks before the start of the CME/CNE/CPE activity, and the presenter agrees in advance to any and all modifications requested by the CME/CNE/CPE committee
To view the ACC .12 Disclosure Digest which contains disclosure information for all ACC .12 and ACC-i2 with TCT speakers, please visit www.accscientificsession.org, and select Education, then Presenter Disclosures. Or, if your smart phone is enabled with a QR code reader, scan the code below:
Disclosure of Financial Relationships • ACC.12
ACC.12 Final Program 49
ACC.12 has something for everyone, including 16 learning pathways designed to address the specific needs of our learners. Plus, ACC.12 features an integrated ACC-i2 with TCT Interventional Learning Pathway, promoting the continued collaboration between the general and interventional cardiology communities.
Please Note: Admission to all sessions is by permissible badge type only on a first-come, first-served basis.
Session FormatsSymposiaThis classic educational format offers detailed discussions of interest to both general cardiologists and subspecialists in various aspects of scientific, clinical and procedural cardiology . Sessions run for 90 minutes, and topics may include novel approaches to clinical issues as well as evidence-based data and/or clinical trial results . Individuals who have directly contributed information to the subject being discussed typically present these sessions .
Oral ContributionsEach year, the meetings feature oral contributions by the original author of some of the best abstracts accepted to the meeting . Groups of several oral abstracts focusing on a similar topic are offered in 90-minute sessions . The allotted time for each abstract is no more than 15 minutes . Many sessions feature a “Year in Review” talk that provides an overview of what has been accomplished in the past year .
Moderated Poster SessionsThis year’s poster abstract sessions feature over a thousand posters in the classic flat board format . Poster abstract sessions feature dedicated viewing hours, poster discussant faculty to facilitate questions/interaction, Best Poster Award judging, and an e-abstract self-directed learning/archival system .
All poster sessions will be moderated; and poster boards will group like subject matter together, fostering interaction between “poster discussants” and presenters/poster audience . There will be two daily dedicated poster presentation/attendee viewing hours: 9:30 a .m . – 10:30 a .m . and 11:00 a .m . – noon . Limited educational programming will
be scheduled during these times to encourage attendees to visit the poster sessions and interact with the presenters .
Poster sessions for ACC-i2 with TCT will be held from 9:30 a .m . to noon on Saturday, March 24 . New this year, all posters within a given pathway will be presented on the same day and will remain on display for the entire time that the Expo Hall is open .
New this year, one poster presentation from each pathway will be selected as a Best Poster Award winner . The presenter will receive a gift certificate good towards an ACCF educational product or program .
ACC.12 OnlineNew this year, attendees will experience ACC .12 Online for free! ACC .12 Online features some of the most critical, cutting-edge presentations from ACC .12 with live webcasts of 60 sessions and 18 on-demand programs from the Legends of CV Medicine Series and Core Curriculum sessions — available to attendees for free during the meeting . Choose to watch them from a Heart Hub or from your own mobile device — multi-tasking among the simultaneous presentations . To access ACC .12 Online and see a complete schedule of live broadcasts, go to: http://acc12online.cardiosource.org and login with your e-mail address and passcode: ACCONLINE
ACC-i2 with TCT Live and Taped CasesThree live and taped case sessions (one session each on Saturday, Sunday and Monday afternoons) allow attendees to watch an actual invasive cardiovascular procedure in progress via satellite feed from a clinical setting . Some pre-taped cases will also be presented .
ACC.12
Scientific Session Descriptions
50 GO for ACC.12!
International Lunch SymposiaACC is co-hosting a series of symposia held over lunchtime with 18 non-U .S .-based cardiovascular societies . These sessions focus on global clinical and patient management issues that can be presented from the perspective of U .S .-based physicians and non-U .S .-based physicians . Attendees are encouraged to bring their own lunch to the sessions . Food for purchase is available at nearby concessions outside of the symposia rooms .
Legends of Cardiovascular MedicineExpand your horizons with the Legends of Cardiovascular Medicine Lecture Series . Each Legend is an individual that is recognized by all cardiologists as a true leader and innovator and has been selected based on their outstanding contributions to the field of cardiovascular medicine . The Legends will share with the audience their unique professional history of accomplishments and contributions to the cardiovascular field; key milestones that changed practice in their area of expertise; and insights into the future of cardiovascular care . During the Q&A segment, the Legends will share biographical information, impressionable moments from mentors, guiding principles, lessons learned and other introspective thoughts from their own life stories .
Meet the Experts“Meet the Experts” are energizing, case-based, interactive sessions that emphasize scholarly discussion and debate in a lively, but informal small-group setting (maximum capacity of 150) . A specific topic is selected for each session and audience participation is encouraged . Provocative clinical case vignettes or organizational scenarios are typically presented with the case presenter and panelists each making their brief remarks and encouraging participant interaction . Audience response systems are available in each of the Meet the Experts rooms — bring your own personal mobile device to participate .
Special SessionsSpecial sessions are unique events that focus on activities of broad interest to many attendees . The Special Topics Learning Pathway highlights these offerings, which include the Opening Showcase, late-breaking clinical trials, the Young Investigators Awards, sessions designed expressly for fellows in training, the new and exciting Legends of Cardiovascular Medicine Lecture Series, the College business meeting, the
61st Annual Convocation, and the closing session, preceded by Innovators in Cardiology, featuring top leaders in the field .
Heart Songs Learning LabBack by popular demand is the highly rated Heart Songs Self-Paced Learning Lab — a unique audio-visual program to refresh cardiac auscultation skills . After a pre-test, attendees will then listen to Heart Sounds while viewing phonocardiograms, echoes, etc . on an iPod® Touch, an iPad® or laptop computer . Attendees can view the sessions and take both the pre-test and post-test on their own device or use devices provided in the room to document improvement in their auscultation skills . Each session takes approximately 30 minutes to complete . Sessions are self-paced and can start anytime from 9 a .m . to 5 p .m .
Lifelong LearningAgain this year, you can obtain Maintenance of Certification (MOC) points at ACC .12 by participating in daily study sessions approved by the American Board of Internal Medicine (ABIM) . You’ll find presentations geared to general cardiology, interventional cardiology and — new this year — electrophysiology . In addition, pediatric cardiologists will have the opportunity to participate in an interactive MOC study session with questions from the American Board of Pediatrics (ABP) . There is no cost for MOC sessions . They are included in your registration fee!
Also back by popular demand is the Cardiology Core Curriculum, offering a review of every major area of cardiology and helping you to prepare for board exams or refresh clinical knowledge and skills at any stage of your career .
Maintenance of CertificationStart with a new self-assessment session featuring clinically relevant guidelines and trials . Then look for 12 additional Recertification Made Easy review sessions, 2 in interventional cardiology, 2 in electrophysiology, and 8 in general cardiology (half based on ABIM home-study modules and half based on new ACC general cardiology modules) . After the study session, nearby computer workstations allow you to immediately take a post-test, each worth 10 MOC points . Earn up to 70 ABIM MOC points .
Scientific Session Descriptions • ACC.12
ACC.12 Final Program 51
ACC.12 • Scientific Session Descriptions
All ABIM workshop participants must be registered for the session and enrolled in the ABIM MOC program to attend . ABIM staff will be available to assist with on-site enrollment and to answer MOC questions, but please arrive at the session 15 minutes prior to the start . Registrants who sign up for the new ACC general cardiology modules will be able to access them online through their CardioSource account .
Pediatric Cardiology MOCThis interactive session is based on a group of home study modules approved by the American Board of Pediatrics (ABP) . You’ll review with the experts, learn alongside your peers, challenge your medical knowledge with test questions, and get instant feedback with an audience response system . Remember to bring your laptop to the MOC review session . Configure it in advance to receive the convention center’s WiFi signal, and make sure you can access your ABP portfolio . During the program, you’ll submit ABP MOC module answers electronically through the portfolio on the ABP website .
The study session prepares you to earn 10 ABP MOC points . The credit approval period for this module is January 1, 2012 – December 31, 2012 . Participants must be an ABP diplomate and enrolled in the ABP MOC process at the time of the session . For information about enrolling in the ABP MOC process, please visit www.abp.org and log into My ABP Portfolio .
Cardiology Core CurriculumWith the constant growth in cardiovascular knowledge and technology, the need to learn doesn’t end once you enter practice . Update your knowledge, refresh your skills, or simply prepare for the board certification examination with ACC’s highly respected Lifelong Learning Cardiology Core Curriculum . Using the Competency-Based Learning System, you begin with an online pre-test that highlights your areas of educational need . Next, select the Core Curriculum sessions that fill your knowledge gaps . After passing an online post-test, you’ll receive 10 ABIM Part 2 MOC credits
52 GO for ACC.12!
Continue Your Education at the ACC.12 ExpoSouth Building, Level 3, Halls A1 and A2
A vital part of your ACC education can be found in the ACC .12 Expo . Gain an understanding of the latest advances in pharmaceuticals, imaging, devices, technologies and the services that you need to help you provide high-quality patient care .
The ACC .12 Expo features the largest gathering of innovative cardiovascular products and services being shown under one roof . More than 300 exhibiting companies and organizations showcase their products, technologies and services in these categories:
• Associations• Education• Food Service, Nutrition and Lifestyle•Hospital/Institution/Practice• Imaging• Information Technology•Medical Devices•Medical Equipment• Pharmaceuticals• Publishing• Research
You don’t have to miss a minute of education to explore the Expo Hall, located in the South Building, Level 3, Halls A1 and A2 . ACC .12 offers more than six hours of dedicated Expo time — unopposed by education sessions — to meet with industry and learn more about their offerings . Round out your day by discovering cutting-edge innovations as you enjoy morning and afternoon coffee breaks, sponsored by Sanofi US, in the Expo Hall . NEW for ACC.12! Join your colleagues for lunch in the Expo Hall on Monday, March 26, from noon to 2:00 p .m .
Expo HoursSaturday, March 24 9:30 a.m. – 4:30 p.m.Dedicated Expo HoursExpo Coffee Break 9:30 a .m . – 11:30 a .m .Expo Mid-Day Break* 11:30 a .m . – 2:00 p .m .Expo Coffee Break 3:30 p .m . – 4:30 p .m .
Sunday, March 25 9:30 a.m. – 4:30 p.m.Dedicated Expo HoursExpo Coffee Break 9:30 a .m . – 10:45 a .m .Expo Mid-Day Break* 12:15 p .m . – 2:00 p .m .Expo Coffee Break 3:30 p .m . – 4:30 p .m .
Monday, March 26 9:30 a.m. – 2:00 p.m.Dedicated Expo HoursExpo Coffee Break 9:30 a .m . – 10:30 a .m .Expo Mid-Day Break*and NEW for ACC .12!Lunch Hospitality Event Noon – 2:00 p .m .
ACC thanks Sanofi US for its sponsorship of the morning and afternoon coffee breaks .
*Limited ACC.12 lunchtime sessions run concurrently during these time periods
Specialty AreasWe help you maximize your time in the Expo Hall by gathering the vendors you want to see into specialty areas .
American College of Cardiology — ACC CentralMcCormick Place South, Hall A1, #10027
At ACC Central you’ll find comprehensive information on ACC’s quality initiatives; NCDR® registries and research; self-assessment tools; live courses; membership opportunities; and ways to ensure practice viability and protect patient access . In addition, don’t miss the exciting new products and services designed to help you translate science into practice .
ACC.12
Expo
ACC.12 Final Program 53
CardioSmart PavilionMcCormick Place South, Hall A1
As society moves toward more heart-healthy products, ACC has teamed up with consumer companies to help guide physicians and patients to make healthier dietary and lifestyle choices . Visit the CardioSmart Pavilion and sample new heart-healthy options being offered by a variety of consumer companies .
Health IT PavilionMcCormick Place South, Hall A1
ACC is highly committed to assisting its members in the adoption and implementation of health IT to promote quality in cardiovascular care . The Health IT Pavilion is dedicated to showcasing health IT companies and consulting firms; their products, services and technologies; and the benefits to health care providers .
Interventional PavilionMcCormick Place South, Hall A1
Learn about groundbreaking products, services and technologies for interventional cardiology in the Interventional Pavilion . With many new devices and technologies coming into the marketplace, interventional and general cardiologists will want to ensure a visit to this pavilion is on their ACC meeting agendas .
Public Service AreaMcCormick Place South, Hall A2
The Public Service Area gathers cardiovascular societies and non-profit organizations into one location . Visit with these organizations for educational materials, market research and information about advocacy efforts in the U .S . and around the world .
Publishers ShowcaseMcCormick Place South, Hall A1
The very popular Publishers Showcase features publishers of medical texts, journals and other relevant materials . Books and subscriptions are also available for purchase in this area .
Networking AreasRelax and recharge as you network with your colleagues in these areas of the Expo Hall .
ACC Member LoungeMcCormick Place South, Hall A1, #22063
The ACC Member Lounge is open to ACC members during all Expo hours . Take time with colleagues to network and relax, check emails and enjoy a cup of coffee in this inviting atmosphere .
Bistro ACCMcCormick Place South, Hall A2, #1100
Bistro ACC is an innovative dining option offering several fresh and healthy menu choices, including international cuisine and regional favorites . An all-inclusive lunch buffet costs $20 and includes your meal, beverages, dessert and tax . You can purchase lunch tickets by visiting the Bistro ACC ticket counter in the Grand Concourse just outside the Expo Hall .
International LoungeMcCormick Place South, Hall A2, #15097
As a service to our international attendees, we offer a designated International Lounge, where you can join colleagues from around the world to discuss and share the latest science, research and treatment modalities in the field of cardiology . ACC membership materials are available in several languages .
Windy City Café & Tech HubMcCormick Place South, Hall A2, #22111
Join colleagues for a more upscale buffet-style dining experience at the Windy City Café & Tech Hub . The Windy City Café offers you a unique environment in which to relax and make plans for your continuing education and remaining time at ACC .12 . Charging stations will be available for your electronic devices — recharge your batteries and your phone’s batteries — all in one location!
Expo • ACC.12
54 GO for ACC.12!
Company Name Booth Number Company Name Booth Number Company Name Booth Number
Abbott . . . . . . . . . . . . . . . . . . . . . . 4040Abbott Vascular . . . . . . . . . . . . . . . 6048Abiomed, Inc . . . . . . . . . . . . . . . . . 9063ACC China Chapter . . . . . . . . . . . .17101ACC Egypt . . . . . . . . . . . . . . . . . . .18100ACC Pakistan Chapter . . . . . . . . . .18104ACC-Caribbean Chapter c/o
Caribbean Cardiac Society . . . .17102Access Closure, Inc . . . . . . . . . . . .10079Accreditation for Cardiovascular
Excellence . . . . . . . . . . . . . . . .19100Accumetrics, Inc . . . . . . . . . . . . . . .19007ACIST Medical Systems/Bracco
Diagnostics . . . . . . . . . . . . . . . 9048Actelion Pharmaceuticals
US, Inc . . . . . . . . . . . . . 8038, 10038Advanced Cardiac
Diagnostics LLC . . . . . . . . . . . .11085Agfa HealthCare . . . . . . . . . . . . . .12055AirStrip Technologies . . . . . . . . . . .13101Alere Home Monitoring . . . . . . . . .19085Amarin Corp . . . . . . . . . . . . . . . . .20015Amazing Charts . . . . . . . . . . . . . . 23020AME Publishing Company . . . . . . . .1005American College of Cardiology
Mexico Chapter . . . . . . . . . . . .17100American College of Cardiology —
ACC Central . . . . . . . . . . . . . 10027American College of Physicians/
Annals of Internal Medicine . . . .1038American College of Radiology . . . . .6101American Express OPEN . . . . . . . 20075American Heart Association . . . . . . 2040American Physician Institute . . . . . 12074American Society of
Echocardiography . . . . . . . . . . 19096American Society of Nuclear
Cardiology . . . . . . . . . . . . . . . 20096Amgen . . . . . . . . . . . . . . . . . . . . . .14036
Amyloidosis Foundation, Inc . . . . . .20102Angelini Pharmaceuticals . . . . . . . .15090AngioScore, Inc . . . . . . . . . . . . . . . 9077ANSAR Medical Technologies, Inc . 23021Aprima Medical Software . . . . . . .18032Arbor Pharmaceuticals, Inc . . . . . . .15089Arstasis Inc . . . . . . . . . . . . . . . . . . 10090Ascendian Healthcare Consulting . .18041Astellas Pharma US, Inc . . . . . . . . .10001AstraZeneca Pharmaceuticals . . . . .6012AtCor Medical, Inc . (USA) . . . . . . . .11089athenahealth, Inc . . . . . . . . . . . . . .17031Atherotech Diagnostics Lab . . . . . .19089Bard Medical Division . . . . . . . . . .18002Bard Peripheral Vascular . . . . . . . . 4048Baxter Healthcare . . . . . . . . . . . . .14082Berkeley HeartLab, Inc . . . . . . . . . .10042Best Vascular . . . . . . . . . . . . . . . . . .7073BG Medicine, Inc . . . . . . . . . . . . . . 19006BioMed Central . . . . . . . . . . . . . . .19049BMS/Pfizer . . . . . . . . . . . . . . . . . . 2001BodyPartChart LLC . . . . . . . . . . . .11087Boehringer Ingelheim . . . . . . . . . . . 6000Borgess Health . . . . . . . . . . . . . . .19078Boston Scientific . . . . . . . . . . . . . . 3063Brazilian Society of Cardiology . . . .18096British Cardiovascular Society . . . .17096Cambridge Heart, Inc . . . . . . . . . . .12081Cameron Health, Inc . . . . . . . . . . . . 2063Canadian Cardiovascular Society . .21107Cardiac CT Angiography Training . .19106CardiacAssist, Inc . . . . . . . . . . . . . . 9088Cardiology News . . . . . . . . . . . . . .17005Cardiology Today/SLACK
Incorporated . . . . . . . . . . . . . . . .1024Cardiomedix/Commwell . . . . . . . . .18000CardioMEMS, Inc . . . . . . . . . . . . . .15088CardioNet, Inc . . . . . . . . . . . . . . . . .11097Cardionics . . . . . . . . . . . . . . . . . . 20091
CardioPulse (formerly CAOS) . . . . 20049Cardiostim 2012/Reed
Expositions France . . . . . . . . . .18105Cardiovascular Business . . . . . . . .12096Cardiovascular Credentialing
International (CCI) . . . . . . . . . . .19105Cardiovascular Research
Foundation . . . . . . . . . . . . . . . . 2048Cardiovascular Systems, Inc . . . . . . 9078CardioVillage/University of
Virginia . . . . . . . . . . . . . . . . . . .15044Carle Physician Group . . . . . . . . . 20080CellAegis Devices Inc . . . . . . . . . . .10087Centers for Medicare &
Medicaid Services . . . . . . . . . .19076Centra . . . . . . . . . . . . . . . . . . . . . .21079Cerner Corporation . . . . . . . . . . . .18049CFI Medical Solutions . . . . . . . . . . 4097Cleveland Clinic . . . . . . . . . . . . . . .23019Cleveland Clinic Abu Dhabi . . . . . .13086Cleveland Clinic C5 Research . . . . .23016The Coca-Cola Company . . . . . . . .19063Community Health Systems . . . . . .10083Compulink Business
Systems, Inc . . . . . . . . . . . . . . .12087Contec Medical
Systems Co ., LTD . . . . . . . . . . 20048Cook Medical . . . . . . . . . . . . . . . . . 9057Corindus Vascular Robotics . . . . . . 3097Crescendo Systems Corp . . . . . . . .18030Cryolife . . . . . . . . . . . . . . . . . . . . 20009CVRx, Inc . . . . . . . . . . . . . . . . . . . 10063Cytokinetics, Inc . . . . . . . . . . . . . . .17083Daiichi Sankyo, Inc . . . . . . . . . . . . .14026Daiichi Sankyo, Inc . &
Lilly USA LLC . . . . . . . . . . . . . .18013DailyCare BioMedical Inc . . . . . . . . .1004Data Strategies, Inc . . . . . . . . . . . 20034Demos Medical Publishing . . . . . . . .1040
ACC.12
ExhibitorsExhibitors as of February 28, 2012. Please refer to the ACC .12 ExpoGuide and the ExpoGuide Addendum, available at the Expo Hall entrances and in your meeting bag, for the most updated list of exhibitors.
ACC.12 Final Program 55
DesAcc, Inc . . . . . . . . . . . . . . . . . .19081Diagnosoft, Inc . . . . . . . . . . . . . . . .18026Diagnostic & Interventional
Cardiology . . . . . . . . . . . . . . . 10004DiaPharma Group, Inc . . . . . . . . . . . 11075Digisonics . . . . . . . . . . . . . . . . . . .10073The Doctors Company . . . . . . . . . 10043Dornier MedTech America, Inc . . . .10088DR Systems, Inc . . . . . . . . . . . . . . .18035DrFirst, Inc . . . . . . . . . . . . . . . . . . .19087Duke Clinical Research Institute . . .11063eCardio . . . . . . . . . . . . . . . . . . . . . 7097eClinicalWorks . . . . . . . . . . . . . . . .19039Edan Instruments, Inc . . . . . . . . . . . .6100Edwards Lifesciences . . . . . . . . . . 3048Ekos Corporation . . . . . . . . . . . . . . 9083Elsevier-ClinicalKey . . . . . . . . . . . . . 1011Emerge Clinical Solutions . . . . . . . 2054Endothelix, Inc . . . . . . . . . . . . . . . . .1055Endovascular Today . . . . . . . . . . . . 8072Epiphany Cardiography Products . .17037Epsilon Imaging, Inc . . . . . . . . . . . .20074ES Physician Agent . . . . . . . . . . . .18004Esaote North America . . . . . . . . . . .2019European Society of Cardiology . . .11080Fibromuscular Dysplasia Society
of America (FMDSA) . . . . . . . . .21105Flexible Informatics . . . . . . . . . . . . 6072Forest Pharmaceuticals . . . . . . . . .18063FUJIFILM Medical Systems
USA, Inc . . . . . . . . . . . . . . . . . .19053Gambro UF Solutions, Inc . . . . . . . .19088GE Healthcare . . . . . . . . . . . . . . . . .8013GEMMS . . . . . . . . . . . . . . . . . . . . 20027GeneDx . . . . . . . . . . . . . . . . . . . . . 6073Genentech and Roche . . . . . . . . . .15027Genway Biotech . . . . . . . . . . . . . . .15084Genzyme . . . . . . . . . . . . . . . . . . . .13083Gilead Sciences . . . . . . . . . 8000, 10006Glenmark Pharmaceuticals . . . . . .10041Guerbet . . . . . . . . . . . . . . . . . . . . . .8071Harvard Clinical Research
Institute . . . . . . . . . . . . . . . . . .16083The Healthcare Network . . . . . . . 20033Health Management Associates . . .21077
Health Outcomes Sciences . . . . . . 4096Heart Institute Diagnostic Lab . . . .20101The Heart Institute for Children,
Hope Children’s Hospital, Advocate Christ Medical Center . 20097
Heart Rhythm Society . . . . . . . . . .20105Heart Test Laboratories, Inc . . . . . .18085Heartbeat International . . . . . . . . 20098HeartSine Technologies, Inc . . . . . .15082HeartWare Inc . . . . . . . . . . . . . . . .11079Henry Schein MicroMD . . . . . . . . 20035Hershey Center for Health &
Nutrition® . . . . . . . . . . . . . . . . 20063Hitachi Aloka Medical . . . . . . . . . .12063HMP Communications, LLC . . . . . . 8049Hokanson . . . . . . . . . . . . . . . . . . 16004Hospital Corporation of America
(HCA) . . . . . . . . . . . . . . . . . . . 10096HRA Healthcare Research &
Analytics . . . . . . . . . . . . . . . . .11086Hypertrophic Cardiomyopathy
Association . . . . . . . . . . . . . . . .21100IEM . . . . . . . . . . . . . . . . . . . . . . . .10089INC Research . . . . . . . . . . . . . . . . .24018INDEC Systems Inc . . . . . . . . . . . . . 9056INFINITT North America . . . . . . . . .12088InfraReDx, Inc . . . . . . . . . . . . . . . . . 3054InspireMD . . . . . . . . . . . . . . . . . . . 2067Intelemage, LLC . . . . . . . . . . . . . . .14084International Society for
Cardiovascular Translational Research . . . . . . . . . . . . . . . . . 21101
Intersocietal Accreditation Commission (IAC) . . . . . . . . . . .20104
Intuitive Solutions . . . . . . . . . . . . 20038Israel Heart Society . . . . . . . . . . . .17104Itamar Medical . . . . . . . . . . . . . . .18016JAMA & Archives Journals . . . . . . . .1030Janssen Pharmaceuticals, Inc . . . . .10007Jaypee Highlights Medical Pub . . . . .1044John Welsh Cardiovascular
Diagnostic Laboratory . . . . . . .19104Jones & Bartlett Learning . . . . . . . .1034JTE Multimedia . . . . . . . . . . . . . . . .1006Kaneka . . . . . . . . . . . . . . . . . . . . 20087
Koven Technology, Inc . . . . . . . . . .11081Lantheus Medical Imaging, Inc . . . . 6099Laurel Bridge Software, Inc . . . . . . 6098Le Cardiologue . . . . . . . . . . . . . . . .1042LifeWatch Services, Inc . . . . . . . . .15083LipoScience . . . . . . . . . . . . . . . . . .18069Lippincott Williams & Wilkins/
Wolters Kluwer Health . . . . . . . .1017Littmann Stethoscopes . . . . . . . . .16001LUMEDX . . . . . . . . . . . . . . . . . . . .17007MAQUET Medical Systems . . . . . . 3096Mars Botanical . . . . . . . . . . . . . . .21063Mayo Clinic . . . . . . . . . . . . . . . . . .19001McGraw-Hill . . . . . . . . . . . . . . . . . .1010McKesson . . . . . . . . . . . . . . . . . . .18027MedActivus . . . . . . . . . . . . . . . . . .19079MedAxiom . . . . . . . . . . . . . . . . . . .12049MedCo Data LLC . . . . . . . . . . . . . 20045The Medical Roundtable
c/o FoxP2 Media LLC . . . . . . . . .1032Medical Simulation Corporation . . . .1051The Medicines Company . . . . . . . . 4054Mednet Healthcare Technologies . . 6097MEDRAD Interventional . . . . . . . . . 6062Medstreaming LLC . . . . . . . . . . . .18007Medtronic, Inc . . . . . . . . . . . . . . . . 6038The Mended Hearts, Inc . . . . . . . . .21069Merck . . . . . . . . . . . . . . . . . . . . . .14008Merge Healthcare . . . . . . . . . . . . .17043Methodist DeBakey Heart &
Vascular Center . . . . . . . . . . . .17082Met-Test, LLC . . . . . . . . . . . . . . . .17089Midmark Corporation . . . . . . . . . . .12080MiE America-Medical Imaging
Electronics . . . . . . . . . . . . . . . .10081Millar Instruments . . . . . . . . . . . . 10000Miller Pharmacal Group, Inc . . . . . . 7096Million Hearts™ . . . . . . . . . . . . . .21067Mortara Instrument . . . . . . . . . . . . 9026Mountain States Health Alliance . .19084National Death Index . . . . . . . . . . .21080National Heart, Lung and
Blood Institute (NHLBI) . . . . . . .16089Navigant,
formerly Paragon Health . . . . . 20051
Company Name Booth Number Company Name Booth Number Company Name Booth Number
ACC.12 • Exhibitors
56 GO for ACC.12!
ndd Medical Technologies . . . . . . .17003New England Journal of Medicine . 16000NextGen Healthcare . . . . . . . . . . . 19043NextServices Inc . . . . . . . . . . . . . . .19035Norav Medical . . . . . . . . . . . . . . . .18001NorthEast Monitoring, Inc . . . . . . . 20081Northwestern Medicine . . . . . . . . .14083Novartis Pharmaceuticals
Corporation . . . . . . . . . 16017, 18020Oklahoma Heart Hospital . . . . . . . .18099Oxford University Press . . . . . . . . . .1012Panasonic . . . . . . . . . . . . . . . . . . .18075PCNA Preventive Cardiovascular
Nurses Association . . . . . . . . . .21104Pediatric and Adult Interventional
Cardiac Symposium (PICS-AICS) . . . . . . . . . . . . . . 10084
Perkins Healthcare Technologies . .21091Philips . . . . . . . . . . . . . . . . . . . . . . .6076PhoneTree . . . . . . . . . . . . . . . . . . .21090PhysBiz Tech . . . . . . . . . . . . . . . . 20043Pie Medical Imaging . . . . . . . . . . . 9090Pikeville Medical Center . . . . . . . . .12086Pivotal Therapeutics Inc . . . . . . . . 24020PracticeLink .com . . . . . . . . . . . . . . 2004PracticeMax . . . . . . . . . . . . . . . . .17029Provation Medical-Wolters
Kluwer Health . . . . . . . . . . . . . 20053Pulmonary Hypertension
Association . . . . . . . . . . . . . . . .21082Pulse Biomedical, Inc . . . . . . . . . . .19082Pulse Medical Inc . . . . . . . . . . . . . .12072QGenda .com . . . . . . . . . . . . . . . . 20039Quaker Oats . . . . . . . . . . . . . . . . .21071Roche Diagnostics . . . . . . . . . . . . 16009Rush University Medical Center . . .10082Saint Alphonsus Health System . . 20076Sanofi . . . . . . . . . . . . . . . .12001, 14000
Saudi Heart Association . . . . . . . . .18102SCHILLER . . . . . . . . . . . . . . . . . . .11054ScImage . . . . . . . . . . . . . . . . . . . . 7063ScottCare Corporation . . . . . . . . . . .2013seca . . . . . . . . . . . . . . . . . . . . . . 20090Shape Medical Systems, Inc . . . . . .14089Shiel Medical Laboratory . . . . . . . .19075Shimadzu Medical Systems USA . . 8048Siemens Healthcare . . . . . . . . . . . . 2026Sim-e-Child . . . . . . . . . . . . . . . . . .18101Singulex, Inc . . . . . . . . . . . . . . . . . .18089Sociedad Latinoamericana
de Cardiologia Intervencionista (SOLACI) . . . . . . . . . . . . . . . . .18097
Sociedad Venezolana de Cardiologia . . . . . . . . . . . . .17105
Society for Cardiovascular Angiography and Interventions (SCAI) . . . . . . . . . 9082
Society for Heart Attack Prevention and Eradication (SHAPE) . . . . .21106
Society of Cardiovascular Computed Tomography . . . . . .19103
Society of Chest Pain Centers . . . 16044Spacelabs Healthcare . . . . . . . . . .11001Spanish Society of Cardiology . . . .21096Spartan Bioscience . . . . . . . . . . . . 9089Springer . . . . . . . . . . . . . . . . . . . . . .1026St . Jude Medical . . . . . . . . . . . . . . .3013St . Luke’s Health System . . . . . . . .19074StopAfib .org . . . . . . . . . . . . . . . . .21098SUBWAY . . . . . . . . . . . . . . . . . . . .21062Summit Doppler Systems . . . . . . . .11073Takeda Pharmaceuticals
North America . . . . . . . . . . . . .15037TeraRecon . . . . . . . . . . . . . . . . . . .18055Terumo Interventional Systems . . .21015Texas Children’s Hospital . . . . . . . .12078
theheart .org . . . . . . . . . . . . . . . . . .12073Thoratec Corporation . . . . . . . . . . .12097TIMI Study Group . . . . . . . . . . . . . .10050TomTec Imaging Systems GmbH . .10097Toshiba America Medical
Systems, Inc . . . . . . . . . . . . . . . 6026Total Vein Systems . . . . . . . . . . . .15045TransAmerican Medical Imaging . . 7098Transgenomic, Inc . . . . . . . . . . . . .11078Trinity Mother Frances Hospitals
& Clinics . . . . . . . . . . . . . . . . . 20084Turkish Society of Cardiology ACC
Istanbul Chapter Consortium . .17103TYRX Inc . . . . . . . . . . . . . . . . . . . . 9085Unfors RaySafe, Inc . . . . . . . . . . . . .1057Universal Medical Resources, Inc . .10039UpToDate . . . . . . . . . . . . . . . . . . . 20057Vascular Solutions . . . . . . . . . . . . . .1053Vasomedical, Inc . . . . . . . . . . . . . . .14097VectraCor . . . . . . . . . . . . . . . . . . .13090The VEINS Chicago 2012 . . . . . . . . 9076Velos, Inc . . . . . . . . . . . . . . . . . . . .12084Verathon Medical . . . . . . . . . . . . . .13089Vital Images . . . . . . . . . . . . . . . . . .11088Volcano Corporation . . . . . . . . . . . 8054W .A . Baum Co ., Inc . . . . . . . . . . . . 10045Weaver and Company . . . . . . . . . .18083Welch Allyn, Inc . . . . . . . . .16037, 16045Western Systems Research, Inc . . .13088Wiley-Blackwell . . . . . . . . . . . . . . . .1016WomenHeart: The National
Coalition for Women with Heart Disease . . . . . . . . . . . . . .21103
World Heart Federation . . . . . . . . .19097Yuma Regional Medical Center . . .19077ZHealth Publishing . . . . . . . . . . . . . .7072Z-Medica Corporation . . . . . . . . . . 8097ZOLL Medical Corporation . . . . . . . 8063
ACC has advised all exhibiting companies that it is each company’s responsibility to ensure adherence to FDA regulations, policies, practices and guidelines, and all other applicable industry guidelines, concerning the demonstration, discussion, use and/or display of products, technologies and/or services the ACC.12 Annual Scientific Session Exposition. Exhibiting companies have also been reminded of the FDA restrictions on the promotion of investigational and pre-approved drugs, devices and procedures. Information regarding FDA regulations should be obtained directly from the FDA.
Company Name Booth Number Company Name Booth Number Company Name Booth Number
Exhibitors • ACC.12
ACC.12 Final Program 57
Learning Destinations™ are diverse, non-accredited, educationally focused areas that offer new and creative ways to expand your educational experience. We invite you to visit these dynamic learning environments, located in the Expo Hall (South Building, Level 3, Halls A1 and A2).
NEW for ACC.12! CardioSmart ForumMcCormick Place South, Hall A2, CV Theater, #22097
You know that behavioral change is one of the most important factors in your patients living a heart-healthy lifestyle . (They know that, too .) So how can you help your patients overcome their resistance to changing their eating behaviors for the better? And for the long term? Visit the CardioSmart Forum* on Saturday, March 24, from 11:15 a .m . to 12:15 p .m . for the presentation “Eat What You Love, Love What You Eat: How to Break Your Eat-Repent-Repeat Cycle .” Dr . Michelle May, author of the award-winning book of the same name, will deconstruct the “Mindful Eating Cycle” and explore the bio-psycho-social drivers of each decision point . You’ll learn a powerful and universal approach to the complex issues contributing to problematic eating behaviors and walk away with six unconventional strategies that promote heart-healthy lifestyles, which could help improve your patients’ outcomes . This presentation is part of the “CardioSmart: Hot Topics for Better Patient Outcomes” series .
CV Innovations Educational ForumMcCormick Place South, Hall A2, CV Theater, #22097
The ACC, in partnership with Elsevier Business Intelligence and the International Society for Cardiovascular Translational Research, will once again offer the CV Innovations Educational Forum*, featuring cutting-edge cardiovascular research and cardiovascular product development . Catch a glimpse of the future on Sunday, March 25, and Monday, March 26, as physicians, researchers, venture capitalists and investment bankers gather for presentations and panel discussions, and explore cardiovascular technologies in development . Refer to the “ACC .12 Learning Destination Presentations” pages at the end of each daily section for the scheduled presentations, speakers and descriptions .
Topics include:
•Device Development and Innovation• Current Approaches for Treating Calcified Peripheral
Arterial Disease• Challenges Associated with Treating Calcified Coronary
Artery Disease• The Role of Innovative Technologies in a Novel Strategy
to Prevent First Coronary Event• The Role of Nanotechnology in Cardiovascular Diseases• Cellular Therapy• Tissue Engineering• Personalized Medicine
NEW for ACC.12! The Heart of Innovation Featured Learning DestinationMcCormick Place South, Hall A1, #1076
In the spectrum of chronic cardiovascular diseases, two of the most significant challenges faced by cardiology professionals today are coronary artery disease and heart failure caused by valvular disease . In the Heart of Innovation Learning Destination*, you will explore the evolution of the standard of care for these two diseases through the lenses of Personalized Medicine, TechnoBiology, Minimally Invasive Procedures and Physician-Patient Engagement .
The Heart of Innovation will allow you to closely examine the protocols, approaches and advances that are driving better clinical outcomes today . To help you see the continuum of progress, you will revisit the innovators and innovations of the past, while exploring the exciting possibilities for the future and weighing in with your own opinions about how new
ACC.12
Learning Destinations™
58 GO for ACC.12!
techniques and technologies will impact your practice in years to come .
The adjoining Thought Leader Theater™ will feature clinically based presentations, as well as discussions with physicians and healthcare providers who are at the forefront of cardiovascular innovation . Refer to the “ACC .12 Learning Destination Presentations” pages at the end of each daily section for the scheduled presentations, speakers and descriptions .
ACC is grateful for the support of the Marquee Heart of Innovation Partner:
Helping you transform patient care through innovations and partnerships
ACC also thanks the following supporting companies:
bioMérieux
CFI Medical Solutions
Corindus Vascular Robotics
Edwards Lifesciences
International Society for Cardiovascular Translational Research
ACC also thanks the following participating companies:
Health Outcomes SciencesMAQUET Medical Systems USA
Medtronic, Inc .Terumo Interventional Systems
Industry-Expert TheaterMcCormick Place South, Hall A1, #22042
Connect with the experts in the Industry-Expert Theater* as presenters share the latest in cardiovascular practices, products, services and technologies while you enjoy refreshments or lunch — presentations are conveniently scheduled during the daily coffee and mid-day breaks . Refer to the “ACC .12 Learning Destination Presentations” pages at the end of each daily section for the scheduled presentations, speakers and descriptions .
• Antiplatelet Therapy Choices for High-Risk PCI Patients in the Era of Generic Clopidogrel: The Role of Platelet Reactivity Testing — Accumetrics
• Considerations for Radionuclide Myocardial Perfusion Imaging in Patients with COPD/Asthma — Astellas Pharma US, Inc.
• Pradaxa® (Dabigatran Etexilate Mesylate) Capsules — Boehringer Ingelheim Pharmaceuticals, Inc.
• A Stroke Prevention Option in Nonvalvular Atrial Fibrillation — Janssen Pharmaceuticals Inc.
•Managing Atherosclerotic Risk with a Particle Focus — New Recommendations and Emerging Data — LipoScience
•Next Generation DES: Evolving the Treatment Paradigm — Medtronic, Inc.
• Emerging Procedures Today, Future Standard of Care — Toshiba Medical Systems
• Treating a Patient at Risk for SCD after PCI — Implant an ICD, Right? The Considerations for Treatment Path Planning, Coverage, and the Role of the Wearable Cardioverter Defibrillator — ZOLL
Interactive Learning LabsMcCormick Place South, Hall A1, #22027, #22035 & #23027
Experience hands-on training and interactive didactic presentations in the Interactive Learning Labs*. This unique educational opportunity puts new technology in your hands and new information in your arsenal . Refer to the “ACC .12 Learning Destination Presentations” pages at the end of each daily section for the scheduled presentations, speakers and descriptions .
Actelion Pharmaceuticals US, Inc. (#23027)• Pulmonary Arterial Hypertension Associated with Adult
Congenital Heart Disease: An Interactive Program• PAH: A Case-Based Exploration of Management
Strategies
Philips Healthcare (#22035)• Speckle Tracking Today for Myocardial Deformation —
A Hands-On Guided Workshop•How Can Cardiology Informatics Enrich My Electronic
Health Records Strategy?• Clinical Application of Real-Time 3D TEE for
Percutaneous Structural Heart Interventions
Learning Destinations™ • ACC.12
ACC.12 Final Program 59
ACC.12 • Learning Destinations™
•Hypothermia for Cardiac Protection in Acute Myocardial Infarction
• Cardiac CT — The Journey from Plaque Recognition to Prognosis
• Benefit of Cardiac Troponin Point-of-Care Testing in the Emergency Department
• Sleep, Breathing and the Heart: Cardiovascular Consequences of Sleep-Disordered Breathing
• Innovations in Cardiovascular Interventions
Terumo Interventional Systems/The Medicines Company (#22027)
• Educating to Help Improve Outcomes: Hands-On Radial Access Simulations
•Optimizing Your Outpatient PCI: What You Need to Know and Consider
* Presentations in the ACC.12 Learning Destinations are not part of the official ACC Annual Scientific Session & Expo and/or ACC-i2 with TCT, as planned by their Program Committees. Presentations in the ACC.12 Learning Destinations do not qualify for continuing medical education (CME), continuing nursing education (CNE) or continuing education (CE) credit.
60 GO for ACC.12!
Friday, March 23, 5:30 p.m. – 9:30 p.m.Swissôtel Chicago323 East Wacker Drive
Optimizing PCI Outcomes: A Vision for 2012Sponsored by Cardiovascular Research Foundation
Course Directors:Martin B . Leon, MD — NewYork-Presbyterian Hospital/
Columbia University Medical Center; New York, NYGregg W . Stone, MD — NewYork-Presbyterian Hospital/
Columbia University Medical Center; New York, NY
Faculty:Antonio Colombo, MD — Columbus Hospital/San Raffaele
Hospital; Milan, ItalyGeorge D . Dangas, MD, PhD — Mount Sinai Medical Center;
New York, NYWilliam F . Fearon, MD — Stanford University Medical Center;
Stanford, CAC . Michael Gibson, MD — Beth Israel Deaconess Medical
Center; Boston, MAEberhard Grube, MD — University Hospital Bonn; Bonn,
GermanyAjay J . Kirtane, MD, SM — NewYork-Presbyterian Hospital/
Columbia University Medical Center; New York, NYYves Louvard, MD — Institut Hospitalier Jacques Cartier;
Massy, FranceAkiko Maehara, MD — Cardiovascular Research Foundation;
New York, NYBrij Maini, MD — Pinnacle Health System; Harrisburg, PARoxana Mehran, MD — Mount Sinai Medical Center; New
York, NYGary S . Mintz, MD — Cardiovascular Research Foundation;
Washington, DCE . Magnus Ohman, MD — Duke University Medical Center;
Durham, NCSeung-Jung Park, MD, PhD — Asan Medical Center; Seoul,
South Korea
Manesh R . Patel, MD — Duke University Medical Center; Durham, NC
Jeffrey J . Popma, MD — Beth Israel Deaconess Medical Center; Boston, MA
Erick Schampaert, MD — Hopital du Sacre-Coeur de Montreal; Montreal, Canada
Patrick W . Serruys, MD, PhD — Thoraxcenter; Rotterdam, The Netherlands
Paul S . Teirstein, MD — Scripps Clinic and Research Foundation; La Jolla, CA
Giora Weisz, MD — NewYork-Presbyterian Hospital/Columbia University Medical Center; New York, NY
Mathew Williams, MD — NewYork-Presbyterian Hospital/Columbia University Medical Center; New York, NY
Saturday, March 24, 6:30 p.m. – 9:00 p.m.Hyatt Regency McCormick Place (Grand Ballroom)2233 South Martin Luther King Drive
Evaluating Recent Clinical Trial Data in the Secondary Prevention of Acute Coronary Syndrome (ACS)Sponsored by theheart.org
Chair:C . Michael Gibson, MD — Chairman, PERFUSE Study Group;
Chairman, WikiDoc Foundation; Chief of Clinical Research CV Division, Beth Israel Deaconess Medical Center; Associate Professor of Medicine, Harvard Medical School; Consulting Professor in Medicine, Duke University School of Medicine; Durham, NC
Faculty:John H . Alexander, MD, MHS — Associate Professor of
Medicine, Division of Cardiovascular Medicine, Duke Clinical Research Institute, Duke University Medical Center; Durham, NC
Freek W . A . Verheugt, MD — Professor of Cardiology, Chairman, Department of Cardiology, Onze Lieve Vrouwe Gasthuis; Amsterdam, The Netherlands
ACC.12
Non-Accredited Educational EventsThese events are not part of the official ACC Annual Scientific Session & Expo and/or ACC-i2 with TCT, as planned by their Program Committees. These events do not qualify for continuing medical education (CME), continuing nursing education (CNE) or continuing education (CE) credit.
Presentation schedules are current as of Feb. 28, 2012, and are subject to change. Please check the ACC .12 ExpoGuide and ExpoGuide Addendum, available at Expo Hall entrances and in your Official Meeting Bag, for updated information. More information is also available at www .expo .acc .org .
ACC.12 Final Program 61
E . Magnus Ohman, MD — Professor of Medicine, Associate Director, Duke Heart Center - Cardiology Clinics; Director, Program for Advanced Coronary Disease, Duke Clinical Research Institute, Duke University Medical Center; Durham, NC
Sunday, March 25, 5:30 a.m. – 7:30 a.m.Hyatt Regency McCormick Place2233 South Martin Luther King Drive
Pathways of Disease Progression in Heart Failure — What Can Galectin-3 Tell Us?Sponsored by BG Medicine, Inc.
Chair:Professor John G .F . Cleland — University of Hull; United
Kingdom
Faculty:Inder Anand, MD, DPhil, FACC, FRCP — University of
Minnesota and Minneapolis VA Medical Center; Minneapolis, MN
Rudolf A . de Boer, MD, PhD — University of Groningen; The Netherlands
Jennifer E . Ho, MD — National Heart, Lung, and Blood Institute’s Framingham Heart Study; Framingham, MA
Kenneth Stein, MD, FACC — Senior Vice President and Chief Medical Officer, Cardiac Rhythm Management at Boston Scientific; Minneapolis, MN
Sunday, March 25, 5:30 a.m. – 7:30 a.m.Chicago Marriott Magnificent Mile540 North Michigan Avenue
3rd Annual Massachusetts General Hospital Optical Coherence Tomography (OCT) Symposium: A Comprehensive Review of OCT in Today’s Cath Lab EnvironmentSponsored by St. Jude Medical
Moderators:Ik Kyung Jang, MD, PhD, FACC — Professor of Medicine,
Harvard Medical School; Interventional Cardiology, Massachusetts General Hospital; Director, Cardiology Laboratory for Integrative Physiology & Imaging (CLIPI); Boston, MA
Jagat Narula, MD, PhD, FACC — Philip J. and Harriet L. Goodhart Chair in Cardiology, Professor of Medicine, Associate Dean for Global Health, Mount Sinai School of
Medicine; Director, Cardiovascular Imaging Program, Zena and Michael A. Wiener Cardiovascular Institute and Marie-Josée and Henry R. Kravis Center for Cardiovascular Health; New York, NY
Speakers:Marco A . Costa, MD, PhD, FACC, FSCAI — Professor of
Medicine; Director, Interventional Cardiovascular Center, Director, Center for Research and Innovation; Harrington-McLaughlin Heart and Vascular Institute; University Hospitals, Case Western Reserve University; Cleveland, OH
Koji Kato, MD, PhD — Research Fellow, Cardiology Division, Massachusetts General Hospital, Harvard Medical School; Boston, MA
Soo Joong Kim, MD, PhD — Associate Professor of Medicine, Kyung Hee University Hospital; Seoul, Korea; Research Fellow, Cardiology Division, Massachusetts General Hospital, Harvard Medical School; Boston, MA
Francesco Prati, MD — Interventional Cardiology, San Giovanni Hospital, CLI Foundation; Rome, Italy
Abhiram Prasad, MD — Professor of Medicine, Division of Cardiovascular Diseases, Mayo Clinic; Rochester, MN
Taishi Yonetsu, MD — Research Fellow, Cardiology Division, Massachusetts General Hospital, Harvard Medical School; Boston, MA
Sunday, March 25, 6:30 p.m. – 8:15 p.m.Four Seasons Hotel Chicago120 East Delaware Place
Baroreflex Activation Therapy (BAT) for Resistant Hypertension & Heart Failure: A Novel Approach to Cardiovascular TreatmentSponsored by CVRx, Inc.
Chairmen:Eugene Braunwald, MD — Distinguished Hersey Professor,
Harvard Medical School; Founding Chairman, TIMI Study Group, Brigham and Women’s Hospital
Alberto Zanchetti, MD — Scientific Director, Istituto Auxologico of Milan; Emeritus Professor of Internal Medicine, University of Milan
Speakers:Prof . John D . Bisognano, MD — Director of Outpatient
Cardiology, University of Rochester Medical CenterProf . George Bakris, MD — Director, Hypertension Center,
The University of Chicago Hospitals
ACC.12 • Non-Accredited Educational Events
62 GO for ACC.12!
Prof . Hermann Haller, MD — Director, Department of Nephrology at Hannover Medical School in Germany
Prof . Hani N . Sabbah, MD — Professor of Medicine, Wayne State University; Director of Cardiovascular Research, Henry Ford Health System
Prof . Uta Hoppe, MD — Director, Department of Internal Medicine II, Paracelsus University Salzburg, Austria
Prof . William T . Abraham, MD — Director, Division of Cardiovascular Medicine, The Ohio State University
Sunday, March 25, 6:30 p.m. – 9:00 p.m.InterContinental Chicago (Grand Ballroom, 7th Floor)505 North Michigan Avenue
SYMPLICITY HTN-3 Trial: Evaluating Renal Denervation for Resistant HypertensionSponsored by Medtronic, Inc.
Physician Panel: Henry Krum — SYMPLICITY HTN-1 Lead Author Murray Esler — SYMPLICITY HTN-2 Lead Author Suzanne Oparil — SYMPLICITY HTN-3 Steering Committee David Kandzari — SYMPLICITY HTN-3 Steering Committee
Non-Accredited Educational Events • ACC.12
ACC.12 Final Program 63
Friday, March 23, 11:00 a.m. – 1:00 p.m.McCormick Place, Room S501
ECMO 2012: New Technologies and New Indications Sponsored by Methodist DeBakey Heart and Vascular Center
11:00 Registration and Lunch11:25 Welcome and Introductions — Wade L . Fischer, MD11:30 ECMO: History, Trials, and Utilization —
Faisal Masud, MD11:50 Use of ECMO in the Acute MI and ARDS Patient —
Wade L . Fischer, MD12:10 ECMO as the Bridge-to-Transplant —
Christian Bermudez, MD12:30 Future Considerations — Matthias Loebe, MD, PhD12:50 Question and Answer1:00 Adjourn
Friday, March 23, Noon – 3:00 p.m.McCormick Place, Room S502
Future Direction of Stem Cells in Cardiovascular DiseaseSponsored by Texas Heart Institute
12:00 Luncheon Buffet12:15 Welcome and Introductions12:20 Stem Cells in Cardiovascular Disease: Where Are
We Today? — James T . Willerson, MD12:40 Peripheral Vascular Disease and Stem Cell Therapy
— Emerson C . Perin, MD, PhD1:00 Cell Therapy of Acute ST Elevation Myocardial
Infarction — Andreas M . Zeiher, MD1:20 Break1:35 Case from Texas Heart Institute —
Emerson C . Perin, MD, PhD1:55 Stem Cell Transplantation for Ischemic
Cardiomyopathy — James T . Willerson, MD2:15 cKit Stem Cell Therapy of Ischemic Cardiomyopathy
— Piero Anversa, MD
2:35 From small-molecules to cardio-regenerative drugsfor heart repair — Jay Schneider, MD, PhD
2:50 Adjourn
Friday, March 23, 8:00 a.m. – 4:30 p.m.McCormick Place, Room N229
28th International Conference on Recent Advances in Echocardiography and Allied TechniquesSponsored by University of Alabama at Birmingham
Case Studies In Echocardiography7:30 Registration, Coffee/Tea7:55 Welcome and Course Orientation —
Dr . Navin Nanda8:00 Session I . Cardiomyopathy, Congenital Heart
Disease, CT/MRI, Intracardiac Echo, LV, Masses, Myocardial Infarction, Percutaneous Devices, Tissue Doppler Imaging, Valvar Heart Disease, Velocity Vector Imaging, 3D Echo, Miscellaneous Case Presentations and Discussion, Cases 1-15
10:00 Refreshment break10:15 Session II . Biventricular Pacing, Cardiomyopathy/
Myocarditis, Coronary Artery Disease, CT/MRI, Echo Quantification, Embolism, LV Diastolic Function, Masses, Post Intervention, Prosthetic Valves, Shunt Lesions, Valvar Heart Disease, 3D Echo . Case Presentations and Discussion, Cases 16-23
11:30 Session III . Aortic Pathologies, Cardiac Dyssynchrony, Congenital Heart Disease, Critical Care, CT/MRI, Masses, Pericarditis, Stress Echo, Valvar Heart Disease, Valve Repair, 3D Echo .
1:00 Lunch on your own2:00 Session IV . Cardiomyopathy/Myocarditis, CT/MRI,
Congenital Heart Disease, Endocarditis, Heart Failure, Post Intervention, Prosthetic Valves, Pulmonary Hypertension, RV Function, Strain and Strain Rate, Valve Repair and Surgery, 3D Echo .
Independent CME/CE-Certified Pre Conference & Evening ProgramsIndependent CME/CE-Certified Pre Conference or Evening Programs are not part of the official ACC Annual Scientific Session & Expo and/or ACC-i2 with TCT, as planned by their Program Committees.
Titles, times and/or locations are subject to change.
64 GO for ACC.12!
3:30 Session V . Cardiomyopathy/Myocarditis, Coronary Aneurysm, Embolism, Endocarditis, Heart Failure, Masses, Myocardial Infarction, Pericardial Disease, Peripheral Arterial Disease, Prosthetic Valves, RV Volume, Systemic Diseases, Trauma, Valvar Heart Disease, Valve Repair, 3D Echo, Miscellaneous .
4:30 Adjournment
Saturday, March 24, 6:30 p.m. – 8:45 p.m.Chicago Marriott Downtown540 North Michigan Avenue
Clinical Challenges in the Secondary Prevention of CADSponsored by Mayo Clinic
6:00 Registration6:30 Introduction6:45 Great Expectations: How to Meet Quality Indicators
for Secondary Prevention in CAD— Randal J . Thomas, MD
7:10 Early Onset CAD: Tests, Treatments, and Family Screening — Iftikhar J . Kullo, MD
7:35 LDL and Beyond: Challenges in Lipid Management for Secondary CAD Prevention — Thomas G . Allison, PhD
8:00 The Obesity Paradox in CAD: How to Assess and Reduce Obesity-Related CAD Risk — Jorge F . Trejo-Gutierrez, MD
8:25 Panel Discussion8:45 Adjourn
Sunday, March 25, 6:30 p.m. – 9:15 p.m.Chicago Marriott Downtown540 North Michigan Avenue
Hemodynamic Catheterization- HFpEF and BeyondSponsored by Mayo Clinic
6:00 Registration6:30 Heart Failure with Preserved EF - When and Why Do
You Need Invasive Hemodynamic Evaluation — Margaret M . Redfield, MD
6:45 Hemodynamic Evaluation of Dyspnea with Normal Ejection Fraction — Barry A . Borlaug, MD
7:15 Invasive Evaluation of Pulmonary Hypertension: Is it The Left Heart, Vasculature or Both — Robert P . Frantz, MD
7:45 Hemodynamic Assessment Pre and Post TAVR — Charanjit S . Rihal, MD
8:15 Jugular Distention and Edema: Myocardium, Pericardium, or Something Else — Barry A . Borlaug, MD
8:45 Hypertrophic Cardiomyopathy: What Cath Will Tell You That Echo Cannot — Paul Sorajja, MD
9:15 Adjourn
Independent CME/CE-Certified Pre Conference & Evening Programs • ACC.12
Your Roadmapto ACC.12
Your Roadmap to ACC.12
ExpEriEncE
Special attendee pricing expires March 27, 2012. *Savings vary with registration category
A12
199
©20
12 A
mer
ican
Col
lege
of C
ardi
olog
y
Order iScience today at the following locations:
• SouthBuilding,GrandConcourseLobby,Level3
• ACCCentral,Booth#10027,intheExhibitHall
Ororderonlineatwww.CMEonCall.com/accEnteryourbadgenumbertoreceivethe
attendeediscount.
Order iScience, the Acc.12 Meeting on Demand, during the meeting, and save over $1,000*!
iScienceisacomprehensivedigitallibraryofpresentationsfromACC.12andincludesover400hoursofeducationalcontent.ItisthemostconvenientwaytoexperiencealltheeducationfromACC.12andallowsyoutowatchpresenters’slideswhilelisteningtofully-synchronizedaudioasifyouwereactuallyattendingeachsession. Features of iScience include:
• Onlineaccesstocontentwithin24hours
• ConvenientUSBdrivewithaccesstotheentireiSciencelibraryforofflineviewing
• StreamingcontentforviewingoniPad®andiPhone®devices.
• DownloadablePDF’sofpresenterslidesforconvenientreferenceandnotetaking
• DownloadableMP3filesforconvenienton-the-goaudio
• Plus,youcanearnadditionalCMEcreditwithiScience
Your
Roa
dmap
to A
CC.1
2
ACC.12 Final Program 65
Planning Tools: Your most important e-navigation tools!NEW! ACC.12 eMeeting Planner App
• Getinstantaccesstoinformationaboutsessions,abstracts,exhibitors,maps,theACC.12twitterfeed,andmore
• DownloadeBooksoftheFinal Program, Program-At-A-Glance andtheJACC Abstract Supplement
• Readthedailynewspaper—CardioSourceNews from ACC.12
SearchACC.12inyourappmarketplaceorbrowsetohttp://ativ.me/acc todownloadtheapponyourmobiledevice(availableforApple®,Android®andKindleFire®devices).
Apple Android
Web-Based Program PlannerGotowww.accscientificsession.org,andselect“PlanYourACC.12”tosearchforsessionsandbuildapersonalizeditinerary.
NEW! ACC.12 OnlineLivewebcastsof60sessionsand18ondemandwebcasts(LegendsandCoreCurriculumsessions)fromanywhereinChicago—availabletoattendeesforfreeduringthemeeting.
LookfortheACC.12OnlineiconintheProgram-At-A-Glance(page72).Gotohttp://acc12online.cardiosource.organdloginwithyoure-mailandpasscode:ACCONLINE.
Connect with Your ColleaguesACC.12 CommunityGotowww.accscientificsession.org/CommunityACC12tojoinindiscussionswithyourcolleaguesandfellowattendees.
Twitter at @ACC_2012Followusforthelatestnews,plus,searchforandusethehashtag#ACC12foreverythingACC.12.
ACC in Touch BlogAtblog.cardiosource.orgforcoverageofthemeetingfromACCleaders
ACC.12 Heart HubsStopbyNorth, Hall B, orSouth, West Transportation Lobby andrelaxwithrefreshmentsinaloungesettingwhilesessionsfromACC.12cometoyouonplasmascreens.
ACC.12 Session Highlights: Science in the Morning; Practical Clinical Application in the Afternoon!ACC.12 Opening Showcase and Late-Breakers
• Saturday,March24,8:00a.m.–10:00a.m.,HallB,ACC.12MainTent.
Legends of Cardiovascular Medicine Lecture SeriesFriday, March 23• Legends of Cardiovascular Medicine — Roundtable
Forum and Reception (ByInvitationOnly)1:30p.m.–5:30p.m.,RoomS100c
Saturday, March 24• 2012 Simon Dack Lecture (duringtheACC.12Opening
Showcase):EugeneBraunwald,MD,MACC—8:00a.m.–10:00a.m.,HallB,ACC.12MainTent
Your Road Map to ACC.12How to navigate and stay connected!
66 GO for ACC.12!
• 43rd Annual Bishop Lecture:MagdiH.Yacoub,MB,BCh,FACC—2:00p.m.–3:00p.m.,RoomN426
Sunday, March 25• 2012 Dan G. McNamara Lecture: JaneSomerville,MD,
FACC—2:00p.m.–3:30p.m.,RoomN228
• James T. Dove Lecture: ValentinFuster,MD,PhD,MACC—4:30p.m.–5:30p.m.,RoomN427
Monday, March 26• 2012 Maseri-Florio International Lecture:
AntonioColombo,MD,FACC—2:00p.m.–3:00p.m.,RoomN231
ACC.12 Closing Session: Innovators in CardiologyFeaturingRobertM.Califf,MD,MACC,KennethChien,MD,PhD,MartinB.Leon,MD,FACC,MichaelJ.Mack,MD,FACCandA.JamilTajik,MD,FACC—Tuesday,March27,9:45a.m.–11:45a.m.,HallB,ACC.12MainTent
Late-Breaking Clinical Trial Sessions—HallB,ACC.12MainTent
Saturday, March 24• ACC.12OpeningShowcaseandLate-Breakers—
8:00a.m.–10:00a.m.
Sunday, March 25 • Late-BreakingClinicalTrialsII—8:00a.m.–9:30a.m.
Monday, March 26• NEW!JointAmericanCollegeofCardiology/New England
Journal of MedicineLate-BreakingClinicalTrials—8:00a.m.–9:30a.m.
• Late-BreakingClinicalTrialsIV—10:30a.m.–Noon
Tuesday, March 27• NEW!JointAmericanCollegeofCardiology/Journal of
the American Medical AssociationLate-BreakingClinicalTrials—8:00a.m.–9:30a.m.
Maintenance of CertificationGetalltheMOCpointsyouneedwithLifelongLearningSessions!
• AttendABIM MOC sessionsworth10ABIMMOCpointsandABPMOCsessionworth10ABPMOCpoints—visittheMOCLoungeinRoomS104btolearnmoreandsign-up.Refertothefulllistingonpage96.
•Cardiology Core Curriculumsessionsofferareviewofeverymajorareaofcardiology.Takeanonlinepost-test,andreceive10ABIMPart2MOCcredits.Refertothefulllistingonpage96.
Joint Society Partner Sessions• CardiovascularResearchFoundation(CRF):TheACC-i2
withTCTpathwayhasbeenplannedanddevelopedincollaborationwithCRF—refertothefulllistingonpage87
• AmericanAssociationforClinicalChemistry—HowtoUseCardiacBiomarkers:Tuesday,March27,8:00a.m.–9:30a.m.,RoomN230
• AmericanAssociationofThoracicSurgeonsandSocietyforThoracicSurgeons—MultidisciplinaryApproachtotheHigh-riskAorticStenosisPatient—Monday,March26,5:45p.m.–9:05p.m.,RoomS401a
• AmericanSocietyofEchocardiography:Afull-dayofsessionsonSunday,March25inRoomS406a—refertothefulllistingonpage94
• AssociationofBlackCardiologists:EthnicandRacialDisparitiesinCardiovascularDisease—ACalltoAction—Sunday,March25,2:00p.m.–3:30p.m.,RoomN230
• HealthcareInformationManagementSystemsSociety(HIMMS):Atwo-partsessiononSunday,March25inRoomN227b—refertothefulllistingonpage98
• HeartFailureSocietyofAmerica:Afull-dayofsessionsonSunday,March25inRoomS406b—refertothefulllistingonpage94
• HeartRhythmSociety:Afull-dayofprogrammingonSunday,March25—refertothefulllistingonpage91
Road Map • ACC.12
ACC.12 Final Program 67
• InternationalSocietyforCardiovascularTranslationalResearch(ISCTR):TranslationalResearchSymposium—Afull-dayofprogrammingonSaturday,March24inRoomN228
• PreventiveCardiovascularNursesAssociation—Monday,March26,10:30a.m.–Noon,RoomS105
• SocietyforVascularSurgery—AdvancesandControversiesinCarotid,AorticandPeripheralArterialDisease—Saturday,March24,4:30p.m.–6:00p.m.,RoomS103c
ACC.12 International SessionsFriday, March 23
• 4thAnnualInternationalCardiovascularConference:FocusontheMiddleEast—8:00a.m.–Noon,RoomS101a
Monday, March 26 • CardiovascularClinicalResearchandPracticeinChina
—8:00a.m.–9:30a.m.,RoomN229
• JointSessionwiththeEuropeanSocietyofCardiology—ManagementofHeartDiseaseinPregnancy—8:00a.m.–9:30a.m.,RoomN426
• 18internationallunchtimesymposia,jointlysponsoredwithcardiologysocietiesfromacrosstheglobe—Monday,March26from12:15p.m.–1:45p.m.—refertothefulllistingonpage83
• JointSymposiumoftheItalianFederationofCardiologyandthePennsylvaniaChapteroftheAmericanCollegeofCardiology:UpdateontheTreatmentofAtrialFibrillation—2:00p.m.–3:30p.m.,RoomN230
• JointSymposiumoftheBritishCardiovascularSocietyandtheCaliforniaChapteroftheAmericanCollegeofCardiology—3:45p.m.–5:15p.m.,RoomN230
•MediterraneanDietandItsProtectiveEffectonCardiovascularDisease—3:45p.m.–5:15p.m.,RoomS405
Tuesday, March 27• JointSessionwiththeEuropeanSocietyofCardiology
—ProsandConsofNewApproachesforAntiplateletandAnticoagulantTherapy—8:00a.m.–9:30a.m.,RoomN426
ACC-i2 with TCT Live CasesHallB,ACC.12MainTent
• LiveandTapedCaseSessionI:MultivesselPCI—PhysiologyandImaging—Saturday,March24,2:00p.m.–5:00p.m.
• LiveandTapedCaseSessionII:LeftMainandBifurcation—ComplexPCI—Sunday,March25,2:00p.m.–5:00p.m.
• LiveandTapedCaseSessionIII:ValvularHeartDisease—Monday,March26,12:30p.m.–2:30p.m.
Heart Songs Learning Lab Listentoheartsoundsonyourmobiledevicetoimproveyourcardiacauscultationskills—VistaRoomLobby,Saturday,March24–Monday,March26,9:00a.m.–5:00p.m.
ACC.12 Specialty SessionsEducating the EducatorsAbootcampforCardiologyFellowshipProgramDirectorsandCoordinators—Saturday,March24,RoomS405a—refertothefulllistingonpage100.
Pharmacology ProgramAfull-dayofprogramming—Saturday,March24,RoomN427
Master Clinician SessionsDiscusscomplexreal-worldcases—Sunday,March25,RoomS401a—refertothefulllistingonpage96
Congenital Cardiology SolutionsSessionsspanningallfourdaysfocusedonpatientcareacrossthecontinuumofCHD—includingcutting-edgelivecases—refertothefulllistingonpage92
The FIT ForumSessionsspanningthreedaysandpackedwithtipsonlaunchingandmaintainingasuccessfulcareer,plus,aspecialMix‘n’MinglejustforFITswithtopACCleaders—refertothefulllistingonpage100
ACC.12 •Road Map
68 GO for ACC.12!
ACC-i2 with TCT Fellows BootcampAfull-dayofprogrammingfocusingoninterventionaltreatmentofcoronaryandstructuralheartdisease—Monday,March26,RoomS103b—refertothefulllistingonpage88
Clinical Focus SessionsCertifiedeveningsessionsheldattheFairmontHotel(unlessotherwiseindicated)willaddressadditionalgapsinknowledge—limitedseatingavailable.
Saturday, March 24, 6:30 p.m. – 9:30 p.m.• FirstLineofDefense:RiskFactors&Preventioninthe
CardiologyPractice
• ChampioningCareforPatientswithAorticStenosis:TheRoleofCardiologistsandPrimaryCarefromRecognitiontoRecovery
Sunday, March 25, 6:30 p.m. – 9:30 p.m.• InnovationsinTranslation:AtrialFibrillation
• InnovationsinTranslation:ACS
Monday, March 26, 5:45 p.m. – 9:05 p.m.•MultidisciplinaryApproachtotheHighRiskAortic
StenosisPatient—ConventionCenter,RoomS401a
Networking OpportunitiesFriday, March 23
• CVTSectionMeeting:6:30p.m.,HiltonChicago,WaldorfRoom
• Sports&ExerciseCardiologySectionMeeting:7:00p.m.,HiltonChicago,MarquetteRoom
• CVTSectionReception:8:00p.m.,HiltonChicago,WillifordC
Saturday, March 24• PracticeAdministratorsWorkGroupMeeting:7:00a.m.,
HyattMcCormickPlace,FieldRoomA
• GeriatricCardiologySectionMeeting:6:00p.m.,HiltonChicago,MarquetteRoom
• ACPCSectionMeeting:6:30p.m.,HiltonChicago,ContinentalA/B
• GeriatricCardiologyReception:7:00p.m.,HiltonChicagoJoliet
Sunday, March 25•WICSectionMeeting:6:00p.m.,HiltonChicago,
WillifordA
• ImagingSectionMeeting:6:00p.m.,HyattMcCormickPlace,CC24A/B/C
• InterventionalSectionMeeting:6:00p.m.,HyattMcCormickPlace,CC23
• AcademicSectionMeeting:6:00p.m.,HyattMcCormickPlace,RegencyA
•WICReception:7:00p.m.,HiltonChicagoAstoria
Monday, March 26• EarlyCareerSectionMeeting:6:30a.m.,
HyattMcCormickPlace,CC12A/B
• 61stAnnualConvocation:6:30p.m.,HallB,ACC.12MainTentRoom
• ACC.12President’s,AllChapter,NewFellows’andAssociates’Reception:ImmediatelyfollowingConvocation
Road Map • ACC.12
ACC.12 Final Program 69
ACC.12 Expo and Learning Destinations™Gainanunderstandingofthelatestadvancesinpharmaceuticals,imaging,devices,technologiesandtheservicesthatyouneedtohelpyouprovidehigh-qualitypatientcare.Learnmoreonpage52.
ExpanduponyoureducationinnewandcreativewaysintheACC.12LearningDestinations—diverse,non-accredited,educationallyfocusedareasthatoffernewandcreativevenuesforlearning.Learnmoreonpage57.
iScience, ACC.12 Meeting on DemandCan’tmakeittoallthesessionsyouwanttoattend?PurchaseiScience,acomprehensivedigitallibraryofpresentationsfromACC.12StopbyGrandConcourseLobby,Level3orACCCentral,Booth#10027,andsave$1,000ormore!
ACC.12 •Road Map
70 GO for ACC.12!
8 a.m. 9 a.m. 10 a.m. 11 a.m. 12 p.m. 1 p.m. 2 p.m.
SaturdayMarch 24
Sunday March 25
MondayMarch 26
TuesdayMarch 27
ACC.12 Opening Showcase & Late-Breakers
Scienti� c SessionsOral Abstracts
LunchtimeSessions
Maintenance of Certi� cation (MOC) Study Sessions
Expo Coffee Break Expo Mid-Day Break
Scienti� c Sessions
Scienti� c SessionsOral Abstracts
LunchtimeSessions
Maintenance of Certi� cation (MOC) Study Sessions
Expo Coffee BreakExpo Mid-Day
Break
Scienti� c Sessions
Scienti� c SessionsOral Abstracts
Scienti� c Sessions
Expo Open
Expo Coffee Break
Expo Mid-Day BreakLunch Hospitality Event
Poster Sessions
Scienti� c Sessions
Scienti� c Sessions
Joint InternationalLunchtime Sessions
Scienti� c Sessions
ACC.12 Closing Session: Innovators in Cardiology
Expo Open
Poster Sessions
Poster Presentations
Poster Presentations
Maintenance of Certi� cation (MOC) Study Sessions
Expo Open
Poster Sessions
Maintenance of Certi� cation (MOC) Study Sessions
Maintenance of Certi� cation (MOC) Study Sessions
Poster Presentations
Poster Presentations
Poster Presentations
Poster Presentations
ACC.12
Schedule-At-A-GlanceAs of 1/3/2012— subject to changeAttendees will be arriving on Friday, March 23, to attend ACC.12, which opens on Saturday, March 24, at 8 a.m.
ACC.12 Final Program 71
3 p.m. 4 p.m. 5 p.m. 6 p.m. 7 p.m. 8 p.m. 9 p.m. 10 p.m.
Maintenance of Certi� cation (MOC) Study Sessions
Scienti� c Sessions
Expo Coffee Break
Maintenance of Certi� cation (MOC) Study Sessions
Scienti� c Sessions
Expo Coffee Break
Maintenance of Certi� cation (MOC) Study Sessions
Scienti� c Sessions
Convocation Reception
ACC Clinical Focus Session
ACC Clinical Focus Session
ACC Clinical Focus Session
72 GO for ACC.12!
Friday, March 23, 2012PATHWAY SESSION TYPE SESS. # TITLE START END ROOM PAGE
Morning SessionsLIFELONG MOC 801 ACCFStudySessionforMaintenanceofCertification:ABIMRecertificationMadeEasy—
ACCSelfAssessmentSession:UpdateinClinicallyRelevantGuidelinesandTrials7:30a.m. 10:00a.m. S105a 105
SPECIAL Symposium 746 4thAnnualCardiovascularConference:FocusontheMiddleEast 8:00a.m. Noon S101a 105
Mid-day SessionsSPECIAL Legends 400 LegendsofCardiovascularMedicine—RoundtableForumandReception(ByInvitationOnly) 1:30p.m. 5:30p.m. S100c 106
Saturday, March 24, 2012PATHWAY SESSION TYPE SESS. # TITLE START END ROOM PAGE
8:00 a.m. – 9:30 a.m. (exceptions noted in bold)
ACC-i2/TCT Symposium 2644 InterventionalFeaturedClinicalStudiesI 8:00a.m. 9:30a.m. S102b 107
ACS Experts 200 ContemporaryManagementofUA/NSTEMI 8:00a.m. 9:30a.m. S504a 107
ACS Oral 902 P2Y12Antagonists:UnravelingtheMechanismsandOptimizingBenefit-Risk 8:00a.m. 9:30a.m. S406b 107
ACS Oral 903 NewTherapeuticOptionsinACS:FromAntiplateletstoAntibiotics 8:00a.m. 9:30a.m. S402 108
ARR Experts 201 HowtoManageaDevice/LeadAdvisory 8:00a.m. 9:30a.m. S503 108
CCS Symposium 202 ComplexIssuesFacingACHDPatients:ObstructiveLesions 8:00a.m. 9:30a.m. S105a 108
CCS MOC 802 ACCFStudySessionforMaintenanceofCertification:AmericanBoardofPediatrics(ABP)RecertificationMadeEasy—2011PediatricCardiologySubspecialtySelf-Assessment
8:00a.m. 10:00 a.m. S105d 109
HF Experts 203 TheLatestinHeartFailurewithPreservedEjectionFraction 8:00a.m. 9:30a.m. S502 109
HF Symposium 732 PharmacologyProgram:PharmacotherapyofChronicHeartFailure 8:00a.m. 9:30a.m. N427 109
HF Oral 905 PredictingOutcomesinHeartFailure:BiomarkersandBeyond 8:00a.m. 9:30a.m. S405 109
HF Oral 906 PathogenicandTherapeuticInsightsfromExperimentalHeartFailureModels 8:00a.m. 9:30a.m. S404 109
IMAG Experts 204 MultimodalityImaginginEvaluationofProstheticValveFunction 8:00a.m. 9:30a.m. S505 110
IMAG Oral 908 ABetterUnderstandingofIschemiaandFunction:InsightsfromCardiacMRI 8:00a.m. 9:30a.m. S403 110
IMAG Oral 909 NewImagingApproachestoAtherosclerosisandtheMicrocirculation 8:00a.m. 9:30a.m. N426 110
ISCHEM Oral 910 Sex,Scoring,Sadness,Statins,StentsandSurgery 8:00a.m. 9:30a.m. N227b 111
LIFELONG MOC 802 ACCFStudySessionforMaintenanceofCertification:AmericanBoardofPediatrics(ABP)RecertificationMadeEasy—2011PediatricCardiologySubspecialtySelf-Assessment
8:00a.m. 10:00 a.m. S105d 111
PRACTICE Symposium 600 CardiologyProcedures2012:HowtoCodeandGetReimbursed 8:00a.m. 9:30a.m. N231 112
QUAL Experts 205 AmIPlacingInappropriateICDsandStents?:RecentRegistrySurprises 8:00a.m. 9:30a.m. S501a 112
QUAL Symposium 601 Patient-CenteredCare:TheNewImperative 8:00a.m. 9:30a.m. N226 112
SPECIAL Special 300 ACC.12OpeningShowcaseandLate-BreakingClinicalTrials:Featuringthe LegendsofCardiovascularMedicineLectureSeries—SimonDackLecture
8:00a.m. 10:00 a.m. Hall B, ACC.12 Main Tent
112
TEST Symposium 602 TranslationalResearchSymposiumwiththeInternationalSocietyfor CardiovascularTranslationalResearch:NewBreakthroughsinCardiovascularGenomics—ApproachingtheClinic
8:00a.m. 9:30a.m. N228 113
TEST Symposium 603 ChallengingSportsCardiologyCasesinYoungerAthletes 8:00a.m. 9:30a.m. N230 113
ACC.12 •Program-At-A-Glance
Daily Schedule Friday, March 23 & Saturday, March 24, 2012
Sessionsarelistedalphabeticallybylearningpathwaybasedontimeblock.
iScienceiconindicatessessionsareincludedaspartofiScience2012:ACC.12MeetingonDemand
TheACC.12Onlineiconindicatessessionsareavailableasliveoron-demandwebcasts.
Pleaserefertopage65foradditionalinformationonaccessingthesefreesessions.
ACC.12 Final Program 73
PATHWAY SESSION TYPE SESS. # TITLE START END ROOM PAGE
8:00 a.m. – 9:30 a.m. (continued — exceptions noted in bold)
VALV Self-Directed
1501 HeartSongsatACC.12:ASelf-PacedMultimediaLearningExperience 9:00 a.m. 5:00 p.m. Vista Room Lobby
113
VASC Oral 931 NewInsightsinPeripheralVascularDisease 8:00a.m. 9:30a.m. N229 113
9:30 a.m. – 10:30 a.m. (exceptions noted in bold)
ACC-i2/TCT Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
9:30a.m. 10:30a.m. Hall A
IMAG Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
9:30a.m. 10:30a.m. Hall A
VASC Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
9:30a.m. 10:30a.m. Hall A
10:30 a.m. – Noon (exceptions noted in bold)
ACC-i2/TCT Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
11:00 a.m. Noon Hall A
CCS Oral 901 FromTargetingErrorstoUNOS:HowQualityandDatabasesCanImpactClinicalCare 10:30a.m. Noon S105a 114
IMAG Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
11:00 a.m. Noon Hall A
PREV Symposium 733 PharmacologyProgram:CardiovascularImplicationsofDietarySupplements 10:30a.m. Noon N427 114
VASC Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
11:00 a.m. Noon Hall A
12:15 p.m. – 1:45 p.m (exceptions noted in bold)
ACC-i2/TCT Experts 2301 AtypicalThromboticACSCaseReviews 12:15p.m. 1:45p.m. S101a 114
ACC-i2/TCT Experts 2302 ChronicTotalOcclusionsandLeftMainCaseReviews 12:15p.m. 1:45p.m. S102b 114
ACC-i2/TCT Experts 2303 CoronaryImagingCaseReviews 12:15p.m. 1:45p.m. S103b 115
ACC-i2/TCT Symposium 2606 TAVR:ProceduralAspectsandBestPractices 12:15p.m. 1:45p.m. S102b 115
ACC-i2/TCT Symposium 2607 AcuteVenousThromboembolicDisease 12:15p.m. 1:45p.m. S103c 115
ACS Symposium 604 ControversiesinACS 12:15p.m. 1:45p.m. S404 115
ARR Experts 206 AlternativestoWarfarinforthePreventionofStrokeinAtrialFibrillation: HowtoDecide?
12:15p.m. 1:45p.m. S503 116
HF Experts 207 AtrialFibrillationandHeartFailure:ADynamicDuo 12:15p.m. 1:45p.m. S502 116
IMAG Experts 208 ImagingPatientswithPericardialDisease 12:15p.m. 1:45p.m. S505 116
IMAG Symposium 605 CardiovascularMagneticResonanceinMyocarditis 12:15p.m. 1:45p.m. S402 116
ISCHEM Symposium 606 RevascularizationinSIHD:IntegratingNewEvidence 12:15p.m. 1:45p.m. S401a 116
ISCHEM Symposium 734 PharmacologyProgram:PharmacologicConsiderationsintheSettingofPCI 12:15p.m. 1:45p.m. N427 116
LIFELONG Symposium 607 EverythingYouWantedtoKnowaboutABIMRecertification(andmore...) 12:15p.m. 1:45p.m. N226 116
LIFELONG MOC 803 ACCFStudySessionsforMaintenanceofCertification:ABIMRecertificationMadeEasy—CardiovascularDisease2010Update(A1-K)
12:30 p.m. 3:00 p.m. S105a 118
LIFELONG MOC 804 ACCFStudySessionsforMaintenanceofCertification:ABIMRecertificationMadeEasy—CardiovascularDisease2011Update(A1-L)
12:30 p.m. 3:00 p.m. S105d 118
PRACTICE Symposium 608 WomeninCardiology 12:15p.m. 1:45p.m. N229 116
PRACTICE Symposium 609 TheChallengesinDailyPractice 12:15p.m. 1:45p.m. N230 117
PREV Symposium 611 IsThereaRoleforHDLTherapy:AreWeAIMingTooHIGH? 12:15p.m. 1:45p.m. S100c 117
QUAL Experts 209 GettingAccesstoData:SuccessfulExamplesfromtheNCDR 12:15p.m. 1:45p.m. S501a 117
QUAL Symposium 610 TranslationalResearchSymposiumwiththeInternationalSocietyfor CardiovascularTranslationalResearch:MissionandStrategyinTranslationalResearch
12:15p.m. 1:45p.m. N228 117
SPECIAL Special 103 EducatingtheEducators:BootcampforCardiologyFellowshipProgram DirectorsandCoordinators
12:15p.m. 1:45p.m. S405a 117
SPECIAL Special 104 FitForumI:FindingtheRightF.I.T.inDevelopingaCareerPlan Part1:FindingtheRightJob
12:15p.m. 1:45p.m. N227b 117
ACC.12 • Daily Schedule • Saturday, March 24, 2012
74 GO for ACC.12!
PATHWAY SESSION TYPE SESS. # TITLE START END ROOM PAGE
12:15 p.m. – 1:45 p.m (continued — exceptions noted in bold)
VALV Experts 210 Organic Mitral Regurgitation Case-Management 12:15 p.m. 1:45 p.m. S504a 118
VALV Symposium 612 The Spectrum of Degenerative Mitral Valve: From Imaging to Treatment 12:15 p.m. 1:45 p.m. N426 118
2:00 p.m. – 3:30 p.m. (exceptions noted in bold)
ACC-i2/TCT Live/Taped Cases
2201 Live and Taped Case Session I: Multivessel PCI — Physiology and Imaging 2:00 p.m. 5:00 p.m. Hall B, ACC.12 Main Tent
119
ACC-i2/TCT Oral 2502 Acute Myocardial Infarction 2:00 p.m. 3:30 p.m. S103b 119
ACC-i2/TCT Symposium 2608 Intravascular Imaging: Restenosis, Thrombosis and Stent Follow-up I: Restenosis and Early Thrombosis
2:00 p.m. 3:30 p.m. S101a 119
ACC-i2/TCT Symposium 2609 Hemodynamics and Angiography I: Basic Issues 2:00 p.m. 3:30 p.m. S102b 120
ACC-i2/TCT Symposium 2610 Renal Interventions for Hypertension and Renal Function Preservation 2:00 p.m. 3:30 p.m. S103c 120
ACC-i2/TCT Symposium 2645 Interventional Featured Clinical Studies II 2:00 p.m. 3:30 p.m. S102c 120
ACS Experts 211 Optimal STEMI Management from Presentation to Post-Discharge Care 2:00 p.m. 3:30 p.m. S504a 121
ACS Symposium 613 State-of-the-Art in STEMI Care 2:00 p.m. 3:30 p.m. S404 121
ACS Symposium 618 Translational Research Symposium with the International Society for Cardiovascular Translational Research: Cellular Therapies
2:00 p.m. 3:30 p.m. N228 121
ARR Experts 212 Management of Difficult AF: When to Change Drugs, When to Give Up 2:00 p.m. 3:30 p.m. S503 121
ARR Symposium 614 Can Remote Disease Management Improve Clinical Outcomes? 2:00 p.m. 3:30 p.m. S406a 121
ARR Symposium 615 Challenges in the Management of Supraventricular Tachycardia 2:00 p.m. 3:30 p.m. S403 121
ARR Symposium 735 Pharmacology Program: Pharmacotherapy of New Antithrombotics 2:00 p.m. 3:30 p.m. N427 122
CCS Symposium 616 Quality, Safety and Resources Enhancing Pediatric Cardiovascular Care 2:00 p.m. 3:30 p.m. N231 122
HF Experts 213 From Shock to Recovery or Bridge to Transplanation: Role of Percutaneous VADs and Other Support Devices
2:00 p.m. 3:30 p.m. S502 122
HF Symposium 617 Cardiorenal Syndrome in Heart Failure: From Definition to Management 2:00 p.m. 3:30 p.m. S406b 122
IMAG Experts 214 Current Topics in Cardiac CT 2:00 p.m. 3:30 p.m. S505 122
IMAG Symposium 619 Multimodality Imaging of Hypertrophic Cardiomyopathy 2:00 p.m. 3:30 p.m. S402 122
ISCHEM Symposium 620 Stable Ischemic Heart Disease in Women: Are They Really from Venus? 2:00 p.m. 3:30 p.m. S401a 123
LIFELONG Core 805 Core Curriculum: Congenital Heart Disease 2:00 p.m. 3:30 p.m. N226 123
LIFELONG Core 806 Core Curriculum: Congestive Heart Failure 2:00 p.m. 3:30 p.m. N229 123
PRACTICE Symposium 621 ACC/MedAxiom/ACCA: Physician/Hospital Integration 101 2:00 p.m. 3:30 p.m. N230 123
PREV Symposium 622 Emerging Trends in Atherosclerosis 2:00 p.m. 3:30 p.m. S100c 123
QUAL Experts 215 When Should a Medicine or Device Stop Being Used in Practice? 2:00 p.m. 3:30 p.m. S501a 123
SPECIAL Special 106 Educating the Educators: Faculty Development for Cardiology Fellowship Program Directors and Coordinators
2:00 p.m. 3:30 p.m. S405a 123
SPECIAL Special 107 FIT Forum I: Finding the Right F.I.T. in Developing a Career Plan Part 2 — Launching a Successful Career
2:00 p.m. 3:15 p.m. N227b 124
SPECIAL Legends 401 Legends of Cardiovascular Medicine Lecture Series — 43rd Annual Louis F. Bishop Lecture
2:00 p.m. 3:00 p.m. N426 124
3:30 p.m. – 6:00 p.m. (exceptions noted in bold)
LIFELONG MOC 807 ACCF Study Sessions for Maintenance of Certification: ABIM Recertification Made Easy — Cardiovascular Disease 2011 Update (A1-L)
3:30 p.m. 6:00 p.m. S105a 124
LIFELONG MOC 808 ACCF Study Sessions for Maintenance of Certification: ABIM Recertification Made Easy — Cardiovascular Disease 2010 Update (A1-K)
3:30 p.m. 6:00 p.m. S105d 124
SPECIAL Special 107A FIT Forum I: Mix ‘n’ Mingle 3:30 p.m. 4:30 p.m. Hall A, Bistro ACC
125
Saturday, March 24, 2012 • Daily Schedule • ACC.12
ACC.12 Final Program 75
PATHWAY SESSION TYPE SESS. # TITLE START END ROOM PAGE
4:30 p.m. – 6:00 p.m. (exceptions noted in bold)
ACC-i2/TCT Experts 2305 VascularAccessChallengesandComplicationsCaseReviews 4:30p.m. 6:00p.m. S102c 125
ACC-i2/TCT Experts 2306 UnusualCasesofACSCaseReviews 4:30p.m. 6:00p.m. S103b 125
ACC-i2/TCT Symposium 2611 IntravascularImaging:Restenosis,ThrombosisandStentFollow-upII: VeryLateStentThrombosisandLateCatch-up
4:30p.m. 6:00p.m. S101a 125
ACC-i2/TCT Symposium 2612 HemodynamicsII(HOCM) 4:30p.m. 6:00p.m. S102b 125
ACC-i2/TCT Symposium 2613 AdvancesandControversiesinCarotid,AorticandPeripheralArterialDisease: InCollaborationwiththeSocietyofVascularSurgery
4:30p.m. 6:00p.m. S103c 126
ACS Symposium 623 AdjunctivePharmacologyinACS:AnticoagulantsandAntiplateletAgents 4:30p.m. 6:00p.m. S404 126
ARR Experts 216 TheRiskversusBenefitofDFTTesting 4:30p.m. 6:00p.m. S503 126
ARR Symposium 624 ManagementofComplicationsofPacemakersandLeads 4:30p.m. 6:00p.m. S403 126
ARR Symposium 627 TranslationalResearchSymposiumwiththeInternationalSocietyfor CardiovascularTranslationalResearch:TissueEngineering
4:30p.m. 5:30 p.m. N228 127
ARR Symposium 736 PharmacologyProgram:PharmacologicConsiderationswith AntiarrhythmicDrugs,andDyslipidemiaandResidualRisk:WhenandHowDoYouAddtoStatinTherapy?
4:00 p.m. 6:00p.m. N427 125
CCS Symposium 625 UpdatesonCareintheCongenitalHeartDiseasePatients 4:30p.m. 6:00p.m. N231 127
HF Experts 217 HeartFailureDiseaseManagement:Issuesfor2012 4:30p.m. 6:00p.m. S502 127
HF Symposium 626 ManagementofAcuteDecompensatedHeartFailure:FromHemodynamic SubsetstoAppropriateTreatmentStrategies
4:30p.m. 6:00p.m. S406b 127
IMAG Experts 218 MyocardialPerfusionImaging:PickingtheRightTest 4:30p.m. 6:00p.m. S505 127
IMAG Symposium 628 Multi-ModalityImaging:ChestPainintheEmergencyDepartment 4:30p.m. 6:00p.m. S402 127
ISCHEM Symposium 629 StableIschemicHeartDisease:What’sNewintheGuidelines(AndWhatShouldBe)? 4:30p.m. 6:00p.m. S401a 128
LIFELONG Core 809 CoreCurriculum:Echocardiography 4:30p.m. 6:00p.m. N226 128
LIFELONG Core 810 CoreCurriculum:CardiacElectrophysiology 4:30p.m. 6:00p.m. N229 128
PRACTICE Symposium 630 InformationTechnology,MedicineandtheFuture 4:30p.m. 6:00p.m. N230 128
PREV Symposium 631 HypertensionGuidelines2012 4:30p.m. 6:00p.m. S100c 128
QUAL Experts 219 MeasuringandOptimizingQualityinyourOutpatientPractice: ThePINNACLERegistry
4:30p.m. 6:00p.m. S501a 128
SPECIAL Special 109 EducatingtheEducators:SymposiumforCardiologyFellowshipProgram DirectorsandCoordinators
4:30p.m. 6:30 p.m. S405a 128
SPECIAL Special 110 FITForumII:Jeopardy 4:30p.m. 6:00p.m. N227b 129
VALV Experts 220 IschemicMitralRegurgitation 4:30p.m. 6:00p.m. S504a 129
VALV Symposium 632 ValveRepair:HowtoAchieveSuccess 4:30p.m. 6:00p.m. N426 129
VALV Symposium 633 TranslationalResearchSymposiumwiththeInternationalSocietyfor CardiovascularTranslationalResearch:Devices
5:30 p.m. 6:50 p.m. N228 129
VASC Symposium 743 CarotidArteryDisease:IsthePictureClarifying? 4:30p.m. 6:00p.m. S406a 129
6:30 p.m. – 9:30 p.m. (exceptions noted in bold)
ARR Symposium 1601 CriticalLinksinAtrialFibrillation:PrioritiesinRiskAssessment,TreatmentandPatientEducation
6:30p.m. 9:00 p.m. Fairmont Hotel, International
Ballroom
129
PREV Clinical Focus
1602 FirstLineofDefense:RiskFactorsandPreventionintheCardiologyPractice—AMasterClassfortheCommunityCardiologist
6:30p.m. 9:30p.m. Fairmont Hotel, Gold Room
130
VALV Clinical Focus
1604 ChampioningCareforthePatientwithAorticStenosis:TheRoleofCardiologistsandPrimaryCarefromRecognitiontoRecovery
6:30p.m. 9:30p.m. Fairmont Hotel, Imperial Ballroom
130
ACC.12 • Daily Schedule • Saturday, March 24, 2012
76 GO for ACC.12!
PATHWAY SESSION TYPE SESS. # TITLE START END ROOM PAGE
8:00 a.m. – 9:30 a.m. (exceptions noted in bold)
ACC-i2/TCT Oral 2500 OutcomesinPatientsTreatedwithTAVR 8:00a.m. 9:30a.m. N227b 137
ACC-i2/TCT Oral 2501 AdjunctPharmacology 8:00a.m. 9:30a.m. S101a 137
ACC-i2/TCT Oral 2504 PCIinComplexLesions 8:00a.m. 9:30a.m. S103c 138
ACC-i2/TCT Oral 2505 PCIinComplexPatients 8:00a.m. 9:30a.m. S102c 138
ACC-i2/TCT Oral 2508 IntravascularDiagnostics 8:00a.m. 9:30a.m. S106b 139
ACC-i2/TCT Oral 2510 VascularAccess 8:00a.m. 9:30a.m. S103b 139
ACC-i2/TCT Symposium 2614 AbnormalitiesoftheAtrium 8:00a.m. 9:30a.m. S102b 140
ACS Experts 221 ComplicationsofAMI 8:00a.m. 9:30a.m. S504a 140
ACS Oral 916 WhatImpactsOutcomesinACS?FromGenestoPlaqueMorphologytoEnvironment 8:00a.m. 9:30a.m. S401a 140
ARR Experts 222 JointSymposiumoftheHeartRhythmSocietyandtheAmericanCollege ofCardiology:GeneticSyndromesfortheClinician(HCM,Brugada,LongQT)
8:00a.m. 9:30a.m. S503 141
ARR Oral 904 JointOralArrhythmiasSessionoftheHeartRhythmSocietyandtheAmericanCollegeofCardiology:ManagementofthePatientwithAtrialFibrillation—AnticoagulationandPreventionofStroke
8:00a.m. 9:30a.m. N426 141
CCS Symposium 634 PreoperativeAssessmentofPatientsontheSingleVentriclePathway: SpecialProblemsCreativeSolutions
8:00a.m. 9:30a.m. N231 141
HF Symposium 635 JointSymposiumoftheHeartFailureSocietyofAmericaandtheAmerican CollegeofCardiology:ContemporaryPharmacologicalTreatmentofSystolicandDiastolicHeartFailure
8:00a.m. 9:30a.m. S406b 141
IMAG Experts 223 CardiacPET:IncorporationintoDailyPractice 8:00a.m. 9:30a.m. S505 142
IMAG Oral 907 JointOralSessionoftheAmericanSocietyofEchocardiographyandtheAmericanCollegeofCardiology:NewestApplicationsofEchotoClinicalPractice
8:00a.m. 9:30a.m. S406a 142
LIFELONG Symposium 731 CCATeam-BasedMaintenanceofCertification 8:00a.m. 10:30 a.m. S105d 142
PHTN Oral 912 What’sNewinPulmonaryHypertension 8:00a.m. 9:30a.m. N226 142
PREV Oral 911 Prevention:FocusonLipids 8:00a.m. 9:30a.m. S100c 142
QUAL Experts 224 ToolstoImproveCareTransition:TheHospitaltoHome(H2H)Experience 8:00a.m. 9:30a.m. S501a 143
QUAL Oral 913 InsightsandInnovationstoImproveCardiacRisk 8:00a.m. 9:30a.m. N229 143
SPECIAL Special 304 Late-BreakingClinicalTrialsII 8:00a.m. 9:30a.m. Hall B, ACC.12 Main Tent
143
SPECIAL Special 405 YoungInvestigatorsAwardCompetition:ACCF/HermanK.GoldYoungInvestigatorsAwardinMolecularandCellularCardiology
8:00a.m. 9:30a.m. S105a 144
TEST Oral 914 DiagnosticTesting:SportsCardiology 8:00a.m. 9:30a.m. S402 144
VALV Oral 915 ValvularOralAbstracts 8:00a.m. 9:30a.m. N427 145
VALV Self-Directed
1502 HeartSongsatACC.12:ASelf-PacedMultimediaLearningExperience 9:00 a.m. 5:00 p.m. Vista Room Lobby
145
9:30 a.m. – 10:30 a.m. (exceptions noted in bold)
ACS Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
9:30a.m. 10:30a.m. Hall A
CCS Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
9:30a.m. 10:30a.m. Hall A
PERI Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
9:30a.m. 10:30a.m. Hall A
PHTN Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
9:30a.m. 10:30a.m. Hall A
ACC.12 •Program-At-A-Glance
Daily Schedule Sunday, March 25, 2012
Sessionsarelistedalphabeticallybylearningpathwaybasedontimeblock.
iScienceiconindicatessessionsareincludedaspartofiScience2012:ACC.12MeetingonDemand
TheACC.12Onlineiconindicatessessionsareavailableasliveoron-demandwebcasts.
Pleaserefertopage65foradditionalinformationonaccessingthesefreesessions.
ACC.12 Final Program 77
PATHWAY SESSION TYPE SESS. # TITLE START END ROOM PAGE
9:30 a.m. – 10:30 a.m. (continued — exceptions noted in bold)
PREV Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
9:30a.m. 10:30a.m. Hall A
TEST Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
9:30a.m. 10:30a.m. Hall A
VALV Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
9:30a.m. 10:30a.m. Hall A
10:45 a.m. – 12:15 p.m. (exceptions noted in bold)
ACC-i2/TCT Oral 2503 BioresorbableVascularScaffolds 10:45a.m. 12:15p.m. S106b 145
ACC-i2/TCT Oral 2506 Drug-elutingStents 10:45a.m. 12:15p.m. S101a 146
ACC-i2/TCT Oral 2507 ImaginginTAVR 10:45a.m. 12:15p.m. S102c 146
ACC-i2/TCT Oral 2509 PreventionandTreatementofRestenosis 10:45a.m. 12:15p.m. S103c 147
ACC-i2/TCT Oral 2511 OutcomesinPatientsTreatedwithPCI 10:45a.m. 12:15p.m. S103b 147
ACC-i2/TCT Symposium 2615 Congenital/Pediatric 10:45a.m. 12:15p.m. S102b 148
ACS Oral 917 ImprovingOutcomesinACS.InsightsfromBasicScienceandPreclinicalResearch. 10:45a.m. 12:15p.m. N227b 148
ACS Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
11:00 a.m. Noon Hall A
ARR Oral 918 CardiacMRIfortheTreatmentandEvaluationofArrhythmias 10:45a.m. 12:15p.m. S404 148
ARR Oral 919 JointOralSessionoftheHeartRhythmSocietyandtheAmericanCollegeofCardiology:CardiacArrestandtheCareoftheICDPatient
10:45a.m. 12:15p.m. N426 149
CCS Symposium 637 Post-OperativeGlennsandFontans:NavigatingTurbulentWaters 10:45a.m. 12:15p.m. N231 149
CCS Oral 920 AdultswithCongenitalHeartDisease:ImagingPredictors,EvolvingTherapiesandOutcomes 10:45a.m. 12:15p.m. S402 149
CCS Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
11:00 a.m. Noon Hall A
HF Experts 225 HeartFailureCarefortheVeryOld:WhatAretheKeyIssuesforSuccess? 10:45a.m. 12:15p.m. S502 150
HF Oral 921 JointOralSessionoftheHeartFailureSocietyofAmericaandtheAmericanCollegeofCardiology:IndividualizingPharmacologicalTherapyinHeartFailure
10:45a.m. 12:15p.m. S406b 150
HF Oral 922 ImprovingPatientSelectionforDevice-BasedTherapies 10:45a.m. 12:15p.m. S405 150
IMAG Symposium 638 JointSymposiumoftheAmericanSocietyofEchocardiographyand theAmericanCollegeofCardiology:Cardiomyopathy—AComprehensiveEchocardiographicApproach
10:45a.m. 12:15p.m. S406a 151
IMAG Oral 924 CardiacCT:TowardaBetterUnderstandingofCAD 10:45a.m. 12:15p.m. S403 151
ISCHEM Oral 923 WhoSaidThere’sNothingNew? 10:45a.m. 12:15p.m. N230 151
PERI Oral 925 AllThatGlittersinMyocardialandPericardialDisease 10:45a.m. 12:15p.m. N226 152
PERI Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
11:00 a.m. Noon Hall A
PHTN Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
11:00 a.m. Noon Hall A
PRACTICE Experts 226 ACC/MedAxiom/ACCA:Physician/HospitalIntegration:MakingItWork 10:45a.m. 12:15p.m. S505 152
PREV Experts 227 UpdateontheATPIVGuidelines 10:45a.m. 12:15p.m. S501a 152
PREV Oral 926 Prevention:RenalSympatheticDenervation—ANovelTherapyforHypertension? 10:45a.m. 12:15p.m. N228 153
PREV Oral 927 Prevention:CardiovascularRiskAssessmentandRehabilitation 10:45a.m. 12:15p.m. S401a 153
PREV Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
11:00 a.m. Noon Hall A
QUAL Symposium 650 U.S.HealthSystemReform:What’sMissing? 10:45a.m. 12:15p.m. S100c 153
QUAL Oral 928 ImprovingPCIOutcomes 10:45a.m. 12:15p.m. N229 153
SPECIAL Special 406 YoungInvestigatorsAwardCompetition:Physiology,Pharmacology,andPathology 10:45a.m. 12:15p.m. S105a 154
TEST Oral 929 DiagnosticTesting:ECGandCardiopulmonaryExerciseTesting 10:45a.m. 12:15p.m. S503 154
TEST Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
11:00 a.m. Noon Hall A
VALV Oral 930 ValvularOralAbstracts 10:45a.m. 12:15p.m. N427 155
ACC.12 • Daily Schedule • Sunday, March 25, 2012
78 GO for ACC.12!
PATHWAY SESSION TYPE SESS. # TITLE START END ROOM PAGE
10:45 a.m. – 12:15 p.m. (continued — exceptions noted in bold)
VALV Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
11:00 a.m. Noon Hall A
VASC Oral 932 NewInsightsinPerpheralVascularDiseaseandYearinReview 10:45a.m. 12:15p.m. S504a 155
12:30 p.m. – 1:45 p.m. (exceptions noted in bold)
ACC-i2/TCT Symposium 646 InterventionalCardiovascularMedicinein2012:AnUpdateforthe Non-InterventionalistandtheDouglasP.Zipes,M.D.,DistinguishedYoungScientistAwardeeLecture
12:15 p.m. 1:45p.m. N228 155
ACC-i2/TCT Special 2101 CardiacCareTeamSessionI:KeynoteAddress 12:30p.m. 1:00 p.m. S103b 156
ACC-i2/TCT Special 2102 CardiacCareTeamSessionII:CathLabofTomorrow—Pathwaytoa High-riskAorticValveProgram
1:00 p.m. 2:30 p.m. S103b 160
ACC-i2/TCT Experts 2308 AorticValveCaseReviews 12:30p.m. 1:45p.m. S101a 156
ACC-i2/TCT Experts 2309 CoronaryComplicationsCaseReviews 12:30p.m. 1:45p.m. S102b 156
ACC-i2/TCT Experts 2310 MultivesselandHemodynamicSupportCaseReviews 12:30p.m. 1:45p.m. S102c 156
ACC-i2/TCT Symposium 2616 EndovascularInterventionforVenousDisease 12:30p.m. 1:45p.m. S103c 156
ACC-i2/TCT Symposium 2617 PlateletInhibitionin2012:WhatYouNeedToKnow 12:30p.m. 1:45p.m. S106b 156
ACS Symposium 639 TheFutureofACSClinicalTrials 12:30p.m. 1:45p.m. S404 156
ARR Symposium 640 JointSymposiumoftheHeartRhythmSocietyandtheAmericanCollege ofCardiology:InvestigationandManagementofSyncope
12:30p.m. 1:45p.m. N426 157
CCS Special 301 Career&MentoringSessionforPediatricandCongenitalCardiologists 12:30p.m. 1:45p.m. N231 157
HF Experts 228 CardiacMRfortheEvaluationoftheHeartFailurePatient 12:30p.m. 1:45p.m. S502 157
HF Symposium 641 JointSymposiumoftheHeartFailureSocietyofAmericaandtheAmerican CollegeofCardiology:ContemporaryIssuesintheDiagnosisandTreatmentofChronicAmbulatoryHeartFailure
12:30p.m. 1:45p.m. S406b 157
HF Symposium 642 CardiotoxicityofCancerChemotherapy:MolecularBasisandStrategiesfor EarlyDetectionandPrevention
12:30p.m. 1:45p.m. S405 157
IMAG Symposium 643 JointSymposiumoftheAmericanSocietyofEchocardiographyandthe AmericanCollegeofCardiology:InterventionalEchocardiography—EvolvingRoleinPatientManagement
12:30p.m. 1:45p.m. S406a 158
IMAG Symposium 644 Cost-EffectiveImaginginPatientswithChronicCAD 12:30p.m. 1:45p.m. S403 158
ISCHEM Symposium 645 ManagingHigh-riskPatientswithStableIschemicHeartDisease 12:30p.m. 1:45p.m. S401a 158
LIFELONG MOC 811 ACCFStudySessionforMaintenanceofCertification:ABIMRecertificationMadeEasy—ACCGeneralCardiologyModulePartA
12:30p.m. 3:00 p.m. S105a 158
LIFELONG MOC 812 ACCFStudySessionforMaintenanceofCertification:ABIMRecertificationMadeEasy—ACCGeneralCardiologyModulePartB
12:30p.m. 3:00 p.m. S105d 158
PERI Experts 229 GraspingtheComplexityofMyocardialandPericardialDiseases 12:30p.m. 1:45p.m. S505 159
PERI Symposium 648 TheNewHypertrophicCardiomyopathyPracticeGuidelines 12:30p.m. 1:45p.m. N226 159
PHTN Symposium 649 EmergingApproachestoPulmonaryHypertensionwithLeftVentricularDysfunction 12:30p.m. 1:45p.m. S402 159
PRACTICE Symposium 647 JointSessionoftheHealthcareInformationandManagementSystemsSociety andtheAmericanCollegeofCardiology:HealthInformationTechnologyPartI:MakingtheElectronicHealthRecordMeaningfulandUseful—AWashingtonPerspective
12:30p.m. 1:45p.m. N227b 159
PREV Experts 230 ManagementofHypertensionintheElderly 12:30p.m. 1:45p.m. S501a 159
SPECIAL Special 111 FITForumIII:HowtoWriteandEvaluateMedicalJournalArticles 12:30p.m. 1:45p.m. N229 159
TEST Symposium 651 RoleofExerciseTreadmillTestingin2012 12:30p.m. 1:45p.m. N230 160
VALV Symposium 652 ControversiesinValveDiseaseI 12:30p.m. 1:45p.m. N427 160
Sunday, March 25, 2012 • Daily Schedule • ACC.12
ACC.12 Final Program 79
PATHWAY SESSION TYPE SESS. # TITLE START END ROOM PAGE
2:00 p.m. – 3:30 p.m. (exceptions noted in bold)
ACC-i2/TCT Special 2131 AnatomyandTranscatheterTherapyfortheStructuralHeartInterventionalistI: MitralandAorticValve(withRemoteDemonstrationsfromtheSeattleScienceFoundation)
2:00p.m. 3:30p.m. S102c 160
ACC-i2/TCT Live/Taped Cases
2202 LiveandTapedCaseSessionII:LeftMainandBirfucation—ComplexPCI 2:00p.m. 5:00 p.m. Hall B, ACC.12 Main Tent
161
ACC-i2/TCT Symposium 2618 ImagingTranscatheterAorticValveProceduresI:Intra-andPost-ProceduralImaging 2:00p.m. 3:30p.m. S101a 161
ACC-i2/TCT Symposium 2619 EmergingTechnologies 2:00p.m. 3:30p.m. S102b 161
ACC-i2/TCT Symposium 2620 PeripheralArteryDisease:SuperficialFemoralArtery 2:00p.m. 3:30p.m. S103c 161
ACC-i2/TCT Symposium 2621 ChronicTotalOcclusions 2:00p.m. 3:30p.m. S106b 162
ACC-i2/TCT Special 2103 CardiacCareTeamSessionIII:MedicationsandOtherTechniquesto ManagethePatientintheCathLab
2:30 p.m. 3:30p.m. S103b 165
ACS Experts 231 ManagementofChestPainintheEmergencyDepartment 2:00p.m. 3:30p.m. S504a 162
ACS Symposium 653 State-of-the-ArtinNonSTElevationAcuteCoronarySyndromes 2:00p.m. 3:30p.m. S404 162
ARR Experts 232 JointSymposiumoftheHeartRhythmSocietyandtheAmericanCollegeof Cardiology:OptimizingtheManagementofthePatientwithImplantableDevices
2:00p.m. 3:30p.m. S503 162
ARR Symposium 654 JointSymposiumoftheHeartRhythmSocietyandtheAmericanCollegeof Cardiology:AtrialFibrillation—PreventionofStroke
2:00p.m. 3:30p.m. N426 162
CCS Legends 402 LegendsinCardiovascularMedicineLectureSeries—2012DanG.McNamaraLecture 2:00p.m. 3:30p.m. N228 162
HF Symposium 655 JointSymposiumoftheHeartFailureSocietyofAmericaandtheAmerican CollegeofCardiology:TheGrowingRoleofDevicesinHeartFailureManagement—ICD,CRT,HemodynamicMonitoringandUltrafiltration
2:00p.m. 3:30p.m. S406b 163
HF Symposium 656 TheNHLBIHeartFailureClinicalTrialsNetwork:ANewParadigmfor InvestigationandTraining
2:00p.m. 3:30p.m. S405 163
IMAG Experts 233 RoleofCMRinValvularHeartDisease 2:00p.m. 3:30p.m. S505 163
IMAG Symposium 657 JointSymposiumoftheAmericanSocietyofEchocardiographyandthe AmericanCollegeofCardiology:HealthcareReform—ImpactonImaging
2:00p.m. 3:30p.m. S406a 163
IMAG Symposium 658 RadionuclideImagingintheHeartFailurePatient 2:00p.m. 3:30p.m. S403 163
ISCHEM Experts 234 HeartFailureInStableIschemicHeartDisease:NotfortheWeakofHeart 2:00p.m. 3:30p.m. S502 163
LIFELONG Symposium 659 MasterClinicianI:DiscussionofThreeComplexRealWorldCases 2:00p.m. 3:30p.m. S401a 163
LIFELONG Core 813 CoreCurriculum:GeneralCardiology 2:00p.m. 3:30p.m. N226 164
LIFELONG Core 814 CoreCurriculum:ValvularHeartDisease 2:00p.m. 3:30p.m. N229 164
PERI Symposium 661 ControversiesinHypertrophicCardiomyopathy 2:00p.m. 3:30p.m. N427 164
PHTN Symposium 662 PulmonaryHypertensionManagementinSpecialPopulations 2:00p.m. 3:30p.m. S402 164
PRACTICE Symposium 660 JointSessionoftheHealthcareInformationandManagementSystems SocietyandtheAmericanCollegeofCardiology:HealthInformationTechnologyPartII:EHRImplementation…LessonsfromtheTrenches
2:00p.m. 3:30p.m. N227b 164
PREV Experts 235 DietaryApproachesforCVDPrevention:MatchingtheDiettothePatient 2:00p.m. 3:30p.m. S501a 164
PREV Symposium 663 ResistantHypertension 2:00p.m. 3:30p.m. S100c 165
QUAL Symposium 664 JointSymposiumoftheAssociationofBlackCardiologistsandtheAmericanCollege ofCardiology:EthnicandRacialDisparitiesinCardiovascularDisease—ACalltoAction
2:00p.m. 3:30p.m. N230 165
SPECIAL Special 302 BusinessMeetingoftheCollege 3:00 p.m. 3:15 p.m. ACC Member Lounge
165
4:30 p.m. – 6:00 p.m. (exceptions noted in bold)
ACC-i2/TCT Special 2104 CardiacCareTeamSessionIV:SameDayDischargeforPCI 3:30 p.m. 5:00 p.m. S103b 165
ACC-i2/TCT Special 2105 CardiacCareTeamV:StructuralHeartDisease—MitralValve 5:00 p.m. 6:00p.m. S103b 171
ACC-i2/TCT Experts 2311 EndovascularCaseReviews 4:30p.m. 6:00p.m. S102b 166
ACC-i2/TCT Symposium 2622 ImagingTranscatheterMitralValveProcedures 4:30p.m. 6:00p.m. S101a 166
ACC-i2/TCT Symposium 2623 PeripheralArteryDisease:CriticalLimbIschemia 4:30p.m. 6:00p.m. S103c 166
ACC-i2/TCT Symposium 2624 VascularAccessandOutcomesfollowingPCIforACS:WhatYouShouldKnow 4:30p.m. 6:00p.m. S106b 167
ACS Symposium 665 LiteratureInterpretationandStatisticalPitfallsinACSTrials 4:30p.m. 6:00p.m. S402 167
ACC.12 • Daily Schedule • Sunday, March 25, 2012
80 GO for ACC.12!
PATHWAY SESSION TYPE SESS. # TITLE START END ROOM PAGE
4:30 p.m. – 6:00 p.m. (continued — exceptions noted in bold)
ARR Symposium 666 JointSymposiumoftheHeartRhythmSocietyandtheAmericanCollege ofCardiology:AtrialFibrillation—ManagementoftheArrhythmia
4:30p.m. 6:00p.m. N426 167
CCS Symposium 667 TheGreatDebates 4:30p.m. 6:00p.m. N231 167
CCS Symposium 668 ACHDfortheGeneralCardiologist 4:30p.m. 6:00p.m. N230 168
HF Symposium 669 JointSymposiumoftheHeartFailureSocietyofAmericaandtheAmerican CollegeofCardiology:ManagementofAdvancedHeartFailureandTransplantation
4:30p.m. 6:00p.m. S406b 168
HF Symposium 670 HeartTransplantation:Challengesin2012 4:30p.m. 6:00p.m. S405 168
HF Symposium 671 PersonalizedMedicineandtheFutureofMedicalCare 4:30p.m. 6:00p.m. S404 168
IMAG Symposium 672 JointSymposiumoftheAmericanSocietyofEchocardiographyandthe AmericanCollegeofCardiology:Echoin2012—WhatYouNeedtoKnowtoKeepUp
4:30p.m. 6:00p.m. S406a 168
LIFELONG Symposium 737 MasterClinician:ClinicalCasesII 4:30p.m. 6:00p.m. S401a 169
LIFELONG MOC 815 ACCFStudySessionforMaintenanceofCertification:ABIMRecertificationMadeEasy—ACCGeneralCardiologyModulePartB
3:30 p.m. 6:00p.m. S105a 165
LIFELONG MOC 816 ACCFStudySessionforMaintenanceofCertification:ABIMRecertificationMadeEasy—ACCGeneralCardiologyModulePartA
3:30 p.m. 6:00p.m. S105d 166
LIFELONG Core 817 CoreCurriculum:CoronaryArteryDisease 4:30p.m. 6:00p.m. N226 169
LIFELONG Core 818 CoreCurriculum:NuclearCardiology 4:30p.m. 6:00p.m. N229 169
PERI Experts 236 GeneticEvaluationofCardiomyopathy 4:30p.m. 6:00p.m. S505 169
PRACTICE Symposium 673 FutureCompensationUnderHealthCareReform 4:30p.m. 6:00p.m. N227b 169
PREV Experts 237 ReducingDisparitiesinCardiovascularPreventiveCare 4:30p.m. 6:00p.m. S501a 169
PREV Symposium 675 What’sNewintheACCF/AHAGuidelines 4:30p.m. 6:00p.m. N228 169
PREV Symposium 730 TheDifficult-to-ManageLipidPatient 4:30p.m. 6:00p.m. S100c 170
SPECIAL Experts 263 TheRoleofTherapeuticHypothermiaintheTreatmentofCardiacArrest 4:30p.m. 6:00p.m. S502 170
SPECIAL Legends 403 LegendsofCardiovascularMedicineLectureSeries— 3rdAnnualJamesT.DoveLecture
4:30p.m. 5:30 p.m. N427 170
SPECIAL Symposium 744a ClinicalDecision-MakingforFellowsinTraining:PartA 4:30p.m. 5:50 p.m. S403 170
SPECIAL Symposium 744b ClinicalDecision-MakingforFellowsinTraining:PartB 4:30p.m. 6:00p.m. S403 170
TEST Experts 261 CardiacDilemmasinAthletes 4:30p.m. 6:00p.m. S503 171
VALV Experts 238 AorticStenosisCaseManagement 4:30p.m. 6:00p.m. S504a 171
6:30 p.m. – 9:30 p.m. (exceptions noted in bold)
ACS Clinical Focus 1605 InnovationsinTranslation:ACS 6:30p.m. 9:30p.m. Fairmont Hotel,
Imperial Ballroom
171
ARR Clinical Focus 1603 JointSessionoftheHeartRhythmSocietyofAmericaandtheAmericanCollegeofCardiology—InnovationsinTranslation:AtrialFibrillation
6:30p.m. 9:30p.m. Fairmont Hotel,
International Ballroom
172
Sunday, March 25, 2012 • Daily Schedule • ACC.12
ACC.12 Final Program 81
PATHWAY SESSION TYPE SESS. # TITLE START END ROOM PAGE
8:00 a.m. – 9:30 a.m. (exceptions noted in bold)
ACC-i2/TCT Special 2111 FellowsBootcamp:CoronaryI 8:00a.m. 9:30a.m. S103b 177
ACC-i2/TCT Special 2121 Multi-DisciplinaryManagementoftheFailingHeart:TeamBasedEvaluation andTherapyofAdvancedHeartDiseaseI
8:00a.m. 9:30a.m. S102c 177
ACC-i2/TCT Symposium 2625 LeftMainDisease:RoleofImagingforAssessment,TreatmentandFollow-Up 8:00a.m. 9:30a.m. S101a 177
ACC-i2/TCT Symposium 2626 TAVRComplications:Incidence,ManagementandAvoidance 8:00a.m. 9:30a.m. S102b 177
ACC-i2/TCT Symposium 2627 ManagementofRenovascularHypertension 8:00a.m. 9:30a.m. S103c 177
ACC-i2/TCT Symposium 2628 LeftMainCoronaryIntervention:State-of-the-Art 8:00a.m. 9:30a.m. S106b 178
ACS Symposium 676 ShockinACS 8:00a.m. 9:30a.m. S401a 178
ARR Experts 239 Case-OrientedGapsintheGuidelines:WhoShouldGetanICD? 8:00a.m. 9:30a.m. S504a 178
ARR Symposium 677 ClinicalManagementoftheAFPatient:TreatingthePatientand theHealthCareProvider
8:00a.m. 9:30a.m. N226 178
CCS Symposium 678 PulmonaryArteryStenosisCurrentTherapyandFutureDirections:LiveCase 8:00a.m. 9:30a.m. N231 178
CCS Symposium 679 WomenwithCongenitalHeartDisease:Fertility,PregnancyandMenopause 8:00a.m. 9:30a.m. S501a 179
HF Experts 240 Myocarditis:WhentoBiopsy,WhotoTreat,WhichTherapy? 8:00a.m. 9:30a.m. S502 179
HF Symposium 680 ControversiesintheManagementofHeartFailure 8:00a.m. 9:30a.m. S406b 179
HF Symposium 681 SurgicalTherapyofHeartFailure 8:00a.m. 9:30a.m. S404 179
IMAG Experts 241 ImagingtheRightVentricle 8:00a.m. 9:30a.m. S505 179
IMAG Symposium 682 AdvancedLVDysfunction:AMultimodalityApproach 8:00a.m. 9:30a.m. S405 179
IMAG Symposium 683 FutureDirectionsforCardiacCT 8:00a.m. 9:30a.m. S403 180
LIFELONG Boot Camp 112 CCAResearchBootcampSessionI:MethodsforEngaginginResearch 8:00a.m. 9:30a.m. S105d 180
PRACTICE Symposium 684 ACC/MedAxiom/ACCA:CardiovascularServiceLines 8:00a.m. 9:30a.m. S105a 180
PREV Symposium 685 ACCChinaChapterSession:CardiovascularClinicalResearchandPracticeinChina 8:00a.m. 9:30a.m. N229 180
PREV Symposium 686 GlobalCVDPrevention:HeartDiseaseandRiskFactorsinSpecificPopulations 8:00a.m. 9:30a.m. S100c 180
QUAL Symposium 687 WhereWillCardiologyBein2015? 8:00a.m. 9:30a.m. N427 180
SPECIAL Special 305 JointAmericanCollegeofCardiology/New England Journal of Medicine Late-BreakingClinicalTrials
8:00a.m. 9:30a.m. Hall B, ACC.12 Main Tent
181
SPECIAL Special 407 YoungInvestigatorsAwardCompetition:ClinicalInvestigations,CongenitalHeartDiseaseandCardiovascularSurgery
8:00a.m. 9:30a.m. N230 181
SPECIAL Symposium 738 JointSessionoftheEuropeanSocietyofCardiologyandtheAmerican CollegeofCardiologyI:ManagementofHeartDiseaseinPregnancy
8:00a.m. 9:30a.m. N426 181
TEST Symposium 688 ChallengingSportsCardiologyCasesinOlderAthletes 8:00a.m. 9:30a.m. N227b 182
VALV Experts 242 TricuspidValveDiseaseCaseManagement 8:00a.m. 9:30a.m. S503 182
VALV Symposium 674 ValvularHeartDiseaseintheOlderAdult(withManyDRGCodes): NavigatingtheOptions
8:00a.m. 9:30a.m. S402 182
VALV Self-Directed 1503 HeartSongsatACC.12:ASelf-PacedMultimediaLearningExperience 9:00 a.m. 5:00 p.m. Vista Room Lobby
182
ACC.12 •Program-At-A-Glance
Daily Schedule Monday, March 26, 2012
Sessionsarelistedalphabeticallybylearningpathwaybasedontimeblock.
iScienceiconindicatessessionsareincludedaspartofiScience2012:ACC.12MeetingonDemand
TheACC.12Onlineiconindicatessessionsareavailableasliveoron-demandwebcasts.
Pleaserefertopage65foradditionalinformationonaccessingthesefreesessions.
82 GO for ACC.12!
PATHWAY SESSION TYPE SESS. # TITLE START END ROOM PAGE
9:30 a.m. – 10:30 a.m. (exceptions noted in bold)
ARR Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
9:30a.m. 10:30a.m. Hall A
HF Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
9:30a.m. 10:30a.m. Hall A
ISCHEM Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
9:30a.m. 10:30a.m. Hall A
QUAL Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
9:30a.m. 10:30a.m. Hall A
10:30 a.m. – Noon (exceptions noted in bold)
ACC-i2/TCT Special 2112 FellowsBootcamp:CoronaryII 10:30a.m. Noon S103b 182
ACC-i2/TCT Special 2122 Multi-DisciplinaryManagementoftheFailingHeart:Team-based EvaluationandTherapyofAdvancedHeartDiseaseII
10:30a.m. Noon S102c 183
ACC-i2/TCT Symposium 2629 EstablishingaCardiacCatheterizationImaging/PhysiologyProgram 10:30a.m. Noon S101a 183
ACC-i2/TCT Symposium 2630 HemodynamicsIII(PVLandASDClosure) 10:30a.m. Noon S102b 183
ACC-i2/TCT Symposium 2631 AllYouNeedtoKnowaboutCarotidArteryStenting 10:30a.m. Noon S103c 183
ACC-i2/TCT Symposium 2632 DES:FutureDirections 10:30a.m. Noon S106b 184
ACS Symposium 689 ImprovingSTEMIOutcomes:SavingMyocardiumandAttenuatingRemodeling 10:30a.m. Noon S401a 184
ARR Experts 243 PerioperativeManagementofPatientswithCardiacImplantableElectronicDevice 10:30a.m. Noon S504a 184
ARR Symposium 690 ControversiesinDeviceTherapy 10:30a.m. Noon S406a 184
ARR Symposium 691 TheGeneticsofSuddenCardiacDeath:WhatDoWeKnowand HowBesttoEvaluateandManageSuchPatients
10:30a.m. Noon N226 184
ARR Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
11:00 a.m. Noon Hall A
CCS Symposium 692 PulmonaryVeinStenosis:WhatAreRealisticExpectations? 10:30a.m. Noon N229 184
CCS Symposium 693 ChallengingImagingIssuesinCongenitalHeartDisease 10:30a.m. Noon N231 185
HF Symposium 694 LVADasDestinationTherapyforAdvancedHeartFailure 10:30a.m. Noon S406b 185
HF Symposium 695 ManagementofPeripartumCardiomyopathy:Update2012 10:30a.m. Noon S404 185
HF Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
11:00 a.m. Noon Hall A
IMAG Symposium 696 CardiacCTin2012:State-of-the-Art 10:30a.m. Noon S405 185
IMAG Symposium 697 RoleofEchointheEvaluationandManagementofPatientswithMitralRegurgitation 10:30a.m. Noon S403 185
ISCHEM Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
11:00 a.m. Noon Hall A
PRACTICE Experts 244 LeadershipandGovernance 10:30a.m. Noon S503 185
PREV Experts 245 Women’sCardiovascularHealth 10:30a.m. Noon S501a 185
PREV Symposium 698 VitaminsandSupplementsinCardiovascularDiseasePrevention 10:30a.m. Noon S100c 186
PREV Symposium 699 JointSymposiumofthePreventiveCardiovascularNursesAssociation andtheAmericanCollegeofCardiology
10:30a.m. Noon S105d 186
QUAL Symposium 700 Lies,DamnedLiesandStatistics:PitfallsinLiteratureInterpretation 10:30a.m. Noon N427 186
QUAL Symposium 742 TheFutureofCardiovascularDiseases:WhereAreWeGoing(andWhere DoWeWanttoGo)
10:30a.m. Noon N426 186
QUAL Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
11:00 a.m. Noon Hall A
SPECIAL Special 306 Late-BreakingClinicalTrialsIV 10:30a.m. Noon Hall B, ACC.12 Main Tent
186
SPECIAL Special 408 YoungInvestigatorsAwardCompetition:CardiovascularHealthOutcomesandPopulationGenetics
10:30a.m. Noon N230 187
SPECIAL Symposium 741 IntegrativeMedicine 10:30a.m. Noon N227b 187
TEST Experts 262 ECGsinAthletes:TheGreatECGScreeningDebateandChallengingCases 10:30a.m. Noon S502 187
VALV Experts 246 ComplicationsofInterventionsforValvularHeartDisease 10:30a.m. Noon S505 187
VASC Experts 264 ChallengingCasesinAnticoagulationManagement:Spotlightonthe NovelAnticoagulants
10:30a.m. Noon S105a 187
Monday, March 26, 2012 • Daily Schedule • ACC.12
ACC.12 Final Program 83
PATHWAY SESSION TYPE SESS. # TITLE START END ROOM PAGE
12:15 p.m. – 1:45 p.m. (exceptions noted in bold)
ACC-i2/TCT Intl. Lunch 502 JointSessionoftheArgentineSocietyofCardiologyandtheAmericanCollege ofCardiology:Carotids
12:15p.m. 1:45p.m. N226 188
ACC-i2/TCT Intl. Lunch 503 JointSessionoftheBrazilianSocietyofCardiologyandtheAmericanCollege ofCardiology:Drug-elutingStents—FromtheEarlyBeginningtoNewStentPlatforms
12:15p.m. 1:45p.m. N426 188
ACC-i2/TCT Intl. Lunch 505 JointSessionoftheChineseSocietyofCardiologyandtheAmericanCollege ofCardiology:CoronaryTotalOcclusions
12:15p.m. 1:45p.m. N228 188
ACC-i2/TCT Intl. Lunch 511 JointSessionoftheKoreanSocietyofCardiologyandtheAmericanCollege ofCardiology:TreatingComplexLesions
12:15p.m. 1:45p.m. N229 188
ACC-i2/TCT Intl. Lunch 518 JointSessionoftheTurkishSocietyofCardiologyandtheAmerican CollegeofCardiology:Devices—ASD’s,VSD’s,PerivalvularLeaks
12:15p.m. 1:45p.m. S505 189
ACC-i2/TCT MOC 819 ACCFStudySessionsforMaintenanceofCertification:ABIMRecertificationMadeEasy—InterventionalCardiology2010Update(B2-K)
12:15p.m. 2:45 p.m. S105a 189
ACC-i2/TCT Special 2113 FellowsBootcamp:CaseReviews 12:15p.m. 1:45p.m. S103b 194
ACC-i2/TCT Live/Taped Cases
2203 LiveandTapedCaseSesionIII:ValvularHeartDisease 12:30 p.m. 2:30 p.m. Hall B, ACC.12 Main Tent
194
ACC-i2/TCT Experts 2313 Non-coronaryComplicationsCaseReviews 12:15p.m. 1:45p.m. S101a 189
ACC-i2/TCT Experts 2314 StructuralCaseReviews 12:15p.m. 1:45p.m. S102b 189
ACC-i2/TCT Experts 2315 ShockandHemodynamicSupportCaseReviews 12:15p.m. 1:45p.m. S102c 189
ACC-i2/TCT Symposium 2633 ControversiesinVascularandEndovascularMedicine 12:15p.m. 1:45p.m. S103c 189
ACC-i2/TCT Symposium 2634 Non-ST-ElevationACSin2012:WhatYouNeedToKnow 12:15p.m. 1:45p.m. S106b 190
ACS Intl. Lunch 513 JointSessionoftheMexicanSocietyofCardiologyandtheAmerican CollegeofCardiology:ImprovingOutcomes
12:15p.m. 1:45p.m. S404 190
ARR Intl. Lunch 501 JointSessionoftheJapaneseCollegeofCardiologyandtheAmerican CollegeofCardiology:RiskStratificationforSuddenCardiacDeath
12:15p.m. 1:45p.m. S403 190
ARR Intl. Lunch 509 JointSessionoftheCardiologicalSocietyofIndiaandtheAmerican CollegeofCardiology:AF—Medical,EP,SurgicalOptions
12:15p.m. 1:45p.m. S401a 190
CCS Intl. Lunch 506 JointSessionoftheEgyptianSocietyofCardiologyandtheAmericanCollege ofCardiology:AdultCongenitalHeartDisease—WhereWeCameFromandWhereWeAre
12:15p.m. 1:45p.m. N231 191
HF Intl. Lunch 517 JointSessionoftheSpanishSocietyofCardiologyandtheAmericanCollege ofCardiology:HeartFailure—DevicestoTransplantation
12:15p.m. 1:45p.m. S501a 191
IMAG Intl. Lunch 507 JointSessionoftheGermanCardiacSocietyandtheAmericanCollege ofCardiology:Imaging—EvolvingStrategies
12:15p.m. 1:45p.m. S406b 191
ISCHEM Intl. Lunch 508 JointSessionoftheBritishCardiovascularSocietyandtheAmericanCollege ofCardiology:NICEGuidelines
12:15p.m. 1:45p.m. N427 191
LIFELONG MOC 819 ACCFStudySessionsforMaintenanceofCertification:ABIMRecertificationMadeEasy—InterventionalCardiology2010Update(B2-K)
12:15p.m. 2:45 p.m. S105a 192
LIFELONG MOC 820 ACCFStudySessionforMaintenanceofCertification:ABIMRecertificationMadeEasy—ClinicalCardiacElectrophysiology2010Update(B3-K)
12:15p.m. 2:45 p.m. S105d 192
PREV Intl. Lunch 512 JointSessionoftheNationalHeartAssociationofMalaysiaandtheAmerican CollegeofCardiology:ResistantHypertension
12:15p.m. 1:45p.m. S504a 192
PREV Intl. Lunch 516 JointSessionoftheSouthAmericanSocietyofCardiologyandtheAmerican CollegeofCardiology:Prevention—AssessingandEducatingAcrossRegions
12:15p.m. 1:45p.m. S502 192
PREV Symposium 701 RoleofPhysicalActivityinCVDPrevention 12:15p.m. 1:45p.m. S100c 193
QUAL Intl. Lunch 510 JointSessionoftheIsraelHeartSocietyandtheAmericanCollegeofCardiology:PCI 12:15p.m. 1:45p.m. N230 193
QUAL Intl. Lunch 515 JointSessionoftheSaudiHeartAssociationandtheAmericanCollegeof Cardiology:QualityRegistries
12:15p.m. 1:45p.m. N227b 193
SPECIAL Special 113 FITForumIV:GuidancefortheFirstStepsofYourCardiologyCareer 12:15p.m. 1:45p.m. S402 193
VALV Intl. Lunch 504 JointSessionoftheCanadianCardiovascularSocietyandtheAmericanCollegeof Cardiology:Repairs/Replacement:Catheter-basedor(MinimallyInvasive)Surgery
12:15p.m. 1:45p.m. S405 193
VASC Intl. Lunch 514 JointSessionofthePakistanCardiacSocietyandtheAmericanCollege ofCardiology:Vascular—VTE,PHTN
12:15p.m. 1:45p.m. S503 194
ACC.12 • Daily Schedule • Monday, March 26, 2012
84 GO for ACC.12!
PATHWAY SESSION TYPE SESS. # TITLE START END ROOM PAGE
2:00 p.m. – 3:30 p.m. (exceptions noted in bold)
ACC-i2/TCT MOC 823 ACCFStudySessionforMaintenanceofCertification:ABIMRecertificationMadeEasy—InterventionalCardiology2011Update(B2-L)
3:00 p.m. 5:30 p.m. S105a 200
ACC-i2/TCT Special 2114 FellowsBootcamp:StructuralHeart 2:00p.m. 3:30p.m. S103b 194
ACC-i2/TCT Special 2132 AnatomyandTranscatheterTherapyfortheStructuralHeart InterventionalistII:LeftAtrialAppendageClosure,PFO,ASDandTransseptalPuncture(withRemoteDemonstrationsfromtheSeattleScienceFoundation)
2:00p.m. 3:30p.m. S102c 195
ACC-i2/TCT Symposium 2635 ImagingTranscatheterAorticValveProceduresII:SelectingtheBestPatient, ValveandVascularApproach
2:00p.m. 3:30p.m. S101a 195
ACC-i2/TCT Symposium 2636 SpotlightSessiononTAVR 2:00p.m. 3:30p.m. S102b 195
ACC-i2/TCT Symposium 2637 ManagementofSymptomaticSevereCarotidArteryDisease 2:00p.m. 3:30p.m. S103c 195
ACC-i2/TCT Symposium 2638 State-of-the-ArtSTEMI:AllYouNeedtoKnow 2:00p.m. 3:30p.m. S106b 196
ARR Symposium 702 SuddenCardiacDeathRiskStratificationinHeartFailure:Past,Present andFutureDirections
2:00p.m. 3:30p.m. S406a 196
ARR Symposium 703 SyncopeinSpecialPopulations 2:00p.m. 3:30p.m. N227b 196
CCS Experts 247 AcquiredHeartDiseaseinChildhoodEpidemiology:CurrentandFutureManagement 2:00p.m. 3:30p.m. S501a 196
HF Symposium 704 CardiacResynchronizationTherapy:WhomtoReferforImplantation? 2:00p.m. 3:30p.m. S406b 196
HF Symposium 705 UnderstandingtheComplexityoftheRightVentricle:ChallengesandProgress 2:00p.m. 3:30p.m. S404 196
HF Symposium 706 JointSymposiumoftheItalianFederationofCardiologyandthePennsylvania ChapteroftheAmericanCollegeofCardiology:UpdateontheTreatmentofAtrialFibrillation
2:00p.m. 3:30p.m. N230 197
IMAG Symposium 707 ManagementofthePatientwithValvularHeartDisease:RoleofEcho 2:00p.m. 3:30p.m. S405 197
IMAG Symposium 708 AdvancesinNuclearCardiology:CurrentandFutureApplications 2:00p.m. 3:30p.m. S403 197
ISCHEM Symposium 709 TransitioningfromACStoStableIschemicHeartDisease 2:00p.m. 3:30p.m. S401a 197
LIFELONG Core 821 CoreCurriculum:CardiacCatheterization 2:00p.m. 3:30p.m. N226 197
LIFELONG Core 822 CoreCurriculum:PreventiveCardiology 2:00p.m. 3:30p.m. N229 198
LIFELONG MOC 823 ACCFStudySessionforMaintenanceofCertification:ABIMRecertificationMadeEasy—InterventionalCardiology2011Update(B2-L)
3:00 p.m. 5:30 p.m. S105a 200
LIFELONG MOC 824 ACCFStudySessionforMaintenanceofCertification:ABIMRecertificationMadeEasy—ClinicalCardiacElectrophysiology2011Update(B3-L)
3:00 p.m. 5:30 p.m. S105d 200
PHTN Experts 249 PearlsandCaveatsinManagingPatientswithPulmonaryHypertension 2:00p.m. 3:30p.m. S505 198
PRACTICE Experts 248 IssuesThatHaveCausedMedicalProfessionalLiabilityClaims:AreYouatRisk? ASpecialPresentationfromTheDoctorsCompany
2:00p.m. 3:30p.m. S504a 198
PRACTICE Symposium 710 ImpactofHealthcarePolicyontheAcademicCardiovascularMission 2:00p.m. 5:30 p.m. S402 198
PREV Experts 250 LabileHypertension:EvaluationandManagement 2:00p.m. 3:30p.m. S502 198
PREV Symposium 711 JointSymposiumoftheAmericanAssociationofClinicalEndocrinologists andtheAmericanCollegeofCardiology:CardiologistsasEndocrinologists—EmergingManagementoftheDiabeticPatient
2:00p.m. 3:30p.m. S100c 199
QUAL Symposium 712 BringingEvidencetotheBedside:MakingGuidelinesMoreAccessibletoClinicians 2:00p.m. 3:30p.m. N427 199
QUAL Symposium 713 MakingaDifference:CardiologyLeadershipintheCommunityandtheWorld 2:00p.m. 3:35 p.m. N228 199
SPECIAL Legends 404 LegendsofCardiovascularMedicineLectureSeries—11thAnnualMaseri-FlorioInternationalLecture
2:00p.m. 3:00 p.m. N231 199
VALV Experts 251 ComplexValvularHeartDisease 2:00p.m. 3:30p.m. S503 199
VALV Symposium 714 CalcificAorticStenosis:DiagnosisandTreatmentinthe21stCentury 2:00p.m. 3:30p.m. N426 199
3:45 p.m. – 5:15 p.m. (exceptions noted in bold)
ACC-i2/TCT Symposium 2639 ControversiesinIntravascularImaging 3:45p.m. 5:15p.m. S101a 202
ACC-i2/TCT Symposium 2640 MitralInterventions 3:45p.m. 5:15p.m. S102b 200
ACC-i2/TCT Symposium 2641 ImportanceofBleedinginPatientswithCVDisease: APersonalizedApproachforTreatmentStrategies
3:45p.m. 5:15p.m. S103b 200
ACC-i2/TCT Symposium 2642 EndovascularManagementofErectileDysfunction 3:45p.m. 5:15p.m. S103c 201
ACC-i2/TCT Symposium 2643 ACS:NewInsightsandNovelTherapies 3:45p.m. 5:15p.m. S106b 201
ARR Symposium 715 ChallengesintheManagementofVentricularArrhythmias 3:45p.m. 5:15p.m. S406a 201
Monday, March 26, 2012 • Daily Schedule • ACC.12
ACC.12 Final Program 85
PATHWAY SESSION TYPE SESS. # TITLE START END ROOM PAGE
3:45 p.m. – 5:15 p.m. (continued — exceptions noted in bold)
ARR Symposium 716 IssuesinCardiacResynchronizationTherapy 3:45p.m. 5:15p.m. N227b 201
CCS Experts 252 GoldenMoments:WhenIstheRightTimetoInterveneinCongenitalHeartDisease? 3:45p.m. 5:15p.m. S501a 201
HF Symposium 717 ImprovingOutcomesandReducingHeartFailureReadmissions 3:45p.m. 5:15p.m. S406b 202
HF Symposium 718 ControversiesinTreatmentofComorbiditiesinHeartFailure:Paradoxesand ChallengesinTreatment
3:45p.m. 5:15p.m. S404 202
IMAG Symposium 719 EmergingApplicationsofCMR 3:45p.m. 5:15p.m. S403 202
LIFELONG Core 825 CoreCurriculum:VascularDisease 3:45p.m. 5:15p.m. N226 202
LIFELONG Core 826 CoreCurriculum:LandmarkTrials 3:45p.m. 5:15p.m. N229 203
PERI Experts 253 ChallengesinHypertrophicCardiomyopathy:CaseStudies 3:45p.m. 5:15p.m. S505 203
PERI Symposium 720 NewDirectionsintheEvaluationandManagementoftheCardiomyopathies 3:45p.m. 5:15p.m. N231 203
PHTN Experts 254 PulmonaryHypertensionToolsfortheCardiologist 3:45p.m. 5:15p.m. S504a 203
PREV Symposium 729 BeyondStatins:LDLManagementintheChallengingPatient 3:45p.m. 5:15p.m. S100c 203
PREV Symposium 745 WorldHellenicBiomedicalAssociation,theHellenicCardiologicalSociety, theCyprusSocietyofCardiologyandtheAmericanCollegeofCardiology:MediterraneanDietandItsProtectiveEffectonCardiovascularDisease
3:45p.m. 5:15p.m. S405 203
QUAL Symposium 721 TransformingHealthCareDeliverythroughCVRegistries 3:45p.m. 5:15p.m. N427 204
QUAL Symposium 722 ApplyingNewerCardiovascularAgentstoOlderAdults 3:45p.m. 5:15p.m. N228 204
SPECIAL Symposium 740 JointSymposiumoftheBritishCardiovascularSocietyandtheCalifornia ChapteroftheAmericanCollegeofCardiology
3:45p.m. 5:15p.m. N230 204
TEST Experts 255 StressTestinginWomen 3:45p.m. 5:15p.m. S502 204
VALV Experts 256 AdvancedHemodynamicsforValvularHeartDisease 3:45p.m. 5:15p.m. S503 204
VALV Symposium 723 ImportanceofRegistriesforValveDisease:AGlimpseintotheACCFuture 3:45p.m. 5:15p.m. N426 204
5:45 p.m. – 9:05 p.m. (exceptions noted in bold)
ACC-i2/TCT Clinical Focus 1607 JointSessionoftheAmericanAssociationforThoracicSurgery,theSocietyofThoracicSurgeonsandtheAmericanCollegeofCardiology:MultidisciplinaryApproachtotheHigh-riskAorticStenosisPatient
5:45p.m. 9:05 p.m. S401a 205
SPECIAL Special 307 61stAnnualConvocation 6:30 p.m. 8:00 p.m. Hall B, ACC.12 Main Tent
205
ACC.12 • Daily Schedule • Monday, March 26, 2012
86 GO for ACC.12!
PATHWAY SESSION TYPE SESS. # TITLE START END ROOM PAGE
8:00 a.m. – 9:30 a.m. (exceptions noted in bold)
ACS Symposium 728 JointSymposiumoftheAmericanAssociationforClinicalChemistryand theAmericanCollegeofCardiology:HowtoUseCardiacBiomarkers
8:00a.m. 9:30a.m. N230 209
ARR Symposium 747 AntithromboticTherapiesforAtrialFibrillation:CurrentStateoftheArt 8:00a.m. 9:30a.m. S404 209
CCS Symposium 724 ComplexConotruncalMalformations:WhattheSurgeonNeedstoKnowand HowtoGettheInformation
8:00a.m. 9:30a.m. N229 209
CCS Symposium 725 ComingofAge:TheHLHSTurns21 8:00a.m. 9:30a.m. N231 209
HF Experts 257 CardiacAmyloidosis 8:00a.m. 9:30a.m. S502 209
IMAG Experts 258 EchoinAssessmentofLowGradientAorticStenosis 8:00a.m. 9:30a.m. S505 210
ISCHEM Experts 259 InnovationsinNoninvasiveEvaluationofStableIschemicHeartDisease 8:00a.m. 9:30a.m. S503 210
LIFELONG Boot Camp 114 CCAResearchBootcampSessionII:SuccessfulResearchExecution andDissemination
8:00a.m. 9:30a.m. S105d 210
PHTN Symposium 726 SesionConjuntaConLaSociedadEspanoladeCardiologíaSociedad InteramericadeCardiología/AmericanCollegeofCardiology:ProblemasRelevantesenCardiología—2012
8:00a.m. 9:30a.m. S403 210
PREV Symposium 727 JointSymposiumoftheAmericanSocietyofHypertensionandtheAmerican CollegeofCardiology:HypertensionintheCriticallyIllPatient
8:00a.m. 9:30a.m. S406a 210
SPECIAL Special 308 JointAmericanCollegeofCardiology/Journal of the American Medical Association Late-BreakingClinicalTrials
8:00a.m. 9:30a.m. Hall B, ACC.12 Main Tent
210
SPECIAL Symposium 739 JointSessionoftheEuropeanSocietyofCardiologyandtheAmericanCollege ofCardiologyII:ProsandConsofNewApproachesforAntiplateletandAnticoagulantTherapy
8:00a.m. 9:30a.m. N426 211
VALV Experts 260 AorticRegurgitation/BAV 8:00a.m. 9:30a.m. S504a 211
9:45 a.m. – 11:45 a.m. (exceptions noted in bold)
SPECIAL Special 309 ACC.12ClosingSession:InnovatorsinCardiology 9:45a.m. 11:45a.m. Hall B, ACC.12 Main Tent
211
ACC.12 •Program-At-A-Glance
Daily Schedule Tuesday, March 27, 2012
Sessionsarelistedalphabeticallybylearningpathwaybasedontimeblock.
iScienceiconindicatessessionsareincludedaspartofiScience2012:ACC.12MeetingonDemand
TheACC.12Onlineiconindicatessessionsareavailableasliveoron-demandwebcasts.
Pleaserefertopage65foradditionalinformationonaccessingthesefreesessions.
ACC.12 Final Program 87
ACC-i2 wITh TCTSESSIONTYPE SESS.# TITLE START END ROOM PAGE
SATuRDAy, MARCh 24, 2012Symposium 2644 InterventionalFeaturedClinicalStudiesI 8:00a.m. 9:30a.m. S102b 107
Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
9:30a.m. 10:30a.m. hall A
Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
11:00a.m. Noon hall A
Symposium 734 PharmacologyProgram:PharmacologicConsiderationsintheSettingofPCI 12:15p.m. 1:45p.m. N427 116
Experts 2301 AtypicalThromboticACSCaseReviews 12:15p.m. 1:45p.m. S101a 114
Experts 2302 ChronicTotalOcclusionsandLeftMainCaseReviews 12:15p.m. 1:45p.m. S102c 114
Experts 2303 CoronaryImagingCaseReviews 12:15p.m. 1:45p.m. S103b 115
Symposium 2606 TAVR:ProceduralAspectsandBestPractices 12:15p.m. 1:45p.m. S102b 115
Symposium 2607 AcuteVenousThromboembolicDisease 12:15p.m. 1:45p.m. S103c 115
Live/Taped Cases
2201 LiveandTapedCaseSessionI:MultivesselPCI—PhysiologyandImaging 2:00p.m. 5:00p.m. hall B, ACC.12 Main Tent
119
Oral 2502 AcuteMyocardialInfarction 2:00p.m. 3:30p.m. S103b 119
Symposium 2608 IntravascularImaging:Restenosis,ThrombosisandStentFollow-upI: RestenosisandEarlyThrombosis
2:00p.m. 3:30p.m. S101a 119
Symposium 2609 HemodynamicsandAngiographyI:BasicIssues 2:00p.m. 3:30p.m. S102b 120
Symposium 2610 RenalInterventionsforHypertensionandRenalFunctionPreservation 2:00p.m. 3:30p.m. S103c 120
Symposium 2645 InterventionalFeaturedClinicalStudiesII 2:00p.m. 3:30p.m. S102c 120
Experts 2305 VascularAccessChallengesandComplicationsCaseReviews 4:30p.m. 6:00p.m. S102c 125
Experts 2306 UnusualCasesofACSCaseReviews 4:30p.m. 6:00p.m. S103b 125
Symposium 2611 IntravascularImaging:Restenosis,ThrombosisandStentFollow-upII: VeryLateStentThrombosisandLateCatch-up
4:30p.m. 6:00p.m. S101a 125
Symposium 2612 HemodynamicsII(HOCM) 4:30p.m. 6:00p.m. S102b 125
Symposium 2613 AdvancesandControversiesinCarotid,AorticandPeripheralArterialDisease: InCollaborationwiththeSocietyofVascularSurgery
4:30p.m. 6:00p.m. S103c 126
SuNDAy, MARCh 25, 2012Oral 2500 OutcomesinPatientsTreatedwithTAVR 8:00a.m. 9:30a.m. N227b 137
Oral 2501 AdjunctPharmacology 8:00a.m. 9:30a.m. S101a 137
Oral 2504 PCIinComplexLesions 8:00a.m. 9:30a.m. S103c 138
Oral 2505 PCIinComplexPatients 8:00a.m. 9:30a.m. S102c 138
Oral 2508 IntravascularDiagnostics 8:00a.m. 9:30a.m. S106b 139
Oral 2510 VascularAccess 8:00a.m. 9:30a.m. S103b 139
Symposium 2614 AbnormalitiesoftheAtrium 8:00a.m. 9:30a.m. S102b 140
Oral 2503 BioresorbableVascularScaffolds 10:45a.m. 12:15p.m. S106b 145
Oral 2506 Drug-elutingStents 10:45a.m. 12:15p.m. S101a 146
Oral 2507 ImaginginTAVR 10:45a.m. 12:15p.m. S102c 146
Oral 2509 PreventionandTreatementofRestenosis 10:45a.m. 12:15p.m. S103c 147
ACC.12 •Program-At-A-Glance
Topic ScheduleSessionsarelistedalphabeticallybylearningpathwaybasedontimeblock.
iScienceiconindicatessessionsareincludedaspartofiScience2012:ACC.12MeetingonDemand
TheACC.12Onlineiconindicatessessionsareavailableasliveoron-demandwebcasts.
Pleaserefertopage65foradditionalinformationonaccessingthesefreesessions.
88 GO for ACC.12!
ACC-i2 wITh TCTSESSIONTYPE SESS.# TITLE START END ROOM PAGE
SuNDAy, MARCh 25, 2012 (continued)
Oral 2511 OutcomesinPatientsTreatedwithPCI 10:45a.m. 12:15p.m. S103b 147
Symposium 2615 Congenital/Pediatric 10:45a.m. 12:15p.m. S102b 148
Symposium 646 InterventionalCardiovascularMedicinein2012:AnUpdatefortheNon-Interventionalist andtheDouglasP.Zipes,M.D.,DistinguishedYoungScientistAwardeeLecture
12:15p.m. 1:45p.m. N228 155
Special 2101 CardiacCareTeamSessionI:KeynoteAddress 12:30p.m. 1:00p.m. S103b 156
Experts 2308 AorticValveCaseReviews 12:30p.m. 1:45p.m. S101a 156
Experts 2309 CoronaryComplicationsCaseReviews 12:30p.m. 1:45p.m. S102b 156
Experts 2310 MultivesselandHemodynamicSupportCaseReviews 12:30p.m. 1:45p.m. S102c 156
Symposium 2616 EndovascularInterventionforVenousDisease 12:30p.m. 1:45p.m. S103c 156
Symposium 2617 PlateletInhibitionin2012:WhatYouNeedtoKnow 12:30p.m. 1:45p.m. S106b 156
Special 2102 CardiacCareTeamSessionII:CathLabofTomorrow—PathwaytoaHigh-risk AorticValveProgram
1:00p.m. 2:30p.m. S103b 160
Special 2131 AnatomyandTranscatheterTherapyfortheStructuralHeartInterventionalistI:Mitraland AorticValve(withRemoteDemonstrationsfromtheSeattleScienceFoundation)
2:00p.m. 3:30p.m. S102c 160
Live/Taped Cases
2202 LiveandTapedCaseSessionII:LeftMainandBirfucation—ComplexPCI 2:00p.m. 5:00p.m. hall B, ACC.12 Main Tent
161
Symposium 2618 ImagingTranscatheterAorticValveProceduresI:Intra-andPost-ProceduralImaging 2:00p.m. 3:30p.m. S101a 161
Symposium 2619 EmergingTechnologies 2:00p.m. 3:30p.m. S102b 161
Symposium 2620 PeripheralArteryDisease:SuperficialFemoralArtery 2:00p.m. 3:30p.m. S103c 161
Symposium 2621 ChronicTotalOcclusions 2:00p.m. 3:30p.m. S106b 162
Special 2103 CardiacCareTeamSessionIII:MedicationsandOtherTechniquestoManagethe PatientintheCathLab
2:30p.m. 3:30p.m. S103b 165
Special 2104 CardiacCareTeamSessionIV:SameDayDischargeforPCI 3:30p.m. 5:00p.m. S103b 165
Experts 2311 EndovascularCaseReviews 4:30p.m. 6:00p.m. S102b 166
Symposium 2622 ImagingTranscatheterMitralValveProcedures 4:30p.m. 6:00p.m. S101a 166
Symposium 2623 PeripheralArteryDisease:CriticalLimbIschemia 4:30p.m. 6:00p.m. S103c 166
Symposium 2624 VascularAccessandOutcomesfollowingPCIforACS:WhatYouShouldKnow 4:30p.m. 6:00p.m. S106b 167
Special 2105 CardiacCareTeamV:StructuralHeartDisease—MitralValve 5:00p.m. 6:00p.m. S103b 171
MONDAy, MARCh 26, 2012Special 2111 FellowsBootcamp:CoronaryI 8:00a.m. 9:30a.m. S103b 177
Special 2121 Multi-DisciplinaryManagementoftheFailingHeart:TeamBasedEvaluationand TherapyofAdvancedHeartDiseaseI
8:00a.m. 9:30a.m. S102c 177
Symposium 2625 LeftMainDisease:RoleofImagingforAssessment,Treatment,andFollow-up 8:00a.m. 9:30a.m. S101a 177
Symposium 2626 TAVRComplications:Incidence,ManagementandAvoidance 8:00a.m. 9:30a.m. S102b 177
Symposium 2627 ManagementofRenovascularHypertension 8:00a.m. 9:30a.m. S103c 177
Symposium 2628 LeftMainCoronaryIntervention:State-of-the-Art 8:00a.m. 9:30a.m. S106b 178
Special 2112 FellowsBootcamp:CoronaryII 10:30a.m. Noon S103b 182
Special 2122 Multi-DisciplinaryManagementoftheFailingHeart:TeamBasedEvaluationand TherapyofAdvancedHeartDiseaseII
10:30a.m. Noon S102c 183
Symposium 2629 EstablishingaCardiacCatheterizationImaging/PhysiologyProgram 10:30a.m. Noon S101a 183
Symposium 2630 HemodynamicsIII(PVLandASDClosure) 10:30a.m. Noon S102b 183
Symposium 2631 AllYouNeedtoKnowaboutCarotidArteryStenting 10:30a.m. Noon S103c 183
Symposium 2632 DES:FutureDirections 10:30a.m. Noon S106b 184
Intl. Lunch 502 JointSessionoftheArgentineSocietyofCardiologyandtheAmericanCollege ofCardiology:Carotids
12:15p.m. 1:45p.m. N226 188
Intl. Lunch 503 JointSessionoftheBrazilianSocietyofCardiologyandtheAmericanCollegeof Cardiology:Drug-elutingStents—FromtheEarlyBeginningtoNewStentPlatforms
12:15p.m. 1:45p.m. N426 188
Topic Schedule • Program-At-A-Glance • ACC.12
ACC.12 Final Program 89
ACC-i2 wITh TCTSESSIONTYPE SESS.# TITLE START END ROOM PAGE
MONDAy, MARCh 26, 2012 (continued)
Intl. Lunch 505 JointSessionoftheChineseSocietyofCardiologyandtheAmericanCollegeof Cardiology:CoronaryTotalOcclusions
12:15p.m. 1:45p.m. N228 188
Intl. Lunch 511 JointSessionoftheKoreanSocietyofCardiologyandtheAmericanCollegeof Cardiology:TreatingComplexLesions
12:15p.m. 1:45p.m. N229 188
Intl. Lunch 518 JointSessionoftheTurkishSocietyofCardiologyandtheAmericanCollegeof Cardiology:Devices—ASD’s,VSD’s,PerivalvularLeaks
12:15p.m. 1:45p.m. S505 189
MOC 819 ACCFStudySessionsforMaintenanceofCertification:ABIMRecertificationMadeEasy—InterventionalCardiology2010Update(B2-K)
12:15p.m. 2:45p.m. S105a 189
Special 2113 FellowsBootcamp:CaseReviews 12:15p.m. 1:45p.m. S103b 194
Experts 2313 Non-coronaryComplicationsCaseReviews 12:15p.m. 1:45p.m. S101a 189
Experts 2314 StructuralCaseReviews 12:15p.m. 1:45p.m. S102b 189
Experts 2315 ShockandHemodynamicSupportCaseReviews 12:15p.m. 1:45p.m. S102c 189
Symposium 2633 ControversiesinVascularandEndovascularMedicine 12:15p.m. 1:45p.m. S103c 189
Symposium 2634 Non-ST-ElevationACSin2012:WhatYouNeedtoKnow 12:15p.m. 1:45p.m. S106b 190
Live/Taped Cases
2203 LiveandTapedCaseSessionIII:ValvularHeartDisease 12:30p.m. 2:30p.m. hall B, ACC.12 Main Tent
194
Special 2114 FellowsBootcamp:StructuralHeart 2:00p.m. 3:30p.m. S103b 194
Special 2132 AnatomyandTranscatheterTherapyfortheStructuralHeartInterventionalistII: LeftAtrialAppendageClosure,PFO,ASDandTransseptalPuncture(withRemoteDemonstrationsfromtheSeattleScienceFoundation)
2:00p.m. 3:30p.m. S102c 195
Symposium 2635 ImagingTranscatheterAorticValveProceduresII:SelectingtheBestPatient, ValveandVascularApproach
2:00p.m. 3:30p.m. S101a 195
Symposium 2636 SpotlightSessiononTAVR 2:00p.m. 3:30p.m. S102b 195
Symposium 2637 ManagementofSymptomaticSevereCarotidArteryDisease 2:00p.m. 3:30p.m. S103c 195
Symposium 2638 State-of-the-ArtSTEMI:AllYouNeedtoKnow 2:00p.m. 3:30p.m. S106b 196
MOC 823 ACCFStudySessionforMaintenanceofCertification:ABIMRecertificationMadeEasy—InterventionalCardiology2011Update(B2-L)
3:00p.m. 5:30p.m. S105a 200
Symposium 2639 ControversiesinIntravascularImaging 3:45p.m. 5:15p.m. S101a 202
Symposium 2640 MitralInterventions 3:45p.m. 5:15p.m. S102b 200
Symposium 2641 ImportanceofBleedinginPatientswithCVDisease:APersonalizedApproach forTreatmentStrategies
3:45p.m. 5:15p.m. S103b 200
Symposium 2642 EndovascularManagementofErectileDysfunction 3:45p.m. 5:15p.m. S103c 200
Symposium 2643 ACS:NewInsightsandNovelTherapies 3:45p.m. 5:15p.m. S106b 201
Clinical Focus 1607 JointSessionoftheAmericanAssociationforThoracicSurgery,theSocietyofThoracicSurgeryandtheAmericanCollegeofCardiology:MultidisciplinaryApproachtotheHighRiskAorticStenosisPatient
5:45p.m. 9:05p.m. S401a 205
ACC.12 •Program-At-A-Glance •Topic Schedule
90 GO for ACC.12!
ACuTE CORONARy SyNDROMESSESSIONTYPE SESS.# TITLE START END ROOM PAGE
SATuRDAy, MARCh 24, 2012Experts 200 ContemporaryManagementofUA/NSTEMI 8:00a.m. 9:30a.m. S504a 107
Oral 902 P2Y12Antagonists:UnravelingtheMechanismsandOptimizingBenefit-Risk 8:00a.m. 9:30a.m. S406b 107
Oral 903 NewTherapeuticOptionsinACS:FromAntiplateletstoAntibiotics 8:00a.m. 9:30a.m. S402 108
Symposium 604 ControversiesinACS 12:15p.m. 1:45p.m. S404 115
Experts 211 OptimalSTEMIManagementfromPresentationtoPost-DischargeCare 2:00p.m. 3:30p.m. S504a 121
Symposium 613 State-of-the-ArtinSTEMICare 2:00p.m. 3:30p.m. S404 121
Symposium 618 TranslationalResearchSymposiumwiththeInternationalSocietyforCardiovascular TranslationalResearch:CellularTherapies
2:00p.m. 3:30p.m. N228 121
Symposium 623 AdjunctivePharmacologyinACS:AnticoagulantsandAntiplateletAgents 4:30p.m. 6:00p.m. S404 126
SuNDAy, MARCh 25, 2012Experts 221 ComplicationsofAMI 8:00a.m. 9:30a.m. S504a 140
Oral 916 WhatImpactsOutcomesinACS?FromGenestoPlaqueMorphologytoEnvironment 8:00a.m. 9:30a.m. S401a 140
Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
9:30a.m. 10:30a.m. hall A
Oral 917 ImprovingOutcomesinACS:InsightsfromBasicScienceandPreclinicalResearch 10:45a.m. 12:15p.m. N227b 148
Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
11:00a.m. Noon hall A
Symposium 639 TheFutureofACSClinicalTrials 12:30p.m. 1:45p.m. S404 156
Experts 231 ManagementofChestPainintheEmergencyDepartment 2:00p.m. 3:30p.m. S504a 162
Symposium 653 State-of-the-ArtinNonSTElevationAcuteCoronarySyndromes 2:00p.m. 3:30p.m. S404 162
Symposium 665 LiteratureInterpretationandStatisticalPitfallsinACSTrials 4:30p.m. 6:00p.m. S402 167
Clinical Focus 1605 InnovationsinTranslation:ACS 6:30p.m. 9:30p.m. Fairmont hotel, Imperial
Ballroom
171
MONDAy, MARCh 26, 2012Symposium 676 ShockinACS 8:00a.m. 9:30a.m. S401a 178
Symposium 689 ImprovingSTEMIOutcomes:SavingMyocardiumandAttenuatingRemodeling 10:30a.m. Noon S401a 184
Intl. Lunch 513 JointSessionoftheMexicanSocietyofCardiologyandtheAmericanCollegeof Cardiology:AcuteCoronarySyndromes—ImprovingOutcomes
12:15p.m. 1:45p.m. S404 190
TuESDAy, MARCh 27, 2012Symposium 728 JointSymposiumoftheAmericanAssociationforClinicalChemistryandthe
AmericanCollegeofCardiology:HowtoUseCardiacBiomarkers8:00a.m. 9:30a.m. N230 209
Topic Schedule • Program-At-A-Glance • ACC.12
ACC.12 Final Program 91
ARRhyThMIASSESSIONTYPE SESS.# TITLE START END ROOM PAGE
Saturday, March 24, 2012Experts 201 HowtoManageaDevice/LeadAdvisory 8:00a.m. 9:30a.m. S503 108
Experts 206 AlternativestoWarfarinforthePreventionofStrokeinAtrialFibrillation:HowtoDecide? 12:15p.m. 1:45p.m. S503 116
Experts 212 ManagementofDifficultAF:WhentoChangeDrugs,WhentoGiveUp 2:00p.m. 3:30p.m. S503 121
Symposium 614 CanRemoteDiseaseManagementImproveClinicalOutcomes? 2:00p.m. 3:30p.m. S406a 121
Symposium 615 ChallengesintheManagementofSupraventricularTachycardia 2:00p.m. 3:30p.m. S403 121
Symposium 735 PharmacologyProgram:PharmacotherapyofNewAntithrombotics 2:00p.m. 3:30p.m. N427 122
Symposium 736 PharmacologyProgram:PharmacologicConsiderationswithAntiarrhythmicDrugs, andDyslipidemiaandResidualRisk:WhenandHowDoYouAddtoStatinTherapy?
4:00p.m. 6:00p.m. N427 125
Experts 216 TheRiskversusBenefitofDFTTesting 4:30p.m. 6:00p.m. S503 126
Symposium 624 ManagementofComplicationsofPacemakersandLeads 4:30p.m. 6:00p.m. S403 126
Symposium 627 TranslationalResearchSymposiumwiththeInternationalSocietyforCardiovascular TranslationalResearch:TissueEngineering
4:30p.m. 5:30p.m. N228 127
Symposium 1601 ANewERAinAtrialFibrillation:StrategiesforImplementingNewTherapies 6:30p.m. 10:00p.m. Fairmont Hotel, International
Ballroom
129
SuNDAy, MARCh 25, 2012Experts 222 JointSymposiumoftheHeartRhythmSocietyandtheAmericanCollegeof
Cardiology:GeneticSyndromesfortheClinician(HCM,Brugada,LongQT)8:00a.m. 9:30a.m. S503 141
Oral 904 JointOralArrhythmiasSessionoftheHeartRhythmSocietyandtheAmericanCollegeofCardiology:ManagementofthePatientwithAtrialFibrillation—AnticoagulationandPreventionofStroke
8:00a.m. 9:30a.m. N426 141
Oral 918 CardiacMRIfortheTreatmentandEvaluationofArrhythmias 10:45a.m. 12:15p.m. S404 148
Oral 919 JointOralSessionoftheHeartRhythmSocietyandtheAmericanCollegeofCardiology:CardiacArrestandtheCareoftheICDPatient
10:45a.m. 12:15p.m. N426 149
Symposium 640 JointSymposiumoftheHeartRhythmSocietyandtheAmericanCollegeof Cardiology:InvestigationandManagementofSyncope
12:30p.m. 1:45p.m. N426 157
Experts 232 JointSymposiumoftheHeartRhythmSocietyandtheAmericanCollegeof Cardiology:OptimizingtheManagementofthePatientwithImplantableDevices
2:00p.m. 3:30p.m. S503 162
Symposium 654 JointSymposiumoftheHeartRhythmSocietyandtheAmericanCollegeof Cardiology:AtrialFibrillation—PreventionofStroke
2:00p.m. 3:30p.m. N426 162
Symposium 666 JointSymposiumoftheHeartRhythmSocietyandtheAmericanCollegeof Cardiology:AtrialFibrillation—ManagementoftheArrhythmia
4:30p.m. 6:00p.m. N426 167
Clinical Focus 1603 JointSessionoftheHeartRhythmSocietyofAmericaandtheAmericanCollegeofCardiology:InnovationsinTranslation—AtrialFibrillation
6:30p.m. 9:30p.m. Fairmont hotel, International
Ballroom
172
MONDAy, MARCh 26, 2012Experts 239 Case-OrientedGapsintheGuidelines:WhoShouldGetanICD? 8:00a.m. 9:30a.m. S504a 178
Symposium 677 ClinicalManagementoftheAFPatient:TreatingthePatientandtheHealthCareProvider 8:00a.m. 9:30a.m. N226 178
Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
9:30a.m. 10:30a.m. hall A
Experts 243 PerioperativeManagementofPatientswithCardiacImplantableElectronicDevice 10:30a.m. Noon S504a 184
Symposium 690 ControversiesinDeviceTherapy 10:30a.m. Noon S406a 184
Symposium 691 TheGeneticsofSuddenCardiacDeath:WhatDoWeKnowandHowBestto EvaluateandManageSuchPatients
10:30a.m. Noon N226 184
Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
11:00a.m. Noon hall A
Intl. Lunch 501 JointSessionoftheJapaneseCollegeofCardiologyandtheAmericanCollege ofCardiology:RiskStratificationforSuddenCardiacDeath
12:15p.m. 1:45p.m. S403 190
Intl. Lunch 509 JointSessionoftheCardiologicalSocietyofIndiaandtheAmericanCollege ofCardiology:AF—Medical,EP,SurgicalOptions
12:15p.m. 1:45p.m. S401a 190
Symposium 702 SuddenCardiacDeathRiskStratificationinHeartFailure:Past,Presentand FutureDirections
2:00p.m. 3:30p.m. S406a 196
ACC.12 •Program-At-A-Glance •Topic Schedule
92 GO for ACC.12!
ARRhyThMIASSESSIONTYPE SESS.# TITLE START END ROOM PAGE
MONDAy, MARCh 26, 2012 (continued)
Symposium 703 SyncopeinSpecialPopulations 2:00p.m. 3:30p.m. N227b 196
Symposium 715 ChallengesintheManagementofVentricularArrhythmias 3:45p.m. 5:15p.m. S406a 201
Symposium 716 IssuesinCardiacResynchronizationTherapy 3:45p.m. 5:15p.m. N227b 201
TuESDAy, MARCh 27, 2012Symposium 747 AntithromboticTherapiesforAtrialFibrillation:CurrentStateoftheArt 8:00a.m. 9:30a.m. S404 209
CONGENITAL CARDIOLOGy SOLuTIONSSESSIONTYPE SESS.# TITLE START END ROOM PAGE
SATuRDAy, MARCh 24, 2012Symposium 202 ComplexIssuesFacingACHDPatients:ObstructiveLesions 8:00a.m. 9:30a.m. S105a 108
Oral 901 FromTargetingErrorstoUNOS:HowQualityandDatabasesCanImpactClinicalCare 10:30a.m. Noon S105a 114
Symposium 616 Quality,SafetyandResourcesEnhancingPediatricCardiovascularCare 2:00p.m. 3:30p.m. N231 122
Symposium 625 UpdatesonCareintheCongenitalHeartDiseasePatients 4:30p.m. 6:00p.m. N231 127
SuNDAy, MARCh 25, 2012Symposium 634 PreoperativeAssessmentofPatientsontheSingleVentriclePathway:
SpecialProblemsCreativeSolutions8:00a.m. 9:30a.m. N231 141
MOC 802 ACCFStudySessionforMaintenanceofCertification:AmericanBoardofPediatrics(ABP)RecertificationMadeEasy—2011PediatricCardiologySubspecialtySelf-Assessment
8:00a.m. 10:00a.m. S105d 109
Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
9:30a.m. 10:30a.m. hall A
Symposium 637 Post-OperativeGlennsandFontans:NavigatingTurbulentWaters 10:45a.m. 12:15p.m. N231 149
Oral 920 AdultswithCongenitalHeartDisease:ImagingPredictors,EvolvingTherapiesandOutcomes 10:45a.m. 12:15p.m. S402 149
Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
11:00a.m. Noon hall A
Special 301 Career&MentoringSessionforPediatricandCongenitalCardiologists 12:30p.m. 1:45p.m. N231 157
Legends 402 LegendsinCardiovascularMedicineLectureSeries—2012DanG.McNamaraLecture 2:00p.m. 3:30p.m. N228 162
Symposium 667 TheGreatDebates 4:30p.m. 6:00p.m. N231 167
Symposium 668 ACHDfortheGeneralCardiologist 4:30p.m. 6:00p.m. N230 168
MONDAy, MARCh 26, 2012Symposium 678 PulmonaryArteryStenosisCurrentTherapyandFutureDirections:LiveCase 8:00a.m. 9:30a.m. N231 178
Symposium 679 WomenwithCongenitalHeartDisease:Fertility,PregnancyandMenopause 8:00a.m. 9:30a.m. S501a 179
Symposium 692 PulmonaryVeinStenosis:WhatAreRealisticExpectations? 10:30a.m. Noon N229 184
Symposium 693 ChallengingImagingIssuesinCongenitalHeartDisease 10:30a.m. Noon N231 185
Intl. Lunch 506 JointSessionoftheEgyptianSocietyofCardiologyandtheAmericanCollegeof Cardiology:AdultCongenitalHeartDisease:WhereWeCameFromandWhereWeAre
12:15p.m. 1:45p.m. N231 191
Experts 247 AcquiredHeartDiseaseinChildhoodEpidemiology:CurrentandFutureManagement 2:00p.m. 3:30p.m. S501a 196
Experts 252 GoldenMoments:WhenIstheRightTimetoInterveneinCongenitalHeartDisease? 3:45p.m. 5:15p.m. S501a 201
TuESDAy, MARCh 27, 2012Symposium 724 ComplexConotruncalMalformations:WhattheSurgeonNeedstoKnowand
HowtoGettheInformation8:00a.m. 9:30a.m. N229 209
Symposium 725 ComingofAge:TheHLHSTurns21 8:00a.m. 9:30a.m. N231 209
Topic Schedule • Program-At-A-Glance • ACC.12
ACC.12 Final Program 93
hEART FAILuRESESSIONTYPE SESS.# TITLE START END ROOM PAGE
SATuRDAy, MARCh 24, 2012Experts 203 TheLatestinHeartFailurewithPreservedEjectionFraction 8:00a.m. 9:30a.m. S502 109
Symposium 732 PharmacologyProgram:PharmacotherapyofChronicHeartFailure 8:00a.m. 9:30a.m. N427 109
Oral 905 PredictingOutcomesinHeartFailure:BiomarkersandBeyond 8:00a.m. 9:30a.m. S405 109
Oral 906 PathogenicandTherapeuticInsightsfromExperimentalHeartFailureModels 8:00a.m. 9:30a.m. S404 109
Experts 207 AtrialFibrillationandHeartFailure:ADynamicDuo 12:15p.m. 1:45p.m. S502 116
Experts 213 FromShocktoRecoveryorBridgetoTransplanation:RoleofPercutaneousVADs andOtherSupportDevices
2:00p.m. 3:30p.m. S502 122
Symposium 617 CardiorenalSyndromeinHeartFailure:FromDefinitiontoManagement 2:00p.m. 3:30p.m. S406b 122
Experts 217 HeartFailureDiseaseManagement:Issuesfor2012 4:30p.m. 6:00p.m. S502 127
Symposium 626 ManagementofAcuteDecompensatedHeartFailure:FromHemodynamic SubsetstoAppropriateTreatmentStrategies
4:30p.m. 6:00p.m. S406b 127
SuNDAy, MARCh 25, 2012Symposium 635 JointSymposiumoftheHeartFailureSocietyofAmericaandtheAmericanCollege
ofCardiology:ContemporaryPharmacologicalTreatmentofSystolicandDiastolicHeartFailure8:00a.m. 9:30a.m. S406b 141
Experts 225 HeartFailureCarefortheVeryOld:WhatAretheKeyIssuesforSuccess? 10:45a.m. 12:15p.m. S502 150
Oral 921 JointOralSessionoftheHeartFailureSocietyofAmericaandtheAmericanCollegeofCardiology:IndividualizingPharmacologicalTherapyinHeartFailure
10:45a.m. 12:15p.m. S406b 150
Oral 922 ImprovingPatientSelectionforDevice-BasedTherapies 10:45a.m. 12:15p.m. S405 150
Experts 228 CardiacMRfortheEvaluationoftheHeartFailurePatient 12:30p.m. 1:45p.m. S502 157
Symposium 641 JointSymposiumoftheHeartFailureSocietyofAmericaandtheAmericanCollege ofCardiology:ContemporaryIssuesintheDiagnosisandTreatmentofChronicAmbulatoryHeartFailure
12:30p.m. 1:45p.m. S406b 157
Symposium 642 CardiotoxicityofCancerChemotherapy:MolecularBasisandStrategiesfor EarlyDetectionandPrevention
12:30p.m. 1:45p.m. S405 157
Symposium 655 JointSymposiumoftheHeartFailureSocietyofAmericaandtheAmericanCollege ofCardiology:TheGrowingRoleofDevicesinHeartFailureManagement—ICD,CRT,HemodynamicMonitoringandUltrafiltration
2:00p.m. 3:30p.m. S406b 163
Symposium 656 TheNHLBIHeartFailureClinicalTrialsNetwork:ANewParadigmforInvestigation andTraining
2:00p.m. 3:30p.m. S405 163
Symposium 669 JointSymposiumoftheHeartFailureSocietyofAmericaandtheAmericanCollege ofCardiology:ManagementofAdvancedHeartFailureandTransplantation
4:30p.m. 6:00p.m. S406b 168
Symposium 670 HeartTransplantation:Challengesin2012 4:30p.m. 6:00p.m. S405 168
Symposium 671 PersonalizedMedicineandtheFutureofMedicalCare 4:30p.m. 6:00p.m. S404 168
MONDAy, MARCh 26, 2012Experts 240 Myocarditis:WhentoBiopsy,WhotoTreat,WhichTherapy? 8:00a.m. 9:30a.m. S502 179
Symposium 680 ControversiesintheManagementofHeartFailure 8:00a.m. 9:30a.m. S406b 179
Symposium 681 SurgicalTherapyofHeartFailure 8:00a.m. 9:30a.m. S404 179
Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
9:30a.m. 10:30a.m. hall A
Symposium 694 LVADasDestinationTherapyforAdvancedHeartFailure 10:30a.m. Noon S406b 185
Symposium 695 ManagementofPeripartumCardiomyopathy:Update2012 10:30a.m. Noon S404 185
Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
11:00a.m. Noon hall A
Intl. Lunch 517 JointSessionoftheSpanishSocietyofCardiologyandtheAmericanCollegeof Cardiology:HeartFailure—DevicestoTransplantation
12:15p.m. 1:45p.m. S501a 191
Symposium 704 CardiacResynchronizationTherapy:WhomtoReferforImplantation? 2:00p.m. 3:30p.m. S406b 196
Symposium 705 UnderstandingtheComplexityoftheRightVentricle:ChallengesandProgress 2:00p.m. 3:30p.m. S404 196
Symposium 706 JointSymposiumoftheItalianFederationofCardiologyandthePennsylvaniaChapter oftheAmericanCollegeofCardiology:UpdateontheTreatmentofAtrialFibrillation
2:00p.m. 3:30p.m. N230 197
ACC.12 •Program-At-A-Glance •Topic Schedule
94 GO for ACC.12!
hEART FAILuRESESSIONTYPE SESS.# TITLE START END ROOM PAGE
MONDAy, MARCh 26, 2012 (continued)
Symposium 717 ImprovingOutcomesandReducingHeartFailureReadmissions 3:45p.m. 5:15p.m. S406b 202
Symposium 718 ControversiesinTreatmentofComorbiditiesinHeartFailure:Paradoxesand ChallengesinTreatment
3:45p.m. 5:15p.m. S404 202
TuESDAy, MARCh 27, 2012Experts 257 CardiacAmyloidosis 8:00a.m. 9:30a.m. S502 209
IMAGINGSESSIONTYPE SESS.# TITLE START END ROOM PAGE
SATuRDAy, MARCh 24, 2012Experts 204 MultimodalityImaginginEvaluationofProstheticValveFunction 8:00a.m. 9:30a.m. S505 110
Oral 908 ABetterUnderstandingofIschemiaandFunction:InsightsfromCardiacMRI 8:00a.m. 9:30a.m. S403 110
Oral 909 NewImagingApproachestoAtherosclerosisandtheMicrocirculation 8:00a.m. 9:30a.m. N426 110
Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
9:30a.m. 10:30a.m. hall A
Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
11:00a.m. Noon hall A
Experts 208 ImagingPatientswithPericardialDisease 12:15p.m. 1:45p.m. S505 116
Symposium 605 CardiovascularMagneticResonanceinMyocarditis 12:15p.m. 1:45p.m. S402 116
Experts 214 CurrentTopicsinCardiacCT 2:00p.m. 3:30p.m. S505 122
Symposium 619 MultimodalityImagingofHypertrophicCardiomyopathy 2:00p.m. 3:30p.m. S402 122
Experts 218 MyocardialPerfusionImaging:PickingtheRightTest 4:30p.m. 6:00p.m. S505 127
Symposium 628 Multi-ModalityImaging:ChestPainintheEmergencyDepartment 4:30p.m. 6:00p.m. S402 127
SuNDAy, MARCh 25, 2012Experts 223 CardiacPET:IncorporationintoDailyPractice 8:00a.m. 9:30a.m. S505 142
Oral 907 JointOralSessionoftheAmericanSocietyofEchocardiographyandtheAmericanCollegeofCardiology:NewestApplicationsofEchotoClinicalPractice
8:00a.m. 9:30a.m. S406a 142
Symposium 638 JointSymposiumoftheAmericanSocietyofEchocardiographyandtheAmerican CollegeofCardiology:Cardiomyopathy—AComprehensiveEchocardiographicApproach
10:45a.m. 12:15p.m. S406a 151
Oral 924 CardiacCT:TowardaBetterUnderstandingofCAD 10:45a.m. 12:15p.m. S403 151
Symposium 643 JointSymposiumoftheAmericanSocietyofEchocardiographyandtheAmerican CollegeofCardiology:InterventionalEchocardiography—EvolvingRoleinPatientManagement
12:30p.m. 1:45p.m. S406a 158
Symposium 644 Cost-EffectiveImaginginPatientswithChronicCAD 12:30p.m. 1:45p.m. S403 158
Experts 233 RoleofCMRinValvularHeartDisease 2:00p.m. 3:30p.m. S505 163
Symposium 657 JointSymposiumoftheAmericanSocietyofEchocardiographyandtheAmerican CollegeofCardiology:HealthcareReform—ImpactonImaging
2:00p.m. 3:30p.m. S406a 163
Symposium 658 RadionuclideImagingintheHeartFailurePatient 2:00p.m. 3:30p.m. S403 163
Symposium 672 JointSymposiumoftheAmericanSocietyofEchocardiographyandtheAmerican CollegeofCardiology:Echoin2012—WhatYouNeedtoKnowtoKeepUp
4:30p.m. 6:00p.m. S406a 168
Topic Schedule • Program-At-A-Glance • ACC.12
ACC.12 Final Program 95
IMAGINGSESSIONTYPE SESS.# TITLE START END ROOM PAGE
MONDAy, MARCh 26, 2012Experts 241 ImagingtheRightVentricle 8:00a.m. 9:30a.m. S505 179
Symposium 682 AdvancedLVDysfunction:AMultimodalityApproach 8:00a.m. 9:30a.m. S405 179
Symposium 683 FutureDirectionsforCardiacCT 8:00a.m. 9:30a.m. S403 180
Symposium 696 CardiacCTin2012:State-of-the-Art 10:30a.m. Noon S405 185
Symposium 697 RoleofEchointheEvaluationandManagementofPatientswithMitralRegurgitation 10:30a.m. Noon S403 185
Intl. Lunch 507 JointSessionoftheGermanCardiacSocietyandtheAmericanCollegeof Cardiology:Imaging—EvolvingStrategies
12:15p.m. 1:45p.m. S406b 191
Symposium 707 ManagementofthePatientwithValvularHeartDisease:RoleofEcho 2:00p.m. 3:30p.m. S405 197
Symposium 708 AdvancesinNuclearCardiology:CurrentandFutureApplications 2:00p.m. 3:30p.m. S403 197
Symposium 719 EmergingApplicationsofCMR 3:45p.m. 5:15p.m. S403 202
TuESDAy, MARCh 27, 2012Experts 258 EchoinAssessmentofLowGradientAorticStenosis 8:00a.m. 9:30a.m. S505 210
ChRONIC CAD/STABLE ISChEMIC hEART DISEASESESSIONTYPE SESS.# TITLE START END ROOM PAGE
SATuRDAy, MARCh 24, 2012Oral 910 Sex,Scoring,Sadness,Statins,StentsandSurgery 8:00a.m. 9:30a.m. N227b 111
Symposium 606 RevascularizationInSIHD:IntegratingNewEvidence 12:15p.m. 1:45p.m. S401a 116
Symposium 620 StableIschemicHeartDiseaseinWomen:AreTheyReallyfromVenus? 2:00p.m. 3:30p.m. S401a 123
Symposium 629 StableIschemicHeartDisease:What’sNewintheGuidelines(AndWhatShouldBe)? 4:30p.m. 6:00p.m. S401a 128
SuNDAy, MARCh 25, 2012Oral 923 WhoSaidThere’sNothingNew? 10:45a.m. 12:15p.m. N230 151
Symposium 645 ManagingHigh-riskPatientswithStableIschemicHeartDisease 12:30p.m. 1:45p.m. S401a 158
Experts 234 HeartFailureinStableIschemicHeartDisease:NotfortheWeakofHeart 2:00p.m. 3:30p.m. S502 163
MONDAy, MARCh 26, 2012Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement
to JACC: Abstracts of Original Contributionsforacompletelisting.9:30a.m. 10:30a.m. hall A
Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
11:00a.m. Noon hall A
Intl. Lunch 508 JointSessionoftheBritishCardiovascularSocietyandtheAmericanCollege ofCardiology:NICEGuidelines
12:15p.m. 1:45p.m. N427 191
Symposium 709 TransitioningfromACStoStableIschemicHeartDisease 2:00p.m. 3:30p.m. S401a 197
TuESDAy, MARCh 27, 2012Experts 259 InnovationsinNoninvasiveEvaluationofStableIschemicHeartDisease 8:00a.m. 9:30a.m. S503 210
ACC.12 •Program-At-A-Glance •Topic Schedule
96 GO for ACC.12!
LIFELONG LEARNINGSESSIONTYPE SESS.# TITLE START END ROOM PAGE
FRIDAy, MARCh 23, 2012MOC 801 ACCFStudySessionforMaintenanceofCertification:ABIMRecertificationMadeEasy—ACCSelf
AssessmentSession:UpdateinClinicallyRelevantGuidelinesandTrials7:30a.m. 10:00a.m. S105a 105
SATuRDAy, MARCh 24, 2012MOC 802 ACCFStudySessionforMaintenanceofCertification:AmericanBoardofPediatrics(ABP)Recertification
MadeEasy—2011PediatricCardiologySubspecialtySelf-Assessment8:00a.m. 10:00a.m. S105d 111
Symposium 607 EverythingYouWantedtoKnowaboutABIMRecertification(andmore...) 12:15p.m. 1:45p.m. N226 116
MOC 803 ACCFStudySessionsforMaintenanceofCertification:ABIMRecertificationMadeEasy—CardiovascularDisease2010Update(A1-K)
12:30p.m. 3:00p.m. S105a 118
MOC 804 ACCFStudySessionsforMaintenanceofCertification:ABIMRecertificationMadeEasy—CardiovascularDisease2011Update(A1-L)
12:30p.m. 3:00p.m. S105d 118
Core 805 CoreCurriculum:CongenitalHeartDisease 2:00p.m. 3:30p.m. N226 123
Core 806 CoreCurriculum:CongestiveHeartFailure 2:00p.m. 3:30p.m. N229 123
MOC 807 ACCFStudySessionsforMaintenanceofCertification:ABIMRecertificationMadeEasy—CardiovascularDisease2011Update(A1-L)
3:30p.m. 6:00p.m. S105a 124
MOC 808 ACCFStudySessionsforMaintenanceofCertification:ABIMRecertificationMadeEasy—CardiovascularDisease2010Update(A1-K)
3:30p.m. 6:00p.m. S105d 127
Core 809 CoreCurriculum:Echocardiography 4:30p.m. 6:00p.m. N226 128
Core 810 CoreCurriculum:CardiacElectrophysiology 4:30p.m. 6:00p.m. N229 128
SuNDAy, MARCh 25, 2012Symposium 731 CCATeam-BasedMaintenanceofCertification 8:00a.m. 10:30a.m. S105d 142
MOC 811 ACCFStudySessionforMaintenanceofCertification:ABIMRecertificationMadeEasy—ACCGeneralCardiologyModulePartA
12:30p.m. 3:00p.m. S105a 158
MOC 812 ACCFStudySessionforMaintenanceofCertification:ABIMRecertificationMadeEasy—ACCGeneralCardiologyModulePartB
12:30p.m. 3:00p.m. S105d 158
Symposium 659 MasterClinicianI:DiscussionofThreeComplexRealWorldCases 2:00p.m. 3:30p.m. S401a 163
Core 813 CoreCurriculum:GeneralCardiology 2:00p.m. 3:30p.m. N226 164
Core 814 CoreCurriculum:ValvularHeartDisease 2:00p.m. 3:30p.m. N229 164
MOC 815 ACCFStudySessionforMaintenanceofCertification:ABIMRecertificationMadeEasy—ACCGeneralCardiologyModulePartB
3:30p.m. 6:00p.m. S105a 165
MOC 816 ACCFStudySessionforMaintenanceofCertification:ABIMRecertificationMadeEasy—ACCGeneralCardiologyModulePartA
3:30p.m. 6:00p.m. S105d 166
Symposium 737 MasterClinician:ClinicalCasesII 4:30p.m. 6:00p.m. S401a 169
Core 817 CoreCurriculum:CoronaryArteryDisease 4:30p.m. 6:00p.m. N226 169
Core 818 CoreCurriculum:NuclearCardiology 4:30p.m. 6:00p.m. N229 169
MONDAy, MARCh 26, 2012Boot Camp 112 CCAResearchBootcampSessionI:MethodsforEngaginginResearch 8:00a.m. 9:30a.m. S105d 180
MOC 819 ACCFStudySessionsforMaintenanceofCertification:ABIMRecertificationMadeEasy—InterventionalCardiology2010Update(B2-K)
12:15p.m. 2:45p.m. S105a 192
MOC 820 ACCFStudySessionforMaintenanceofCertification:ABIMRecertificationMadeEasy—ClinicalCardiacElectrophysiology2010Update(B3-K)
12:15p.m. 2:45p.m. S105d 192
Core 821 CoreCurriculum:CardiacCatheterization 2:00p.m. 3:30p.m. N226 197
Core 822 CoreCurriculum:PreventiveCardiology 2:00p.m. 3:30p.m. N229 198
MOC 823 ACCFStudySessionforMaintenanceofCertification:ABIMRecertificationMadeEasy—InterventionalCardiology2011Update(B2-L)
3:00p.m. 5:30p.m. S105a 200
MOC 824 ACCFStudySessionforMaintenanceofCertification:ABIMRecertificationMadeEasy—ClinicalCardiacElectrophysiology2011Update(B3-L)
3:00p.m. 5:30p.m. S105d 200
Topic Schedule • Program-At-A-Glance • ACC.12
ACC.12 Final Program 97
LIFELONG LEARNINGSESSIONTYPE SESS.# TITLE START END ROOM PAGE
MONDAy, MARCh 26, 2012 (continued)
Core 825 CoreCurriculum:VascularDisease 3:45p.m. 5:15p.m. N226 202
Core 826 CoreCurriculum:LandmarkTrials 3:45p.m. 5:15p.m. N229 203
TuESDAy, MARCh 27, 2012Boot Camp 114 CCAResearchBootcampSessionII:SuccessfulResearchExecutionandDissemination 8:00a.m. 9:30a.m. S105d 210
PERICARDIAL/MyOCARDIAL DISEASESESSIONTYPE SESS.# TITLE START END ROOM PAGE
SuNDAy, MARCh 25, 2012Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement
to JACC: Abstracts of Original Contributionsforacompletelisting.9:30a.m. 10:30a.m. hall A
Oral 925 AllThatGlittersinMyocardialandPericardialDisease 10:45a.m. 12:15p.m. N226 152
Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
11:00a.m. Noon hall A
Experts 229 GraspingtheComplexityofMyocardialandPericardialDiseases 12:30p.m. 1:45p.m. S505 159
Symposium 648 TheNewHypertrophicCardiomyopathyPracticeGuidelines 12:30p.m. 1:45p.m. N226 159
Symposium 661 ControversiesinHypertrophicCardiomyopathy 2:00p.m. 3:30p.m. N427 164
Experts 236 GeneticEvaluationofCardiomyopathy 4:30p.m. 6:00p.m. S505 169
MONDAy, MARCh 26, 2012Experts 253 ChallengesinHypertrophicCardiomyopathy:CaseStudies 3:45p.m. 5:15p.m. S505 203
Symposium 720 NewDirectionsintheEvaluationandManagementoftheCardiomyopathies 3:45p.m. 5:15p.m. N231 203
PuLMONARy hyPERTENSIONSESSIONTYPE SESS.# TITLE START END ROOM PAGE
SuNDAy, MARCh 25, 2012Oral 912 What’sNewinPulmonaryHypertension 8:00a.m. 9:30a.m. N226 142
Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
9:30a.m. 10:30a.m. hall A
Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
11:00a.m. Noon hall A
Symposium 649 EmergingApproachestoPulmonaryHypertensionwithLeftVentricularDysfunction 12:30p.m. 1:45p.m. S402 159
Symposium 662 PulmonaryHypertensionManagementinSpecialPopulations 2:00p.m. 3:30p.m. S402 164
MONDAy, MARCh 26, 2012Experts 249 PearlsandCaveatsinManagingPatientswithPulmonaryHypertension 2:00p.m. 3:30p.m. S505 198
Experts 254 PulmonaryHypertensionToolsfortheCardiologist 3:45p.m. 5:15p.m. S504a 203
TuESDAy, MARCh 27, 2012Symposium 726 SesionConjuntaConLaSociedadEspanoladeCardiologíaSociedadInteramericade
Cardiología/AmericanCollegeofCardiology:ProblemasRelevantesenCardiología—20128:00a.m. 9:30a.m. S403 210
ACC.12 •Program-At-A-Glance •Topic Schedule
98 GO for ACC.12!
PRACTICE PERFORMANCE, IMPROvEMENT AND ADMINISTRATIONSESSIONTYPE SESS.# TITLE START END ROOM PAGE
SATuRDAy, MARCh 24, 2012Symposium 600 CardiologyProcedures2012:HowtoCodeandGetReimbursed 8:00a.m. 9:30a.m. N231 112
Symposium 608 WomeninCardiology 12:15p.m. 1:45p.m. N229 116
Symposium 609 TheChallengesinDailyPractice 12:15p.m. 1:45p.m. N230 117
Symposium 621 ACC/MedAxiom/ACCA:Physician/HospitalIntegration101 2:00p.m. 3:30p.m. N230 123
Symposium 630 InformationTechnology,MedicineandtheFuture 4:30p.m. 6:00p.m. N230 128
SuNDAy, MARCh 25, 2012Experts 226 ACC/MedAxiom/ACCA:Physician/HospitalIntegration:MakingitWork 10:45a.m. 12:15p.m. S505 152
Symposium 647 JointSessionoftheHealthcareInformationandManagementSystemsSocietyand theAmericanCollegeofCardiology:HealthInformationTechnologyPartI:MakingtheElectronicHealthRecordMeaningfulandUseful—AWashingtonPerspective
12:30p.m. 1:45p.m. N227b 159
Symposium 660 JointSessionoftheHealthcareInformationandManagementSystemsSocietyand theAmericanCollegeofCardiology:HealthInformationTechnologyPartII:EHRImplementation…LessonsfromtheTrenches
2:00p.m. 3:30p.m. N227b 164
Symposium 673 FutureCompensationunderHealthCareReform 4:30p.m. 6:00p.m. N227b 169
MONDAy, MARCh 26, 2012Symposium 684 ACC/MedAxiom/ACCA:CardiovascularServiceLines 8:00a.m. 9:30a.m. S105a 180
Experts 244 LeadershipandGovernance 10:30a.m. Noon S503 185
Experts 248 IssuesthatHaveCausedMedicalProfessionalLiabilityClaims:AreYouatRisk? ASpecialPresentationfromTheDoctorsCompany
2:00p.m. 3:30p.m. S504a 198
Symposium 710 ImpactofHealthcarePolicyontheAcademicCardiovascularMission 2:00p.m. 5:30p.m. S402 198
PREvENTIONSESSIONTYPE SESS.# TITLE START END ROOM PAGE
SATuRDAy, MARCh 24, 2012Symposium 733 PharmacologyProgram:CardiovascularImplicationsofDietarySupplements 10:30a.m. Noon N427 114
Symposium 611 IsThereaRoleforHDLTherapy:AreWeAIMingTooHIGH? 12:15p.m. 1:45p.m. S100c 117
Symposium 622 EmergingTrendsinAtherosclerosis 2:00p.m. 3:30p.m. S100c 123
Symposium 631 HypertensionGuidelines2012 4:30p.m. 6:00p.m. S100c 128
Clinical Focus 1602 FirstLineofDefense:RiskFactorsandPreventionintheCardiologyPractice—AMasterClassfortheCommunityCardiologist
6:30p.m. 9:30p.m. Fairmont hotel, Gold
Room
130
SuNDAy, MARCh 25, 2012Oral 911 Prevention:FocusonLipids 8:00a.m. 9:30a.m. S100c 142
Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
9:30a.m. 10:30a.m. hall A
Experts 227 UpdateontheATPIVGuidelines 10:45a.m. 12:15p.m. S501a 157
Oral 926 Prevention:RenalSympatheticDenervation—ANovelTherapyforHypertension? 10:45a.m. 12:15p.m. N228 153
Oral 927 Prevention:CardiovascularRiskAssessmentandRehabilitation 10:45a.m. 12:15p.m. S401a 153
Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
11:00a.m. Noon hall A
Experts 230 ManagementofHypertensionintheElderly 12:30p.m. 1:45p.m. S501a 159
Experts 235 DietaryApproachesforCVDPrevention:MatchingtheDiettothePatient 2:00p.m. 3:30p.m. S501a 164
Topic Schedule • Program-At-A-Glance • ACC.12
ACC.12 Final Program 99
PreventionSESSION TYPE SESS. # TITLE START END rooM PAGE
SUnDAY, MArCH 25, 2012 (continued)
Symposium 663 Resistant Hypertension 2:00 p.m. 3:30 p.m. S100c 165
Experts 237 Reducing Disparities in Cardiovascular Preventive Care 4:30 p.m. 6:00 p.m. S501a 169
Symposium 675 What’s New in the ACCF/AHA Guidelines 4:30 p.m. 6:00 p.m. n228 169
Symposium 730 The Difficult-to-Manage Lipid Patient 4:30 p.m. 6:00 p.m. S100c 170
MonDAY, MArCH 26, 2012Symposium 685 ACC China Chapter Session: Cardiovascular Clinical Research and Practice in China 8:00 a.m. 9:30 a.m. n229 180
Symposium 686 Global CVD Prevention: Heart Disease and Risk Factors in Specific Populations 8:00 a.m. 9:30 a.m. S100c 180
Experts 245 Women’s Cardiovascular Health 10:30 a.m. Noon S501a 185
Symposium 698 Vitamins and Supplements in Cardiovascular Disease Prevention 10:30 a.m. Noon S100c 186
Symposium 699 Joint Symposium of the Preventive Cardiovascular Nurses Association and the American College of Cardiology
10:30 a.m. Noon S105d 186
Intl. Lunch 512 Joint Session of the National Heart Association of Malaysia and the American College of Cardiology: Resistant Hypertension
12:15 p.m. 1:45 p.m. S504a 192
Intl. Lunch 516 Joint Session of the South American Society of Cardiology and the American College of Cardiology: Prevention — Assessing and Educating Across Regions
12:15 p.m. 1:45 p.m. S502 192
Symposium 701 Role of Physical Activity in CVD Prevention 12:15 p.m. 1:45 p.m. S100c 193
Experts 250 Labile Hypertension: Evaluation and Management 2:00 p.m. 3:30 p.m. S502 198
Symposium 711 Joint Symposium of the American Association of Clinical Endocrinologists and the American College of Cardiology: Cardiologists as Endocrinologists — Emerging Management of the Diabetic Patient
2:00 p.m. 3:30 p.m. S100c 199
Symposium 729 Beyond Statins: LDL Management in the Challenging Patient 3:45 p.m. 5:15 p.m. S100c 203
Symposium 745 World Hellenic Biomedical Association, the Hellenic Cardiological Society, the Cyprus Society of Cardiology and the American College of Cardiology: Mediterranean Diet and Its Protective Effect on Cardiovascular Disease
3:45 p.m. 5:15 p.m. S405 203
tUeSDAY, MArCH 27, 2012Symposium 727 Joint Symposium of the American Society of Hypertension and the American
College of Cardiology: Hypertension in the Critically Ill Patient8:00 a.m. 9:30 a.m. S406a 210
QUAlitY of CAre AnD oUtCoMeSSESSION TYPE SESS. # TITLE START END rooM PAGE
SAtUrDAY, MArCH 24, 2012Experts 205 Am I Placing Inappropriate ICDs and Stents? Recent Registry Surprises 8:00 a.m. 9:30 a.m. S501a 112
Symposium 601 Patient-Centered Care: The New Imperative 8:00 a.m. 9:30 a.m. n226 112
Experts 209 Getting Access to Data: Successful Examples from the NCDR 12:15 p.m. 1:45 p.m. S501a 117
Symposium 610 Translational Research Symposium with the International Society for Cardiovascular Translational Research: Mission and Strategy in Translational Research
12:15 p.m. 1:45 p.m. n228 117
Experts 215 When Should a Medicine or Device Stop Being Used in Practice? 2:00 p.m. 3:30 p.m. S501a 123
Experts 219 Measuring and Optimizing Quality in your Outpatient Practice: The PINNACLE Registry 4:30 p.m. 6:00 p.m. S501a 128
SUnDAY, MArCH 25, 2012Experts 224 Tools to Improve Care Transition: The Hospital to Home (H2H) Experience 8:00 a.m. 9:30 a.m. S501a 143
Oral 913 Insights and Innovations to Improve Cardiac Risk 8:00 a.m. 9:30 a.m. n229 143
ACC.12 • Program-At-A-Glance • Topic Schedule
100 GO for ACC.12!
QuALITy OF CARE AND OuTCOMESSESSIONTYPE SESS.# TITLE START END ROOM PAGE
SuNDAy, MARCh 25, 2012 (continued)
Symposium 650 U.S.HealthSystemReform:What’sMissing? 10:45a.m. 12:15p.m. S100c 153
Oral 928 ImprovingPCIOutcomes 10:45a.m. 12:15p.m. N229 153
Symposium 664 JointSymposiumoftheAssociationofBlackCardiologistsandtheAmericanCollege ofCardiology:EthnicandRacialDisparitiesinCardiovascularDisease—ACalltoAction
2:00p.m. 3:30p.m. N230 165
MONDAy, MARCh 26, 2012Symposium 687 WhereWillCardiologyBein2015? 8:00a.m. 9:30a.m. N427 180
Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
9:30a.m. 10:30a.m. hall A
Symposium 700 Lies,DamnedLiesandStatistics:PitfallsinLiteratureInterpretation 10:30a.m. Noon N427 186
Symposium 742 TheFutureofCardiovascularDiseases:WhereAreWeGoing(andWhereDoWeWanttoGo) 10:30a.m. Noon N426 186
Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
11:00a.m. Noon hall A
Intl. Lunch 510 JointSessionoftheIsraelHeartSocietyandtheAmericanCollegeofCardiology:PCI 12:15p.m. 1:45p.m. N230 193
Intl. Lunch 515 JointSessionoftheSaudiHeartAssociationandtheAmericanCollegeofCardiology: QualityRegistries
12:15p.m. 1:45p.m. N227b 193
Symposium 712 BringingEvidencetotheBedside:MakingGuidelinesMoreAccessibletoClinicians 2:00p.m. 3:30p.m. N427 199
Symposium 713 MakingaDifference:CardiologyLeadershipintheCommunityandtheWorld 2:00p.m. 3:35p.m. N228 199
Symposium 721 TransformingHealthCareDeliverythroughCVRegistries 3:45p.m. 5:15p.m. N427 204
Symposium 722 ApplyingNewerCardiovascularAgentstoOlderAdults 3:45p.m. 5:15p.m. N228 204
SPECIAL TOPICSSESSIONTYPE SESS.# TITLE START END ROOM PAGE
FRIDAy, MARCh 23, 2012Symposium 746 4thAnnualCardiovascularConference:FocusontheMiddleEast 8:00a.m. Noon S101a 105
Legends 400 LegendsofCardiovascularMedicine—RoundtableForumandReception(ByInvitationOnly) 1:30p.m. 5:30p.m. S100c 106
SATuRDAy, MARCh 24, 2012Special 300 ACC.12OpeningShowcaseandLate-BreakingClinicalTrials:FeaturingtheLegendsof
CardiovascularMedicineLectureSeries—SimonDackLecture8:00a.m. 10:00a.m. hall B, ACC.12
Main Tent112
Special 103 EducatingtheEducators:BootcampforCardiologyFellowshipProgram DirectorsandCoordinators
12:15p.m. 1:45p.m. S405a 117
Special 104 FitForumI:FindingtheRightF.I.T.inDevelopingaCareerPlan Part1:FindingtheRightJob
12:15p.m. 1:45p.m. N227b 117
Special 106 EducatingtheEducators:FacultyDevelopmentforCardiologyFellowship ProgramDirectorsandCoordinators
2:00p.m. 3:30p.m. S405a 123
Special 107 FITForumI:FindingtheRightF.I.T.inDevelopingaCareerPlan Part2:LaunchingaSuccessfulCareer
2:00p.m. 3:15p.m. N227b 124
Legends 401 LegendsofCardiovascularMedicineLectureSeries—43rdAnnualLouisF.BishopLecture 2:00p.m. 3:00p.m. N426 124
Special 107A FITForumI:Mix‘n’Mingle 3:30p.m. 4:30p.m. hall A, Bistro ACC
125
Special 109 EducatingtheEducators:SymposiumforCardiologyFellowshipProgram DirectorsandCoordinators
4:30p.m. 6:30p.m. S405a 128
Special 110 FITForumII:Jeopardy 4:30p.m. 6:00p.m. N227b 129
Topic Schedule • Program-At-A-Glance • ACC.12
ACC.12 Final Program 101
SPECIAL TOPICSSESSIONTYPE SESS.# TITLE START END ROOM PAGE
SuNDAy, MARCh 25, 2012Special 304 Late-BreakingClinicalTrialsII 8:00a.m. 9:30a.m. hall B, ACC.12
Main Tent143
Special 405 YoungInvestigatorsAwardCompetition:ACCF/HermanK.GoldYoungInvestigatorsAwardinMolecularandCellularCardiology
8:00a.m. 9:30a.m. S105a 144
Special 406 YoungInvestigatorsAwardCompetition:Physiology,Pharmacology,andPathology 10:45a.m. 12:15p.m. S105a 154
Special 111 FITForumIII:HowtoWriteandEvaluateMedicalJournalArticles 12:30p.m. 1:45p.m. N229 159
Special 302 BusinessMeetingoftheCollege 3:00p.m. 3:15p.m. ACC Member Lounge
165
Experts 263 TheRoleofTherapeuticHypothermiaintheTreatmentofCardiacArrest 4:30p.m. 6:00p.m. S502 170
Legends 403 LegendsofCardiovascularMedicineLectureSeries—ThirdAnnualJamesT.DoveLecture 4:30p.m. 5:30p.m. N427 170
Symposium 744a ClinicalDecisionMakingforFellowsinTraining:PartA 4:30p.m. 5:50p.m. S403 170
Symposium 744b ClinicalDecisionMakingforFellowsinTraining:PartB 4:30p.m. 6:00p.m. S403 170
MONDAy, MARCh 26, 2012Special 305 JointAmericanCollegeofCardiology/New England Journal of Medicine
Late-BreakingClinicalTrials8:00a.m. 9:30a.m. hall B, ACC.12
Main Tent181
Special 407 YoungInvestigatorsAwardCompetition:ClinicalInvestigations,CongenitalHeartDiseaseandCardiovascularSurgery
8:00a.m. 9:30a.m. N230 181
Symposium 738 JointSessionoftheEuropeanSocietyofCardiologyandtheAmericanCollege ofCardiologyI:ManagementofHeartDiseaseinPregnancy
8:00a.m. 9:30a.m. N426 181
Special 306 Late-BreakingClinicalTrialsIV 10:30a.m. Noon hall B, ACC.12 Main Tent
186
Special 408 YoungInvestigatorsAwardCompetition:CardiovascularHealthOutcomesandPopulationGenetics 10:30a.m. Noon N230 187
Symposium 741 IntegrativeMedicine 10:30a.m. Noon N227b 187
Special 113 FITForumIV:GuidancefortheFirstStepsofYourCardiologyCareer 12:15p.m. 1:45p.m. S402 193
Legends 404 LegendsofCardiovascularMedicineLectureSeries—11thAnnualMaseri-FlorioInternational 2:00p.m. 3:00p.m. N231 199
Symposium 740 JointSymposiumoftheBritishCardiovascularSocietyandtheCalifornia ChapteroftheAmericanCollegeofCardiology
3:45p.m. 5:15p.m. N230 204
Special 307 61stAnnualConvocation 6:30p.m. 8:00p.m. hall B, ACC.12 Main Tent
205
TuESDAy, MARCh 27, 2012Special 308 JointAmericanCollegeofCardiology/Journal of the American Medical Association
Late-BreakingClinicalTrials8:00a.m. 9:30a.m. hall B, ACC.12
Main Tent210
Symposium 739 JointSessionoftheEuropeanSocietyofCardiologyandtheAmericanCollegeof CardiologyII:ProsandConsofNewApproachesforAntiplateletandAnticoagulantTherapy
8:00a.m. 9:30a.m. N426 211
Special 309 ACC.12ClosingSession:InnovatorsinCardiology 9:45a.m. 11:45a.m. hall B, ACC.12 Main Tent
211
ACC.12 •Program-At-A-Glance •Topic Schedule
102 GO for ACC.12!
DIAGNOSTIC TESTING: ECG ExERCISE AND SPORTSSESSIONTYPE SESS.# TITLE START END ROOM PAGE
SATuRDAy, MARCh 24, 2012Symposium 602 TranslationalResearchSymposiumwiththeInternationalSocietyforCardiovascular
TranslationalResearch:NewBreakthroughsinCardiovascularGenomics—ApproachingtheClinic8:00a.m. 9:30a.m. N228 113
Symposium 603 ChallengingSportsCardiologyCasesinYoungerAthletes 8:00a.m. 9:30a.m. N230 113
SuNDAy, MARCh 25, 2012Oral 914 DiagnosticTesting:SportsCardiology 8:00a.m. 9:30a.m. S402 144
Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
9:30a.m. 10:30a.m. hall A
Oral 929 DiagnosticTesting:ECGandCardiopulmonaryExerciseTesting 10:45a.m. 12:15p.m. S503 154
Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
11:00a.m. Noon hall A
Symposium 651 RoleofExerciseTreadmillTestingin2012 12:30p.m. 1:45p.m. N230 160
Experts 261 CardiacDilemmasinAthletes 4:30p.m. 6:00p.m. S503 171
MONDAy, MARCh 26, 2012Symposium 688 ChallengingSportsCardiologyCasesinOlderAthletes 8:00a.m. 9:30a.m. N227b 182
Experts 262 ECGsinAthletes:TheGreatECGScreeningDebateandChallengingCases 10:30a.m. Noon S502 187
Experts 255 StressTestinginWomen 3:45p.m. 5:15p.m. S502 204
vALvuLAR hEART DISEASESESSIONTYPE SESS.# TITLE START END ROOM PAGE
SATuRDAy, MARCh 24, 2012Self-Directed 1501 HeartSongsatACC.12:ASelf-PacedMultimediaLearningExperience 9:00a.m. 5:00p.m. vista Room
Lobby113
Experts 210 OrganicMitralRegurgitationCase-Management 12:15p.m. 1:45p.m. S504a 118
Symposium 612 TheSpectrumofDegenerativeMitralValve:FromImagingtoTreatment 12:15p.m. 1:45p.m. N426 118
Experts 220 IschemicMitralRegurgitation 4:30p.m. 6:00p.m. S504a 129
Symposium 632 ValveRepair:HowtoAchieveSuccess 4:30p.m. 6:00p.m. N426 129
Symposium 633 TranslationalResearchSymposiumwiththeInternationalSocietyfor CardiovascularTranslationalResearch:Devices
5:30p.m. 6:50p.m. N228 129
Clinical Focus 1604 ChampioningCareforthePatientwithAorticStenosis:TheRoleofCardiologistsandPrimaryCarefromRecognitiontoRecovery
6:30p.m. 9:30p.m. Fairmont hotel, Imperial Ballroom
130
SuNDAy, MARCh 25, 2012Oral 915 ValvularOral 8:00a.m. 9:30a.m. N427 145
Self-Directed 1502 HeartSongsatACC.12:ASelf-PacedMultimediaLearningExperience 9:00a.m. 5:00p.m. vista Room Lobby
145
Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
9:30a.m. 10:30a.m. hall A
Oral 930 ValvularOral 10:45a.m. 12:15p.m. N427 155
Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
11:00a.m. Noon hall A
Symposium 652 ControversiesinValveDiseaseI 12:30p.m. 1:45p.m. N427 160
Experts 238 AorticStenosisCaseManagement 4:30p.m. 6:00p.m. S504a 171
Topic Schedule • Program-At-A-Glance • ACC.12
ACC.12 Final Program 103
vALvuLAR hEART DISEASESESSIONTYPE SESS.# TITLE START END ROOM PAGE
MONDAy, MARCh 26, 2012Experts 242 TricuspidValveDiseaseCaseManagement 8:00a.m. 9:30a.m. S503 182
Symposium 674 ValvularHeartDiseaseintheOlderAdult(withManyDRGCodes):NavigatingtheOptions 8:00a.m. 9:30a.m. S402 182
Self-Directed 1503 HeartSongsatACC.12:ASelf-PacedMultimediaLearningExperience 9:00a.m. 5:00p.m. vista Room Lobby
182
Experts 246 ComplicationsofInterventionsforValvularHeartDisease 10:30a.m. Noon S505 187
Intl. Lunch 504 JointSessionoftheCanadianCardiovascularSocietyandtheAmericanCollegeof Cardiology:Repairs/Replacement—CatheterBasedor(MinimallyInvasive)Surgery
12:15p.m. 1:45p.m. S405 193
Experts 251 ComplexValvularHeartDisease 2:00p.m. 3:30p.m. S503 199
Symposium 714 CalcificAorticStenosis:DiagnosisandTreatmentinthe21stCentury 2:00p.m. 3:30p.m. N426 199
Experts 256 AdvancedHemodynamicsforValvularHeartDisease 3:45p.m. 5:15p.m. S503 204
Symposium 723 ImportanceofRegistriesforValveDisease:AGlimpseintotheACCFuture 3:45p.m. 5:15p.m. N426 204
TuESDAy, MARCh 27, 2012Experts 260 AorticRegurgitation/BAV 8:00a.m. 9:30a.m. S504a 211
PERIPhERAL vASCuLAR, AORTIC AND CAROTID DISEASESESSIONTYPE SESS.# TITLE START END ROOM PAGE
SATuRDAy, MARCh 24, 2012Oral 931 NewInsightsinPeripheralVascularDisease 8:00a.m. 9:30a.m. N229 113
Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
9:30a.m. 10:30a.m. hall A
Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.
11:00a.m. Noon hall A
Symposium 743 CarotidArteryDisease:IsthePictureClarifying? 4:30p.m. 6:00p.m. S406a 129
SuNDAy, MARCh 25, 2012Oral 932 NewInsightsinPerpheralVascularDiseaseandYearinReview 10:45a.m. 12:15p.m. S504a 155
MONDAy, MARCh 26, 2012Experts 264 ChallengingCasesinAnticoagulationManagement:SpotlightontheNovelAnticoagulants 10:30a.m. Noon S105a 187
Intl. Lunch 514 JointSessionofthePakistanCardiacSocietyandtheAmericanCollegeofCardiology:Vascular—VTE,PHTN
12:15p.m. 1:45p.m. S503 194
ACC.12 •Program-At-A-Glance •Topic Schedule
Visit us at ACC Central
Booth 10027
quality chasm?quality chasm?WHAT
Achieving quality care is your challenge.
Take it on with NCDR.
With guidelines-focused clinical registries from the NCDR®,
you’ll always know which quality improvement steps to take and when to take them.
NCDR® is an initiative of the American College of Cardiology Foundation®, with partnering support from the following organizations: CARE Registry®—The Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, American Academy of Neurology, American Association of Neurological Surgeons/Congress of Neurological Surgeons, Society for Vascular Medicine, and Society of Vascular and Interventional Neurology; CathPCI Registry®—The Society for Cardiovascular Angiography and Interventions; ICD Registry™—Heart Rhythm Society; IMPACT Registry®—The Society for Cardiovascular Angiography and Interventions and American Academy of Pediatrics; PINNACLE Registry®—MedAxiom; STS/ACC TVT Registry™—An initiative of The Society of Thoracic Surgeons and the American College of Cardiology Foundation; ACTION Registry®–GWTG™—An initiative of the American College of Cardiology Foundation and the American Heart Association, with partnering support from Society of Chest Pain Centers, The American College of Emergency Physicians, and The Society of Hospital Medicine.© 2012 American College of Cardiology Foundation. All rights reserved. B12016
www.ncdr.com/takeiton
ACC.12
Friday, March 23 & Saturday, March 24
Fri., March 23 & Sat., M
arch 24
ACC.12 Final Program 105
Morning SeSSionS
LIFELONG
MOC
801
ACCF Study Session for Maintenance of Certification: ABIM Recertification Made Easy — ACC Self Assessment Session: Update in Clinically Relevant Guidelines and TrialsFriday, March 23, 2012, 7:30 a.m. – 10:00 a.m.McCormick Place South, S105aCME/CNE Hours: 2.5
ACCF’s Maintenance of Certification Sessions allows you to easily obtain ABIM’s Maintenance of Certification (MOC) points during at ACC.12. Tickets are required for admittance to this session. Ticketed registrants must arrive no later than 15 minutes before the start of the session. Seats will be released at this time and an “open seating” policy will apply.
Attendees must be enrolled in the ABIM’s MOC program to claim MOC points. If you are not enrolled, please allow sufficient time to do this prior to the start of the session. ABIM staffs are available onsite to answer your MOC questions and help with enrollment.
For convenience, there will be computer terminals in the ACC MOC Center onsite in Room S104b for attendees to take the ABIM MOC test after the study session concludes, if desired. Electrical power is provided in the classrooms so that attendees who wish to bring their own devices may ‘power up’ to access relevant question modules.
Access to the online modules will also be available for participants for a short period of time following the annual meeting.
Attendees may not claim CME credits from ABIM as it is against ACCME and AMA guidelines to claim credit twice for the same activity. MOC credit is available from the ABIM after completion of the MOC module.
Co-Chairs: Patrick T. O’Gara, Boston, MA Rick A. Nishimura, Rochester, MN
Question James Fang, Cleveland, OH Moderators: Steve R. Ommen, Rochester, MN
SPECIAL
SyMPOSIUM
746
4th Annual Cardiovascular Conference Focus on the Middle EastFriday, March 23, 2012, 8:00 a.m. – NoonMcCormick Place South, S101aCME/CNE Hours: 3.75
Co-Chairs: Aaron D. Kugelmass, Springfield, MA Mohamed Sobhy Aly, Alexandria, Egypt
8:00 Introduction, Overview, Reflection on Program — Huon Gray, Southampton, United Kingdom, David R. Holmes, Jr., Rochester, MN, Aaron D. Kugelmass, Springfield, MA, Mohamed Sobhy Aly, Alexandria, Egypt
8:15 Plenary Lecture: Sudden Death: What Do We Know? — Douglas P. Zipes, Indianapolis, IN
Session I: Global Challenge and Success in CHF —
Co-Chairs: William A. Zoghbi, Houston, TX Hani Najm, Riyadh, Saudi Arabia
Panelists: Farida Al Habib, Sharq, Kuwait, Mohamad B. Bdeir, Riyadh, Saudi Arabia, Mahmoud Hassanein, Cairo, Egypt, Douglas L. Mann, Saint Louis, MO
8:45 Myocardial Regeneration and Repair — Jonathan Leor, Tel Hashomer, Israel
9:00 What’s on the Horizon for Decompensated CHF — Hani N. Sabbah, Detroit, MI
9:15 Middle Eastern Models for Heart Failure Clinics and Centers — Alessandro Salustri, Abu Dhabi, United Arab Emirates
9:30 Community Wide Management of Heart Failure — the Dangers of Siloed Metrics Focused on Hospitals — Robert M. Califf, Durham, NC
9:45 Panel Discussion: Global Challenge and Success in CHF
10:00 Break
Session II: Cardiometabolic Syndrome: An Epidemic that Ignores Borders, Time Zones, and Religion
Co-Chairs: Nanette Kass Wenger, Atlanta, GA Chaim Lotan, Jerusalem, Israel
Panelists: Ziyad Ghazzal, Atlanta, GA, Feridoun Noohi Bezanjani, Tehran, Islamic Republic of Iran, Adel El Etriby, Cairo, Egypt, Paul D. Thompson, Hartford, CT
10:15 Cardiometabolic Syndrome in the Middle East: A Growing Import from the West — Incidence, Trends, and Regional Challenges — Jassim M. S. Al Suwaidi, Doha, Qatar
10:30 Lifestyle Modification in Cardiometabolic Syndrome — Alison Bailey, Lexington, KY
10:45 The Crucial Role of Women in Addressing This Challenge — Azin Alizadehasl, Tabriz, Islamic Republic of Iran
11:00 Children Should be the Target to Reverse This Challenge — Michele Mietus-Snyder, Washington, DC
11:15 Panel Discussion: Cardiometabolic Syndrome — An Epidemic That Ignores Borders, Time Zones and Religion
11:30 Introduction to Collaborative Research Project — Omar Mahmoud Lattouf, Atlanta, GA
11:45 Wrap Up — Aaron D. Kugelmass, Springfield, MA, Mohamed Sobhy Aly, Alexandria, Egypt, William A. Zoghbi, Houston, TX, Hani Najm, Riyadh, Saudi Arabia, Nanette Kass Wenger, Atlanta, GA, Chaim Lotan, Jerusalem, Israel
ACC.12 Scientific Session
Friday, March 23, 2012Please Note: The following sessions are listed alphabetically by learning pathway abbreviation based on session start time.
Morning
106 GO for ACC.12!
AFTE
RNOO
N
Afternoon SeSSionS
SPECIAL
LEGENDS
400
Legends of Cardiovascular Medicine: Roundtable Forum and Reception (By Invitation Only)Friday, March 23, 2012, 1:30 p.m. – 5:30 p.m.McCormick Place South, S100cCME/CNE Hours: 3
Chair: Anthony N. DeMaria, San Diego, CA
1:30 Introduction of Eugene Braunwald, MD, MACC
1:35 Presentation by Eugene Braunwald, MD, MACC — Eugene Braunwald, Boston, MA
1:55 Introduction of Antonio Colombo, MD, FACC
2:00 Presentation by Antonio Colombo, MD, FACC — Antonio Colombo, Milan, Italy
2:20 Introduction of Valentin Fuster, MD, PhD, MACC
2:25 Presentation by Valentin Fuster, MD, PhD, MACC — Valentin Fuster, New York, NY
2:45 Introduction of Jane Somerville, MD, FACC
2:50 Presentation by Jane Somerville, MD, FACC — Jane Somerville, London, United Kingdom
3:10 Introduction of Magdi H. yacoub, MB, BCh, FACC
3:15 Presentation by Magdi H. yacoub, MB, BCh, FACC — Magdi H. Yacoub, Harefield, Middlesex, United Kingdom
3:35 Panel Discussion and Audience Question and Answer
4:30 Private Reception Immediately Follows in Faculty Lounge S100a
Friday, March 23, 2012 • ACC.12
ACC.12 Final Program 107
Morning SeSSionS
ACC-i2/TCT
SyMPOSIUM
2644
Interventional Featured Clinical Studies ISaturday, March 24, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S102bCME/CNE Hours: 1.5
Co-Chairs: George D. Dangas, New York, NY Ted Feldman, Evanston, IL
Panelists: Matthew J. Price, La Jolla, CA, Jan Kovac, Leicestershire, UK
8:00 Pharmacodynamic Effects of Switching Therapy in PCI Patients with High on Treatment Platelet Reactivity and Genotype Variation: High Clopidogrel Dose versus Prasugrel (RESET Trial) — GENNARO SARDELLA, Simone Calcagno, Carlotta De Carlo, Mauro Pennacchi, Filippo Placentino, Rocco Stio, Massimo Mancone, Luigi Lucisano, Emanuele Canali, Francesco Fedele, Dept.Cardiovascular Sciences,Policlinico Umberto I, Rome, Italy
8:10 Panel Discussion
8:15 A New Strategy for Discontinuation of Dual Antiplatelet Therapy: Real Safety and Efficacy of 3-months Dual Antiplatelet Therapy following Endeavor Zotarolimus-eluting Stent Implantation — Myeong-Ki Hong, Byeong-Keuk Kim, Dong-Ho Shin, Young-Guk Ko, Donghoon Choi, Jung-Han Yoon, Hyuck-Moon Kwon, Yangsoo Jang, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, South Korea
8:25 Panel Discussion
8:30 Treatment of High Risk Aortic Stenosis Patients with Transcatheter Medtronic CoreValve Implantation: Results from the International Multi-center ADVANCE Study — Axel Linke, Ulrich Gerckens, Peter Wenaweser, Corrado Tamburino, Johan Bosmans, Stephen Brecker, Robert Bauernschmitt, University of Leipzig Heart Center, Leipzig, Germany
8:40 Panel Discussion
8:45 First Pharmacogenomic Analysis Using Whole Exome Sequencing to Identify Novel Genetic Determinants of Clopidogrel Response Variability: Results of the Genotype Information and Functional Testing (GIFT) EXOME Study — Matthew J. Price, Andrew R. Carson, Sarah S. Murray, Tierney Phillips, Lee Janel, Rebecca Tisch, Eric Topol, Samuel Levy, Scripps Translational Science Institute, La Jolla, CA, Scripps Clinic, La Jolla, CA
8:55 Panel Discussion
9:00 Long-term Outcomes following Transcatheter Aortic Valve Implantation: Insights on Prognostic Factors and Valve Durability from the Canadian Multicenter Experience — Josep Rodes-Cabau, John Webb,
Anson Cheung, Jian Ye, Eric Dumont, Feindel Chris, mark osten, Madhu Natarajan, James L. Velianou, Giussepe Martucci, Benoit DeVarennes, Chris R. Thompson, Robert Chisholm, Mark Peterson, Samuel Lichtenstein, Stefan Toggweiler, Daniel Doyle, Robert DeLarochellière, Jean Dumesnil, Kevin Teoh, Victor Chu, Asim Cheema, David Wood, Philippe Pibarot, Eric Horlick, Quebec Heart and Lung Institute, Quebec, Canada, St. Paul’s Hospital, Vancouver, Canada
9:10 Panel Discussion
9:15 A Double-blind Randomized Study to Evaluate the Efficacy of Bindarit in Preventing Coronary Stent Restenosis — Antonio Colombo, Ugo Limbruno, corrado lettieri, Ernesto Lioy, Angelo Guglielmotti, Marco Calabresi, Marco Valgimigli, Daniela Pierucci, San Raffaele Hospital, Milan, Italy
9:25 Panel Discussion
ACS
EXPERTS
200
Contemporary Management of UA/NSTEMISaturday, March 24, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S504aCME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-065-L01-P
Chair: Keith A. A. Fox, Edinburgh, Scotland, United Kingdom
Case Presenter: Vamsi Krishna, Los Angeles, CA
Panelists: Eric R. Bates, Ann Arbor, MI, James M. Brophy, Montreal, Canada, Roxana Mehran, New York, NY, Charanjit S. Rihal, Rochester, MN
ACS
ORAL
902
P2y12 Antagonists: Unraveling the Mechanisms and Optimizing Benefit-RiskSaturday, March 24, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S406bCME/CNE Hours: 1.5
Co-Chairs: Anthony Gershlick, Leicester LE3 9QP, United Kingdom, Glenn A. Hirsch, Baltimore, MD
8:00 902–3 Timing and Clinical Setting of Cardiovascular Death or Myocardial Infarction following PCI for ACS: Observations from the TRITON-TIMI 38 Trial — Benjamin Scirica, David Morrow, Elliott Antman, Marc Bonaca, Sabina Murphy, Eugene Braunwald, Stephen Wiviott, TIMI Study Group, Boston, MA, Brigham and Women’s Hospital, Boston, MA
8:13 902–4 Prasugrel 5 Mg in Low Body Weight Patients Reduces Platelet Reactivity to a Similar Extent as Prasugrel 10 Mg in Higher Body Weight Patients: Results from the FEATHER Trial — David Erlinge, Jurrien Ten Berg, David Foley, Dominick Angiolillo, Patricia Brown, Henrik Wagner, Chunmei Zhou, Joe Jakubowski, Thomas Bergmeijer, Stefan James, Kenneth Winters, Department of Cardiology, Lund, Sweden
ACC.12 Scientific Session
Saturday, March 24, 2012Please Note: The following sessions are listed alphabetically by learning pathway abbreviation based on session start time.
Morning
108 GO for ACC.12!
Mor
ning
8:26 902–5 Discharge Aspirin Dose and Clinical Outcomes in Patients with ACS: An Analysis from the TRITON-TIMI 38 Study — Payal Kohli, Jacob Udell, Sabina Murphy, Elliott Antman, Eugene Braunwald, Stephen Wiviott, TIMI Study Group, Boston, MA, Brigham & Women’s Hospital, Boston, MA
8:39 902–6 Restoring Platelet Function Ex Vivo by Adding Fresh Platelets within 24-hours of a Prasugrel 60 mg Loading Dose — M. Urooj Zafar, Carlos Santos-Gallego, David Vorchheimer, Juan Viles-Gonzalez, Sammy Elmariah, Chiara Giannarelli, David Small, Joseph Jakubowski, Valentin Fuster, Juan Badimon, Mount Sinai School of Medicine, New York, NY, Eli Lilly and Company, Indianapolis, IN
8:52 902–7 Adenosine May Mediate Ticagrelor-Induced Dyspnea — Li-ming Gan, Ann Wittfeldt, Hakan Emanuelsson, Sven Nylander, Jenny Jonasson, Institute of Clinical and Molecular Medicine, Sahlgrenska Academy at Göteborg University, Göteborg, Sweden
9:05 902–8 Effect of Upstream Clopidogrel Treatment on Infarct Size and Microvascular Obstruction Assessed by CMR in Patients with STEMI Undergoing Primary PCI — Suzanne de Waha, Ingo Eitel, Steffen Desch, Georg Fuernau, Philipp Lurz, Gerhard Schuler, Holger Thiele, University of Leipzig – Heart Center, Department of Internal Medicine – Cardiology, Leipzig, Germany
ACS
ORAL
903
New Therapeutic Options in ACS: From Antiplatelets to AntibioticsSaturday, March 24, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S402CME/CNE Hours: 1.5
Co-Chairs: David P. Faxon, Boston, MA Shamir R. Mehta, Hamilton, Canada
8:00 903–3 Intracoronary Stem Cell Therapy in Patients with Acute Myocardial Infarction: 36-month Results of a Randomized, Double-blind, Placebo Controlled Trial with Serial MRI Follow-ups — Jochen Woehrle, Fabian von Scheidt, Sinisa Markovic, Peter Schauwecker, Klaus Schwarz, Markus Wiesneth, Hubert Schrezenmeier, Vinzenz Hombach, Wolfgang Rottbauer, Peter Bernhardt, University of Ulm, Ulm, Germany
8:15 903–4 Transradial versus Transulnar Artery Coronary Interventions: A Randomized Study — George Hahalis, Ioanna Xanthopoulou, Grigorios Tsigkas, Theodora E. Plakomyti, Anastasia Galati, Periklis Davlouros, Christos Pappas, Nikolaos Grapsas, Dimitrios Alexopoulos, Patras University Hospital, Patras, Greece
8:30 903–5 Panacea or Personalized Medicine? Optimizing Antiplatelet Therapy in Acute Coronary Syndrome: A Cost-effectiveness Analysis — Dhruv Kazi, Alan M. Garber, Rashmee Shah, Ceron Rhee, Solomon Moshkevich, Matthew W. Mell, MD, Derek Boothroyd, Douglas K. Owens, Mark Hlatky, Stanford University, Stanford, CA, Veterans Affairs Medical Center, Palo Alto, CA
8:45 903–6 Early Short-term Doxycycline Therapy in Patients with Acute Myocardial Infarction and Left Ventricular Dysfunction and the Ominous Progression to Adverse Remodeling (TIPTOP): A Randomized Controlled Trial — Giampaolo Cerisano, Piergiovanni Buonamici, Renato Valenti, Roberto Sciagrà, Silvia Raspanti, Nazario Carrabba, Alberto Santini, Emilio Vincenzo Dovellini, David Antoniucci, Careggi Hospital, Florence, Italy
9:00 903–7 Ticagrelor versus Prasugrel in Acute Coronary Syndrome Patients with High on Clopidogrel Treatment Platelet Reactivity Post PCI: A Pharmacodynamic Study — Dimitrios Alexopoulos, Ioanna Xanthopoulou, Eleni Mavronasiou, Anastasia Galati, George Kassimis, Konstantinos C. Theodoropoulos, George Makris, Anastasia Damelou, Grigorios Tsigkas, Periklis Davlouros, George Hahalis, Patras University Hospital, Patras, Greece
9:15 903–8 Pharmacodynamics of Vorapaxar, a Platelet PAR-1 Antagonist, and Its Interaction with P2y12 Receptor Pathway in the TRA·CER Trial — Lisa K. Jennings, David Moliterno, Robert Storey, Edward Hord, Jayaprakash Kotha, Richard Becker, Susan Smyth, Luis Providencia, Tiziano Moccetti, Marco Valgimigli, Jean-Pierre Dery, J.H. Cornel, Gregory Thomas, Kurt Huber, Edmond Chen, John Strony, Tyrus Rorick, Pierluigi Tricoci, Kenneth Mahaffey, CirQuest Labs and the Department of Medicine, University of Tennessee Health Science Center, Memphis, TN
ARR
EXPERTS
201
How to Manage a Device/Lead AdvisorySaturday, March 24, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S503CME/CNE Hours: 1.5
Chair: Robert G. Hauser, Minneapolis, MN
Case Presenter: Kenneth A. Ellenbogen, Richmond, VA
Panelists: Andrew E. Epstein, Philadelphia, PA, David L. Hayes, Rochester, MN, Randall J. Lee, San Francisco, CA
CCS
SyMPOSIUM
202
Complex Issues Facing ACHD Patients: Obstructive LesionsSaturday, March 24, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S105aCME/CNE Hours: 1.5
Co-Chairs: Curtis J. Daniels, Columbus, OH Gary D. Webb, Cincinnati, OH, Eric V. Krieger, Boston, MA
Case Presenter: Eric V. Krieger, Boston, MA
Panelists: Michael Earing, Milwaukee, WI, Wayne J. Franklin, Houston, TX, Michelle Gurvitz, Boston, MA, Craig S. Broberg, Portland, OR, Angela T. Yetman, Salt Lake City, UT
Saturday, March 24, 2012 • ACC.12
ACC.12 Final Program 109
Morning
CCS
MOC
802
ACCF Study Session for Maintenance of Certification: American Board of Pediatrics (ABP) Recertification Made Easy — 2011 Pediatric Cardiology Subspecialty Self-AssessmentSaturday, March 24, 2012, 8:00 a.m. – 10:00 a.m.McCormick Place South, S105dCME Hours: 2
Please refer to the full session listing, listed on page 111, for additional session information.
HF
EXPERTS
203
The Latest in Heart Failure with Preserved Ejection FractionSaturday, March 24, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S502CME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-067-L01-P
Chair: James C. Fang, Cleveland, OH
Case Presenter: David Aguilar, Houston, TX
Panelists: Barry Borlaug, Rochester, MN, Anita Deswal, Houston, TX, William Little, Winston Salem, NC, Margaret M. Redfield, Rochester, MN, Patricia Uber, Baltimore, MD
HF
SyMPOSIUM
732
Pharmacology Program: Pharmacotherapy of Chronic Heart FailureSaturday, March 24, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N427CME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-148-L04-P
Co-Chairs: Joseph S. Alpert, Tucson, AZ David Parra, West Palm Beach, FL
Panelists: Jesus Almendral, New Brunswick, NJ, Akshay S. Desai, Boston, MA, Narith Ou, Rochester, MN, Jo E. Rodgers, Chapel Hill, NC
8:00 Pharmacotherapy of Chronic Heart Failure — David Parra, West Palm Beach, FL
9:00 Panel Discussion
HF
ORAL
905
Predicting Outcomes in Heart Failure: Biomarkers and BeyondSaturday, March 24, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S405CME/CNE Hours: 1.5
Chair: Maya E. Guglin, Tampa, FL
8:00 905–3 Galectin-3, a Marker of Cardiac Fibrosis, Predicts Incident Heart Failure in the Community — Jennifer Ho, Chunyu Liu, Asya Lyass, Paul Courchesne, Michael Pencina, Vasan Ramachandran, martin larson, Daniel Levy, Framingham Heart Study, Framingham, MA
8:15 905–4 Long-term Trajectory of Two Unique Cardiac Biomarkers and Subsequent Left Ventricular Structural Pathology and Risk of Incident Heart Failure in Community Dwelling Older Adults — Christopher R. DeFilippi, Danielle Glick, Robert Christenson, John Gottdiener, Stephen Seliger, University of Maryland School of Medicine, Baltimore, MD
8:30 905–5 Association of Total and High-Molecular-Weight Adiponectin with New-Onset Heart Failure in Older Adults: The Cardiovascular Health Study — Maria G. Karas, David Benkeser, Alice M. Arnold, Luc Djousse, Susan Zieman, Kenneth J. Mukamal, Russell Tracy, Christos S. Mantzoros, David Siscovick, John Gottdiener, Joachim Ix, Jorge Kizer, Weill Cornell Medical College, New York, NY
8:45 905–6 Echocardiographic and Biomarker Phenotype of Heart Failure with Preserved Ejection Fraction (HFPEF) in Older Individuals in Comparison to Hypertension without Heart Failure (HTN), Elderly with Risk Factors and Healthy Aging: Importance of Myocyte Injury, Fibrosis, LV Hypertrophy and Diastolic Load — John S. Gottdiener, Traci Bartz, Christopher DeFilippi, Willem Kop, Dalane Kitzman, Eddy Barasch, Stephen Seliger, Donald Lloyd-Jones, University of Maryland School of Medicine, Baltimore, MD
9:00 905–7 Post-Exercise Levels of Biomarkers of Cardiomyocyte Stress Improve Prediction of Adverse Outcomes in Patients with Advanced Heart Failure — Petr Jarolim, Michael J. Conrad, David Morrow, John Rozehnal, Martin Kotrc, Josef Kautzner, Vojtech Melenovsky, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, Institute of Clinical and Experimental Medicine, Prague, Czech Republic
9:15 905–8 Concentric Left Ventricular Hypertrophy as Independent Predictor of 1-year Rehospitalization and Mortality in Patients Hospitalized for Acute Heart Failure and Preserved Ejection Fraction — Liang Zhong, Yee How Lau, Ling Ling Sim, David Sim, Bernard Kwok, Terrance Chua, Raymond Lee, Ru-San Tan, National Heart Centre Singapore, Singapore, Singapore, Novena Heart Centre Singapore, Singapore
HF
ORAL
906
Pathogenic and Therapeutic Insights from Experimental Heart Failure ModelsSaturday, March 24, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S404CME/CNE Hours: 1.5
Co-Chairs: Biykem Bozkurt, Houston, TX Javed Butler, Atlanta, GA
8:00 906–3 Connexin43 Expression Is Essential for Functional Cardiomyogenic Differentiation of Human Fetal Mesenchymal Stem Cells — Arti Ramkisoensing, Daniël Pijnappels, Martin Schalij, Antoine de Vries, Douwe Atsma, Leiden University Medical Center, Leiden, The Netherlands
8:15 906–4 An Injectable Acellular Capillary Hydrogel Improves Left Ventricular Function after Myocardial Infarction — Domenico G. Della Rocca, Bradley J. Willenberg, Leonardo F. Franklin, Stacy L. Porvasnik, John W. Petersen, Prateek S. Wate, Eileen M. Handberg, Gregory Schultz, Francesco Romeo, Christopher D. Batich, Barry J. Byrne, Carl J. Pepine, University of Florida, Gainesville, FL
ACC.12 • Saturday, March 24, 2012
110 GO for ACC.12!
Mor
ning
8:30 906–5 Characterization and Biocompatibility of Perfusion-Decellularized Human Heart Matrix: Toward Bioengineering Perfusable Human Heart Grafts — Pedro L Sanchez, Mª Eugenia Fernandez-Santos, Salvatore Costanza, Hugo Rodríguez-Abella, Stefan Kren, Gregorio Garrido, Jose Luis Escalante, Rafael Matesanz, Doris Taylor, Fernandez-Aviles Francisco, Hospital General Universitario Gregorio Marañon, Madrid, Spain, University of Minnesota, Minneapolis, MN
8:45 906–6 Mechanical Unloading with Left Ventricular Assist Device after Acute Myocardial Infarction Prevents Adverse Cardiac Remodeling — Xufeng Wei, Department of Surgery, University of Maryland School of Medicine, Baltimore, MD
9:00 906–7 Calcium Cycling Protein S100A1 Does not Recover Following Continuous-flow Left Ventricular Assist Device Support of the Failing Human Heart — Mosi Kadin Bennett, Wendy Sweet, Wai Hong Tang, Maria Mountis, Randall Starling, Christine Moravec, Cleveland Clinic, Cleveland, OH
9:15 906–8 Lack of Cardiac Myosin Binding Protein-C Phosphorylation Is a Model of Heart Failure with Preserved Ejection Fraction — Carl Wei-Chan Tong, Mohamed I. Abdalla, Xin Wu, yang liu, Mariappan Muthuchamy, Richard Moss, Texas A&M Health Science Center College of Medicine, Temple, TX, University of Wisconsin School of Medicine and Public Health, Madison, WI
IMAG
EXPERTS
204
Multimodality Imaging in Evaluation of Prosthetic Valve FunctionSaturday, March 24, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S505CME/CNE Hours: 1.5
Chair: James G. Jollis, Durham, NC
Case Presenters: Julie Damp, Nashville, TN, Jennifer Dickerson, Columbus, OH
Panelists: Paul A. Grayburn, Dallas, TX, Fletcher A. Miller, Rochester, MN, David Orsinelli, Columbus, OH
IMAG
ORAL
908
A Better Understanding of Ischemia and Function: Insights from Cardiac MRISaturday, March 24, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S403CME/CNE Hours: 1.5
Co-Chairs: Rosario Freeman, Seattle, WA Issam A. Mikati, Chicago, IL
8:00 908–3 Quantification of Absolute Myocardial Perfusion in Patients with Coronary Artery Disease: Comparison between Cardiac Magnetic Resonance and Positron Emission Tomography — Geraint Morton, Amedeo Chiribiri, Masaki Ishida, Shazia Hussain, Andreas Schuster, Andreas Indermuehle, Divaka Perera, Erik Hedstrom, Sally Barrington, Eike Nagel, King’s College London, London, United Kingdom
8:15 908–4 Prevalence and Significance of Coronary Microvascular Dysfunction in Hypertrophic Cardiomyopathy: A Cardiovascular Magnetic
Resonance Study — Tevfik Fehmi Ismail, Andrew Jabbour, Francisco D. Alpendurada, Niraj Mistry, Benjamin Hewins, Amy Mallorie, Natasha Davendralingam, Ankur Gulati, Ricardo Wage, Dudley Pennell, Sanjay Prasad, Royal Brompton Hospital, London, United Kingdom
8:30 908–5 Infarct Heterogeneity Is an Independent and Incremental Predictor of Mortality in Patients with Severe Ischemic Cardiomyopathy — Lisa Asamoto, Rory Hachamovitch, Zoran Popovic, Randall Starling, Scott Flamm, Thomas Marwick, Deborah Kwon, Cleveland Clinic, Cleveland, OH
8:45 908–6 Necrosis and Ischemia for Risk Stratification in Patients with Known or Suspected Ischemic Cardiomyopathy: Study with Stress Cardiac Magnetic Resonance — Clara Bonanad, Vicente Bodi, Mª Pilar López, JVicente Monmeneu, Juan Sanchis, Julio Nunez, Fabian Chaustre, Angel Llacer, Clara Bonanad, Valencia, Spain
9:00 908–7 Fractional Flow Reserve Correlates with Blood Oxygen Level-Dependent (BOLD) Magnetic Resonance Imaging in Coronary Artery Disease — Peter Bernhardt, Wolfgang Rottbauer, Jochen Woehrle, University of Ulm, Ulm, Germany
9:15 908–8 Aortic Biomechanics by MRI: Relation with Age, Gender and Traditional Cardiovascular Risk Factors — A Cross-sectional and Longitudinal Study: The Multi-Ethnic Study of Atherosclerosis (MESA) — Gisela Teixido, Atul Chugh, Alban Redheuil, Chia Ying Liu, Richard Stacey, Colin Wu, Harry Dietz, Antoinette Gomes, Martin Prince, Artur Evangelista, Greg Hundley, David Bluemke, Joao Lima, Hospital Universitari vall d’Hebron, Barcelona, Spain, Johns Hopkins Hospital, Baltimore, MD
IMAG
ORAL
909
New Imaging Approaches to Atherosclerosis and the MicrocirculationSaturday, March 24, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N426CME/CNE Hours: 1.5
Co-Chairs: Robert W.W. Biederman, Pittsburgh, PA Prem Soman, Pittsburgh, PA
8:00 909–3 Assessing Mild Coronary Atherosclerosis by Means of Transthoracic Enhanced Doppler Echocardiography in Convergent Color Doppler Mode: A Validation Study versus Intravascular Ultrasound — Carlo Caiati, Mario Lepera, Daniela Santoro, Marco Marzullo, Stefano Giuseppe Primitivo, Paolo Pollice, Caterina Rizzo, Filippo Masi, Donato Guagliara, Stefano Favale, Bari, Italy
8:15 909–4 Arrest of Atherosclerotic Progression and Reduction in Inflammatory Burden by Long-term Apocynin Treatment: Molecular and Ultrasound Imaging of Vascular Phenotype — Ya Ni Liu, Brian Davidson, Qi Yue, Yan Zhao, Todd Belcik, Aris Xie, Yoichi Inaba, Ruggeri M. Zaverio, Beat Kaufmann, Jonathan Lindner, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China, Oregon Health and Science University, Portland, OR
Saturday, March 24, 2012 • ACC.12
ACC.12 Final Program 111
Morning
8:30 909–5 Correlation of Vasa Vasorum and Plaque Progression and Response to Atorvastatin Therapy an a Rabbit Model of Atherosclerosis: In Vivo Intravascular Ultrasound and Contrast-Enhanced Ultrasound Imaging Study — JinWei Tian, Sining Hu, Haibo Jia, Jingbo Hou, Shaosong Zhang, Bo Yu, Ik-Kyung Jang, The Second Affiliated Hospital of Harbin Medical University, Haerbin, People’s Republic of China, Massachusetts General Hospital, Harvard Medical School, Boston, MA
8:45 909–6 Incremental Diagnostic Value of Dynamic CT-based Myocardial Perfusion Imaging for the Detection of Hemodynamic Relevant Coronary Artery Stenosis as Determined by Fractional Flow Reserve — Alexander Becker, Fabian Bamberg, Martin Greif, Franz von Ziegler, Christoph Becker, University of Munich, Munich, Germany
9:00 909–7 Early Detection of Severe Microvascular Dysfunction with Multidetector Computed Tomography Immediately after Primary Angioplasty in Patients with Acute Myocardial Infarction — Koichi Tamita, Shuichiro Kaji, Toshiharu Iwamura, Mika Maeda, Toshiki Fujiwara, Junichi Yoshikawa, Nishinomiya Watanabe Cardiovascular Center, Nishinomiya, Japan, Kobe City Medical Center General Hospital, Kobe, Japan
9:15 909–8 Computed Tomography Angiography-Derived Coronary Plaque Arc Calcification is Associated with Culprit Lesion Status in Acute Coronary Syndromes — Rani K. Hasan, Andrea Vavere, Carlos Rochitte, Armin Arbab-Zadeh, Ilan Gottlieb, John Texter, Marc Dewey, Hiroyuki Niinuma, Melvin Clouse, Joao Lima, Jeffrey Brinker, Julie Miller, Johns Hopkins University, Baltimore, MD
ISCHEM
ORAL
910
Sex, Scoring, Sadness, Statins, Stents and SurgerySaturday, March 24, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N227bCME/CNE Hours: 1.5
Co-Chairs: Joaquin Cigarroa, Portland, OR Adolph M. Hutter, Boston, MA
8:00 910–3 Gender Effects on Coronary Microvascular Dysfunction in Patients with Suspected Coronary Artery Disease — Venkatesh Murthy, Masanao Naya, Sharmila Dorbala, Ron Blankstein, Marcelo Di Carli, Brigham & Women’s Hospital, Boston, MA
8:15 910–4 Combined Anatomical and Clinical Factors for the Risk Stratification of Patients Undergoing Percutaneous Coronary Intervention: The Logistic Clinical SyNTAX Score — Vasim Farooq, Yvonne Vergouwe, Lorenz Raber, Pascal Vrancx, Hector Garcia, Salvatore Brugaletta, A. Kappetein, Marie-angèle Morel, Ton de Vries, Michael Swart, Keith Dawkins, Marco Valgimigli, Stephan Windecker, Ewout W. Steyerberg, Patrick Serruys, Thorax Center, Rotterdam, The Netherlands
8:30 910–5 Do Behavioral Risk Factors Explain the Association Between Depressive Symptoms and Cardiovascular Risk In Individuals with Coronary Heart Disease? Report from the Reasons for
Geographic and Racial Differences in Stroke (REGARDS) Study — Siqin Ye, Paul Muntner, Daichi Shimbo, Joshua Richman, Suzanne Judd, Karina Davidson, Monika Safford, Columbia University Medical Center, New York, NY, University of Alabama at Birmingham, Birmingham, AL
8:45 910–6 The Clinical Benefit of Therapies That Raise High-density Lipoprotein Cholesterol Added to Treatment with a Statin — Brian Anthony Ference, Nitin Mahajan, Wonsuk Yoo, Luis Afonso, John Flack, Wayne State University School of Medicine, Detroit, MI
9:00 910–7 Long-term Mortality following Coronary Artery Bypass Graft Surgery and Stenting with Drug-eluting Stents — Chuntao Wu, Songyang Zhao, Fabian T. Camacho, Edward Hannan, Penn State Hershey College of Medicine, Hershey, PA, University at Albany School of Public Health, State University of New York, Rensselar, NY
9:15 910–8 Impact of Interventional versus Conservative Approach on 5-year Mortality of Patients with Stable Angina and Documented Coronary Artery Disease in Clinical Practice: Results of the STAR-Registry — Anselm K. Gitt, Uwe Zeymer, Andrea Papp, Ralf Zahn, Jochen Senges, STAR-Study-Group, Herzzentrum Ludwigshafen, Ludwigshafen, Germany, Institut f. Herzinfarktforschung Ludwigshafen an der Universitaet Heidelberg, Ludwigshafen, Germany
LIFELONG
MOC
802
ACCF Study Session for Maintenance of Certification: American Board of Pediatrics (ABP) Recertification Made Easy — 2011 Pediatric Cardiology Subspecialty Self-AssessmentSaturday, March 24, 2012, 8:00 a.m. – 10:00 a.m.McCormick Place South, S105dCME/CNE Hours: 2
The American College of Cardiology Foundation (ACCF) and the American Board of Pediatrics have joined forces to help pediatric cardiologists attending ACC.12 earn Maintenance of Certification (MOC) credit.
Tickets are required for entrance to the session and attendance is limited. If you have not registered in advance, please visit the session in advance of the session to check to availability.
Participants must be registered as an ABP diplomate and enrolled at the time of the session in the ABP MOC process. For information about enrolling as an ABP diplomate in the ABP MOC process, please visit www.abp.org and log into My ABP Portfolio.
Each session registrant must bring his/her own laptop, set up to receive Wi-Fi access. All attendees should program and test the laptop prior to the ABP MOC session to ensure 1) the laptop will receive the convention center’s wireless signal 2) the attendee’s ABP portfolio can be accessed. During the program, each attendee will submit ABP MOC module answers electronically through the ABP website.
Electrical power is provided in the classrooms so that attendees who wish to bring their own devices may ‘power up’ to access relevant question modules. No
ACC.12 • Saturday, March 24, 2012
112 GO for ACC.12!
Mor
ning
paper copies of the module will be provided. Attendees will not be able to leave the room with notes, answers or other relevant session discussion. 10 MOC credits are available for this activity.
Chair: Steven R. Neish, San Antonio, TX
MOC Faculty: Mark B. Lewin, Seattle, WA, Karen K. Stout, Seattle, WA
PRACTICE
SyMPOSIUM
600
Cardiology Procedures 2012: How to Code and Get ReimbursedSaturday, March 24, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N231CME/CNE Hours: 1.5
Co-Chairs: James C. Blankenship, Danville, PA Kenneth P. Brin, Loves Park, IL
8:00 What’s New in Coding? CPT Codes for 2012 — Robert N. Piana, Nashville, TN
8:20 Questions and Answers
8:25 Getting Paid in 2012: Upcoming Changes in Reimbursement — James C. Blankenship, Danville, PA
8:45 Questions and Answers
8:50 Breaking the Code: Tips and Tricks on Coding and Reimbursement — Linda Gates-Striby, Indianapolis, IN
9:10 Questions and Answers
9:15 Peek into the Future: Coding and Reimbursement Initiatives in 2013 — Kenneth P. Brin, Loves Park, IL
QUAL
EXPERTS
205
Am I Placing Inappropriate ICDs and Stents?: Recent Registry SurprisesSaturday, March 24, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S501aCME/CNE Hours: 1.5
Chair: Frederick A. Masoudi, Denver, CO
Case Presenter: Paul D. Varosy, Denver, CO
Panelists: Paul Chan, Kansas City, MO, Manesh R. Patel, Durham, NC, Khether E. Raby, Stoneham, MA, Bruce L. Wilkoff, Cleveland, OH
QUAL
SyMPOSIUM
601
Patient-Centered Care: The New ImperativeSaturday, March 24, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N226CME/CNE Hours: 1.5
Co-Chairs: Blair D. Erb, Bozeman, MT Mary Norine Walsh, Indianapolis, IN
8:00 Patients are More than a P-value — Bray Patrick-Lake, Boulder, CO
8:16 CardioSmart: An Extension of your Practice — Joanne M. Foody, Boston, MA
8:32 Engaging Patients through the Community — Andrew M. Freeman, Denver, CO
8:48 Partnering with your Patient — Suzanne Hughes, Hudson, OH
9:04 Shared Decision Making for Patients — William R. Lewis, Cleveland, OH
9:20 Question and Answer
SPECIAL
SPECIAL
300
ACC.12 Opening Showcase and Late-Breaking Clinical TrialsSaturday, March 24, 2012, 8:00 a.m. – 10:00 a.m.McCormick Place North, Hall B, ACC.12 Main TentCME/CNE/CPE Hours: 2 ACPE No. 0012-9999-12-132-L04-P
Join us for the ACC.12 Opening Showcase session, which welcomes attendees to Chicago! The session will feature the Presidential Address from David R. Holmes, Jr., MD, FACC. The 2012 Simon Dack Lecture will be presented, as part of our Legends of Cardiovascular Medicine Series, by Eugene Braunwald, MD, MACC.
In addition, you won’t want to miss the ground-breaking late-breaking clinical trials presented as part of this exciting showcase session.
8:00 Opening Video and National Anthem
8:04 Welcome, Introductions and Acknowledgements — David R. Holmes, Jr., Rochester, MN
8:10 Introduction of Keynote Lecturer — David R. Holmes, Jr., Rochester, MN
8:12 Simon Dack Lecture: The Treatment of Acute Myocardial Infarction — Into the Second Century — Eugene Braunwald, Boston, MA
8:37 ACC Presidential Address — David R. Holmes, Jr., Rochester, MN
9:00 Late-Breaking Clinical Trial Presentations
Chair: David R. Holmes, Jr., Rochester, MN
Panelists: Roberto Bolli, Louisville, KY, Robert M. Califf, Durham, NC, Eduardo Marban, Los Angeles, CA, Andreas M. Zeiher, Frankfurt, Germany
9:05 Opening Remarks — David R. Holmes, Jr., Rochester, MN
9:08 Effect of Transendocardial Autologous Bone Marrow Mononuclear Cell Delivery on Functional Capacity, Left Ventricular Function and Perfusion in Chronic Ischemic Heart Failure: The FOCUS Randomized Trial — Emerson C. Perin, James Willerson, Stephen Ellis, Timothy Henry, Carl Pepine, David Zhao, Dejian Lai, Barry Byrne, Antonis Hatzopoulos, Marc Penn, Jay Traverse, Adrian Gee, Marvin Kronenberg, Daniel Martin, James Thomas, Doris Taylor, Christopher Cogle, Sonia Skarlatos, Lem Moye, Robert Simari, Cardiovascular Cell Therapy Research Network (CCTRN), Houston, TX
9:23 Panel Discussion
9:30 Evaluation of a Novel Antiplatelet Agent for Secondary Prevention in Patients with Atherosclerotic Disease: Results of the Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P) — TIMI 50 Trial — David A. Morrow, Brigham & Women’s Hospital, Boston, MA
9:46 Panel Discussion
9:53 Closing Remarks — David R. Holmes, Jr., Rochester, MN
Saturday, March 24, 2012 • ACC.12
ACC.12 Final Program 113
Morning
TEST
SyMPOSIUM
602
Translational Research Symposium with the International Society for Cardiovascular Translational Research: New Breakthroughs in Cardiovascular Genomics: Approaching the ClinicSaturday, March 24, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N228CME/CNE Hours: 1.5
Chair: Jennifer L. Hall, Minneapolis, MN
8:00 9p21: A Major Genetic Predictor of Cardiovascular Disease — Function and Application — Robert Roberts, Ottawa, Canada
8:20 Genetic Testing: How it All Fits — Robert Superko, Alameda, CA, Geoffrey S. Ginsburg, Durham, NC
8:30 Advances in Genomic Biomarkers and Diagnostics — Geoffrey S. Ginsburg, Durham, NC
8:40 Proteomics Role in Personalized Medicine — Jennifer Van Eyk, Baltimore, MD
9:00 Panel Discussion
TEST
SyMPOSIUM
603
Challenging Sports Cardiology Cases in younger AthletesSaturday, March 24, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N230CME/CNE Hours: 1.5
Co-Chairs: Anne M. Dubin, Palo Alto, CA Reginald L. Washington, Denver, CO
8:00 Case Presentation: 17 year-old Collegiate Soccer Player with Long QT — Martin O’Riordan, Ardmore, PA
8:05 Abnormal ECGs in Adolescent Athletes: Long QT, WPW, Brugada — Anne M. Dubin, Palo Alto, CA
8:30 Case Presentation: 35 year-old Rugby Player with Syncope and Frequent PVC/NSVT — Mike Slawnych, Calgary, Canada
8:35 Sports Cardiology for the Faint-Hearted: The Athlete with Syncope — Domenico Corrado, Padova, Italy
9:00 Case Presentation: 21 year-old Male Basketball Player with Hyper Trabeculated LV — Joseph Jenkins Thompson, Lexington, KY
9:05 Is It Athletic Heart Syndrome or Pathological Hypertrophy? — Aaron L. Baggish, Boston, MA
VASC
ORAL
931
New Insights in Peripheral Vascular DiseaseSaturday, March 24, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N229CME/CNE Hours: 1.5
Chair: James B. Froehlich, Ann Arbor, MI
8:00 931–3 Long-term Coffee Consumption Is Associated with Improved Endothelial Function in Elderly Individuals: Ikaria Study — Evangelos Oikonomou, Gerasimos Siasos, Christine Chrysohoou, Dimitris Tousoulis, Marina Zaromitidou, Elias Gialafos, Konstantinos Zisimos, Stamatios Kioufis, Georgios Marinos, Nikolaos Papageorgiou, Athanasios G. Papavassiliou, Christos Pitsavos, Christodoulos Stefanadis, University of Athens Medical School, Department of Cardiology, Hippokration General Hospital, Athens, Greece
8:15 931–4 Long-term Efficacy of Endovascular Treatment for Patients with Critical Limb Ischemia Due to Isolated below the Knee Lesions — Kiyonori Nanto, Osamu iida, Yoshimitsu Soga, Kenji Suzuki, Terutoshi Yamaoka, Nobuhiro Suematsu, Yusuke Miyashita, Junichi Tazaki, Kansai Rosai Hospital, Amagasaki, Japan
8:30 931–5 Dual Antiplatelet Therapy Responsiveness in Patients Undergoing Percutaneous Revascularization for Peripheral Arterial Occlusive Disease — Chad Kliger, Anvar Babaev, Binita Shah, Frederick Feit, James Slater, Michael Attubato, Lenox Hill Heart and Vascular Institute, New York, NY, New York University School of Medicine, New York, NY
8:45 931–6 Impact of Perioperative Complication after Aortoiliac Stenting for Patients with Peripheral Artery Disease — Kei Sato, Osamu iida, Yoshimitsu Soga, Kenji Suzuki, Terutoshi Yamaoka, Nobuhiro Suematsu, Yusuke Miyashita, Junichi Tazaki, Masaaki Uematsu, Kansai Rosai Hospital Cardiovascular Center, Amagasaki, Japan
9:00 931–7 The S Curve: A Novel Morphological Finding in the Internal Carotid Artery in Patients with Fibromuscular Dysplasia — Sanjum S. Sethi, Joe Lau, Phillip Erwin, Susan Gustavson, Jeffrey Olin, Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai School of Medicine, New York, NY
9:15 931–8 Peripheral Artery Dissection in Patients with Fibromuscular Dysplasia: A Report from the United States Fibromuscular Dysplasia Patient Registry — Jeffrey W. Olin, Xiaokui Gu, James Froehlich, J. Michael Bacharach, Kim Eagle, Bruce Gray, Mark Grise, Michael Jaff, Soo Hyun Kim, Eva Kline-Rogers, Pamela Mace, Alan Matsumoto, Robert McBane, Heather Gornik, Mount Sinai School of Medicine, New York, NY
VALV
SELF-DIRECTED
1501
Heart Songs at ACC.12: A Self-Paced Multimedia Learning ExperienceSaturday, March 24, 2012, 9:00 a.m. – 5:00 p.m.McCormick Place, Vista Room LobbyCME/CNE Hours: 2
Back by popular demand is the highly rated Heart Songs Self-Paced Learning Lab — a unique audio-visual program to refresh cardiac auscultation skills. After a pre-test, attendees will listen to Heart Sounds while viewing phonocardiograms, echoes, and more, on an iPod® Touch, iPad® or laptop computer. Attendees can view the sessions and take both the pre-test and post-test on their own device, or use devices provided in the room, to document improvement in their auscultation skills. This clinical skills workshop provides attendees with a choice of three sessions: the first on 5 common heart murmurs and the second on more advanced sounds including bicuspid aortic valve, mitral valve prolapse and hypertrophic cardiomyopathy, among others. The third session is for experts on topics such as combined aortic stenosis and regurgitation; and combined mitral stenosis and regurgitation. In addition, there will be a 3-D echo/auscultation training program available in the Self-Paced Learning Lab. This video
ACC.12 • Saturday, March 24, 2012
114 GO for ACC.12!
Mor
ning
program will combine 3-D echo images with the auscultation findings on 4 common valvular abnormalities. Studies have shown that the range of repetition needed to acquire auditory skills can vary four fold. This workshop will tailor the learning to each individual’s need for repetition. Each session takes approximately 30 minutes to complete. This workshop will appeal to cardiovascular specialists and cardiac care team members who want to improve their auscultation skill in both common and more advanced heart sounds.
Co-Chairs: Michael J. Barrett, Blue Bell, PA, Ginger K. O’Sullivan, Allentown, PA, Matthew W. Martinez, Allentown, PA, Justin Roberts, Allentown, PA
CCS
ORAL
901
From Targeting Errors to UNOS: How Quality and Databases Can Impact Clinical CareSaturday, March 24, 2012, 10:30 a.m. – NoonMcCormick Place South, S105aCME/CNE Hours: 1.5
Co-Chairs: Robert H. Beekman, Cincinnati, OH Ralf Holzer, Columbus, OH
10:30 901–3 Improving Survival By Targeting Errors — Frederic Jacques, Osami Honjo, Michael-Alice Moga, Francesco Grasso, Kenji Baba, Edward Hickey, Tilman Humpl, Steven Schwartz, Christopher Caldarone, Andrew Redington, Glen Van Arsdell, The Hospital for Sick Children (SickKids), Toronto, Canada
10:45 901–4 Vitamin D Status in Neonates Undergoing Cardiac Operations: Relationship to Cardiopulmonary Bypass and Outcomes — Eric Matthew Graham, Sarah N. Taylor, Sinai Zyblewski, Bethany Wolf, Scott Bradley, Bruce W. Hollis, Francis X. McGowan, Jr, Andrew Atz, Medical University of South Carolina, Charleston, SC
11:00 901–5 Progressive Left Ventricular Changes Predict the Likelihood of Survival in Pediatric Dilated Cardiomyopathy: Findings from the Pediatric Cardiomyopathy Registry — Paul Fraser Kantor, Endel Orav, James Wilkinson, Steven Webber, Charles Canter, Steven Colan, Jeffrey Towbin, Melanie Everitt, Elfriede Pahl, Stephanie Ware, Beth Kaufman, Paolo Rusconi, Jacqueline Lamour, John Jefferies, Linda Addonizio, Steven Lipshultz, University of Miami, Miller School of Medicine, Miami, FL, Hospital for Sick Children, Toronto, Canada
11:15 901–6 Pediatric Heart Transplantation from Donors with Depressed Ventricular Function: An Analysis of the United Network of Organ Sharing Database — Joseph William Rossano, Kimberly Lin, Stephen Paridon, J. William Gaynor, Robert Shaddy, Beth Kaufman, Children’s Hospital of Philadelphia, Philadelphia, PA, University of Pennsylvania, Philadelphia, PA
11:30 901–7 Identified Mortality Risk Factors Associated with Presentation, Initial Hospitalization, and Interstage Period for the Norwood Operation: A Report from the Joint Council on Congenital Heart Disease National Quality Improvement Collaborative — Russell R. Cross, Ashraf Harahsheh, Robert McCarter, Gerard Martin, Children’s National Medical Center, Washington, DC
11:45 901–8 IMPACT Registry™ (IMproving Pediatric and Adult Congenital Treatment): First Data Report — Gerard R. Martin, Lisa Bergersen, Lee Benson, Robert Beekman, Ralf Holzer, Frank Ing, Kathy Jenkins, John Moore, Richard Ringel, Jonathan Rome, Carlos Ruiz, Robert Vincent, Children’s National Medical Center, Washington, DC, Children’s Hospital, Boston, MA
PREV
SyMPOSIUM
733
Pharmacology Program: Cardiovascular Implications of Dietary SupplementsSaturday, March 24, 2012, 10:30 a.m. – NoonMcCormick Place North, N427CME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-149-L04-P
Co-Chairs: Joseph S. Alpert, Tucson, AZ David Parra, West Palm Beach, FL
Panelists: Lynne Braun, Chicago, IL, Steven P. Dunn, Charlottesville, VA, Arshad Jahangir, Phoenix, AZ
10:30 Cardiovascular Implications of Dietary Supplements — Rhonda M. Cooper-Dehoff, Gainesville, FL
11:30 Panel Discussion
noon SeSSionS
ACC-i2/TCT
EXPERTS
2301
Atypical Thrombotic ACS Case ReviewsSaturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S101aCME/CNE Hours: 1.5
Co-Chairs: Richard C. Becker, Durham, NC A. Michael Lincoff, Cleveland, OH
Case Ali Ataya, Cleveland, OH, Daniel Gutteridge, Flint, MI,Presenters: Nael Hawwa, Cleveland, OH, Taiyeb M. Khumri ,
Kansas City, MO, Yukio Mizuguchi, Kobe, Japan
Panelists: David J. Moliterno, Lexington, KY, Peter B. Berger, Danville, PA
ACC-i2/TCT
EXPERTS
2302
Chronic Total Occlusions and Left Main Case ReviewsSaturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S102cCME/CNE Hours: 1.5
Co-Chairs: David E. Kandzari, Atlanta, GA Patrick L. Whitlow, Cleveland, OH
Case Stephen Y. Chen, Augusta, GA, Michael E. Halkos,Presenters: Atlanta, GA, Tesfaldet T. Michael, Dallas, TX, Koyu
Sakai, Kitakyushu, Japan
Panelists: James Aaron Grantham, Kansas City, MO, Corrado Tamburino, Catania, Italy, Davide Capodanno, Catania, Italy
Saturday, March 24, 2012 • ACC.12
noon
ACC.12 Final Program 115
NooN
ACC-i2/TCT
EXPERTS
2303
Coronary Imaging Case ReviewsSaturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S103bCME/CNE Hours: 1.5
Co-Chairs: John McB Hodgson, Wilkes-Barre, PA Morton J. Kern, Orange, CA
Case Joon Hyung Doh, Goyang, South Korea, Yu Kataoka, Presenters: Cleveland, OH, Paula de Lima Santos Eryazici,
Chicago, IL, Syed Rab, Atlanta, GA, Hiroyuki Nagai, Osaka, Japan
Panelists: Akiko Maehara, New York, NY, Marco A. Costa, Cleveland, OH, Giulio G. Guagliumi, Bergamo, Italy
ACC-i2/TCT
SyMPOSIUM
2606
TAVR: Procedural Aspects and Best PracticesSaturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S102bCME/CNE Hours: 1.5
Co-Chairs: Steven J. Yakubov, Columbus, OH E. Murat Tuzcu, Cleveland, OH
12:15 Debate: General Anesthesia is Best — Balthasar Eberle, Bern, Switzerland
12:20 Debate: Conscious Sedation is Better — Augusto Pichard, Washington, DC
12:25 Panel Discussion
12:30 Debate: Location — Hybrid OR — Todd M. Dewey, Dallas, TX
12:35 Debate: Location — Cardiac Cath Lab — Helen Eltchaninoff, Rouen, France
12:40 Panel Discussion
12:45 Debate: Imaging with Flouro is Sufficient — G. Alain Cribier, Rouen, France
12:50 Debate: Echo Imaging is Required — Mark J. Monaghan, London, United Kingdom
12:55 Panel Discussion
1:05 Assessing Results: VARC and RE-VARC — Patrick W. Serruys, Rotterdam, Netherlands
1:15 Durability and Valve-in-Valve — Josep Rodes-Cabau, Quebec, Canada
1:25 The Low-risk Patient: New Trials — Martin B. Leon, New York, NY
1:35 Nursing Considerations — Maria Held, Cleveland, OH
ACC-i2/TCT
SyMPOSIUM
2607
Acute Venous Thromboembolic DiseaseSaturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S103cCME/CNE Hours: 1.5
Co-Chairs: Raghu Kolluri, Springfield, IL Samuel Z. Goldhaber, Boston, MA
12:15 VTE Treatment Guidelines: What a Venous Interventionalist Must Know — The American Heart Association Consensus Statement — Are they Different from the American College of Chest Physician Guidelines? — M. Sean McMurtry, Edmonton, AB
12:27 Thrombolysis & Anticoagulation for Extensive DVT: The Science & Clinical Practice — Anthony J. Comerota, Toledo, OH
12:39 Appropriate Patient Selection and Access Site Selection for Venous Intervention: Tips and Tricks — Mahmood K. Razavi, Orange, CA
12:51 Pharmaco-Mechanical Thrombectomy Devices: When to Use What — Gregory J. Mishkel, Springfield, IL
1:03 Central Venous Occlusions and Upper Extremity Venous Interventions — Tino Pena, Miami, FL
1:13 IVC Filters: What Are the Indications and Implications — Robert Schainfeld, Waltham, MA
1:25 Interventional Management of Acute Pulmonary Embolism — Appropriate Patient Selection — Speaker TBD
1:35 Panel Discussion
ACS
SyMPOSIUM
604
Controversies in ACSSaturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S404CME/CNE Hours: 1.5
Debate: Radial versus Femoral Access for ACS Patients Undergoing Early Invasive Strategy
Co-Chairs: Ajay J. Kirtane, New York, NY Sunil V. Rao, Durham, NC
12:15 Femoral Access Is Tried and True: No Need to Change Now — David Alan Cox, Allentown, PA
12:27 Radial Access Is Preferred in the ACS Patient — David E. Kandzari, Atlanta, GA
12:39 Debate Summary — Ajay J. Kirtane, New York, NY
Debate: Platelet Reactivity and Genotype Testing: An Aid to Clinical Decision-making or an Investigational Tool
Chair: Gregg W. Stone, New York, NY
12:45 Time for Personalized Medicine Is Now — Paul A. Gurbel, Baltimore, MD
12:57 Not Ready for Prime Time — Sanjay Kaul, Los Angeles, CA
1:09 Debate Summary — Gregg W. Stone, New York, NY
Debate: Therapeutic Hypothermia: Cooling Heads and Hearts Improves Outcomes
Co-Chairs: William W. O’Neill, Miami, FL Ivan Rokos, Altadena, CA
1:15 Evidence Is Clearcut — Timothy D. Henry, Minneapolis, MN
1:27 Evidence Is Shaky — Benjamin M. Scirica, Boston, MA
1:39 Debate Summary — William W. O’Neill, Miami, FL
ACC.12 • Saturday, March 24, 2012
116 GO for ACC.12!
NooN
ARR
EXPERTS
206
Alternatives to Warfarin for the Prevention of Stroke in Atrial Fibrillation: How to Decide?Saturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S503CME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-068-L01-P
Chair: Michael M. Ezekowitz, Wynnewood, PA
Case Presenter: Peter Kowey, Wynnewood, PA
Panelists: John Eikelboom, Hamilton, Canada, Gerald V. Naccarelli, Hershey, PA, Salim Yusuf, Hamilton, Canada
HF
EXPERTS
207
Atrial Fibrillation and Heart Failure: A Dynamic DuoSaturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S502CME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-069-L01-P
Chair: Denis Roy, Montreal, Canada
Case Presenter: Maya E. Guglin, Tampa, FL
Panelists: John G. F. Cleland, Cottingham, United Kingdom, Anne B. Curtis, Buffalo, NY, Prakash C. Deedwania, Fresno, CA, Bengt Herweg, Tampa, FL, J. Marcus Wharton, Charleston, SC
IMAG
EXPERTS
208
Imaging Patients with Pericardial DiseaseSaturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S505CME/CNE Hours: 1.5
Chair: Allan L. Klein, Cleveland, OH
Case Presenter: K. Maganti, Chicago, IL
Panelists: Ron Blankstein, Boston, MA, James C. Carr, Chicago, IL, Jae K. Oh, Rochester, MN
IMAG
SyMPOSIUM
605
Cardiovascular Magnetic Resonance in MyocarditisSaturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S402CME/CNE Hours: 1.5
Co-Chairs: Robert W. W. Biederman, Pittsburgh, PA Raymond J. Kim, Durham, NC
12:15 Role of CMR in Children with Myocarditis — Michael D. Taylor, Cincinnati, OH
12:33 CMR Tissue Characterization in Myocarditis — Matthias Friedrich, Calgary, Canada
12:51 CMR and Prognosis in Myocarditis — Raymond Y. K. Kwong, Boston, MA
1:09 Future Developments in CMR Imaging Sequences for Myocarditis — Andrew E. Arai, Bethesda, MD
1:27 Clinical Evaluation of the Patient with Myocarditis — Dennis M. McNamara, Pittsburgh, PA
ISCHEM
SyMPOSIUM
606
Revascularization in SIHD: Integrating New EvidenceSaturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S401aCME/CNE Hours: 1.5
Co-Chairs: Cindy L. Grines, Royal Oak, MI Michael J. Mack, Plano, TX
12:15 Revascularization (Or Not) in the Patient with Heart Failure? — Robert O. Bonow, Chicago, IL
12:35 Question and Answer
12:45 Revascularization in Diabetics: Back to the Drawing Board? — Robert H. Jones, Durham, NC
1:05 Question and Answer
1:15 Revascularization in the Patient with Normal LV Function: Who, How and When? — David R. Holmes, Jr., Rochester, MN
1:35 Question and Answer
ISCHEM
SyMPOSIUM
734
Pharmacology Program: Pharmacologic Considerations in the Setting of PCISaturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place North, N427CME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-150-L04-P
Co-Chairs: Joseph S. Alpert, Tucson, AZ David Parra, West Palm Beach, FL
Panelists: Paul Dobesh, Omaha, NE, Douglas E. Drachman, Boston, MA
12:15 Pharmacologic Considerations in the Setting of PCI — Sarah A. Spinler, Philadelphia, PA
1:15 Panel Discussion
LIFELONG
SyMPOSIUM
607
Everything you Wanted to Know about ABIM Recertification (and more...)Saturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place North, N226CME Hours: 1.5
Chair: Steve R. Ommen, Rochester, MN
12:15 Why Maintenance of Certification (MOC)? — Steve R. Ommen, Rochester, MN
12:25 Current MOC Part IV Requirements and How to Achieve Them — William J. Oetgen, Alexandria, VA
12:55 Evolutions in MOC: What to Expect in the Future — John Gordon Harold, Los Angeles, CA
1:25 What the College Can Do to Help: Question and Answer
PRACTICE
SyMPOSIUM
608
Women in CardiologySaturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place North, N229CME/CNE Hours: 1.5
Can’t get everything done? Constantly overwhelmed? During this special session with acclaimed life coach, Jill Farmer, WIC members will learn how to be more productive, peaceful, and connected to the things that really matter. Ms. Farmer’s 45-minute talk will
Saturday, March 24, 2012 • ACC.12
ACC.12 Final Program 117
NooN
be followed by a Q & A Session moderated by members of the ACC’s Women in Cardiology Council.
Chair: Carol Warnes, Rochester, MN
12:15 There’s Not Enough Time!… And Other Lies We Tell Ourselves — Jill Farmer, Saint Louis, MO
1:00 Panel Discussion
PRACTICE
SyMPOSIUM
609
The Challenges in Daily PracticeSaturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place North, N230CME/CNE Hours: 1.5
Co-Chairs: Blair D. Erb, Bozeman, MT Michael K. Schroyer, Zionsville, IN
12:15 MOC and MOL: Where Are We Headed? — John Gordon Harold, Los Angeles, CA
12:33 Who Decides What Quality Is? — John E. Brush, Norfolk, VA
12:51 Core Measure and Beyond — Michael K. Schroyer, Zionsville, IN
1:09 Data Collection for Beginners — Cathleen Biga, Woodridge, IL
1:27 Pinnacle, AUC and Beyond: Making the ACC Tools Work for you — Blair D. Erb, Bozeman, MT
PREV
SyMPOSIUM
611
Is There a Role for HDL Therapy: Are We AIMing Too HIGH?Saturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S100cCME/CNE Hours: 1.5
Co-Chairs: Michael H. Davidson, Chicago, IL Richard H. Karas, Boston, MA
12:15 AIM-HIGH: Case Closed for HDL? — William E. Boden, Buffalo, NY
12:30 AIM HIGH in Context: From ARBITER to HPS2-THRIVE — Allen J. Taylor, Washington, DC
12:45 Should We Reconsider Fibrates? — Michael H. Davidson, Chicago, IL
1:00 Current Status of CETP Inhibitors — Christie M. Ballantyne, Houston, TX
1:15 HDL Form and Function — Prediman K. Shah, Los Angeles, CA
1:30 Apo A1 Mimetics and HDL Infusions — Prediman K. Shah, Los Angeles, CA
QUAL
EXPERTS
209
Getting Access to Data: Successful Examples from the NCDRSaturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S501aCME/CNE Hours: 1.5
Chair: Tracy Wang, Durham, NC
Case Presenter: Robert W. Yeh, Boston, MA
Panelists: Paul Chan, Kansas City, MO, Thomas M. Maddox, Denver, CO, Amy Leigh Miller, Boston, MA, John S. Rumsfeld, Denver, CO, Thomas Tehsin Tsai, Denver, CO
QUAL
SyMPOSIUM
610
Translational Research Symposium with the International Society for Cardiovascular Translational Research: Mission and Strategy in Translational ResearchSaturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place North, N228CME/CNE Hours: 1.5
Co-Chairs: Anthony N. DeMaria, San Diego, CA Spencer B. King, Atlanta, GA
12:15 Keynote Address: Trends and Direction in Cardiovascular Medicine — David R. Holmes, Jr., Rochester, MN
12:40 Translation Clinical Research in Clinical Practice — Anthony N. DeMaria, San Diego, CA
1:00 ISCTR/ACC’s Mission in Cardiovascular Translational Research — Nabil Dib, Gilbert, AZ
1:15 Challenges and Opportunities in Cardiovascular Translational Research — Jack Lewin, Washington, DC
1:30 ISCTR/ACC Translational Research Scholarship — Spencer B. King, Atlanta, GA
SPECIAL
SPECIAL
103
Educating the Educators: Bootcamp for Cardiology Fellowship Program Directors and CoordinatorsSaturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S405aCME Hours: 1.5
Co-Chairs: Jeffrey T. Kuvin, Boston, MA Chittur A. Sivaram, Oklahoma City, OK
12:15 Welcome and Overview — Marcia J. Jackson, Santee, SC, Jeffrey T. Kuvin, Boston, MA, Chittur A. Sivaram, Oklahoma City, OK
12:30 Focus on ACC Education — Rick A. Nishimura, Rochester, MN, Patrick T. O’Gara, Boston, MA, Mary Ellen Beliveau, Washington, DC
12:45 ACGME and the 2012 Requirements — James A. Arrighi, Povidence, RI
1:30 Heart Failure: ABIM and ACGME Updates — Marvin A. Konstam, Boston, MA
SPECIAL
SPECIAL
104
Fit Forum I: Finding the Right F.I.T. in Developing a Career Plan — Part 1: Finding the Right JobSaturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place North, N227bCME Hours: 1.5
12:15 Pros and Cons: Large Academic Medical Center — Charanjit S. Rihal, Rochester, MN
12:30 Pros and Cons: Large Private Practice Group, Self-Owned — C. Michael Valentine, Lynchburg, VA
12:45 Pros and Cons: Hospital-Owned Cardiology Group — Thomas D. Stuckey, Greensboro, NC, B. Hadley Wilson, Charlotte, NC
1:00 Pros and Cons: Solo Practitioner — Eric B. Carlson, Greenville, NC
1:15 Pros and Cons: Non-Traditional Practice — Michael R. Bristow, Aurora, CO
1:30 Discussion with Audience Question and Answer
ACC.12 • Saturday, March 24, 2012
118 GO for ACC.12!
NooN
VALV
EXPERTS
210
Organic Mitral Regurgitation Case-ManagementSaturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S504aCME/CNE Hours: 1.5
Co-Chairs: Robert J. Siegel, Los Angeles, CA Thoralf M. Sundt, Boston, MA
Case Harold M. Burkhart, Rochester, MN, Amar Presenters: Krishnaswamy, Cleveland, OH, Vuyisile Nkomo,
Rochester, MN
Panelists: Blase A. Carabello, Houston, TX, Robert J. Siegel, Los Angeles, CA
VALV
SyMPOSIUM
612
The Spectrum of Degenerative Mitral Valve: From Imaging to TreatmentSaturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place North, N426CME/CNE Hours: 1.5
Co-Chairs: Elyse Foster, San Francisco, CA Brian P. Griffin, Cleveland, OH
12:15 New Insights into the Pathophysiology of MVP — Albert Alain Hagege, Paris, France
12:33 Asymptomatic Degenerative MR: Who Should Undergo Valve Repair? — Maurice Enriquez-Sarano, Rochester, MN
12:51 Role of 3-D TEE in the Operating Room for Mitral Repair — Salvatore Costa, Lebanon, NH
1:09 Repair of Degenerative MR: A Perfect Solution? — Rakesh Suri, Rochester, MN
1:27 E-Clip of MVP Is Useful in My Practice — Francesco Maisano, Milan, Italy
LIFELONG
MOC
803
ACCF Study Sessions for Maintenance of Certification: ABIM Recertification Made Easy — Cardiovascular Disease 2010 Update (A1-K)Saturday, March 24, 2012, 12:30 p.m. – 3:00 p.m.McCormick Place South, S105aCME Hours: 2.5
ACCF’s Maintenance of Certification Sessions allows you to easily obtain ABIM’s Maintenance of Certification (MOC) points during at ACC.12. Tickets are required for admittance to this session. Ticketed registrants must arrive no later than 15 minutes before the start of the session. Seats will be released at this time and an “open seating” policy will apply.
Attendees must be enrolled in the ABIM’s MOC program to claim MOC points. If you are not enrolled, please allow sufficient time to do this prior to the start of the session. ABIM staffs are available onsite to answer your MOC questions and help with enrollment.
For convenience, there will be computer terminals in the ACC MOC Center onsite in Room S104b for attendees to take the ABIM MOC test after the study session concludes, if desired. Electrical power is provided in the classrooms so that attendees who wish to bring their own devices may ‘power up’ to access relevant question modules.
Access to the online modules will also be available for participants for a short period of time following the annual meeting.
Attendees may not claim CME credits from ABIM as it is against ACCME and AMA guidelines to claim credit twice for the same activity. MOC credit is available from the ABIM after completion of the MOC module; CME credit only (no CNE credit) is available from ACC.
Chair: Paul Sorajja, Rochester, MN
MOC Faculty: Elizabeth A. Jackson, Ann Arbor, MI, Sherry Saxonhouse, Charlotte, NC
LIFELONG
MOC
804
ACCF Study Sessions for Maintenance of Certification: ABIM Recertification Made Easy — Cardiovascular Disease 2011 Update (A1-L)Saturday, March 24, 2012, 12:30 p.m. – 3:00 p.m.McCormick Place South, S105dCME Hours: 2.5
ACCF’s Maintenance of Certification Sessions allows you to easily obtain ABIM’s Maintenance of Certification (MOC) points during at ACC.12. Tickets are required for admittance to this session. Ticketed registrants must arrive no later than 15 minutes before the start of the session. Seats will be released at this time and an “open seating” policy will apply.
Attendees must be enrolled in the ABIM’s MOC program to claim MOC points. If you are not enrolled, please allow sufficient time to do this prior to the start of the session. ABIM staffs are available onsite to answer your MOC questions and help with enrollment.
For convenience, there will be computer terminals in the ACC MOC Center onsite in Room S104b for attendees to take the ABIM MOC test after the study session concludes, if desired. Electrical power is provided in the classrooms so that attendees who wish to bring their own devices may ‘power up’ to access relevant question modules.
Access to the online modules will also be available for participants for a short period of time following the annual meeting.
Attendees may not claim CME credits from ABIM as it is against ACCME and AMA guidelines to claim credit twice for the same activity. MOC credit is available from the ABIM after completion of the MOC module; CME credit only (no CNE credit) is available from ACC.
Chair: Ralph J. Verdino, Philadelphia, PA
MOC Faculty: Emmanouil S. Brilakis, Dallas, TX, Jesus Almendral, New Brunswick, NJ
Saturday, March 24, 2012 • ACC.12
ACC.12 Final Program 119
AFTERNOON
Afternoon SeSSionS
ACC-i2/TCT
CASE REVIEW
2201
Live and Taped Case Session I: Multivessel PCI- Physiology and ImagingSaturday, March 24, 2012, 2:00 p.m. – 5:00 p.m.McCormick Place North, Hall B, ACC.12 Main TentCME/CNE Hours: 3
Co-Chairs: Gary S. Mintz, Washington, DC William Fuller Fearon, Stanford, CA
Panelists: Sigmund Silber, Zell, Germany, Ajay J. Kirtane, New York, NY, Eric R. Bates, Ann Arbor, MI, Marco A. Costa, Cleveland, OH, Manish Parikh, New York, NY, Alan C. Yeung, Palo Alto, CA, David J. Moliterno, Lexington, KY, John McB Hodgson, Wilkes-Barre, PA
2:00 Live Case from Northwestern Memorial Hospital, Chicago, IL — Charles J. Davidson, Chicago, IL
3:30 FFR after FAME-I and FAME-II: The Appropriate Use of Physiology in the Cath Lab in 2012 — William Fuller Fearon, Stanford, CA
3:45 The Exploding World of Intravascular Imaging: IVUS, OCT, NIRS, etc — Practical Use during PCI — Gary S. Mintz, Washington, DC
4:00 Panel Discussion
4:15 Taped Case from the University of Texas Southwestern Medical Center, Dallas, TX — Emmanouil S. Brilakis, Dallas, TX
ACC-i2/TCT
ORAL
2502
Acute Myocardial InfarctionSaturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S103bCME/CNE Hours: 1.5
Co-Chairs: Stephen G. Ellis, Cleveland, OH Jose P. Henriques, Amsterdam, Netherlands
Panelists: Dmitriy N. Feldman, New York, NY, Timothy A. Sanborn, Evanston, IL, Bimmer E. Claessen, Amsterdam, Netherlands
2:00 year in Review — Speaker TBD
2:15 2502–7 Initial Ambulance Transport of ST-Elevation Myocardial Infarction (STEMI) to Rural Hospitals Leads to Better Door In-Door Out and First Door to Balloon Reperfusion Times within 90 Minutes — B. Hadley Wilson, Angela Humphrey, Robert Haber, William Downey, John Cedarholm, Glen Kowalchuk, Michael Rinaldi, Denise Miller, Jennifer Sarafin, Kevin Collier, J. Garvey, Sanger Heart & Vascular Institute at Carolinas Medical Center, Charlotte, NC
2:25 2502–8 Panel Discussion
2:30 2502–9 The Role of Primary Multivessel Intervention in Acute Myocardial Infarction Complicated by Cardiogenic Shock — Darren Mylotte, Thierry Lefevre, Hélène Eltchaninoff, Nicolas Briole, Karim Tazarourte, Alain Margenet, Dominique Thébert, Yves Louvard, Marie-Claude Morice, Philippe Garot, Institut Cardiovasculaire Paris Sud, Massy, France
2:40 2502–10 Panel Discussion
2:45 2502–11 Outcomes of Culprit versus Multivessel Intervention in Patients with Multivessel Coronary
Artery Disease Presenting with Acute Myocardial Infarction Complicated by Cardiogenic Shock — Matthew Cavender, Penny Houghtaling, Elizabeth Lieber, Michael Kiernan, Melanie Maytin, Andrew Rassi, Patrick Whitlow, Venu Menon, Stephen Ellis, Mehdi Shishehbor, Cleveland Clinic, Cleveland, OH
2:55 2502–12 Panel Discussion
3:00 2502–13 Reference Coronary Flow Velocity Reserve Determined after Primary Percutaneous Coronary Intervention for a First Acute Anterior Myocardial Infarction is an Independent Predictor of Cardiac Mortality at Long Term Follow-up — Tim P. van de Hoef, Matthijs Bax, Martijn Meuwissen, Peter Damman, Ronak Delewi, Robbert de Winter, Karel Th Koch, Carl Schotborgh, José Henriques, Jan Tijssen, Jan Piek, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands, Haga Teaching Hospital, The Hague, The Netherlands
3:10 2502–14 Panel Discussion
3:15 2502–15 Impact of Bivalirudin and Paclitaxel-eluting Stents in Patients with STEMI Undergoing Primary PCI of the Left Anterior Descending Artery: The HORIZONS-AMI Trial — Jochen Woehrle, Helen Parise, Roxana Mehran, Gregg Stone, University of Ulm, Ulm, Germany, Columbia University Medical Center and Cardiovascular Research Foundation, New York, NY
3:25 2502–16 Panel Discussion
ACC-i2/TCT
SyMPOSIUM
2608
Intravascular Imaging: Restenosis, Thrombosis and Stent Follow-up I: Restenosis and Early ThrombosisSaturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S101aCME/CNE Hours: 1.5
Co-Chairs: Steven R. Bailey, San Antonio, TX Alan C. Yeung, Palo Alto, CA
2:00 Mechanisms and Findings in Restenosis and Early Stent Thrombosis: IVUS, VH-IVUS, OCT, Spectroscopy, and Beyond — Lisette Jensen, Odense, Denmark
2:12 Does Acute Stent Malapposition Cause Restenosis or Early Stent Thrombosis? — Neil J. Weissman, Washington, DC
2:24 IVUS Predictors of Restenosis and Early Stent Thrombosis: What are the Ideal Stent-Implantation Endpoints? — Soo-Jin Kang, Suwon, Republic of Korea
2:36 OCT Predictors of Restenosis and Early Stent Thrombosis: Including an Update from the MGH-OCT Registry — Ik-Kyung Jang, Boston, MA
2:48 Is there a Role for CT Angiography in Long-term Stent Assessment (Restenosis and/or Stent Thrombosis)? — Szilard Voros, Atlanta, GA
3:00 When and How Should In-stent Restenosis Be Treated? FFR, IVUS and Other Data — Habib Samady, Atlanta, GA
ACC.12 • Saturday, March 24, 2012
120 GO for ACC.12!
AFTE
RNOO
N
3:10 Case Presentation — Jinman Cho, Seoul, Republic of Korea
3:15 Case Presentation — William J. Kostis, Boston, MA
3:20 Case Presentation — Ozgur Bayturan, Izmir, Turkey
3:25 Panel Discussion
ACC-i2/TCT
SyMPOSIUM
2609
Hemodynamics and Angiography I (Basic Issues)Saturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S102bCME/CNE Hours: 1.5
Co-Chairs: Maurice Enriquez-Sarano, Rochester, MN, John W. Hirshfeld, Philadelphia, PA
2:00 Hemodynamics of MR Pre- and Post-Percutaneous Therapy — Ted Feldman, Evanston, IL
2:15 Pitfalls in the Assessment of AS Severity — Zachary Gertz, Havertown, PA
2:30 Cath Assessment of TAVR, BAV, and Complications — Raj R. Makkar, Los Angeles, CA
2:45 Integrating Echo into the Percutaneous Valve Procedures — Frank E. Silvestry, Wayne, PA
3:00 Hemodynamics of IABP, Mitral, Tricuspid and Pulmonary Stenosis — Morton J. Kern, Orange, CA
3:15 Hemodynamic Pitfalls — Zoltan G. Turi, Camden, NJ
ACC-i2/TCT
SyMPOSIUM
2610
Renal Interventions for Hypertension and Renal Function PreservationSaturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S103cCME/CNE Hours: 1.5
Co-Chairs: Gregory J. Mishkel, Springfield, IL Douglas E. Drachman, Boston, MA
2:00 CORAL, ASTRAL & STAR: Good News, Bad News — Jeffrey W. Olin, New York, NY
2:15 eGFR Is Not a Valid Estimate of Renal Function in Patients with Atherosclerotic Renal Artery Disease — Ryan Madder, Troy, MI
2:30 How to Predict Improved Blood Pressure after Renal Stenting — Jason H. Rogers, Sacramento, CA
2:45 How to Predict Improved Renal Function after Renal Stenting — Stephen Textor, Rochester, MN
3:00 Is Renal Sympathetic Denervation a Viable Option for Treating Hypertension — Krishna J. Rocha-Singh, Springfield, IL
3:15 Panel Discussion
ACC-i2/TCT
SyMPOSIUM
2645
Interventional Featured Clinical Studies IISaturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S102cCME/CNE Hours: 1.5
Co-Chairs: Hector M. Garcia, Rotterdam, Netherlands Giora Weisz, New York, NY
Panelists: Ron Waksman, Washington, DC, Daniel J. McCormick, Moorestown, NJ
2:00 A Prospective Randomized Study Using Optical Coherence Tomography to Assess Endothelial Coverage and Neointimal Proliferation at 6-months after Implantation of a Coronary Everolimus-eluting Stent Compared with a Bare Metal Stent Postdilated with a Paclitaxel-Eluting Balloon (OCTOPUS Trial) — Tudor C. Poerner, Sylvia Otto, Florian Janiak, Johannes Gassdorf, Hans R. Figulla, University Hospital of Jena, Jena, Germany
2:10 Panel Discussion
2:15 Visual-Functional Mismatch between Coronary Angiography and Fractional Flow Reserve — Seung-Jung Park, Soo-Jin Kang, Jung-Min Ahn, Eun-Bo Shim, Young-Tae Kim, Sung-Cheol Yoon, Haegeun Song, Jong-Young Lee, Won-Jang Kim, Duk-Woo Park, Seung-Whan Lee, Young-Hak Kim, Cheol Whan Lee, Seong-Wook Park, Seong-Wook Park, Asan Medical Center, Seoul, South Korea, Kangwon National University, Chuncheon, South Korea
2:25 Panel Discussion
2:30 Sirolimus-eluting Stent with Biodegradable Polymer versus Sirolimus Eluting Stent with Durable Polymer for the Treatment of Patients with de novo Coronary Artery Lesions (EVOLUTION): A Randomized Non-inferiority Trial — Junbo Ge, Lei Ge, Juying Qian, Guosheng Fu, Huiliang Liu, Genshan Ma, Yitong Ma, Weiyi Fang, Hui Li, Yujie Zhou, Yongwen Qin, Yigang Li, Lianqun Cui, Chengzhi Lu, Bin Liu, Jifei Tang, Zheng Zhang, Meixiang Xiang, Xuefeng Guang, Dadong Zhang, Qing He, Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, People’s Republic of China
2:40 Panel Discussion
2:45 Late Benefit of Intra-Aortic Balloon Counterpulsation during High-risk Percutaneous Coronary Intervention: Long-term Mortality Data from the Balloon Pump-assisted Coronary Intervention Study (BCIS-1) — Divaka Perera, Rod Stables, Kalpa DeSilva, Matthew Lumley, Daša Zugwitz, Lucy Clack, Martyn Thomas, Simon Redwood, Kings College London, London, United Kingdom, Liverpool Heart and Chest Hospital, Liverpool, United Kingdom
2:55 Panel Discussion
3:00 Biodegradable Polymer Drug-eluting Stents versus Durable Polymer Sirolimus-eluting Stents in Patients Undergoing Percutaneous Coronary Intervention: A Pooled Analysis of Individual Patient Data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS Randomized Trials at 4-years — Robert A. Byrne, Giulio Stefanini, Patrick Serruys, Antoinette de Waha, Bernhard Meier, Steffen Massberg, Peter Juni, Stephan Windecker, Adnan Kastrati, Deutches Herzzentrum, Munich, Germany, Bern University Hospital, Bern, Switzerland
3:10 Panel Discussion
3:15 2-year Clinical Outcomes from the Pivotal RESOLUTE US Study — Laura Mauri, Martin Leon, Donald Cutlip, Jeffrey Popma, Peter Fitzgerald, Joseph Massaro, Alan Yeung, Brigham and Women’s
Saturday, March 24, 2012 • ACC.12
ACC.12 Final Program 121
AFTERNOON
Hospital, Boston, MA, Stanford University Medical Center, Palo Alto, CA
3:25 Panel Discussion
ACS
EXPERTS
211
Optimal STEMI Management from Presentation to Post-Discharge CareSaturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S504aCME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-072-L01-P
Chair: Charanjit S. Rihal, Rochester, MN
Case Presenter: Tamim Nazif, New York, NY
Panelists: Somjot Singh Brar, Los Angeles, CA, Bojan Cercek, Los Angeles, CA, Cindy L. Grines, Royal Oak, MI, Freek W. A. Verheugt, Amsterdam, Netherlands
ACS
SyMPOSIUM
613
State-of-the-Art in STEMI CareSaturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S404CME/CNE Hours: 1.5
Co-Chairs: C. Michael Gibson, Boston, MA Ajay J. Kirtane, New York, NY
2:00 Pre-hospital Triage and Emergency Medical System Activation for STEMI: The Clock Starts Ticking Early — Ivan Rokos, Altadena, CA
2:12 Time to Reperfusion across Systems of Care: The Role of PCI, Lytics, Transfer and Adjunctive Therapies — Duane S. Pinto, Boston, MA, Timothy D. Henry, Minneapolis, MN
2:36 Guidelines Debate
2:36 ACC/AHA Guidelines Are Evidence-based, User-friendly and Pragmatic — Elliott M. Antman, Boston, MA, Jean-Pierre L. Bassand, Besancon, France, Paul Wayne Armstrong, Edmonton, Canada
3:06 Featured Lecture: Progress in STEMI — What’s Next? — Valentin Fuster, New York, NY
3:21 Moderated Summary — C. Michael Gibson, Boston, MA
ACS
SyMPOSIUM
618
Translational Research Symposium with the International Society for Cardiovascular Translational Research: Cellular TherapiesSaturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place North, N228CME/CNE Hours: 1.5
Co-Chairs: Andreas M. Zeiher, Frankfurt, Germany Andre Terzic, Rochester, MN
2:00 Regeneration Enhancement in Acute Myocardical Infarction: Advancing Stem Call Therapy — Andreas M. Zeiher, Frankfurt, Germany
2:10 Refractory Angina: A Stem Cell Approach from Bench to Phase 3 Clinical Trials — Douglas W. Losordo, Chicago, IL
2:20 Cardiac-derived Stem Cells: From Product Development to Clinical Application — Eduardo Marban, Los Angeles, CA
2:30 Promoting Cardiopoiesis to Enhance Cell Therapy in Chronic Heart Failure — Andre Terzic, Rochester, MN
2:40 Does the Route of Application Matter for Clinical Effects of Cell Therapy — Nabil Dib, Gilbert, AZ
2:50 Pathway to IND — Steve Winitsky, Silver Spring, MD
3:05 Panel Discussion
ARR
EXPERTS
212
Management of Difficult AF: When to Change Drugs, When to Give UpSaturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S503CME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-073-L01-P
Chair: Leslie A. Saxon, Los Angeles, CA
Case Presenter: Brian Powell, Rochester, MN
Panelists: David Callans, Philadelphia, PA, Robert C. Kowal, Dallas, TX, Andrea Natale, Austin, TX
ARR
SyMPOSIUM
614
Can Remote Disease Management Improve Clinical Outcomes?Saturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S406aCME/CNE Hours: 1.5
Co-Chairs: Christopher Liu, New York, NY Niraj Varma, Cleveland, OH
2:00 What Is the Evidence from Clinical Trials? — George H. Crossley, Nashville, TN
2:18 Utilization of Heart Failure Diagnostics: Can We Minimize Heart Failure Admissions? — William T. Abraham, Columbus, OH
2:36 How to Use Monitoring Technologies in the Management of Atrial Fibrillation — Paul A. Levine, Sylmar, CA
2:54 Monitoring Outcomes Using Remote Monitoring Databases — David L. Hayes, Rochester, MN
3:12 Cost-Benefit Ratio — Mark H. Schoenfeld, New Haven, CT
ARR
SyMPOSIUM
615
Challenges in the Management of Supraventricular TachycardiaSaturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S403CME/CNE Hours: 1.5
Chair: Bindi K. Shah, Philadelphia, PA
2:00 Atrial Flutter — Sei Iwai, Stony Brook, NY
2:12 Atrial Tachycardia Arising from Pulmonary Veins — Atul Verma, Toronto, Canada
2:18 AV Nodal Re-Entry Tachycardia — Melvin M. Scheinman, San Francisco, CA
2:36 SVT in the Presence of an Accessory Pathway — Eric N. Prystowsky, Indianapolis, IN
2:54 Focal Atrial Tachycardia — Bradley P. Knight, Chicago, IL
ACC.12 • Saturday, March 24, 2012
122 GO for ACC.12!
AFTE
RNOO
N
ARR
SyMPOSIUM
735
Pharmacology Program: Pharmacotherapy of New AntithromboticsSaturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place North, N427CME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-151-L04-P
Co-Chairs: Joseph S. Alpert, Tucson, AZ David Parra, West Palm Beach, FL
2:00 Pharmacotherapy of New Antithrombotics — Joseph S. Alpert, Tucson, AZ
3:00 Panel Discussion
Panelists: Jonathan L. Halperin, New York, NY, Michael Gulseth, Sioux Falls, SD
CCS
SyMPOSIUM
616
Quality, Safety and Resources Enhancing Pediatric Cardiovascular CareSaturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place North, N231CME/CNE Hours: 1.5
Co-Chairs: Jean A. Connor, Boston, MA Gerard Martin, Washington, DC
2:00 Increasing Access to Care and Evaluation of Quality for Pediatric Nurse Practitioner Managed Cardiac Clinics — Theresa A. Saia, Boston, MA
2:15 Radiation Risk for Pediatric Patients in the Catheterization Laboratory, the Evidence and Measurement of Risk — Ralf Holzer, Columbus, OH
2:30 Optimizing Growth of the Cardiovascular Infant — Jeffrey Anderson, Cincinnati, OH
2:45 Enhancing a Distraction Free Environment the Redzone Medication Safety Initiative — Jeanne Ahern, Boston, MA
3:00 Clinical Handoffs: Models That Can Be Safely and Practically Implemented — Kshitij P. Mistry, Charlotte, NC
3:15 Quality Improvement amongst Cardiovascular Programs in Developing Countries — Kathy J. Jenkins, Boston, MA
HF
EXPERTS
213
From Shock to Recovery or Bridge to Transplanation: Role of Percutaneous VADs and Other Support DevicesSaturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S502CME/CNE Hours: 1.5
Chair: Mariell Jessup, Philadelphia, PA
Case Presenter: Jeffrey Teuteberg, Pittsburgh, PA
Panelists: Michael A. Acker, Philadelphia, PA, David DeNofrio, Boston, MA, William W. O’Neill, Miami, FL, Francis D. Pagani, Ann Arbor, MI
HF
SyMPOSIUM
617
Cardiorenal Syndrome in Heart Failure: From Definition to ManagementSaturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S406bCME/CNE Hours: 1.5
Co-Chairs: Wai Hong Wilson Tang, Cleveland, OH Maya E. Guglin, Tampa, FL
2:00 What Truly Is Cardiorenal Syndrome? Novel Insights into the Pathophysiology and Subtypes of Cardiorenal Syndrome — Javed Butler, Atlanta, GA
2:15 Question and Answer
2:18 Predictors of Response to ADHF Treatment and Development of Cardiorenal Syndrome — Gregg C. Fonarow, Los Angeles, CA
2:33 Question and Answer
2:36 Aggressive versus Conservative Diuresis in Treatment of ADHF: The Benefit versus Risk — G. Michael Felker, Durham, NC
2:51 Question and Answer
2:54 What Changes during Therapy of ADHF? From Patient Symptoms to Physical Findings and Biomarkers — Biykem Bozkurt, Houston, TX
3:09 Question and Answer
3:12 Novel Therapeutic Targets and Strategies for Nonresponders to Initial ADHF Therapy — Maria Rosa Costanzo, Naperville, IL
3:27 Question and Answer
IMAG
EXPERTS
214
Current Topics in Cardiac CTSaturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S505CME/CNE Hours: 1.5
Chair: Joao A. C. Lima, Baltimore, MD
Case Presenters: Mouaz H. Al-Mallah, Riyadh, Saudi Arabia, John P. Reilly, New Orleans, LA
Panelists: C. Richard Conti, Gainesville, FL, Richard T. George, Monkton, MD, Harvey S. Hecht, New York, NY, Robert C. Hendel, Miami, FL
IMAG
SyMPOSIUM
619
Multimodality Imaging of Hypertrophic CardiomyopathySaturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S402CME/CNE Hours: 1.5
Co-Chairs: Barry J. Maron, Minneapolis, MN Steve R. Ommen, Rochester, MN
2:00 Cardiac MR in Diagnosis and Management of HCM — Karin Dill, Chicago, IL
2:18 Catheterization and Hemodynamics in Diagnosis and Management of HCM — Rick A. Nishimura, Rochester, MN
2:36 Echocardiography in the Diagnosis and Management of HCM — Sherif F. Nagueh, Houston, TX
2:54 Nuclear Imaging in the Diagnosis and Management of HCM — Vasken Dilsizian, Baltimore, MD
3:12 Computed Tomography in the Diagnosis and Managment of HCM — Milind Y. Desai, Cleveland, OH
Saturday, March 24, 2012 • ACC.12
ACC.12 Final Program 123
AFTERNOON
ISCHEM
SyMPOSIUM
620
Stable Ischemic Heart Disease in Women: Are They Really from Venus?Saturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S401aCME/CNE Hours: 1.5
Co-Chairs: Sharon L. Mulvagh, Rochester, MN Carl Pepine, Gainesville, FL
2:00 What Does Ischemia without Obstructive CAD Really Mean? — Martha Gulati, Columbus, OH
2:15 Question and Answer
2:22 Autoimmune Disorders in Women and Their Role in CAD — Rekha Mankad, Rochester, MN
2:37 Question and Answer
2:45 Treating Women and Men: What’s Different and What’s the Same? — C. Noel Bairey Merz, Los Angeles, CA
3:00 Question and Answer
3:07 Putting it All Together: How to Choose the Best Test — Leslee J. Shaw, Atlanta, GA
3:22 Question and Answer
LIFELONG
CORE
805
Core Curriculum: Congenital Heart DiseaseSaturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place North, N226CME/CNE Hours: 1.5
Chair: Alex J. Auseon, Columbus, OH
2:00 Congenital Heart Disease I: Simple — M. Regina Lantin-Hermoso, Houston, TX
2:25 Congenital Heart Disease II: Complex — Jennifer Grando-Ting, Hummelstown, PA
2:50 Cardiovascular Disease and Pregnancy — Karen K. Stout, Seattle, WA
3:15 Question and Answer
LIFELONG
CORE
806
Core Curriculum: Congestive Heart FailureSaturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place North, N229CME/CNE Hours: 1.5
Chair: John A. McPherson, Nashville, TN
2:00 Evaluation and Management of Acute Decompensated CHF: Systolic and Diastolic — Akshay S. Desai, Boston, MA
2:25 Evaluation and Management of Chronic CHF: Systolic and Diastolic — Larry A. Allen, Aurora, CO
2:50 PHTN: Evaluation and Management — Anne Marie Valente, Boston, MA
3:15 Question and Answer
PRACTICE
SyMPOSIUM
621
ACC/MedAxiom/ACCA: Physician/Hospital Integration 101Saturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place North, N230CME/CNE Hours: 1.5
Co-Chairs: Jerome L. Hines, Hinsdale, IL Dipti Itchhaporia, Newport Beach, CA
2:00 Contracts 2012: What Models Exist to Integrate with My Hospital — Suzette Jaskie, Grand Rapids, MI
2:15 Negotiating 101: Defining Physician Value — Matthew Phillips, Austin, TX
2:30 Creating Value through Integration — Charles L. Brown, III, Atlanta, GA
2:45 Avoiding Pitfalls — Cathleen Biga, Woodridge, IL
3:00 The Fallout of Integration on Patients — C. Michael Valentine, Lynchburg, VA
3:15 Renegotiating the Contract — Howard T. Walpole, Nashville, TN
PREV
SyMPOSIUM
622
Emerging Trends in AtherosclerosisSaturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S100cCME/CNE Hours: 1.5
Co-Chairs: Peter Ganz, San Francisco, CA Roxana Mehran, New York, NY
2:00 Multimodality Plaque Imaging — Valentin Fuster, New York, NY
2:15 Prevention Strategies — William S. Weintraub, Newark, DE
2:30 Risk Factor Control — Sidney Smith, Jr., Chapel Hill, NC
2:45 Invasive Imaging of Subclinical Disease — Gregg W. Stone, New York, NY
3:00 Pathogenesis of Atherosclerosis — Renu Virmani, Gaithersburg, MD
3:15 Evaluation of Vascular Function — Joseph A. Vita, Boston, MA
QUAL
EXPERTS
215
When Should a Medicine or Device Stop Being Used in Practice?Saturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S501aCME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-075-L01-P
Chair: Robert W. Yeh, Boston, MA
Case Presenter: Scott Wright, Rochester, MN
Panelists: Robert G. Hauser, Minneapolis, MN, Steven E. Nissen, Cleveland, OH, Frederic S. Resnic, Boston, MA, Paul D. Varosy, Denver, CO
SPECIAL
SPECIAL
106
Educating the Educators: Faculty Development for Cardiology Fellowship Program Directors and CoordinatorsSaturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S405aCME Hours: 1.5
Co-Chairs: Jeffrey T. Kuvin, Boston, MA Chittur A. Sivaram, Oklahoma City, OK
2:00 Faculty Development — Joseph S. Green, Washington, DC, Marcia J. Jackson, Santee, SC
ACC.12 • Saturday, March 24, 2012
124 GO for ACC.12!
AFTE
RNOO
N
2:00 Satellite Session for Fellowship Program Coordinators — Tabitha Fineberg, Boston, MA Faculty Lounge, S100, Conference Room A
3:00 Self Assessment — David Davis, Washington, DC
SPECIAL
SPECIAL
107
FIT Forum I: Finding the Right F.I.T. in Developing a Career Plan — Part 2: Launching a Successful CareerSaturday, March 24, 2012, 2:00 p.m. – 3:15 p.m.McCormick Place North, N227bCME Hours: 1.25
2:00 Early Career Funding Opportunities — C. William Balke, San Francisco, CA
2:20 Question and Answer
2:25 Social Media to Promote Clinical Research — Robert A. Harrington, Durham, NC
2:45 Question and Answer
2:50 Evolution of Technology and Medicine: Using Handheld Technology to Improve Patient Care — Kirk T. Spencer, Chicago, IL
3:00 Evolution of Technology and Medicine: How IT Can be Used to Improve Patient Care — Amy Leigh Miller, Boston, MA
3:10 Question and Answer
SPECIAL
LEGENDS
401
Legends of Cardiovascular Medicine Lecture Series — 43rd Annual Louis F. Bishop LectureSaturday, March 24, 2012, 2:00 p.m. – 3:00 p.m.McCormick Place North, N426CME/CNE Hours: 1
Chair: Lawrence H. Cohn, Boston, MA
2:00 Introduction of Dr. Magdi H. yacoub — Lawrence H. Cohn, Boston, MA
2:05 43rd Annual Louis F. Bishop Lecture: In Search of Excellence — Magdi H. Yacoub, Harefield, Middlesex, United Kingdom
2:35 One-on-One Interview with Dr. Magdi H. yacoub — Lawrence H. Cohn, Boston, MA
2:50 Audience Question and Answer
LIFELONG
MOC
807
ACCF Study Sessions for Maintenance of Certification: ABIM Recertification Made Easy — Cardiovascular Disease 2011 Update (A1-L)Saturday, March 24, 2012, 3:30 p.m. – 6:00 p.m.McCormick Place South, S105aCME Hours: 2.5
ACCF’s Maintenance of Certification Sessions allows you to easily obtain ABIM’s Maintenance of Certification (MOC) points during at ACC.12. Tickets are required for admittance to this session. Ticketed registrants must arrive no later than 15 minutes before the start of the session. Seats will be released at this time and an “open seating” policy will apply.
Attendees must be enrolled in the ABIM’s MOC program to claim MOC points. If you are not enrolled, please allow sufficient time to do this prior to the start of the session. ABIM staffs are available onsite
to answer your MOC questions and help with enrollment.
For convenience, there will be computer terminals in the ACC MOC Center onsite in Room S104b for attendees to take the ABIM MOC test after the study session concludes, if desired. Electrical power is provided in the classrooms so that attendees who wish to bring their own devices may ‘power up’ to access relevant question modules.
Access to the online modules will also be available for participants for a short period of time following the annual meeting.
Attendees may not claim CME credits from ABIM as it is against ACCME and AMA guidelines to claim credit twice for the same activity. MOC credit is available from the ABIM after completion of the MOC module; CME credit only (no CNE credit) is available from ACC.
Chair: Steve R. Ommen, Rochester, MN
MOC Faculty: James C. Fang, Cleveland, OH, Samuel Asirvatham, Rochester, MN
LIFELONG
MOC
808
ACCF Study Sessions for Maintenance of Certification: ABIM Recertification Made Easy — Cardiovascular Disease 2010 Update (A1-K)Saturday, March 24, 2012, 3:30 p.m. – 6:00 p.m.McCormick Place South, S105dCME Hours: 2.5
ACCF’s Maintenance of Certification Sessions allows you to easily obtain ABIM’s Maintenance of Certification (MOC) points during at ACC.12. Tickets are required for admittance to this session. Ticketed registrants must arrive no later than 15 minutes before the start of the session. Seats will be released at this time and an “open seating” policy will apply.
Attendees must be enrolled in the ABIM’s MOC program to claim MOC points. If you are not enrolled, please allow sufficient time to do this prior to the start of the session. ABIM staffs are available onsite to answer your MOC questions and help with enrollment.
For convenience, there will be computer terminals in the ACC MOC Center onsite in Room S104b for attendees to take the ABIM MOC test after the study session concludes, if desired. Electrical power is provided in the classrooms so that attendees who wish to bring their own devices may ‘power up’ to access relevant question modules.
Access to the online modules will also be available for participants for a short period of time following the annual meeting.
Attendees may not claim CME credits from ABIM as it is against ACCME and AMA guidelines to claim credit twice for the same activity. MOC credit is available from the ABIM after completion of the MOC module; CME credit only (no CNE credit) is available from ACC.
Chair: Andrew Wang, Durham, NC
MOC Faculty: Julia H. Indik, Tucson, AZ, Mehdi H. Shishehbor, Cleveland, OH
Saturday, March 24, 2012 • ACC.12
ACC.12 Final Program 125
AFTERNOON
SPECIAL
SPECIAL
107A
FIT Forum I: Mix ‘n’ MingleSaturday, March 24, 2012, 3:30 p.m. – 4:30 p.m.McCormick Place South, Hall A, Bistro ACCCME/CNE Hours: 0
ARR
SyMPOSIUM
736
Pharmacology Program: Pharmacologic Considerations with Antiarrhythmic Drugs, and Dyslipidemia and Residual Risk: When and How Do you Add to Statin Therapy?Saturday, March 24, 2012, 4:00 p.m. – 6:00 p.m.McCormick Place North, N427CME/CNE/CPE Hours: 2 ACPE No. 0012-9999-152-04-P
Co-Chairs: Joseph S. Alpert, Tucson, AZ David Parra, West Palm Beach, FL
4:00 Pharmacologic Considerations with Antiarrhythmic Drugs — James Tisdale, Indianapolis, IN
4:45 Panel Discussion
Panelists: Melanie T. Gura, OH, Kristen K. Patton, Seattle, WA, Cynthia Sanoski, Philadelphia, PA
5:00 Dyslipidemia and Residual Risk: When and How Do you Add to Statin Therapy? — Matthew K. Ito, San Diego, CA
5:45 Panel Discussion
Panelists: Robert Lee Page, II, Aurora, CO, Janet B. Long, Providence, RI, Karol E. Watson, Redondo Beach, CA
ACC-i2/TCT
EXPERTS
2305
Vascular Access Challenges and Complications Case ReviewsSaturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S102cCME/CNE Hours: 1.5
Co-Chairs: Tift Mann, Raleigh, NC Robert J. Applegate, Winston-Salem, NC
Case Robert Dieter, Chicago, IL, Shigenori Ito, Nagoya, Japan, Presenters: Sangeeta Mandapaka, Charleston, WV, Gopi
Manthripragada, Los Angeles, CA, Mohammad Reza Movahed, Tucson, AZ
Panelists: Ian C. Gilchrist, Hershey, PA,Harold L. Dauerman, Shelburne, VT, James C. Blankenship, Danville, P
ACC-i2/TCT
EXPERTS
2306
Unusual Cases of Acute Coronary Syndromes Case ReviewsSaturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S103bCME/CNE Hours: 1.5
Co-Chairs: John W. Hirshfeld, Philadelphia, PA, William J. French, Torrance, CA
Case Natasha Purai Arora, Detroit, MI, Sam Mcelwee,Presenters: Birmingham, AL, Syed Tanveer Rab, Atlanta, GA,
Adurthy Ananth Shankar, Syracuse, NY, Lauren Simprini, Washington, DC
Panelists: Neal S. Kleiman, Houston, TX, James E. Tcheng, Durham, NC, A. Michael Lincoff, Cleveland, OH
ACC-i2/TCT
SyMPOSIUM
2611
Intravascular Imaging: Restenosis, Thrombosis and Stent Follow-up II: Very Late Stent Thrombosis and Late Catch-upSaturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S101aCME/CNE Hours: 1.5
Co-Chairs: Renu Virmani, Gaithersburg, MD Evelyn Regar, Rotterdam, Netherlands
4:30 Comparative Mechanisms of Early, Late and Very Late Stent Thrombosis: Findings from IVUS Studies — Yasuhiro Honda, Stanford, CA
4:42 Comparative Mechanisms of Early, Late and Very Late Stent Thrombosis: Findings from OCT Studies — Ik-Kyung Jang, Boston, MA
4:54 In-stent Neoatherosclerosis: Time Course, Pathologic Findings in BMS and DES, and Pathologic Validation of OCT Studies — Gaku Nakazawa, Isehara, Japan
5:06 In-stent Neoatherosclerosis in BMS — Mitsuyasu Terashima, Kobe, Japan
5:18 In-stent Neoatherosclerosis in DES — Soo-Jin Kang, Suwon, Republic of Korea
5:30 Bioabsorbable Stents: IVUS, RF-IVUS, OCT, CT Angiographic, and Physiologic Assessment — John A. Ormiston, Auckland, New Zealand
5:42 Case Presentation — Masamichi Takano, Chiba, Japan
5:47 Case Presentation — Jingbo Hou, Harbin, China
5:52 Panel Discussion
ACC-i2/TCT
SyMPOSIUM
2612
Hemodynamics II (HOCM)Saturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S102bCME/CNE Hours: 1.5
Co-Chairs: Srihari S. Naidu, New York, NY Ulrich Sigwart, Geneva, Switzerland
4:30 Hemodynamic Assessment of HOCM — Michael A. Fifer, Boston, MA
4:45 Case Presentation: HOCM, Ideal for Surgery — Milind Y. Desai, Cleveland, OH
5:00 Myomectomy Should be the First Choice for Most Patients — Nicholas G. Smedira, Cleveland, OH
5:15 Case Presentation: HOCM, Ideal for Alcohol Septal Ablation — Quang T. Bui, Philadelphia, PA
5:30 Why Alcohol Septal Ablation Should be the First Choice for Most Patients — Carey D. Kimmelstiel, Boston, MA
5:45 Panel Discussion
ACC.12 • Saturday, March 24, 2012
126 GO for ACC.12!
AFTE
RNOO
N
ACC-i2/TCT
SyMPOSIUM
2613
Advances and Controversies in Carotid, Aortic and Peripheral Arterial Disease: In Collaboration with the Society of Vascular SurgerySaturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S103cCME/CNE Hours: 1.5
Co-Chairs: Michael R. Jaff, Boston, MA Peter Gloviczki, Rochester, MN
4:30 Controversies in Carotid Stenting vs. Carotid Endarterectomy in Patients with Symptomatic Carotid Artery Disease: The Cardiologist’s Perspective — William A. Gray, New York, NY
4:40 Controversies in Carotid Stenting vs. Carotid Endarterectomy in Patients with Symptomatic Carotid Artery Disease: The SVS Guidelines — John J. Ricotta, Washington, DC
4:50 Indications for Endovascular vs. Open Repair of Abdominal Aortic Aneurysms in 2012 — Peter Gloviczki, Rochester, MN
5:00 Indications for Endovascular vs. Open Repair of Abdominal Aortic Aneurysms in 2012 — Robert M. Bersin, Seattle, WA
5:10 The Future of Endovascular Repair of Thoracic and Thoracoabdominal Aneurysms — Gustavo Oderich, Rochester, MN
5:20 Endovascular, Hybrid or Open Treatment of TASC C and D Iliac Lesions: The Cardiologist’s Perspective — John R. Laird, El Macero, CA
5:30 Endovascular, Hybrid or Open Treatment of TASC C and D Iliac Lesions: The SVS Perspective — Sean Lyden, Cleveland, OH
5:40 Endovascular First for Infrainguinal Peripheral Arterial Disease? The SVS Perspective — Michael S. Conte, San Francisco, CA
5:50 Endovascular First for Infrainguinal Peripheral Arterial Disease? The Cardiologist’s Perspective — Michael R. Jaff, Boston, MA
ACS
SyMPOSIUM
623
Adjunctive Pharmacology in ACS: Anticoagulants and Antiplatelet AgentsSaturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S404CME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-134-L04-P
Co-Chairs: Peter B. Berger, Danville, PA Hyeon-Cheol Gwon, Seoul, Republic of Korea
4:30 Optimal Anticoagulant: Overview of UFH — Marc Cohen, Newark, NJ
4:36 Optimal Anticoagulant: Overview of Bivalirudin — Gregg W. Stone, New York, NY
4:42 Optimal Anticoagulant: Overview of LMWH — Gilles Montalescot, Paris, France
4:48 Moderated Discussion
5:00 Optimal Antiplatelet: Overview of Clopidogrel — Malcolm Bell, Rochester, MN
5:06 Optimal Antiplatelet: Overview of Prasugrel — Stephen D. Wiviott, Boston, MA
5:12 Optimal Antiplatelet: Overview of Ticagrelor — Stefan K. James, Uppsala, Sweden
5:18 Moderated Discussion
5:30 Agents on the Horizon: Back to the Future (Current Role of GP IIb/IIIa Receptor Antagonists) — Sarah A. Spinler, Philadelphia, PA
5:36 Agents on the Horizon: Novel Oral Agents (Anti-Xa or IIa, TRA) — William Dager, San Francisco, CA
5:42 Agents on the Horizon: Novel Intravenous Agents (P2y12 Antagonists, Elinogrel, Aptamer) — David J. Moliterno, Lexington, KY
5:48 Moderated Discussion
ARR
EXPERTS
216
The Risk versus Benefit of DFT TestingSaturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S503CME/CNE Hours: 1.5
Chair: Andrea M. Russo, Moorestown, NJ
Case Presenter: Noel G. Boyle, Los Angeles, CA
Panelists: Martin C. Burke, Chicago, IL, Jeanne E. Poole, WA, William H. Sauer, Aurora, CO
ARR
SyMPOSIUM
624
Management of Complications of Pacemakers and LeadsSaturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S403CME/CNE Hours: 1.5
Co-Chairs: Charles L. Byrd, Fort Lauderdale, FL Laurence Mark Epstein, Boston, MA
4:30 What Can Go Wrong with the Implantation of a Device? — Laurence Mark Epstein, Boston, MA
4:48 Clinical Presentation, Diagnostic Clues and Management of Late Perforations — Alaa A. Shalaby, Pittsburgh, PA
5:06 Management of Device Infections: When Is Medical Therapy Appropriate? — David L. Hayes, Rochester, MN
5:24 Potential Complications/Ramifications Associated with Lead Extraction — Charles L. Byrd, Fort Lauderdale, FL
5:42 Optimal Strategies for the Management of Antiplatelet and Anticoagulation Medications Prior to Cardiac Device Implantation in Patients with Atrial Fibrillation or Prosthetic Valves — Christine Tompkins, Baltimore, MD
Saturday, March 24, 2012 • ACC.12
ACC.12 Final Program 127
AFTERNOON
ARR
SyMPOSIUM
627
Translational Research Symposium with the International Society for Cardiovascular Translational Research: Tissue EngineeringSaturday, March 24, 2012, 4:30 p.m. – 5:30 p.m.McCormick Place North, N228CME/CNE Hours: 1
Co-Chairs: Karen L. Christman, La Jolla, CA Magdi H. Yacoub, Harefield, Middlesex, United Kingdom
4:30 Role of Tissue Engineering in Cardiovascular Medicine — Magdi H. Yacoub, Harefield, Middlesex, United Kingdom
4:45 Tissue Engineering Approaches to Cardiovascular Devices: From Bench to Bedside — Todd McAllister, Navoto, CA
4:55 Materials for Cardiac Repair: The Product and the Animal Model — William Wagner, Pittsburgh, PA
5:05 Injectable Materials for Treating Myocardial Infarction and Peripheral Artery Disease — Karen L. Christman, La Jolla, CA
5:15 Panel Discussion
CCS
SyMPOSIUM
625
Updates on Care in the Congenital Heart Disease PatientsSaturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place North, N231CME/CNE Hours: 1.5
Co-Chairs: Randall M. Bryant, Jacksonville, FL Michael Earing, Milwaukee, WI
4:30 Newer Antiarrhythmic and Anticoagulant Therapy and Potential Applications for Adults with Congenital Heart Disease — Karen K. Stout, Seattle, WA
4:48 The Use of Leadless Subcutaneous Defibrillators in Congenital Heart Disease — Charles Berul, Washington, DC
5:06 Update on the Changing Approaches and Outcomes for Immunosuppression in Heart Transplant Patients — Lori West, Edmonton, Canada
5:24 Outcomes after Wider Application of the Cone Reconstruction for the Tricuspid Insufficiency: What Do We Know and What Do We Need to Know? — Joseph A. Dearani, Rochester, MN
5:42 Ventricular Assist Device: Current Indications and Options — David Morales, TX
HF
EXPERTS
217
Heart Failure Disease Management: Issues for 2012Saturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S502CME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-084-L01-P
Chair: Robin Trupp, Tampa, FL
Case Presenter: Paul A. Heidenreich, Palo Alto, CA
Panelists: Gregg C. Fonarow, Los Angeles, CA, Sara Paul, Hickory, NC, Ileana L. Pina, Cleveland Heights, OH, Kismet Rasmusson, Salt Lake City, UT
HF
SyMPOSIUM
626
Management of Acute Decompensated Heart Failure: From Hemodynamic Subsets to Appropriate Treatment StrategiesSaturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S406bCME/CNE Hours: 1.5
Chair: Mihai Gheorghiade, Chicago, IL
4:30 Classification and Subclassification of ADHF — Anju Nohria, Boston, MA
4:45 Question and Answer
4:48 Is There a Role for Hemodynamic Characterization in ADHF — Biykem Bozkurt, Houston, TX
5:03 Question and Answer
5:06 Role of Biomarkers in Management of ADHF — Wai Hong Wilson Tang, Cleveland, OH
5:21 Question and Answer
5:24 Current Strategies in Volume Management of ADHF — G. Michael Felker, Durham, NC
5:39 Question and Answer
5:42 Inotropes, Vasodilators and Novel Treatment Strategies in ADHF — John R. Teerlink, San Francisco, CA
5:57 Question and Answer
IMAG
EXPERTS
218
Myocardial Perfusion Imaging: Picking the Right TestSaturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S505CME/CNE Hours: 1.5
Chair: John R. Lesser, Minneapolis, MN
Case Presenter: Julius M. Gardin, Hackensack, NJ
Panelists: Richard T. George, Monkton, MD, Rory Hachamovitch, Cleveland, OH, W. Gregory Hundley, Winston Salem, NC, Joao A. C. Lima, Baltimore, MD
IMAG
SyMPOSIUM
628
Multi-Modality Imaging: Chest Pain in the Emergency DepartmentSaturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S402CME/CNE Hours: 1.5
Co-Chairs: Sanjiv Kaul, Portland, OR Leslee J. Shaw, Atlanta, GA
4:30 Case Presentation — Michael C. Kontos, Glen Allen, VA
4:36 Let’s Start with a CTA... — Harvey S. Hecht, New York, NY
4:54 Myocardial Perfusion Imaging for the Emergency Department Patient — Raymond J. Gibbons, Rochester, MN
5:12 A Stress Echo, of Course — Farooq A. Chaudhry, New York, NY
5:30 What about Radiation Safety? — Gilbert Raff, Royal Oak, MI
5:42 Panel Discussion/Question and Answer
ACC.12 • Saturday, March 24, 2012
128 GO for ACC.12!
AFTE
RNOO
N
ISCHEM
SyMPOSIUM
629
Stable Ischemic Heart Disease: What’s New in the Guidelines (and What Should Be)?Saturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S401aCME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-135-L04-P
Co-Chairs: Joaquin Cigarroa, Portland, OR Wanpen Vongpatanasin, Dallas, TX
4:30 BP: How Low Should We Go and How Do We Get There? — Rhonda M. Cooper-DeHoff, Gainesville, FL
4:48 Dyslipidemia: Recent Trials That Should Change the Guidelines — Robert P. Giugliano, Boston, MA
5:06 PCI: Too Much, Too Little, or Too Late? — John Bittl, Ocala, FL
5:24 CABG: When Is Cold Steel the Best Deal? — Michael Jessen, Dallas, TX
5:42 SIHD: Is There Really Anything New? — Joanne M. Foody, Boston, MA
LIFELONG
CORE
809
Core Curriculum: EchocardiographySaturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place North, N226CME/CNE Hours: 1.5
Chair: Alex J. Auseon, Columbus, OH
4:30 Cardiomyopathies and Pericardial Disease — Sangeeta B. Shah, New Orleans, LA
4:55 Valvular Heart Disease — Rosario Freeman, Seattle, WA
5:20 Diastology — Issam A. Mikati, Chicago, IL
5:45 Question and Answer
LIFELONG
CORE
810
Core Curriculum: Cardiac ElectrophysiologySaturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place North, N229CME/CNE Hours: 1.5
Chair: Bindi K. Shah, Philadephia, PA
4:30 Atrial Fibrillation and the SVT’s — Sherry Saxonhouse, Charlotte, NC
4:55 Sudden Cardiac Death: Epidemiology, Evaluation and Management — Ralph J. Verdino, Philadelphia, PA
5:20 Pacing and AICD Device Therapy Guidelines — Oussama M. Wazni, Solon, OH
5:45 Question and Answer
PRACTICE
SyMPOSIUM
630
Information Technology, Medicine and the FutureSaturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place North, N230CME/CNE Hours: 1.5
Co-Chairs: Cathleen Biga, Woodridge, IL Frank Leonard Mikell, Springfield, IL
4:30 I Hate My EHR: Is There a Better System? — Michael J. Mirro, Fort Wayne, IN
4:48 Meaningful Use: What It Means for the Practicing Cardiologist — Cathleen Biga, Woodridge, IL
5:06 ICD-10: Can They Make This Any More Complicated? — Linda Gates-Striby, Indianapolis, IN
5:24 CPOE: The Good, the Bad, and the Ugly — Frank Leonard Mikell, Springfield, IL
5:42 Question and Answer
PREV
SyMPOSIUM
631
Hypertension Guidelines 2012Saturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S100cCME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-136-L04-P
Co-Chairs: Thomas D. Giles, Metairie, LA Suzanne Oparil, Birmingham, AL
4:30 Updates and New Guidelines for Hypertension Management in 2012 — Suzanne Oparil, Birmingham, AL
4:45 Initial Drug Choices in Low-risk and High-risk Populations — Kenneth A. Jamerson, Ann Arbor, MI
5:00 Should Target Blood Pressure Change in the New Guidelines? — William C. Cushman, Memphis, TN
5:15 Treatment of Hypertension in Diabetes and Chronic Kidney Disease — George L. Bakris, Chicago, IL
5:30 Lifestyle Modification — John D. Bisognano, Rochester, NY
5:45 Hypertension in Ethnic Minorities — Ronald G. Victor, Los Angeles, CA
QUAL
EXPERTS
219
Measuring and Optimizing Quality in your Outpatient Practice: The PINNACLE RegistrySaturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S501aCME/CNE Hours: 1.5
Chair: John E. Brush, Norfolk, VA
Case Presenter: William J. Oetgen, Alexandria, VA
Panelists: Suzanne V. Arnold, Kirkwood, MO, Blair D. Erb, Bozeman, MT, David Crockett May, Lewisville, TX, Thomas M. Maddox, Denver, CO
SPECIAL
SPECIAL
109
Educating the Educators: Symposium for Cardiology Fellowship Program Directors and CoordinatorsSaturday, March 24, 2012, 4:30 p.m. – 6:30 p.m.McCormick Place South, S405aCME Hours: 2
Chair: Chittur A. Sivaram, Oklahoma City, OK
4:30 ABIM Milestones and Competencies — William Iobst, Philadelphia, PA, Eric S. Williams, Indianapolis, IN
5:10 Research Training during Fellowship — Joseph A. Hill, Dallas, TX, Chittur A. Sivaram, Oklahoma City, OK , Sunil V. Rao, Durham, NC
5:40 Fellowship Match Changes, Fellow Learning Portfolio and In-Training Examination — Jeffrey T. Kuvin, Boston, MA
6:10 Follow-Up On Previous Projects
Saturday, March 24, 2012 • ACC.12
ACC.12 Final Program 129
AfternooneVening
6:25 Wrap-Up — Jeffrey T. Kuvin, Boston, MA, Chittur A. Sivaram, Oklahoma City, OK, Marcia J. Jackson, Santee, SC
SPECIAL
SPECIAL
110
FIT Forum II: JeopardySaturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place North, N227bCME Hours: 1.5
Judges: Kyle W. Klarich, Rochester, MN, Marvin A. Konstam, Boston, MA, Padmini Varadarajan, Redlands, CA
VALV
EXPERTS
220
Ischemic Mitral RegurgitationSaturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S504aCME/CNE Hours: 1.5
Chair: Vuyisile Nkomo, Rochester, MN
Case John Gorcsan, Pittsburgh, PA, Judy W. Hung, Boston,Presenters: MA, Saibal Kar, Los Angeles, CA
Panelists: Steven F. Bolling, Ann Arbor, MI, Paul A. Grayburn, Dallas, TX, Suzanne J. Wingate, Silver Spring, MD
VALV
SyMPOSIUM
632
Valve Repair: How to Achieve SuccessSaturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place North, N426CME/CNE Hours: 1.5
Co-Chairs: Maurice Enriquez-Sarano, Rochester, MN Patrick M. McCarthy, Chicago, IL
4:30 Echo to Select Patients for Mitral and Aortic Repair — Sunil V. Mankad, Rochester, MN
5:06 Durability of Mitral Repair: What Is the Truth? — David H. Adams, New York, NY
5:24 Thorascopic Mitral Repair Is the Easiest — Clark Hargrove, Philadelphia, PA
4:48 Mitral Regurgitation with Atrial Fibrillation: Worth the Repair and MAZE? — Patrick M. McCarthy, Chicago, IL
5:42 What Is an Advanced Valve Repair Center? — Harold M. Burkhart, Rochester, MN
VASC
SyMPOSIUM
743
Carotid Artery Disease: Is the Picture Clarifying?Saturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S406aCME/CNE Hours: 1.5
Co-Chairs: Ruth Bush, Temple, TX Jonathan L. Halperin, New York, NY
4:30 Stroke Risk in the Symptomatic and Asymptomatic Internal Carotid Artery. Where Are We Today? — Naomi Hamburg, Boston, MA
4:45 Novel Technologies in the Assessment of Stroke Risk in Asymptomatic Carotid Artery Disease — Ahmed A. Tawakol, Boston, MA
5:00 Hostile Necks: What Defines the High Surgical Risk and High Stent Risk Patient? — Sriram S. Iyer, New York, NY
5:15 After CREST, Is it the Procedure or the Operator? Should All In-practice Interventionists Be Allowed
to Place Carotid Stents? — William A. Gray, New York, NY
5:30 Do We Need More Carotid Revascularization Clinical Trials? — Joshua A. Beckman, Boston, MA
5:45 Panel Discussion
VALV
SyMPOSIUM
633
Translational Research Symposium with the International Society for Cardiovascular Translational Research: DevicesSaturday, March 24, 2012, 5:30 p.m. – 6:50 p.m.McCormick Place North, N228CME/CNE Hours: 1.5
Co-Chairs: Nicolas A. F. Chronos, Atlanta, GA Mitchell W. Krucoff, Durham, NC
5:30 Percutaneous and Other Approaches to Aortic Vavle Replacement: From Bench to Bedside — James Fonger, Atlanta, GA
5:40 Percuteanous Mitral Valve Repair: From Bench to Bedside — David Reuter, Kirkland, WA
5:50 Wireless Approaches to Physiological Monitoring: From Bench to Bedside — Jay S. Yadav, Atlanta, GA
6:00 Removing Barriers to Device Innovation — Mitchell W. Krucoff, Durham, NC
6:10 Pathway to IDE and 510K — Bram D. Zuckerman, Rockville, MD
6:25 Panel Discussion
6:40 Summary and Closing Remarks — Anthony N. DeMaria, San Diego, CA
ARR
SyMPOSIUM
1601
Critical Links in Atrial Fibrillation: Priorities in Risk Assessment, Treatment and Patient EducationSaturday, March 24, 2012, 6:00 p.m. – 9:00 p.m.Fairmont Hotel, International BallroomCME/CNE Hours: 2.5
Co-Chairs: Jonathan L. Halperin, New York, NY Stuart A. Winston, Ann Arbor, MI
6:00 Dinner
6:30 Welcome and Overview — Jonathan L. Halperin, New York, NY
6:45 The New Science of Atrial Fibrillation Pharmacotherapy — Christopher B. Granger, Durham, NC
7:10 Using Performance and Medical Record Data to Improve Practice — Patrick J. Daley, Jr., Fort Wayne, IN
7:25 Current and Future Performance Measures for Atrial Fibrillation: What is Expected Now and How Will Expectations Change in the Future? — N.A. Mark Estes, III, Boston, MA
7:45 A New ERA for the Physician: How Performance Improvement CME Enhances Atrial Fibrillation Risk Assessment and Treatment — Joseph P. Drozda, Jr., St. Louis, MO
ACC.12 • Saturday, March 24, 2012
130 GO for ACC.12!
eVen
ing
8:05 The Impact of Improved Communication and Educational Tools on Patient Outcomes — Stuart A. Winston, Ann Arbor, MI
8:20 Case-Based Panel Discussion and Q&A
8:50 Concluding Remarks
9:00 Adjournment
PREV
CLINICAL FOCUS
1602
First Line of Defense: Risk Factors and Prevention in the Cardiology Practice — A Master Class for the Community CardiologistSaturday, March 24, 2012, 6:30 p.m. – 9:30 p.m.Fairmont Hotel, Gold RoomCME/CNE Hours: 2.5
Tickets are required for admittance to this session. Ticketed registrants must arrive no later than 15 minutes before the start of the session. Seats will be released at this time and an “open seating” policy will apply.
Chair: Nanette Kass Wenger, Atlanta, GA
6:30 Registration and Dinner
7:00 Introduction and General Remarks — Nanette Kass Wenger, Atlanta, GA
7:05 Hypertension Management in Contemporary Practice — Suzanne Oparil, Birmingham, AL
7:20 Case Discussion/Questions and Answers
7:40 Managing Dyslipidemia and Atherosclerotic Risk — Michael H. Davidson, Chicago, IL
8:00 Case Discussion/Questions and Answers
8:15 Managing Cardiovascular Risk in Patients with Type2 Diabetes — Mark Stolar, Chicago, IL
8:35 Case Discussion/Questions and Answers
8:50 Stable Ischemic Heart Disease : Risk Recognition and Assessment, Diagnosis and Treatment — Benjamin M. Scirica, Boston, MA
9:10 Case Discussion/Questions and Answers
9:25 Concluding Remarks — Nanette Kass Wenger, Atlanta, GA
VALV
CLINICAL FOCUS
1604
Championing Care for the Patient with Aortic Stenosis: The Role of Cardiologists and Primary Care from Recognition to RecoverySaturday, March 24, 2012, 6:30 p.m. – 9:30 p.m.Fairmont Hotel, Imperial BallroomCME/CNE Hours: 2.5
Tickets are required for admittance to this session. Ticketed registrants must arrive no later than 15 minutes before the start of the session. Seats will be released at this time and an “open seating” policy will apply.
6:30 Registration and Dinner
7:00 Introduction — Aaron Kugelmass, Boston, MA
7:10 Aortic Stenosis in 2012 — Has the Paradigm Changed? Natural History and Therapeutic Options — Blase Carabello, Houston, TX
7:40 “Appropriate Use” of Echocardiography for Aortic Stenosis — Robert Hendel, Miami, FL
8:05 A Surgeon’s Perspective on Treating Aortic Stenosis: What is Acceptable Risk for Open Surgical Replacement? — Michael Mack, Dallas, TX
8:30 TAVR: An Expert’s Perspective and Case Studies — E. Murat Tuczu, Cleveland, OH
8:55 The Asymptomatic Patient with Severe Aortic Stenosis — Patrick O’Gara, Boston, MA
9:20 Concluding Remarks — Aaron Kugelmass, Boston, MA
Saturday, March 24, 2012 • ACC.12
ACC.12 Final Program 131
CardioSmart ForumSouth Building, Hall A2, CV Theater, #22097
11:15 a.m. – 12:15 p.m.Eat What you Love, Love What you Eat: How to Break your Eat-Repent-Repeat Cycle — Part of the “CardioSmart: Hot Topics for Better Patient Outcomes” Series — Michelle May, MD, CSP, Phoenix, AZ — Founder and CEO, Am I Hungry?® Mindful Eating Workshops
The Heart of Innovation Featured Learning Destination South Building, Hall A1, #1076
9:30 a.m. – 10:15 a.m.Educational content including taped cases, physician interviews, panel discussions and more
10:15 a.m. – 10:35 a.m.Autologus Stem Cells Therapy for the Treatment of Refractory Angina — Timothy D. Henry, MD, FACC, Minneapolis, MN — Director of Research, Minneapolis Heart Institute Foundation; Interventional Cardiologist, Minneapolis Heart Institute/Abbott Northwestern Hospital; Professor of Medicine, University of Minnesota School of Medicine
10:35 a.m. – 10:55 a.m.Stem Cells and Biomatrixes — Anthony N. DeMaria, MD, MACC, San Diego, CA — Judith and Jack White Chair in Cardiology, Founding Director, Sulpizio Cardiovascular Center, University of California San Diego
10:55 a.m. – 11:15 a.m.The Regulatory Pathway of Cellular Therapy — Steve Winitsky, MD, Rockville, MD — Medical Officer, U.S. Food and Drug Administration, CBER/OCTGT/DCEPT
11:15 a.m. – 11:35 a.m.ePHR COPE — The Use of PHR to Engage Patients Post-Coronary Revascularization — Michael J. Mirro, MD, FACC, Fort Wayne, IN — Cardiologist, Fort Wayne Cardiology
11:35 a.m. – 11:55 a.m.Role of Real-Time 3D TEE Integration for Complex Transcatheter SHD Repairs — John D. Carroll, MD, FACC, FSCAI, Aurora, CO — Professor of Medicine, Director of Interventional Cardiology, University of Colorado; Medical Director, Cardiac and Vascular Center, University of Colorado Hospital
11:55 a.m. – 12:15 p.m.Digital Intervention — JoAnne M. Foody, MD, FACC, FAHA, Boston, MA — Medical Director, Cardiovascular Wellness Program, Brigham and Women’s Hospital
12:15 p.m. – 12:35 p.m.Applying Personalized Medicine in the Cath Lab by Tailoring Treatment to Patient Risks — John A. Spertus, MD, MPH, FACC, Kansas City, MO — Professor, Daniel J. Lauer Missouri Endowed Chair in Metabolism and Vascular Disease Research, University of Missouri, Kansas City; Director, Cardiovascular Education and Outcomes Research, Mid America Heart Institute
12:35 p.m. – 12:55 p.m.Robotic-Assisted PCI: Opportunities for Improved Precision and Efficiency — George W. Vetrovec, MD, FACC, FSCAI, Richmond, VA — Professor of Medicine, VCU Pauley Heart Center at Virginia Commonwealth University; Executive of Board of Directors, Virginia Commonwealth University Health System
12:55 p.m. – 1:15 p.m.Heart-Derived Cells for the Treatment of Acute Myocardial Infarction — Eduardo Marbán, MD, PhD, FACC, Los Angeles, CA — Director, Cedars-Sinai Heart Institute, Mark S. Siegel Family Professor
1:15 p.m. – 1:45 p.m.Genetic Testing 101: What Are the Benefits?
Jeffrey A. Towbin, MD, FACC, FAAP, FAHA, Cincinnati, OH — Executive Co-Director, The Heart Institute; Kindervelt-Samuel Kaplan Professor and Chief, Pediatric Cardiology, Cincinnati Children's Hospital Medical Center
1:45 p.m. – 3:45 p.m.Educational content including taped cases, physician interviews, panel discussions and more
3:45 p.m. – 4:15 p.m.Moderated Discussion: Viability of Robotic TECAB
Moderator: James B. McClurken, MD, FACC, FACS, FCCP, FESC, Philadelphia, PA — Professor of Surgery, Director of Performance Improvement, Cardiothoracic Surgery, Temple University Health System
Panelists: Johannes O. Bonatti, MD, FETCS, Baltimore, MD — Professor of Surgery, Director of Coronary Surgery and Advanced Coronary Interventions, University of Maryland Medical Center; Ralph J. Damiano, Jr., MD, FACC, St. Louis, MO — John M. Shoenberg Professor of Surgery, Chief of Cardiac Surgery, Washington University in St. Louis School of Medicine
4:15 p.m. – 4:30 p.m.Educational content including taped cases, physician interviews, panel discussions and more
ACC.12 Learning Destination™ Presentations
Saturday, March 24, 2012Learning Destinations™ are diverse, non-accredited, educationally focused areas that offer new and creative venues in which you can expand your educational experience.*
Presentation schedules are current as of Feb. 29, 2012, and are subject to change. For more information, please check the ACC.12 ExpoGuide and ExpoGuide Addendum, available at Expo Hall entrances and in your official meeting bag, and the Heart of Innovation Resource Guide, available at the Heart of Innovation Learning Destination (South Building, Hall A1, #1076) and in your official meeting bag.
132 GO for ACC.12!
Industry-Expert TheaterSouth Building, Hall A1, #22042
10:15 a.m. – 11:15 a.m. (Morning Coffee Break) Pradaxa® (Dabigatran Etexilate Mesylate) Capsules — Alan K. Jacobson, MD, Loma Linda, CA — Director, Anticoagulation Services and Staff Cardiologist, Loma Linda VA Medical Center, Loma Linda University School of MedicinePresented by Boehringer Ingelheim Pharmaceuticals, Inc.
12:30 p.m. – 1:30 p.m. (Mid-Day Break)Next Generation DES: Evolving the Treatment Paradigm — Peter J. Fitzgerald, MD, PhD, FACC, Palo Alto, CA — Director, Center for Cardiovascular Technology, Stanford University; Alan Yeung, MD, Palo Alto, CA — Professor — Med Center Line, Medicine — Cardiovascular Medicine, Stanford University; Krishna Rocha-Singh, MD, FACC, Springfield, IL — Medical Director, Prairie Education & Research CooperativePresented by Medtronic, Inc.
3:30 p.m. – 4:30 p.m. (Afternoon Coffee Break)Treating a Patient at Risk for SCD after PCI — Implant an ICD, Right? The Considerations for Treatment Path Planning, Coverage, and the Role of the Wearable Cardioverter Defibrillator — Sunil V. Rao, MD, Durham, NC — Associate Professor of Medicine, Duke University Medical Center; Director, Cardiac Catheterization Laboratories, Durham VA Medical CenterPresented by ZOLL
Interactive Learning LabsSouth Building, Hall A1, #22027, #22035, #23027
Actelion Pharmaceuticals US, Inc.Interactive Learning Lab #23027
9:30 a.m. – 11:30 a.m.Pulmonary Arterial Hypertension Associated with Adult Congenital Heart Disease: An Interactive Program — Wayne J. Franklin, MD, FACC, Houston, TX — Director, Texas Adult Congenital Heart Program, Texas Children’s Hospital; Assistant Professor of Medicine and Pediatrics, Baylor College of Medicine; Richard A. Krasuski, MD, FACC, FAHA, Cleveland, OH — Director of Adult Congenital Heart Disease Services, Cleveland Clinic Foundation; Michael J. Landzberg, MD, Boston, MA — Director, Boston Adult Congenital Heart Service, Children’s Hospital, Brigham & Women’s Hospital, Harvard Medical School
12:30 p.m. – 2:15 p.m.PAH: A Case-Based Exploration of Management Strategies — Michael Earing, MD, Milwaukee, WI — Medical College of Wisconsin; Ramagopal Tumuluri, MD, Milwaukee, WI — Aurora St. Luke’s Medical Center
Philips HealthcareInteractive Learning Lab #22035
9:30 a.m. – 10:30 a.m.Speckle Tracking Today for Myocardial Deformation — A Hands-On Guided Workshop — Roberto M. Lang, MD, FACC, FAHA, FASE, FESC, FRCP, Chicago, IL — Professor of Medicine and Radiology; Director, Noninvasive Cardiac Imaging Laboratories; Associate Director, Cardiology Fellowship Program; University of Chicago Medical Center; Ivan Salgo, MD, Andover, MA — Senior Director, Cardiology; Philips Healthcare
11:00 a.m. – NoonHow Can Cardiology Informatics Enrich My Electronic Health Records Strategy? — James E. Tcheng, MD, FACC, Durham, NC — Professor of Medicine; Professor of Community and Family Medicine (Informatics); Duke University Health System
12:30 p.m. – 1:30 p.m.Discussing Optimizing Patient Safety and Radiation Exposure with Use of XperSwing with Radial Artery Access for Coronary Angiography — John C. Messenger, MD, FACC, FSCAI, Denver, CO — Associate Professor of Medicine, Director, Cardiac Catheterization Labs, University of Colorado Hospital
3:30 p.m. – 4:30 p.m.Clinical Application of Real-Time 3D TEE for Percutaneous Structural Heart Interventions — David Liang, MD, PhD, Palo Alto, CA — Associate Professor, Cardiovascular Medicine, Stanford University School of Medicine; Robert J. Siegel, MD, Los Angeles, CA — Director, Cardiac Noninvasive Laboratory, Cedars-Sinai Medical Center
Terumo Interventional Systems and The Medicines CompanyInteractive Learning Lab #22027
9:30 a.m. – 10:30 a.m.Hands-On Radial Access Simulation
10:45 a.m. – 11:45 a.m.Hands-On Radial Access Simulation
Noon – 1:00 p.m.Optimizing your Outpatient PCI: What you Need to Know and Consider
1:00 p.m. – 2:00 p.m.Hands-On Radial Access Simulation
2:30 p.m. – 3:30 p.m.Hands-On Radial Access Simulation
* Learning Destination presentations are not part of the official ACC Annual Scientific Session & Expo and/or ACC-i2 with TCT, as planned by their Program Committees. Learning Destination presentations do not qualify for continuing medical education (CME), continuing nursing education (CNE) or continuing education (CE) credit.
Saturday, March 24, 2012 • ACC.12
Mobile AppPowered by Skyscape
FREE CardioSource Mobile App
The American College of Cardiology and Skyscape are pleased to offer a comprehensive suite of trusted resources for cardiovascular professionals!
Download CardioSource’s most popular and clinically relevant content on your mobile device today for FREE!
Scan the Microsoft Tag or visit http://bit.ly/csapp on your mobile device.
Visit ACC Central, Booth #10027
CardioSource©
2012
Am
eric
an C
olle
ge o
f Car
diol
ogy.
W12
05
©2012 American College of Cardiology. X1253
ACC is Your CardioSourceACC is Your CardioSourceCardioSourceYou can trust the ACC to provide information that helps you be the best cardiovascular professional you can be. And ACC Central is the place that brings it all to you.
Visit ACC Central, Booth 10027, to � nd out about:
• Lifelong Learning: Learn how to take an individualized approach to cardiovascular education. Improve your performance. Impact your patients.
• Advancing Quality: Get the latest data collection and quality improvement tools and resources to help you demonstrate excellence in your hospital or practice.
• Member Center: Learn how ACC membership can help you advance your career & apply on site! Current members can � nd out how to get more involved, discover the newest membership bene� ts, pay dues and more.
• Advocacy and Practice Support: Learn more about the ACC’s efforts to set a new standard for health care delivery and get the tools you need to ensure patient access to the right care at the right time.
• Mobile Applications: Get your free CardioSource Mobile Applications designed to put the latest science directly at your � ngertips. Also, learn
about other applications available for those on the go.
Fast. Informative. Convenient.
Visit ACC Central at Booth 10027
Visit ACC Central at Booth 10027
SAVE
15% off Select
Self-Assessment Tools and Live Courses
©2012 A
mer
ican
Col
lege
of C
ardi
olog
y A1
304
Join us for a whole new learning experience — in a whole new city — as we bring you the education that keeps you at the forefront of your profession and helps improve the quality of care for your patients.
www.accscientificsession.org
TM
Visit ACC Central, Booth #10027
Help Shape the Future of CardioSmart (and win a free iPad!)� e ACC is re-launching CardioSmart, and we want your input. � e new CardioSmart will provide tools to improve the patient-clinician relationship.
If you’re a practicing clinician, come and tell us what you need. It only takes � ve minutes. We’ll give you a token of our appreciation and enter you in a drawing to win an iPad!
ACC.12
SundayMarch 25
Sunday, March 25
©2012 American College of Cardiology. X1253
ACC is Your CardioSourceACC is Your CardioSourceCardioSourceYou can trust the ACC to provide information that helps you be the best cardiovascular professional you can be. And ACC Central is the place that brings it all to you.
Visit ACC Central, Booth 10027, to � nd out about:
• Lifelong Learning: Learn how to take an individualized approach to cardiovascular education. Improve your performance. Impact your patients.
• Advancing Quality: Get the latest data collection and quality improvement tools and resources to help you demonstrate excellence in your hospital or practice.
• Member Center: Learn how ACC membership can help you advance your career & apply on site! Current members can � nd out how to get more involved, discover the newest membership bene� ts, pay dues and more.
• Advocacy and Practice Support: Learn more about the ACC’s efforts to set a new standard for health care delivery and get the tools you need to ensure patient access to the right care at the right time.
• Mobile Applications: Get your free CardioSource Mobile Applications designed to put the latest science directly at your � ngertips. Also, learn
about other applications available for those on the go.
Fast. Informative. Convenient.
Visit ACC Central at Booth 10027
Visit ACC Central at Booth 10027
SAVE
15% off Select
Self-Assessment Tools and Live Courses
Sund
ay, M
arch
25
ACC.12 Final Program 137
Morning SeSSionS
ACC-i2/TCT
OrAl
2500
Outcomes in Patients Treated with TAVrSunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N227bCME/CNE Hours: 1.5
Co-Chairs: Stephen R. Ramee, New Orleans, LA Allan Schwartz, New York, NY
Panelists: Ganesh Manoharan, Belfast, United Kingdom, Nicolas Dumonteil, Toulouse, France, Jan Kovac, Leicestershire, United Kingdom
8:00 2500–6 Year in review — Martin B. Leon, New York, NY
8:15 2500–7 The Importance of Vascular Complications after Trans-Femoral Trans-catheter Aortic Valve replacement (TAVr): Insights from the PArTNEr Trial — Philippe Genereux, John Webb, Jeffrey Moses, Susheel Kodali, Mathew Williams, Michael Mack, D. Craig Miller, Lars Svensson, E. Murat Tuzcu, Craig Smith, Martin Leon, for the PARTNER Trial Investigators, Columbia University Medical Center and The Cardiovascular Research Foundation, New York, NY
8:25 2500–8 Panel Discussion
8:30 2500–9 Incidence, Predictors and Impact of Bleeding Events after Transcatheter Aortic Valve replacement (TAVr) Compared to Surgical Aortic Valve replacement (SAVr): Insights from the PArTNEr Trial — Philippe Genereux, Lars Svensson, Susheel Kodali, Mathew Williams, Jeffrey Moses, Michael Mack, D. Craig Miller, E. Murat Tuzcu, John Webb, Craig Smith, Martin Leon, for the PARTNER Trial Investigators, Columbia University Medical Center and The Cardiovascular Research Foundation, New York, NY
8:40 2500–10 Panel Discussion
8:45 2500–11 Incidence and Impact of Acute Kidney Injury (AKI) Post Trans-catheter Aortic Valve replacement (TAVr) Using the New Valve Academic research Consortium (VArC) Criteria — Philippe Genereux, Susheel Kodali, Martin Leon, A. Garvey Rene, Benoit Daneault, Jean-Michel Paradis, Philip Green, Isaac George, Rebecca Hahn, Ajay Kirtane, Jeffrey Moses, Craig Smith, Mathew Williams, Columbia University Medical Center and The Cardiovascular Research Foundation, New York, NY
8:55 2500–12 Panel Discussion
9:00 2500–13 Transcatheter Aortic Valve Implantation for Patients with Bicuspid Severe Aortic Valve Stenosis — Kentaro Hayashida, Thierry Lefèvre, Bernard Chevalier, Thomas Hovasse, Mauro Romano, Philippe Garot, Arnaud Farge, Patrick Donzeau-Gouge, Erik Bouvier, Bertrand Cormier, Marie-Claude Morice, Institut Cardiovasculaire Paris Sud, Massy, France
9:10 2500–14 Panel Discussion
9:15 2500–15 Prevalence and Impact of Myocardial Injury following Transfemoral and Transapical Transcatheter Aortic Valve replacement — Israel Barbash, Itsik Ben-Dor, Danny Dvir, Paul Corso, Steven Boyce, Steven Goldstein, Zuyue Wang, Rebecca Torguson, Lowell Satler, Augusto Pichard, Ron Waksman, MedStar Health Research Institute, Washington, DC
9:25 2500–16 Panel Discussion
ACC-i2/TCT
OrAl
2501
Adjunct PharmacologySunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S101aCME/CNE Hours: 1.5
Chair: George W. Vetrovec, Richmond, VA
Panelists: Kimberly A. Skelding, Danville, PA, Peter B. Berger, Danville, PA, Usman Baber, New York, NY
8:00 2501–6 Dual Antiplatelet Therapy and long-term Clinical Outcomes after Primary PCI: The HOrIZONS-AMI Trial — Georgios J. Vlachojannis, Roxana Mehran, Bernhard Witzenbichler, Giulio Guagliumi, Jan Z. Peruga, Bruce Brodie, Martin Fahy, Ran Kornowski, Bernard Gersh, Helen Parise, George Dangas, Gregg Stone, Cardiovascular Research Foundation, New York, NY, Mount Sinai Medical Center, New York, NY
8:10 2501–7 Panel Discussion
8:15 2501–8 Individualized Bleeding risk Estimates Prior to PCI Impact Physicians’ Use of Bivalirudin in High-risk Patients — Seshu Rao, Adnan Chhatriwalla, kevin kennedy, Carole Decker, Elizabeth Gialde, John Spertus, Steven Marso, Saint Luke’s Mid America Heart Institute, Kansas City, MO, University of Missouri Kansas City, Kansas City, MO
8:25 2501–9 Panel Discussion
8:30 2501–10 Impact of Ejection Fraction on Mortality in Patients Undergoing PCI: A Patient-level Pooled Analysis from the rEPlACE-2, ACUITY and HOrIZONS-AMI Trials — Jennifer Yu, George Dangas, Usman Baber, Georgios Vlachojannis, Tim Clayton, Stuart Pocock, Frederick Feit, David Cox, Bruce Brodie, A. Lincoff, Efthymios Deliargyris, Bernard Gersh, C. Michael Gibson, Roxana Mehran, Gregg Stone, Mount Sinai Medical Center, New York, NY, Cardiovascular Research Foundation, New York, NY
8:40 2501–11 Panel Discussion
8:45 2501–12 The loss-of-function Impact of CYP2C19*2 vs. *3 Allele in Patients Undergoing PCI Treated with High Maintenance-dose Clopidogrel of 150 mg/day: The results of the ACCEl-DOUBlE-2N3 Study — Young-Hoon Jeong, udaya tantry, Yonghwi Park, Seok-Jae Hwang, Kevin Bliden, Choong Hwan Kwak, Jin-Yong Hwang, Paul Gurbel, Sinai Center for Thrombosis Research, Baltimore, MD, Gyeongsang Natl Univ Hosp, Jinju, South Korea
ACC.12 Scientific Session
Sunday, March 25, 2012Please Note: The following sessions are listed alphabetically by learning pathway abbreviation based on session start time.
Morning
138 GO for ACC.12!
Mor
ning
9:00 2501–13 Panel Discussion
9:05 2501–14 Impact of Point-of-Care Platelet Function Testing among Patients with and without ACS Undergoing PCI with Drug-Eluting Stents: An ADAPT-DES Sub-study — Ajay J. Kirtane, Michael Rinaldi, Helen Parise, Bernhard Witzenbichler, Giora Weisz, Franz-Josef Neumann, David Metzger, Timothy Henry, David Cox, Peter Duffy, Bruce Brodie, Thomas Stuckey, Ernest Mazzaferri, Ecaterina Cristea, Roxana Mehran, Gregg Stone, Columbia University Medical Center / New York-Presbyterian Hospital, New York, NY, Cardiovascular Research Foundation, New York, NY
9:15 2501–15 Panel Discussion
9:20 2501–16 Does Platelet Function Testing Add Significant Incremental risk Stratification to Unselected Patients Undergoing DES Implantation? The ADAPT-DES Study — Ajay J. Kirtane, Helen Parise, Bernhard Witzenbichler, Giora Weisz, Michael Rinaldi, Franz-Josef Neumann, David Metzger, Timothy Henry, David Cox, Peter Duffy, Bruce Brodie, Thomas Stuckey, Ernest Mazzaferri, Ecaterina Cristea, Roxana Mehran, Gregg Stone, Columbia University Medical Center / New York-Presbyterian Hospital, New York, NY, Cardiovascular Research Foundation, New York, NY
9:25 2501–17 Panel Discussion
ACC-i2/TCT
OrAl
2504
PCI in Complex lesionsSunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S103cCME/CNE Hours: 1.5
Co-Chairs: Samin K. Sharma, New York, NY Etsuo Tsuchikane, Toyohashi, Japan
Panelists: Panayiotis Avraamides, Nicosia, Cyprus, Robert Pyo, Bayside, NY, Emmanouil S. Brilakis, Dallas, TX
8:00 2504–6 Year in review — David E. Kandzari, Atlanta, GA
8:15 2504–7 A report from Japanese Multicenter registry Data for Clinical results of retrograde Approach in Percutaneous Coronary Interventions for Chronic Total Occlusions — ATSUNORI OKAMURA, Masahisa Yamane, Makoto Muto, Tsutomu Fujita, Tetsuo matsubara, Yasumi Igarashi, Shigeru Nakamura, Toshiya Muramatsu, Mitsunori Abe, Etsuo Tsuchikane, Toyohashi Heart Center, Toyohashi, Japan, Sakurabashi Watanabe Hospital, Osaka, Japan
8:25 2504–8 Panel Discussion
8:30 2504–9 Natural History of Side Branch Jailed By Drug Eluting Stent — Masahiro Yamawaki, Toshiya Muramatsu, Yasunari Sakamoto, Hideyuki Takimura, Hiroshi Ishimori, Reiko Tsukahara, Saiseikai Yokohama City Eastern, Yokohama, Japan
8:40 2504–10 Panel Discussion
8:45 2504–11 Is Double Stenting the Optimal Treatment for Complex Coronary Bifurcation lesions? — Ricardo A. Costa, Fausto Feres, Rodolfo Staico,
J. Ribamar Costa, Jr, Dimytri Siqueira, Alexandre Abizaid, Luiz F. Tanajura, Amanda Sousa, J. Eduardo Sousa, Antonio Colombo, Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil, EMO GVM Centro Cuore Columbus, Milan, Italy
8:55 2504–12 Panel Discussion
9:00 2504–13 long-term Clinical results of Adverse Outcomes after Drug-eluting Stent Implantation for Bifurcation lesions in a real-World Practice — results from the COBIS (Coronary Bifurcation Stenting) II registry — Jeong Hoon Yang, Pil Sang Song, Young Bin Song, Joo-Yong Hahn, Seung-Hyuk Choi, Jin-Ho Choi, Hyo-Soo Kim, Seung-Woon Rha, Cheol Woong Yu, Jong-Seon Park, Jin-Ok Jeong, Hyeon-Cheol Gwon, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
9:10 2504–14 Panel Discussion
9:15 2504–15 The ESTrOFA-lM registry: Comparison of Paclitaxel-eluting Stents and Everolimus-eluting Stents in left Main Coronary Artery Disease — results at 3-years Follow-up — Jose de la Torre Hernandez, Angel Sanchez-Recalde, Bruno Garcia del Blanco, Manuel Jimenez Navarro, Federico Gimeno, Ramon Calvino, Neus Salvatella, Tamara Garcia Camarero, Felipe Hernandez, Fernando Rivero, Jose Moreu, Jose R. Rumoroso, Francisco Bosa, Monica Masotti, Victoria Martin, Juan A. Bullones, Arsenio Gallardo, Jose A. Fernandez Diaz, Victor Aragon, ESTROFA study group, Spain, Spain
9:25 2504–16 Panel Discussion
ACC-i2/TCT
OrAl
2505
PCI in Complex PatientsSunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S102cCME/CNE Hours: 1.5
Co-Chairs: Carlo Di Mario, London, United Kingdom Corrado Tamburino, Catania, Italy
Panelists: William S. Weintraub, Newark, DE, Brian P. O’Neill, Miami, FL, Eugenia Nikolsky, Haifa, Israel
8:00 2505–6 Characteristics and Outcomes of Patients Undergoing Percutaneous Coronary Intervention within One-year of Coronary Artery Bypass Grafting Surgery — Mark A. Kotowycz, Anirban Choudhury, Lauren M. Morrison, mark osten, Vladimir Dzavik, Chris Overgaard, Peter Munk Cardiac Centre, University Health Network, Toronto General Hospital, Toronto, Canada
8:10 2505–7 Panel Discussion
8:15 2505–8 CorPath-PrECISE: Final results of the First Pivotal Study for robotically-enhanced PCI — Giora Weisz, Christopher Metzger, Ronald Caputo, Juan Granada, J. Marshall, Mark Reisman, George Vetrovec, Ron Waksman, Jeffrey Moses, Joseph Carrozza, NewYork Presbyterian Hospital - Columbia University Medical Center, New York, NY
8:25 2505–9 Panel Discussion
Sunday, March 25, 2012 • ACC.12
ACC.12 Final Program 139
Morning
8:30 2505–10 Periprocedural Glycemic Control in Patients Undergoing Coronary Angiography and Intervention — Binita Shah, Nicholas Amoroso, Xingchen Mai, Jeffrey Lorin, Ann Danoff, Steven Sedlis, New York University School of Medicine, New York, NY, VA New York Harbor Healthcare System, New York Campus, New York, NY
8:40 2505–11 Panel Discussion
8:45 2505–12 The Impact of Anemia on 6-month Angiographic and 1-year Clinical Outcomes in Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention — Ji Young Park, Seung-Woon Rha, Amro Elnagar, Byoung Geol Choi, sung il Im, Sunwon Kim, Jin Oh Na, Seongwoo Han, Cheol Ung Choi, Hong Euy Lim, Jin Won Kim, Eung Ju Kim, Hong-Seog Seo, Chang Gyu Park, Dong Joo Oh, Cardiology Department, Eulji General Hospital, Seoul, South Korea, Cardiovascular Center, Korea University Guro Hospital, Seoul, South Korea
8:55 2505–13 Panel Discussion
9:00 2505–14 Characteristics, In-Hospital and long-term Clinical Outcomes of Nonagenarian AMI Patients Compared with Octogenarian AMI Patients — Ki Hong Lee, Young Keun Ahn, Myung Ho Jeong, Donghan Kim, Shung Chull Chae, Young Jo Kim, Jei Keon Chae, Myeong Chan Cho, Chong Jin Kim, Chonnam National University Hospital, Gwangju, South Korea, Heart Research Center of Chonnam National University Hospital, Gwangju, South Korea
9:10 2505–15 Panel Discussion
9:15 2505–16 The Effect of Drug-eluting Stents on Clinical and Angiographic Outcomes in renal Failure Patients with Dialysis: Multicenter registry in Asia — Sunao Nakamura, Hisao Ogawa, Jang-Ho Bae, Hans Yeo, Wasan Udayachalerm, Damras Tresukosol, Sudaratana Tansuphaswadikul, New Tokyo Hospital, Chiba, Japan
9:25 2505–17 Panel Discussion
ACC-i2/TCT
OrAl
2508
Intravascular DiagnosticsSunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S106bCME/CNE Hours: 1.5
Co-Chairs: Alexandra J. Lansky, New Haven, CT Jagat Narula, New York, NY
Panelists: Elias Sanidas, New York, NY, Jennifer Yu, New York, NY
8:00 2508–6 Does Aggressive Statin Therapy reduce Coronary Atherosclerotic Plaque lipid Content? results from reduction in YEllow Plaque by Aggressive lipid lOWering Therapy (YEllOW) Trial — Annapoorna Subhash Kini, Pedro Moreno, Jason Kovacic, Atul Limaye, Ziad Ali, Joseph Sweeny, Usman Baber, George Dangas, Samin Sharma, Mount Sinai Medical Center, New York City, NY
8:10 Panel Discussion
8:15 2508–7 The Impact of Sex Differences on Fractional Flow reserve-Guided Percutaneous Coronary Intervention: A FAME Substudy — Hyun-Sook Kim,
Pim Tonino, Bernard De Bruyne, Andy Yong, Jennifer Tremmel, Nico Pijls, William Fearon, Stanford University Medical Center, Palo Alto, CA, Hallym University Sacred Heart Hospital, Anyang, South Korea
8:25 2508–8 Panel Discussion
8:30 2508–9 A New Method for Assessing Neointimal Coverage after Drug-eluting Stent Implantation Using Three-dimensional Optical Coherence Tomography — Byeong-Keuk Kim, Jinyong Ha, Jung-Sun Kim, Dong-Ho Shin, Young-Guk Ko, Donghoon Choi, Yangsoo Jang, Myeong-Ki Hong, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, South Korea
8:40 2508–10 Panel Discussion
8:45 2508–11 Coronary Computed Tomographic Angiography Morphologic Characteristics of lipid-core Plaques Identified by Intracoronary Near-infrared Spectroscopy — James L. Smith, Ryan Madder, A Neil Bilolikar, Simon Dixon, James Goldstein, William Beaumont Hospital, Royal Oak, MI, Spectrum Health, Grand Rapids, MI
8:55 2508–12 Panel Discussion
9:00 2508–13 Spectroscopic Detection of Fibrous Cap Thickness Overlying lipid Core Coronary Plaques with a Catheter-Based Near-infrared Spectroscopy System — Sean Madden, Joel Raichlen, James Muller, Infraredx, Inc., Burlington, MA
9:10 2508–14 Panel Discussion
9:15 2508–15 Impact of Early and late Stent Malapposition on long-term Clinical Outcomes: Three-year Follow-up from the HOrIZONS-AMI IVUS Sub-study — Tadayuki Yakushiji, Gary Mintz, Bernhard Witzenbichler, Giulio Guagliumi, Ecaterina Cristea, Ovidiu Dressler, Roxana Mehran, Gregg Stone, Akiko Maehara, Cardiovascular Research Foundation, New York, NY
9:25 2508–16 Panel Discussion
ACC-i2/TCT
OrAl
2510
Vascular AccessSunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S103bCME/CNE Hours: 1.5
Co-Chairs: Mehdi H. Shishehbor, Cleveland, OH Robert J. Applegate, Winston-Salem, NC
Panelists: Jason H. Rogers, Sacramento, CA, Alexios P. Dimas, Athens, Greece, Samir B. Pancholy, Chinchilla, PA
8:00 2510–6 Year in review — Zoltan G. Turi, Camden, NJ
8:15 2510–7 Economic Impact of Transradial Percutaneous Coronary Intervention — David M. Safley, Dmitri Baklanov, Rebecca Mills, John House, Steven Marso, Saint Luke’s Mid America Heart Institute, Kansas City, MO, University of Missouri - Kansas City, Kansas City, MO
8:25 2510–8 Panel Discussion
8:30 2510–9 Adequate Screening Can reduce radial Access Failure rates in ST-Elevation Myocardial Infarction Patients Undergoing Primary
ACC.12 • Sunday, March 25, 2012
140 GO for ACC.12!
Mor
ning
Percutaneous Coronary Intervention — Jean-Pierre Dery, Marie-Pier Bouchard, Ugo Dery, Melanie Roy, Josep Rodes-Cabau, Stephane Rinfret, Eric Larose, Gerald Barbeau, Jacques Rouleau, Louis Roy, Bernard Noel, can nguyen, Onil Gleeton, Guy Proulx, Jean-Rock Boudreault, Robert DeLa Rochellière, Sunil Rao, Olivier Bertrand, Quebec Heart and Lung Institute, Quebec City, Canada, Duke University Clinical Research Institute, Durham, NC
8:40 2510–10 Panel Discussion
8:45 2510–11 risk of Brain Injury related to Silent Cerebral Embolization during Diagnostic Coronary Angiography: Direct Comparison between right radial and left radial Approach — Andrea Pacchioni, Antonio Mugnolo, Carlo Penzo, Dimitrios Nikas, Salvatore Saccà, Luca Favero, Bernhard Reimers, Francesco Versaci, Divisione di Cardiologia, Ospedale Civile, Mirano, Italy
8:55 2510–12 Panel Discussion
9:00 2510–13 large-bore Common Femoral Arterial Access Using Fluoroscopic Guidance with Computed Tomographic Angiography Overlay: Safe Entry and Exit — Bryce Einhorn, Chad Kliger, Vladimir Jelnin, Leandro Maranan, Howard Cohen, Itzhak Kronzon, Carlos Ruiz, Lenox Hill Heart and Vascular Institute, New York, NY
9:10 2510–14 Panel Discussion
9:15 2510–15 Major Bleeding Impacts Death Following Percutaneous Coronary Intervention: Insights from the NCDr® — Adnan Chhatriwalla, Amit Amin, kevin kennedy, John House, Sunil Rao, John Messenger, David Cohen, Steven Marso, Saint Luke’s Mid America Heart Institute, Kansas City, MO
9:25 2510–16 Panel Discussion
ACC-i2/TCT
SYMPOSIUM
2614
Abnormalities of the AtriumSunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S102bCME/CNE Hours: 1.5
Co-Chairs: Jonathan M. Tobis, Los Angeles, CA Maurice Buchbinder, La Jolla, CA
8:00 Conditions Associated with PFO — Speaker TBD
8:15 Pros and Cons of Closure for Stroke — Anthony Furlan, Cleveland, OH
8:30 Pros and Cons of Closure for Migraine with Aura — Jonathan Tobis, Los Angeles, CA
8:45 lAA Device Closure PrO: Preferred Therapy for AF — Ken Huber, Kansas City, MO
9:00 lAA Device Closure CON: It Should Not be Done — Sanjay Kaul, Los Angeles, CA
9:15 Panel Discussion
ACS
ExPErTS
221
Complications of AMISunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S504aCME/CNE Hours: 1.5
Chair: Prediman K. Shah, Los Angeles, CA
Case Presenter: Steven M. Stevens, Los Angeles, CA
Panelists: Judith S. Hochman, New York, NY, Roger J. Laham, Boston, MA, Melchior Seyfarth, Muenchen, Germany, Holger Thiele, Leipzig, Germany
ACS
OrAl
916
What Impacts Outcomes in ACS? From Genes to Plaque Morphology to Environment.Sunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S401aCME/CNE Hours: 1.5
Co-Chairs: Venu Menon, Cleveland, OH Doron Zahger, Beer Sheva, Israel
8:00 916–3 The Year in review — Robert P. Giugliano, Boston, MA
8:15 916–4 Characteristics and Clinical Significance of Angiographically Mild lesions in ACS: Insights from the PrOSPECT Study — Sorin J. Brener, Gary Mintz, Ecaterina Cristea, Giora Weisz, Akiko Maehara, John McPherson, Steven Marso, Naim Farhat, Hans E. Botker, Ovidiu Dressler, Ke Xu, Barry Templin, Zhen Zhang, Alexandra Lansky, Bernard de Bruyne, Patrick Serruys, Gregg Stone, New York Methodist Hospital, Brooklyn, NY, Cardiovascular Research Foundation, New York, NY
8:30 916–5 Timing of Angiography and Clinical Outcomes after Fibrinolysis: A Patient-level Analysis of randomized Early Invasive Clinical Trials — Mina Madan, Mary Tan, Sigrun halvorsen, Cynthia M. Westernout, Warren Cantor, Michel R. Le May, Francesco Borgia, Federico Piscione, Carlo Di Mario, Bruno Scheller, Paul Armstrong, Francisco Fernandez-Aviles, Pedro L. Sanchez, John Graham, Andrew Yan, Shaun Goodman, Sunnybrook Health Sciences Centre, Toronto, Canada, Canadian Heart Research Centre, Toronto, Canada
8:45 916–6 The Effects of Hurricane Katrina on Acute Myocardial Infarction Five Years after the Storm — John Moscona, Sumit Tiwari, Kartik Munshi, Sudesh Srivastav, Patrice Delafontaine, Anand Irimpen, Tulane University Heart and Vascular Institute, New Orleans, LA
9:00 916–7 Coronary Plaque Characteristics in Patients with Diabetes Mellitus Who Presented with Acute Coronary Syndrome: Optical Coherence Tomography Study — Jingbo Hou, Lei Xing, Haibo Jia, zhigang han, Shuang Yang, Lingbo Meng, Koji Kato, Tiashi Yonetsu, Soo Joong Kim, Hang Lee, Shaosong Zhang, Yu Bo, Ik-Kyung Jang, Department of Cardiology, 2nd Affiliated Hospital of Harbin Medical University, Harbin, People’s Republic of China, Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA
9:15 916–8 Telomere length and Cardiovascular Outcomes — Christian T. Ruff, Jessica Mega, David
Sunday, March 25, 2012 • ACC.12
ACC.12 Final Program 141
Morning
Morrow, Benjamin Scirica, Edward C. Frackelton, Hakon Hakonarson, Kevin Crowley, Charles Contant, Christopher Cannon, Eugene Braunwald, Marc Sabatine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
Arr
ExPErTS
222
Joint Symposium of the Heart rhythm Society and the American College of Cardiology: Genetic Syndromes for the Clinician (HCM, Brugada, long QT)Sunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S503CME/CNE Hours: 1.5
Chair: Jeffrey A. Towbin, Cincinnati, OH
Panelists: Michael J. Ackerman, Rochester, MN, Bernard J. Gersh, Rochester, MN, Arthur J. Moss, Rochester, NY
Arr
OrAl
904
Joint Oral Arrhythmias Session of the Heart rhythm Society and the American College of Cardiology: Management of the Patient with Atrial Fibrillation — Anticoagulation and Prevention of Stroke — Sunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N426CME/CNE Hours: 1.5
Co-Chairs: Anne M. Gillis, Calgary, Canada Julia H. Indik, Tucson, AZ
8:00 904–3 The Year in review — Anne M. Gillis, Calgary, Canada
8:15 904–4 Stroke risk in Post-menopausal Women with Atrial Fibrillation in the Women’s Health Initiative: A Validation and Comparison of the CHADS2 and CHA2DS2-VASc risk Scores — JoEllyn Carol Moore M. Abraham, Sylvia Wassertheil-Smoller, Joseph Larson, Mina Chung, J. D. Curb, Anne Curtis, Kamakshi Lakshminarayan, Jonathan Newman, Marco Perez, Kathryn Rexrode, Nawar Shara, Allen Solomon, Marcia L. Stefanick, James C. Torner, Bruce Wilkoff, Cleveland Clinic, Cleveland, OH, Women’s Health Initiative, Bethesda, MD
8:27 904–5 The CHA2DS2-VASc Score Identifies AF Patients with A CHADS2 Score of 0 or 1 Treated with Antiplatelet Therapy Who Are Unlikely to Benefit from Oral Anticoagulant Therapy — Michiel Coppens, John Eikelboom, Robert Hart, Salim Yusuf, Gregory Lip, Paul Dorian, Olga Shestakovska, Stuart Connolly, Population Health Research Institute, McMaster University, Hamilton, Canada
8:39 904–6 Dabigatran and Myocardial Infarction, Drug or Class Effect: Meta-Analysis of randomized Trials with Oral Direct Thrombin Inhibitors — Ramin Artang, Eric Rome, Humberto Vidaillet, University of Nebraska Medical Center, Omaha, NE, Marshfield Clinic, Marshfield, WI
8:51 904–7 Bleeding with Aspirin and Apixaban in Patients Unsuitable for Vitamin K Antagonist Therapy: The AVErrOES Study — Greg C. Flaker, John Eikelboom, Stuart Connolly, Salim Yusuf, Gregory Lip, Robert Hart, University of Missouri,
Columbia, MO, McMaster University and Hamilton Health Scineces, Hamilton, Canada
9:03 904–8 Evaluation of recombinant Activated Factor Vii, Prothrombin Complex Concentrate and Fibrinogen Concentrate to reverse Apixaban in a rabbit Model — Martin Anne-Céline, Le-Bonniec Bernard, Lecompte thomas, Fischer Anne-Marie, Emmerich Joseph, Samama Charles marc, Godier Anne, HIA val de grâce, Paris, France, INSERM 765, Paris, France
9:15 904–9 Efficacy and Safety of Apixaban Compared with Warfarin According to CHADS2 and HASBlED risk Scores for Stroke Prevention in Atrial Fibrillation — Renato D. Lopes, Sana Al-Khatib, Lars Wallentin, Hongqiu Yang, Jack Ansell, J. Donald Easton, Cetin Erol, Justin Ezekowitz, Bernard Gersh, Stefan Hohnloser, Elaine Hylek, Cecilia Bahit, John Horowitz, Raffaele De Caterina, Puneet Mohan, Dragos Vinereanu, Christopher Granger, John Alexander, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC
CCS
SYMPOSIUM
634
Preoperative Assessment of Patients on the Single Ventricle Pathway: Special Problems, Creative SolutionsSunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N231CME/CNE Hours: 1.5
Co-Chairs: John F. Rhodes, Durham, NC Mark Scheurer, Charleston, SC
8:00 Case Presentation — Joshua Kanter, DC
8:10 Pre-Glenn Assessment in the Current Era: Significance of the Sano and Hybrid Stage 1 Modifications — Henri Justino, Houston, TX
8:30 Systemic-to-Pulmonary Arterial Collaterals: Do They Matter and What Should We Do About Them? — Mathew Gillespie, Philadelphia, PA
8:50 Considerations in Single Ventricle Patients with Heterotaxy — Doff B. McElhinney, Boston, MA
9:10 Non-Invasive Pre-Glenn and Pre-Fontan Assessment: When Is Catheterization Not Indicated? — David W. Brown, Boston, MA
HF
SYMPOSIUM
635
Joint Symposium of the Heart Failure Society of America and the American College of Cardiology: Contemporary Pharmacological Treatment of Systolic and Diastolic Heart FailureSunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S406bCME/CNE Hours: 1.5
Co-Chairs: William H. Gaasch, Burlington, MA Dennis M. McNamara, Pittsburgh, PA
8:00 Stage A — Thomas J. Wang, Boston, MA
8:20 Stage B — Marvin A. Konstam, Boston, MA
8:40 Stage C — Barry H. Greenberg, San Diego, CA
9:00 HF-PEF — Michael R. Zile, Charleston, SC
9:20 Question and Answer
ACC.12 • Sunday, March 25, 2012
142 GO for ACC.12!
Mor
ning
IMAG
ExPErTS
223
Cardiac PET: Incorporation into Daily PracticeSunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S505CME/CNE Hours: 1.5
Chair: Sharmila Dorbala, Boston, MA
Case Presenter: Ritesh Dhar, Detroit, MI
Panelists: Karthikeyan Ananthasubramaniam, West Bloomfield, MI, Timothy M. Bateman, Kansas City, MO, Rob S. B. Beanlands, Ottawa, Canada, Panithaya Chareonthaitawee, Rochester, MN, Marcelo F. Di Carli, Boston, MA
IMAG
OrAl
907
Joint Oral Session of the American Society of Echocardiography and the American College of Cardiology: Newest Applications of Echo to Clinical PracticeSunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S406aCME/CNE Hours: 1.5
Co-Chairs: Theodore P. Abraham, Baltimore, MD Susan E. Wiegers, Philadelphia, PA
8:00 907–3 The Year in review – Imaging — Jonathan R. Lindner, Portland, OR
8:15 907–4 Diastolic Function and Survival in Patients with Severe Aortic Stenosis and Normal left Ventricular Ejection Fraction — Omar Khalique, Yat Wa Li, Robert Belkin, MD, Wilbert Aronow, Cesare Russo, Chul Ahn, Mala Sharma, Columbia University Medical Center, New York, NY, New York Medical College, Valhalla, NY
8:30 907–5 Deformation Imaging Is an Independent Predictor of Outcomes in Asymptomatic Aortic Stenosis with Normal Ejection Fraction — Teerapat Yingchoncharoen, Gibby Conrad, Brian Griffin, L. Leonardo Rodriguez, Richard Grimm, Thomas Marwick, Cleveland Clinic, Cleveland, OH
9:00 907–7 Activation Imaging: A Novel Approach to Three-dimensional Mechanical Mapping Using Speckle Tracking Strain — Toshinari Onishi, Tetsuari Onishi, Mohamed Ahmed, Josef Marek, Samir Saba, David Schwartzman, John Gorcsan, University of Pittsburgh, Pittsburgh, PA
9:15 907–8 Accurate Quantification of Chronic Mitral regurgitation by Automated True 3-D Proximal Isovelocity Surface Area Using real-Time Volume Color Flow Doppler Transthoracic Echocardiography: In Vitro and Clinical Validation — Paaladinesh Thavendiranathan, Shizhen Liu, Saurabh Datta, Thomas Ryan, Stephen Igo, Matthew S. Jackson, Nathalie De Michelis, Stephen Little, Mani Vannan, The Ohio State University, Columbus, OH, The Methodist DeBakey Heart & Vascular Center, Houston, TX
lIFElONG
SYMPOSIUM
731
CCA Team-Based Maintenance of CertificationSunday, March 25, 2012, 8:00 a.m. – 10:30 a.m.McCormick Place South, S105dCME/CNE/CPE Hours: 2.5 ACPE No. 0012-9999-12-080-l04-P
Chair: Jane A. Linderbaum, Rochester, MN
Co-Chair: Michael G. Clark, Bedford, TX
MOC Faculty: Rhonda M. Cooper-DeHoff, Gainesville, FL, Eileen M. Handberg, Gainesville, FL
PHTN
OrAl
912
What’s New in Pulmonary HypertensionSunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N226CME/CNE Hours: 1.5
Co-Chairs: Gautam V. Ramani, Baltimore, MD Stacy Mandras, New Orleans, LA
8:00 912–3 The Year in review — Pulmonary Hypertension — Michael A. Mathier, Pittsburgh, PA
8:15 912–4 Effect of Obesity on Mortality in Pulmonary Arterial Hypertension: A retrospective Analysis — Marwan Badri, Wajeeha Saeed, Ankush Lahoti, Jason Salamon, Eric Gnall, Ronald Zolty, Rizwan Sardar, Lankenau Medical Center, Wynnewood, PA, Montefiore Medical Center, New York, NY
8:30 912–5 Does Obesity Affect Brain Natriuretic Peptide levels in Patients with Pulmonary Arterial Hypertension? — Omar Batal, Kyle Buchanan, Andrea Elliott, Jonathon Wertz, Matthew Lander, Anthi Katsouli, David Ishizawar, Michael Mathier, Angel Lopez-Candales, University of Pittsburgh Medical Center, Pittsburgh, PA
8:45 912–6 Prognostic Factors in Pulmonary Hypertension: The Obesity Paradox — Barak Zafrir, Waseem Shehadeh, Nabia Salman, Yochai Adir, Offer Amir, Lady Davis Carmel Medical Center, Haifa, Israel, Lin Medical Center, Haifa, Israel
9:00 912–7 The Prognostic Ability of Pulmonary Arterial Capacitance Exceeds that of Pulmonary Vascular resistance in Advanced left-sided Heart Failure — Matthias Dupont, Wilfried Mullens, Yuping Wu, Wai Hong Tang, Cleveland Clinic Foundation, Cleveland, OH, Cleveland State University, Cleveland, OH
9:15 912–8 Impaired Global right Ventricular longitudinal Strain Predicts long-term Adverse Outcomes in Patients with Primary Pulmonary Hypertension — Jae-Hyeong Park, Margaret Park, Samar Farha, Jacqueline Sharp, Erika Lundgrin, Suzy Comhair, Wai Hong Tang, Serpil C. Erzurum, James Thomas, Cleveland Clinic, Cleveland, OH
PrEV
OrAl
911
Prevention: Focus on lipidsSunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S100cCME/CNE Hours: 1.5
Co-Chairs: James A. De Lemos, Dallas, TX Neil Stone, Winnetka, IL
8:00 911–3 The Year in review — Prevention — Christie M. Ballantyne, Houston, TX
Sunday, March 25, 2012 • ACC.12
ACC.12 Final Program 143
Morning
8:12 911–4 Safety Profile of Statin-Treated Patients with lDl-C < 30mg/dl — Brendan Everett, Samia Mora, Joseph Grossbard, Jean MacFadyen, Paul Ridker, Brigham and Women’s Hospital, Boston, MA, Harvard Medical School, Boston, MA
8:25 911–5 The Effects of Co-administering a Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease, rEGN727/SAr236553, with 10 and 80 mg Atorvastatin Compared to 80 mg Atorvastatin Alone in Patients with Primary Hypercholesterolemia (NCT: 01288469) — Eli M. Roth, James McKenney, Corinne Hanotin, Gaelle Asset, Evan Stein, Sanofi-aventis US, Inc, Bridgewater, NJ, Regeneron Pharmaceuticals, Inc, Tarrytown, NY
8:38 911–6 lack of Association between Polymorphisms in the SLCO1B1 Gene and Clinical Myalgia following rosuvastatin Therapy — Jacqueline Suk Danik, Jean MacFadyen, Fredrik Nyberg, Paul Ridker, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, AstraZeneca, MoIndal, Sweden
8:51 911–7 The Association between lower levels of low-density lipoprotein Cholesterol and Cancer Predates the Diagnosis of Cancer by 18 Years — Paul Michael Lavigne, Haseeb Jafri, Richard Karas, Tufts Medical Center, Boston, MA, Johns Hopkins University, Baltimore, MD
9:04 911–8 lipid Transfer to High Density lipoproteins in Type 2 Diabetic Patients with and without Coronary Artery Disease — Marília C O Sprandel, Whady Hueb, Antonio Casella-Filho, Alexandre Segre, Paulo Cury Rezende, Ana L O Carvalho, Desiderio Favarato, Raul C. Maranhão, Jose Ramires, Roberto Kalil-Filho, Heart Institute University of Sao Paulo, Sao Paulo, Brazil
9:17 911–9 The Effect of Statins on Skeletal Muscle Function — Beth A. Parker, Jeffrey A. Capizzi, Adam Grimaldi, Donna Polk, Priscilla M. Clarkson, Stephanie M. Cole, Justin Keadle, Stuart Chipkin, Linda S. Pescatello, Kathleen Simpson, C. Michael White, Paul Thompson, Hartford Hospital, Hartford, CT
9:30 911–10 ETC-1002 lowers lDl-C and Beneficially Modulates Other Cardio-Metabolic risk Factors in Hypercholesterolemic Subjects with Either Normal or Elevated Triglycerides — Christie M. Ballantyne, Michael Davidson, Diane MacDougall, Janice Margulies, Lorenzo DiCarlo, Roger Newton, Baylor College of Medicine, Houston, TX, Esperion Therapeutics, Inc., Plymouth, MI
QUAl
ExPErTS
224
Tools to Improve Care Transition: The Hospital to Home (H2H) ExperienceSunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S501aCME/CNE Hours: 1.5
Chair: Harlan M. Krumholz, New Haven, CT
Case Presenter: John E. Brush, Norfolk, VA
Panelists: Larry A. Allen, Aurora, CO, Ileana L. Pina, Cleveland Heights, OH, Adrian F. Hernandez, Durham, NC, Mary N. Walsh, Indianapolis, IN
QUAl
OrAl
913
Insights and Innovations to Improve Cardiac riskSunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N229CME/CNE Hours: 1.5
Co-Chairs: Thomas M. Maddox, Denver, CO John S. Rumsfeld, Denver, CO
8:00 913–3 The Year in review — Quality of Care — John S. Rumsfeld, Denver, CO
8:15 913–4 Impact of Massachusetts Health reform on Preventable Admissions for the Previously Insured — Karen Joynt, David C. Chan, Ashish K. Jha, Brigham and Women’s Hospital, Boston, MA, Harvard School of Public Health, Boston, MA
8:30 913–5 Total Medical Costs Avoided with Apixaban versus Aspirin Treatment among Atrial Fibrillation Patients Unable or Unwilling to Take Warfarin: Based on the Averroes Trial results — Alpesh N. Amin, Steven Deitelzweig, Yonghua Jing, Dinara Makenbaeva, Daniel Wiederkehr, Jay Lin, John Graham, University of California, Irvine, Orange, CA
8:45 913–6 Immediate Impact of a 10–week Middle School Intervention to Improve Health Behaviors and reduce Cardiovascular risk Factors: Project Healthy Schools in Michigan — Taylor F. Eagle, Roopa Gurm, Cydni Smith, Nicole Corriveau, Jean Du-Russel-Weston, LaVaughn Palma-Davis, Susan Aaronson, Caren Goldberg, Eva Kline-Rogers, Elizabeth Jackson, Kim Eagle, University of Michigan, Ann Arbor, MI
9:00 913–7 Patterns of Early Thienopyridine Use among Contemporary STEMI and NSTEMI Patients in the US: Insights from ACTION registry-Get with the Guidelines — Matthew William Sherwood, Tracy Wang, Matthew Roe, Pankaj Madan, Szu-Po Peng, James de Lemos, Eric Peterson, Stephen Wiviott, Duke University Medical Center, Durham, NC, Brigham and Women’s Hospital/Harvard Medical School, Boston, MA
9:15 913–8 Effectiveness of a Clinical Decision Support System Incorporating a Validated QT Interval Prolongation risk Score for reducing the risk of QT Interval Prolongation in Hospitalized Patients — James Tisdale, Heather Wroblewski, Joanna Kingery, Brian Overholser, Tate N. Trujillo, Richard Kovacs, Purdue University, Indianapolis, IN, Indiana University, Indianapolis, IN
SPECIAl
SPECIAl
304
late-Breaking Clinical Trials IISunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, Hall B, ACC.12 Main TentCME/CNE Hours: 1.5
Co-Chairs: George D. Dangas, New York, NY Robert A. Harrington, Durham, NC
Panelists: Gilles Montalescot, Paris, France, Erik Magnus Ohman, Durham, NC, Philippe Gabriel Steg, Paris, France, Alexander G. Turpie, Dundas, Canada
8:00 Outcomes of Non-Primary PCI at Hospitals with and without On-site Cardiac Surgery: CPOrT-E Trial — Final Medical Outcomes — Thomas Aversano, Johns Hopkins University, Baltimore, MD
ACC.12 • Sunday, March 25, 2012
144 GO for ACC.12!
Mor
ning
8:15 Panel Discussion
8:22 INFUSE-AMI: A 2x2 Factorial, Multicenter, Prospective, randomized Evaluation of Intracoronary Abciximab and Aspiration Thrombectomy in Patients Undergoing Primary PCI for Anterior STEMI — Gregg W. Stone, Akiko Maehara, Bernhard Witzenbichler, Jan Godlewski, Ecaterina Cristea, Helen Parise, Jan Henk Dembrink, Andrzej Ochala, Steven Wolff, Saqib Chowdhary, Magdi El-Omar, Thomas D Neunteuff, D. Christopher Metzger, C. Michael Gibson, Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY
8:37 Panel Discussion
8:44 randomized Comparison of Adding Cilostazol versus Doubling the Dose of Clopidogrel after receiving Percutaneous Coronary Intervention: The HOST-ASSUrE randomized Trial — Kyung Woo Park, Hyo Soo Kim, Hyun-Jae Kang, Bon-Kwon Koo, In-Ho Chae, Seoul National University Hospital, Seoul, South Korea
8:59 Panel Discussion
9:06 A Multifaceted Intervention to Narrow the Evidence-Based Gap in the Treatment of ACS: Main results from the BrIDGE-ACS Cluster randomized Trial — Otavio Berwanger, Helio Guimaraes, Alexandre Cavalcanti, Ligia Laranjeira, Eliana Santucci, Ana Zazula, Uri Flato, Marcos Tenuta, Alessandra Kodama, Elivane Victor, Mariana Carballo, Vera Mira, Luiz Mota, Eric Peterson, Renato Lopes, Research Institute of Cardiac Hospital (HCor), Sao Paulo, Brazil, Brazilian Clinical Research Institute, Sao Paulo, Brazil
9:21 Panel Discussion
SPECIAl
SPECIAl
405
Young Investigators Award Competition: ACCF/Herman K. Gold Young Investigators Award in Molecular and Cellular CardiologySunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S105aCME/CNE Hours: 1.5
Chair: Douglas Sawyer, Nashville, TN
Judges: Michael T. Chin, Seattle, WA Cam Patterson, Chapel Hill, NC
Funding for the ACCF/Herman K. Gold Young Investigator’s Award in Molecular and Cellular Cardiology session was provided by a grant from CVPath Institute and the family of Herman K. Gold
8:00 405–4 Correlation between Circulating Angiogenic Cell Mobilizations and recovery of Coronary Flow reserve in Patients with Acute Myocardial Infarction — Han Saem Jeong, Soon Jun Hong, Jae Hyoung Park, Jong-Ho Kim, Seung Cheol Choi, Chul-Min Ahn, Je Sang Kim, Do-Sun Lim, Department of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Seoul, South Korea
8:15 405–5 Novel role of Anticoagulant Heparan Sulfate in Antithrombin Anti-Inflammatory Signaling — Nicole C. Smits, Dartmouth Medical School, Hanover, NH
8:30 405–6 Protein Kinase-C Beta Activation Contributes to Impaired Endothelial Insulin Signaling in Humans with Diabetes Mellitus — Corey E. Tabit, Sherene M. Shenouda, Monika Holbrook, Alissa A. Frame, Matthew A. Kluge, Mai-Ann Duess, Brian H. Kim, Aaron D. Levit, Aaron Held, James L. Rosenzweig, Neil B. Ruderman, Joseph A. Vita, Naomi M. Hamburg, Boston University School of Medicine, Boston, MA
8:45 405–7 Telethonin Mutations Associated with Brugada Syndrome reduce Cardiac Sodium Currents — Isik Turker, Takeru Makiyama, Takeshi Ueyama, Wataru Shimizu, Minoru Horie, Matteo Watta, Peng-Sheng Chen, Tomohiko Ai, Indiana University, Indianapolis, IN
TEST
OrAl
914
Diagnostic Testing: Sports CardiologySunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S402CME/CNE Hours: 1.5
Co-Chairs: Rachel J. Lampert, New Haven, CT Brian Olshansky, Iowa City, IA
8:00 914–3 The Year in review — Diagnostic Testing: Sports — Barry J. Maron, Minneapolis, MN
8:15 914–4 re-appraisal of Electrocardiogram Interpretation in Young Athletes: Should Axis Deviation and Voltage Criterion for Atrial Enlargement Be Catergorised as Abnormal in Athletes — Sabiha Gati, Saqib Ghani, Abbas Zaidi, Nabeel Sheikh, Michael Papadakis, nicolene van nierkerk, lucia chen, matthew reed, Sanjay Sharma, St. George’s University, London, United Kingdom
8:30 914–5 left Ventricular Dimensions Derived by Echocardiography Correlate with Body Mass Index in a large Population of Multiethnic Athletes Screened in the Texas Adolescent Athlete Heart Screening registry (TAAHSr) — Silvana M. Lawrence, Harold W. Kohl, III, Patrick W. Austin, Kim A. Frost, Jennifer Y. Hutchings, Arnold Fenrich, Eva M. Garcia, James Guerrero, George P. Rodgers, Baylor College of Medicine, Houston, TX, Championship Hearts Foundation, Austin, TX
8:45 914–6 Global longitudinal Strain by Speckle Tracking in Middle Aged Athletically Trained Subjects with ECG repolarization Abnormalities during Exercise Stress Test — Emilia E. D’Elia, Silvia Celada, Daniele Poggio, Valentina Casali, Carla Auguadro, Giuseppe Specchia, Monza Polyclinic, Monza, Italy
9:00 914–7 Do We Need Ethnicity-Specific Guidelines for Pre-participation Screening of Athletes? — Nabeel Sheikh, Michael Papadakis, Saqib Ghani, Abbas Zaidi, Sabiha Gati, Navin Chandra, Rachel Bastiaenen, Lynne Millar, Noel Emmanuel, Sanjay Sharma, St. George’s University of London, London, United Kingdom
Sunday, March 25, 2012 • ACC.12
ACC.12 Final Program 145
Morning
9:15 914–8 The Impact of Exercise Training on left Ventricular Torsion is Sport-Specific: A New Twist on the Morganroth Hypothesis — Rory B. Weiner, Adolph Hutter, Gregory Lewis, Francis Wang, Brant Berkstresser, Thomas Wang, Michael Picard, Aaron Baggish, Massachusetts General Hospital, Boston, MA, Harvard University Health Services, Cambridge, MA
VAlV
OrAl
915
Valvular OralSunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N427CME/CNE Hours: 1.5
Co-Chairs: Joseph Maalouf, Rochester, MN David Messika-Zeitoun, Paris, France
8:00 915–3 The Year in review – Valvular — Maurice Enriquez-Sarano, Rochester, MN
8:15 915–4 Transcatheter Aortic Valve Implantation (TAVI) in Patients with low-Flow, low-Gradient Aortic Stenosis — Alexander Lauten, Ralf Zahn, Jochen Senges, Hans R. Figulla, on behalf of the German Transcatheter Aortic ValveInterventions-Registry Investigators, University Heart Center Jena, Department of Cardiology, Jena, Germany, Institut fuer Herzinfarktforschung, Ludwigshafen, Germany
8:30 915–5 long-term Survival following Aortic Valve replacement among High-risk Elderly Patients in the United States: Insights from the STS Adult Cardiac Surgery Database, 1991 - 2007 — J. Matthew Brennan, Fred Edwards, Yue Zhao, Sean O’Brien, Pamela Douglas, eric D. peterson, Duke Clinical Research Institute, Durham, NC
8:45 915–6 Predictive Factors and Clinical Consequences of Persistent left Bundle Branch Block following Transcatheter Aortic Valve Implantation with a Balloon-expandable Valve — Marina Urena, Michael Mok, Luis Nombela-Franco, Robert DeLarochellière, Daniel Doyle, Eric Larose, Ignacio Ignacio Amat-Santos, Mélanie Côté, Philippe Pibarot, François Philippon, Eric Dumont, Josep Rodés-Cabau, Laval Heart&Lung Institute, Québec, Canada
9:00 915–7 Prognostic Value of Brain Natriuretic Peptide in Elderly Patients with Aortic Stenosis (The COFrASA-GENErAC Study) — Claire Cimadevilla, Caroline Cueff, Nadia Berjeb, Bernard Iung, Alex Vahanian, David Messika-Zeitoun, Bichat Hospital, Paris, France
9:15 915–8 Aortic Valve Calcium Score by Computed Tomography in Predicting Perivalvular Aortic Insufficiency Post Transcatheter Aortic Valve Implantation (TAVI) — Junsoo Alex Lee, Tania Singh, Itsik Ben Dor, Rebecca Torguson, Petros Okubagzi, Lowell Satler, Steven Goldstein, Allen Taylor, William Guy Weigold, Augusto Pichard, Zuyue Wang, Gaby Weissman, Ron Waksman, Washington Hospital Center, Washington, DC, Georgetown University Hospital, Washington, DC
VAlV
SElF-DIrECTED
1502
Heart Songs at ACC.12: A Self-Paced Multimedia learning ExperienceSunday, March 25, 2012, 9:00 a.m. – 5:00 p.m.McCormick Place, Vista Room LobbyCME/CNE Hours: 2
Back by popular demand is the highly rated Heart Songs Self-Paced Learning Lab — a unique audio-visual program to refresh cardiac auscultation skills. After a pre-test, attendees will listen to Heart Sounds while viewing phonocardiograms, echoes, and more, on an iPod® Touch, iPad® or laptop computer. Attendees can view the sessions and take both the pre-test and post-test on their own device, or use devices provided in the room, to document improvement in their auscultation skills. This clinical skills workshop provides attendees with a choice of three sessions: the first on 5 common heart murmurs and the second on more advanced sounds including bicuspid aortic valve, mitral valve prolapse and hypertrophic cardiomyopathy, among others. The third session is for experts on topics such as combined aortic stenosis and regurgitation; and combined mitral stenosis and regurgitation. In addition, there will be a 3-D echo/auscultation training program available in the Self-Paced Learning Lab. This video program will combine 3-D echo images with the auscultation findings on 4 common valvular abnormalities. Studies have shown that the range of repetition needed to acquire auditory skills can vary four fold. This workshop will tailor the learning to each individual’s need for repetition. Each session takes approximately 30 minutes to complete. This workshop will appeal to cardiovascular specialists and cardiac care team members who want to improve their auscultation skill in both common and more advanced heart sounds.
Co-Chairs: Michael J. Barrett, Blue Bell, PA Larry E. Jacobs, Allentown, PA Andrew M. Freeman, Denver, CO Tyler Seto, Los Angeles, CA Bruce A. Feldman, Allentown, PA
ACC-i2/TCT
OrAl
2503
Bioresorbable Vascular ScaffoldsSunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place South, S106bCME/CNE Hours: 1.5
Co-Chairs: Ron Waksman, Washington, DC Patrick Serruys, Rotterdam, Netherlands
Panelists: Alaide Chieffo, Milan, Italy, Juan Granada, Orangeburg, NY
10:45 2503–6 The Year in review — Patrick W. Serruys, Rotterdam, Netherlands
11:00 2503–7 Comparisons of Safety Profile between Durable and Biodegradable Polymer Based Drug- eluting Stents in Porcine Coronary Artery Model — Takeshi Ijichi, Gaku Nakazawa, Toshiro Shinke, Daisuke Matsumoto, Hiromasa Otake, Sho Torii, Ayako Yoshikawa, Junya Shite, Yuji Ikari, Tokai University School of Medicine, Isehara, Kanagawa, Japan
11:10 2503–8 Panel Discussion
ACC.12 • Sunday, March 25, 2012
146 GO for ACC.12!
Mor
ning
11:10 2503–9 Differential Vascular Healing Patterns with rapid Absorption Biodegradable Polymer Sirolimus-eluting Stents versus Durable Polymer Everolimus-eluting Stents — Tomohisa Tada, Robert Byrne, Rezarta Cuni, Lamin King, Michael Joner, Albert Schomig, Adnan Kastrati, Deutsches Herzzentrum Munchen, Munich, Germany
11:20 2503–10 Panel Discussion
11:25 2503–11 First Sequential Assessment at 6-months and 2-years of the 2nd Generation Absorb Everolimus-eluting Bioresorbable Scaffold: A Multi-Imaging Modality Study — Yoshinobu Onuma, Cecile Dorange, Karine Miquel-Hebert, Patrick W. Serruys, the ABSORB B investigators, Thorax centre, Rotterdam, The Netherlands, Abbott Vascular Belgium, Diegem, Belgium
11:35 2503–12 Panel Discussion
11:45 2503–13 Vascular response of the Segments Adjacent to the Proximal and Distal Edges of the ABSOrB Everolimus-eluting Bioresorbable Vascular Scaffold: 6-months and 1-year Follow-up Assessment: A Serial Intravascular Ultrasound radiofrequency Data Analysis from the First in Man ABSOrB Cohort B Trial — Bill D. Gogas, Patrick W. Serruys, Vasim Farooq, Salvatore Brugaletta, Maria Radu, Jung Ho Heo, Robert Jan M. van Geuns, Evelyn Regar, Bernard de Bruyne, Bernard Chevalier, Leif Thuesen, Jacques Koolen, Stefan Windecker, Karine Miquel-Hebert, Cecile Dorange, Richard Rapoza, John Ormiston, Thoraxcenter, Erasmus University Medical Center, Rotterdam, The Netherlands
11:55 2503–14 Panel Discussion
12:00 2503–15 Evaluation of the ABSOrB Everolimus-eluting Bioresorbable Vascular Scaffold (ABSOrB BVS) in the Treatment of Patients with de Novo Native Coronary Artery lesions: 2-year Clinical results of ABSOrB Cohort B Trial — Dariusz Dudek, Jagiellonian University Medical College, Krakow, Poland
12:10 2503–16 Panel Discussion
ACC-i2/TCT
OrAl
2506
Drug-eluting StentsSunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place South, S101aCME/CNE Hours: 1.5
Co-Chairs: Andreas M. Zeiher, Frankfurt, Germany Gennaro Sardella, Rome, Italy
Panelists: Didier Carrie, Toulouse, France, Ozgen Dogan, Brooklyn, NY
10:45 2506–6 The Year in review — Matthew J. Price, La Jolla, CA
11:00 2506–7 longitudinal Stent Deformation: Quantitative Coronary Angiographic Analysis from the Perseus WH and Platinum WH randomized Controlled Clinical Trials — Dean J. Kereiakes, Louis Cannon, David Kandzari, Carey Kimmelstiel, Ian Meredith, Jeffrey Popma, Gregg Stone, Paul Teirstein, Stefan Verheye, Dominic Allocco, Keith Dawkins, Christ Hospital Heart & Vascular Center/
Lindner Center for Research & Education at The Christ Hospital, Cincinnati, OH
11:10 2506–8 Panel Discussion
11:15 2506–9 Stent Thrombosis: Insights on Outcomes, Predictors and Impact of Dual Antiplatelet Therapy Interruption from the SPIrIT II, SPIrIT III, SPIrIT IV and COMPArE Trials — Elvin Kedhi, Gregg Stone, Dean Kereiakes, Patrick Serruys, Helen Parise, Martin Fahy, Charles Simonton, Krishnan Sudhir, Poornima Sood, Pieter Smits, Maasstad Hospital, Rotterdam, The Netherlands
11:25 2506–10 Panel Discussion
11:30 2506–11 Definite and Probable Stent Thrombosis after revascularization with Everolimus- and Sirolimus-eluting Stents: From the SOrT OUT IV Trial — Lisette Okkels Jensen, Per Thayssen, Michael Maeng, Hans-Henrik Tilsted, Anne Kaltoft, Knud Hansen, Evald Christiansen, Anders Junker, Jan Ravkilde, Leif Thuesen, Jens Lassen, Odense University Hospital, Odense, Denmark
11:40 2506–12 Panel Discussion
11:45 2506–13 Two-year results of the PlATINUM randomized Trial Comparing Platinum Chromium PrOMUS Element and Cobalt Chromium PrOMUS/xIENCE V Everolimus-eluting Stents in de Novo Coronary Artery lesions — Gregg W. Stone, Paul Teirstein, Ian Meredith, Alain Bouchard, Didier Carrié, Helge Möllmann, Keith Oldroyd, Jack Hall, Dominic Allocco, Keith Dawkins, Columbia University Medical Center, New York, NY
11:55 2506–14 Panel Discussion
12:00 2506–15 Ten-year Follow-up of the Desire registry: A Single-center Perspective on Drug-eluting Stents a Decade later — José de Ribamar Costa, Amanda Sousa, Adriana Moreira, Ricardo Costa, Manuel Cano, Galo Maldonado, Bruno Palmieri, J. Eduardo Sousa, Hospital do Coração, Sao Paulo, Brazil
12:10 2506–16 Panel Discussion
ACC-i2/TCT
OrAl
2507
Imaging in TAVrSunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place South, S102cCME/CNE Hours: 1.5
Co-Chairs: Eric Van Belle, F-59037 Lille, France James K. Min, New York, NY
Panelist: Bernhard Reimers, Mirano, Italy
10:45 2507–6 The Year in review — Rebecca T. Hahn, New York, NY
11:05 2507–9 Integrated 3D Echo-x-ray Image Guidance for Structural Heart Interventions — Stacey D. Clegg, James Chen, Ernesto Salcedo, Robert Quaife, John Carroll, University of Colorado Hospital, Aurora, CO
11:15 2507–10 Panel Discussion
11:20 2507–11 reduction of Para-Valvular regurgitation with Post-Dilatation following Balloon-Expandable Transcatheter Aortic Valve replacement — Benoit Daneault, Elana Koss, Rebecca Hahn, Susheel Kodali,
Sunday, March 25, 2012 • ACC.12
ACC.12 Final Program 147
Morning
Mathew Williams, Philippe Genereux, Jean-Michel Paradis, Isaac George, Craig Smith, Jeffrey Moses, Martin Leon, Columbia University Medical Center, New York, NY
11:30 2507–12 Panel Discussion
11:35 2507–13 Differences in Clinical Outcomes Based on Adherence to Valve Sizing Criteria Using 2D Echocardiography or 3D Computed Tomography in Patients Undergoing Transcatheter Aortic Valve Implantation — Nicolo Piazza, Alexander Hill, Gernot Brockmann, Anke Opitz, Domenico Mazzitelli, Yacine Elhmidi, Hendrik Ruge, Sabine Bleiziffer, Rudiger Lange, German Heart Centre, Munich, Germany, Medtronic, Inc., Mounds View, MN
11:45 2507–14 Panel Discussion
11:50 2507–15 regional Apical Motion Abnormality Early after Transapical Aortic Valve replacement: Prevalence and Outcome — Israel Barbash, Itsik Ben-Dor, Danny Dvir, Paul Corso, Steven Boyce, Steven Goldstein, Zuyue Wang, Rebecca Torguson, Ana Laynez Carnicero, Lowell Satler, Augusto Pichard, Ron Waksman, MedStar Health Research Institute, Washington, DC
12:00 2507–16 Panel Discussion
ACC-i2/TCT
OrAl
2509
Prevention and Treatment of restenosisSunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place South, S103cCME/CNE Hours: 1.5
Co-Chairs: Christodoulos Stefanadis, Athens, Greece David J. Moliterno, Lexington, KY
Panelists: Tayo A. Addo, Dallas, TX, Manish Parikh, New York, NY, Emilia Solinas, Italy
10:45 2509–6 The Year in review — Alexandre Abizaid, Sao Paulo, Brazil
11:00 2509–7 Compassionate Use of a Paclitaxel Coated Balloon Catheter in Patients with refractory Coronary In-stent restenosis — Yvonne P. Clever, Bruno Scheller, Michael Böhm, Bodo Cremers, Klinik fuer Innere Medizin III, Universitaetsklinikum des Saarlandes, Homburg/Saar, Germany
11:10 2509–8 Panel Discussion
11:15 2509–9 Sequent Please World Wide registry: Efficacy of Paclitaxel Coated Balloon Angioplasty for Treatment of Drug-eluting Stent restenosis Compared with Bare-metal Stent restenosis — Jochen Woehrle, Wolfgang Motz, Sven Moebius-Winkler, Matthias Leschke, Christian Opitz, Waqas Ahmed, Paul Barragan, Jean-Philippe Simon, Graham Cassel, Luis Elbal, Bruno Scheller, University of Ulm, Ulm, Ghana
11:25 2509–10 Panel Discussion
11:30 2509–11 long-term Quantitative Coronary Angiographic Assessment of Sirolimus-eluting Stents in Very late Target lesion revascularization — David Anthony Burke, Alexandra Almonacid, Jeffrey Popma, Beth Israel Deaconess Medical Center, Boston, MA
11:40 2509–12 Panel Discussion
11:45 2509–13 Statin reduces late Tlr (beyond 1-year) “late Catch-up Phenomenon” as well as early Tlr (within 1-year) after Sirolimus-eluting StentIimplantation: From J-Cypher registry — Yoshihiro Katoh, Masahiro Natsuaki, Yoshihisa Nakagawa, Takeshi Kimura, Saiseikai Noe Hospital, Osaka, Japan, Department of the Cardiology, Kyoto, Japan
11:55 2509–14 Panel Discussion
12:00 2509–15 A Novel Method for Capturing Endothelial Progenitor Cells (EPCs) by Coronary Stents: Application of Vascular Endothelial Growth Factor (VEGF)-bound Platform — Shu Takabatake, Toshinari Tsubokawa, Takehisa Matsuda, Masakazu Yamagishi, Division of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan, Kanazawa Institute of Technology, Kanazawa, Japan
12:10 2509–16 Panel Discussion
ACC-i2/TCT
OrAl
2511
Outcomes in Patients Treated with PCISunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place South, S103bCME/CNE Hours: 1.5
Co-Chairs: Hugo A. Katus, Heidelberg, Germany Jan Kovac, Leicestershire, United Kingdom
Panelists: Issam D. Moussa, Jacksonville, FL, Davide Capodanno, Jacksonville, FL, Germano DiSciascio, Rome, Italy
10:45 Year in review — Laura Mauri, Boston, MA
11:00 2511–7 CrP levels 180 Days after PCI for ACS, but Not Earlier, Predict late Adverse Cardiac Events Independent of Plaque Characteristics: The PrOSPECT Study — Christopher Kelly, Giora Weisz, Akiko Maehara, Gary Mintz, John McPherson, Stefan Verheye, Ke Xu, Martin Fahy, Barry Templin, Bernard De Bruyne, Patrick Serruys, Gregg Stone, NewYork-Presbyterian Hospital / Columbia University Medical Center, New York, NY, Cardiovascular Research Foundation, New York, NY
11:10 2511–8 Panel Discussion
11:15 2511–9 Acute Complications of Non-primary PCI at Hospitals with and without On-site Cardiac Surgery: Cport-E Project — Thomas Aversano, Johns Hopkins University, Baltimore, MD
11:25 2511–10 Panel Discussion
11:30 2511–11 Contemporary Incidence and Predictors of Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Interventions: Insights from the NCDr Cath-PCI registry — Thomas Tsai, Uptal Patel, Tara I. Chang, Kevin F. Kennedy, Frederick Masoudi, Michael Matheny, Mikhail Kosiborod, John Messenger, John Rumsfeld, John Spertus, Denver VA Medical Center / U of Colorado Denver, Denver, CO, Mid America Heart Institute, Kansas City, MO
11:40 2511–12 Panel Discussion
11:45 2511–13 Cost-Effectiveness of Transradial Percutaneous Coronary Intervention:
ACC.12 • Sunday, March 25, 2012
148 GO for ACC.12!
Mor
ning
A Decision-analytic Model — Amit P. Amin, Steven P. Marso, Adnan Chhatriwalla, David Safley, kevin kennedy, John House, Rebecca Mills, Adam Salisbury, John Spertus, David Cohen, Dmitri Baklanov, Mid America Heart Institute, Saint Lukes Hospital, Kansas City, MO
11:55 2511–14 Panel Discussion
12:00 2511–15 The Epidemiology and Outcomes of Percutaneous Coronary Intervention before High-risk Non-cardiac Surgery: Insights from the BMC2 registry — Palaniappan Muthappan, Dean Smith, Herbert Aronow, Kim Eagle, David Wohns, James Fox, David Share, Hitinder Gurm, University of Michigan Cardiovascular Center, Ann Arbor, MI
12:10 2511–16 Panel Discussion
ACC-i2/TCT
SYMPOSIUM
2615
Congenital/PediatricSunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place South, S102bCME/CNE Hours: 1.5
Co-Chairs: Michael J. Landzberg, Boston, MA William E. Hellenbrand, New York, NY
10:45 Spectrum/Overview of Pulmonary Valve Disorders — Jeffrey Meadows, Boston, MA
10:57 Outcomes of Melody Valve Implantation in the rVOT — Doff B. McElhinney, Boston, MA
11:09 Outcomes of Sapien Valve Implantation in the rVOT — Ziyad M. Hijazi, Chicago, IL
11:21 Device Closure of Congenital VSD — Wolfgang A. K. Radtke, Wilmington, DE
11:33 PDA in Children and Adults — Johnn W. M. Moore, San Diego, CA
11:45 Coarctation: Percutaneous Therapy Should be First line — Daniel S. Levi, Los Angeles, CA
11:57 Coarctation: Surgery remains the Preferred Option — Joseph A. Dearani, Rochester, MN
12:09 Panel Discussion
ACS
OrAl
917
Improving Outcomes in ACS. Insights from Basic Science and Preclinical research.Sunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place North, N227bCME/CNE Hours: 1.5
Co-Chairs: Aamer Abbas, El Paso, TX Jesse Currier, Los Angeles, CA
10:45 917–3 Ultrasound-induced Stimulation of Microbubbles reduces Scar Formation and Improves left-ventricular Function after Acute Myocardial Infarction in Mice — Alexander Ghanem, Jonas Dörner, Georg Nickenig, Dept. of Cardiology, Univ. of Bonn, Bonn, Germany
11:00 917–4 Human Umbilical Vein Endothelial Cells Attenuate the left Ventricular remodeling after Acute Myocardial Infarction in rats via a regulation of Matrix Metalloproteinases/Tissue Inhibitor of Metalloproteinases Balance by Endothelial Nitric Oxide Synthase — Young Keun Ahn, Jin-Sook Kwon,
Yong Sook Kim, Ae Shin Cho, Hyang Hee Cho, Jeong Sook Kim, Moon Hwa Hong, Wan Seok Kang, Jang-Whan Bae, Myung Ho Jeong, Myeong-Chan Cho, Chonnam National University Hospital, Gwangju, South Korea, Heart Research Center of Chonnam National University Hospital, Gwangju, South Korea
11:15 917–5 No Association of Paraoxonase-1 Q192r and Thrombotic Events during Dual Anti-platelet Therapy in Patients after Acute Myocardial Infarction — Jeffrey JW Verschuren, Helèn Boden, Judith A. Wessels, B. L. van der Hoeven, Henk-Jan Guchelaar, Martin Schalij, Johan Jukema, Leiden University Medical Center, Leiden, The Netherlands
11:45 917–7 Novel role for Bioactive lipids in Stem Cell Mobilization during Myocardial Ischemia: A Potential Therapeutic Target — Ahmed Abdel-Latif, Anush K. Karapetyan, Khaled Ziada, Manjula Sunkara, Ewa K. Zuba-Surma, Samy Selim, Susan Smyth, Mariusz Z. Ratajczak, Andrew J. Morris, University of Kentucky, Lexington, KY, University of Louisville, Louisville, KY
12:00 917–8 Development of Ultrasound responsive Thrombus-targeting Drug Delivery System for Coronary Thrombolysis — Hiroyuki Kawata, Tsunenari Soeda, Yasuhiro Takemoto, Ji-Hee Sung, Yoshiko Uesugi, Yasuhiko Tabata, Keiji Kato, Kenichi Ishigami, Manabu Horii, Shiro Uemura, Yoshihiko Saito, Nara Medical University, Kashihara, Japan
Arr
OrAl
918
Cardiac MrI for the Treatment and Evaluation of ArrhythmiasSunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place South, S404CME/CNE Hours: 1.5
Co-Chairs: Aiden Abidov, Tucson, AZ Kristen K. Patton, Seattle, WA
10:45 918–3 The role of Magnetic resonance Imaging in Identifying Patients with Cardiac Sarcoidosis and Preserved left Ventricular Function in Predicting Future Ventricular Arrhythmias — Thomas Crawford, Sinan Sarsam, Gisela Mueller, Sanjaya Gupta, Timir Baman, Karl Ilg, Diego Belardi, Mohamad Sinno, William Sauer, Khaled Abdul-Nour, Henry Kim, Mouaz AI-Mallah, Joseph Schuller, Fred Morady, Frank Bogun, University of Michigan Health System, Ann Arbor, MI, Henry Ford Hospital, Detroit, MI
11:00 918–4 Myocardial Infarct Heterogeneity Assessed by late Gadolinium-enhanced Cardiovascular Magnetic resonance (lGE-CMr) Is Associated with the Development of Ventricular Tachycardias after Acute Myocardial Infarction — Lourens Robbers, Ronak Delewi, Michiel Kemme, Robin Nijveldt, Aernout Beek, Alexander Hirsch, Anja Van Der Laan, Pieter van der Vleuten, Jan Piek, Felix Zijlstra, Albert van Rossum, VU University Medical Center, Amsterdam, The Netherlands, Interuniversity Cardiology Institute of the Netherlands, Utrecht, The Netherlands
11:15 918–5 Mitral regurgitation recovery and Atrial reverse remodeling following Pulmonary Vein Isolation Procedure in Patients with Atrial Fibrillation: A Proof of Concept Clinical Observation
Sunday, March 25, 2012 • ACC.12
ACC.12 Final Program 149
Morning
Cardiac MrI Study — Sahadev T. Reddy, M, William Belden, Mark Doyle, Diane Vido, Ronald Williams, M, June Yamrozik, Moneal Shah, Robert Biederman, The Gerald McGinnis Cardiovascular Institute, Allegheny General Hospital, Pittsburgh, PA
11:30 918–6 Indication of Fat Pad Modification for Patients with Atrial Fibrillation: An Approach by the Extent of Fibrosis on left Atrium Obtained from late Gadolinium Enhancement MrI — Koji Higuchi, Mehmet Akkaya, Joshua Blauer, Kavitha Damal, Chankevin Tek, Nathan Burgon, Eugene Kholmovski, Rob MacLeod, Nassir Marrouche, Comprehensive Arrhythmia Research & Management Center, University of Utah, Salt Lake City, UT
11:45 918–7 Catheter Ablation Guided By real-time Magnetic resonance Imaging: Initial Clinical Applications — Peter Nordbeck, Meinrad Beer, Mark E. Ladd, Harald H. Quick, Wolfgang R. Bauer, Oliver Ritter, University Hospital Wuerzburg, Wuerzburg, Germany
12:00 918–8 Acute Identification of Gaps in Atrial radiofrequency Ablation lesion Sets Using MrI — Ravi Ranjan, Eugene Kholmovski, Sathya Vijayakumar, Joshua Blauer, Kamal Vij, Rob MacLeod, Nassir F. Marrouche, University of Utah, Salt Lake City, UT
Arr
OrAl
919
Joint Oral Session of the Heart rhythm Society and the American College of Cardiology: Cardiac Arrest and the Care of the ICD PatientSunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place North, N426CME/CNE Hours: 1.5
Co-Chairs: Sana Al-Khatib, Durham, NC Paul J. Wang, Stanford, CA
11:00 919–4 Temporal Trends in Quality of Care among ICD recipients: Insights from the NCDr ICD registry — John A. Dodson, Jeptha P. Curtis, Yongfei Wang, Stephen C. Hammill, Paul Varosy, Rachel Lampert, Yale University School of Medicine, New Haven, CT
11:15 919–5 Inappropriate Therapy for Atrial Flutter/Fibrillation Is lower with Dual- than Single-Chamber ICD in MADIT-CrT — Nitesh Sood, Arthur Moss, Scott Mcnitt, Christopher Clyne, University of Connecticut/Hartford Hospital, Hartford, CT, University of Rochester, Rochester, NY
11:30 919–6 Gender Differences in Inappropriate Device Therapies from MADIT — Christine Tompkins, Scott McNitt, James Daubert, Paul Wang, Arthur Moss, Wojciech Zareba, University of Rochester Medical Center, Rochester, NY
11:45 919–7 riata ICD lead Failure: results of the Manufacturers Analysis of returned leads — Robert G. Hauser, Linda Kallinen, Minneapolis Heart Institute Foundation, Minneapolis, MN
12:00 919–8 Follow-up riata Screening in Northern Ireland — Emily Hodkinson, Vivek Kodoth, Kyle Ashfield, Carol Wilson, Ernest Lau, David McEneaney, Michael Roberts, Royal Victoria Hospital, Belfast, United Kingdom, Craigavon Cardiac Centre, Craigavon, United Kingdom
CCS
SYMPOSIUM
637
Post-Operative Glenns and Fontans: Navigating Turbulent WatersSunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place North, N231CME/CNE Hours: 1.5
Co-Chairs: Andrew Atz, Charleston, SC Jacqueline Kreutzer, Pittsburgh, PA
10:45 Case Presentation — Henri Justino, Houston, TX
10:55 Take Action When the Post Operative Fontan Isn’t What You Hoped For — Jacqueline Kreutzer, Pittsburgh, PA
11:15 Outcomes: Update from the Pediatric Heart Network (PHN) Single Ventricle reconstruction (SVr) Trial — John F. Rhodes, Durham, NC
11:35 The Blue Glenn — Aimee K. Armstrong, Ann Arbor, MI
11:55 role of the Catheterization lab for the Failing Fontan — Joshua Kanter, Washington, DC
CCS
OrAl
920
Adults with Congenital Heart Disease: Imaging Predictors, Evolving Therapies and OutcomesSunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place South, S402CME/CNE Hours: 1.5
Co-Chairs: Michael H. Crawford, San Francisco, CA William R. Davidson, Hershey, PA
10:45 920–3 The Year in review — Congenital Cardiology Solutions — Thomas P. Graham, Jr., Franklin, TN
11:00 920–4 Cancer in Adults with Congenital Heart Disease Compared to the General Population — Michelle Gurvitz, Louise Pilote, Patrick Lawler, Mark Eisenberg, Raluca Ionescu-Ittu, Ariane Marelli, Children’s Hospital Boston, Boston, MA
11:15 920–5 Echocardiographic Predictors of Outcome in Eisenmenger Syndrome — Pamela Moceri, Konstantinos Dimopoulos, Emmanouil Liodakis, Aleksander Kempny, Gerhard-Paul Diller, Wei Li, Michael Gatzoulis, Royal Brompton Hospital, London, United Kingdom, University Hospital of Nice, Nice, France
11:30 920–6 Can Selective Pulmonary Vasodilator Therapy Be Used to Target Pulmonic regurgitation? results of the Pinot Noir Trial — Stephen A. Hart, Ganesh Devendra, Yuli Kim, Vidyasagar Kalahasti, Scott Flamm, Richard Krasuski, Cleveland Clinic, Cleveland, OH
11:45 920–7 Is Pregnancy Associated with Adverse right Ventricular remodeling in Women with repaired Tetralogy of Fallot? — Gabriele Egidy Assenza, Anne Marie Valente, Daiana Cassater, Jenna Schreier, Katherine Economy, Dionne Graham, Massimo Volpe, Nancy Barker, Tal Geva, Michael Landzberg, Anne Marie Valente, Children’s Hospital Boston, Boston, MA
12:00 920–8 right Atrial Size Predicts Arrhythmia and Death in Patients with repaired Tetralogy of Fallot — Beatrice Bonello, Aleksander Kempny, Anselm Uebing, Wei Li, Philip Kilner, Dudley J. Pennell, Michael Gatzoulis, Gerhard-Paul Diller, Sonya Babu-Narayan, BRU Ressearch Unit, Royal Brompton Hospital, London, United Kingdom
ACC.12 • Sunday, March 25, 2012
150 GO for ACC.12!
Mor
ning
HF
ExPErTS
225
Heart Failure Care for the Very Old: What Are the Key Issues for Success?Sunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place South, S502CME/CNE Hours: 1.5
Chair: Suzanne J. Wingate, Silver Spring, MD
Case Presenter: Sarah J. Goodlin, Salt Lake City, UT
Panelists: Ali Ahmed, Birmingham, AL, Jalal K. Ghali, Detroit, MI, Robert Lee Page, II, Aurora, CO, Michael W. Rich, Saint Louis, MO
HF
OrAl
921
Joint Oral Session of the Heart Failure Society of America and the American College of Cardiology: Individualizing Pharmacological Therapy in Heart FailureSunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place South, S406bCME/CNE Hours: 1.5
Co-Chairs: Akshay S. Desai, Boston, MA Barry M. Massie, San Francisco, CA
10:45 921–3 The Year in review – Heart Failure — Barry M. Massie, San Francisco, CA
11:00 921–4 Beta-1 Adrenergic receptor Genotype Ser49Gly Is Associated with Beta-Blocker Survival Benefit in Patients with Heart Failure — Jasmine Talameh, Amanda Garrand, Jalal Ghali, Ron M. Oren, Stephanie Dunlap, Adrian Van Bakel, Ileana Pina, J. Herbert Patterson, Carla Sueta, Frank McGrew, Alan Miller, Todd Schwartz, Kirkwood Adams, University of North Carolina-Chapel Hill, Chapel Hill, NC
11:15 921–5 The Association of Beta-blocker Use and Selectivity with Outcomes in Heart Failure Patients with Chronic Obstructive Pulmonary Disease: Findings from the Organized Program to Initiate life-saving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) — Robert J. Mentz, Daniel Wojdyla, Mona Fiuzat, Karen Chiswell, Tariq Ahmad, Gregg Fonarow, Christopher O’Connor, Duke University Medical Center, Durham, NC, Duke Clinical Research Institute, Durham, NC
11:30 921–6 Influence of Baseline and Worsening renal Function on Efficacy of Spironolactone in Patients with Severe Heart Failure Enrolled in the randomized Aldactone Evaluation Study — Orly Vardeny, Faiez Zannad, Bertram Pitt, Scott Solomon, University of Wisconsin, Madison, WI, Brigham and Women’s Hospital, Boston, MA
11:45 921–7 Autologous CD133+ Bone Marrow Cells and Bypass Grafting for regeneration of Ischemic Myocardium: results of the Cardio133 Trial — Boris Alexander Nasseri, Marian Kukucka, Michael Dandel, Wolfram Ebell, Roland Hetzer, Christof Stamm, Deutsches Herzzentrum Berlin, Berlin, Germany, Berlin Center for Regenerative Therapies, Berlin, Germany
12:00 921–8 ranolazine for the Treatment of Diastolic Heart Failure in Patients with Preserved Ejection Fraction: results from the rAlI-DHF Study — Lars Maier, Rolf Wachter, Frank Edelmann, Beth
Layug, Ewa Karwatowska-Prokopczuk, Luiz Belardinelli, Gerd Hasenfuss, Claudius Jacobshagen, University of Goettingen, Goettingen, Germany, Gilead, Foster City, Palo Alto, CA
HF
OrAl
922
Improving Patient Selection for Device-Based TherapiesSunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place South, S405CME/CNE Hours: 1.5
Co-Chairs: Mark H. Drazner, Dallas, TX Scott Silvestry, Philadephia, PA
10:45 922–3 The Impact of Myocardial Scar by Cardiac Magnetic resonance in Patients with Non-Ischemic Dilated Cardiomyopathy referred for an Implantable Cardioverter Defibrillator for Primary Prevention of Sudden Cardiac Death — Tomas G. Neilan, Otavio Coelho-Filho, Stephan Danik, Daniel J. Verdini, Tokuda Michifumi, Ravi Shah, Usha Tedrow, William Stevenson, Michael Jerosch-Herold, Brian Ghoshhajra, Raymond Kwong, Brigham and Women’s Hospital, Boston, MA, Massachusettes General Hospital, Boston, MA
11:00 922–4 Baseline Burden of Heart Failure limits Duration of Benefit of ICD for Medicare recipients — Soko Setoguchi, Chih-Ying Chen, Lynne Stevenson, John Seeger, Lauren Williams, Jessica Jalbert, Andrew Rothman, Garrick Stewart, Brigham and Women’s Hospital, Boston, MA, Duke Clinical Research Institute, Durham, NC
11:15 922–5 Impact of remote, Wireless Pulmonary Artery Hemodynamic Monitoring in Patients with Atrial Fibrillation and Chronic Heart Failure: Insights from the CHAMPION Trial — Alan B. Miller, John Teerlink, Peter Carson, Wayne Levy, Eugene Chung, Edward Gilbert, Brad Jeffries, Jay Yadav, Susan Neville, Pam Cowart, Phillip Adamson, William Abraham, university of florida, jacksonville, FL
11:30 922–6 Cardiac resynchronization Therapy Benefits Patients Eighty-years of Age or Older — Evan C. Adelstein, John Gorcsan, Sandeep Jain, Samir Saba, University of Pittsburgh, Pittsburgh, PA
11:45 922–7 Improvement in Ejection Fraction Predicts Survival following Cardiac resynchronization Therapy in Patients with Both left Bundle and Non-left Bundle Branch Block Morphologies — Jack Rickard, Bruce Lindsay, Niraj Varma, Mina Chung, Greg Jackson, Bryan Baranowski, Wai Hong Tang, Bruce Wilkoff, Cleveland Clinic, Cleveland, OH
12:00 922–8 Impact of AV- and VV-Delay Optimization in Patients Treated with Cardiac resynchronization Therapy: A Meta-Analysis — Dominique Auger, Ulas Höke, Jeroen Bax, Eric Boersma, Victoria Delgado, LUMC, Leiden, The Netherlands, Centre Hospitalier de l’Université de Montréal, Montreal, Canada
Sunday, March 25, 2012 • ACC.12
ACC.12 Final Program 151
Morning
IMAG
SYMPOSIUM
638
Joint Symposium of the American Society of Echocardiography and the American College of Cardiology: Cardiomyopathy — A Comprehensive Echocardiographic ApproachSunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place South, S406aCME/CNE Hours: 1.5
Co-Chairs: Alex J. Auseon, Columbus, OH James D. Thomas, Cleveland, OH
10:45 Insights into lV Mechanics Using Advanced Echo Imaging — James D. Thomas, Cleveland, OH
11:00 Importance of Diastolic Function in Patients with Cardiomyopathy — Sherif F. Nagueh, Houston, TX
11:15 Don’t Forget the right Ventricle — Lawrence G. Rudski, Montreal, Canada
11:30 Echo Assessment of the left Atrium as reservoir, Pump and Embolic — Teresa S.M. Tsang, Vancouver, Canada
11:45 Echocardiography in Guiding Cardiac resynchronization Therapy — Theodore P. Abraham, Baltimore, MD
12:00 Echo Is the Only Test Needed in Assessment of Patients with Cardiomyopathy: Comparison with Other Imaging Modalities — Mario J. Garcia, Bronx, NY
IMAG
OrAl
924
Cardiac CT: Toward a Better Understanding of CADSunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place South, S403CME/CNE Hours: 1.5
Co-Chairs: Dipan J. Shah, Houston, TX Eric J. Velazquez, Durham, NC
10:45 924–3 The Significance of Non-Obstructive Coronary Artery Disease upon Multi-Detector Computed Tomography in Patients Presenting with Acute Chest Pain — Roy Beigel, Sella Brosh, Orly Goitein, Einat Gutman, Amit Segev, Eli Konen, Dan Oieru, Hanoch Hod, Shlomi Matetzky, The Leviev Heart Center, Sheba Medical Center, Tel Hashomer, Israel, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
11:00 924–4 A Comparison of Outcomes with Coronary Artery Calcium in Unselected Populations: The Multi-ethnic Study of Atherosclerosis (MESA) and Heinz Nixdorf recall Study (HNr) — Matthew J. Budoff, Stefan Möhlenkamp, Robyn McClelland, Joseph Delaney, Marcus Bauer, Heinz Karl Jockel, Hagen Kalsch, Richard Kronmal, Khurram Nasir, Susanne Moebus, Raimund Erbel, Los Angeles Biomedical Research Institute, Torrance, CA, University of Duisburg-Essen, Essen, Germany
11:15 924–5 Does Noncalcified Plaque Improve the Diagnostic and Prognostic Utility of Coronary CT Angiography? A Study of Propensity-Matched Individuals with Similar Coronary Calcium Scores from the Prospective Multicenter International CONFIrM registry — Rine Nakanishi, Heidi Gransar, Daniel S. Berman, Victor Cheng, Damini Dey, Troy LaBounty, Fay Lin, Stephan Achenbach, Mouaz
Al-Mallah, Matthew J. Budoff, Filippo Cademartiri, Tracy Callister, Kavitha Chinnaiyan, Benjamin J. W. Chow, Augustin Delago, Martin Hadamitzky, Joerg Hausleiter, Gilbert Raff, Todd Villines, Leslee J. Shaw, Allison Dunning, James K. Min, Departments of Imaging and Medicine, Cedars-Sinai Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA
11:30 924–6 A Previously Validated Peripheral Gene Expression Score is Mostly Determined by Non-Calcified Plaque and luminal Stenosis as Assessed by Quantitative, 3-Dimensional Measurements by CT Angiography in the Multi-Center, Prospective COMPASS Study — Szilard Voros, Gregory Thomas, Alexandra Lansky, John McPherson, Michael Elashoff, Sarah Rinehart, Andrea Johnson, Steven Rosenberg, Integrated Cardiovascular Research Group, Atlanta, GA, CardioDx, Palo Alto, CA
11:45 924–7 Hypertensive Individuals Have an Increased Prevalence of Coronary Artery Disease and risk of Adverse Events: A Comparison of 15,091 Individuals from CONFIrM (Coronary Computed Tomographic Angiography Evaluation for Clinical Outcomes: An International Multicenter registry) — Troy M. LaBounty, Stephan Achenbach, Mouaz Al-Mallah, Daniel Berman, Matthew Budoff, Filippo Cademartiri, Tracy Callister, Victor Cheng, Kavitha Chinnaiyan, Benjamin Chow, Augustin DeLago, Allison Dunning, Millie Gomez, Martin Hadamitzky, Joerg Hausleiter, Philipp Kaufmann, Fay Lin, Gilbert Raff, Leslee Shaw, Todd Villines, James Min, Cedars-Sinai Medical Center, Los Angeles, CA
12:00 924–8 Prospective Evaluation of the Updated 2010 ACCF Cardiac CT Appropriate Use Criteria — William Guy Weigold, Michael Rich, Daisuke Utsunomiya, Lauren Simprini, Gaby Weissman, Allen Taylor, Washington Hospital Center and MedStar Health Research Institute, Washington, DC, Georgetown University School of Medicine, Washington, DC
ISCHEM
OrAl
923
Who Said There’s Nothing New?Sunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place North, N230CME/CNE Hours: 1.5
Co-Chairs: Subhash Banerjee, Dallas, TX Ellen Keeley, Charlottesville, VA
10:45 923–3 The Year in review — Chronic Coronary Artery Disease/Stable Ischemic Heart Disease — Steven R. Bailey, San Antonio, TX
11:00 923–4 Effects of AMG 145, a Fully Human Monoclonal Antibody Against PCSK9, on low-Density lipoprotein Cholesterol in Subjects Taking Statins: A Phase 1, randomized, Double-blind, Placebo-controlled, Ascending Multiple-dose Study — Clapton Dias, Adam Shaywitz, Blaire Cooke, Stephen Uy, Maurice Emery, John Gibbs, Caroline Crispino, Karen Smirnakis, Brian Smith, Bing Gao, Scott Wasserman, Evan Stein, Amgen Inc, Thousand Oaks, CA, Metabolic and Atherosclerosis Research Center, Cincinnati, OH
11:12 923–5 Sustained Clinical Improvements after Intramyocardial Injection of Mesenchymal Stromal
ACC.12 • Sunday, March 25, 2012
152 GO for ACC.12!
Mor
ning
Cells in Patients with Severe Stable Coronary Artery Disease: 24-months Follow-up — Anders Bruun Mathiasen, Mandana Haack-Sørensen, Erik Jorgensen, Jens Kastrup, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
11:24 923–6 Instantaneous Wave-free ratio (iFr) Has a Similar Diagnostic Efficiency to Fractional Flow reserve (FFr) in Single and Multi-vessel Disease: Secondary Analysis of Advise (Adenosine Vasodilator Independent Stenosis Evaluation) Study — Justin E. Davies, Sayan Sen, Javier Escaned, Carlo Di Mario, Rafael Mila, Iqbal Malik, Darrel Francis, Alun Hughes, Jamil Mayet, Imperial College, London, United Kingdom, Hospital Clinico San Carlos, Madrid, Spain
11:36 923–7 Sitagliptin Improves regional Myocardial Function during Dobutamine Stress in Type 2 Diabetes Mellitus and Coronary Artery Disease — Liam M. McCormick, Anna Kydd, Philip Read, Stephen Hoole, David Dutka, Department of Cardiovascular Medicine, University of Cambridge, Cambridge, United Kingdom
11:48 923–8 A Peripheral Blood Gene Expression Score for Coronary Artery Disease in Non-diabetic Patients Identifies Patients at low-risk for Major Cardiovascular Events and Interventional Procedures in the Next 12 Months — William E. Kraus, Szilard Voros, Robert S. Schwartz, Stephen Ellis, Ron Waksman, Naeem Tahirkheli, Hsiao Lieu, Michael R. Elashoff, Steven Rosenberg, John McPherson, Alexandra Lansky, Eric Topol, Duke University, Durham, NC, CardioDx, Inc., Palo Alto, CA
12:00 923–9 Comparison of Fractional Flow reserve versus Instant Wave-Free ratio for Assessment of Coronary Artery Stenosis Severity in routine Practice — Colin Berry, Marcel van’t Veer, William Fearon, Petr Kala, Nils Witt, Stelios Pyxaras, Pim Tonino, Bernard De Bruyne, Nico Pijls, Keith Oldroyd, University of Glasgow, Glasgow, United Kingdom
PErI
OrAl
925
All That Glitters in Myocardial and Pericardial DiseaseSunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place North, N226CME/CNE Hours: 1.5
Chair: Patricia A. Uber, Baltimore, MD
10:45 925–3 The Year in review – Pericardial/Myocardial Disease — Leslie T. Cooper, Rochester, MN
11:00 925–4 Female Gender Is Associated with Major Adverse Cardiovascular Events in Patients with Hypertrophic Cardiomyopathy — Susie N. Hong-Zohlman, Raymond Chan, Barry Maron, iacopo olivotto, Gabriele E. Assenza, John Lesser, Tammy Haas, Christiane Gruner, Andrew Crean, Harry Rakowski, James Udelson, Ethan Rowin, Benedetta Tomberli, Paolo Spirito, Francesco Formisano, Elena Biagini, Claudio Rapezzi, Carlo Nicola De Cecco, Camillo Autore, E. Francis Cook, Thomas Hauser, C. Michael Gibson, Warren Manning, Evan Appelbaum, Martin Maron, Beth Israel Deaconess Medical Center, Boston, MA, Tufts Medical Center, Boston, MA
11:15 925–5 Prognostic Utility of Contrast-enhanced Cardiovascular Magnetic resonance in Hypertrophic Cardiomyopathy: An International Multicenter Study — Raymond H. Chan, Barry Maron, iacopo olivotto, Gabriele Assenza, M, Susie Hong, John Lesser, Tammy Haas, Christiane Gruner, Andrew Crean, Harry Rakowski, James Udelson, Ethan Rowin, Benedetta Tomberli, Paolo Spirito, Francesco Formisano, Elena Biagini, Claudio Rapezzi, Carlo Nicola De Cecco, Camillo Autore, Earl Francis Cook, Thomas Hauser, C. Michael Gibson, Warren Manning, Evan Appelbaum, Martin Maron, Beth Israel Deaconess Medical Center/PERFUSE Core Laboratories, Boston, MA, Tuft’s Medical Center, Boston, MA
11:30 925–6 The Impact of Colchicine on the Incidence and recurrence of Pericardial Inflammation: A Comprehensive Meta-Analysis of All randomized Clinical Trials — Mahboob Alam, Salman Bandeali, Waleed Kayani, henry huang, Salim Virani, Kodangudi Ramanathan, Hani Jneid, Memphis Veterans Affairs Medical Center / University of Tennessee Health Sciences Center, Memphis, TN, Baylor College of Medicine, Houston, TX
11:45 925–7 Characteristics of 2067 Patients Hospitalized with Peripartum Cardiomyopathy — David Peter Kao, Eileen Hsich, Joann Lindenfeld, University of Colorado School of Medicine, Aurora, CO, Cleveland Clinic, Cleveland, OH
12:00 925–8 Heart rate Variability and the Substrate for Ventricular Tachycardia in Arrhythmogenic right Ventricular Cardiomyopathy — Pasquale Santangeli, Antonio Dello Russo, Michela Casella, Gemma Pelargonio, Luigi Di Biase, Pietro Santarelli, Stefano Bartoletti, Rong Bai, Prasant Mohanty, Sanghamitra Mohanty, Agnes Pump, Andrea Natale, Texas Cardiac Arrhythmia Institute, Austin, TX, Catholic University of the Sacred Heart, Rome, Italy
PrACTICE
ExPErTS
226
ACC/MedAxiom/ACCA: Physician/Hospital Integration: Making It WorkSunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place South, S505CME/CNE Hours: 1.5
Co-Chairs: Jerome L. Hines, Hinsdale, IL Marc E. Shelton, Springfield, IL
Panelists: Marc E. Shelton, Springfield, IL, Howard T. Walpole, Nashville, TN, Donald E. Casey, Morristown, NJ, R. Terry Heath, Indianapolis, IN
PrEV
ExPErTS
227
Update on the ATP IV GuidelinesSunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place South, S501aCME/CNE Hours: 1.5
Co-Chairs: Christie M. Ballantyne, Houston, TX Neil Stone, Winnetka, IL
Case Presenters: James H. Stein, Madison, WI, Salim S. Virani, Bellaire, TX
Panelists: C. Noel Bairey Merz, Los Angeles, CA, Patrick E. McBride, Madison, WI, Jennifer Robinson, Iowa City, IA, Neil Stone, Winnetka, IL
Sunday, March 25, 2012 • ACC.12
ACC.12 Final Program 153
Morning
PrEV
OrAl
926
renal Sympathetic Denervation: A Novel Therapy for Hypertension?Sunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place North, N228CME/CNE Hours: 1.5
Co-Chairs: George L. Bakris, Chicago, IL Suzanne Oparil, Birmingham, AL
10:45 926–3 long-term Follow-up of Catheter-based renal Sympathetic Denervation for resistant Hypertension Confirms Durable Blood Pressure reduction — Henry Krum, Neil Barman, Markus Schlaich, Paul Sobotka, Murray Esler, Felix Mahfoud, Monash University and The Alfred Hospital, Melbourne, Australia
11:00 926–4 renal Sympathetic Denervation for Treatment of resistant Hypertension: One-year results from the Symplicity HTN-2 randomized Controlled Trial — Murray D. Esler, Henry Krum, Markus Schlaich, Roland Schmieder, Michael Bohm, Paul Sobotka, Baker IDI Heart and Diabetes Institute, Melbourne, Australia
11:15 926–5 6-months Follow-up in a real life Situation after renal Denervation — Willemien Verloop, Wilko Spiering, Pierfrancesco Agostoni, Pieter Stella, Kevin Onsea, P. Doevendans, Michiel voskuil, UMC Utrecht, Utrecht, The Netherlands
11:30 926–6 Effects of renal Sympathetic Denervation on 24-hour Blood Pressure Variability — Axel Bauer, Christine Zuern, Konstantinos Rizas, Christian Eick, Meinrad Gawaz, Eberhard-Karls-Universität Tübingen, Tuebingen, Germany
11:45 926–7 Percutaneous renal Denervation for resistant Hypertension: real World Outcomes — Darren Mylotte, Hakim Benamer, Thierry Unterseeh, Yves Louvard, Marie Claude Morice, Philippe GArot, Thierry Lefevre, Institut Cardiovasculaire Paris Sud, Paris, France
12:00 926–8 Chronic Effects of Percutaneous renal Sympathetic Denervation on renal Hemodynamics and Plasma Norepinephrine levels Using a Novel Catheter for radiofrequency Ablation — I. Tatsis, Konstantinos P. Tsioufis, Vasilios Papademetriou, K. Dimitriadis, D. Tsiachris, C. Thomopoulos, Euljoon Park, C. Stefanadis, First Cardiology Clinic, University of Athens, Hippokration Hospital, Athens, Greece
PrEV
OrAl
927
Cardiovascular risk Assessment and rehabilitationSunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place South, S401aCME/CNE Hours: 1.5
Co-Chairs: Alison Bailey, Lexington, KY Elizabeth A. Jackson, Ann Arbor, MI
10:45 927–3 The Association of Anthropometric Obesity Measures with CT-measured Non-alcoholic Fatty liver Disease in the Multi-ethnic Study of Atherosclerosis — Geoffrey H. Tison, Michael Blaha, Khurram Nasir, Roger Blumenthal, Moyses Szklo, Jingzhong Ding, Matthew Budoff, Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, MD
11:00 927–4 Comparative Effectiveness of U.S. Population Screening Strategies for Coronary Heart Disease (CHD): Evaluation of Framingham risk Score (FrS), Society for Heart Attack Prevention and Education (SHAPE), Texas Heart Attack Prevention Bill, JUPITEr, and Treat-All Approaches — Benjamin Z. Galper, Y. Claire Wang, Andrew J. Einstein, Brigham and Women’s Hospital Department of Cardiovascular Medicine, Boston, MA, Columbia University Medical Center, Department of Cardiology, New York, NY
11:15 927–5 Is Body Fat Protective in a Population with Preserved Ejection Fraction? — Alban De Schutter, Carl Lavie, Dharmendrakumar Patel, Richard Milani, Ochsner Health System, New Orleans, LA, Cleveland Clinic Florida, Weston, FL
11:30 927–6 Cardiac rehabilitation reduces Mortality following Coronary Artery Bypass: A 10-year Community Study — Quinn R. Pack, Kashish Goel, Brian Lahr, Kevin Greason, Ray Squires, Randal Thomas, Mayo Clinic, Rochester, MN
11:45 927–7 lifetime risk Algorithm Identifies More Patients with Carotid and Femoral Plaques than 10-year or 30-year Framingham risk Algorithms — John Postley, Yanting Luo, Nathan Wong, Julius Gardin, Columbia University, New York, NY
12:00 927–8 Optimizing the Incremental Predictive Value of Coronary Calcium: MESA versus Framingham 10-year or lifetime Cardiovascular risk? — Allen J. Taylor, Todd Villines, Medstar Heart Institute, Washington, DC, Walter Reed National Military Medical Center, Washington, DC
QUAl
SYMPOSIUM
650
U.S. Health System reform: What’s Missing?Sunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place South, S100cCME/CNE Hours: 1.25
Chair: Jack Lewin, Washington, DC
Panelists: Richard E. Anderson, Napa, CA, James W. Fasules, Washington, DC, Jerry D. Kennett, Columbia, MO, Kavita Patel, Washington, DC
10:45 Introduction: U.S. Health System reform — What’s Missing? — Jack Lewin, Washington, DC
10:50 Medical liability reform — Richard E. Anderson, Napa, CA
11:15 Payment reform — Kavita Patel, Washington, DC
11:40 Panel Discussion
QUAl
OrAl
928
Improving PCI OutcomesSunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place North, N229CME/CNE Hours: 1.5
Co-Chairs: David J. Cohen, Kansas City, MO Paul D. Varosy, Denver, CO
10:45 928–3 Prevalence and Outcomes of radial and Femoral Approaches to Percutaneous Coronary Intervention: Insights from the National Veterans Affairs Clinical Assessment, reporting and Tracking Program — Antonio Gutierrez, Thomas Tsai, Maggie Stanislawski, Mladen Vidovich, Walter
ACC.12 • Sunday, March 25, 2012
154 GO for ACC.12!
Mor
ning
Woody, Christopher Bryson, Deepak Bhatt, John Rumsfeld, Sunil Rao, Duke Clinical Research Institute, Durham, NC
11:00 928–4 Non-system reasons for Delay in Door-to-Balloon Time and In-hospital Mortality: A report from the National Cardiovascular Data registry® — Rajesh V. Swaminathan, Tracy Wang, Lisa Kaltenbach, Luke Kim, Robert Minutello, Dmitriy Feldman, New York Presbyterian Hospital, Weill Cornell Medical College, New York, NY, Duke Clinical Research Institute, Durham, NC
11:15 928–5 Do Extreme risk Cases Impact Hospitals’ risk-Adjusted PCI Mortality ratings? results from the NCDr® — Eric D. Peterson, Dadi (David) Dai, Sean O’Brien, J. Matthew Brennan, Kalon Ho, Frederick Masoudi, John Messenger, W. Douglas Weaver, Duke Clinical Research Institute, Durham, NC
11:30 928–6 Gender and Bleeding risk following Percutaneous Coronary Interventions: A Contemporary report from the NCDr® — Stacie L. Daugherty, Sunghee Kim, Lauren Thompson, Sunil Rao, Sumeet Subherwal, Thomas Tsai, John Messenger, Frederick Masoudi, University of Colorado Denver, Aurora, CO
11:45 928–7 Geospatial Analysis of Percutaneous Coronary Intervention Hospitals — James R. Langabeer, Timothy Henry, Jami Delli Fraine, Jamie Emert, Richard King, Leilani Stuart, Wendy Segrest, University of Texas Health Science Center, Houston, TX
12:00 928–8 Hospital Characteristics Associated with Providing Optimal Medical Therapy for Percutaneous Coronary Intervention Patients: A report from the NCDr® — William Borden, John Spertus, Alvin I. Mushlin, Matthew Roe, Lisa Kaltenbach, Rita Redberg, Weill Cornell Medical College, New York, NY
SPECIAl
SPECIAl
406
Young Investigators Award Competition: Physiology, Pharmacology and PathologySunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place South, S105aCME/CNE Hours: 1.5
Chair: Sanjay Rajagopalan, Columbus, OH
Judges: Daniel A. Duprez, Minneapolis, MN Arshed A. Quyyumi, Atlanta, GA
10:45 406–4 Platelet Inhibitory Effect of Clopidogrel in Patients Treated with Omeprazole, Pantoprazole or Famotidine: A Prospective randomized Crossover Study — Yaron Arbel, tasmc cardiology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
11:00 406–5 Mitral leaflet Changes following Myocardial Infarction: Evidence for Maladaptive remodeling Favoring Ischemic Mitral regurgitation — Jonathan Beaudoin, Jacob Dal-Bianco, Elena Aikawa, Joyce Bischoff, Luis Guerrero, Suzanne Sullivan, Jill Wylie-Sears, Jacob Aaron, Robert A. Levine, Massachusetts General Hospital, Boston, MA, Harvard Medical School, Boston, MA
11:15 406–6 right to left Shunting through Patent Foramen Ovale during Simulated Episodes of Obstructive Sleep Apnea — Tomas Konecny, Amber D. Khann, Jan Novak, Abdi A. Jama, Jan Bukartyk, Marek Orban, Tomas Kara, Barry A. Borlaug, Virend K. Somers, Guy Reeder, Mayo Clinic, Rochester, MN
11:30 406–7 QT-rr Hysteresis is Caused by Differential Autonomic States during Exercise and recovery — Daniel J. Pelchovitz, Jason Ng, Alexandru B. Chicos, Daniel W. Bergner, Jeffrey J. Goldberger, Northwestern University Feinberg School of Medicine, Chicago, IL
11:45 406–8 Traumatic lower Extremity Amputations Cause Disturbed Blood Flow in The Infrarenal Aorta leading to Abdominal Aortic Aneurisms — Alexander V. Smolensky, Stephanie Clement-Guinaudeau, John N. Oshinski, William R. Taylor, Emory University School of Medicine, Atlanta, GA
TEST
OrAl
929
Diagnostic Testing; ECG and Cardiopulmonary Exercise TestingSunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place South, S503CME/CNE Hours: 1.5
Co-Chairs: Paul Kligfield, New York, NY John Wells Askew, Rochester, MN
10:45 929–3 The Year in review — Diagnostic Testing — Michael S. Lauer, Bethesda, MD
11:00 929–4 Determinants of VE/VCO2 Slope in Normal Individuals: Ventilatory Efficiency Is Modifiable with Endurance Training — Ryan M. Murphy, Rory B. Weiner, Stacyann S. Hough, Paul P. Pappagianopoulos, David M. Systrom, Adolph M. Hutter, Aaron L. Baggish, Gregory D. Lewis, Massachusetts General Hospital, Boston, MA
11:15 929–5 Heart rate versus rr Interval recovery after Exercise: Which Is More Physiologic? — Jeffrey J. Goldberger, Haris Subacius, Jason Ng, Northwestern University, Chicago, IL
11:30 929–6 Validation of a Cardiopulmonary Exercise Test Score in Heart Failure — Jonathan N. Myers, Ricardo Oliveira, Marco Guazzi, Paul Chase, Daniel Bensimhon, Euan Ashley, Daniel Forman, Mary Ann Peberdy, Erin West, Ross Arena, VA Palo Alto Health Care System, Palo Alto, CA
11:45 929–7 Cardiorespiratory Fitness and Short-term Outcomes with Coronary Artery Bypass Graft Surgery — James L. Smith, Thomas A. Verrill, Judy A. Boura, Marc P. Sakwa, Francis L. Shannon, Barry Franklin, William Beaumont Hospital, Royal Oak, MI
12:00 929–8 Impact of Utilizing a Women-based Formula for the Calculation of Chronotropic response during Exercise Treadmill Testing in Women: long-term Outcome — Sahar S. Abdelmoneim, Sharon Mulvagh, Laurie Barr, Quinn Pack, Martha Gulati, Thomas Allison, Mayo Clinic, Rochester, MN, The Ohio State University, Columbus, OH
Sunday, March 25, 2012 • ACC.12
ACC.12 Final Program 155
Morning
VAlV
OrAl
930
Valvular OralSunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place North, N427CME/CNE Hours: 1.5
Co-Chairs: Arsene J. Basmadjian, Montreal, Canada Vuyisile Nkomo, Rochester, MN
10:45 930–3 ACCESS EUrOPE: A Post-market Study of the MitraClip System for the Treatment of Significant Mitral regurgitation (Mr) in Europe: Analysis of Outcomes at 6-months — Francesco Maisano, Olaf Franzen, Stephan Baldus, Joerg Hausleiter, Christian Butter, Ulrich Schafer, Giovanni Pedrazzini, Gian Paolo Ussia, Horst Sievert, Lars Soendergaard, Wolfgang Schillinger, on behalf of the ACCESS EUROPE Investigators, San Rafaelle Hospital, Milano, Italy
11:00 930–4 The relationship between the Magnitude of reduction in Mitral regurgitation Severity and left Ventricular and left Atrial Volumes Post-Treatment with the MitraClip Device — Paul Grayburn, Chithra Sangli, Joseph Massaro, Laura Mauri, Neil Weissman, Donald Glower, Ted Feldman, Elyse Foster, on behalf of the EVEREST II Investigators, Baylor Univ Medical Center, Dallas, TX
11:15 930–5 long-term Impact of repeat Percutaneous Mitral Commissurotomy on the Need for Surgery in Mitral Stenosis: Insights from a Series of 912 Patients with a 20-year Follow-up — Claire Bouleti, Bernard Iung, Dominique Himbert, David Messika-Zeitoun, Eric Brochet, eric garbarz, Alex Vahanian, Bichat Hospital, Paris, France
11:30 930–6 Mitral regurgitation of Degenerative as Opposed to Functional Origin Negatively Impacts Outcomes of MitraClip Therapy: Single-Center Experience with 255 Consecutive Patients — Volker Rudolph, Edith Lubos, Daniel Lubs, Malgorzata Knap, Michael Schlüter, Stefan Blankenberg, Stefan Blankenberg, Stephan Baldus, University Heart Center Hamburg, Hamburg, Germany
11:45 930–7 risk Factors for Progression of Mitral Annulus Calcification: The Multi-ethnic Study of Atherosclerosis — Sammy Elmariah, Matthew Budoff, Joseph AC Delaney, Khurram Nasir, Yasmin Hamirani, Richard Kronmal, Valentin Fuster, Jonathan Halperin, Kevin O’Brien, Massachusetts General Hospital, Boston, MA
12:00 930–8 Prevalence of Significant Tricuspid regurgitation and Its Clinical Significance in Patients with Successful Percutaneous Mitral Valvuloplasty for Mitral Stenosis: results from 12-year Follow-up of One Center Prospective registry — Seung-Pyo Lee, Hyung-Kwan Kim, Kyung-Hee Kim, Ji-Hyun Kim, Hyo Eun Park, Yong-Jin Kim, Dae Won Sohn, Seoul National University Hospital, Seoul, South Korea
VASC
OrAl
932
New Insights in Perpheral Vascular Disease and Year in reviewSunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place South, S504aCME/CNE Hours: 1.5
Co-Chairs: Joshua A. Beckman, Boston, MA Soo Hyun Kim, Avon, OH
10:45 932–3 The Year in review — Vascular — Michael R. Jaff, Boston, MA
11:00 932–4 Two Methods of Calculating Ankle Brachial Index: Differences in Predicting Peripheral Arterial Disease Burden — Bassem M. Chehab, Vinodh Jeevanantham, Sravanthi Nagavalli, Edgar Austria, Rakesh Shrivastava, Mark Wiley, Peter Tadros, Jayant Nath, Buddhadeb Dawn, Kamal Gupta, University of Kansas Medical Center, Kansas City, KS
11:15 932–5 Is There a Smoking Gun? The Impact of Tobacco Use on Peripheral Vascular Intervention Indications and Outcomes: Observations from Blue Cross Blue Shield of Michigan Cardiovascular Consortium — Shea Elizabeth Hogan, Khan Munir, Hitinder Gurm, Jeffrey Rubin, M. Ashraf Mansour, P. Michael Grossman, University of Michigan, Ann Arbor, MI, Harper University Hospital, Detroit, MI
11:30 932–6 Vulnerable Plaque in Atherosclerosis Is Characterized by Microvasculature Involving the Vessels Derived from “Vasa Vasorum Interna” — Mie Kurata, Ehime University Graduate School of Medicine, Toon city, Ehime, Japan
11:45 932–7 National Institute of Health Stroke Scale (NIHSS) Should be the Outcome Measure of Choice When Utilizing the Care registry — John H. Lee, kevin kennedy, Christopher White, Ochsner Heart and Vascular Institute, New Orleans, LA
noon SeSSionS
ACC-i2/TCT
SYMPOSIUM
646
Interventional Cardiovascular Medicine in 2012: An Update for the Non-Interventionalist and the Douglas P. Zipes, MD, Distinguished Young Scientist Awardee lectureSunday, March 25, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place North, N228CME/CNE Hours: 1.5
Co-Chairs: Gregg W. Stone, New York, NY E. Murat Tuzcu, Cleveland, OH
12:15 Introduction to the Douglas P. Zipes, MD, Distinguished Young Scientist Awardee lecture — Douglas P. Zipes, Indianapolis, IN
12:20 Douglas P. Zipes, MD, Distinguished Young Scientist lecture: Incidence, Mechanisms, Predictors and Clinical Significance of Periprocedural Myocardial Infarction Due to Percutaneous Coronary Intervention — Duk-Woo Park, Seoul, Republic of Korea,
12:40 Discussion
12:45 Coronary Artery Disease Intervention in the Patient with Stable Angina — George D. Dangas, New York, NY
noon
ACC.12 • Sunday, March 25, 2012
156 GO for ACC.12!
NooN
12:57 ACS, Optimal Adjunct Pharmacology — Dean J. Kereiakes, Cincinnati, OH
1:09 Imaging and Physiology — Gary S. Mintz, Washington, DC
1:21 Endovascular Intervention — Michael R. Jaff, Boston, MA
1:33 Adult Structural and Valvular Intervention — Alan Zajarias, Saint Louis, MO
ACC-i2/TCT
SPECIAl
2101
Cardiac Care Team Session I: Keynote AddressSunday, March 25, 2012, 12:30 p.m. – 1:00 p.m.McCormick Place South, S103bCME/CNE Hours: 1
Chair: Janet Fredal Wyman, Detroit, MI
12:30 Keynote Address: Team-based Care — David R. Holmes, Jr., Rochester, MN
12:50 Discussion
ACC-i2/TCT
ExPErTS
2308
Aortic Valve Case reviewsSunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place South, S101aCME/CNE Hours: 1.5
Co-Chairs: John G. Webb, Vancouver, Canada Allan Schwartz, New York, NY
Case Itsik Ben-Dor, Washington, DC, Sammy Elmariah,Presenters: Boston, MA, Amar Krishnaswamy, Cleveland, OH,
Atman P. Shah, Chicago, IL
Panelists: Vasilis Babaliaros, Atlanta, GA, Raoul Bonan, Montreal, Canada, Raj R. Makkar, Los Angeles, CA
ACC-i2/TCT
ExPErTS
2309
Coronary Complications Case reviewsSunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place South, S102bCME/CNE Hours: 1.5
Co-Chairs: Paul S. Teirstein, La Jolla, CA Jeffrey J. Popma, Newton, MA
Case Hajime Iwama, Nara, Japan, Gautam Kumar, Atlanta, Presenters: GA, Sunil Naik, Southfield, MI, Sowmya Sreekanth,
New York, NY, Sergio Gustavo Tarbine, Curitiba, Brazil
Panelists: David Alan Cox, Allentown, PA, Stephen G. Ellis, Cleveland, OH,James Bernard Hermiller, Indianapolis, IN
ACC-i2/TCT
ExPErTS
2310
Multivessel and Hemodynamic Support Case reviewsSunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place South, S102cCME/CNE Hours: 1.5
Co-Chairs: Igor F. Palacios, Boston, MA Zoltan G. Turi, Camden, NJ
Case David Bartov, Mineola, NY, Carlos Deluca, Buenos Presenters: Aires, Argentina, Sammy Elmariah, Boston, MA,
Saurabh Kumar Gupta, New Delhi, India, Suresh Vijaybasappa Patted, Belgaum, India
Panelists: John Hirschfeld, Philadelphia, PA, Nicola Corjava, Stamford, CT, Charles J. Davidson, Chicago, IL
ACC-i2/TCT
SYMPOSIUM
2616
Endovascular Intervention for Venous DiseaseSunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place South, S103cCME/CNE Hours: 1.5
Co-Chairs: John Rundback, Teaneck, NJ Kenneth Rosenfield, Boston, MA
12:30 Patient Selection and Indications for Endovascular Intervention in Acute DVT — Kenneth Rosenfield, Boston, MA
12:43 Debate: Provisional Stenting is the Treatment of Choice for Acute DVT — Stephan Wicky, Boston, MA
12:55 Debate: Primary Stenting is the Treatment of Choice for Acute DVT — Mohsen Sharifi, Mesa, AZ
1:07 IVC Filter Placement and retrieval: Indication, Types and Technique — Tino Pena, Miami, FL
1:20 Endoluminal Ablative Therapy of Saphenous Venous System — Step-by-Step — laser or rF, or Does it Matter — Raghu Kolluri, Springfield, IL
1:33 Case Presentation: Endovascular Intervention to Treat Acute Venous Thromboembolism — Robert Schainfeld, Waltham, MA
ACC-i2/TCT
SYMPOSIUM
2617
Platelet Inhibition in 2012: What You Need To KnowSunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place South, S106bCME/CNE Hours: 1.5
Co-Chairs: C. Michael Gibson, Boston, MA Neal S. Kleiman, Houston, TX
12:30 Debate: Genotyping and Point of Care Platelet Function Testing Are ready for Prime Time — Dominick J. Angiolillo, Jacksonville, FL
12:40 Debate: Genotyping and Point of Care Platelet Function Testing Are Not Yet Clinically Useful — Marc Steven Sabatine, Boston, MA
12:50 Optimizing DAPT — Matthew J. Price, La Jolla, CA
1:00 DAPT: Issues regarding Duration, Safe Interruption and Discontinuation — Laura Mauri, Boston, MA
1:10 Triple Therapy: DAPT plus Thrombin Inhibition — Harvey D. White, Auckland 1142, New Zealand
1:20 New Insights into Drug-Drug Interactions — Paul A. Gurbel, Baltimore, MD
1:30 Novel Strategies for Anticoagulation and Platelet Inhibition — David J. Moliterno, Lexington, KY
1:40 Panel Discussion
ACS
SYMPOSIUM
639
The Future of ACS Clinical TrialsSunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place South, S404CME/CNE Hours: 1.25
Co-Chairs: Paul Wayne Armstrong, Edmonton, Canada Robert A. Harrington, Durham, NC
12:30 Clinical Trial Endpoints Today and Tomorrow — Sunil V. Rao, Durham, NC
Sunday, March 25, 2012 • ACC.12
ACC.12 Final Program 157
NooN
12:42 Clinical Trials in the Age of Comparative Effectiveness — Sanjay Kaul, Los Angeles, CA
12:54 The Current and Future State of Clinical Trial Funding: The role of Industry and Non-Industry Sources — Robert A. Harrington, Durham, NC
1:07 Clinical Trials in the Trenches: Is it Worth Being a Site in a Trial Any More? US Perspective — Giora Weisz, New York, NY
1:20 Clinical Trials in the Trenches: OUS Perspective — Lars Wallentin, Uppsala, Sweden
1:32 Summary — Paul Wayne Armstrong, Edmonton, Canada
Arr
SYMPOSIUM
640
Joint Symposium of the Heart rhythm Society and the American College of Cardiology: Investigation and Management of SyncopeSunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place North, N426CME/CNE Hours: 1.25
Co-Chairs: Julia H. Indik, Tucson, AZ Robert S. Sheldon, Calgary, Canada
12:30 risk Stratification of the Patient who Presents with Syncope — David G. Benditt, Minneapolis, MN
12:45 The role of Tilt Table Testing and Ilrs — Andrew D. Krahn, London, Canada
1:00 Management of Neuromediated Syncope — Carlos A. Morillo, Hamilton, Canada
1:15 Treatment of Postural Tachycardia Syndrome (POTS) — Satish Raj, Nashville, TN
1:30 Question and Answer
CCS
SPECIAl
301
Career & Mentoring Session for Pediatric and Congenital CardiologistsSunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place North, N231CME/CNE Hours: 1.25
Chair: Jeffrey A. Towbin, Cincinnati, OH
Panelists: Charles Berul, Washington, DC, Mark B. Lewin, Seattle, WA, Lloyd Y. Tani, Salt Lake City, UT
12:30 Welcome and Introduction — Jeffrey A. Towbin, Cincinnati, OH
12:35 How Do You Choose a Fourth Year Fellowship? — Mark B. Lewin, Seattle, WA
12:45 How I Found the right Mentor — John L. Jefferies, Cincinnati, OH
12:55 Financing and Health Care reform — James W. Fasules, Washington, DC
1:05 How Do I Interview for a Job? — Girish S. Shirali, Charleston, SC
1:15 Panel Discussion: Choosing a Job and lasting in It
1:35 Question and Answer
HF
ExPErTS
228
Cardiac Mr for the Evaluation of the Heart Failure PatientSunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place South, S502CME/CNE Hours: 1.25
Chair: Subha V. Raman, Columbus, OH
Case Presenter: Erik Schelbert, Pittsburgh, PA
Panelists: Sanjeev A. Francis, Boston, MA, Mario J. Garcia, Bronx, NY, Matthias Friedrich, Calgary, Canada
HF
SYMPOSIUM
641
Joint Symposium of the Heart Failure Society of America and the American College of Cardiology: Contemporary Issues in the Diagnosis and Treatment of Chronic Ambulatory Heart FailureSunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place South, S406bCME/CNE Hours: 1.25
Co-Chairs: David DeNofrio, Boston, MA G. Michael Felker, Durham, NC
12:30 Imaging the Heart Failure Patient: Which Patients and What Modality: Echo — Scott D. Solomon, Boston, MA
12:45 Imaging the Heart Failure Patient: Which Patients and What Modality: Nuclear — James E. Udelson, Boston, MA
1:00 Imaging the Heart Failure Patient: Which Patients and What Modality: Mr — Joao A. C. Lima, Baltimore, MD
1:15 The Evolving role of Biomarkers in the Management of Heart Failure Patients — James L. Januzzi, Jr., Boston, MA
1:30 Exercise and the Heart Failure Patient: Why, Who and How? — Ileana L. Pina, Cleveland Heights, OH
HF
SYMPOSIUM
642
Cardiotoxicity of Cancer Chemotherapy: Molecular Basis and Strategies for Early Detection and PreventionSunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place South, S405CME/CNE/CPE Hours: 1.25 ACPE No. 0012-9999-12-137-l01-P
Co-Chairs: Anceta Fadol, Houston, TX Edward T. Yeh, Houston, TX
12:30 Cardiotoxicity of Cancer Chemotherapeutic Agents: The Extent and Magnitude of Problem and Clinical Evidence — Daniel J. Lenihan, Nashville, TN
12:45 Cellular Basis of Myocardial Injury and left Ventricular Dysfunction with Cancer Chemotherapy — Raymond R. Russell, New Haven, CT
1:00 Monitoring of left Ventricular Function during Chemotherapy — Davinder Jassal, Winnipeg, Canada
1:15 Biomarkers for Cardiotoxicity — Bonnie Ky, Philadelphia, PA
1:30 Novel Methods to Prevent and Image Cardiotoxicity — Ban-An Khaw, Boston, MA
ACC.12 • Sunday, March 25, 2012
158 GO for ACC.12!
NooN
IMAG
SYMPOSIUM
643
Joint Symposium of the American Society of Echocardiography and the American College of Cardiology: Interventional Echocardiography — Evolving role in Patient ManagementSunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place South, S406aCME/CNE Hours: 1.25
Co-Chairs: Issam A. Mikati, Chicago, IL Patricia A. Pellikka, Rochester, MN
12:30 Echo in the EP lab (lAA Closure Devices) — Frank E. Silvestry, Wayne, PA
12:46 Echo in the Cath lab (Mr, TAVI, Perivalvular regurgitation Closure) — Rebecca T. Hahn, New York, NY
1:02 Echo in Assessment of Heart Failure Devices — Jerry Estep, Houston, TX
1:18 Echo in the Interventional ACHD lab (ASD, VSD) — Frank E. Silvestry, Wayne, PA
1:34 Question and Answer
IMAG
SYMPOSIUM
644
Cost-Effective Imaging in Patients with Chronic CADSunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place South, S403CME/CNE Hours: 1.25
Co-Chairs: Kirsten E. Fleischmann, San Francisco, CA R. Parker Ward, Chicago, IL
12:30 What Is Cost-Effective Imaging? — Rita F. Redberg, San Francisco, CA
12:45 role of CMr — Christopher M. Kramer, Charlottesville, VA
1:00 role of Nuclear Imaging — Rory Hachamovitch, Cleveland, OH
1:15 role of CT — Matthew J. Budoff, Torrance, CA
1:30 role of Echo — Pamela S. Douglas, Durham, NC
ISCHEM
SYMPOSIUM
645
Managing High-risk Patients with Stable Ischemic Heart DiseaseSunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place South, S401aCME/CNE/CPE Hours: 1.25 ACPE No. 0012-9999-12-138-l04-P
Co-Chairs: Bernard J. Gersh, Rochester, MN Rhondalyn McLean, Baltimore, MD
12:30 Diabetic Patients: replacing Fallacies with Facts — Darren K. McGuire, Dallas, TX
12:42 Question and Answer
12:48 Chronic Kidney Disease: What Should I Do for These Patients? — Amy W. Williams, Rochester, MN
1:00 Question and Answer
1:07 Elderly Patients: Treatment Pearls and Pitfalls — Karen P. Alexander, Durham, NC
1:20 Question and Answer
1:26 Minorities: How Does race/Ethnicity Affect Our Approach? — Keith C. Ferdinand, Atlanta, GA
1:38 Question and Answer
lIFElONG
MOC
811
ACCF Study Session for Maintenance of Certification: ABIM recertification Made Easy — ACC General Cardiology Module Part ASunday, March 25, 2012, 12:30 p.m. – 3:00 p.m.McCormick Place South, S105aCME Hours: 2.5
ACCF’s Maintenance of Certification Sessions allows you to easily obtain ABIM’s Maintenance of Certification (MOC) points during at ACC.12. Tickets are required for admittance to this session. Ticketed registrants must arrive no later than 15 minutes before the start of the session. Seats will be released at this time and an “open seating” policy will apply.
Attendees must be enrolled in the ABIM’s MOC program to claim MOC points. If you are not enrolled, please allow sufficient time to do this prior to the start of the session. ABIM staffs are available onsite to answer your MOC questions and help with enrollment.
For convenience, there will be computer terminals in the ACC MOC Center onsite in Room S104b for attendees to take the ABIM MOC test after the study session concludes, if desired. Electrical power is provided in the classrooms so that attendees who wish to bring their own devices may ‘power up’ to access relevant question modules.
Access to the online modules will also be available for participants for a short period of time following the annual meeting.
Attendees may not claim CME credits from ABIM as it is against ACCME and AMA guidelines to claim credit twice for the same activity. MOC credit is available from the ABIM after completion of the MOC module; CME credit only (no CNE credit) is available from ACC.
Chair: Jeffrey J. Cavendish, San Diego, CA
MOC Faculty: Maya E. Guglin, Tampa, FL, John A. McPherson, Nashville, TN
lIFElONG
MOC
812
ACCF Study Session for Maintenance of Certification: ABIM recertification Made Easy — ACC General Cardiology Module Part BSunday, March 25, 2012, 12:30 p.m. – 3:00 p.m.McCormick Place South, S105dCME Hours: 2.5
ACCF’s Maintenance of Certification Sessions allows you to easily obtain ABIM’s Maintenance of Certification (MOC) points during at ACC.12. Tickets are required for admittance to this session. Ticketed registrants must arrive no later than 15 minutes before the start of the session. Seats will be released at this time and an “open seating” policy will apply.
Attendees must be enrolled in the ABIM’s MOC program to claim MOC points. If you are not enrolled, please allow sufficient time to do this prior to the start of the session. ABIM staffs are available onsite to answer your MOC questions and help with enrollment.
For convenience, there will be computer terminals in the ACC MOC Center onsite in Room S104b for attendees to take the ABIM MOC test after the study
Sunday, March 25, 2012 • ACC.12
ACC.12 Final Program 159
NooN
session concludes, if desired. Electrical power is provided in the classrooms so that attendees who wish to bring their own devices may ‘power up’ to access relevant question modules.
Access to the online modules will also be available for participants for a short period of time following the annual meeting.
Attendees may not claim CME credits from ABIM as it is against ACCME and AMA guidelines to claim credit twice for the same activity. MOC credit is available from the ABIM after completion of the MOC module; CME credit only (no CNE credit) is available from ACC.
Chair: Kyle W. Klarich, Rochester, MN
MOC Faculty: Douglas E. Drachman, Boston, MA, Jeffrey T. Kuvin, Boston, MA
PErI
ExPErTS
229
Grasping the Complexity of Myocardial and Pericardial DiseasesSunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place South, S505CME/CNE Hours: 1.25
Chair: Jae K. Oh, Rochester, MN
Case Alex J. Auseon, Columbus, OH, Scott Silvestry, Presenters: Philadephia, PA, Mauricio Velez, Detroit, MI
Panelists: William Little, Winston Salem, NC, Sunil V. Mankad, Rochester, MN
PErI
SYMPOSIUM
648
The New Hypertrophic Cardiomyopathy Practice GuidelinesSunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place North, N226CME/CNE Hours: 1.25
Co-Chairs: Harry M. Lever, Solon, OH Steve R. Ommen, Rochester, MN
12:30 Genetic Testing: The Basics and What You and Your Patient Need to Know — Michael J. Ackerman, Rochester, MN
12:42 Echocardiography: 2-D, Doppler and Strain Imaging — Milind Y. Desai, Cleveland, OH
12:55 Cardiac MrI: Diagnosis and risk Stratification — Martin S. Maron, Boston, MA
1:07 The Importance of Myocardial Ischemia — Perry M. Elliott, London, United Kingdom
1:20 risk Stratification: Who Gets an ICD? — Matthew W. Martinez, Allentown, PA
1:32 Septal reduction Therapy: Surgery or Ablation? — Paul Sorajja, Rochester, MN
PHTN
SYMPOSIUM
649
Emerging Approaches to Pulmonary Hypertension with left Ventricular DysfunctionSunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place South, S402CME/CNE Hours: 1.25
Co-Chairs: Teresa De Marco, San Francisco, CA Michael A. Mathier, Pittsburgh, PA
12:30 Prevalence and Significance of Pulomary Hypertension in left Ventricular Dysfunction — Selma Mohammed, Rochester, MN
12:45 Approach to the Dyspneic Patient with Echocardiographic Evidence of Pulmonary Hypertension: PAH, HFpEF or Both? — Paul Forfia, Philadelphia, PA
1:00 Characterization of PH in lVD: Beyond resting Hemodynamic Measurements — Gregory D. Lewis, Boston, MA
1:15 lessons learned from Continuous Pulmonary Arterial Pressure Measurements in Heart Failure Patients: Emerging roles for Implantable Monitoring Devices — Robert C. Bourge, Birmingham, AL
1:30 Targeted Therapy for Pulmonary Hypertension in left Ventricular Dysfunction — Marc J. Semigran, Boston, MA
PrACTICE
SYMPOSIUM
647
Joint Session of the Healthcare Information and Management Systems Society and the American College of Cardiology: Health Information Technology Part I: Making the Electronic Health record Meaningful and Useful — A Washington PerspectiveSunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place North, N227bCME/CNE Hours: 1.25
Chair: John R. Windle, Omaha, NE
Panelists: Alfred A. Bove, Philadelphia, PA, Michael J. Mirro, Fort Wayne, IN, James E. Tcheng, Durham, NC
12:30 Introduction to Keynote Speaker — Jack Lewin, Washington, DC
12:35 A View from the Top: Meaningful Use Present and Future — Farzad Mostashari, Washington, DC
1:15 Panel Discussion
PrEV
ExPErTS
230
Management of Hypertension in the ElderlySunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place South, S501aCME/CNE/CPE Hours: 1.25 ACPE No. 0012-9999-12-128-l01-P
Chair: George L. Bakris, Chicago, IL
Case Presenter: Michael Chen, Seattle, WA
Panelists: Stanley S. Franklin, Irvine, CA, Carey D. Kimmelstiel, Boston, MA, Marvin Moser, Scarsdale, NY
SPECIAl
SPECIAl
111
FIT Forum III: How to Write and Evaluate Medical Journal ArticlesSunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place North, N229CME/CNE Hours: 1.25
Chair: Anthony N. DeMaria, San Diego, CA
12:30 How to Write Publishable Papers (with Examples of Do’s and Don’ts) — Anthony N. DeMaria, San Diego, CA
12:45 Discussion with Audience Question and Answer
ACC.12 • Sunday, March 25, 2012
160 GO for ACC.12!
NooN
12:55 How to revise Your Manuscript — Jagat Narula, New York, NY
1:10 Discussion with Audience Question and Answer
1:20 Evaluating a research Paper: What Constitutes a Good review — Spencer B. King, Atlanta, GA
1:35 Discussion with Audience Question and Answer
TEST
SYMPOSIUM
651
role of Exercise Treadmill Testing in 2012Sunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place North, N230CME/CNE Hours: 1.25
Co-Chairs: Brian G. Abbott, East Greenwich, RI Gerald F. Fletcher, Jacksonville, FL
12:30 Standard Treadmill Assessment: What’s the role for a low-Tech Test in a High-Tech World? — Todd D. Miller, Rochester, MN
12:42 risk Stratification: looking Beyond the ECG during Stress Testing — Michael S. Lauer, Bethesda, MD
12:54 Pearls and Pitfalls in Exercise Testing — Daniel E. Forman, Boston, MA
1:06 Approach to Stress Testing in Patients with Pacemakers, Defibrillators and resynchronization Devices — Derek V. Exner, Calgary, Canada
1:18 Cardiopulmonary Exercise Testing: Indications and Utility — Ross Arena, Albuquerque, NM
1:30 Question and Answer
VAlV
SYMPOSIUM
652
Controversies in Valve Disease ISunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place North, N427CME/CNE Hours: 1.25
Co-Chairs: Blase A. Carabello, Houston, TX William A. Zoghbi, Houston, TX
12:30 TAVI Should Be reserved for Inoperable Patients — Thoralf Sundt, Boston, MA
12:43 TAVI Should Not Be reserved for Inoperable Patients — Martin B. Leon, New York, NY
1:02 Summary
1:08 Mitral E-Clip Is a reasonable Option for Functional Mr — Saibal Kar, Los Angeles, CA
1:21 Mitral E-Clip Is Not a reasonable Option for Functional Mr — Robert Dion, Belgium
1:40 Summary
Afternoon SeSSionS
ACC-i2/TCT
SPECIAl
2102
Cardiac Care Team Session II: Cath lab of Tomorrow — Pathway to a High-risk Aortic Valve ProgramSunday, March 25, 2012, 1:00 p.m. – 2:30 p.m.McCormick Place South, S103bCME/CNE Hours: 1
Co-Chairs: Marian Hawkey, New York, NY Janet Fredal Wyman, Detroit, MI
1:00 Setting up an Aortic Valve Program — Sandra Lauck, Vancouver, Canada
1:12 Who is the Severe Aortic Stenosis Patient? — Marian Hawkey, New York, NY
1:24 Gathering the Data/Coordinating the Assessment Process — Jasminka Stegic, Los Angeles, CA
1:36 Psychosocial Issues with High risk Aortic Stenosis — Martina Speight, Stanford, CA
1:48 Inter-professional Decision-making: Playing in the Same Sandbox — Todd M. Dewey, Dallas, TX
2:00 Preparing Your Cath lab for an Aortic Valve Program — Michael Guiry, New York, NY
2:12 Anticipating Post-procedure Needs Pre-procedure — Susan Schnell, New York, NY
2:24 Panel Discussion
ACC-i2/TCT
SPECIAl
2131
Anatomy and Transcatheter Therapy for the Structural Heart Interventionalist I: Mitral and Aortic Valve (with remote Demonstrations from the Seattle Science Foundation)Sunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S102cCME/CNE Hours: 1.5
Remote Mark Reisman, Seattle, WADemonstrator:
Co-Chairs: Nicolo Piazza, Montreal, Canada Ted Feldman, Evanston, IL
Panelists: Saibal Kar, Los Angeles, CA, Frank E. Silvestry, Wayne, PA
2:00 Mitral Valve Anatomy — Mark Reisman, Seattle, WA
2:15 Mitral Valve Case Presentation — Speaker TBD
2:20 Case Presentation: Mitral Annuloplasty — Steven L. Goldberg, Seattle, WA
2:25 Mitral Valve Devices — Mark Reisman, Seattle, WA
2:40 Aortic Valve Anatomy — Mark Reisman, Seattle, WA
2:55 Case Presentation: Transfemoral of Balloon Expandable TAVr — Susheel Kodali, New York, NY
3:00 Case Presentation: Transapical of Balloon Expanding TAVr — Michael J. Mack, Plano, TX
3:05 Anatomical Prespectives for a Balloon Expandable Aortic Valve — Mark Reisman, Seattle, WA
3:20 Case Presentation: Transfemoral of a Self Expandable TAVr — Nicolo Piazza, Montreal, Canada
3:25 Anatomical Perspectives for a Self Expandable TAVr — Mark Reisman, Seattle, WA
Afte
rnoo
n
Sunday, March 25, 2012 • ACC.12
ACC.12 Final Program 161
AFTERNOON
ACC-i2/TCT
CASE rEVIEW
2202
live and Taped Case Session II: left Main and Bifurcation- Complex PCISunday, March 25, 2012, 2:00 p.m. – 5:00 p.m.McCormick Place North, Hall B, ACC.12 Main TentCME/CNE Hours: 3
Co-Chairs: Dean J. Kereiakes, Cincinnati, OH Raj R. Makkar, Los Angeles, CA
Panelists: Alexandre Abizaid, Sao Paulo, Brazil, Manish Parikh, New York, NY, Alaide Chieffo, Milan, Italy, Matthew J. Price, La Jolla, CA, John A. Ormiston, Auckland, New Zealand, John M. Lasala, Saint Louis, MO, Seung-Jung Park, Seoul, Republic of Korea
2:00 live Case from the University of Pennsylvania, Philadelphia, PA — Howard C. Herrmann, Philadelphia, PA
3:30 Surgery versus PCI for lMCA revascularization: The Surgeon’s Perspective — David Taggart, Oxford, United Kingdom
3:40 Surgery versus PCI for lMCA revascularization: The Interventionalist’s Perspective — David E. Kandzari, Atlanta, GA
3:50 Panel Discussion
4:00 Practical Approach to Non-left Main Bifurcation Disease: Techniques and Outcomes — Corrado Tamburino, Catania, Italy
4:15 Taped Case from Baylor, Houston, Tx — Neal S. Kleiman, Houston, TX
ACC-i2/TCT
SYMPOSIUM
2618
Imaging Transcatheter Aortic Valve Procedures I: Intra- and Post-procedural ImagingSunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S101aCME/CNE Hours: 1.5
Co-Chairs: William J. Stewart, Cleveland, OH Victoria Delgado, Leiden, Netherlands
2:00 Multi-modality Imaging for Intra-procedural THV Positioning: Balloon-expandable THV — Susheel Kodali, New York, NY
2:10 Multi-modality Imaging for Intra-procedural THV Positioning: Self-expanding THV — Nicolo Piazza, Montreal, Canada
2:20 Multi-modality Imaging for Intra-procedural THV Positioning: Is TEE Necessary for TAVr? — Sherif F. Nagueh, Houston, TX
2:30 Predicting and Managing TAVr Complications: Nuances in Evaluation and Management of Perivalvular leak — Stamatios Lerakis, Atlanta, GA
2:40 Predicting and Managing TAVr Complications: Hemodynamic Emergencies — the role of TEE — Rebecca T. Hahn, New York, NY
2:50 Post-procedural Imaging of Embolic Events: CT, MrI, Transcranial Doppler — TBD
3:00 Post-procedural CT Evaluation: What Have We learned? — Jonathan Leipsic, Vancouver, Canada
3:10 Panel Discussion: THV Misadventures and Their Management
ACC-i2/TCT
SYMPOSIUM
2619
Emerging TechnologiesSunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S102bCME/CNE Hours: 1.5
Co-Chairs: Mathew Williams, New York, NY Alan Zajarias, Saint Louis, MO
2:00 large Bore Femoral Artery Closure — Vasilis Babaliaros, Atlanta, GA
2:10 Percutaneous Transapical TAVr/Closure Devices — Lars G. Svensson, Cleveland, OH
2:20 Embolic Protection during TAVr — John G. Webb, Vancouver, Canada
2:30 New Mitral repair and replacement Technology — Jason H. Rogers, Sacramento, CA
2:40 PFO and lAA Devices — Horst Sievert, Frankfurt, Germany
2:50 New Aortic Valves: Transfemoral — Steven R. Bailey, San Antonio, TX
3:00 New Aortic Valves: Transapical — Thomas Walther, Bad Nauheim, Germany
3:10 New Imaging Technology: Echo 4-D, ICE — Itzhak Kronzon, New York, NY
3:20 Minimally Invasive Aortic repair and replacement — Eric Roselli, Cleveland, OH
ACC-i2/TCT
SYMPOSIUM
2620
Peripheral Artery Disease: Superficial Femoral ArterySunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S103cCME/CNE Hours: 1.5
Co-Chairs: D. Christopher Metzger, Kingsport, TN Peter Angelopoulos, Garden City, NY
2:00 What is the role of Covered Stents for Iliac and Fem-Pop Stenosis/Occlusions in 2012? — Matthew T. Menard, Boston, MA
2:15 Debate: Provisional Stenting is the Treatment of Choice for 7–10 cm Fem-Pop lesions — Speaker TBD
2:30 Debate: Primary Stenting is the Treatment of Choice for 7–10 cm Fem-Pop lesions — Mehdi H. Shishehbor, Cleveland, OH
2:45 Step-by-Step Approach to long Superficial Femoral Artery Occlusion: What Are the Options? — Ivan P. Casserly, Aurora, CO
3:00 Drug Eluting Balloons: Where Do We Stand in 2012? — Herbert Aronow, Ypsilanti, MI
3:15 Case-based Presentation: How to Manage In-stent restenosis and Complications Associated with Fem-Pop Endovascular Intervention — Peter Angelopoulos, Garden City, NY
ACC.12 • Sunday, March 25, 2012
162 GO for ACC.12!
AFTE
RNOO
N
ACC-i2/TCT
SYMPOSIUM
2621
Chronic Total OcclusionsSunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S106bCME/CNE Hours: 1.5
Co-Chairs: Jeffrey W. Moses, New York, NY Masahiko Ochiai, Kanagawa, Japan
2:00 Accessory Imaging (MSCT and/or IVUS) in Procedural Planning and Execution — Yuji Oikawa, Tokyo, Japan
2:15 Step-by-Step Moderately Difficult Antegrade Techniques — Alfredo R. Galassi, Aicastello, Italy
2:30 Step-by-Step retrograde Techniques — Etsuo Tsuchikane, Toyohashi, Japan
2:45 Dissection and re-entry Facilitated CTO-PCI — James Aaron Grantham, Kansas City, MO
3:00 A Multitechnique Case (the Hybrid Approach) — William L. Lombardi, Bellingham, WA
3:15 Complications and Pitfalls of CTO-PCI — TBD
ACS
ExPErTS
231
Management of Chest Pain in the Emergency DepartmentSunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S504aCME/CNE Hours: 1.5
Chair: Ezra A. Amsterdam, Sacramento, CA
Case Presenter: Mario Goessl, Rochester, MN
Panelists: Kim A. Eagle, Ann Arbor, MI, Judd Hollander, Philadelphia, PA, James K. Min, New York, NY
ACS
SYMPOSIUM
653
State-of-the-Art in Non ST Elevation ACSSunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S404CME/CNE Hours: 1.5
Co-Chairs: James A. De Lemos, Dallas, TX Shaun G. Goodman, Toronto, Canada
2:00 Emerging Tools for risk Assessment in NSTE ACS — Bertil Lindahl, Uppsala, Sweden
2:15 Navigating Antiplatelet and Antithrombotic Choices in the Generic Clopidogrel Era — Stefan K. James, Uppsala, Sweden
2:30 Selection and Timing for Invasive Therapy in NSTE ACS — Alexandra J. Lansky, New York, NY
2:45 Safety Cost and Quality Are the New Drivers of NSTE ACS Care — Matthew T. Roe, Durham, NC
3:00 ACS Guidelines Are Evidence-Based, User-Friendly and Practical — Alice K. Jacobs, Boston, MA
3:10 ACS Guidelines Are Not Evidence-Based, User-Friendly and Practical — James M. Brophy, Montreal, Canada
3:20 Discussion
Arr
ExPErTS
232
Joint Symposium of the Heart rhythm Society and the American College of Cardiology: Optimizing the Management of the Patient with Implantable DevicesSunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S503CME/CNE Hours: 1.5
Chair: Bruce L. Wilkoff, Cleveland, OH
Panelists: Kenneth A. Ellenbogen, Richmond, VA, Derek V. Exner, Calgary, Canada, Bernard Thibault, Montreal, Canada
Arr
SYMPOSIUM
654
Joint Symposium of the Heart rhythm Society and the American College of Cardiology: Atrial Fibrillation — Prevention of StrokeSunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place North, N426CME/CNE Hours: 1.5
Co-Chairs: Richard I. Fogel, Carmel, IN Anne M. Gillis, Calgary, Canada
2:00 role of Anticoagulants — Michael M. Ezekowitz, Wynnewood, PA
2:20 risk Stratification for Stroke: CHADs2 versus CHA2DS2-VASc — A. John Camm, London, United Kingdom
2:40 risk Stratification for Bleeding Complications: HASBlED vs. ATrIA Study — Greg C. Flaker, Columbia, MO
3:00 Implementing the AF Guidelines into Clinical Practice — Eric N. Prystowsky, Indianapolis, IN
3:20 Question and Answer
CCS
lEGENDS
402
legends of Cardiovascular Medicine lecture Series — 2012 Dan G. McNamara lectureSunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place North, N228CME/CNE Hours: 1.5
Co-Chairs: Kathy J. Jenkins, Boston, MA Roberta G. Williams, Los Angeles, CA
2:00 Welcome and Overview of Session — Kathy J. Jenkins, Boston, MA
2:05 reflecting on McNamara lecture — Daniel J. Murphy, Palo Alto, CA
2:10 Introduction of Dr. Jane Somerville — Roberta G. Williams, Los Angeles, CA
2:15 2012 Dan G. McNamara lecture: Fifty Years with Cardiac Surgeons — Jane Somerville, London, United Kingdom
2:45 Question and Answer — Carole A. Warnes, Rochester, MN
3:05 Panel Discussion: lifelong Care of the CHD Patient
Chair: Kathy J. Jenkins, Boston, MA
Panelists: Gerard R. Martin, Washington, DC, Daniel J. Murphy, Palo Alto, CA, Jane Somerville, London, United Kingdom, James S. Tweddell, Milwaukee, WI, Carole A. Warnes, Rochester, MN, Roberta G. Williams, Los Angeles, CA
Sunday, March 25, 2012 • ACC.12
ACC.12 Final Program 163
AFTERNOON
HF
SYMPOSIUM
655
Joint Symposium of the Heart Failure Society of America and the American College of Cardiology: The Growing role of Devices in Heart Failure Management — ICD, CrT, Hemodynamic Monitoring and UltrafiltrationSunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S406bCME/CNE Hours: 1.5
Co-Chairs: Andrew E. Epstein, Philadelphia, PA Mandeep R. Mehra, Baltimore, MD
2:00 Current Indications and Outcomes with ICD Therapy — Arthur J. Moss, Rochester, NY
2:20 Optimal Use of Cardiac resynchronization Therapy — Jagmeet Singh, Boston, MA
2:40 Current and Future role of Implantable Hemodynamic Monitoring — William T. Abraham, Columbus, OH
3:00 Advantages and Pitfalls of Ultrafiltration Therapy — Bradley Bart, Minneapolis, MN
3:20 Question and Answer
HF
SYMPOSIUM
656
The NHlBI Heart Failure Clinical Trials Network: A New Paradigm for Investigation and TrainingSunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S405CME/CNE Hours: 1.5
Co-Chairs: Eugene Braunwald, Boston, MA Alice M. Mascette, Bethesda, MD
2:00 The Changing Face of Heart Failure in the United States and Implications for Clinical Trials — Douglas L. Mann, Saint Louis, MO
2:15 The Structure and Mission of the NHlBI Network — Alice M. Mascette, Bethesda, MD
2:30 Study Design and Outcome Analysis in Clinical Heart Failure Trials: Selecting Meaningful Endpoints — Kerry Lee, Durham, NC
2:45 Clinical Implications of Competed Network Clinical Trials (DOSE-HF, rElAx, CArESS) — Margaret M. Redfield, Rochester, MN
3:00 Ongoing and Planned Network Clinical Trials: Focus on Innovative Therapies — Elizabeth Ofili, Atlanta, GA
3:15 Ancillary Studies and Biomarkers in Network Trials — Robb D. Kociol, Durham, NC
IMAG
ExPErTS
233
role of CMr in Valvular Heart DiseaseSunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S505CME/CNE Hours: 1.5
Chair: Raymond J. Kim, Durham, NC
Case Tandeep K. Bhatti, New York, NY, Lubna Choudhury, Presenters: Chicago, IL
Panelists: Mario J. Garcia, Bronx, NY, Seth Uretsky, New York, NY
IMAG
SYMPOSIUM
657
Joint Symposium of the American Society of Echocardiography and the American College of Cardiology: Healthcare reform — Impact on ImagingSunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S406aCME/CNE Hours: 1.5
Chair: Thomas John Ryan, Columbus, OH
2:00 Impact of HCr on Imaging: Current Status — Benjamin F. Byrd, III, Nashville, TN
2:15 What to Expect and What to do About It — Michael H. Picard, Boston, MA
2:30 Appropriate Use Criteria, Quality and the Available Evidence — Neil J. Weissman, Washington, DC
2:45 HCr: Impact on Technology — Patricia A. Pellikka, Rochester, MN
3:00 Panel Discussion
IMAG
SYMPOSIUM
658
radionuclide Imaging in the Heart Failure PatientSunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S403CME/CNE Hours: 1.5
Co-Chairs: James E. Udelson, Boston, MA Kim Allan Williams, Detroit, MI
2:00 Myocardial Perfusion Imaging in the Heart Failure Patient — Gary V. Heller, Hartford, CT
2:18 Assessment of lV Function in the Heart Failure Patient — E. Gordon DePuey, III, New York, NY
2:36 Selecting Patients for Coronary revascularization: Should We Assess Viability? — Robert O. Bonow, Chicago, IL
2:54 Guiding Device Therapy in Heart Failure — Mark I. Travin, Pleasantville, NY
3:12 Molecular Imaging in the Heart Failure Patient — Vasken Dilsizian, Baltimore, MD
ISCHEM
ExPErTS
234
Heart Failure in Stable Ischemic Heart Disease: Not for the Weak of HeartSunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S502CME/CNE Hours: 1.5
Chair: Brooks Edwards, Rochester, MN
Case Mustafa Ahmed, Jacksonville, FL, Erin Bohula, Presenters: Boston, MA, J. Jacob Mancuso, San Antonio, TX
Panelists: Juan M. Aranda, Gainesville, FL, Akshay S. Desai, Boston, MA, James C. Fang, Cleveland, OH, Daniel P. Judge, Baltimore, MD
lIFElONG
SYMPOSIUM
659
Master Clinician I: Discussion of Three Complex real World CasesSunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S401aCME/CNE Hours: 1.5
Co-Chairs: James B. McClurken, Philadelphia, PA Marc E. Shelton, Springfield, IL
ACC.12 • Sunday, March 25, 2012
164 GO for ACC.12!
AFTE
RNOO
N
Panelists: R. Michael Benitez, Baltimore, MD, Allan S. Jaffe, Rochester, MN, Joseph V. Messer, Chicago, IL, Shahbudin H. Rahimtoola, Los Angeles, CA, Stephen D. Wiviott, Boston, MA
2:00 Case Presentation: MI or Not? — Allan S. Jaffe, Rochester, MN
2:20 Panel Discussion
2:30 Case Presentation: Complex Mr — James B. McClurken, Philadelphia, PA
2:50 Panel Discussion
3:00 Case Presentation: Apical Ballooning? — Marc E. Shelton, Springfield, IL
3:20 Panel Discussion
lIFElONG
COrE
813
Core Curriculum: General CardiologySunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place North, N226CME/CNE Hours: 1.5
Chair: Bindi K. Shah, Philadephia, PA
2:00 Pre-Operative Cardiac risk Stratification — Joshua A. Beckman, Boston, MA
2:25 Basic Concepts of Stress Testing: When, Which Test and What Do the results Tell You — Karthikeyan Ananthasubramaniam, West Bloomfield, MI
2:50 Interventional Cardiology for the Non-Interventionalist — Sunil V. Rao, Durham, NC
3:15 Question and Answer
lIFElONG
COrE
814
Core Curriculum: Valvular Heart DiseaseSunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place North, N229CME/CNE Hours: 1.5
Chair: Alex J. Auseon, Columbus, OH
2:00 Aortic Stenosis/ Aortic Insufficiency — Maurice Enriquez-Sarano, Rochester, MN
2:25 Mitral Stenosis/Mitral regurgitation — Stephen H. Little, Houston, TX
2:50 Selection and Management Issues of the Prosthetic Valve — Salvatore Costa, Lebanon, NH
3:15 Question and Answer
PErI
SYMPOSIUM
661
Controversies in Hypertrophic CardiomyopathySunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place North, N427CME/CNE Hours: 1.5
Chair: Steve R. Ommen, Rochester, MN
2:00 HCM Is Predominantly a Disease of lVOT Obstruction — Martin S. Maron, Boston, MA
2:15 The Devil Is in Diastole in HCM — William McKenna, London, United Kingdom
2:30 Medical Therapy for Difficult Symptoms — Mark V. Sherrid, Mamaroneck, NY
2:45 The Case for Surgical Myectomy — Joseph A. Dearani, Rochester, MN
3:00 The role of Alcohol Septal Ablation — Paul Sorajja, Rochester, MN
3:15 The Utility of the ICD — Bernard J. Gersh, Rochester, MN
PHTN
SYMPOSIUM
662
Pulomary Hypertension Management in Special PopulationsSunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S402CME/CNE Hours: 1.5
Co-Chairs: Hamang M. Patel, New Orleans, LA Frances A. Rogers, Philadelphia, PA
2:00 Pulmonary Hypertension in Congenital Heart Disease — Michael Landzberg, Boston, MA
2:20 Chronic Thromboembolic Pulmonary Hypertension — William R. Auger, San Diego, CA
2:40 Pulmonary Hypertension in Pregnancy — Dianne Lynn Zwicke, Milwaukee, WI
3:00 Pulmonary Hypertension in Connective Tissue Disease — Hunter Clay Champion, Pittsburg, PA
3:20 Question and Answer
PrACTICE
SYMPOSIUM
660
Joint Session of the Healthcare Information and Management Systems Society and the American College of Cardiology: Health Information Technology Part II: EHr Implementation… lessons from the TrenchesSunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place North, N227bCME/CNE Hours: 1.5
Chair: James E. Tcheng, Durham, NC
Panelists: Jay H. Alexander, Deerfield, IL, Lee R. Goldberg, Philadelphia, PA, R. Jeffrey Westcott, Seattle, WA
2:00 Cardiology Private Practice EHr lessons — Jay H. Alexander, Deerfield, IL
2:20 large Hospital System Implementation — Lee R. Goldberg, Philadelphia, PA
2:40 Epic and Centricity EHrs — R. Jeffrey Westcott, Seattle, WA
3:00 Panel Discussion
PrEV
ExPErTS
235
Dietary Approaches for CVD Prevention: Matching the Diet to the PatientSunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S501aCME/CNE Hours: 1.5
Chair: Michael J. Wong, Los Angeles, CA
Case Erin Michos, Baltimore, MD, Malissa Jane Wood, Presenters: Boston, MA
Panelists: Catherine Christie, Jacksonville, FL, Amy Locke, Ann Arbor, MI, Elif Oral, Ann Arbor, MI, Neil Stone, Winnetka, IL
Sunday, March 25, 2012 • ACC.12
ACC.12 Final Program 165
AFTERNOON
PrEV
SYMPOSIUM
663
resistant HypertensionSunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S100cCME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-139-l04-P
Co-Chairs: Thomas D. Giles, Metairie, LA William B. White, Farmington, CT
2:00 How to Detect Pseudo resistance and White Coat Hypertension — William B. White, Farmington, CT
2:15 Detection and Management of Hyperaldosteronism — Wanpen Vongpatanasin, Dallas, TX
2:30 When and How to Assess for renovascular Disease — Stephen Textor, MN
2:45 role of New vs Old Anti-hypertensive Drug Classes — William Elliott, Yakima, WA
3:00 Baroreflex Activation Therapy and renal Sympathetic Denervation — Henry Krum, Prahran, Victoria, Australia
3:15 Use of Generic Medications in the Management of resistant Hypertension — Rhonda M. Cooper-DeHoff, Gainesville, FL
QUAl
SYMPOSIUM
664
Joint Symposium of the Association of Black Cardiologists and the American College of Cardiology: Ethnic and racial Disparities in Cardiovascular Disease — A Call to ActionSunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place North, N230CME/CNE Hours: 1.5
Co-Chairs: T. David Gbadebo, Chattanooga, TN Hector O. Ventura, New Orleans, LA
2:00 Pharmacogenomics of Heart Failure in African-Americans — Dennis M. McNamara, Pittsburgh, PA
2:12 Question and Answer
2:15 Cardiovascular Disease in Hispanics: Special Considerations — Carlos Jose Rodriguez, Winston-Salem, NC
2:27 Question and Answer
2:30 racial and Ethnic Disparities in the Complications of Atrial Fibrillation — David E. Bush, Baltimore, MD
2:42 Question and Answer
2:45 The Importance of registries in reducing Cardiovascular Disparities — Eric Peterson, Durham, NC
2:57 Question and Answer
3:00 Cardiovascular Disparities under Health Care reform: What Have We learned? — Michelle Albert, Boston, MA
3:12 Question and Answer
3:15 Keeping PACE Initiative — Karol E. Watson, Los Angeles, CA
3:27 Question and Answer
ACC-i2/TCT
SPECIAl
2103
Cardiac Care Team Session III: Medications and Other Techniques to Manage the Patient in the Cath labSunday, March 25, 2012, 2:30 p.m. – 3:30 p.m.McCormick Place South, S103bCME/CNE Hours: 1
Chair: Lisa A. Riggs, Kansas City, MO
2:30 Antiplatelet Therapy: Which One, When? — Laura Mauri, Boston, MA
2:50 The Dos and Don’ts of Beta Blockers in AMI Non-pharmacologic Techniques in Your Nursing Toolkit for Pain and Anxiety — David J. Moliterno, Lexington, KY
3:10 Non-pharmacologic Interventions to reduce Cardiac Procedure Stress — Timm Reed, Ft. Wayne, IN
SPECIAl
SPECIAl
302
Business Meeting of the CollegeSunday, March 25, 2012, 3:00 p.m. – 3:15 p.m.McCormick Place, ACC Member LoungeCME/CNE Hours: 0
Co-Chairs: David R. Holmes, Jr., Rochester, MN Thad Waites, Hattiesburg, MS Richard A. Chazal, Fort Myers, FL Alfred A. Bove, Philadelphia, PA
ACC-i2/TCT
SPECIAl
2104
Cardiac Care Team Session IV: Same Day Discharge for PCISunday, March 25, 2012, 3:30 p.m. – 5:00 p.m.McCormick Place South, S103bCME/CNE Hours: 1
Co-Chairs: Caroline Lloyd Doherty, Philadelphia, PA Sandra M. Oliver-McNeil, Farmington Hills, MI
3:30 State of the Evidence of Outpatient PCI — Gregory J. Dehmer, Temple, TX
3:45 Teamwork to Same Day Discharge: Developing the Program — Denise A. Rhodes, Hershey, PA
4:05 Case Selection: Vascular and Coronary Anatomy Issues — David Wohns, Grand Rapids, MI
4:25 A Cost and “Sense” Analysis: Is Outpatient PCI a Win-Win? — Denise K. Busman, Grand Rapids, MI
4:45 Panel Discussion
lIFElONG
MOC
815
ACCF Study Session for Maintenance of Certification: ABIM recertification Made Easy — ACC General Cardiology Module Part BSunday, March 25, 2012, 3:30 p.m. – 6:00 p.m.McCormick Place South, S105aCME Hours: 2.5
ACCF’s Maintenance of Certification Sessions allows you to easily obtain ABIM’s Maintenance of Certification (MOC) points during at ACC.12. Tickets are required for admittance to this session. Ticketed registrants must arrive no later than 15 minutes before the start of the session. Seats will be released at this time and an “open seating” policy will apply.
Attendees must be enrolled in the ABIM’s MOC program to claim MOC points. If you are not enrolled,
ACC.12 • Sunday, March 25, 2012
166 GO for ACC.12!
AFTE
RNOO
N
please allow sufficient time to do this prior to the start of the session. ABIM staffs are available onsite to answer your MOC questions and help with enrollment.
For convenience, there will be computer terminals in the ACC MOC Center onsite in Room S104b for attendees to take the ABIM MOC test after the study session concludes, if desired. Electrical power is provided in the classrooms so that attendees who wish to bring their own devices may ‘power up’ to access relevant question modules.
Access to the online modules will also be available for participants for a short period of time following the annual meeting.
Attendees may not claim CME credits from ABIM as it is against ACCME and AMA guidelines to claim credit twice for the same activity. MOC credit is available from the ABIM after completion of the MOC module; CME credit only (no CNE credit) is available from ACC.
Chair: Sunil V. Mankad, Rochester, MN
MOC Faculty: Brian Powell, Rochester, MN, Allen J. Taylor, Washington, DC
lIFElONG
MOC
816
ACCF Study Session for Maintenance of Certification: ABIM recertification Made Easy — ACC General Cardiology Module Part ASunday, March 25, 2012, 3:30 p.m. – 6:00 p.m.McCormick Place South, S105dCME Hours: 2.5
ACCF’s Maintenance of Certification Sessions allows you to easily obtain ABIM’s Maintenance of Certification (MOC) points during at ACC.12. Tickets are required for admittance to this session. Ticketed registrants must arrive no later than 15 minutes before the start of the session. Seats will be released at this time and an “open seating” policy will apply.
Attendees must be enrolled in the ABIM’s MOC program to claim MOC points. If you are not enrolled, please allow sufficient time to do this prior to the start of the session. ABIM staffs are available onsite to answer your MOC questions and help with enrollment.
For convenience, there will be computer terminals in the ACC MOC Center onsite in Room S104b for attendees to take the ABIM MOC test after the study session concludes, if desired. Electrical power is provided in the classrooms so that attendees who wish to bring their own devices may ‘power up’ to access relevant question modules.
Access to the online modules will also be available for participants for a short period of time following the annual meeting.
Attendees may not claim CME credits from ABIM as it is against ACCME and AMA guidelines to claim credit twice for the same activity. MOC credit is available from the ABIM after completion of the MOC module; CME credit only (no CNE credit) is available from ACC.
Chair: Biykem Bozkurt, Houston, TX
MOC Faculty: Andrew D. Krahn, London, Canada, Matthew W. Martinez, Allentown, PA
ACC-i2/TCT
ExPErTS
2311
Endovascular Case reviewsSunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S102bCME/CNE Hours: 1.5
Co-Chairs: William A. Gray, New York, NY Christopher J. White, New Orleans, LA
Case Karthik Challa, Charleston, WV, Suresh Davis,Presenters Hyderabad, India, Takayuki Ishihara, Amagasaki,
Japan, Michael Nuyles, Dyer, IN, Yoshimitsu Soga, Kitakyushu, Japan
Panelists: John R. Laird, El Macero, CA , Mehdi H. Shihehbor, Cleveland, OH
ACC-i2/TCT
SYMPOSIUM
2622
Imaging Transcatheter Mitral Valve ProceduresSunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S101aCME/CNE Hours: 1.5
Co-Chairs: Robert J. Siegel, Los Angeles, CA Frank E. Silvestry, Wayne, PA
4:30 Mitral Valve Imaging and Anatomy for Percutaneous Intervention: What do Interventionalists really Need to Know/See? — Frank E. Silvestry, Wayne, PA
4:45 3D Imaging in the Cath lab: What Does it really Add? Do We really Need It? — Rebecca T. Hahn, New York, NY
5:00 Mitral Valve repair Cases: Mitraclip (Best, Worst, Complications) — Saibal Kar, Los Angeles, CA
5:15 Imaging for Percutaneous repair of Mr in Europe: lessons learned from Functional and High-risk Cases — Olaf Franzen, Copenhagen, Denmark
5:30 Challenges in Assessment of Percutaneous MV repair (before, during, after), How Do We really Know if We Fixed the Problem? — Elyse Foster, San Francisco, CA
5:45 Panel Discussion
ACC-i2/TCT
SYMPOSIUM
2623
Peripheral Artery Disease: Critical limb IschemiaSunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S103cCME/CNE Hours: 1.5
Co-Chairs: Tyrone J. Collins, New Orleans, LA Matthew T. Menard, Boston, MA
4:30 Critical limb Ischemia — Open vs Endo: What Does the Data Tell Us? — Michael S. Conte, San Francisco, CA
4:45 Debate: Drug-eluting Coronary Stents are the Treatment of Choice for Below-knee lesions — Andrew J. Feiring, Milwaukee, WI
5:00 Debate: Drug-eluting Coronary Stents are NOT the Treatment of Choice for Below-knee lesions — TBD
5:15 Peripheral Stem Cell Therapy: Clinical Trial results for Critical limb Ischemia — Douglas W. Losordo, Chicago, IL
Sunday, March 25, 2012 • ACC.12
ACC.12 Final Program 167
AFTERNOON
5:30 Management of Complications Associated with Endovascular Intervention for Tibial Artery Disease — Nicholas J. Ruggiero, II, Philadelphia, PA
5:45 Case-based Presentation: Tips and Tricks for Pedal, Tibial and Antegrade Access — TBD
ACC-i2/TCT
SYMPOSIUM
2624
Vascular Access and Outcomes following PCI for ACS: What You Should KnowSunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S106bCME/CNE Hours: 1.5
Co-Chairs: Thierry Lefevre, Massy, France Tift Mann, Raleigh, NC
4:30 Does Access Site Influence Bleeding Complication rates and Mortality following PCI for ACS — Sunil V. Rao, Durham, NC
4:42 Are There Specific Patient Cohorts Where radial Access is Preferred? Insights from the rIVAl and Other Trials — Sanjit S. Jolly, West Hamilton, Canada
4:54 Defining the Transradial learning Curve: Should low Volume Operators Utilize this Technique? — Ian C. Gilchrist, Hershey, PA
5:06 Complications and Pitfalls of Transradial Access: Multiple Illustrative Case Examples — Jean-Pierre Dery, Quebec, Canada
5:18 In Search of the Optimal Vascular Access for PCI in ACS: radial is Best — Harold L. Dauerman, Shelburne, VT
5:28 In Search of the Optimal Vascular Access for PCI in ACS: Femoral is Better — Shing-Chiu Wong, New York, NY
5:38 Debate: Vascular Closure Devices — VCD are Useful for Improving Patient Satisfaction and Clinical Outcomes — Timothy A. Sanborn, Evanston, IL
5:49 Debate: Vascular Closure Devices — VCD are Clinically Unproven with Added Costs — Zoltan G. Turi, Camden, NJ
ACS
SYMPOSIUM
665
literature Interpretation and Statistical Pitfalls in ACS TrialsSunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S402CME/CNE Hours: 1.5
Co-Chairs: Sanjay Kaul, Los Angeles, CA Debabrata Mukherjee, El Paso, TX
Panelists: David J. Cohen, Kansas City, MO, Ajay J. Kirtane, New York, NY, Helen Parise, New York, NY
4:30 Playing with P Values: Misplaced Emphasis on Significance Testing — Sanjay Kaul, Los Angeles, CA
4:40 Panel Discussion
4:45 Composite Endpoints: How to Interpret Them? — Stuart Pocock, London, United Kingdom
4:55 Panel Discussion
5:00 Subgroup Analyses: Informative or a Minefield of Optical Illusions? — Salim Yusuf, Hamilton, Canada
5:10 Panel Discussion
5:15 Making Sense of Comparative Effectiveness and Noninferiority Analysis — Helen Parise, New York, NY
5:25 Panel Discussion
5:30 Meta-analyses and Observational Studies: Where do They Belong in the Evidentiary Hierarchy? — Peter Juni, Berne, Switzerland
5:40 Panel Discussion
5:45 Balancing Benefit-risk Tradeoffs: Qualitative Judgment or Quantitative Precision? — Sanjay Kaul, Los Angeles, CA
5:55 Panel DIscussion
Arr
SYMPOSIUM
666
Joint Symposium of the Heart rhythm Society and the American College of Cardiology: Atrial Fibrillation — Management of the ArrhythmiaSunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place North, N426CME/CNE Hours: 1.5
Co-Chairs: Hugh Calkins, Baltimore, MD Richard L. Page, Seattle, WA
4:30 rate Control: Targets and Drug Choices — Mario Talajic, Montreal, QC
4:50 rhythm Control: Selecting the Appropriate Anti-arrhythmic Drug — Richard I. Fogel, Carmel, IN
5:10 Upstream Therapies for Prevention: Is There a role? — Anne M. Gillis, Calgary, Canada
5:30 Ablation of AF: Who and When to refer? — Douglas L. Packer, Rochester, MN
5:50 Question and Answer
CCS
SYMPOSIUM
667
The Great DebatesSunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place North, N231CME/CNE Hours: 1.5
Co-Chairs: Bryan C. Cannon, Rochester, MN Arwa S. Saidi, Gainesville, FL
4:30 Digoxin Is First line Therapy for Newborns with SVT — Stephen P. Seslar, Seattle, WA
4:42 Digoxin Is Not the First line Therapy for Newborns with SVT — Edward P. Walsh, Boston, MA
5:00 Indications for Pulmonary Valve replacement in Tetralogy of Fallot Apply to Pulmonary regurgitation after Balloon Valvuloplasty — David M. Harrild, Boston, MA
5:12 Indications for Pulmonary Valve replacement in Tetralogy of Fallot Do Not Apply to Pulmonary regurgitation after Balloon Valvuloplasty — Judith Therrien, Canada
5:30 Stimulants Can Be Used in Patients with Congenital Heart Disease — John Kugler, NE
5:42 Stimulants Can Not Be Used in Patients with Congenital Heart Disease — Randall M. Bryant, Jacksonville, FL
ACC.12 • Sunday, March 25, 2012
168 GO for ACC.12!
AFTE
RNOO
N
CCS
SYMPOSIUM
668
ACHD for the General CardiologistSunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place North, N230CME/CNE Hours: 1.5
Co-Chairs: William R. Davidson, Hershey, PA Michael J. Landzberg, Boston, MA
4:30 The Imaging Approach to the Adult with repaired CHD — Karen K. Stout, Seattle, WA
4:50 The Approach to Arrhythmia Management in the Adult with repaired CHD — Paul Khairy, Montreal, Canada
5:10 Adult with TOF: Get with the Guidelines — Anne Marie Valente, Boston, MA
5:30 Management of ASDs in Adulthood — Curtis J. Daniels, Columbus, OH
5:50 Question and Answer
HF
SYMPOSIUM
669
Joint Symposium of the Heart Failure Society of America and the American College of Cardiology: Management of Advanced Heart Failure and TransplantationSunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S406bCME/CNE Hours: 1.5
Co-Chairs: Donna M. Mancini, New York, NY Randall C. Starling, Cleveland, OH
4:30 Medical Management — Lynne Warner Stevenson, Boston, MA
4:48 Cardiorenal Syndrome: Mechanisms and Management — Barry M. Massie, San Francisco, CA
5:06 lVADs: Which Patients? Which Device? What results? — Keith D. Aaronson, Ann Arbor, MI
5:24 Update on Transplantation: Patient Selection, Post-transplant Management — Sharon Hunt, Palo Alot, CA
5:42 regenerative Therapy: Is it a Dream? — Leslie W. Miller, Tampa, FL
HF
SYMPOSIUM
670
Heart Transplantation: Challenges in 2012Sunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S405CME/CNE Hours: 1.5
Co-Chairs: Jon A. Kobashigawa, Los Angeles, CA Michael Shullo, Pittsburgh, PA
4:30 Who Is a Candidate for Heart Transplantion? 2012 Criteria — Ravi Ramani, Pittsburgh, PA
4:48 Calcineurin-Free Immunosuppression after Transplantation: Why and Which Patients? — Sean Patrick Pinney, New York, NY
5:06 Single Agent Immunosuppression: How low Can You Go? — David Baran, Newark, NJ
5:24 Transplanting the “Untransplantable”: Technology and Pharmacology for Managing the Highly Sensitized Pre-transplant Patient — Savitri Fedson, Chicago, IL
5:42 Antibodies Post-transplant: Screening, Diagnosis and Current Treatment Options — Josef Stehlik, Salt Lake City, UT
HF
SYMPOSIUM
671
Personalized Medicine and the Future of Medical CareSunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S404CME/CNE Hours: 1.5
Co-Chairs: Geoffrey S. Ginsburg, Durham, NC Jennifer L. Hall, Minneapolis, MN
4:30 Whole Genome Sequencing and the Impact on Clinical Care in the Next Decade — Elizabeth McNally, Chicago, IL
4:48 Sequencing and Personalized Medicine — Howard Jacob, Milwakuee, WI
5:06 Protemoics and Personalized Medicine — Jennifer Van Eyk, Baltimore, MD
5:24 Determining the Cost-Effectiveness of Genetic Testing — Mark A. Hlatky, Stanford, CA
5:42 Predicting the Future of Care for Individuals with Heart Failure — Jeffrey A. Towbin, Cincinnati, OH
IMAG
SYMPOSIUM
672
Joint Symposium of the American Society of Echocardiography and the American College of Cardiology: Echo in 2012 — What You Need to Know to Keep UpSunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S406aCME/CNE Hours: 1.5
Co-Chairs: Allan L. Klein, Cleveland, OH Thomas Richard Porter, Omaha, NE
4:30 Case Presentation: Hand-Held Echocardiography in 2012 — Rosa Sicari, Pisa, Italy
4:40 review of Current Data and Future Use — Kirk T. Spencer, Chicago, IL
4:55 Case Presentation: 3-D Echocardiography in 2012 — Judy W. Hung, Boston, MA
5:05 review of Current Data and Future Use — Judy W. Hung, Boston, MA
5:20 Case Presentation: Appropriate Use Criteria for Echocardiography in 2012 — R. Parker Ward, Chicago, IL
5:30 review of Current Data and Future Considerations — Neil J. Weissman, Washington, DC
5:45 Question and Answer
Sunday, March 25, 2012 • ACC.12
ACC.12 Final Program 169
AFTERNOON
lIFElONG
SYMPOSIUM
737
Master Clinician: Clinical Cases IISunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S401aCME/CNE Hours: 1.5
Co-Chairs: John M. Miller, Indianapolis, IN Eric S. Williams, Indianapolis, IN
Panelists: Douglas E. Drachman, Boston, MA, Bernard J. Gersh, Rochester, MN, Michael J. Mack, Plano, TX, John M. Miller, Indianapolis, IN, Thomas John Ryan, Columbus, OH
4:30 Case Presentation: A 60 year-old Man with Heart Failure, Chest Pain and a Murmur
4:50 Panel Discussion
5:00 Case Presentation: A 56 Year-old Woman with Palpitations and Shock
5:20 Panel Discussion
5:30 Case Presentation: A 36 Year-old Woman with Near-Syncope
5:50 Panel Discussion
lIFElONG
COrE
817
Core Curriculum: Coronary Artery DiseaseSunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place North, N226CME/CNE Hours: 1.5
Chair: Paul Sorajja, Rochester, MN
4:30 Evaluation and Management of Unstable Angina/NSTEMI — Michael Peter Hudson, Detroit, MI
4:55 Evaluation and Management of STEMI — Malcolm Bell, Rochester, MN
5:20 Management of Chronic CAD: Medical Therapy vs. PCI vs. CABG — Eric R. Bates, Ann Arbor, MI
5:45 Question and Answer
lIFElONG
COrE
818
Core Curriculum: Nuclear CardiologySunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place North, N229CME/CNE Hours: 1.5
Chair: Alex J. Auseon, Columbus, OH
4:30 risk Stratification and Prognosis — Alex J. Auseon, Columbus, OH
4:55 Myocardial Perfusion Imaging for Viability: SPECT and PET — Mouaz H. Al-Mallah, Riyadh, Saudi Arabia
5:20 CTA and Cardiac Mr: Basic Concepts — Mushabbar A. Syed, Oak Park, IL
5:45 Question and Answer
PErI
ExPErTS
236
Genetic Evaluation of CardiomyopathySunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S505CME/CNE Hours: 1.5
Chair: Ray E. Hershberger, Miami, FL
Case Michael J. Ackerman, Rochester, MN, Ray E. Presenters: Hershberger, Miami, FL, Calum A. MacRae, Boston, MA
Panelists: Teresa Kruisselbrink, Rochester, MN, William McKenna, London, United Kingdom
PrACTICE
SYMPOSIUM
673
Future Compensation Under Health Care reformSunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place North, N227bCME/CNE Hours: 1.5
Co-Chairs: Paul Casale, Lancaster, PA Gregory D. Timmers, Springfield, IL Patrick J. White, South Lyon, MI
4:30 Fee for Service: Will It Survive — Gregory S. Thomas, Dana Point, CA
4:50 Your Fee Schedule: Why and How You Get Paid Now — Cathleen Biga, Woodridge, IL
5:10 New Payment Models — Paul Casale, Lancaster, PA
5:30 Value-based Purchasing — Gregory D. Timmers, Springfield, IL
5:50 Question and Answer
PrEV
ExPErTS
237
reducing Disparities in Cardiovascular Preventive CareSunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S501aCME/CNE Hours: 1.5
Chair: Keith C. Ferdinand, Atlanta, GA
Case Rosario Freeman, Seattle, WA, Kenneth A. Jamerson, Presenters: Ann Arbor, MI
Panelists: Eileen M. Handberg, Gainesville, FL, Jennifer H. Mieres, Lake Success, NY, Ileana L. Pina, Cleveland Heights, OH, Clyde W. Yancy, Chicago, IL
PrEV
SYMPOSIUM
675
What’s New in the ACCF/AHA GuidelinesSunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place North, N228CME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-140-l04-P
Chair: Jeffrey L. Anderson, Murray, UT
4:30 Update on ACCF/AHA Clinical Practice Guideline Methodology — Alice K. Jacobs, Boston, MA
4:45 2011 ACCF/AHA/SCAI Guideline on Percutaneous Coronary Intervention — Glenn Levine, Houston, TX
5:00 Question and Answer
5:05 2011 ACCF/AHA Guideline on Coronary Artery Bypass Graft Surgery — Peter K. Smith, Durham, NC
5:20 Question and Answer
5:25 2011 ACCF/AHA Focused Update on Peripheral Artery Disease — Alan T. Hirsch, Minneapolis, MN
ACC.12 • Sunday, March 25, 2012
170 GO for ACC.12!
AFTE
RNOO
N
5:35 Question and Answer
5:40 2012 ACCF/AHA Guideline on ST-Elevation Myocardial Infarction — Patrick T. O’Gara, Boston, MA
5:55 Question and Answer
PrEV
SYMPOSIUM
730
The Difficult-to-Manage lipid PatientSunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S100cCME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-147-l04-P
Co-Chairs: Andrew M. Kates, Saint Louis, MO Jeffrey T. Kuvin, Boston, MA
Panelists: Robert Sidney Rosenson, New York, NY, Anne C. Goldberg, St. Louis, MO
4:30 Case Presentation — Donna M. Polk, Hartford, CT
4:40 Panel Discussion
4:55 Audience Question and Answer
5:15 Case Presentation — Elizabeth A. Jackson, Ann Arbor, MI
5:25 Panel Discussion
5:40 Audience Question and Answer
SPECIAl
ExPErTS
263
The role of Therapeutic Hypothermia in the Treatment of Cardiac ArrestSunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S502 CME/CNE Hours: 1.5
Co-Chairs: John A. McPherson, Nashville, TN Barbara T. Unger, Minneapolis, MN
Case Presenters: Jason Neil Katz, Morrisville, NC, Karl B. Kern, Tucson, AZ, Paul McMullan, New Orleans, LA, Michael R. Mooney, Minneapolis, MN, Nainesh C. Patel, Allentown, PA, David Seder, Portland, ME
SPECIAl
lEGENDS
403
legends of Cardiovascular Medicine lecture Series — Third Annual James T. Dove lectureSunday, March 25, 2012, 4:30 p.m. – 5:30 p.m.McCormick Place North, N427CME/CNE Hours: 1
The James T. Dove Lecture is supported by the James T. Dove Fund
Chair: Prediman K. Shah, Los Angeles, CA
4:30 Introduction of Dr. Valentin Fuster — Prediman K. Shah, Los Angeles, CA
4:35 Third Annual James T. Dove lecture: Transition from Cardiovascular Disease to Health (2012 – 2020): The Challenge of Identifying Subclinical Disease — Valentin Fuster, New York, NY
5:05 One-on-One Interview with Dr. Valentin Fuster — Prediman K. Shah, Los Angeles, CA
5:20 Audience Question and Answer
SPECIAl
SYMPOSIUM
744A
Clinical Decision Making for Fellows in Training: Part ASunday, March 25, 2012, 4:30 p.m. – 5:50 p.m.McCormick Place South, S403CME/CNE Hours: 1.25
Co-Chairs: John E. Brush, Norfolk, VA David R. Holmes, Jr., Rochester, MN Rick A. Nishimura, Rochester, MN Patrick T. O’Gara, Boston, MA
4:30 Management of late Complications in Adult Congenital Heart Disease: Surviving the Storm — Robert J. Mentz, Sudarshan Rajagopal, Tariq Ahmad, Christopher H. Swan, Duke University Medical Center, Durham, NC
4:40 Questions and Answers
4:46 Searching for the Etiology of Non-Ischemic Cardiomyopathy: When Zebras and Horses run Together — Nada Shaban, Saneka Chakravarty, Alireza Hosseini Khalili, Sabeena Arora, Richard Soucier, Hoffman Heart and Vascular Institute, St. Francis Hospital and Medical Center, Hartford, CT, University of Connecticut Health Center, Farmington, CT
4:56 Questions and Answers
5:02 High Output HF Secondary to a Hemodialysis Arteriovenous Fistula — Dawn Scantlebury, Mayo Clinic, Rochester, MN
5:12 Questions and Answers
5:18 Too Severe or Not Too Severe: “Grading” Aortic Stenosis — Ahmad M. Jeroudi, Sameer A. Gafoor, Gautam Kumar, Emory University, Atlanta, GA
5:28 Questions and Answers
5:34 Hypertrophic Cardiomyopathy or Hypertensive Heart Disease? Diagnostic Challenge in Older Patients Suspected of HCM and Therapeutic Implications — Farbod Raiszadeh, Krysthel Engstrom-Koch, Mario J. Garcia, Montefiore Einstein Heart Center, New York, NY, Jacobi Medical Center, New York, NY
5:44 Questions and Answers
SPECIAl
SYMPOSIUM
744B
Clinical Decision Making for Fellows in Training: Part BSunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S403CME/CNE Hours: 1.5
5:50 Novel Presentation of Ventricular Tachycardia Due to Invasion of the right Ventricle by Aspergillosis — Kyle G. Ulveling, Jamil Y. Abuzetun, Venkata M. Alla, W. Paul Biddle, Aryan Mooss, The Cardiac Center of Creighton University Medical Center, Omaha, NE
5:50 Current of Injury Found Guilty of Perjury in a Case of Myocardial Infraction Committed by Non-hodgkin lymphoma — Morteza Farasat, Nada M. Shaban, Nishant Sethi, Carolyn Ray, Anthony F. Posteraro, III, Anita M. Kelsey, Saint Francis Hospital and Medical Center, Hartford, CT, University of Connecticut Health Center, Farmington, CT
Sunday, March 25, 2012 • ACC.12
ACC.12 Final Program 171
Afternoon
5:50 Out-of-Hospital Cardiac Arrest Due to a Concealed Diagnosis: Clinical Decision-making from the Hospital to Home — Manoj Kesarwani, Mohan N. Viswanathan, University of Washington, Seattle, WA
5:50 Early repolarization and Anomalous right Coronary Artery: A Perfect Storm for Sudden Cardiac Death — Andrew Choi, Gaby Weissman, Robert Lowery, Susan O’Donoghue, Edriss Charaf, Federico Asch, Washington Hospital Center, Washington, DC, Georgetown University Medical Center, Washington, DC
5:50 A Case of Multiple Medical Issues and Percutaneous Coronary Intervention for restenosis: Is less Sometimes More? — Amit Noheria, Sanjay Kaul, Cedars-Sinai Medical Center, Los Angeles, CA
5:50 Severe Coronary Spasm and Sudden Cardiac Death: Is There a Concensus for Management? — Tarek M. Mousa, Emmanuel N. Moustakakis, Gregory Gustafson, Seth E. Goldbarg, Chong H. Park, New York Hospital Medical Center of Queens, New York, NY, Cornell University Weill Medical College, New York, NY
5:50 Mitral Valve Endocarditis in the Setting of Hypertrophic Cardiomyopathy — Neha Yadav, John H Stroger Hospital of Cook County, Chicago, IL
5:50 When Are Patients with Amyloidosis Eligible for Heart Transplant? — Michael A. Burke, Rodney H. Falk, Lynne W. Stevenson, Brigham and Women’s Hospital, Boston, MA
5:50 Heart Failure and Mitral regurgitation — Murali K. Senapathi, Gerard P. Aurigemma, Dennis Tighe, University of Massachusetts Medical Center, Worcester, MA
5:50 Dyspnea and Hemoptysis following Aortic and Mitral Valve Surgery with Atrial Fibrillation Ablation: Expanding the Differential Diagnosis — Megan Coylewright, Terrence D. Welch, Samuel J. Asirvatham, Mayo Clinic, Rochester, MN
TEST
ExPErTS
261
Cardiac Dilemmas in AthletesSunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S503CME/CNE Hours: 1.5
Chair: Richard J. Kovacs, Indianapolis, IN
Panelists: Adolph M. Hutter, Boston, MA, Jonathan Rhodes, Boston, MA, Malissa Jane Wood, Boston, MA
Case Paolo Enzo Angelini, Houston, TX, Jeffrey Hastings, Presenters: Dallas, TX, Melanie S. Sulistio, Dallas, TX
VAlV
ExPErTS
238
Aortic Stenosis Case ManagementSunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S504aCME/CNE Hours: 1.5
Chair: Jean G. Dumesnil, Sainte Foy, Canada
Panelists: Marian Hawkey, New York, NY, Aaron V. Kaplan, Lebanon, NH
Case Kevin Greason, Rochester, MN, David Messika-Zeitoun,Presenters: France, Igor F. Palacios, Boston, MA
ACC-i2/TCT
SPECIAl
2105
Cardiac Care Team V: Structural Heart Disease — Mitral ValveSunday, March 25, 2012, 5:00 p.m. – 6:00 p.m.McCormick Place South, S103bCME/CNE Hours: 1
Co-Chairs: Julie A. Logan, La Jolla, CA Martina Speight, Stanford, CA
5:00 Pathophysiology: Understanding Mitral Anatomy — Russell A. Brandwein, New York, NY
5:20 When to Treat: Guidelines the Cardiologist Should live by — Steven F. Bolling, Ann Arbor, MI
5:40 What Is on the Horizon — Julie A. Logan, La Jolla, CA
ACS
ClINICAl FOCUS
1605
Innovations in Translation: Acute Coronary SyndromesSunday, March 25, 2012, 6:30 p.m. – 9:30 p.m.Fairmont Hotel, Imperial BallroomCME/CNE Hours: 2.5
Tickets are required for admittance to this session. Ticketed registrants must arrive no later than 15 minutes before the start of the session. Seats will be released at this time and an “open seating” policy will apply.
6:30 registration and Dinner
7:00 Program Overview and Introductions —Ajay Kirtane, New York, NY
Focus #1: Pharmacoinvasive Management in NSTEACS
Moderator: Sunil Rao, Durham, NC
Panelists: Ajay Kirtane, New York, NY, Dirk Sibbing, Munich, Germany
7:05 Antiplatelet and Antithrombotic Strategies in NSTEACS —Dirk Sibbing, Munich, Germany
7:20 Case review and Panel Discussion
Focus #2: Pharmacologic Therapy in STEMI
Moderator: Gilles Montalescot, Paris, France
Panelists: Stefan James, Uppsala, Sweden, Stephen D. Wiviott, Boston, MA
7:50 Navigating Antithrombic and Antiplatelet Agents in STEMI —Stefan James, Uppsala, Sweden
8:05 Panel Discussion
Focus #3: Systems of Care for Patients with Acute Coronary Syndromes
Moderator: Gregg Stone, New York, NY
Panelists: Duane S. Pinto, Boston, MA, James A. de Lemos, Dallas, TX
8:35 Primary PCI vs Fibrinolytics: Making the right Choice for Individual Patients —Duane S. Pinto, Boston, MA
8:50 Panel Discussion
9:20 Concluding remarks —Ajay Kirtane, New York, NY
ACC.12 • Sunday, March 25, 2012
eVening
172 GO for ACC.12!
eVen
ing
Arr
ClINICAl FOCUS
1603
Joint Session of the Heart rhythm Society of America and the American College of Cardiology — Innovations in Translation: Atrial FibrillationSunday, March 25, 2012, 6:30 p.m. – 9:30 p.m.Fairmont Hotel, International BallroomCME/CNE Hours: 2.5
Tickets are required for admittance to this session. Ticketed registrants must arrive no later than 15 minutes before the start of the session. Seats will be released at this time and an “open seating” policy will apply.
Chair: Peter Kowey, Wynnewood, PA
6:30 registration and Dinner
7:00 Opening remarks, General Introduction and Overview —Peter Kowey, Wynnewood, PA
7:05 Emerging Concepts in Stroke Prevention —Kenneth A. Ellenbogen, Richmond, VA
7:35 rate vs. rhythm Control: Which Strategy is Best for my Patient? —Albert L. Waldo, Cleveland, OH
8:05 Achieving rate Control —N. A. Mark Estes, Boston, MA
8:35 Achieving rhythm Control — Pharmacologic Options —Eric N. Prystowsky, Indianapolis, IN
8:55 Achieving rhythm Control — Non-pharmacologic Options —Douglas L. Packer, Rochester, MN
9:15 Questions and Answers —Peter Kowey, Wynnewood, PA
ACC.12 Final Program 173
CV Innovations Educational ForumSouth Building, Hall A2, CV Theater, #22097
Device Development & Innovation9:30 a.m. – 10:45 a.m.
9:30 a.m. – 9:45 a.m.Translational Considerations for Medtech Financing and International Strategies — Nic Chronos, MD, FACC, FESC, FFAHA, FRCP, Atlanta, GA — President, St. Joseph’s Translational Research Institute
9:45 a.m. – 9:55 a.m.Selecting the Right Experimental Models for Device Testing and Validation — Juan F. Granada, MD, New York, NY — Executive Director and Chief Scientific Officer, The Jack H. Skirball Center for Cardiovascular Research, Cardiovascular Research Foundation
9:55 a.m. – 10:05 a.m.Device Strategies for the Management of Hypertension — Todd Brinton, MD, Palo Alto, CA — Clinical Assistant Professor of Medicine (Cardiology) and Lecturer in Bioengineering, Stanford University
10:05 a.m. – 10:15 a.m.Biodegradable Stents — Jai Pal Singh, PhD, Atlanta, GA — Chief Scientific Officer, St. Joseph’s Translational Research Institute
10:15 a.m. – 10:30 a.m.Innovation for the Mitral Valve — David Reuter, MD, PhD, Kirkland, WA — Co-Founder & Chief Medical Officer, Cardiac Dimensions
10:30 a.m. – 10:45 a.m.Panel Discussion
Challenges Associated with Treating Calcified Coronary Artery Disease 12:15 p.m. – 1:10 p.m.
12:15 p.m. – 12:23 p.m.Complications Associated with Treating Calcified Lesions During Coronary Intervention — Jeffrey W. Chambers, MD, Buffalo, NY — Cardiology
12:23 p.m. – 12:31 p.m.Long-Term Clinical Results of the Orbital Treatment for De Novo Calcified Coronary Lesions: ORBIT I Trial — Puneet Khanna, MD, FACC, Rancho Mirage, CA — Desert Cardiology Center
12:31 p.m. – 12:39 p.m.Clinical Study Design of the Orbital Treatment for De Novo Calcified Coronary Lesions: ORBIT II Trial — Stevan I. Himmelstein, MD, FACC, Southaven, TN — Memphis Heart Clinic
12:39 p.m. – 12:47 p.m.Orbital Atherectomy Case Study of Calcified Coronary Arteries Using IVUS — Richard A. Shlofmitz, MD, FACC, Roslyn, NY — Director, Department of Cardiology, St. Francis Hospital
12:47 p.m. – 12:55 p.m.Use of Intravascular Ultrasound to Identify Calcified Coronary Lesions for Treatment Using Orbital Atherectomy before Stenting — Gregg W. Stone, MD, FACC, FSCAI, New York, NY — Director of Cardiovascular Research and Education, Columbia University Medical Center
12:55 p.m. – 1:10 p.m.Panel Discussion
Current Approaches for Treating Calcified Peripheral Arterial Disease1:10 p.m. – 2:00 p.m.
1:10 p.m. – 1:18 p.m.Prevalence and Impact of Calcium on the Management of Peripheral Arterial Disease — William A. Gray, MD, New York, NY
1:18 p.m. – 1:26 p.m.Unique Challenges for Treating Patients with Critical Limb Ischemia: Clinical Considerations and Lesion Morphologies — Speaker to be announced
1:26 p.m. – 1:34 p.m.New Approaches for Treating Critical Limb Ischemia — Clinical Data — Tony S. Das, MD, FACC, FACP, Dallas, TX — Cardiology and Interventional Vascular Associates
1:34 p.m. – 1:42 p.m.Advanced Treatment Options for Lower Extremity Peripheral Arterial Disease — Jihad Mustapha, MD, Grand Rapids, MI — Director of Endovascular Interventions and Research, Metro Health Hospital
1:42 p.m. – 1:50 p.m.Peripheral Academic Research Consortium — Definitions in Trials in the Treatment of Patients with Lower Extremity Peripheral Arterial Disease — Manesh R. Patel, MD, Durham, NC — Duke University
1:50 p.m. – 2:00 p.m.Panel Discussion
ACC.12 Learning Destination™ Presentations
Sunday, March 25, 2012Learning Destinations™ are diverse, non-accredited, educationally focused areas that offer new and creative venues in which you can expand your educational experience.*
Presentation schedules are current as of Feb. 29, 2012, and are subject to change. For more information, please check the ACC.12 ExpoGuide and ExpoGuide Addendum, available at Expo Hall entrances and in your official meeting bag, and the Heart of Innovation Resource Guide, available at the Heart of Innovation Learning Destination (South Building, Hall A1, #1076) and in your official meeting bag
174 GO for ACC.12!
The role of Innovative Technologies in a Novel Strategy to Prevent First Coronary Event3:30 p.m. – 4:30 p.m.
3:30 p.m. – 3:45 p.m.Genetic Testing and Other Novel Methods to Screen for Increased Coronary risks — Robert Roberts, MD, MACC, FRCPC, Ottawa, ON, Canada — President, Chief Executive Officer and Chief Scientific Officer, University of Ottawa Heart Institute
3:45 p.m. – 3:55 p.m.The role of Non-Invasive Imaging with CTA and Other Means to Identify Increased risks — Szilard Voros, MD, FACC, Atlanta, GA — Fuqua Heart Center at Piedmont Hospital
3:55 p.m. – 4:10 p.m.The role of Invasive Imaging with IVUS, NIr, and OCT to Confirm the Presence of Vulnerable Plaques — James Muller, MD, Burlington, MA — Chief Medical Officer, InfraReDx, Inc.
4:10 p.m. – 4:20 p.m.PrOSPECT Data: Potential local and Systemic Concepts for Stabilizing Vulnerable Plaques — Charles Simonton, MD, FACC, FSCAI, Abbott Park, IL — Divisional Vice President, Medical Affairs and Chief Medical Officer, Abbott Vascular
4:20 p.m. – 4:30 p.m.Panel Discussion
The Heart of Innovation Featured Learning Destination South Building, Hall A1, #1076
9:30 a.m. – 9:45 a.m.Educational content including taped cases, physician interviews, panel discussions and more
9:45 a.m. – 10:05 a.m.Presenting Options to Patients with Advanced Heart Failure — Lynne Warner Stevenson, MD, FACC, Boston, MA — Director, Cardiomyopathy and Heart Failure Program, Brigham and Women's Hospital; Professor, Harvard Medical School
10:05 a.m. – 10:30 a.m.Transcatheter Aortic Valve replacement: Where Are We and Where Do We Go? — G. Alain Cribier, MD, Rouen, France — Professor of Cardiology, University Hospital Charles Nicolle
10:30 a.m. – 12:30 p.m.Educational content including taped cases, physician interviews, panel discussions and more
12:30 p.m. – 12:55 p.m.Pharmacogenetic Development and Targeting of Cardiovascular Drugs — Michael R. Bristow, MD, PhD, FACC, FAHA, Aurora, CO — Professor of Medicine (Cardiology), Co-Director, CU Cardiovascular Institute, University of Colorado Anschultz Medical Campus
12:55 p.m. – 1:20 p.m.Cell Therapy for Chronic Ischemic Heart Disease from Concept to Clinic — Joshua M. Hare, MD, FACC, FAHA, Miami, FL — Louis
Lemberg Professor of Medicine; Director, Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine
1:20 p.m. – 1:45 p.m.Devices Used for Heart Failure — Leslie W. Miller, MD, FACC, Tampa, FL — Professor of Medicine, Chief and Chairman, Department of Cardiovascular Sciences; CEO and Director of Cardiovascular Service, University of South Florida
1:45 p.m. – 3:45 p.m.Educational content including taped cases, physician interviews, panel discussions and more
3:45 p.m. – 4:15 p.m.Moderated Discussion: role of Genetics and Proteomics and How They Will Alter the Management of Heart Disease
Moderator: Jennifer L. Hall, PhD, FACC, FAHA, Minneapolis, MN — Associate Professor of Medicine, University of Minnesota; Director, Program in Translational Cardiovascular Genomics, Lillehei Heart Institute Developmental Biology Center
Panelists: Robert Roberts, MD, MACC, FACP, FAHA, FESC, FISHR, FRCPC, FRSM, Ottawa, ON, Canada — President and CEO, University of Ottawa Heart Institute; President, CEO and Chief Scientific Officer, Ottawa Heart Institute Research Corporation; Director, Ruddy Canadian Cardiovascular Genetics Centre; Professor of Medicine, University of Ottawa; Adjunct Professorship of Medicine, Baylor College of Medicine; Jennifer E. Van Eyk, PhD, Baltimore, MD — Director, Johns Hopkins NHLBI Proteomics Center, Johns Hopkins School of Medicine
4:15 p.m. – 4:30 p.m.Educational content including taped cases, physician interviews, panel discussions and more
Industry-Expert TheaterSouth Building, Hall A1, #22042
9:45 a.m. – 10:45 a.m. (Morning Coffee Break)Antiplatelet Therapy Choices for High-risk PCI Patients in the Era of Generic Clopidogrel: The role of Platelet reactivity Testing
The Platelet reactivity Hypothesis — Paul A. Gurbel, MD , Baltimore, MD — Director, Sinai Center for Thrombosis Research; Associate Professor of Medicine, Johns Hopkins University
Platelet reactivity Testing: A Synthesis of the Data — Matthew J. Price, MD, FACC, FSCAI, La Jolla, CA — Director, Cardiac Catheterization Laboratory at Scripps Clinic; Assistant Professor at Scripps Translational Science Institute
Clinical Pathways for Platelet reactivity: real World Application — Speaker to be announced
Presented by Accumetrics
Sunday, March 25, 2012 • ACC.12
ACC.12 Final Program 175
12:30 p.m. – 1:30 p.m. (Mid-Day Break)A Stroke Prevention Option in Nonvalvular Atrial Fibrillation — James A. Reiffel, MD, New York, NY — Professor of Clinical Medicine, Columbia University; Cardiologist, Electrophysiologist, and Co-Director ECG Laboratory, Columbia University Medical Center
Presented by Janssen Pharmaceuticals Inc.
3:30 p.m. – 4:30 p.m. (Afternoon Coffee Break)Emerging Procedures Today, Future Standard of Care
TAVR: Starting a Program and Beyond — Richard Smalling, MD, Houston, TX — Director of Interventional Cardiovascular Medicine, Memorial Hermann
Transradial Procedures: Fast Track to the Default Access — J. Chris McClish, MD, San Angelo, TX — Interventional Cardiologist, Shannon West Texas Memorial Hospital
Procedures Outside the Heart: The Optimal Cath Lab — Stephen Ramee, MD, New Orleans, LA — Interventional Cardiologist, Ochsner Clinic Interventional Cardiology
Presented by Toshiba Medical Systems
Interactive Learning LabsSouth Building, Hall A1, #22027, #22035, #23027
Actelion Pharmaceuticals US, Inc.Interactive Learning Lab #23027
9:30 a.m. – 11:30 a.m.Pulmonary Arterial Hypertension Associated with Adult Congenital Heart Disease: An Interactive Program — Wayne J. Franklin, MD, FACC, Houston, TX — Director, Texas Adult Congenital Heart Program, Texas Children’s Hospital; Assistant Professor of Medicine and Pediatrics, Baylor College of Medicine; Richard A. Krasuski, MD, FACC, FAHA, Cleveland, OH — Director of Adult Congenital Heart Disease Services, Cleveland Clinic Foundation; Michael J. Landzberg, MD, Boston, MA — Director, Boston Adult Congenital Heart Service, Children’s Hospital, Brigham & Women’s Hospital, Harvard Medical School
12:30 p.m. – 2:15 p.m.PAH: A Case-Based Exploration of Management Strategies — Michael Earing, MD, Milwaukee, WI — Medical College of Wisconsin; Ramagopal Tumuluri, MD, Milwaukee, WI — Aurora St. Luke’s Medical Center
Philips HealthcareInteractive Learning Lab #22035
9:30 a.m. – 10:30 a.m.Speckle Tracking Today for Myocardial Deformation — A Hands-On Guided Workshop — Roberto M. Lang, MD, FACC, FAHA, FASE, FESC, FRCP, Chicago, IL — Professor of Medicine and Radiology; Director, Noninvasive Cardiac Imaging Laboratories; Associate Director, Cardiology Fellowship Program; University of Chicago Medical Center; Ivan Salgo, MD, Andover MA — Senior Director, Cardiology; Philips Healthcare
11:00 a.m. – NoonHow Can Cardiology Informatics Enrich My Electronic Health records Strategy? — James E. Tcheng, MD, FACC, Durham, NC — Professor of Medicine; Professor of Community and Family Medicine (Informatics); Duke University Health System
12:30 p.m. – 1:30 p.m.Innovations in Cardiovascular Interventions — Speaker to be announced
2:00 p.m. – 3:00 p.m.Hypothermia for Cardiac Protection in Acute Myocardial Infarction — David Erlinge, MD, PhD, FESC, Sweden — Head, Department of Cardiology, Lund University Hospital
3:30 p.m. – 4:30 p.m.Clinical Application of real-Time 3D TEE for Percutaneous Structural Heart Interventions — David Liang, MD, PhD, Palo Alto, CA — Associate Professor, Cardiovascular Medicine, Stanford University School of Medicine; Robert J. Siegel, MD, Lost Angeles, CA — Director, Cardiac Noninvasive Laboratory, Cedars-Sinai Medical Center
Terumo Interventional Systems and The Medicines CompanyInteractive Learning Lab #22027
9:30 a.m. – 10:30 a.m.Hands-On radial Access Simulation
10:45 a.m. – 11:45 a.m.Hands-On radial Access Simulation
Noon – 1:00 p.m.Optimizing your Outpatient PCI: What You Need to Know and Consider
1:00 p.m. – 2:00 p.m.Hands-On radial Access Simulation
2:30 p.m. – 3:30 p.m.Hands-On radial Access Simulation
* Learning Destination presentations are not part of the official ACC Annual Scientific Session & Expo and/or ACC-i2 with TCT, as planned by their Program Committees. Learning Destination presentations do not qualify for continuing medical education (CME), continuing nursing education (CNE) or continuing education (CE) credit.
ACC.12 • Sunday, March 25, 2012
New for ACC.12! Heart of Innovation Featured Learning Destination| South Building, Hall A1, #1076
In this multi-vendor educational venue, explore the evolution of the standard of care for coronary artery disease and heart failure caused by valvular disease through the lenses of Personalized Medicine, TechnoBiology, Minimally Invasive Procedures and Physician-Patient Engagement. The adjoining Thought Leader TheaterTM will feature speakers discussing past, present and future advances in patient care.
ACC is grateful for the support of the Marquee Heart of Innovation Partner:
Helping you transform patient care through innovations and partnerships
New for ACC.12! CardioSmart Forum | South Building, Hall A2, CV Theater, #22097 Join Dr. Michelle May on Saturday for “Eat What You Love, Love What You Eat: How to Break the Eat-Repent-Repeat Cycle.” Learn strategies to help your patients change their eating patterns and improve their outcomes.
CV Innovations Educational Forum | South Building, Hall A2, CV Theater, #22097 Explore the future on Sunday and Monday during presentations and panel discussions on cutting-edge cardiovascular research and cardiovascular technologies in development.
Industry-Expert Theater | South Building, Hall A1, #22042 Connect with the experts as presenters share the latest in cardiovascular practices, services and technologies in a theater setting.
Interactive Learning Labs | South Building, Hall A1, #22027, #22035, #23027 Experience hands-on training and interactive didactic presentations. This unique educational opportunity puts new technology in your hands and new information in your arsenal.
©2012 American College of Cardiology. A12194
More information is available in the ACC.12 Final Program, the ACC.12 ExpoGuide and ExpoGuide Addendum, and at www.accscientificsession.org/learningdestinations.
Learning Destination presentations are not part of the official ACC Annual Scientific Session & Expo and/or ACC-i2 with TCT, as planned by their Program Committees. Learning Destination presentations do not qualify for continuing medical education (CME), continuing nursing education (CNE) or continuing education (CE) credit.
ACC.12Learning DestinationsTM
Expand Your Educational Experience in These Diverse and Creative Venues
ACC.12
MondayMarch 26
Monday, M
arch 26
New for ACC.12! Heart of Innovation Featured Learning Destination| South Building, Hall A1, #1076
In this multi-vendor educational venue, explore the evolution of the standard of care for coronary artery disease and heart failure caused by valvular disease through the lenses of Personalized Medicine, TechnoBiology, Minimally Invasive Procedures and Physician-Patient Engagement. The adjoining Thought Leader TheaterTM will feature speakers discussing past, present and future advances in patient care.
ACC is grateful for the support of the Marquee Heart of Innovation Partner:
Helping you transform patient care through innovations and partnerships
New for ACC.12! CardioSmart Forum | South Building, Hall A2, CV Theater, #22097 Join Dr. Michelle May on Saturday for “Eat What You Love, Love What You Eat: How to Break the Eat-Repent-Repeat Cycle.” Learn strategies to help your patients change their eating patterns and improve their outcomes.
CV Innovations Educational Forum | South Building, Hall A2, CV Theater, #22097 Explore the future on Sunday and Monday during presentations and panel discussions on cutting-edge cardiovascular research and cardiovascular technologies in development.
Industry-Expert Theater | South Building, Hall A1, #22042 Connect with the experts as presenters share the latest in cardiovascular practices, services and technologies in a theater setting.
Interactive Learning Labs | South Building, Hall A1, #22027, #22035, #23027 Experience hands-on training and interactive didactic presentations. This unique educational opportunity puts new technology in your hands and new information in your arsenal.
©2012 American College of Cardiology. A12194
More information is available in the ACC.12 Final Program, the ACC.12 ExpoGuide and ExpoGuide Addendum, and at www.accscientificsession.org/learningdestinations.
Learning Destination presentations are not part of the official ACC Annual Scientific Session & Expo and/or ACC-i2 with TCT, as planned by their Program Committees. Learning Destination presentations do not qualify for continuing medical education (CME), continuing nursing education (CNE) or continuing education (CE) credit.
ACC.12Learning DestinationsTM
Expand Your Educational Experience in These Diverse and Creative Venues
Mon
day,
Mar
ch 2
6
ACC.12 Final Program 177
Morning SeSSionS
ACC-i2/TCT
SpeCiAl
2111
Fellows Bootcamp: Coronary iMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S103bCMe Hours: 1.5
Co-Chairs: Sunil V. Rao, Durham, NC Duane S. Pinto, Boston, MA
8:00 Vascular Access: Femoral and Radial Approaches — Robert J. Applegate, Winston-Salem, NC
8:15 Balloons, Wires and Guides — Adam B. Greenbaum, Detroit, MI
8:30 Beyond Angiography: Using iVUS, OCT and FFR to Optimize Therapy — Marco A. Costa, Cleveland, OH
8:45 Tips and Tricks for Challenging Stent Delivery: Case Reviews — Duane S. Pinto, Boston, MA
9:00 The ABC’s of pCi pharmacology — Paul A. Gurbel, Baltimore, MD
9:15 Roundtable Discussion
ACC-i2/TCT
SpeCiAl
2121
Multi-Disciplinary Management of the Failing Heart: Team-based evaluation and Therapy of Advanced Heart Disease iMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S102cCMe/CNe Hours: 1.5
Chair: James A. Goldstein, Royal Oak, MI
Panelists: Jagat Narula, New York, NY, Paul Sorajja, Rochester, MN, Spencer B. King, Atlanta, GA, Neal Kleiman, Houston, TX, Simon R. Dixon, Royal Oak, MI, Gregg C. Fonarow, Los Angeles, CA, Gus J. Vlahakes, Boston, MA
8:00 Changing Nature of Advanced Heart Failure: The Need for Multi-disciplinary Management — James A. Goldstein, Royal Oak, MI
8:15 Case presentation 1 — Brian P. O’Neill, Miami, FL
8:20 panel Discussion
8:50 Case presentation 2 — Todd K. Zynda, Manhattan Beach, CA
8:55 panel Discussion
ACC-i2/TCT
SyMpOSiUM
2625
left Main Disease: Role of imaging for Assessment, Treatment and Follow-UpMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S101aCMe/CNe Hours: 1.5
Co-Chairs: Robert J. Russo, La Jolla, CA Massoud A. Leesar, Cincinnati, OH
8:00 What do We Know about left Main Disease Subtypes and Natural History? — Akiko Maehara, New York, NY
8:12 What is the Role of MSCT in the Assessment and Follow-up of left Main Disease? — Stephan Achenbach, Erlangen, Germany
8:24 left Main evaluation with iVUS: What Cutoff Value Should i Use? — Jose de la Torre Hernandez, Santander, Spain
8:36 left Main evaluation with FFR: What is the impact of Downstream Disease? — John McB Hodgson, Wilkes-Barre, PA
8:48 iVUS Guidance for DeS implantation to Treat lMCA Disease: Optimal endpoints and long-term Results — Soo-Jin Kang, Suwon, Republic of Korea
9:00 Case presentation: How Much Adenosine is enough? — Michael J. Lim, Saint Louis, MO
9:07 Case presentation — Alaide Chieffo, Milan, Italy
9:14 Case presentation — Ning Guo, Xi’an Shaanxi, China, Cincinnati, OH
9:21 panel Discussion
ACC-i2/TCT
SyMpOSiUM
2626
TAVR Complications: incidence, Management, and AvoidanceMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S102bCMe/CNe Hours: 1.5
Chair: Eric Roselli, Cleveland, OH
8:00 Vascular — Susheel Kodali, New York, NY
8:12 Ai-Assessment, imaging, Treatment — Raj R. Makkar, Los Angeles, CA
8:24 Stroke — Josep Rodes-Cabau, Quebec, Canada
8:36 Conduction System Abnormalities — Raoul Bonan, Montreal, Canada
8:48 Coronary Occlusion/Aortic Rupture — Samir R. Kapadia, Cleveland, OH
9:00 Device embolization/Migration — James B. Hermiller, Indianapolis, IN
9:12 Transapical — Wilson Y. Szeto, Philadelphia, PA
9:24 panel Discussion
ACC-i2/TCT
SyMpOSiUM
2627
Management of Renovascular HypertensionMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S103cCMe/CNe Hours: 1.5
Co-Chairs: Christopher J. White, New Orleans, LA Joseph M. Garasic, Jamaica Plain, MA
8:00 predictors of Response to Renal Artery Revascularization — Ehtisham Mahmud, San Diego, CA
ACC.12 Scientific Session
Monday, March 26, 2012Please Note: The following sessions are listed alphabetically by learning pathway abbreviation based on session start time.
Morning
178 GO for ACC.12!
Mor
ning
8:15 Debate: Stenting is the Treatment of Choice for ≥ 70% Renal Artery Stenosis with Uncontrolled Hypertension that has Failed 3-drug Therapy — Christopher J. Cooper, Toledo, OH
8:30 Debate: Stenting is NOT the Treatment of Choice for ≥ 70% Renal Artery Stenosis with Uncontrolled Hypertension that has Failed 3-drug Therapy — Lance Dworkin, Providence, RI
8:45 Renal Sympathetic Denervation: pro’s and Con’s — Deepak L. Bhatt, Boston, MA
9:00 Renal Stenting: Avoiding Complications — James S. Jenkins, River Ridge, LA
9:15 Renal Stenting: Case presentations: Techniques and pitfalls — Douglas E. Drachman, Boston, MA
ACC-i2/TCT
SyMpOSiUM
2628
left Main Coronary intervention: State-of-the-ArtMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S106bCMe/CNe Hours: 1.5
Co-Chairs: Patrick L. Whitlow, Cleveland, OH George D. Dangas, New York, NY
8:00 Review of Current Data and Guidelines — David E. Kandzari, Atlanta, GA
8:15 Risk Stratification of lMT pCi — Davide Capodanno, Jacksonville, FL
8:25 Review of lMT pCi Techniques — Matthew J. Price, La Jolla, CA
8:40 Functional and Anatomical Assessment — William Fuller Fearon, Stanford, CA
8:55 Case 1: A Case with low Syntax Score — Khaled M. Ziada, Lexington, KY
9:05 panel Discussion
9:10 Case 2: A Case with High Syntax Score — Thierry Corcos, Paris, France
9:20 panel Discussion
ACS
SyMpOSiUM
676
Shock in ACSMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S401aCMe/CNe Hours: 1.5
Co-Chairs: Jose P. Henriques, Amsterdam, Netherlands Annapoorna Subhash Kini, New York, NY
8:00 pathophysiology of Cardiogenic Shock and Adjunct Therapies — Michael C. Kim, New York, NY
8:10 Question and Answer
8:15 primary pCi in STeMi: Does it Reduce Shock incidence? — Sameer Mehta, Miami, FL
8:25 Question and Answer
8:30 Role of lV Assist Device in Cardiogenic Shock — John M. Lasala, Saint Louis, MO
8:40 Question and Answer
8:45 portable lV Assist Devices: liFeBRiDGe, eCMO and Other — Semih Buz, Berlin, Germany
8:55 Question and Answer
9:00 CHF illustrative Case presentations — Annapoorna Subhash Kini, New York, NY
9:12 CHF illustrative Case presentations — Jose P. Henriques, Amsterdam, Netherlands
9:25 Summary — Annapoorna Subhash Kini, New York, NY
ARR
expeRTS
239
Case-Oriented Gaps in the Guidelines: Who Should Get an iCD?Monday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S504aCMe/CNe Hours: 1.5
Chair: Bruce D. Lindsay, Cleveland, OH
Case Andrew E. Epstein, Philadelphia, PA, Mark S. Kremers,Presenters: Charlotte, NC, Andrea M. Russo, Moorestown, NJ
Panelists: Mandeep Bhargava, Cleveland, OH, Anne B. Curtis, Buffalo, NY, N. A. Mark Estes, Boston, MA, Paul A. Heidenreich, Palo Alto, CA
ARR
SyMpOSiUM
677
Clinical Management of the AF patient: Treating the patient and the Health Care providerMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N226CMe/CNe Hours: 1.5
Co-Chairs: Stephen C. Hammill, Rochester, MN Albert L. Waldo, Cleveland, OH
8:00 Reducing the Risk of Anticoagulation — Michael M. Ezekowitz, Wynnewood, PA
8:18 Drug Therapy for Difficult AF — James A. Reiffel, Scarsdale, NY
8:36 When to Give Up on Sinus Rhythm — Win-Kuang Shen, Phoenix, AZ
8:54 Utility of patient Care pathways in AF patients — Luigi Di Biase, Austin, TX
9:12 Reimbursement Considerations in AF Care — Richard I. Fogel, Carmel, IN
CCS
SyMpOSiUM
678
pulmonary Artery Stenosis Current Therapy and Future Directions: live CaseMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N231CMe/CNe Hours: 1.5
Co-Chairs: Frank F. Ing, Houston, TX Lisa T. Bergersen, Boston, MA Mathew Gillespie, Philadelphia, PA
8:00 live Case: pulmonary Artery Stenosis — Jonathan J. Rome, Philadelphia, PA
8:45 pulmonary Artery Rehabilitation Current State of Knowledge: What Do We Need to Know to improve This procedure — James E. Lock, Boston, MA
9:10 Devices Studies and pMA indications in Congenital Heart Disease: past Failures, Successes and Future Directions — Robert H. Beekman, Cincinnati, OH
9:25 panel Discussion
Monday, March 26, 2012 • ACC.12
ACC.12 Final Program 179
Morning
CCS
SyMpOSiUM
679
Women with Congenital Heart Disease: Fertility, pregnancy and MenopauseMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S501aCMe/CNe Hours: 1.5
Co-Chairs: Mary Canobbio, Los Angeles, CA Carole A. Warnes, Rochester, MN
8:00 Biomarkers: How They Can Be Utilized during pregnancy — Candice Silversides, Toronto, Canada
8:16 My Cardiologist Cleared Me for pregnancy but What the Obstetrician Needs to Know — Anthony Gregg, Gainesville, FL
8:32 The Menopause: Not All palpitations Are Cardiac! — Stephen C. Cook, Columbus, OH
8:48 Difficult Decisions i Have to Make in the Care of the pregnant ACHD patient — Katherine Economy, Boston, MA
9:04 psychological Challenges of the Childbearing years — Adrienne H. Kovacs, Toronto, Canada
9:20 Question and Answer
HF
expeRTS
240
Myocarditis: When to Biopsy, Who to Treat, Which Therapy?Monday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S502CMe/CNe Hours: 1.5
Chair: Peter P. Liu, Toronto, Canada
Case Presenter: Lori Blauwet, Rochester, MN
Panelists: Leslie T. Cooper, Rochester, MN, Joshua M. Hare, Miami, FL, Hans Peter Schultheiss, Berlin, Germany, Guillermo Torre-Amione, TX, Jeffrey A. Towbin, Cincinnati, OH
HF
SyMpOSiUM
680
Controversies in the Management of Heart FailureMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S406bCMe/CNe/Cpe Hours: 1.5 ACpe No. 0012-9999-141-l04-p
Co-Chairs: Carl V. Leier, Columbus, OH Barry M. Massie, San Francisco, CA
8:00 Anemia is a Therapeutic Target in Heart Failure — Inder Anand, Minneapolis, MN
8:10 Anemia is Not a Therapeutic Target in Heart Failure — G. William Dec, Boston, MA
8:26 Role of Diuretics in Treatment of Heart Failure: A Necessary evil — Gadi Cotter, Durham, NC
8:36 Diuretics Are the Best Available Treatment for Heart Failure — Maya E. Guglin, Tampa, FL
8:52 Serial BNp Measurements Are Useful in Heart Failure Management — Alain Cohen-Solal, France
9:02 Serial BNp Measurements Are Not Useless in Heart Failure Management — Richard W. Troughton, Christchurch, New Zealand
9:18 Discussion
HF
SyMpOSiUM
681
Surgical Therapy of Heart FailureMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S404CMe/CNe Hours: 1.5
Co-Chairs: Michael A. Acker, Philadelphia, PA Steven F. Bolling, Ann Arbor, MI
8:00 Aortic Stenosis and low ejection Fraction — Blase A. Carabello, Houston, TX
8:15 Coronary Revascularization in the post-STiCH era — Eric J. Velazquez, Durham, NC
8:30 Mitral Regurgitation and low ejection Fraction — Ted Feldman, Evanston, IL
8:45 Destination Therapy for Advanced Heart Failure — Bartley P. Griffith, Baltimore, MD
9:00 Gene Therapy for Advanced Heart Failure — Roger J. Hajjar, New York, NY
9:15 Cellular Therapy of Heart Failure — Daniel J. Garry, Minneapolis, MN
iMAG
expeRTS
241
imaging the Right VentricleMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S505CMe/CNe Hours: 1.5
Chair: Lawrence G. Rudski, Montreal, QC, Canada
Case Presenter: Laxmi S. Mehta, Powell, OH
Panelists: Tal Geva, Boston, MA, Subha V. Raman, Columbus, OH, Nelson B. Schiller, San Francisco, CA, Dennis A. Tighe, Worcester, MA
iMAG
SyMpOSiUM
682
Advanced lV Dysfunction: A Multimodality ApproachMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S405CMe/CNe Hours: 1.5
Co-Chairs: Judy W. Hung, Boston, MA Issam A. Mikati, Chicago, IL
8:00 Role of MRi in Acute Heart Failure — Andrew E. Arai, Bethesda, MD
8:15 3-D echo — Roberto M. Lang, Chicago, IL
8:30 Strain and Strain Rate imaging: A Multimodality Approach — Thomas H. Marwick, Cleveland, OH
8:45 echo in VAD patients — William F. Armstrong, Ann Arbor, MI
9:00 How and When to Assess Viability — Eric J. Velazquez, Durham, NC
9:15 Cardiac CT in Advanced Heart Failure — Daniel S. Berman, Los Angeles, CA
ACC.12 • Monday, March 26, 2012
180 GO for ACC.12!
Mor
ning
iMAG
SyMpOSiUM
683
Future Directions for Cardiac CTMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S403CMe/CNe Hours: 1.5
Co-Chairs: Lawrence M. Boxt, Bronx, NY William Guy Weigold, Washington, DC
8:00 CT Viability and infarct Detection — Kelley Branch, Seattle, WA
8:18 Cardiac CT for Coronary Flow — James K. Min, New York, NY
8:36 CT Valve Morphology and Function — Mario J. Garcia, Bronx, NY
8:54 CTA plaque imaging: What We Know and Where it is Headed — Szilard Voros, Atlanta, GA
9:12 CT imaging for plaque progression — Matthew J. Budoff, Torrance, CA
liFelONG
BOOT CAMp
112
CCA Research Bootcamp Session i: Methods for engaging in ResearchMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S105dCMe/CNe/Cpe Hours: 1.5 ACpe No. 0012-9999-12-121-l04-p
Chair: Margo B. Minissian, Los Angeles, CA
8:00 Developing a Research project: Getting Started — Sandra M. Oliver-McNeil, Farmington Hills, MI
8:25 Methodology Development after Determining the Research Question — Eileen M. Handberg, Gainesville, FL
8:50 instrument Selection and investigator Developed Case Report Forms — Kay Blum, Baltimore, MD
9:15 Question and Answer
pRACTiCe
SyMpOSiUM
684
ACC/MedAxiom/ACCA: Cardiovascular Service linesMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S105aCMe/CNe Hours: 1.5
Co-Chairs: Michael K. Schroyer, Zionsville, IN C. Michael Valentine, Lynchburg, VA
8:00 Structure and Models — Keith Churchwell, Nashville, TN, Robin Steaban, Nashville, TN
8:30 Defining Clinical Focus for the Future — Michael K. Schroyer, Zionsville, IN
8:45 Financial Opportunities/Value Based purchasing — Cathleen Biga, Woodridge, IL
9:00 Merging Cultures — Robert Gianguzzi, Fountain Hills, AZ
9:15 panel Discussion
pReV
SyMpOSiUM
685
ACC China Chapter Session: Cardiovascular Clinical Research and practice in ChinaMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N229CMe/CNe Hours: 1.5
Co-Chairs: Dong Zhao, Beijing, China Dipti Itchhaporia, Newport Beach, CA
8:00 Opening Remarks — Dong Zhao, Beijing, China
8:05 Chinese Hypertension 3G Management: From Guideline to practice — Li Jianping, Beijing, China
8:25 Hypertension Treatment in China: China STATUS ii Study — Yong Huo, Beijing, China
8:45 The Return on expenditure Achieved for lipid Therapy in China Survey — Yujie Zhou, Beijing, China
9:05 A Randomized, Double-blinded Comparison of iopromide and iodixanol in Renally impaired patients Undergoing Cardiac Catheterization (DiReCT Study) — Chen Yundai, Beijing, China
9:25 Closing Remarks — Jack Lewin, Washington, DC
pReV
SyMpOSiUM
686
Global CVD prevention: Heart Disease and Risk Factors in Specific populationsMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S100cCMe/CNe Hours: 1.5
Co-Chairs: Krishnaswami Vijayaraghvan, Phoenix, AZ Salim Yusuf, Hamilton, Canada
8:00 CVD prevention in South Asia — Krishnaswami Vijayaraghvan, Phoenix, AZ
8:15 prevention Strategies in China — Dayi Hu, Beijing, China
8:30 prevention Trends in the Middle east — Mouaz H. Al-Mallah, Riyadh, Saudi Arabia
8:45 CVD prevention in South America — Hector O. Ventura, New Orleans, LA
9:00 Approaches to preventing CVD in Africa — Elizabeth Ofili, Atlanta, GA
9:15 World Wide Risk Factors: Do They Differ? — Salim Yusuf, Hamilton, Canada
QUAl
SyMpOSiUM
687
Where Will Cardiology Be in 2015?Monday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N427CMe/CNe Hours: 1.5
Co-Chairs: James B. Froehlich, Ann Arbor, MI Scott Wright, Rochester, MN
8:00 The Accountable Care Act (ACA) for Dummies — Jack Lewin, Washington, DC
8:18 Reimbursement in the era of Reform — Len Nichols, Washington, DC
8:36 public Reporting: What Does it Mean if My Hospital Gets A Bad Report Card? — Kalon K. L. Ho, Boston, MA
8:54 eHR: Meaningful Use or Meaningfully Useful? — Michael S. Blum, San Francisco, CA
9:12 putting it All Together: What Does This Mean for your practice? — Scott Wright, Rochester, MN
Monday, March 26, 2012 • ACC.12
ACC.12 Final Program 181
Morning
SpeCiAl
SpeCiAl
305
Joint American College of Cardiology/New England Journal of Medicine late-Breaking Clinical TrialsMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, Hall B, ACC.12 Main TentCMe/CNe Hours: 1.5
Co-Chairs: Patrick T. O’Gara, Boston, MA E. Murat Tuzcu, Cleveland, OH
Panelists: G. Alain Cribier, Rouen, France, Thomas C. Gerber, Jacksonville, FL, C. Michael Gibson, Boston, MA, Robert A. Guyton, Atlanta, GA
8:00 CORONARy: The Coronary Artery Bypass Grafting Surgery Off or On pump Revascularization Study — Andre Lamy, on behalf of the CORONARY Study Investigators, Population Health Research Institute, McMaster University, Hamilton Health Sciences, Hamilton, Canada
8:15 panel Discussion
8:22 ACRiN pA 4005: Multicenter Randomized Controlled Study of a Rapid “Rule Out” Strategy Using CT Coronary Angiogram Versus Traditional Care for low-risk eD patients with potential ACS — Harold Litt, Chadwick Miller, Constantine Gatsonis, Brad Snyder, Harjit Singh, Laurence Gavin, Daniel Entrikin, James Leaming, Carlos Jamis-Dow, Joan Lacomis, Judd Hollander, University of Pennsylvania, Philadelphia, PA, American College of Radiology Imaging Network, Philadelphia, PA
8:37 panel Discussion
8:44 Oral Rivaroxaban Alone for Symptomatic pulmonary embolism: The eiNSTeiN pe Study — Harry Roger Buller, Academic Medical Center, Amsterdam, The Netherlands
8:59 panel Discussion
9:06 late (≥ 2 year) Clinical and echocardiographic Outcomes after Transcatheter vs. Surgical Aortic Valve Replacement: Results from the High-risk Cohort of the pARTNeR Trial — Martin Leon, John Webb, Jeffrey Moses, Michael Mack, D. Craig Miller, Lars Svensson, E. Murat Tuzcu, Craig Smith, Susheel K. Kodali, for the PARTNER Trial Investigators, Columbia University Medical Center and The Cardiovascular Research Foundation, New York, NY
9:21 panel Discussion
SpeCiAl
SpeCiAl
407
young investigators Award Competition: Clinical investigations, Congenital Heart Disease, and Cardiovascular SurgeryMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N230CMe/CNe Hours: 1.5
Chair: Marc Steven Sabatine, Boston, MA
Judges: Brian H. Annex, Charlottesville, VA Nicholas L. Mills, Edinburgh, Scotland, United Kingdom
8:00 407–4 Sex Differences in Arterial Stiffness and Arterial-Ventricular interactions — Thais Coutinho, Patricia A. Pellikka, Iftikhar J. Kullo, Mayo Clinic, Rochester, MN
8:15 407–5 Coronary Arterial 18f-naf Uptake: A Novel Marker of plaque Biology — Marc R. Dweck, Marcus WL Chow, Nikhil V. Joshi, MIchelle C. Williams, Charlotte Jones, Alison M. Fletcher, Hamish Richardson, Audrey White, Graham McKillop, Edwin JR van Beek, Nicholas A. Boon, James HF Rudd, David E. Newby, University of Edinburgh, Edinburgh, United Kingdom, Univeristy of Cambridge, Cambridge, United Kingdom
8:30 407–6 impact of CT-guided Valve Sizing on post-procedural Aortic Regurgitation in Transcatheter Aortic Valve implantation — Kentaro Hayashida, Erik Bouvier, Thierry Lefevre, Thomas Hovasse, Marie-Claude Morice, Bernard Chevalier, Mauro Romano, Philippe Garot, Darren Mylotte, Arnaud Farge, Patrik Donzeau-Gouge, Bertrand Cormier, Institut Cardiovasculaire Paris Sud, Massy, France
8:45 407–7 impact of Jeopardized Myocardium on Therapeutic Benefit Associated with Completeness of Revascularization vs. Medical Therapy in patients with left Ventricular Systolic Dysfunction: A peT Myocardial perfusion and Metabolism Study — Lee Fong Ling, Thomas Cook, Thomas H. Marwick, Demetrio R. Flores, Weal A. Jaber, Richard C. Brunken, Manuel D. Cerqueira, Rory Hachamovitch, Cleveland Clinic, Cleveland, OH
9:00 407–8 Accuracy of Aortic Annuli Measurements Obtained from Three-dimensional echocardiography, Computed Tomography and Magnetic Resonance imaging Using an in Vitro Model — Wendy Tsang, Michael G. Bateman, Lynn Weinert, Gian Pellegrini, Victor Mor-Avi, Lissa Sugeng, Hubert Yeung, Amit R. Patel, Alexander J. Hill, Paul A. Iazzo, Roberto M. Lang, University of Chicago Medical Center, Chicago, IL
SpeCiAl
SyMpOSiUM
738
Joint Session of the european Society of Cardiology and the American College of Cardiology i: Management of Heart Disease in pregnancyMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N426CMe/CNe Hours: 1.5
Co-Chairs: Michel Komajda, Paris, France John Gordon Harold, Los Angeles, CA
8:00 Congenital Heart Disease — Elyse Foster, San Francisco, CA
8:18 Valvular Heart Disease — Petronella G. Pieper, Groningen, Netherlands
8:36 Cardiomyopathy and Heart Failure — Uri Elkayam, Los Angeles, CA
8:54 Arrhythmias — Speaker TBD
9:12 Hypertension — Irmtraut Kruck, Ludwigsburg, Germany
ACC.12 • Monday, March 26, 2012
182 GO for ACC.12!
Mor
ning
TeST
SyMpOSiUM
688
Challenging Sports Cardiology Cases in Older AthletesMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N227bCMe/CNe Hours: 1.5
Co-Chairs: Joseph C. Marek, Oak Brook, IL Robert Vogel, Baltimore, MD
8:00 Case presentation: NFl Combine player with Abnormal eCG — Eugene H. Chung, Chapel Hill, NC
8:05 This player’s eCG is Abnormal: What Now? — Alfred A. Bove, Philadelphia, PA
8:30 Case presentation: 70 year-old Veteran of 114 Marathons, S/p RCA Stent — Stephen A. Siegel, New York, NY
8:35 Detecting CAD in Older Athletes and What to Recommend When you Find it — Paul D. Thompson, Hartford, CT
9:00 Case presentation: 52 year-old Cross Country Skier with Fatigue during the Birkebeiner — Thomas Allison, Rochester, MN
9:05 Should Atrial Arrhythmias be Treated Differently in Athletes? — Mark S. Link, Boston, MA
VAlV
expeRTS
242
Tricuspid Valve Disease Case ManagementMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S503CMe/CNe Hours: 1.5
Chair: Luc Pierard, Liège, Belgium
Case Grace Lin, Rochester, MN, Patrick M. McCarthy,Presenters: Chicago, IL, Yan Topilsky, MN
Panelists: Vera H. Rigolin, Chicago, IL, William J. Stewart, Cleveland, OH
VAlV
SyMpOSiUM
674
Valvular Heart Disease in the Older Adult (with Many DRG Codes): Navigating the OptionsMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S402CMe/CNe Hours: 1.5
Co-Chairs: Maurice Enriquez-Sarano, Rochester, MN Daniel E. Forman, Boston, MA
8:00 Case presenter — Joseph Maalouf, Rochester, MN
8:05 evaluating the Older Adult Cardiac patient Who’s Failing Medical Therapy — Jeffrey S. Borer, New York, NY
8:14 What’s in the Registries: NCDR, Cath, pC and the Older Adult — Ralph G. Brindis, Oakland, CA
8:23 What’s in the Registries: STS Database, Valvular Outcomes and the Older Adult — Frederick L. Grover, Aurora, CO
8:32 Mitral Transcatheter Options and the Older Adult — Martin B. Leon, New York, NY
8:41 Mitral Surgical Options and the Older Adult — W. Randolph Chitwood, Greenville, NC
8:50 TAVi/TAVR Update — David R. Holmes, Jr., Rochester, MN
8:59 Surgical Aortic Valve Replacement and the Older Adult — Richard J. Shemin, Los Angeles, CA
9:08 Hybrid Approaches: Maximized Gain/Minimized pain? — Stephen Ball, Nashville, TN
9:17 Summary Discussion
VAlV
SelF-DiReCTeD
1503
Heart Songs at ACC.12: A Self-paced Multimedia learning experienceMonday, March 26, 2012, 9:00 a.m. – 5:00 p.m.McCormick Place, Vista Room LobbyCMe/CNe Hours: 2
Back by popular demand is the highly rated Heart Songs Self-Paced Learning Lab — a unique audio- visual program to refresh cardiac auscultation skills. After a pre-test, attendees will listen to Heart Sounds while viewing phonocardiograms, echoes, and more, on an iPod® Touch, iPad® or laptop computer. Attendees can view the sessions and take both the pre-test and post-test on their own device, or use devices provided in the room, to document improvement in their auscultation skills. This clinical skills workshop provides attendees with a choice of three sessions: the first on 5 common heart murmurs and the second on more advanced sounds including bicuspid aortic valve, mitral valve prolapse and hypertrophic cardiomyopathy, among others. The third session is for experts on topics such as combined aortic stenosis and regurgitation; and combined mitral stenosis and regurgitation. In addition, there will be a 3-D echo/auscultation training program available in the Self-Paced Learning Lab. This video program will combine 3-D echo images with the auscultation findings on 4 common valvular abnormalities. Studies have shown that the range of repetition needed to acquire auditory skills can vary four fold. This workshop will tailor the learning to each individual’s need for repetition. Each session takes approximately 30 minutes to complete. This workshop will appeal to cardiovascular specialists and cardiac care team members who want to improve their auscultation skill in both common and more advanced heart sounds.
Co-Chairs: Michael J. Barrett, Blue Bell, PA Carolyn S. Lacey, Fairfield, CA Tahmeed A. Contractor, Allentown, PA Garima Sharma, Philadelphia, PA
ACC-i2/TCT
SpeCiAl
2112
Fellows Bootcamp: Coronary iiMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place South, S103bCMe Hours: 1.5
Co-Chairs: Susheel Kodali, New York, NY James Bernard Hermiller, Jr., Indianapolis, IN
10:30 Avoiding and Treating Complications — James Bernard Hermiller, Jr., Indianapolis, IN
10:45 Bifurcations: Simple and Complex — Thierry Lefevre, Massy, France
11:00 pCi in STeMi and Shock — Timothy D. Henry, Minneapolis, MN
11:15 The post CABG patient: pCi via the liMA and SVG intervention — Susheel Kodali, New York, NY
Monday, March 26, 2012 • ACC.12
ACC.12 Final Program 183
Morning
11:30 Chronic Total Occlusions: The Fundamentals — William L. Lombardi, Bellingham, WA
11:45 Roundtable Discussion
ACC-i2/TCT
SpeCiAl
2122
Multi-Disciplinary Management of the Failing Heart: Team-based evaluation and Therapy of Advanced Heart Disease iiMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place South, S102cCMe/CNe Hours: 1.5
Chair: Srihari S. Naidu, New York, NY
Panelists: Juan Carlos Plana, Cleveland, OH, Michael J. Lim, Saint Louis, MO, Marc J. Semigran, Boston, MA, Mauricio G. Cohen, Miami, FL, Frank Pelosi, Ann Arbor, MI, John B. O’Connell, Atlanta, GA, Steven R. Bailey, San Antonio, TX, Michael J. Mack, Plano, TX
10:30 The Role of interventionalists in Heart Failure: From Assist Devices to Valves — Srihari S. Naidu, New York, NY
10:45 Case presentation 3 — James A. Watts, Boston, MA
10:50 panel Discussion
11:15 Case presentation 4 — David Bartov, New York, NY
11:20 panel Discussion
11:50 Where Do We Go From Here? — Morton J. Kern, Orange, CA
ACC-i2/TCT
SyMpOSiUM
2629
establishing a Cardiac Catheterization imaging/physiology programMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place South, S101aCMe/CNe Hours: 1.5
Co-Chairs: Neil J. Weissman, Washington, DC Emmanouil S. Brilakis, Dallas, TX
10:30 intravascular Ultrasonography — Robert J. Russo, La Jolla, CA
10:40 Optical Coherence Tomography and Near-infrared Spectroscopy — Emmanouil S. Brilakis, Dallas, TX
10:50 Fractional Flow Reserve — Michael J. Lim, St. Louis, MO
11:00 imaging for Guiding Structural Heart Disease interventions: Tee and iCe — Rebecca T. Hahn, New York, NY
11:10 emerging imaging Applications in the Cardiac Catheterization laboratory — John D. Carroll, Aurora, CO
11:20 Training of Cath lab personnel and Setup for Cath lab Based imaging — Akiko Maehara, New York, NY
11:30 Case presentation: intravascular imaging — Kendrick A. Shunk, San Francisco, CA
11:35 Case presentation: echocardiography (Tee, TTe, etc.) — Amar Krishnaswamy, Cleveland, OH
11:40 Case presentation: FFR — Joel A. Garcia, Denver, CO
11:45 panel Discussion: What Are the Appropriate Real-world indications for These procedures?
ACC-i2/TCT
SyMpOSiUM
2630
Hemodynamics iii (pVl and ASD Closure)Monday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place South, S102bCMe/CNe Hours: 1.5
Co-Chairs: Charanjit S. Rihal, Rochester, MN Igor F. Palacios, Boston, MA
10:30 Anatomy, prevalence, pathophysiology of pVl and ASD — Samir R. Kapadia, Cleveland, OH
10:45 imaging Considerations: echo — Nina Wunderlich, Frankfurt, Germany
10:55 imaging Considerations: CT Guidance — Carlos E. Ruiz, New York, NY
11:05 Case presentation: Transseptal Mitral — Steven L. Goldberg, Seattle, WA
11:10 Case presentation: Transapical Mitral — Chad Kliger, New York, NY
11:15 Case presentation: Retrograde Aortic — Oluseun O. Alli, Rochester, MN
11:20 Overall Results of pVl Closure: US experience — Paul Sorajja, Rochester, MN
11:30 Overall Results of pVl Closure: european experience — Horst Sievert, Frankfurt, Germany
11:40 Case presentation: VSD Closure — George S. Hanzel, Birmingham, MI
11:50 Results post infarct VSD Closure — Ziyad M. Hijazi, Chicago, IL
ACC-i2/TCT
SyMpOSiUM
2631
All you Need to Know About Carotid Artery StentingMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place South, S103cCMe/CNe Hours: 1.5
Co-Chairs: Seemant Chaturvedi, Detroit, MI D. Christopher Metzger, Kingsport, TN
10:30 Carotid Stenting Case Selection: Which patients and Which Anatomy Should be Avoided? — Christopher J. White, New Orleans, LA
10:45 Debate: Carotid Stenting Should be Offered as an Alternative to CeA for Asymptomatic > 80% Average Surgical Risk patients — Kenneth Rosenfield, Boston, MA
11:00 Debate: Carotid Stenting Should Not be Offered as an Alternative to CeA for Asymptomatic > 80% Average Surgical Risk patients — Anthony J. Comerota, Toledo, OH
11:15 proximal Versus Distal protection during Carotid Artery Stenting: Does it Really Matter? — Marco Roffi, Geneva 1211, Switzerland
11:30 Hybrid Approach to Severe Carotid and Coronary Artery Disease — Case Selection — Jan Van der Heyden, Nieuwegein, Netherlands
11:45 Carotid Stenting: Case presentation — Management of Complications — William A. Gray, New York, NY
ACC.12 • Monday, March 26, 2012
184 GO for ACC.12!
Mor
ning
ACC-i2/TCT
SyMpOSiUM
2632
DeS: Future DirectionsMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place South, S106bCMe/CNe Hours: 1.5
Co-Chairs: Gregg W. Stone, New York, NY George D. Dangas, New York, NY
10:30 limitations of Current DeS: A pathologist’s View — Renu Virmani, Gaithersburg, MD
10:42 The Clinical perspective: 1st and 2nd Generation DeS Are Not perfect — Ron Waksman, Washington, DC
10:54 Challenges in Creating a Fully Bioresorbable effective Stent — John A. Ormiston, Auckland, New Zealand
11:06 Bioabsorbable Stents: What’s in the pipeline — Raimund A. Erbel, Essen, Germany
11:16 Bioresorbable Coatings and polymer-free DeS — Alexandre Abizaid, Sao Paulo, Brazil
11:26 Drug-eluting Balloons: Novel Techonology and Applications — Sigmund Silber, Zell, Germany
11:36 The Future is Here: BVS Update — Patrick W. Serruys, Rotterdam, Netherlands
11:48 panel Discussion
ACS
SyMpOSiUM
689
improving STeMi Outcomes: Saving Myocardium and Attenuating RemodelingMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place South, S401aCMe/CNe Hours: 1.5
Co-Chairs: Jane A. Linderbaum, Rochester, MN Debabrata Mukherjee, El Paso, TX
10:30 The importance of ischemic Time in Assessing STeMi Treatment Outcomes — Holger Thiele, Leipzig, Germany
10:43 Stem Cell Therapy for Mi — Warren Sherman, New York, NY
10:55 Stem Cell Therapy Not for Mi — Jochen Wöhrle, Ulm, Germany
11:13 Reducing post Mi Remodeling — Mitchell W. Krucoff, Durham, NC
11:27 Remote ischemic preconditioning in STeMi: Fact or Fiction — Hans Erik Botker, Skejby, Denmark
11:41 State-of-the-Art STeMi Care — Eric R. Bates, Ann Arbor, MI
11:55 Summary — Debabrata Mukherjee, El Paso, TX
ARR
expeRTS
243
perioperative Management of patients with Cardiac implantable electronic DeviceMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place South, S504aCMe/CNe Hours: 1.5
Chair: George H. Crossley, Nashville, TN
Case Presenter: Michael Robert Gold, Charleston, SC
Panelists: Mina Chung, Cleveland, OH, Melanie T. Gura, Akron, OH, Jeanne E. Poole, Seattle, WA
ARR
SyMpOSiUM
690
Controversies in Device TherapyMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place South, S406aCMe/CNe Hours: 1.5
Co-Chairs: Thomas F. Deering, Atlanta, GA Cara Pellegrini, San Francisco, CA
10:30 Should patients with RBBB Be Considered for CRT? — William T. Abraham, Columbus, OH
10:48 Should All patients Have an MRi Conditional Device implanted? — William R. Lewis, Cleveland, OH
11:06 Should the Contraindications for Device implantation for primary prevention Be expanded? — James P. Daubert, Durham, NC
11:24 Should every patient Receive a Dual Chamber iCD? — Bruce L. Wilkoff, Cleveland, OH
11:42 Should All Chronic leads Be extracted? — Charles J. Love, Columbus, OH
ARR
SyMpOSiUM
691
The Genetics of Sudden Cardiac Death: What Do We Know and How Best to evaluate and Manage Such patientsMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place North, N226CMe/CNe Hours: 1.5
Co-Chairs: Federico Gentile, Naples, Italy Arthur J. Moss, Rochester, NY
10:30 Sudden Death in the General population — Sumeet Chugh, Los Angeles, CA
10:48 Short QT Syndrome and early Repolarization — Michael Howard Gollob, London, Canada
11:06 long QT Syndrome — Michael J. Ackerman, Rochester, MN
11:24 Brugada Syndrome — Koonlawee Nadamanee, Inglewood, CA
11:42 Catecholaminergic polymorphic Ventricular Tachycardia — Arthur A. Wilde, Amsterdam, Netherlands
CCS
SyMpOSiUM
692
pulmonary Vein Stenosis: What Are Realistic expectations?Monday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place North, N229CMe/CNe Hours: 1.5
Co-Chairs: Piers E. F. Daubeney, London, United Kingdom James E. Lock, Boston, MA
10:30 Case presentation — Jeffrey Darst, Aurora, CO
10:48 epidemiology and Natural History of pulmonary Vein Stenosis: evolution in Our Understanding — Anna Seale, London, United Kingdom
11:06 pathology and pathogenesis of pulmonary Vein Stenosis: How Well Do We Know This enemy? — Stephen Sanders, Boston, MA
11:24 Surgery for pulmonary Vein Stenosis: Outcomes and expectations in the Current era — Christopher Caldarone, Toronto, Canada
11:42 Transcatheter pulmonary Vein interventions: Do They Help? How and When? — Alan William Nugent, Dallas, TX
Monday, March 26, 2012 • ACC.12
ACC.12 Final Program 185
Morning
CCS
SyMpOSiUM
693
Challenging imaging issues in Congenital Heart DiseaseMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place North, N231CMe/CNe Hours: 1.5
Co-Chairs: Nancy Ayres, Houston, TX William Mahle, Atlanta, GA
10:30 When 3-D imaging Can Make a Difference — Girish S. Shirali, Charleston, SC
10:48 Quantification of Collateral Flow in Congenital Heart Disease: When and How — Ashwin Prakash, Boston, MA
11:24 What Stress imaging Adds to echocardiography in CHD — Luc Mertens, Toronto, Canada
11:42 Cardiac MRi of Complex Congenital Heart Disease: Rules to live By — Andrew Powell, Boston, MA
HF
SyMpOSiUM
694
lVAD as Destination Therapy for Advanced Heart FailureMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place South, S406bCMe/CNe Hours: 1.5
Co-Chairs: Joseph G. Rogers, Durham, NC Randall C. Starling, Cleveland, OH
10:30 Current State and Up and Coming in MCS — Paul J. Mather, Philadelphia, PA
10:45 When to Support — Andrew Boyle, Milwaukee, WI
11:00 Modeling Risk Assessment — Jennifer Cowger, MI
11:15 BTT and DT: is There a Difference? — Jeffrey Teuteberg, Pittsburgh, PA
11:30 long-term Support: What Are the pitfalls? — Shashank Desai, Fairfax, VA
11:45 Transitioning Back to the Community — Kathleen Grady, Chicago, IL
HF
SyMpOSiUM
695
Management of peripartum Cardiomyopathy: Update 2012Monday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place South, S404CMe/CNe Hours: 1.5
Co-Chairs: Uri Elkayam, Los Angeles, CA Kismet Rasmusson, Salt Lake City, UT
10:30 Racial Differences in Risk and Outcomes in peripartum Cardiomyopathy — Kalgi A. Modi, Shreveport, LA
10:48 Bromocriptine and Recovery — Julie Damp, Nashville, TN
11:06 Risk of Subsequent pregnancies — Angela Kealey, Canada
11:24 internet as Clinical Resource and Research Tool — Jordan Safirstein, NJ
11:42 NHlBi ppCM Network and the ipAC Study — Dennis M. McNamara, Pittsburgh, PA
iMAG
SyMpOSiUM
696
Cardiac CT in 2012: State-of-the-ArtMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place South, S405CMe/CNe Hours: 1.5
Co-Chairs: Ricardo C. Cury, Miami, FL Jack A. Ziffer, Miami, FL
10:30 Calcium Scoring in the Age of CT Angiography — Khurram Nasir, New Haven, CT
10:48 Cardiac Computed Tomographic Angiography: Diagnosis and prognosis of CAD — Benjamin J. W. Chow, Ottawa, Canada
11:06 ischemic Chest pain in the eR — Ronald P. Karlsberg, Beverly Hills, CA
11:24 Cardiac CT Radiation exposures — Sandra Halliburton, Cleveland, OH
11:42 Advances in CT Hardware — Stephan Achenbach, Erlangen, Germany
iMAG
SyMpOSiUM
697
Role of echo in the evaluation and Management of patients with Mitral RegurgitationMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place South, S403CMe/CNe Hours: 1.5
Co-Chairs: Judy W. Hung, Boston, MA Robert A. Levine, Boston, MA
10:30 How echo Has Aided in Our Understanding of MR — Robert A. Levine, Boston, MA
10:45 Role of echo during percutaneous interventions — Judy W. Hung, Boston, MA
11:00 Qualitative versus Quantitative Approaches to Severity — Paul A. Grayburn, Dallas, TX
11:15 Debate: 3-D echo is indispensible for intraoperative evaluation — Roberto M. Lang, Chicago, IL
11:27 3-D echo is Not indispensible for intraoperative evaluation — Patrick M. McCarthy, Chicago, IL
11:45 physiology of Myxomatous Disease: insights from 3-D echo — Sunil V. Mankad, Rochester, MN
pRACTiCe
expeRTS
244
leadership and GovernanceMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place South, S503CMe/CNe Hours: 1.5
Co-Chairs: Suzette Jaskie, Grand Rapids, MI Matthew Phillips, Austin, TX
Panelists: Robert Campbell, Atlanta, GA, C. Michael Valentine, Lynchburg, VA, Blair D. Erb, Bozeman, MT, Matthew Phillips, Austin, TX, Suzette Jaskie, Grand Rapids, MI
pReV
expeRTS
245
Women’s Cardiovascular HealthMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place South, S501aCMe/CNe Hours: 1.5
Chair: Laxmi S. Mehta, Columbus, OH
Case Stacie L. Daugherty, Aurora, CO, Jennifer H. Mieres, Presenters: Lake Success, NY
Panelists: Claire S. Duvernoy, Ann Arbor, MI, Jennifer H. Mieres, Lake Success, NY, Mary N. Walsh, Indianapolis, IN
ACC.12 • Monday, March 26, 2012
186 GO for ACC.12!
Mor
ning
pReV
SyMpOSiUM
698
Vitamins and Supplements in Cardiovascular Disease preventionMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place South, S100cCMe/CNe/Cpe Hours: 1.5 ACpe No. 0012-9999-142-l04-p
Co-Chairs: Lynne Braun, Chicago, IL Elizabeth A. Jackson, Ann Arbor, MI
10:30 Vitamin D and CVD — Erin Michos, Baltimore, MD
10:48 Dietary Supplements: Use and Misuse — Rhonda M. Cooper-DeHoff, Gainesville, FL
11:06 Role of integrative Medicine in CVD prevention — Sara Warber, Ann Arbor, MI
11:24 intensive lifestyle Changes for the Treatment of Coronary Heart Disease — Dean Ornish, Sausalito, CA
pReV
SyMpOSiUM
699
Joint Symposium of the preventive Cardiovascular Nurses Association and the American College of CardiologyMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place South, S105dCMe/CNe Hours: 1.5
Chair: Barbara Fletcher, Jacksonville Beach, FL
10:30 Welcome and Symposium Objectives — Barbara Fletcher, Jacksonville Beach, FL
10:35 Maximizing Team efforts for improving patient Outcomes — Alan S. Brown, Naperville, IL
10:50 improving patient Adherence to Complex Regimens — Cindy Lamendola, Palo Alto, CA
11:05 patient Centeredness: What Does it Mean in prevention? — Suzanne Hughes, Akron, OH
11:20 Team-based patient Care: Adhering to Guidelines — Sidney Smith, Jr., Chapel Hill, NC
11:35 patient education in 2012 — Sherry Bumpus, Ann Arbor, MI
11:50 Discussion/Question and Answer
QUAl
SyMpOSiUM
700
lies, Damned lies and Statistics: pitfalls in literature interpretationMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place North, N427CMe/CNe Hours: 1.5
Co-Chairs: Robert A. Harrington, Durham, NC Sharon-Lise T. Normand, Boston, MA
10:30 Non-inferiority Studies — Ralph B. D’Agostino, Boston, MA
10:48 propensity Scores and instrumental Variables — Robert W. Yeh, Boston, MA
11:06 Secondary endpoints and Subgroup Analyses in Clinical Trials — Salim Yusuf, Hamilton, Canada
11:24 Reclassification and Discrimination — Michael Pencina, Boston, MA
11:42 Small effect Size and Number Needed to Treat — Sanjay Kaul, Los Angeles, CA
QUAl
SyMpOSiUM
742
The Future of Cardiovascular Diseases: Where Are We Going (and Where Do We Want to Go)Monday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place North, N426CMe/CNe Hours: 1.5
Co-Chairs: John Gordon Harold, Los Angeles, CA William A. Zoghbi, Houston, TX
10:30 United Nations Summit: The prevention of Noncommunicable Diseases among Women — Nanette Kass Wenger, Atlanta, GA
10:50 Million Hearts: preventing a Million Hearts Attacks and Strokes in Five years — Janet S. Wright, Baltimore, MD
11:10 Transformation of Cardiovascular practice and Care in the emerging World — Jack Lewin, Washington, DC
11:30 Global prevention of Cardiovascular Diseases — Dorairaj Prabhakaran, New Delhi, India
11:50 panel Discussion
SpeCiAl
SpeCiAl
306
late-Breaking Clinical Trials iVMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place North, Hall B, ACC.12 Main TentCMe/CNe Hours: 1.5
Co-Chairs: Peter A. Brady, Rochester, MN Karol E. Watson, Los Angeles, CA
Panelists: Christie M. Ballantyne, Houston, TX, C. Noel Bairey Merz, Los Angeles, CA, Jorge Plutzky, Boston, MA
10:30 Comparison of Bariatric Surgical procedures and Advanced Medical Therapy for the Treatment of Type 2 Diabetes in patients with Moderate Obesity: 1-year STAMpeDe Trial Results — Philip Raymond Schauer, Sangeeta Kashyap, Kathy Wolski, Stacy Brethauer, John Kirwanj, Claire Pothier, Susan Thomas, Beth Abood, Steven Nissen, Deepak Bhatt, Cleveland Clinic, Cleveland, OH
10:45 panel Discussion
10:52 A Mendelian Randomized Controlled Trial of long-term Reduction in low-density lipoprotein Cholesterol Beginning early in life — Brian Anthony Ference, Nitin Mahajan, Issa Alesh, Wonsuk Yoo, Karolina K. Mirowska, Abhishek Mewada, Luis Afonso, Joel Kahn, Kim Williams, John Flack, Wayne State University School of Medicine, Detroit, MI
11:07 panel Discussion
11:14 A Randomized, Double-blind, placebo-controlled Trial of the Safety and efficacy of a Monoclonal Antibody to proprotein Convertase Subtilisin/Kexin Type 9 Serine protease, ReGN727/SAR236553, in patients with primary Hypercholesterolemia (NCT: 01288443) — James McKenney, Michael Koren, Dean Kereiakes, Corinne Hanotin, ANNE-CATHERINE FERRAND, Evan Albert Stein, Regeneron Pharmaceuticals, Incorporated, Tarrytown, NY, Sanofi-aventis US Incorporated, Bridgewater, NJ
11:29 panel Discussion
Monday, March 26, 2012 • ACC.12
ACC.12 Final Program 187
Morning
11:36 pacemaker Therapy in patients with Neurally-mediated Syncope and Documented Asystole — Michele Brignole, on the behalf of the ISSUE-3 Investigators, Ospedali del Tigullio, Lavagna, Italy
11:51 panel Discussion
SpeCiAl
SpeCiAl
408
young investigators Award Competition: Cardiovascular Health Outcomes and population GeneticsMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place North, N230CMe/CNe Hours: 1.5
Chair: Paul Chan, Kansas City, MO
Judges: Rajendra Mehta, Ann Arbor, MI Leslee J. Shaw, Atlanta, GA
10:30 408 – 4 Temporal Relationship of Conduction System Disease and Ventricular Dysfunction in LMNA Cardiomyopathy — Chad R. Brodt, Cardiovascular Division, University of Miami Miller School of Medicine, Miami, FL
10:45 408 – 5 An indirect pooled Comparison of Clinical endpoints with eplerenone and Other Aldosterone Antagonists in Heart Failure: A Systematic Review — Saurav Chatterjee, Chaim Moeller, Nidhi Shah, Oluwaseyi Bolorunduro, Norbert Moskovits, Edgar Lichstein, Debabrata Mukherjee, Maimonides Medical Center, Brooklyn,NY, NY, Texas Tech University Health Sciences Center, El Paso, TX
11:00 408 – 6 Vitamin D Deficiency is Associated with Diastolic Dysfunction in Children with Chronic Kidney Disease — Amit Patange, Rudolph Valentini, Wei Du, Michael Pettersen, Children’s Hospital of Michigan, Detroit, MI
11:15 408 – 7 Differences in the Outcome of patients Undergoing percutaneous Coronary interventions at Teaching versus Non-teaching Hospitals — Amneet Sandhu, Dean Smith, Hitinder S. Gurm, University of Michigan, Ann Arbor, MI
11:30 408 – 8 Cardiac Transplantation in African Americans: A Single Center experience — Prakash Goutham Suryanarayana, Hannah Copeland, Mark Friedman, Jack Copeland, University of Arizona, Tucson, AZ, University of California San Diego, San Diego, CA
SpeCiAl
SyMpOSiUM
741
integrative MedicineMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place North, N227bCMe/CNe Hours: 1.5
Co-Chairs: Jeffery Dusek, Minneapolis, MN Erminia Guarneri, La Jolla, CA
10:30 A proactive, personalized preventive Approach to Cardiovascular Disease — Erminia Guarneri, La Jolla, CA
10:50 integrative Cardiology: Translating Science into improved Clinical Care — Kevin Barrows, San Francisco, CA
11:10 Rationale for Use of integrative Medicine along with Conventional Cardiac Care — Courtney Baechler, St. Paul, MN
11:30 The evidence Base for Use of integrative Medicine for Cardiovascular patients: Model of inpatient integrative Medicine — Jeffery Dusek, Minneapolis, MN
11:50 Question and Answer
TeST
expeRTS
262
eCGs in Athletes: The Great eCG Screening Debate and Challenging CasesMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place South, S502CMe/CNe Hours: 1.5
Chair: Sanjay Sharma, London, United Kingdom
Panelists: Joseph Atallah, Edmonton, Canada, Anthony Magalski, Leawood, KS, Barry J. Maron, Minneapolis, MN, Antonio Pelliccia, Rome, Italy
10:30 To eCG or Not To eCG: All Athletes Should Be Screened — Antonio Pelliccia, Rome, Italy
10:45 To eCG or Not To eCG: All Athletes Should Not Be Screened — Barry J. Maron, Minneapolis, MN
11:10 interpretation of eCGs in Athletes (with ARS) — Christine E. Lawless, Chicago, IL
11:10 panel Discussion
VAlV
expeRTS
246
Complications of interventions for Valvular Heart DiseaseMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place South, S505CMe/CNe Hours: 1.5
Chair: Maurice Enriquez-Sarano, Rochester, MN
Case Raoul Bonan, Montreal, Canada, Todd M. Dewey,Presenters: Dallas, TX
Panelists: Kevin Greason, Rochester, MN, David Messika-Zeitoun, Paris, France
VASC
expeRTS
264
Challenging Cases in Anticoagulation Management: Spotlight on the Novel AnticoagulantsMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place South, S105aCMe/CNe Hours: 1.5
Chair: Heather L. Gornik, Cleveland, OH
Case Presenter: Aditya M. Sharma, Cleveland, OH
Panelists: Samuel Z. Goldhaber, Boston, MA, Jonathan L. Halperin, New York, NY, John Heit, Rochester, MN, Jeffrey I. Weitz, Hamilton, Canada
ACC.12 • Monday, March 26, 2012
188 GO for ACC.12!
NooN
noon SeSSionS
ACC-i2/TCT
iNTl. lUNCH
502
Joint Session of the Argentine Society of Cardiology and the American College of Cardiology: CarotidsMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place North, N226CMe/CNe Hours: 1.5
Co-Chairs: John R. Laird, El Macero, CA Carlos M. Barrero, Buenos Aires, Argentina
Panelists: Cesar A. Belziti, Buenos Aires, Argentina, Jorge Atilio Belardi, Buenos Aires, Argentina
12:15 introduction — John R. Laird, El Macero, CA
12:20 Carotid Disease: Argentine perspective — Oscar A. Mendiz, Buenos Aires, Argentina
12:32 Carotid Disease: US perspective — William A. Gray, New York, NY
12:44 Aortic Disease: Argentine perspective — Juan Carlos Parodi, Buenos Aires, Argentina
12:56 Aortic Disease: US perspective — Robert M. Bersin, Seattle, WA
1:08 lower extremity Vascular Disease: Argentinian perspective — Daniel H. Berrocal, Buenos Aires, Argentina
1:20 lower extremity Vascular Disease: US perspective — Mehdi H. Shishehbor, Cleveland, OH
1:32 Conclusion — Carlos M. Barrero, Buenos Aires, Argentina
ACC-i2/TCT
iNTl. lUNCH
503
Joint Session of the Brazilian Society of Cardiology and the American College of Cardiology: Drug-eluting Stents — From the early Beginning to New Stent platformsMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place North, N426CMe/CNe Hours: 1.5
Co-Chairs: Patrick T. O’Gara, Boston, MA Jadelson P. Andrade, Salvador-Bahia, Brazil
Panelist: Antonio CP Chagas, Sao Paulo, Brazil
12:15 introduction — Patrick T. O’Gara, Boston, MA
12:20 From the Beginning Up to the Second Generation of Drug-eluting Stents: A Decade of learning — Luiz Alberto Mattos, Sao Paolo, Brazil
12:32 Current pattern of DeS Utilization in the United States — Ron Waksman, Washington, DC
12:44 Durable polymers versus Biodegradable Ones: Which is the Best for Device Selection? — Pedro A. Lemos, Sao Paulo, Brazil
12:56 impact of Changing Health Care economics in the United States on Future Use of Drug-eluting Stents — David J. Cohen, Kansas City, MO
1:08 Bioabsorbable everolimus-eluting Stent Research program: State-of-the-Art in 2012 — Alexandre Abizaid, Sao Paulo, Brazil
1:20 Rationale and Design of the Absorb iii Trial — Stephen G. Ellis, Cleveland, OH
1:32 Conclusion — Jadelson P. Andrade, Salvador-Bahia, Brazil
ACC-i2/TCT
iNTl. lUNCH
505
Joint Session of the Chinese Society of Cardiology and the American College of Cardiology: Coronary Total OcclusionsMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place North, N228CMe/CNe Hours: 1.5
Co-Chairs: Jack Lewin, Washington, DC Dayi Hu, Beijing, China
Panelists: Jung Han Yoon, Seoul, Republic of Korea
12:15 introduction — Jack Lewin, Washington, DC
12:20 Current Status of Antegrade Approach for CTO pCi in China — Yaling Han, Shenyang, Liaoning, China
12:32 Complex Antegrade CTO Case example — Dimitri Karmpalotis, Atlanta, GA
12:44 TRi in China and for CTO lesions: Strategic and Technical experience — YueJin Yang, Beijing, China
12:56 prognosis of Successful CTO pCi — James Aaron Grantham, Kansas City, MO
1:08 Retrograde Approach in CTO — Jiyan Chen, Guangzhou, China
1:15 Radial pCi: is it Best Suited for AMi? — Michael C. Kim, New York, NY
1:20 Retrograde CTO Case example — William L. Lombardi, Bellingham, WA
1:32 Conclusion — Dayi Hu, Beijing, China
ACC-i2/TCT
iNTl. lUNCH
511
Joint Session of the Korean Society of Cardiology and the American College of Cardiology: Treating Complex lesionsMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place North, N229CMe/CNe Hours: 1.5
Co-Chairs: Martin B. Leon, New York, NY Ki-Bae Seung, Seoul, Republic of Korea
12:15 introduction — Martin B. Leon, New York, NY
12:20 left Main Case presentation — Duk-Woo Park, Seoul 138-736, Republic of Korea
12:25 left Main Revascularization Decisions: What is on the Horizon? — David E. Kandzari, Atlanta, GA
12:35 left Main lecture — Seung-Jung Park, Songpa-Ku Seoul, Republic of Korea
12:45 imaging Guided Optimal pCi Case presentation — Jang-Ho Bae, Daejeon, Republic of Korea
1:00 imaging Guided Optimal pCi lecture — Myeong-Ki Hong, Seoul, Republic of Korea
1:10 AMi Case presentation — Young Keun Ahn, Gwangju, Republic of Korea
Monday, March 26, 2012 • ACC.12
ACC.12 Final Program 189
NooN
1:25 AMi lecture — Myung Ho Jeong, Gwang Ju, Republic of Korea
1:35 Conclusion — Ki-Bae Seung, Seoul, Republic of Korea
ACC-i2/TCT
iNTl. lUNCH
518
Joint Session of the Turkish Society of Cardiology and the American College of Cardiology: Devices: ASD’s, VSD’s, perivalvular leaksMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S505CMe/CNe Hours: 1.5
Co-Chairs: E. Murat Tuzcu, Cleveland, OH Omer Kozan, Izmir, Turkey
12:15 introduction — E. Murat Tuzcu, Cleveland, OH
12:20 percutaneous Closure of Multiple ASD Case presentation — Erdogan Ilkay, Ankara, Turkey
12:25 percutaneous Closure of Multiple ASD — Omer Goktekin, Eskisehir, Turkey
Panelists: Muzaffer Degertekin, Istanbul, Turkey, John F. Rhodes, Durham, NC
12:45 VSD Closure in Complex Cases Case presentation — Oktay Ergene, Izmir, Turkey
12:50 VSD Closure in Complex Cases — Levent Saltik, Istanbul, Turkey
Panelists: Baris Okcun, Istanbul, Turkey, Larry A. Latson, Cleveland, OH
1:15 percutaneous large prosthetic Mitral Valvular leak Closure Case presentation — Cevat Kirma, Istanbul, Turkey
1:20 percutaneous large prosthetic Mitral Valvular leak Closure — Mehmet Okzan, Istanbul, Turkey
Panelists: Kudret Aytemir, Ankara, Turkey, Charanjit S. Rihal, Rochester, MN
1:40 Conclusion — Omer Kozan, Izmir, Turkey
ACC-i2/TCT
MOC
819
ACCF Study Sessions for Maintenance of Certification: ABiM Recertification Made easy — interventional Cardiology 2010 Update (B2-K)Monday, March 26, 2012, 12:15 p.m. – 2:45 p.m.McCormick Place South, S105aCMe Hours: 2.5
Please refer to the full session listing, listed on page 192, for additional session information.
ACC-i2/TCT
expeRTS
2313
Non-Coronary Complications Case ReviewsMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S101aCMe/CNe Hours: 1.5
Co-Chairs: Ziyad M. Hijazi, Chicago, IL Larry Latson, Hollywood, FL
Case Frank J. Arena, Hammond, LA, Gamini Galappatthy,Presenters: Colombo, Sri Lanka, Ankur Kalra, Camden, NJ,
Rikesh Patel, San Antonio, TX, Suresh Vijaybasappa Patted, Belgaum, India
Panelists: Quang T. Bui, Torrance, CA, Jose Wiley, New York, NY, John M. Lasala, Saint Louis, MO
ACC-i2/TCT
expeRTS
2314
Structural Case ReviewsMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S102bCMe/CNe Hours: 1.5
Co-Chairs: Carlos E. Ruiz, New York, NY Peter C. Block, Atlanta, GA
Case Sammy Elmariah, Boston, MA, Prabhu Channabasappa Presenters: Halkati, Belgaum, India, Pranav Loyalka, Houston,
TX, Thomas S. Metkus, Baltimore, MD, Anvesha Singh, Derby, United Kingdom
Panelists: Steven R. Bailey, San Antonio, TX, Zahid Amin, Rush, IL, Samir R. Kapadia, Cleveland, OH
ACC-i2/TCT
expeRTS
2315
Shock and Hemodynamic Support Case ReviewsMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S102cCMe/CNe Hours: 1.5
Co-Chairs: William W. O’Neill, Miami, FL Srihari S. Naidu, New York, NY
Case M Chadi Alraies, Cleveland, OH, Joanne Ilustre, Park Presenters: Ridge, IL, Andrew Edward Kott, Chicago, IL,
Emanuele Meliga, Turin, Italy, Syed Tanveer Rab, Atlanta, GA
Panelists: Biswajit Kar, Houston, TX, Erik Magnus Ohman, Durham, NC, Simon R. Dixon, Royal Oak, MI
ACC-i2/TCT
SyMpOSiUM
2633
Controversies in Vascular and endovascular MedicineMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S103cCMe/CNe Hours: 1.5
Co-Chairs: Lawrence A. Garcia, Boston, MA Robert Schainfeld, waltham, MA
12:15 Renal Artery Stenting: Optimal patient Selection and Techniques for endovascular interventions — Herbert Aronow, Ypsilanti, MI
12:30 Asymptomatic Carotid Artery Stenting: Optimal patient Selection and Techniques for endovascular interventions — Marco Roffi, Geneva 1211, Switzerland
12:45 Deep Venous Thrombosis: Optimal patient Selection and Techniques for endovascular interventions — Mohsen Sharifi, Mesa, AZ
1:00 Acute Stroke intervention: Optimal patient Selection and Techniques for endovascular interventions — Alex Abou-Chebl, Louisville, KY
1:15 iliac and Femoral TASC C/D lesions: Optimal patient Selection and Techniques for endovascular interventions — Sahil A. Parikh, Cleveland, OH
1:30 panel Discussion
ACC.12 • Monday, March 26, 2012
190 GO for ACC.12!
NooN
ACC-i2/TCT
SyMpOSiUM
2634
Non-ST-elevation ACS in 2012: What you Need To KnowMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S106bCMe/CNe Hours: 1.5
Co-Chairs: Dean J. Kereiakes, Cincinnati, OH Christopher P. Cannon, Boston, MA
12:15 Routine invasive Treatment Strategy — Keith A. A. Fox, Edinburgh, Scotland, United Kingdom
12:30 Optimal periprocedural pharmacotherapy for pCi in NSTeACS — David J. Moliterno, Lexington, KY
12:45 Revascularization Strategy(s) for NSTeACS — Sorin J. Brener, Brooklyn, NY
1:00 Optimal Vascular Access for pCi in NSTeACS: pros and Cons of Radial Access — Sunil V. Rao, Durham, NC
1:10 Optimal Vascular Access for pCi in NSTeACS: pros and Cons of Femoral Access — Shing-Chiu Wong, New York, NY
1:20 Specific Risk Cohorts for Consideration — Roxana Mehran, New York, NY
1:30 panel Discussion
ACS
iNTl. lUNCH
513
Joint Session of the Mexican Society of Cardiology and the American College of Cardiology: ACS — improving OutcomesMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S404CMe/CNe Hours: 1.5
Co-Chairs: Eric R. Bates, Ann Arbor, MI Carlos R. Martinez-Sanchez, Mexico City, Mexico Erick Alexanderson, Mexico, DF, Mexico
12:15 introduction to Session — Eric R. Bates, Ann Arbor, MI
12:20 STeMi — Juan P. Verdejo, Mexico City, Mexico
12:30 Guidelines for ACS: Translating the evidence to Best practice — Jeffrey L. Anderson, Murray, UT
12:45 Treatment Strategy of the Acute Coronary Syndrome patient with left Main Disease — Jorge Gaspar-Hernandez, Mexico, DF, Mexico
1:00 implementing Clinical practice Guidelines in ACS to improve Clinical Outcomes — Eric D. Peterson, Chapel Hill, NC
1:15 How to Select the Best Antiplatelet Therapy in Acute Coronary Syndrome — Jose Luis Leiva Pons, San Luis Potosi, Mexico
1:30 Conclusion: New insights Gained from the Mexican Society of Cardiology experience
ARR
iNTl. lUNCH
501
Joint Session of the Japanese College of Cardiology and the American College of Cardiology: Risk Stratification for Sudden Cardiac DeathMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S403CMe/CNe Hours: 1.5
Co-Chairs: Stuart Winston, Ann Arbor, MI Shunichi Miyazaki, Osaka, Japan
12:15 introduction to Session — Stuart Winston, Ann Arbor, MI
12:20 introduction: The Burden of Cardiovascular Disease in the Region, Membership in the Society and initiatives Ongoing or planned — Shunichi Miyazaki, Osaka, Japan
12:30 Noninvasive Testing in Conjunction with lV Function is the Best predictor — Eric N. Prystowsky, Indianapolis, IN
12:45 lV Function Alone is the Best predictor — Tohru Masuyama, Nishinomiya, Japan
1:00 iCDs Should be Used More Judiciously in the primary prevention population — Alfred E. Buxton, Boston, MA
1:15 prophylactic iCD implantation is the Best Way to Reduce the Risk for SCD — Takashi Kurita, Tokyo, Japan
1:30 Conclusion: New insights Gained from the Japanese College of Cardiology experience
ARR
iNTl. lUNCH
509
Joint Session of the Cardiological Society of india and the American College of Cardiology: AF — Medical, ep, Surgical OptionsMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S401aCMe/CNe Hours: 1.5
Co-Chairs: Dipti Itchhaporia, Newport Beach, CA Samuel K. Mathew, Chennai, India
12:15 introduction to Session — Dipti Itchhaporia, Newport Beach, CA
12:20 Case presentation: Nuance of AF, RHD, Moderate MS/MR in a 50 year-old — Navin C. Nanda, Birmingham, AL
12:30 AF Spectrum: primary and Associated With Valvular/Structural Heart Disease — Sanjeev Saksena, Warren, NJ
12:45 Case presentation: Rheumatic HD with AF and Valvular involvement — Amit Vora, Mumbai, India
1:00 Approaches to the patient with AF and Rheumatic Valvular Heart Disease — Ralph J. Damiano, St. Louis, MO
1:15 Approaches in india to AF Treatment in Rheumatic Heart Disease — Calambur Narasimhan, Hyderabad, India
1:30 New insights Gained from the Cardiological Society of india experience
Monday, March 26, 2012 • ACC.12
ACC.12 Final Program 191
NooN
CCS
iNTl. lUNCH
506
Joint Session of the egyptian Society of Cardiology and the American College of Cardiology: Adult Congenital Heart Disease: Where We Came from and Where We AreMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place North, N231CMe/CNe Hours: 1.5
Co-Chairs: Gerard R. Martin, Washington, DC Mohamed Sobhy Aly, Alexandria, Egypt
12:15 introduction to Session — Gerard R. Martin, Washington, DC
12:20 Changing the Face of ACHD in egypt — Magdi H. Yacoub, Harefield, Middlesex, United Kingdom
12:30 Where We Are Now: The epidemiology and ACHD Databases in North America — Paul Khairy, Montreal, Canada
12:45 Multimodality Non-invasive imaging for Assessment of Adult Congenital Heart Disease — Magdy Rashwan, Alexandria, Egypt
1:00 Cath like an egyptian Congenital interventionalist — Makram R. Ebeid, Jackson, MS
1:15 Catheter intervention in Adult Congenital Heart Disease: Cairo University experience — Khaled Sorour, Cairo, Egypt
1:30 Conclusion: New insights Gained from the egyptian Society of Cardiology experience
HF
iNTl. lUNCH
517
Joint Session of the Spanish Society of Cardiology and the American College of Cardiology: Heart Failure — Devices to TransplantationMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S501aCMe/CNe Hours: 1.5
Co-Chairs: Juan M. Aranda, Gainesville, FL Nicolas Manito, Barcelona, Spain
12:15 introduction to Session — Juan M. Aranda, Gainesville, FL
12:20 Heart Failure: Devices to Transplantation — Akshay S. Desai, Boston, MA
12:30 Contemporary pharmacologic Management of Advanced Heart Failure — Lee R. Goldberg, Philadelphia, PA
12:45 Current indications and Controversies in CRT — Juan Delgado, Madrid, Spain
1:00 Hemodynamic Monitoring Devices in Heart Failure — Robert C. Bourge, Birmingham, AL
1:15 Destination lVAD and Current Role for Heart Transplantation — Javier Segovia, Madrid, Spain
1:30 Conclusion: New insights Gained from the Spanish Society of Cardiology experience
iMAG
iNTl. lUNCH
507
Joint Session of the German Cardiac Society and the American College of Cardiology: imaging — evolving StrategiesMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S406bCMe/CNe Hours: 1.5
Co-Chairs: William A. Zoghbi, Houston, TX Christoph Bode, Freiburg, Germany
12:15 introduction to Session — William A. Zoghbi, Houston, TX
12:20 Case presentation: imaging — evolving Strategies — Orlando Escarcega, Philadelphia, PA
12:30 emerging imaging Modalities in Guiding Valvular interventions — Linda D. Gillam, New York, NY
12:45 imaging: Cardiac Vessels — Raimund A. Erbel, Essen, Germany
1:00 Role of 3-D echo — Frank E. Silvestry, Wayne, PA
1:15 imaging: Myocardium — Georg Ertl, Wuerzburg, Germany
1:30 Conclusion: New insights Gained from the German Cardiac Society experience
iSCHeM
iNTl. lUNCH
508
Joint Session of the British Cardiovascular Society and the American College of Cardiology: NiCe GuidelinesMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place North, N427CMe/CNe Hours: 1.5
Co-Chairs: John Gordon Harold, Los Angeles, CA Iain A. Simpson, Southampton, United Kingdom
12:15 introduction to Session — John Gordon Harold, Los Angeles, CA
12:20 introduction to Guideline preparation: A UK perspective — Huon Gray, Southampton, United Kingdom
12:30 Biomarkers of ischemia: Clinical practice and Guidelines — David A. Morrow, Boston, MA
12:45 Stable Angina: A UK perspective — Robert A. Henderson, Nottingham, United Kingdom
1:00 international participation in NiH and NHS Studies: Not Always NiCe (Applicability, ethical and Financial Considerations) — Richard A. Lange, San Antonio, TX
1:15 ACS: A UK perspective — Mark A. de Belder, Middlesbrough, United Kingdom
1:30 Conclusion: New insights Gained from the British Cardiovascular Society experience
ACC.12 • Monday, March 26, 2012
192 GO for ACC.12!
NooN
liFelONG
MOC
819
ACCF Study Sessions for Maintenance of Certification: ABiM Recertification Made easy — interventional Cardiology 2010 Update (B2-K)Monday, March 26, 2012, 12:15 p.m. – 2:45 p.m.McCormick Place South, S105aCMe Hours: 2.5
Chair: Paul Sorajja, Rochester, MN
MOC Faculty: John A. McPherson, Nashville, TN, Alan Zajarias, Saint Louis, MO
ACCF’s Maintenance of Certification Sessions allows you to easily obtain ABIM’s Maintenance of Certification (MOC) points during at ACC.12. Tickets are required for admittance to this session. Ticketed registrants must arrive no later than 15 minutes before the start of the session. Seats will be released at this time and an “open seating” policy will apply.
Attendees must be enrolled in the ABIM’s MOC program to claim MOC points. If you are not enrolled, please allow sufficient time to do this prior to the start of the session. ABIM staffs are available onsite to answer your MOC questions and help with enrollment.
For convenience, there will be computer terminals in the ACC MOC Center onsite in Room S104b for attendees to take the ABIM MOC test after the study session concludes, if desired. Electrical power is provided in the classrooms so that attendees who wish to bring their own devices may ‘power up’ to access relevant question modules.
Access to the online modules will also be available for participants for a short period of time following the annual meeting.
Attendees may not claim CME credits from ABIM as it is against ACCME and AMA guidelines to claim credit twice for the same activity. MOC credit is available from the ABIM after completion of the MOC module; CME credit only (no CNE credit) is available from ACC.
liFelONG
MOC
820
ACCF Study Session for Maintenance of Certification: ABiM Recertification Made easy—Clinical Cardiac electrophysiology, 2010 Update (B3-K)Monday, March 26, 2012, 12:15 p.m. – 2:45 p.m.McCormick Place South, S105dCMe Hours: 2.5
Chair: Peter A. Brady, Rochester, MN
MOC Faculty: Kristen K. Patton, Seattle, WA, Sherry Saxonhouse, Charlotte, NC
ACCF’s Maintenance of Certification Sessions allows you to easily obtain ABIM’s Maintenance of Certification (MOC) points during at ACC.12. Tickets are required for admittance to this session. Ticketed registrants must arrive no later than 15 minutes before the start of the session. Seats will be released at this time and an “open seating” policy will apply.
Attendees must be enrolled in the ABIM’s MOC program to claim MOC points. If you are not enrolled, please allow sufficient time to do this prior to the start
of the session. ABIM staffs are available onsite to answer your MOC questions and help with enrollment.
For convenience, there will be computer terminals in the ACC MOC Center onsite in Room S104b for attendees to take the ABIM MOC test after the study session concludes, if desired. Electrical power is provided in the classrooms so that attendees who wish to bring their own devices may ‘power up’ to access relevant question modules.
Access to the online modules will also be available for participants for a short period of time following the annual meeting.
Attendees may not claim CME credits from ABIM as it is against ACCME and AMA guidelines to claim credit twice for the same activity. MOC credit is available from the ABIM after completion of the MOC module; CME credit only (no CNE credit) is available from ACC.
pReV
iNTl. lUNCH
512
Joint Session of the National Heart Association of Malaysia and the American College of Cardiology: Resistant HypertensionMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S504aCMe/CNe Hours: 1.5
Co-Chairs: Richard A. Chazal, Fort Myers, FL Kui-Hian Sim, Sarawak, Malaysia
12:15 introduction to Session — Richard A. Chazal, Fort Myers, FL
12:20 Challenging Cases from Malaysia — Wan Azman Wan Ahmad, Malaya, Malaysia
12:45 Hypertension Strategies: From Simple to Complex — David J. Becker, Philadelphia, PA
1:00 percutaneous Renal interventions — Robaayah Zambahari, Kuala Lumpur, Malaysia
1:15 Sequential Selections: Choosing/Adding Agents — Marc E. Shelton, Springfield, IL
1:30 Conclusion: New insights Gained from the National Heart Association of Malaysia experience
pReV
iNTl. lUNCH
516
Joint Session of the South American Society of Cardiology and the American College of Cardiology: prevention — Assessing and educating across RegionsMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S502CMe/CNe Hours: 1.5
Co-Chairs: Ralph G. Brindis, Oakland, CA Maria Paniagua de Decoud, Asuncion, Paraguay
12:15 introduction to Session — Ralph G. Brindis, Oakland, CA
12:22 Heart Failure in South America — Hector O. Ventura, New Orleans, LA
12:39 Cardio-prevention Strategies in South America — Paola Varleta, Santiago, Chile
12:56 Utilizing imaging for Cardiovascular prevention — Miguel A. Quinones, Houston, TX
Monday, March 26, 2012 • ACC.12
ACC.12 Final Program 193
NooN
1:13 Diet, exercise, Vitamins and Other Non-prescription Therapeutics — Jorge Lerman, Buenos Aires, Argentina
1:30 Conclusion: New insights Gained from the South American Society of Cardiology experience
pReV
SyMpOSiUM
701
Role of physical Activity in CVD preventionMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S100cCMe/CNe Hours: 1.5
Co-Chairs: Barbara Fletcher, Jacksonville Beach, FL Elizabeth A. Jackson, Ann Arbor, MI
12:15 Biophysiological effects of physical Activity on CVD Reduction — Gerald Fletcher, Jacksonville, FL
12:33 physical Activity in primary prevention — Vera Bittner, Birmingham, AL
12:51 Role of exercise Following ACS — Barry A. Franklin, Royal Oak, MI
1:09 Use of the internet to improve physical Activity — Caroline Richardson, Ann Arbor, MI
1:27 issues of Adherence and Quality of life — Jane Nelson Worel, Middleton, WI
QUAl
iNTl. lUNCH
510
Joint Session of the israel Heart Society and the American College of Cardiology: pCiMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place North, N230CMe/CNe Hours: 1.5
Co-Chairs: George D. Dangas, New York, NY Chaim Lotan, Jerusalem, Israel
12:15 introduction to Session — George D. Dangas, New York, NY
12:20 Case presentation: Strategies to Reduce Bleeding in patients with ACS undergoing pCi — Aryeh Shalev, Los Angeles, CA
Panelists: Aaron D. Kugelmass, Springfield, MA, Amit Segev, Tel Aviv, Israel
12:25 panel Discussion
12:40 establishing a Useful pCi Registry to inform Outcomes — John C. Messenger, Aurora, CO
12:55 Case presentation: Treatment of the Non-culprit lesion in patients with ACS — STeMi and NSTeMi — Mony Shuvy, Jerusalem, Israel
Panelists: Aaron D. Kugelmass, Springfield, MA, Yoseph Rozenman, Holon, Israel
1:00 panel Discussion
1:15 Qi examples to improve pCi Outcomes — Steven P. Marso, Kansas City, MO
1:30 Conclusion: New insights Gained from the israel Heart Society experience
QUAl
iNTl. lUNCH
515
Joint Session of the Saudi Heart Association and the American College of Cardiology: Quality RegistriesMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place North, N227bCMe/CNe Hours: 1.5
Co-Chairs: Frederick A. Masoudi, Denver, CO Hani Najm, Riyadh, Saudi Arabia
12:15 introduction to Session — Frederick A. Masoudi, Denver, CO
12:20 Case Outcomes: Quality Registries — Paul D. Varosy, Denver, CO
12:30 establishing a Useful Quality Registry — John S. Rumsfeld, Denver, CO
12:45 Acute Heart Failure: Real life versus Clinical Trials — Khalid F. Alhabib, Riyadh, Saudi Arabia
1:00 Heart Function Clinic: Real life versus Clinical Trials — Abdelfatah A. Elasfar, Riyadh, Saudi Arabia
1:15 Using Registry Data to inform Quality improvement — Hitinder S. Gurm, Ann Arbor, MI
1:30 Conclusion: New insights Gained from the Saudi Heart Association experience
SpeCiAl
SpeCiAl
113
FiT Forum iV: Guidance for the First Steps of your Cardiology CareerMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S402CMe Hours: 1.5
12:15 Welcome — Justin Matthew Bachmann, Dallas, TX
12:20 How Do you pass the Boards? — David E. Winchester, Gainesville, FL
12:30 Another perspective on Boards — Joseph G. Murphy, Rochester, MN
12:40 Question and Answer
12:45 interviewing Tips and Contract Negotiations — Susan Childs, Rougement, NC
1:10 Question and Answer
1:15 Financial planning for Future Cardiologists — Michael F. Merrill, Portland, OR
1:27 Financial planning for Future Cardiologists — Anders Ramstad, Portland, OR
1:40 Question and Answer
VAlV
iNTl. lUNCH
504
Joint Session of the Canadian Cardiovascular Society and the American College of Cardiology: Repairs/Replacement: Catheter-based or (Minimally invasive) SurgeryMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S405CMe/CNe Hours: 1.5
Co-Chairs: David R. Holmes, Jr., Rochester, MN Blair J. O’Neill, Edmonton, Canada
12:15 introduction to Session — David R. Holmes, Jr., Rochester, MN
ACC.12 • Monday, March 26, 2012
194 GO for ACC.12!
AFTE
RNOO
N
12:20 Three-Dimensional echocardiographic imaging of Catheter-based Valve Treatment — Joseph Maalouf, Rochester, MN
12:30 Minimally invasive Mitral Repair — W. Randolph Chitwood, Greenville, NC
12:45 TAVi: World-wide and Canadian Results and existing and Changing indications — Josep Rodes-Cabau, Quebec, Canada
1:00 periprosthetic Regurgitation Closure — Charanjit S. Rihal, Rochester, MN
1:15 Structural Heart Disease interventions: Now and Over the Next Ten years — Anita W. Asgar, Montreal, Canada
1:30 Conclusion: New insights Gained from the Canadian Cardiovascular Society experience
VASC
iNTl. lUNCH
514
Joint Session of the pakistan Cardiac Society and the American College of Cardiology: VTe, pHTNMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S503CMe/CNe Hours: 1.5
Co-Chairs: Shahbudin H. Rahimtoola, Los Angeles, CA Azhar Faruqui, Karachi, Pakistan
12:15 introduction to Session — Shahbudin H. Rahimtoola, Los Angeles, CA
12:20 A Case of Recurrent VTe Resulting in pHTN — Syed Zahid Jamal, Karachi, Pakistan
12:30 Clinical Recognition and prevention of DVT — Khan Shah Zaman, Karachi, Pakistan
12:45 Venous Thromboembolism (VTe) as it Related to Chronic Thromboembolic Disease — William R. Auger, San Diego, CA
1:00 US experience with endovascular Management of DVT — Riyaz Bashir, Philadelphia, PA
1:15 Medical Management and Device Treatment of Chronic Recurrent VTe — Syed Zahid Jamal, Karachi, Pakistan
1:30 Conclusion: New insights Gained from the pakistan Cardiac Society experience
Afternoon SeSSionS
ACC-i2/TCT
SpeCiAl
2113
Fellows Bootcamp: Case ReviewsMonday, March 26, 2012, 12:30 p.m. – 1:30 p.m.McCormick Place South, S103bCMe Hours: 1
Co-Chairs: Thomas Tu, Louisville, KY Ajay J. Kirtane, New York, NY
12:30 pCi left Main Radial pCi — Sunil V. Rao, Durham, NC
12:45 i Can’t Get the *?@# Stent There — Ajay J. Kirtane, New York, NY
1:00 Multi-vessel pCi Guided FFR — William Fuller Fearon, Stanford, CA
1:15 perforation — Thomas Tu, Louisville, KY
ACC-i2/TCT
CASe ReVieW
2203
live and Taped Case Sesion iii: Valvular Heart DiseaseMonday, March 26, 2012, 12:30 p.m. – 2:30 p.m.McCormick Place North, Hall B, ACC.12 Main TentCMe/CNe Hours: 2
Co-Chairs: John G. Webb, Vancouver, Canada Michael J. Mack, Plano, TX
Panelists: James Bernard Hermiller, Indianapolis, IN, Rebecca T. Hahn, New York, NY, Jonathon Leipsic, Vancouver, BC, Ganesh Manoharan, Belfast, United Kingdom, G. Alain Cribier, Rouen, France, John Carroll, Aurora, CO, Vasilis Babaliaros, Atlanta, GA, Augusto Pichard, Washington, DC
12:30 live Case from the University of pennsylvania, philadelphia, pA — Howard C. Herrmann, Philadelphia, PA
1:15 Requirements for a Successful TAVR program: The Multi-disciplinary Heart Team and Beyond — Samir R. Kapadia, Cleveland, OH
1:25 A Surgeon’s perspective of Aortic Valve Therapy in the era of TAVR — Vinod H. Thourani, Atlanta, GA
1:35 Status Update on Transcatheter Mitral Valve Therapies — Ted Feldman, Evanston, IL
1:50 panel Discussion
2:00 Taped Case from Cedars-Sinai Medical Center, los Angeles, CA — Saibal Kar, Los Angeles, CA
ACC-i2/TCT
SpeCiAl
2114
Fellows Bootcamp: Structural HeartMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S103bCMe Hours: 1.5
Co-Chairs: Raoul Bonan, Montreal, Canada D. Scott Lim, Charlottesville, VA
2:00 Adult Congenital intervention (ASD/pFO⋯.) — D. Scott Lim, Charlottesville, VA
2:15 Transseptal Technique: Hemodynamic Aortic and Mitral Valve — Raoul Bonan, Montreal, Canada
2:30 TAVi and BAV — Jeffrey J. Popma, Newton, MA
2:45 percutaneous Mitral Repair and Replacement — Anita W. Asgar, Montreal, Canada
3:00 left Appendage Closure — Saibal Kar, Los Angeles, CA
3:15 Roundtable Discussion
Monday, March 26, 2012 • ACC.12
noon
ACC.12 Final Program 195
AFTERNOON
ACC-i2/TCT
SpeCiAl
2132
Anatomy and Transcatheter Therapy for the Structural Heart interventionalist ii: left Atrial Appendage Closure, pFO, ASD and Transseptal puncture (with Remote Demonstrations from the Seattle Science Foundation)Monday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S102cCMe/CNe Hours: 1.5
Remote Mark Reisman, Seattle, WADemonstrator:
Co-Chairs: John D. Carroll, Aurora, CO Carlos E. Ruiz, New York, NY
Panelists: Ziyad M. Hijazi, Chicago, IL, Steven J. Yakubov, Columbus, OH, Michael J. Landzberg, Boston, MA, Matthew J. Price, La Jolla, CA, Horst Sievert, Frankfurt, Germany, Saibal Kar, Los Angeles, CA
2:00 pFO and ASD Anatomy — Mark Reisman, Seattle, WA
2:15 Case presentation: pFO — John D. Carroll, Aurora, CO
2:20 Case presentation: ASD — Ziyad M. Hijazi, Chicago, IL
2:25 Anatomical perspectives for pFO and ASD Devices — Mark Reisman, Seattle, WA
2:40 left Atrial Appendage Anatomy — Mark Reisman, Seattle, WA
2:55 Case presentation: left Atrial Appendage Closure Device — Saibal Kar, Los Angeles, CA
3:00 Case presentation: left Atrial Appendage Closure Device — Horst Sievert, Frankfurt, Germany
3:05 Case presentation: left Atrial Appendage ligation Device — Steven J. Yakubov, Columbus, OH
3:10 Anatomical perspectives of left Atrial Appendage Devices — Mark Reisman, Seattle, WA
3:25 panel Discussion
ACC-i2/TCT
SyMpOSiUM
2635
imaging Transcatheter Aortic Valve procedures ii: Selecting the Best patient, Valve and Vascular ApproachMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S101aCMe/CNe Hours: 1.5
Co-Chairs: Augusto Pichard, Washington, DC Igor F. Palacios, Boston, MA
2:00 life after pARTNeR: Where We Go from Here — Martin B. Leon, New York, NY
2:08 Aortic Valve Anatomy: Understanding the Transcatheter Valve landing Zone — Jeffrey J. Popma, Newton, MA
2:16 patient Selection for TAVR: Role of echocardiography — Robert J. Siegel, Los Angeles, CA
2:24 The Role of MRi and CT for the Aortic Valvular Complex and Arteries — Paul Schoenhagen, Cleveland, OH
2:32 The Role of imaging in THV Choice: it’s Not Just about the Annulus — Balloon-expandable THV — Robert R. Moss, Vancouver, Canada
2:38 The Role of imaging in THV Choice: it’s Not Just about the Annulus — Self-expanding THV — Ganesh Manoharan, Belfast, United Kingdom
2:44 The Role of imaging in THV Choice: it’s Not Just about the Annulus — imaging Clues to Select one Valve Over the Other — Stamatios Lerakis, Atlanta, GA
2:50 panel Discussion: Which imaging Modality is the Most Useful in TAVR? CT-MRi — Paul Schoenhagen, Cleveland, OH
2:58 panel Discussion: Which imaging Modality is the Most Useful in TAVR? Tee — Robert J. Siegel, Los Angeles, CA
3:06 panel Discussion: Which imaging Modality is the Most Useful in TAVR? Fluoroscopy/Angiography — Augusto Pichard, Washington, DC
3:14 imaging Approach to Choosing Vascular Access: Femoral Artery, Subclavian Artery, Aortic or Apical Access — Dominik Fleischmann, Stanford, CA
3:22 Role of imaging in predicting and preventing Stroke — Samir R. Kapadia, Cleveland, OH
ACC-i2/TCT
SyMpOSiUM
2636
Spotlight Session on TAVRMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S102bCMe/CNe Hours: 1.5
Co-Chairs: D. Craig Miller, Stanford, CA Lars G. Svensson, Cleveland, OH
2:00 How to Choose patients for TAVR vs Open AVR — Blase A. Carabello, Houston, TX
2:15 The procedure — Working Together, the Heart Valve Team Concept, is it Real? — Michael J. Mack, Plano, TX
2:30 Training Requirements: Training, Site Readiness — the Society’s View — Helene Eltchaninoff, Rouen, France
2:45 Debate:TAVR — The Future is Bright, TAVR Will Grow Well Beyond the inoperable patient — Martin B. Leon, New York, NY
3:00 Debate: TAVR — TAVR Will Remain limited to inoperable and Very High Risk patients Due to Complications — Neil E. Moat, London, United Kingdom
3:15 Can We Afford TAVR: impact on Hospitals and CMS — David J. Cohen, Kansas City, MO
ACC-i2/TCT
SyMpOSiUM
2637
Management of Symptomatic Severe Carotid Artery DiseaseMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S103cCMe/CNe Hours: 1.5
Co-Chairs: Daniel G. Clair, Cleveland, OH Jay S. Yadav, Atlanta, GA
2:00 patient and equipment Selection to Optimize Carotid Stent Outcomes in Symptomatic patients — Gary S. Roubin, New York, NY
ACC.12 • Monday, March 26, 2012
196 GO for ACC.12!
AFTE
RNOO
N
2:15 Acute Stroke Therapy: State-of-the-Art — Stephen R. Ramee, New Orleans, LA
2:30 Debate: Carotid Stenting Should be Considered an Alternative to CeA for Symptomatic Carotid Disease in Average Surgical Risk patients — Herbert D. Aronow, Ypsilanti, MI
2:45 Debate: Carotid Stenting Should Not be Considered an Alternative to CeA for Symptomatic Carotid Disease in Average Surgical Risk patients — Anthony J. Comerota, Toldeo, OH
3:00 Case presentation: When and How to Treat Common Carotid, Subclavian and innominate Stenosis — Douglas E. Drachman, Boston, MA
3:15 panel Discussion
ACC-i2/TCT
SyMpOSiUM
2638
State-of-the-Art STeMi: All you Need to KnowMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S106bCMe/CNe Hours: 1.5
Co-Chairs: Erik Magnus Ohman, Durham, NC Bruce R. Brodie, Greensboro, NC
2:00 Optimizing Time to Treatment for STeMi: emphasis on Total ischemic Time — Alice K. Jacobs, Boston, MA
2:15 Optimal Adjunctive pharmacotherapy for primary pCi — George Dangas, New York, NY
2:30 Strategies for Thrombus Removal — C. Michael Gibson, Boston, MA
2:45 Mechanical Support for Treatment of Cardiogenic Shock and Hemodynamic instability — John M. Lasala, Saint Louis, MO
3:00 protective and Reparative Therapies in STeMi — Timothy D. Henry, Minneapolis, MN
3:15 illustrative Case example and panel Discussion — Eric R. Bates, Ann Arbor, MI
ARR
SyMpOSiUM
702
Sudden Cardiac Death Risk Stratification in Heart Failure: past, present and Future DirectionsMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S406aCMe/CNe Hours: 1.5
Chair: A. John Camm, London, United Kingdom
2:00 Assessment of lV Function — Sumeet Chugh, CA
2:15 Markers of Autonomic Tone — Marek Malik, Surrey, United Kingdom
2:30 T Wave Alternans — Richard L. Verrier, Boston, MA
2:45 electrophysiologic Study — Ralph J. Verdino, Philadelphia, PA
3:00 imaging to predict Sudden Death: Going Beyond the ejection Fraction — Alan H. Kadish, Chicago, IL
3:15 Genomics — Dawood Darbar, Nashville, TN
ARR
SyMpOSiUM
703
Syncope in Special populationsMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place North, N227bCMe/CNe Hours: 1.5
Co-Chairs: Stefan H. Hohnloser, Frankfurt am Main, Germany Robert Myerburg, Miami, FL
2:00 The ederly patient — Steven M. Markowitz, New York, NY
2:18 The Athlete with Syncope — Andrew E. Epstein, Philadelphia, PA
2:36 patients with Structural Heart Disease and lVeF >35% — Robert Myerburg, Miami, FL
2:54 patients with a Family History of Sudden Cardiac Death — Hugh Calkins, Baltimore, MD
3:12 eCG Features That May indicate a potenitally life Threatening Arrhythmia as the Cause for Syncope — Joseph Edward Marine, Baltimore, MD
CCS
expeRTS
247
Acquired Heart Disease in Childhood epidemiology: Current and Future ManagementMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S501aCMe/CNe Hours: 1.5
Chair: Jane Newburger, Boston, MA
Case Presenter: Agustin E. Rubio, Seattle, WA
Panelists: Sarah De Ferranti, Boston, MA, Peter Morelli, Stoneybrook, NY, Masato Takahashi, CA, Lloyd Y. Tani, Salt Lake City, UT
HF
SyMpOSiUM
704
Cardiac Resynchronization Therapy: Whom to Refer for implantation?Monday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S406bCMe/CNe Hours: 1.5
Co-Chairs: James P. Daubert, Durham, NC Marc Pfeffer, Boston, MA
2:00 Mechanical and eletrical effects of Cardiac Resynchronization Therapy — David Spragg, Baltimore, MD
2:16 echocardiographic evidence for CRT effects on Myocardial Structure and Function — Scott D. Solomon, Boston, MA
2:32 Role of QRS Duration and Morphology in Selecting patients for CRT-D — Wojciech Zareba, Rochester, NY
2:48 effect of CRT on Heart Failure and Arrhythmia endpoints — Michael Robert Gold, Charleston, SC
3:04 CRT in Atrial Fibrillation patients: Feasibility and effects — Jonathan S. Steinberg, New York, NY
3:20 panel Discussion
HF
SyMpOSiUM
705
Understanding the Complexity of the Right Ventricle: Challenges and progressMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S404CMe/CNe Hours: 1.5
Co-Chairs: Teresa De Marco, San Francisco, CA Srinivas Murali, Pittsburgh, PA
2:00 Decompensated Right Heart Failure: pharmacologic Support — Paul R. Forfia, Philadelphia, PA
Monday, March 26, 2012 • ACC.12
ACC.12 Final Program 197
AFTERNOON
2:13 The Right Ventricle in pAH: The Determinant Factor — Vallerie V. McLaughlin, Ann Arbor, MI
2:26 Assessing the RV during exercise — Gregory D. Lewis, Boston, MA
2:40 Decompensated Right Heart Failure: Mechanical Approaches — Myung H. Park, Baltimore, MD
2:53 evaluation and Management of Right Heart Failure in Severe lV Dysfunction: is the RV Healthy enough for Advanced Therapies? — Marc A. Simon, Pittsburgh, PA
3:07 Clinical Scenarios of Concordant and Discordant RV and lV Failure — Navin Rajagopalan, Lexington, KY
3:20 Question and Answer
HF
SyMpOSiUM
706
Joint Symposium of the italian Federation of Cardiology and the pennsylvania Chapter of the American College of Cardiology: Update on the Treatment of Atrial FibrillationMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place North, N230CMe/CNe Hours: 1.5
Co-Chairs: Gerald V. Naccarelli, Hershey, PA Marino Scherillo, Benevento, Italy
2:00 Catheter Ablation for Atrial Fibrillation: patient Selection, efficacy and Anticoagulation Management — Francis E. Marchlinski, Bala Cynwyd, PA
2:20 Atrial Fibrillation Management: The Current Guidelines — Sandeep K. Jain, Pittsburgh, PA
2:40 The Role of New Antithrombotic Drugs in the Treatment of Atrial Fibrillation — Salvatore Novo, Rome, Italy
3:00 New insights in the pathogenesis of Atrial Fibrillation — Francesco Romeo, Rome, Italy
3:20 Question and Answer
iMAG
SyMpOSiUM
707
Management of the patient with Valvular Heart Disease: Role of echoMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S405CMe/CNe Hours: 1.5
Co-Chairs: Linda D. Gillam, New York, NY Judy W. Hung, Boston, MA
2:00 Management of Degenerative Mitral Regurgitation Using 2-D and 3-D echocardiography — Vera H. Rigolin, Chicago, IL
2:15 ischemic Mitral Reurgitation Assessment by echocardiography — Judy W. Hung, Boston, MA
2:30 patient prosthesis Mismatch: Diagnosis and Scope of the problem — Philippe Pibarot, Sainte Foy, Canada
2:45 Stress echocardiography in Management of Valvular Heart Disease — Luc Pierard, Liège, Belgium
3:00 Update on prosthetic Valve Assessment by echocardiography Guidelines — Stephen H. Little, Houston, TX
3:15 echo Assessment of the Tricuspid Valve — Muhamed Saric, New York, NY
iMAG
SyMpOSiUM
708
Advances in Nuclear Cardiology: Current and Future ApplicationsMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S403CMe/CNe Hours: 1.5
Co-Chairs: George A. Beller, Charlottesville, VA E. Gordon DePuey, III, New York, NY
2:00 Advances in SpeCT Hardware and Software: Where Are We and What is Applicable ? — Milena J. Henzlova, New York, NY
2:15 Radiation Reduction in SpeCT: How to Maximize the yield with protocols and Technology Advances — John J. Mahmarian, Houston, TX
2:30 Non-Coronary Advances in SpeCT: emerging Role of MiBG imaging in Heart Failure Risk Stratification — Mark I. Travin, Pleasantville, NY
2:45 BMipp SpeCT imaging in Acute Chest pain imaging — Vasken Dilsizian, Baltimore, MD
3:00 SpeCT in Cardiac Dyssynchrony — Ernest V. Garcia, Atlanta, GA
3:15 Molecular Applications of SpeCT imaging: Atherosclerosis, Apoptosis and Beyond — Albert J. Sinusas, New Haven, CT
iSCHeM
SyMpOSiUM
709
Transitioning from ACS to Stable ischemic Heart DiseaseMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S401aCMe/CNe Hours: 1.5
Co-Chairs: Donna M. Polk, Hartford, CT Nanette Kass Wenger, Atlanta, GA
2:00 Antiplatelet Therapy: From Start to Finish — Stephen D. Wiviott, Boston, MA
2:15 Question and Answer
2:23 Risk Stratification: Who Gets What and When? — Rita F. Redberg, San Francisco, CA
2:38 Question and Answer
2:45 Sexual Activity: is “Don’t Ask, Don’t Tell” the Best policy? — Richard A. Lange, San Antonio, TX
3:00 Question and Answer
3:08 Cardiac Rehabilitation: Why Break a Sweat? — Vera Bittner, Birmingham, AL
3:23 Question and Answer
liFelONG
CORe
821
Core Curriculum: Cardiac CatheterizationMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place North, N226CMe/CNe Hours: 1.5
Chair: Zoltan G. Turi, Camden, NJ
2:00 Angiography: Approach to interpretation and pitfalls — Ajay J. Kirtane, New York, NY
ACC.12 • Monday, March 26, 2012
198 GO for ACC.12!
AFTE
RNOO
N
2:25 left Heart Hemodynamics: HCM, Aortic and Mitral Disease — Morton J. Kern, Orange, CA
2:50 Cardiac Constriction, Restriction, and Tamponade — Barry Borlaug, Rochester, MN
3:15 Question and Answer
liFelONG
CORe
822
Core Curriculum: preventive CardiologyMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place North, N229CMe/CNe Hours: 1.5
Chair: Karthikeyan Ananthasubramaniam, West Bloomfield, MI
2:00 lipids and Cardiovascular Disease — Elizabeth A. Jackson, Ann Arbor, MI
2:25 Diabetes and Cardiovascular Disease — David Aguilar, Houston, TX
2:50 Hypertension and Cardiovascular Disease — Andrew M. Kates, Saint Louis, MO
3:15 Question and Answer
pHTN
expeRTS
249
pearls and Caveats in Managing patients with pulmonary HypertensionMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S505CMe/CNe/Cpe Hours: 1.5 ACpe No. 0012-9999-12-129-l01-p
Chair: Michael A. Mathier, Pittsburgh, PA
Case Presenter: Dana McGlothlin, San Francisco, CA
Panelists: Michael Cuttica, Chicago, IL, Robert P. Frantz, Rochester, MN, Mardi Gomberg-Maitland, Chicago, IL
pRACTiCe
expeRTS
248
issues That Have Caused Medical professional liability Claims: Are you at Risk? A Special presentation from The Doctors CompanyMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S504aCMe/CNe Hours: 1.5
Chair: Richard A. Chazal, Fort Myers, FL
Case Presenters: Robin Diamond, Napa, CA, David B. Troxel, Napa, CA
pRACTiCe
SyMpOSiUM
710
impact of Healthcare policy on the Academic Cardiovascular MissionMonday, March 26, 2012, 2:00 p.m. – 5:30 p.m.McCormick Place South, S402CMe/CNe Hours: 3.5
Co-Chairs: Joseph A. Hill, Dallas, TX Marvin A. Konstam, Boston, MA
2:00 Welcome and introduction — Joseph A. Hill, Dallas, TX
Training the Next Generation of Cardiovascular practitioners
2:05 Training Cardiovascular Specialists in 2012 — Chittur A. Sivaram, Oklahoma City, OK
2:20 perspective of ACGMe — Thomas J. Nasca, Chicago, IL
education for a lifetime
2:35 lifelong education — Eric S. Williams, Indianapolis, IN
2:50 Roundtable Discussion: Rising to the Challenge — What Will (Should) Training and education look like in 2022?
Panelists: Justin Matthew Bachmann, Dallas, TX, Lisa A. Mendes, Brentwood, TN, Rick A. Nishimura, Rochester, MN, Chittur A. Sivaram, Oklahoma City, OK, Eric S. Williams, Indianapolis, IN
Research: Novel Diagnostic and Therapeutic Strategies for the Future
3:15 Academic Cardiovascular Research: Where Are We Today? — Douglas L. Mann, St. Louis, MO
3:30 perspective of the NHlBi — Sonia I. Skarlatos, Bethesda, MD
3:45 Roundtable Discussion: Rising to the Challenge — What Will (Should) Academic CV Research look like in 2022?
Panelists: Robert O. Bonow, Chicago, IL, James A. De Lemos, Dallas, TX, Douglas L. Mann, Saint Louis, MO, Gordon Tomaselli, Baltimore, MD
4:05 Break
Delivery of Superior, Coordinated Clinical Care
4:20 efficient, Cost-effective, Coordinated Care in the Academic Setting — Marvin A. Konstam, Boston, MA
4:35 Roundtable Discussion: What Will (Should) Clinical Cardiovascular Care in an Academic Setting look like in 2022?
Panelists: Joseph P. Drozda, Saint Louis, MO, Blair D. Erb, Bozeman, MT, Gregory Ehle, Burlington, VT, Marvin A. Konstam, Boston, MA, Richard J. Kovacs, Indianapolis, IN, Jack Lewin, Washington, DC, Margo B. Minissian, Los Angeles, CA
Core principles That Define Our Mission
5:00 Quo Vadis Academis? — David R. Holmes, Jr., Rochester, MN
5:10 Roundtable Discussion: What Will (Should) the Academic Mission Be in 2022?
Panelists: Pamela S. Douglas, Durham, NC, David R. Holmes, Jr., Rochester, MN, Joseph A. Hill, Dallas, TX, Jack Lewin, Washington, DC
5:30 Summary and Closing Remarks — Joseph A. Hill, Dallas, TX
pReV
expeRTS
250
labile Hypertension: evaluation and ManagementMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S502CMe/CNe/Cpe Hours: 1.5 ACpe No. 0012-9999-12-130-l01-p
Chair: Franz H. Messerli, New York, NY
Case Ronald G. Victor, Los Angeles, CA, Wanpen Presenters: Vongpatanasin, Dallas, TX
Panelists: Joshua A. Beckman, Boston, MA, Suzanne Oparil, Birmingham, AL, Andrew R. Weintraub, Boston, MA
Monday, March 26, 2012 • ACC.12
ACC.12 Final Program 199
AFTERNOON
pReV
SyMpOSiUM
711
Joint Symposium of the American Association of Clinical endocrinologists and the American College of Cardiology: Cardiologists as endocrinologists — emerging Management of the Diabetic patientMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S100cCMe/CNe Hours: 1.5
Co-Chairs: Samuel Dagogo-Jack, Memphis, TN Mikhail Kosiborod, Leawood, KS
2:00 The Comprehensive Approach to Treating Diabetes — Samuel Dagogo-Jack, Memphis, TN
2:15 improving Metabolic Risk Factors through lifestyle — Vera Bittner, Birmingham, AL
2:30 Goals and Drugs for Glycemic Management: Cardiologists perspective — Amit Khera, Dallas, TX
2:45 Glycemic Control in the inpatient Setting: Consensus or Confusion? — Steven P. Marso, Kansas City, MO
3:00 Cardiovascular effects of New Agents in the Management of Diabetes — Elif Oral, Ann Arbor, MI
3:15 Bariatric Surgery: Cure for Obesity? — Peter A. McCullough, Novi, MI
QUAl
SyMpOSiUM
712
Bringing evidence to the Bedside: Making Guidelines More Accessible to CliniciansMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place North, N427CMe/CNe Hours: 1.5
Co-Chairs: Jeffrey Anderson, Cincinnati, OH Frederick A. Masoudi, Denver, CO
2:00 Do Guidelines Contain enough level i evidence? — Sanjay Kaul, Los Angeles, CA
2:18 Balancing COi and Committee Responsibility — Robert A. Harrington, Durham, NC
2:36 incorporating evidence into a living Guideline Document — Scott Wright, Rochester, MN
2:54 Bridging Guidelines and practice with Appropriate Use Criteria — Frederick A. Masoudi, Denver, CO
3:12 Accessibility of Guidelines for Clinicians — Patrick T. O’Gara, Boston, MA
QUAl
SyMpOSiUM
713
Making a Difference: Cardiology leadership in the Community and the WorldMonday, March 26, 2012, 2:00 p.m. – 3:35 p.m.McCormick Place North, N228CMe/CNe Hours: 1.5
Co-Chairs: Valentin Fuster, New York, NY Eva M. Kline-Rogers, Ann Arbor, MI
2:00 project My Heart your Heart — Thomas C. Crawford, Ann Arbor, MI
2:15 indian Health Service — James M. Galloway, Chicago, IL
2:30 partners in Health — Gene Bukhman, Boston, MA
2:50 early Career/Kenya — Gerald S. Bloomfield, Durham, NC
3:05 project Healthy Schools: A Community/Health System Collaboration — Kim A. Eagle, Ann Arbor, MI
3:20 African initiatives — Edward P. Havranek, Denver, CO
SpeCiAl
leGeNDS
404
legends of Cardiovascular Medicine lecture Series — 11th Annual Maseri-Florio international lectureMonday, March 26, 2012, 2:00 p.m. – 3:00 p.m.McCormick Place North, N231CMe/CNe Hours: 1
Chair: Gregg W. Stone, New York, NY
2:00 Welcome, introduction of Dr. Attilio Maseri and History of the Maseri-Florio international lecture — Jack Lewin, Washington DC
2:04 Founder, Maseri-Florio endowment Fund of the American College of Cardiology — Attilio Maseri, Florence, Italy
2:05 introduction of Named lecturer/legend — Gregg W. Stone, New York, NY
2:07 11th Annual Maseri-Florio international lecture: personal insights leading to Scientific Developments — Antonio Colombo, Milan, Italy
2:37 One-on-One interview with Dr. Antonio Colombo — Gregg W. Stone, New York, NY
2:50 Question and Answer
VAlV
expeRTS
251
Complex Valvular Heart DiseaseMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S503CMe/CNe Hours: 1.5
Chair: Sorin Pislaru, Rochester, MN
Case Gilbert Habib, Marseille, France, Joseph Maalouf, Presenters: Rochester, MN, Josep Rodes-Cabau, Quebec, Canada
Panelists: Mario J. Garcia, Bronx, NY, Bernard Iung, Paris, France
VAlV
SyMpOSiUM
714
Calcific Aortic Stenosis: Diagnosis and Treatment in the 21st CenturyMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place North, N426CMe/CNe Hours: 1.5
Co-Chairs: David Newby, Edinburgh, Scotland, United Kingdom Andrew Wang, Durham, NC
2:00 The Role of epidemiology Risk Factors for Secondary prevention of Calcific Aortic Valve Disease — Catherine M. Otto, Seattle, WA
2:22 The Cellular Mechanisms of Calcific Aortic Valve Disease — Nalini Marie Rajamannan, Chicago, IL
2:44 The Role 3-D and 4-D echo imaging in Aortic Valve Disease — Jae K. Oh, Rochester, MN
3:07 The Role of TAVi in Calcific Aortic Valve Disease — Peter C. Block, Atlanta, GA
ACC.12 • Monday, March 26, 2012
200 GO for ACC.12!
AFTE
RNOO
N
ACC-i2/TCT
MOC
823
ACCF Study Session for Maintenance of Certification: ABiM Recertification Made easy — interventional Cardiology 2011 Update (B2-l)Monday, March 26, 2012, 3:00 p.m. – 5:30 p.m.McCormick Place South, S105aCMe Hours: 2.5
Please refer to the full session listing, listed below, for additional session information.
liFelONG
MOC
823
ACCF Study Session for Maintenance of Certification: ABiM Recertification Made easy — interventional Cardiology 2011 Update (B2-l)Monday, March 26, 2012, 3:00 p.m. – 5:30 p.m.McCormick Place South, S105aCMe Hours: 2.5
Chair: Mehdi H. Shishehbor, Cleveland, OH
MOC Faculty: John P. Reilly, New Orleans, LA, Subhash Banerjee, Dallas, TX
ACCF’s Maintenance of Certification Sessions allows you to easily obtain ABIM’s Maintenance of Certification (MOC) points during at ACC.12. Tickets are required for admittance to this session. Ticketed registrants must arrive no later than 15 minutes before the start of the session. Seats will be released at this time and an “open seating” policy will apply.
Attendees must be enrolled in the ABIM’s MOC program to claim MOC points. If you are not enrolled, please allow sufficient time to do this prior to the start of the session. ABIM staffs are available onsite to answer your MOC questions and help with enrollment.
For convenience, there will be computer terminals in the ACC MOC Center onsite in Room S104b for attendees to take the ABIM MOC test after the study session concludes, if desired. Electrical power is provided in the classrooms so that attendees who wish to bring their own devices may ‘power up’ to access relevant question modules.
Access to the online modules will also be available for participants for a short period of time following the annual meeting.
Attendees may not claim CME credits from ABIM as it is against ACCME and AMA guidelines to claim credit twice for the same activity. MOC credit is available from the ABIM after completion of the MOC module; CME credit only (no CNE credit) is available from ACC.
liFelONG
MOC
824
ACCF Study Session for Maintenance of Certification: ABiM Recertification Made easy—Clinical Cardiac electrophysiology, 2011 Update (B3-l)Monday, March 26, 2012, 3:00 p.m. – 5:30 p.m.McCormick Place South, S105dCMe Hours: 2.5
Chair: Peter N. Smith, Marshfield, WI
MOC Faculty: Byron Kwock Lee, San Francisco, CA, Bindi K. Shah, Philadephia, PA
ACCF’s Maintenance of Certification Sessions allows you to easily obtain ABIM’s Maintenance of Certification (MOC) points during at ACC.12. Tickets
are required for admittance to this session. Ticketed registrants must arrive no later than 15 minutes before the start of the session. Seats will be released at this time and an “open seating” policy will apply.
Attendees must be enrolled in the ABIM’s MOC program to claim MOC points. If you are not enrolled, please allow sufficient time to do this prior to the start of the session. ABIM staffs are available onsite to answer your MOC questions and help with enrollment.
For convenience, there will be computer terminals in the ACC MOC Center onsite in Room S104b for attendees to take the ABIM MOC test after the study session concludes, if desired. Electrical power is provided in the classrooms so that attendees who wish to bring their own devices may ‘power up’ to access relevant question modules.
Access to the online modules will also be available for participants for a short period of time following the annual meeting.
Attendees may not claim CME credits from ABIM as it is against ACCME and AMA guidelines to claim credit twice for the same activity. MOC credit is available from the ABIM after completion of the MOC module; CME credit only (no CNE credit) is available from ACC.
ACC-i2/TCT
SyMpOSiUM
2640
Mitral interventionsMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place South, S102bCMe/CNe Hours: 1.5
Co-Chairs: Ted Feldman, Evanston, IL Peter C. Block, Atlanta, GA
3:45 echo Anatomy for percutaneous MR Therapy — Nina Wunderlich, Frankfurt, Germany
4:00 Defining High-risk in MV Surgery — Maurice Enriquez-Sarano, Rochester, MN
4:15 pitfalls in Current Studies of percutaneous Therapy for MR — Gregg W. Stone, New York, NY
4:30 percutaneous Therapy (MitraClip and Carollion) is Best for High-risk RM patients — Olaf Franzen, Copenhagen, Denmark
4:45 Surgery is the Best Therapy for High Risk MR patients — Steven F. Bolling, Ann Arbor, MI
5:00 panel Discussion
ACC-i2/TCT
SyMpOSiUM
2641
importance of Bleeding in patients with CV Disease: A personalized Approach for Treatment StrategiesMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place South, S103bCMe/CNe Hours: 1.5
Co-Chairs: Robert A. Harrington, Durham, NC Roxana Mehran, New York, NY
3:45 importance of Bleeding — Thomas Tehsin Tsai, Denver, CO
3:58 predictors of Bleeding in ACS and elective pCi — Steven Vahe Manoukian, Nashville, TN
Monday, March 26, 2012 • ACC.12
ACC.12 Final Program 201
AFTERNOON
4:11 New Anti-platelet Agents: Which Drug and for Whom; Balancing Bleeding and ischemia — Deepak L. Bhatt, Boston, MA
4:24 Use of Risk Scores for Stratification: is it Feasbile? Which is the ideal Score To Use? — Steven P. Marso, Kansas City, MO
4:37 Bleeding Definitions: Which Component of Bleeding Matters? — Roxana Mehran, New York, NY
4:50 Strategies to Reduce Bleeding Complications in pCi: The Radial Approach — Sanjit S. Jolly, West Hamilton, Canada
5:03 panel Discussion
ACC-i2/TCT
SyMpOSiUM
2642
endovascular Management of erectile DysfunctionMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place South, S103cCMe/CNe Hours: 1.5
Co-Chairs: J. Michael Bacharach, Sioux Falls, SD Andrew J. Feiring, Milwaukee, WI
3:45 Appropriate patient Selection for pudendal Artery intervention — Krishna J. Rocha-Singh, Springfield, IL
4:05 patient Assessment to Diagnose Obstructive Atherosclerosis as the Cause of erectile Dysfunction — Aravinda Nanjundappa, Charleston, WV
4:25 Outcomes of the ZeN Trial: What Did We learn — James P. Zidar, Raleigh, NC
5:05 panel Discussion
ACC-i2/TCT
SyMpOSiUM
2643
ACS: New insights and Novel TherapiesMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place South, S106bCMe/CNe Hours: 1.5
Co-Chairs: A. Michael Lincoff, Cleveland, OH Eric R. Bates, Ann Arbor, MI
3:45 Determining the Adequacy of Myocardial Reperfusion in STeMi: Clinical, Angiographic and Tomographic Measures of Reperfusion — Correlation with Time to Treatment and Total ischemic Time — Manesh R. Patel, Durham, NC
3:57 Adjunctive Therapies to Mitigate ischemia-Reperfusion injury — William W. O’Neill, Miami, FL
4:09 limitations of Clopidogrel platelet inhibition: prevalence and Mechanisms prevalence and Mechanisms — Paul A. Gurbel, Baltimore, MD
4:19 limitations of Clopidogrel platelet inhibition: Therapeutic Options: New insights from GRAViTAS, TRiGGR-pCi, ARCTiC and ReClOSe-2 ACS — Dominick J. Angiolillo, Jacksonville, FL
4:29 Appropriate Utilization of Novel Anti-thrombotic Agents in ACS: Ticagrelor, Vorapaxar — Lars Wallentin, Uppsala, Sweden
4:41 The Role of platelet Gpiib/iiia Blockade in ACS: Valuable Adjunct — Jochen Woehrle, Ulm, Germany
4:51 The Role of platelet Gpiib/iiia Blockade in ACS: Not Necessary — Gilles Montalescot, Paris, France
5:01 panel Discussion
ARR
SyMpOSiUM
715
Challenges in the Management of Ventricular ArrhythmiasMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place South, S406aCMe/CNe/Cpe Hours: 1.5 ACpe No. 0012-9999-143-l04-p
Co-Chairs: Alfred E. Buxton, Boston, MA Paul A. Friedman, Rochester, MN
3:45 Ventricular ectopy in the patient with a Structurally Normal Heart — Francis E. Marchlinski, Bala Cynwyd, PA
4:03 Ablation of Ventricular Tachycardia in ischemic Cardiomyopathy — William G. Stevenson, Boston, MA
4:21 Ablation of Ventricular Tachycardia in Non-ischemic Cardiomyopathy — Kalyanam Shivkumar, Los Angeles, CA
4:39 All patients with iCD Shocks for VT Should Undergo Catheter Ablation — David J. Wilber, Maywood, IL
4:54 All patients with iCD Shocks for VT Should Not Undergo Catheter Ablation — Paul A. Friedman, Rochester, MN
ARR
SyMpOSiUM
716
issues in Cardiac Resynchronization TherapyMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place North, N227bCMe/CNe Hours: 1.5
Co-Chairs: Melanie T. Gura, Akron, OH Ralph J. Verdino, Philadelphia, PA
3:45 CRT for patients with NyHA i or ii — Andrew E. Epstein, Philadelphia, PA
4:00 Reducing Atrial Fibrillation and Hospitalization with CRT — Jonathan S. Steinberg, New York, NY
4:15 Gender Disparities with CRT — Jennifer E. Cummings, Akron, OH
4:30 Management of the CRT Non-Responder — William T. Abraham, Columbus, OH
4:45 Management of AF patients Referred for CRT implant: Ablation of Atrial Fibrillation versus AV Node Ablation — Andrea Natale, Austin, TX
5:00 Targeted left Ventricular lead placement to improve Response to CRT — Fakhar Z. Khan, Cambridge, United Kingdom
CCS
expeRTS
252
Golden Moments: When is the Right Time to intervene in Congenital Heart Disease?Monday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place South, S501aCMe/CNe Hours: 1.5
Chair: Daniel J. Murphy, Palo Alto, CA
Case Presenter: Charles Shepard, Minneapolis, MN
Panelists: Bryan C. Cannon, Rochester, MN, Mark E. Galantowicz, Columbus, OH, Thomas K. Jones, Seattle, WA, Mark B. Lewin, Seattle, WA, William R. Morrow, Little Rock, AR, Anne Marie Valente, Boston, MA
ACC.12 • Monday, March 26, 2012
202 GO for ACC.12!
AFTE
RNOO
N
HF
SyMpOSiUM
717
improving Outcomes and Reducing Heart Failure ReadmissionsMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place South, S406bCMe/CNe Hours: 1.5
Co-Chairs: Katherine J. Hoercher, Cleveland, OH Rene J. Alvarez, Pittsburgh, PA
3:45 Heart Failure Readmissions: Scope of the problem — Gregg C. Fonarow, Los Angeles, CA
3:58 Does Telemonitoring Help prevent Readmissions? — Harlan M. Krumholz, New Haven, CT
4:12 Do implanted Device (Defibrillators and pacemakers) Help prevent Readmissions? — Niraj Varma, Cleveland, OH
4:25 Does Hemodynamic Monitoring Help prevent Readmissions? — Robert C. Bourge, Birmingham, AL
4:38 Transition from Hospital to Home — Sara Paul, Hickory, NC
4:51 performance Measures: Do they Assess Quality? — Nancy M. Albert, Cleveland, OH
5:03 Discussion
HF
SyMpOSiUM
718
Controversies in Treatment of Comorbidities in Heart Failure: paradoxes and Challenges in TreatmentMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place South, S404CMe/CNe Hours: 1.5
Co-Chairs: Biykem Bozkurt, Houston, TX Akshay S. Desai, Boston, MA
3:45 Diabetes and Heart Failure — David Aguilar, Houston, TX
4:00 Question and Answer
4:03 Obesity and Heart Failure — Tamara Horwich, Los Angeles, CA
4:18 Question and Answer
4:21 Hypertension and Heart Failure — Biykem Bozkurt, Houston, TX
4:36 Question and Answer
4:39 Sleep Apnea and Heart Failure — Shahrokh Javaheri, Cincinnatti, OH
4:54 Question and Answer
4:57 Atrial Fibrillation and Heart Failure — Maya E. Guglin, Tampa, FL
5:12 Question and Answer
iMAG
SyMpOSiUM
719
emerging Applications of CMRMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place South, S403CMe/CNe Hours: 1.5
Co-Chairs: W. Gregory Hundley, Winston Salem, NC Sanjay Prasad, London, England, United Kingdom
3:45 New Approaches to Quantitate Systolic Function — Michael Markl, Chicago, IL
4:03 Assessment of ischemia and Viability — Daniel C. Lee, Chicago, IL
4:21 Molecular imaging — David E. Sosnovik, Charlestown, MA
4:39 Role of MRi in Valvular Heart Disease — Dipan J. Shah, Houston, TX
4:57 expanding Role of CMR in interventional Cardiology — Dara Kraitchman, Baltimore, MD
ACC-i2/TCT
SyMpOSiUM
2639
Controversies in intravascular imagingMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place South, S101aCMe/CNe Hours: 1.5
Co-Chairs: John McB Hodgson, Wilkes-Barre, PA Jonathan M. Tobis, Los Angeles, CA
3:45 Assessing lesion Severity: FFR is the Gold Standard — Habib Samady, Atlanta, GA
3:55 Assessing lesion Severity: Are There any Anatomic Critieria — iVUS or OCT — That Can be Used instead of FFR? — Bon Kwon Koo, Chongno-gu, Seoul, Republic of Korea
4:05 Assessing lesion Severity: Can Cardiovascular CT provide insight into Stenosis Severity? — Szilard Voros, Atlanta, GA
4:10 panel Discussion with Case presentations — Habib Samady, Atlanta, GA
4:15 Case presentation — Itsik Ben-Dor, Rockville, MD
4:20 Case presentation — Muzaffer Degertekin, Istanbul, Turkey
4:25 Distal embolization during pCi: Definition of the problem: Frequency, Clinical Setting, Clinical predictors, etc. — Simon R. Dixon, Royal Oak, MI
4:30 Distal embolization during pCi: predicting Distal embolization Using Grayscale iVUS, RF-iVUS, OCT, and NiRS — Emmanouil S. Brilakis, Dallas, TX
4:40 Distal embolization during pCi: prediction of Distal embolization Based on CTA — Yukio Ozaki, Toyoake, Japan
4:45 Optimal endpoints for Stent implantation and Guidance: A Review of the iVUS literature — Kenichi Fujii, Nishinomiya Hyogo, Japan
4:55 Optimal endpoints for Stent implantation and Guidance: Can OCT Replace iVUS in Optimizing Stent implantation? — Marco A. Costa, Cleveland, OH
5:05 panel Discussion
liFelONG
CORe
825
Core Curriculum: Vascular DiseaseMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place North, N226CMe/CNe Hours: 1.5
Chair: Alex J. Auseon, Columbus, OH
3:45 peripheral Arterial Disease — Douglas E. Drachman, Boston, MA
4:10 Aortopathies — Emile R. Mohler, III, Philadelphia, PA
Monday, March 26, 2012 • ACC.12
ACC.12 Final Program 203
AFTERNOON
4:35 Carotid and Cerebrovascular Disease — Michael R. Jaff, Boston, MA
5:00 Question and Answer
liFelONG
CORe
826
Core Curriculum: landmark TrialsMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place North, N229CMe/CNe Hours: 1.5
Chair: Karthikeyan Ananthasubramaniam, West Bloomfield, MI
3:45 landmark Trials in Hyperlipidemia — Anand Rohatgi, Dallas, TX
4:05 landmark Trials in Heart Failure — David E. Lanfear, Detroit, MI
4:25 landmark Trials in ACS — Stephen D. Wiviott, Boston, MA
4:45 landmark Trials in electrophysiology — Joseph Edward Marine, Baltimore, MD
5:05 Question and Answer
peRi
expeRTS
253
Challenges in Hypertrophic Cardiomyopathy: Case StudiesMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place South, S505CMe/CNe Hours: 1.5
Chair: Barry J. Maron, Minneapolis, MN
Case Martin S. Maron, Boston, MA, Matthew W. Martinez, Presenters: Allentown, PA, Paul Sorajja, Rochester, MN
Panelists: Perry M. Elliott, London, United Kingdom, Harry M. Lever, Cleveland, OH, William McKenna, London, United Kingdom, Ulrich Sigwart, Geneva, Switzerland
peRi
SyMpOSiUM
720
New Directions in the evaluation and Management of the CardiomyopathiesMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place North, N231CMe/CNe Hours: 1.5
Co-Chairs: Nancy K. Sweitzer, Madison, WI Hector O. Ventura, New Orleans, LA
3:45 Familial Dilated Cardiomyopathy Syndromes: What is the Role for Genetic Testing? — Neal Lakdawala, Boston, MA
3:59 peripartum Cardiomyopathy: New Concepts in pathophysiology and Management — Uri Elkayam, Los Angeles, CA
4:13 Myocarditis and Other ‘Reversible’ Causes of Cardiomyopathy — Leslie T. Cooper, Rochester, MN
4:27 Cardiac Sarcoidosis: Diagnosis, evaluation and Management: Whom Should We Treat? — Andrew M. Freeman, Denver, CO
4:41 Arrhythmogenic Right Ventricular Cardiomyopathy: Genetics, pathophysiology, imaging and Management — Hugh Calkins, Baltimore, MD
4:55 Multidisciplinary evaluation of patients with Cardiomyopathies — Rodney Falk, Boston, MA
5:10 Question and Answer
pHTN
expeRTS
254
pulmonary Hypertension Tools for the CardiologistMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place South, S504aCMe/CNe/Cpe Hours: 1.5 ACpe No. 0012-9999-12-131-l01-p
Chair: Ronald J. Oudiz, Torrance, CA
Case Paul Forfia, Philadelphia, PA, Gregory D. Lewis, Presenters: Boston, MA, Vallerie V. McLaughlin, Ann Arbor, MI
pReV
SyMpOSiUM
729
Beyond Statins: lDl Management in the Challenging patientMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place South, S100cCMe/CNe/Cpe Hours: 1.5 ACpe No. 0012-9999-12-146-l04-p
Co-Chairs: Amit Khera, Dallas, TX Donna M. Polk, Hartford, CT
3:45 Role of Genetic Testing — Christie M. Ballantyne, Houston, TX
4:03 Dietary effects and phytosterols — Michael J. Blaha, Baltimore, MD
4:21 Combination Therapy: When and Which Ones? — Jennifer Robinson, Iowa City, IA
4:39 lDl Apheresis as a Treatment Option — Patrick M. Moriarty, Kansas City, KS
4:57 Mipomersen and pCSK9 inhibitors — Evan A. Stein, Cincinnati, OH
pReV
SyMpOSiUM
745
World Hellenic Biomedical Association, the Hellenic Cardiological Society, the Cyprus Society of Cardiology and the American College of Cardiology: Mediterranean Diet and its protective effect on Cardiovascular DiseaseMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place South, S405CMe/CNe Hours: 1.5
Co-Chairs: George D. Dangas, New York, NY George Parharidis, Athens, Greece
3:45 introduction to Session — George D. Dangas, New York, NY
3:50 The Role of Sodium and potassium in CV Health — George L. Bakris, Chicago, IL
4:05 The Role of Cardiovascular imaging in Coronary Heart Disease — Petros Nihoyannopoulos, London, United Kingdom
4:20 An Overview of the Cypriot Contribution to the Diet — Panayiotis Avraamides, Nicosia, Cyprus
4:35 Cardiovascular Mortality in Greece — Vlassios N. Pyrgakis, Nerantza Corinthias, Greece
4:50 effects of Diet, exercise and Weight loss on inflammation — Christie M. Ballantyne, Houston, TX
5:05 Question and Answer
ACC.12 • Monday, March 26, 2012
204 GO for ACC.12!
AFTE
RNOO
N
QUAl
SyMpOSiUM
721
Transforming Health Care Delivery through CV RegistriesMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place North, N427CMe/CNe Hours: 1.5
Co-Chairs: Eva M. Kline-Rogers, Ann Arbor, MI Eric D. Peterson, Durham, NC
3:45 The SCAAR Registry — Stefan K. James, Uppsala, Sweden
4:00 The Danish Registry experience — Leif Thuesen, Aarhus, Denmark
4:15 BMC2: The Michigan pCi Registry — Hitinder S. Gurm, Ann Arbor, MI
4:30 MSTCVS: The Michican Surgical Registry — Richard L. Prager, Ann Arbor, MI
4:45 CART-Cl: The VA Cath lab Quality program — Thomas M. Maddox, Denver, CO
5:00 Mandatory participation and Reporting of Registry Data — Ralph G. Brindis, Oakland, CA
QUAl
SyMpOSiUM
722
Applying Newer Cardiovascular Agents to Older AdultsMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place North, N228CMe/CNe/Cpe Hours: 1.5 ACpe No. 0012-9999-12-144-l04-p
Co-Chairs: Michael Chen, Seattle, WA Tracy Wang, Durham, NC
3:45 pharmacology in Older Adults — Jeffrey Washam, Durham, NC
4:00 pCi Medications in Older Adults — Harold L. Dauerman, Shelburne, VT
4:15 polypharmacy and Adherence — Jeffrey Washam, Durham, NC
4:30 AF Anticoagulants in Older Adults — James B. Froehlich, Ann Arbor, MI
4:45 Does My 90 year-old patient Need a Statin? — Michael W. Rich, Saint Louis, MO
5:00 Aldosterone Blockade in Older Adults — Milton Packer, Dallas, TX
SpeCiAl
SyMpOSiUM
740
Joint Symposium of the British Cardiovascular Society and the California Chapter of the American College of CardiologyMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place North, N230CMe/CNe Hours: 1.5
Co-Chairs: Daniel S. Berman, Los Angeles, CA Ronald P. Karlsberg, Beverly Hills, CA S. Richard Underwood, London, United Kingdom
3:45 Twinning of BCS and the California Chapter of the ACC — Huon Gray, Southampton, United Kingdom
3:50 New Frontiers in echocardiography — Anthony N. DeMaria, San Diego, CA
4:15 Future of Cardiac Magnetic Resonance — Dudley J. Pennell, London, United Kingdom
4:30 Coronary CT Angiography: Beyond Coronary Stenosis — James K. Min, New York, NY
4:45 New Directions in Cardiac peT-CT — David E. Newby, Edinburgh, Scotland, United Kingdom
5:00 Noninvasive Cardiac imaging in Great Britain — S. Richard Underwood, London, United Kingdom
5:05 Noninvasive Cardiac imaging in the US — Daniel S. Berman, Los Angeles, CA
5:10 Discussion
TeST
expeRTS
255
Stress Testing in WomenMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place South, S502CMe/CNe Hours: 1.5
Chair: Alison Bailey, Lexington, KY
Case Presenter: Janet B. Long, Providence, RI
Panelists: C. Noel Bairey Merz, Los Angeles, CA, Martha Gulati, Columbus, OH, Jennifer H. Mieres, Lake Success, NY, Leslee J. Shaw, Atlanta, GA, Nanette Kass Wenger, Atlanta, GA
VAlV
expeRTS
256
Advanced Hemodynamics for Valvular Heart DiseaseMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place South, S503CMe/CNe Hours: 1.5
Chair: Salvatore Costa, Lebanon, NH
Case Jean G. Dumesnil, Sainte Foy, Canada, Rick A. Presenters: Nishimura, Rochester, MN, Luc Pierard, Liège, Belgium
Panelists: Salvatore Costa, Lebanon, NH, Steve R. Ommen, Rochester, MN
VAlV
SyMpOSiUM
723
importance of Registries for Valve Disease: A Glimpse into the ACC FutureMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place North, N426CMe/CNe Hours: 1.5
Co-Chairs: David J. Malenka, Lebanon, NH Hector I. Michelena, Rochester, MN
3:45 What ACC Needs to Do for Valve Registries — David R. Holmes, Jr., Rochester, MN
4:03 The euro-Heart Survey: What is the picture of Valve Disease practice in europe — Bernard Iung, Paris, France
4:21 MiDA: The Research and the practice in an international Registry of MR — Francesco Grigioni, Italy
4:39 The UK TAVi Registry — Jan Kovac, Leicestershire, United Kingdom
4:57 The Canadian Registry of TAVi — Josep Rodes-Cabau, Quebec, Canada
Monday, March 26, 2012 • ACC.12
ACC.12 Final Program 205
evening
ACC-i2/TCT
CliNiCAl FOCUS
1607
Joint Session of the American Association for Thoracic Surgery, the Society of Thoracic Surgery and the American College of Cardiology: Multidisciplinary Approach to the High-risk Aortic Stenosis patientMonday, March 26, 2012, 5:45 p.m. – 9:05 p.m.McCormick Place South, S401aCMe/CNe Hours: 2.5
5:45 Registration and Dinner
Co-Chairs: Ralph J. Damiano, St. Louis, MO E. Murat Tuzcu, Cleveland, OH Todd M. Dewey, Dallas, TX| Raoul Bonan, Montreal, Canada
TAVR: Where Are We in 2012
6:15 Balloon expandable Valve — Samir R. Kapadia, Cleveland, OH
6:25 Self expanding Valve — Gregory P. Fontana, Los Angeles, CA
6:35 panel Discussion
Risk Assessment of an Aortic Stenosis patient
6:45 Who is a Candidate for TAVR — Vinod H. Thourani, Atlanta, GA
6:55 pearls from echocardiography — Rebecca T. Hahn, New York, NY
7:05 Can’t do without CT imaging — Jonathan Leipsic, Vancouver, Canada
7:15 panel Discussion
Complications, impact, precautions, Management
7:25 Vascular Trauma and Bleeding — Wilson Y. Szeto, Philadephia, PA
7:35 Stroke — Josep Rodes-Cabau, Quebec, Canada
7:45 Aortic Regurgitation — Jeffrey J. Popma, Newton, MA
7:55 panel Discussion
Debates
8:05 Debate: TAVR Should be Reserved only for inoperable patients — Todd M. Dewey, Dallas, TX
8:15 Debate: TAVR Should be Reserved only for inoperable patients — Thierry Lefevre, Massy, France
8:25 panel Discussion
8:35 Debate: Stroke Risk is prohibitive for all but a Small Fraction of Aortic Stenosis patients — D. Craig Miller, Stanford, CA
8:45 Debate: Stroke Risk is prohibitive for all but a Small Fraction of Aortic Stenosis patients — Martin B. Leon, New York, NY
8:55 panel Discussion
SpeCiAl
SpeCiAl
307
61st Annual ConvocationMonday, March 26, 2012, 6:30 p.m. – 8:00 p.m.McCormick Place North, Hall B, ACC.12 Main Tent
ACC.12 • Monday, March 26, 2012
206 GO for ACC.12!
CV Innovations Educational ForumSouth Building, Hall A2, CV Theater, #22097
The Role of Nanotechnology in Cardiovascular Diseases9:30 a.m. – 10:30 a.m.
9:30 a.m. – 9:40 a.m.Nanotechnology — Steven Bailey, MD, San Antonio, TX — University of Texas, San Antonio
9:40 a.m. – 9:50 a.m.Nano particle Delivery — Mauro Farrari, PhD, Houston, TX — President and CEO of The Methodist Hospital Research Institute (invited)
9:50 a.m. – 10:00 a.m.imaging of Stem Cells — Jeff W.M. Bulte, PhD, Baltimore, MD — Professor, Johns Hopkins University (invited)
10:00 a.m. – 10:10 a.m.imaging of Cells and plaque — Sam Wickline, MD, St. Louis, MO — Professor, Washington University (invited)
10:10 a.m. – 10:20 a.m.imaging of Vulnerable plaque — Todd D. Giorgio, PhD, Nashville, TN — Professor, Vanderbilt School of Engineering (invited)
10:20 a.m. – 10:30 a.m.panel Discussion
Cellular Therapy Noon – 1:00 p.m.
Noon – 12:10 p.m.Very Small embryonic-like Stem Cells for Cardiovascular Repair — Wojtek Wojakowski, MD, Katowice, Poland —Third Division of Cardiology, Medical University of Silesia
12:10 p.m. – 12:20 p.m.Methods of Stem Cell Therapy and Future Direction — Nabil Dib, MD, MSc, FACC, Gilbert, AZ — Director, Heart Sciences Center
12:20 p.m. – 12:30 p.m.ischemia Tolerant Mesenchymal Stem Cell — Nicholai Tankovich, MD, PhD, San Diego, CA — President and Chief Medical Officer, Stemedica Cell Technologies, Inc.
12:30 p.m. – 12:40 p.m.Role of Shock Wave/Ultrasound in Stem Cell Transplantation — Andreas M. Zeiher, MD, Frankfurt, Germany — Chairman, Department of Medicine III/Cardiology, University of Frankfurt
12:40 p.m. – 12:50 p.m.The Regulatory pathways of Stem Cells: industry point of View — Randal Mills, PhD, Columbia, MD — President and Chief Executive Officer, Osiris Therapeutics
12:50 p.m. – 1:00 p.m.panel Discussion
Tissue engineering 1:00 p.m. – 1:40 p.m.
1:00 p.m. – 1:10 p.m.The living Valve — Sir Magdi Yacoub, MD, FRCS, London, United Kingdom — Professor, Cardiothoracic Surgery, Imperial College
1:10 p.m. – 1:20 p.m.Myocardial Matrix — Karen Christman, PhD, San Diego, CA — Assistant Professor of Bioengineering, University of California San Diego
1:20 p.m. – 1:30 p.m.Abbott Vascular’s Bioresorbable Scaffold program… A New paradigm in pCi? — Richard J. Rapoza, PhD, Abbott Park, IL — Division Vice President of Research & Development, Abbott Vascular
1:30 p.m. – 1:40 p.m.panel Discussion
personalized Medicine 1:40 p.m. – 2:00 p.m.
1:40 p.m. – 1:50 p.m.personalized Medicine — Robert Roberts, MD, MACC, FRCPC, Ottawa, ON, Canada — President, Chief Executive Officer and Chief Scientific Officer, University of Ottawa Heart Institute
1:50 p.m. – 2:00 p.m.A New Gene expression Test to Detect Coronary Artery Disease — Mark Monane, MD, MS, FACP, Palo Alto, CA — Chief Medical Officer, CardioDx
ACC.12 Learning Destination™ Presentations
Monday, March 26, 2012Learning Destinations™ are diverse, non-accredited, educationally focused areas that offer new and creative venues in which you can expand your educational experience.*
Presentation schedules are current as of Feb. 29, 2012, and are subject to change. For more information, please check the ACC.12 ExpoGuide and ExpoGuide Addendum, available at Expo Hall entrances and in your official meeting bag, and the Heart of Innovation Resource Guide, available at the Heart of Innovation Learning Destination (South Building, Hall A1, #1076) and in your official meeting bag
ACC.12 Final Program 207
The Heart of Innovation Featured Learning Destination South Building, Hall A1, #1076
9:30 a.m. – 9:45 a.m.educational content including taped cases, physician interviews, panel discussions and more
9:45 a.m. – 10:15 a.m.Moderated Discussion: A New Approach to Delivering Stem Cell Therapy for patients with CHF
Moderator: Anthony N. DeMaria, MD, MACC, San Diego, CA — Judith and Jack White Chair in Cardiology; Founding Director, Sulpizio Cardiovascular Center, University of California San Diego
Panelists: Bernard J. Gersh, MB, ChB, DPhil, FACC, Rochester, MN — Professor of Medicine, Cardiovascular Diseases, Mayo Clinic; Andreas M. Zeiher, MD, Frankfurt, Germany — Chairman, Department of Medicine III/Cardiology, University of Frankfurt
10:15 a.m. – 12:15 p.m.educational content including taped cases, physician interviews, panel discussions and more
12:15 p.m. – 12:45 p.m.Biomarker Guided Heart Failure Management — James L. Januzzi, Jr., MD, FACC, Cambridge, MA — Director, Cardiac Intensive Care Unit, Massachusetts General Hospital; Associate Professor of Medicine, Harvard Medical School
12:45 p.m. – 1:05 p.m.physician-patient engagement and Shared Decision Making — John R. Windle, MD, FACC, Omaha, NE — Professor and Chief, Internal Medicine, Division of Cardiology, University of Nebraska Medical Center
1:05 p.m. – 1:25 p.m.The evolution of Radiation protection — Christian E. Machado, MD, FACC, FAHA, FHRS, Detroit, MI — Clinical Associate Professor, Wayne State University School of Medicine; Senior Partner, Heart Cardiology Consultants; Director, Cardiac Electrophysiology and Cardiac Rhythm Management Device Clinic, Providence Hospital
1:25 p.m. – 1:45 p.m.Current Status and Future Direction of Stem Cell Therapy for Cardiovascular Disease — Nabil Dib, MD, MSc, FACC, Gilbert, AZ — Director, Cardiovascular Research, Heart Sciences Center; Director; Clinical Cardiovascular Cell Therapy, Associate Professor of Medicine, University of California, San Diego; Medical Director, Celebration Stem Cell Centre; President, International Society for Cardiovascular Translational Research; Editor in Chief, Journal of Cardiovascular Translational Research
1:45 p.m. – 2:00 p.m.educational content including taped cases, physician interviews, panel discussions and more
Industry-Expert TheaterSouth Building, Hall A1, #22042
9:45 a.m. – 10:30 a.m. (Morning Coffee Break)Managing Atherosclerotic Risk with a particle Focus — New Recommendations and emerging Data — Robert S. Rosenson, MD, New York, NY — Professor, Department of Medicine/Cardiology, Director, Cardiometabolic Disorders, Mount Sinai School of Medicine
presented by lipoScience
12:30 p.m. – 1:30 p.m. (lunch Break)Considerations for Radionuclide Myocardial perfusion imaging in patients with COpD/Asthma — Kim Williams, MD, Detroit, MI — Chair, Division of Cardiology and Professor of Medicine; Wayne State University School of Medicine
presented by Astellas pharma US, inc.
Interactive Learning LabsSouth Building, Hall A1, #22027, #22035, #23027
philips HealthcareInteractive Learning Lab #22035
9:30 a.m. – 10:30 a.m.Cardiac CT — The Journey from plaque Recognition to prognosis — Patrick Donnelly, MD, MB BCh, MRCP, United Kingdom — Consultant Cardiologist, Southeastern Health and Social Care Trust, Director Northern Ireland Cardiovascular Research Network; Honorary Senior Lecturer, The Queens University, Belfast Director, Belfast Cardiac CT Academy
11:00 a.m. – NoonBenefit of Cardiac Troponin point-of-Care Testing in the emergency Department — Charles B. Cairns, MD, FACEP, FAHA, Chapel Hill, NC — Professor and Chair, Department of Emergency Medicine, University of North Carolina
12:30 p.m. – 1:30 p.m.Sleep, Breathing and the Heart: Cardiovascular Consequences of Sleep-Disordered Breathing — Babak Mokhlesi, MD, MSc, Chicago, IL — Associate Professor of Medicine Director, Sleep Disorders Center and Sleep Fellowship Program; Section of Pulmonary and Critical Care, University of Chicago
Terumo interventional Systems and The Medicines CompanyInteractive Learning Lab #22027
9:30 a.m. – 10:30 a.m.Hands-On Radial Access Simulation
10:30 a.m. – 11:00 a.m.Optimizing your Outpatient pCi: What you Need to Know and Consider
11:30 a.m. – 12:30 p.m.Hands-On Radial Access Simulation
* Learning Destination presentations are not part of the official ACC Annual Scientific Session & Expo and/or ACC-i2 with TCT, as planned by their Program Committees. Learning Destination presentations do not qualify for continuing medical education (CME), continuing nursing education (CNE) or continuing education (CE) credit.
ACC.12 • Monday, March 26, 2012
©20
12 A
mer
ican
Col
lege
of C
ardi
olog
y Z
1207
©20
12 A
mer
ican
Col
lege
of C
ardi
olog
y Z
1207
TM
Manage your heart health with
CardioSmart National Care
Initiative
Impacting healthy lifestyles and providing patients everyday strategies for heart health.
Small changes add up to big results over time.
Brought to you by:
Everyday Strategies for Heart Health.Go to www.CardioSmart.org today.
Visit ACC Central - Booth #10027.
ACC.12
Tuesday March 27
Tuesday, March 27
Visit us at ACC Central
Booth 10027
quality chasm?WHAT
Achieving quality care is your challenge.
Take it on with NCDR.
With guidelines-focused clinical registries from the NCDR®,
you’ll always know which quality improvement steps to take and when to take them.
NCDR® is an initiative of the American College of Cardiology Foundation®, with partnering support from the following organizations: CARE Registry®—The Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, American Academy of Neurology, American Association of Neurological Surgeons/Congress of Neurological Surgeons, Society for Vascular Medicine, and Society of Vascular and Interventional Neurology; CathPCI Registry®—The Society for Cardiovascular Angiography and Interventions; ICD Registry™—Heart Rhythm Society; IMPACT Registry®—The Society for Cardiovascular Angiography and Interventions and American Academy of Pediatrics; PINNACLE Registry®—MedAxiom; STS/ACC TVT Registry™—An initiative of The Society of Thoracic Surgeons and the American College of Cardiology Foundation; ACTION Registry®–GWTG™—An initiative of the American College of Cardiology Foundation and the American Heart Association, with partnering support from Society of Chest Pain Centers, The American College of Emergency Physicians, and The Society of Hospital Medicine.© 2012 American College of Cardiology Foundation. All rights reserved. B12016
www.ncdr.com/takeiton
Tues
day,
Mar
ch 2
7
ACC.12 Final Program 209
Morning SeSSionS
ACS
SympoSium
728
Joint Symposium of the American Association for Clinical Chemistry and the American College of Cardiology: How to use Cardiac BiomarkersTuesday, march 27, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N230CmE/CNE Hours: 1.5
Co-Chairs: Allan S. Jaffe, Rochester, MN L. Kristin Newby, Durham, NC
8:00 What Every Clinician Should Know about measuring Cardiac Troponin — Fred S. Apple, Minneapolis, MN
8:15 using Cardiac Troponin Clinically — Allan S. Jaffe, Rochester, MN
8:30 Question and Answer
8:45 What Every Clinician Should Know about measuring Natriuretic peptides — John C. Burnett, Rochester, MN
9:00 using Cardiac Natriuretic peptides Clinically — James L. Januzzi, Jr., Boston, MA
9:15 Question and Answer
ARR
SympoSium
747
Antithrombotic Therapies for Atrial Fibrillation: Current State-of-the-ArtTuesday, march 27, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S404CmE/CNE Hours: 1.5
Co-Chairs: Samuel Z. Goldhaber, Boston, MA Julia H. Indik, Tucson, AZ
8:00 Who Should Get Anti-thrombotic Rx for AF: CHADs2
vs. CHA2DS2-VASc and All Those Not meeting Trial Criteria — Jonathan L. Halperin, New York, NY
8:15 pros and Cons of Thrombin inhibitor versus. Warfarin — Samuel Z. Goldhaber, Boston, MA
8:30 pros and Cons of Xa inhibitor versus Warfarin — Lars Wallentin, Uppsala, Sweden
8:45 Time in Therapeutic Range for Warfarin: Effect of Home monitoring — Jack E. Ansell, New York, NY
9:00 putting it All Together: What Should We Do Now? — A. John Camm, London, United Kingdom
9:15 panel Discussion
CCS
SympoSium
724
Complex Conotruncal malformations: What the Surgeon Needs to Know and How to Get the informationTuesday, march 27, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N229CmE/CNE Hours: 1.5
Co-Chairs: Leo Lopez, New York, NY James S. Tweddell, Milwaukee, WI
8:00 Complex Conotruncal malformations: pathologic Considerations — Paul M. Weinberg, Philadelphia, PA
8:18 Complex Conotruncal malformations: The Whole picture — Meryl Cohen, Philadelphia, PA
8:36 Double outlet Right Ventricle with Straddling Atrioventricular Valves: Surgical Considerations — Pedro Del Nido, Boston, MA
8:54 Double outlet Right Ventricle with Complete Atrioventricular Septal Defect: What i Need for a Two Ventricle Repair — Francois G. Lacour-Gayet, New York, NY
9:12 Transposition of the Great Arteries with Ventricular Septal Defect and pulmonary Stenosis: Surgical options — Victor O. Morell, Pittsburgh, PA
CCS
SympoSium
725
Coming of Age: The HLHS Turns 21Tuesday, march 27, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N231CmE/CNE Hours: 1.5
Co-Chairs: Karen S. Kuehl, Washington, DC Erwin N. Oechslin, Toronto, ON
8:00 HLHS: At the Beginning.… — Peter Lang, Cambridge, MA
8:18 HLHS: What We Have Learned about the physiology — Jack Rychik, Philadelphia, PA
8:36 HLHS: How imaging the HLH patient Has Changed — Craig A. Sable, Washington, DC
8:54 Surgical Evolution in the past Two Decades: Striving for optimal Long-Term outcome — Kirk Kanter, Atlanta, GA
9:12 Failing Fontan: is the Hypoplastic Left Heart patient Any Different? — Gruschen R. Veldtman, Toronto, Canada
HF
EXpERTS
257
Cardiac AmyloidosisTuesday, march 27, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S502CmE/CNE Hours: 1.5
Chair: Rodney Falk, Boston, MA
Case Presenter: David C. Seldin, Boston, MA
Panelists: Jeffrey Alexis, Rochester, NY, Morie Gertz, MN, Raymond Y. K. Kwong, Boston, MA, Joseph Selvanayagam, Adelaide, Australia, Marc J. Semigran, Boston, MA
ACC.12 Scientific Session
Tuesday, March 27, 2012Please Note: The following sessions are listed alphabetically by learning pathway abbreviation based on session start time.
Morning
210 GO for ACC.12!
Mor
ning
imAG
EXpERTS
258
Echo in Assessment of Low Gradient Aortic StenosisTuesday, march 27, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S505CmE/CNE Hours: 1.5
Chair: Catherine M. Otto, Seattle, WA
Case Sunil V. Mankad, Rochester, MN, Alan Zajarias, Presenters: Saint Louis, MO
Panelists: Ian G. Burwash, Ottawa, Canada, Patrick M. McCarthy, Chicago, IL, Rick A. Nishimura, Rochester, MN, Catherine M. Otto, Seattle, WA
iSCHEm
EXpERTS
259
innovations in Noninvasive Evaluation of Stable ischemic Heart DiseaseTuesday, march 27, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S503CmE/CNE Hours: 1.5
Chair: Albert C. Lardo, Baltimore, MD
Case Erin Bohula, Boston, MA, William Luke, Gainesville, FL,Presenters: J. Jacob Mancuso, San Antonio, TX
Panelists: Theodore P. Abraham, Baltimore, MD, Daniel S. Berman, Los Angeles, CA, Shelton D. Caruthers, Saint Louis, MO, Gregory M. Lanza, Saint Louis, MO
LiFELoNG
BooT CAmp
114
CCA Research Bootcamp Session ii: Successful Research Execution and DisseminationTuesday, march 27, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S105dCmE/CNE/CpE Hours: 1.5 ACpE No. 0012-9999-12-122-L04-p
Chair: Nancy M. Albert, Chesterland, OH
8:00 optimizing the Data Collection process — Desiree A. Fleck, Philadelphia, PA
8:25 Submitting a Competitive Abstract — Lynne Braun, Chicago, IL
8:50 Disseminating Research — Nancy M. Albert, Cleveland, OH
9:15 Question and Answer
pHTN
SympoSium
726
Sesion Conjunta Con La Sociedad Espanola de Cardiología Sociedad interamerica de Cardiología/American College of Cardiology: problemas Relevantes en Cardiología — 2012Tuesday, march 27, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S403CmE/CNE Hours: 1.5
Co-Chairs: Vicente Bertomeu Martinez, Madrid, Spain Valentin Fuster, New York, NY Daniel Pineiro, Buenos Aires, Argentina
8:00 Riesgo Cardiovascular, Como Causa de obstrucion de la microcirculacion Cerebral y Disfuncion Cognativa — Valentin Fuster, New York, NY
8:18 El Holter implantable: ¿Tenemos Claras las indicaciones? — Arcadio Garcia-Alberola, Madrid-Cartagena, Spain
8:36 Empleo de Cardiodesfibriladores en Latinoamérica y uSA: Semajanzas y Diferencias — Gabriel Vanerio, Montevideo, Uruguay
8:54 La Circulación pulmonar, el Ventrículo Derecho, y la Resonancia magnetica — Javier Sanz, New York, NY
9:12 Hipertensión pulmonar en Grandes Alturas — Dante Penaloza, Lima, Peru
pREV
SympoSium
727
Joint Symposium of the American Society of Hypertension and the American College of Cardiology: Hypertension in the Critically ill patientTuesday, march 27, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S406aCmE/CNE/CpE Hours: 1.5 ACpE No. 0012-9999-12-145-L04-p
Co-Chairs: Daniel A. Duprez, Minneapolis, MN C. Venkata S. Ram, Dallas, TX
8:00 perioperative Hypertension — James B. Froehlich, Ann Arbor, MI
8:18 Hypertension in patients with intracranial Hemorrhage — Phillip B. Gorelick, Chicago, IL
8:36 Hypertension in Acute ischemic Stroke — Thompson Robinson, Leicester, United Kingdom
8:54 Hypertensive urgency and Emergency — George L. Bakris, Chicago, IL
9:12 Hypertension in the Emergency Department and Critical Care unit — Stanley S. Franklin, Irvine, CA
SpECiAL
SpECiAL
308
Joint American College of Cardiology/Journal of the American Medical Association Late-Breaking Clinical TrialsTuesday, march 27, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, Hall B, ACC.12 Main TentCmE/CNE Hours: 1.5
Co-Chairs: Elliott M. Antman, Boston, MA Michael H. Crawford, San Francisco, CA
Panelists: Matthew J. Budoff, Torrance, CA, Bernard J. Gersh, Rochester, MN, Alice K. Jacobs, Boston, MA, Frans J. J. Van de Werf, Leuven, Belgium
8:00 Survival after pCi or CABG in older patients with Stable multivessel Coronary Disease: Results from the ACCF-STS Database Collaboration on the Comparative Effectiveness of Revascularization Strategies — William S. Weintraub, Maria V. Grau-Sepulveda, Jocelyn Weiss, Sean O’Brien, Eric Peterson, Paul Kolm, Zugui Zhang, Lloyd Klein, Richard Shaw, Charles McKay, Laura Ritzenthaler, Jeffrey Popma, John Messenger, David Shahian, Frederick Grover, John Mayer, Cynthia M. Shewan, Kirk Garratt, Issam Moussa, George Dangas, Fred Edwards, American College of Cardiology, Washington, DC, USA, The Society of Thoracic Surgeons, Chicago, IL, USA
8:15 panel Discussion
8:22 multicenter Randomized Comparative Effectiveness Trial of Cardiac CT versus Alternative Triage Strategies in Acute Chest pain patients in the
Tuesday, March 27, 2012 • ACC.12
ACC.12 Final Program 211
Morning
Emergency Department: Results from the RomiCAT ii Trial — Udo Hoffmann, Quynh Truong, Hang Lee, Eric Chou, Pamela Woodard, John Nagurney, James H. Pope, Thomas Hauser, Charles White, Scott Weiner, Alexander Goehler, Pearl Zakroysky, Ruth Kirby, Douglas Hayden, Stephen Wiviott, Jerome Fleg, Scott Gazelle, David Schoenfeld, James Udelson, Massachusetts General Hospital — Cardiac MR PET CT Program, Boston, MA, USA
8:37 panel Discussion
8:44 Results of the immEDiATE (immediate myocardial metabolic Enhancement During initial Assessment and Treatment in Emergency Care) Trial: A Double-blind Randomized Controlled Trial of intravenous Glucose, insulin, and potassium (GiK) for ACS in Emergency medical Services — Harry P. Selker, Joni R. Beshansky, Patricia R. Sheehan, Robin Ruthazer, John L. Griffith, James E. Udelson, Joseph M. Massaro, Ralph B. D’Agostino, IMMEDIATE Trial Investigators, Tufts Medical Center, Boston, MA, USA
8:59 panel Discussion
9:06 moderate pulmonary Embolism Treated with Thrombolysis (mopETT Study) — Mohsen Sharifi, Curt Bay, Laura Skrocki, Farnoosh Rahimi, Mahshid Mehdipour, Arizona Cardiovascular Consultants, Mesa, AZ, USA, A.T.Still University, Mesa, AZ, USA
9:21 panel Discussion
SpECiAL
SympoSium
739
Joint Session of the European Society of Cardiology and the American College of Cardiology ii: pros and Cons of New Approaches for Antiplatelet and Anticoagulant TherapyTuesday, march 27, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N426CmE/CNE Hours: 1.5
Chair: Marc Steven Sabatine, Boston, MA
8:00 New Anticoagulants — Michael M. Ezekowitz, Wynnewood, PA
8:18 New Antiplatelet Drugs — Christopher B. Granger, Durham, NC
8:36 Value of Functional Testing with Antiplatelet Drugs — Thomas Cuisset, Marseille, France
8:54 Value of Genetic Testing with Antiplatelet and Anticoagulant Drugs — Franz-Josef Neumann, Munich, Germany
9:12 Non-pharmacologic Approaches to Embolic Stroke prevention — Horst Sievert, Frankfurt, Germany
VALV
EXpERTS
260
Aortic Regurgitation/BAVTuesday, march 27, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S504aCmE/CNE Hours: 1.5
Chair: Robert O. Bonow, Chicago, IL
Case Anthony DiScipio, Lebanon, NH, Hector I. Michelena, Presenters: Rochester, MN, Agnès Pasquet, Brussels, Belgium
Panelists: Robert O. Bonow, Chicago, IL, Joseph S. Coselli, Houston, TX, Patrick T. O’Gara, Boston, MA
SpECiAL
SpECiAL
309
ACC.12 Closing Session: innovators in CardiologyTuesday, march 27, 2012, 9:45 a.m. – 11:45 a.m.McCormick Place North, Hall B, ACC.12 Main TentCmE/CNE/CpE Hours: 2 ACpE No. 0012-9999-12-133-L04-p
Chair: David R. Holmes, Jr., Rochester, MN
Panelists: Gary S. Mintz, Washington, DC, Rick A. Nishimura, Rochester, MN, Patrick T. O’Gara, Boston, MA, E. Murat Tuzcu, Cleveland, OH
9:45 innovators in Cardiology: Regenerative Tissue perspective — Kenneth Chien, Boston, MA
10:05 panel Discussion
10:08 innovators in Cardiology: interventional perspective — Martin B. Leon, New York, NY
10:28 panel Discussion
10:31 innovators in Cardiology: Surgical perspective — Michael J. Mack, Plano, TX
10:51 panel Discussion
10:54 innovators in Cardiology: imaging perspective — A. Jamil Tajik, Milwaukee, WI
11:14 panel Discussion
11:17 innovators in Cardiology: Clinical and Translational Research — Application to practice perspective — Robert M. Califf, Durham, NC
11:37 panel Discussion
11:40 Closing Remarks — David R. Holmes, Rochester, MN
ACC.12 • Tuesday, March 27, 2012
Get Your DailY Dose of Quality at aCC.12
©2012 American College of Cardiology. E1204
Learn more about ACC’s quality improvement programs and how you
can get involved during ACC.12
aCC Central (Booth #10027)
American College of CardiologyIndustry Training Program
ACC’s Industry Training Program is helping to enhance and improve your interactions with industry personnel. Comprehensive, thorough and non-biased education will help medical and device representatives to function as your partners — supporting positive outcomes for your patients.
Key components of the ACC Industry Training program include —
• Cardiovascular clinical knowledge• Disease mechanisms• Clinical treatment options• Appropriate industry/professional organization interaction
Look for the Industry Training Seal on your representatives’ business cards.
Visit ACC Central, Booth 10027, or go to www.CardioSource.org/IndustryTraining for more information.
©2
01
2 A
mer
ican
Col
lege
of
Car
diol
ogy
C1
20
6
The European Society of Cardiology presents the world’s premier conference
on the science, management and prevention of cardiovascular disease.
ESC Congress 201225-29 AUGUST
munichG E R M A N Y
This year’s spotlight is “From bench to practice“
Win a free congress registrationScan this QR code (or visit www.escardio.org/esc2012-prizedraw) to enter the prize draw* for a free registration for ESC Congress 2012 in Munich*Rules and regulations available at www.escardio.org
Instructions: 1- Download a free QR code reader (ex: www.getscanlife.com) on to your smartphone 2- Launch the reader3- Scan this QR code with your phone camera.
www.escardio.org
Live interventions
Highly innovative poster area
Interaction with the audience
■ 32 000+ healthcare professionals from 150+ countries ▲ 1200+ faculty from around the globe ● 28 joint sessions organised with professional societies from the 5 continents ▲ 4 200+ abstracts to be presented
2011 Key figures: 5 days of scientific sessions ■ 400+ ESC sessions ▲ 10 800+ abstracts submitted■ 70 industry sponsored sessions ▲200 exhibiting companies ■ + unique & unlimited opportunities to network!
Register before 31 May at www.escardio.org
your next international Cardiology CongressOnly 5 months until
Advance programme now available online
Come see us
at booth
11080
Stay up-to-date with NEW official magazines of the American College of Cardiology — CardioSource WorldNews and CardioSource InterventionalNews! These complimentary, monthly magazines are edgy, provocative and deliver point and counter point perspectives on the latest in cardiovascular research, medicine and technology. Learn the latest advances with:
• Perspectivesfromthoughtleaders
• Debatesonthekeycontroversiesinmedicine
• Practicalinsightsintocomplexclinicaldata—implicationsforyourpractice
Visit www.cswnews.org and www.csinewslive.org to access the electronic versions today.
Stop by ACC CentrAl, booth #10027 to leArn more! ©
2012
American
College
ofC
ardiolog
y.G1
212
Chris’s CornerWelcome to CardioSource World NewsPAGE 2
Jack In The BackCreating the futurePAGE 48
Number CheckInteresting stats and tidbits to ponderPAGE 36
Patient FocusHow you can help your patients with obesity
PAGE 42
IN THIS ISSUE:
CLINICAL NEWS
JANUARY 2012VOLUME 1 | ISSUE 1
www.cswnews.org
PREMIER ISSUEYour Source for News and Views from the World of Cardiology
CardioSource WorldNews
THE
ISFUTURENOWHow new anticoagulants will impact stroke prevention in AF — PAGE 20
Gregg C. Fonarow, MD on Home Monitoring—page 13 Suzanne Oparil, MD
on JNC 8—page 31Steven E. Nissen, MD on Politics vs. Science—page 46
46%Reduction in Incidence of MI
50% Reduction in Sudden Cardiac Deaths
Cardiology Countdown 3JACC in a Flash 8Journal Scan 9ACCEL Summaries 10Hot Topic 13Special Meeting Coverage 14
George’s Take
Life after COURAGE
PAGE 2
Jack In The Back
Problems with
PCI reimbursement
PAGE 48
Number Check
New data points from
NCDR databases
PAGE 36
Novel Techniques:
Grasping transradial
access
PAGE 42
IN THIS ISSUE:
CLINICAL NEWS
MARCH 2012 VOLUME 1 | ISSUE 1
www.cswnews.org
PREMIER ISSUE
Your Source for News and Views from the World of Cardiology
CardioSource InterventionalNews
Stents
in the Elderly—page 18
What ACOs Mean
for Intervention—page 23
The Issue of
Clopidogrel Resistance —page 36
JACC in a Flash 8
Journal Scan 9
Cardiology Countdown 12
ACCEL Intervention 14
Hot Topic 15
The New Frontier:
Will Change Everything
How the Development of TAVI
Save 15% off select educational products and courses purchased on site!
Visit ACC Central, Booth #10027!
©2012 American College of Cardiology. J1204
ACC.12
Author Index
Author Index
Mobile AppPowered by Skyscape
FREE CardioSource Mobile App
The American College of Cardiology and Skyscape are pleased to offer a comprehensive suite of trusted resources for cardiovascular professionals!
Download CardioSource’s most popular and clinically relevant content on your mobile device today for FREE!
Scan the Microsoft Tag or visit http://bit.ly/csapp on your mobile device.
Visit ACC Central, Booth #10027
CardioSource©
2012
Am
eric
an C
olle
ge o
f Car
diol
ogy.
W12
05
Auth
or In
dex
ACC.12 Final Program 217
Aaron, Jacob: 406 · 154
Aaronson, Keith D.: 669 · 168
Aaronson, Susan: 913 – 6 · 143
Abbas, Aamer: 917 · 148
Abbott, Brian G.: 651 · 160
Abdalla, Mohamed I.: 906 – 8 · 110
Abdel-Latif, Ahmed: 917 – 7 · 148
Abdelmoneim, Sahar S.: 929 – 8 · 154
Abdul-Nour, Khaled: 918 – 3 · 148
Abe, Mitsunori: 2504 – 7 · 138
Abidov, Aiden: 918 · 148
Abizaid, Alexandre: 2504 – 11 · 138, 2632 · 184, 2202 · 161, 2509 – 6 · 147, 503 · 188
Abood, Beth: 306 · 186
Abou-Chebl, Alex: 2633 · 189
Abraham, JoEllyn C.M.: 904 – 4 · 141
Abraham, Theodore P.: 259 · 210, 638 · 151, 907 · 142
Abraham, William: 922 – 5 · 150
Abraham, William T.: 614 · 121, 655 · 163, 716 · 201, 690 · 184
Abuzetun, Jamil Y.: 744b · 170
ACCESS EUROPE Investigators: 930 – 3 · 155
Achenbach, Stephan: 924 – 5 · 151, 2625 · 177, 696 · 185, 924 – 7 · 151
Acker, Michael A.: 213 · 122, 681 · 179
Ackerman, Michael J.: 222 · 141, 236 · 169, 648 · 159, 691 · 184
Adams, David H.: 632 · 129
Adams, Kirkwood: 921 – 4 · 150
Adamson, Phillip: 922 – 5 · 150
Addo, Tayo A.: 2509 · 147
Addonizio, Linda: 901 – 5 · 114
Adelstein, Evan C.: 922 – 6 · 150
Adir, Yochai: 912 – 6 · 142
Afonso, Luis: 2306 · 125, 306 · 186, 910 – 6 · 111
Agnihotri, Arvind: 2308 · 156, 2310 · 156
Agostoni, Pierfrancesco: 926 – 5 · 153
Aguilar, David: 203 · 109, 718 · 202, 822 · 198
Ahern, Jeanne: 616 · 122
Ahmad, Tariq: 744a · 170, 921 – 5 · 150
Ahmed, Ali: 225 · 150
Ahmed, Mohamed: 907 – 7 · 142
Ahmed, Mustafa: 234 · 163, 2306 · 125
Ahmed, Waqas: 2509 – 9 · 147
Ahn, Chul: 907 – 4 · 142
Ahn, Chul-Min: 405 · 144
Ahn, Jung-Min: 2645 · 120
Ahn, Young Keun: 917 – 4 · 148, 2505 – 14 · 139, 511 · 188
Ai, Tomohiko: 405 · 144
AI-Mallah, Mouaz: 918 – 3 · 148
Aikawa, Elena: 406 · 154
Akkaya, Mehmet: 918 – 6 · 148
Al Habib, Farida: 746 · 105
Al Suwaidi, Jassim M.: 746 · 105
Al-Khatib, Sana: 904 – 9 · 141, 919 · 149
Al-Mallah, Mouaz: 924 – 5 · 151, 924 – 7 · 151
Al-Mallah, Mouaz H.: 214 · 122, 686 · 180, 818 · 169
Alam, Mahboob: 925 – 6 · 152
Albert, Michelle: 664 · 165
Albert, Nancy M.: 114 · 210, 717 · 202
Alesh, Issa: 306 · 186
Alexander, Jay H.: 660 · 164
Alexander, John: 904 – 9 · 141
Alexander, Karen P.: 645 · 158
Alexanderson, Erick: 513 · 190
Alexis, Jeffrey: 257 · 209
Alexopoulos, Dimitrios: 903 – 4 · 108, 903 – 7 · 108
Alhabib, Khalid F.: 515 · 193
Ali, Ziad: 2508 – 6 · 139
Alizadehasl, Azin: 746 · 105
Alla, Venkata M.: 744b · 170
Allen, Larry A.: 224 · 143, 806 · 123
Alli, Oluseun O.: 2630 · 183
Allison, Thomas: 688 · 182, 929 – 8 · 154
Allocco, Dominic: 2506 – 7 · 146, 2506 – 13 · 146
Almendral, Jesus: 732 · 109, 804 · 118
Almonacid, Alexandra: 2509 – 11 · 147
Alpendurada, Francisco D.: 908 – 4 · 110
Alpert, Joseph S.: 732 · 109, 733 · 114, 734 · 116, 735 · 122, 736 · 125
Alraies, M Chadi: 2301 · 114, 2315 · 189
Alvarez, Paola: 2303 · 115
Alvarez, Rene J.: 717 · 202
Ambar, Sameer: 2310 · 156, 2313 · 189, 2314 · 189
Amin, Alpesh N.: 913 – 5 · 143
Amin, Amit: 2510 – 15 · 140
Amin, Amit P.: 2511 – 13 · 147
Amin, Zahid: 2314 · 189
Amir, Offer: 912 – 6 · 142
Amoroso, Nicholas: 2505 – 10 · 139
Amsterdam, Ezra A.: 231 · 162
Anand, Inder: 680 · 179
Ananthasubramaniam, Karthikeyan: 223 · 142, 813 · 164, 822 · 198, 826 · 203
Anderson, Allen: 2308 · 156
Anderson, Jeffrey: 616 · 122, 712 · 199
Anderson, Jeffrey L.: 513 · 190, 675 · 169
Anderson, Richard E.: 650 · 153
Andrade, Jadelson P.: 503 · 188
Angelini, Paolo E.: 261 · 171
Angelopoulos, Peter: 2620 · 161
Angiolillo, Dominick: 902 – 4 · 107
Angiolillo, Dominick J.: 2617 · 156, 2643 · 201
Anne, Godier: 904 – 8 · 141
Anne-Céline, Martin: 904 – 8 · 141
Anne-Marie, Fischer: 904 – 8 · 141
Annex, Brian H.: 407 · 181
Ansell, Jack: 904 – 9 · 141
Ansell, Jack E.: 747 · 209
Antman, Elliott: 902 – 3 · 107, 902 – 5 · 108
Antman, Elliott M.: 613 · 121, 308 · 210
Antoniucci, David: 903 – 6 · 108
Appelbaum, Evan: 925 – 4 · 152, 925 – 5 · 152
Apple, Fred S.: 728 · 209
Applegate, Robert J.: 2111 · 177, 2305 · 125, 2510 · 139
Aragon, Victor: 2504 – 15 · 138
Arai, Andrew E.: 605 · 116, 682 · 179
Aranda, Juan M.: 234 · 163, 517 · 191
Arbab-Zadeh, Armin: 909 – 8 · 111
Arbel, Yaron: 406 · 154
Arena, Frank J.: 2313 · 189
Arena, Ross: 651 · 160, 929 – 6 · 154
Armstrong, Aimee K.: 637 · 149
Armstrong, Paul: 916 – 5 · 140
Armstrong, Paul W.: 613 · 121, 639 · 156, 639 · 156
Armstrong, William F.: 682 · 179
Arnold, Alice M.: 905 – 5 · 109
Arnold, Suzanne V.: 219 · 128
Aronow, Herbert: 2511 – 15 · 147
Aronow, Herbert D.: 2637 · 195, 2620 · 161, 2633 · 189
Aronow, Wilbert: 907 – 4 · 142
Arora, Natasha P.: 2306 · 125
Arora, Rajat: 2310 · 156, 2313 · 189
Arora, Rajat: 2314 · 189
Arora, Sabeena: 744a · 170
Arrighi, James A.: 103 · 117
Artang, Ramin: 904 – 6 · 141
Arzamendi, Dabit: 2310 · 156, 2314 · 189
Asamoto, Lisa: 908 – 5 · 110
Asch, Federico: 744b · 170
Asgar, Anita W.: 2114 · 194, 504 · 193
Ashfield, Kyle: 919 – 8 · 149
Ashley, Euan: 929 – 6 · 154
Asirvatham, Samuel: 807 · 124
Asirvatham, Samuel J.: 744b · 170
Askew, John W.: 929 · 154
Assenza, M, Gabriele: 925 – 5 · 152
Assenza, Gabriele E.: 925 – 4 · 152
Asset, Gaelle: 911 – 5 · 143
ACC.12
Author Index
218 GO for ACC.12!
Last Name, First Name: Session # · Page #
Author Index • ACC.12
Atallah, Joseph: 262 · 187
ataya, ali: 2301 · 114
Ataya, Ali: 2315 · 189
Atsma, Douwe: 906 – 3 · 109
Attubato, Michael: 931 – 5 · 113
Atz, Andrew: 637 · 149, 901 – 4 · 114
Auger, Dominique: 922 – 8 · 150
Auger, William R.: 514 · 194, 662 · 164
Auguadro, Carla: 914 – 6 · 144
Aurigemma, Gerard P.: 744b · 170
Auseon, Alex J.: 638 · 151, 229 · 159, 805 · 123, 809 · 128, 814 · 164, 818 · 169, 825 · 202
Austin, Patrick W.: 914 – 5 · 144
Austria, Edgar: 932 – 4 · 155
Autore, Camillo: 925 – 5 · 152, 925 – 4 · 152
Aversano, Thomas: 2511 – 9 · 147, 304 · 143
Avraamides, Panayiotis: 2504 · 138, 745 · 203
Awata, Masaki: 2311 · 166
Ayres, Nancy: 693 · 185
Baba, Kenji: 901 – 3 · 114
Babaev, Anvar: 931 – 5 · 113
Babaliaros, Vasilis: 2203 · 194, 2308 · 156, 2619 · 161
Baber, Usman: 2501 · 137, 2508 – 6 · 139, 2501 – 10 · 137
Babu-Narayan, Sonya: 920 – 8 · 149
Bacharach, J. Michael: 2642 · 201, 931 – 8 · 113
Bachmann, Justin M.: 710 · 198, 113 · 193
Badimon, Juan: 902 – 6 · 108
Badri, Marwan: 912 – 4 · 142
Bae, Jang-Ho: 511 · 188, 2505 – 16 · 139
Bae, Jang-Whan: 917 – 4 · 148
Baechler, Courtney: 741 · 187
Baggish, Aaron: 914 – 8 · 144
Baggish, Aaron L.: 603 · 113, 929 – 4 · 154
Bahit, Cecilia: 904 – 9 · 141
Bai, Rong: 925 – 8 · 152
Bailey, Alison: 255 · 204, 746 · 105, 927 · 153
Bailey, Steven R.: 2608 · 119, 2619 · 161, 2122 · 183, 2314 · 189, 923 – 3 · 151
Bairey Merz, C. Noel: 227 · 152, 255 · 204, 620 · 123, 306 · 186
Baker, Joshua: 2308 · 156, 2310 · 156
Baklanov, Dmitri: 2510 – 7 · 139, 2511 – 13 · 147
Bakris, George L.: 631 · 128, 230 · 159, 727 · 210, 745 · 203, 926 · 153
Baldus, Stephan: 930 – 3 · 155, 930 – 6 · 155
Balke, C. William: 107 · 124
Ball, Stephen: 674 · 182
Ballantyne, Christie M.: 227 · 152, 729 · 203, 911 – 3 · 142, 911 – 10 · 143, 306 · 186, 611 · 117, 745 · 203
Baman, Timir: 918 – 3 · 148
Bamberg, Fabian: 909 – 6 · 111
Bandeali, Salman: 925 – 6 · 152
Banerjee, Subhash: 2302 · 114, 823 · 200, 923 · 151
Baran, David: 670 · 168
Baranowski, Bryan: 922 – 7 · 150
Barasch, Eddy: 905 – 6 · 109
Barbash, Israel: 2500 – 15 · 137, 2507 – 15 · 147
Barbeau, Gerald: 2510 – 9 · 139
Barker, Nancy: 920 – 7 · 149
Barman, Neil: 926 – 3 · 153
Baron, Julia: 2314 · 189
Barr, Laurie: 929 – 8 · 154
Barragan, Paul: 2509 – 9 · 147
Barrero, Carlos M.: 502 · 188, 502 · 188
Barrington, Sally: 908 – 3 · 110
Barrows, Kevin: 741 · 187
Bart, Bradley: 655 · 163
Bartoletti, Stefano: 925 – 8 · 152
Bartov, David: 2310 · 156, 2122 · 183
Bartz, Traci: 905 – 6 · 109
Bashir, Riyaz: 514 · 194
Basmadjian, Arsene J.: 930 · 155
Bassand, Jean-Pierre L.: 613 · 121
Bastiaenen, Rachel: 914 – 7 · 144
Batal, Omar: 912 – 5 · 142
Bateman, Michael G.: 407 · 181
Bateman, Timothy M.: 223 · 142
Bates, Eric R.: 200 · 107, 2638 · 196, 2643 · 201, 689 · 184, 2201 · 119, 513 · 190, 817 · 169
Batich, Christopher D.: 906 – 4 · 109
Bauer, Axel: 926 – 6 · 153
Bauer, Marcus: 924 – 4 · 151
Bauer, Wolfgang R.: 918 – 7 · 148
Bauernschmitt, Robert: 2644 · 107
Bax, Jeroen: 922 – 8 · 150
Bax, Matthijs: 2502 – 13 · 119
Bay, Curt: 308 · 210
Bayturan, Ozgur: 2608 · 119
Bdeir, Mohamad B.: 746 · 105
Beanlands, Rob S. B.: 223 · 142
Beaudoin, Jonathan: 406 · 154
Becker, Alexander: 909 – 6 · 111
Becker, Christoph: 909 – 6 · 111
Becker, David J.: 512 · 192
Becker, Richard: 903 – 8 · 108
Becker, Richard C.: 107A · 125, 2301 · 114
Beckman, Joshua A.: 250 · 198, 813 · 164, 743 · 129, 932 · 155
Beek, Aernout: 918 – 4 · 148
Beekman, Robert: 901 – 8 · 114
Beekman, Robert H.: 678 · 178, 901 · 114
Beer, Meinrad: 918 – 7 · 148
Beigel, Roy: 924 – 3 · 151
Belardi, Diego: 918 – 3 · 148
Belardi, Jorge A.: 502 · 188
Belardinelli, Luiz: 921 – 8 · 150
Belcik, Todd: 909 – 4 · 110
Belden, William: 918 – 5 · 148
Beliveau, Mary Ellen: 103 · 117
Belkin, MD, Robert: 907 – 4 · 142
Bell, Malcolm: 623 · 126, 817 · 169
Beller, George A.: 708 · 197
Belziti, Cesar A.: 502 · 188
Ben Dor, Itsik: 915 – 8 · 145
Ben-Dor, Itsik: 2308 · 156, 2500 – 15 · 137, 2507 – 15 · 147, 2639 · 202
Benamer, Hakim: 926 – 7 · 153
Benditt, David G.: 640 · 157
Benitez, R M.: 659 · 163
Benkeser, David: 905 – 5 · 109
Bennett, Mosi K.: 906 – 7 · 110
Bensimhon, Daniel: 929 – 6 · 154
Benson, Lee: 901 – 8 · 114
Berger, Peter B.: 623 · 126, 2301 · 114, 2501 · 137
Bergersen, Lisa: 901 – 8 · 114
Bergersen, Lisa T.: 678 · 178
Bergmeijer, Thomas: 902 – 4 · 107
Bergner, Daniel W.: 406 · 154
Berjeb, Nadia: 915 – 7 · 145
Berkstresser, Brant: 914 – 8 · 144
Berman, Daniel: 924 – 7 · 151
Berman, Daniel S.: 682 · 179, 259 · 210, 740 · 204, 924 – 5 · 151
Bernard, Le-Bonniec: 904 – 8 · 141
Bernhardt, Peter: 908 – 7 · 110, 903 – 3 · 108
Berrocal, Daniel H.: 502 · 188
Berry, Colin: 923 – 9 · 152
Bersin, Robert M.: 2613 · 126, 502 · 188
Bertomeu Martinez, Vicente: 726 · 210
Bertrand, Olivier: 2510 – 9 · 139
Berul, Charles: 625 · 127, 301 · 157
Berwanger, Otavio: 304 · 143
Beshansky, Joni R.: 308 · 210
Bhandare, Deepti: 2306 · 125
Bhargava, Mandeep: 239 · 178
Bhatt, Deepak: 306 · 186, 928 – 3 · 153
Bhatt, Deepak L.: 2627 · 177, 2641 · 200, 107A · 125
Bhatti, Tandeep K.: 233 · 163
Biagini, Elena: 925 – 4 · 152, 925 – 5 · 152
Biddle, W. P.: 744b · 170
Biederman, Robert: 918 – 5 · 148
Biederman, Robert W. W.: 605 · 116, 909 · 110
Biga, Cathleen: 609 · 117, 630 · 128, 673 · 169, 684 · 180, 621 · 123
Bilolikar, A Neil: 2508 – 11 · 139
Bischoff, Joyce: 406 · 154
Bisognano, John D.: 631 · 128
Bittl, John: 629 · 128
Bittner, Vera: 701 · 193, 711 · 199, 709 · 197
Blaha, Michael: 927 –3 · 153
Blaha, Michael J.: 729 · 203
Blankenberg, Stefan: 930 – 6 · 155, 930 – 6 · 155
Blankenship, James C.: 600 · 112, 600 · 112, 2305 · 125
Blankstein, Ron: 208 · 116, 910 – 3 · 111
ACC.12 Final Program 219
Last Name, First Name: Session # · Page #
ACC.12 • Author Index
Blauer, Joshua: 918 – 8 · 148, 918 – 6 · 148
Blauwet, Lori: 240 · 179
Bleiziffer, Sabine: 2507 – 13 · 147
Bliden, Kevin: 2501 – 12 · 137
Block, Peter C.: 2640 · 200, 714 · 199, 2314 · 189
Bloomfield, Gerald S.: 713 · 199
Bluemke, David: 908 – 8 · 110
Blum, Kay: 112 · 180
Blum, Michael S.: 687 · 180
Blumenthal, Roger: 927 –3 · 153
Bo, Yu: 916 – 7 · 140
Bode, Christoph: 507 · 191
Boden, Helèn: 917 – 5 · 148
Boden, William E.: 611 · 117
Bodi, Vicente: 908 – 6 · 110
boersma, eric: 922 – 8 · 150
Bogun, Frank: 918 – 3 · 148
Bohm, Michael: 926 – 4 · 153
Böhm, Michael: 2509 – 7 · 147
Bohula, Erin: 234 · 163, 259 · 210
Bolli, Roberto: 300 · 112
Bolling, Steven F.: 220 · 129, 2640 · 200, 681 · 179, 2105 · 171
Bolorunduro, Oluwaseyi: 408 · 187
Bonaca, Marc: 902 – 3 · 107
Bonan, Raoul: 2114 · 194, 246 · 187, 2626 · 177, 1607 · 205, 2308 · 156
Bonanad, Clara: 908 – 6 · 110
Bonello, Beatrice: 920 – 8 · 149
Bonow, Robert O.: 260 · 211, 606 · 116, 658 · 163, 107A · 125, 710 · 198
Booker, Julian: 2306 · 125
Boon, Nicholas A.: 407 · 181
Boothroyd, Derek: 903 – 5 · 108
Borden, William: 928 – 8 · 154
Borer, Jeffrey S.: 674 · 182
Borgia, Francesco: 916 – 5 · 140
Borlaug, Barry: 203 · 109, 821 · 197
Borlaug, Barry A.: 406 · 154
Bosa, Francisco: 2504 – 15 · 138
Bosmans, Johan: 2644 · 107
Botker, Hans E.: 916 – 4 · 140, 689 · 184
Bouchard, Alain: 2506 – 13 · 146
Bouchard, Marie-Pier: 2510 – 9 · 139
Boudreault, Jean-Rock: 2510 – 9 · 139
Bouleti, Claire: 930 – 5 · 155
Boura, Judy A.: 929 – 7 · 154
Bourge, Robert C.: 649 · 159, 517 · 191, 717 · 202
Bouvier, Erik: 2500 – 13 · 137, 407 · 181
Bove, Alfred A.: 302 · 165, 647 · 159, 688 · 182
Boxt, Lawrence M.: 683 · 180
Boyce, Steven: 2500 – 15 · 137, 2507 – 15 · 147
Boyle, Andrew: 694 · 185
Boyle, Noel G.: 216 · 126
Bozkurt, Biykem: 617 · 122, 626 · 127, 718 · 202, 816 · 166, 906 · 109
Bradley, Scott: 901 – 4 · 114
Brady, Peter A.: 306 · 186, 820 · 192
Branch, Kelley: 683 · 180
Brandwein, Russell A.: 2105 · 171
Brar, Somjot S.: 211 · 121
Braun, Lynne: 114 · 210, 698 · 186, 733 · 114
Braunwald, Eugene: 300 · 112, 400 · 106, 656 · 163, 902 – 3 · 107, 902 – 5 · 108, 916 – 8 · 140
Brecker, Stephen: 2644 · 107
Brener, Sorin J.: 2634 · 190, 916 – 4 · 140
Brennan, J. Matthew: 915 – 5 · 145, 928 – 5 · 154
Brethauer, Stacy: 306 · 186
Brignole, Michele: 306 · 186
Brilakis, Emmanouil: 2302 · 114
Brilakis, Emmanouil S.: 2201 · 119, 2504 · 138, 2629 · 183, 2639 · 202, 804 · 118
Brin, Kenneth P.: 600 · 112
Brindis, Ralph G.: 721 · 204, 516 · 192, 674 · 182
Brinker, Jeffrey: 909 – 8 · 111
Briole, Nicolas: 2502 – 9 · 119
Bristow, Michael R.: 104 · 117
Broberg, Craig S.: 202 · 108
Brochet, Eric: 930 – 5 · 155
Brockmann, Gernot: 2507 – 13 · 147
Brodie, Bruce: 2501 – 6 · 137, 2501 – 10 · 137, 2501 – 14 · 138, 2501 – 16 · 138
Brodie, Bruce R.: 2638 · 196
Brodt, Chad R.: 408 · 187
Brophy, James M.: 200 · 107, 653 · 162
Brosh, Sella: 924 – 3 · 151
Brown, Alan S.: 699 · 186
Brown, III, Charles L.: 621 · 123
Brown, David W.: 634 · 141
Brown, Patricia: 902 – 4 · 107
Brugaletta, Salvatore: 2503 – 13 · 146, 910 – 4 · 111
Brunken, Richard C.: 407 · 181
Brush, John E.: 219 · 128, 224 · 143, 609 · 117, 744a · 170
Bruyne, Bernard D.: 923 – 9 · 152
Bryant, Randall M.: 625 · 127, 667 · 167
Bryson, Christopher: 928 – 3 · 153
Buchanan, Kyle: 912 – 5 · 142
Buchbinder, Maurice: 2614 · 140
Budoff, Matthew: 924 – 7 · 151, 927 –3 · 153, 930 – 7 · 155
Budoff, Matthew J.: 644 · 158, 683 · 180, 924 – 4 · 151, 924 – 5 · 151, 308 · 210
Bui, Quang T.: 2612 · 125, 2313 · 189
Bukartyk, Jan: 406 · 154
Bukhman, Gene: 713 · 199
Buller, Harry R.: 305 · 181
Bullones, Juan A.: 2504 – 15 · 138
Bumpus, Sherry: 699 · 186
Buonamici, Piergiovanni: 903 – 6 · 108
Burgon, Nathan: 918 – 6 · 148
Burke, David A.: 2509 – 11 · 147
Burke, Martin C.: 216 · 126
Burke, Michael A.: 744b · 170
Burkhart, Harold M.: 210 · 118, 632 · 129
Burnett, John C.: 728 · 209
Burwash, Ian G.: 258 · 210
Bush, David E.: 664 · 165
Bush, Ruth: 743 · 129
Busman, Denise K.: 2104 · 165
Butler, Javed: 617 · 122, 906 · 109
Butter, Christian: 930 – 3 · 155
Buxton, Alfred E.: 715 · 201, 501 · 190
Buz, Semih: 676 · 178
Byrd, III, Benjamin F.: 657 · 163
Byrd, Charles L.: 624 · 126
Byrne, Barry: 300 · 112
Byrne, Barry J.: 906 – 4 · 109
Byrne, Robert: 2503 – 9 · 146
Byrne, Robert A.: 2645 · 120
Cademartiri, Filippo: 924 – 5 · 151, 924 – 7 · 151
Caiati, Carlo: 909 – 3 · 110
Calabresi, Marco: 2644 · 107
Calcagno, Simone: 2644 · 107
Caldarone, Christopher: 692 · 184, 901 – 3 · 114
Califf, Robert M.: 107A · 125, 300 · 112, 309 · 211, 746 · 105
Calkins, Hugh: 666 · 167, 703 · 196, 720 · 203
Callans, David: 212 · 121
Callister, Tracy: 924 – 5 · 151, 924 – 7 · 151
Calvino, Ramon: 2504 – 15 · 138
Camacho, Fabian T.: 910 – 7 · 111
Camm, A. John: 654 · 162, 702 · 196, 747 · 209
Campbell, Robert: 244 · 185
Canali, Emanuele: 2644 · 107
Cannon, Bryan C.: 252 · 201, 667 · 167
Cannon, Christopher: 916 – 8 · 140
Cannon, Christopher P.: 2634 · 190, 107A · 125
Cannon, Louis: 2506 – 7 · 146
Cano, Manuel: 2506 – 15 · 146
Canobbio, Mary: 679 · 179
Canter, Charles: 901 – 5 · 114
Cantor, Warren: 916 – 5 · 140
Capizzi, Jeffrey A.: 911 – 9 · 143
Capodanno, Davide: 2627 · 178, 2302 · 114, 2511 · 147
Caputo, Ronald: 2505 – 8 · 138
Carabello, Blase A.: 2636 · 195, 652 · 160, 681 · 179, 210 · 118
Carballo, Mariana: 304 · 143
Carlson, Eric B.: 104 · 117
Carr, James C.: 208 · 116
Carrabba, Nazario: 903 – 6 · 108
Carrie, Didier: 2506 · 146
Carrié, Didier: 2506 – 13 · 146
220 GO for ACC.12!
Last Name, First Name: Session # · Page #
Author Index • ACC.12
Carroll, John: 2507 – 9 · 146
Carrozza, Joseph: 2505 – 8 · 138
Carson, Andrew R.: 2644 · 107
Carson, Peter: 922 – 5 · 150
Caruthers, Shelton D.: 259 · 210
Carvalho, Ana L.: 911 – 8 · 143
Casale, Paul: 673 · 169, 673 · 169
Casali, Valentina: 914 – 6 · 144
Casella, Michela: 925 – 8 · 152
Casella-Filho, Antonio: 911 – 8 · 143
Casey, Donald E.: 226 · 152
Cassater, Daiana: 920 – 7 · 149
Cassel, Graham: 2509 – 9 · 147
Casserly, Ivan P.: 2620 · 161
Cavalcanti, Alexandre: 304 · 143
Cavender, Matthew: 2502 – 11 · 119
Cavendish, Jeffrey J.: 811 · 158
Cedarholm, John: 2502 – 7 · 119
Celada, Silvia: 914 – 6 · 144
Cercek, Bojan: 211 · 121
Cerisano, Giampaolo: 903 – 6 · 108
Cerqueira, Manuel D.: 407 · 181
Chae, In-Ho: 304 · 143
Chae, Jei Keon: 2505 – 14 · 139
Chae, Shung Chull: 2505 – 14 · 139
Chagas, Antonio C.: 503 · 188
Chakravarty, Saneka: 744a · 170
Challa, Karthik: 2311 · 166
Champion, Hunter C.: 662 · 164
Chan, David C.: 913 – 4 · 143
Chan, Paul: 205 · 112, 209 · 117, 408 · 187
Chan, Raymond: 925 – 4 · 152
Chan, Raymond H.: 925 – 5 · 152
Chandra, Navin: 914 – 7 · 144
Chang, Tara I.: 2511 – 11 · 147
Charaf, Edriss: 744b · 170
Chareonthaitawee, Panithaya: 223 · 142
Charles marc, Samama: 904 – 8 · 141
Chase, Paul: 929 – 6 · 154
Chatterjee, Saurav: 408 · 187
Chaturvedi, Seemant: 2631 · 183
Chaudhry, Farooq A.: 628 · 127
Chaustre, Fabian: 908 – 6 · 110
Chazal, Richard A.: 248 · 198, 302 · 165, 512 · 192
Cheema, Asim: 2644 · 107
Chehab, Bassem M.: 932 – 4 · 155
Chen, Chih-Ying: 922 – 4 · 150
Chen, Edmond: 903 – 8 · 108
Chen, James: 2507 – 9 · 146
Chen, Jiyan: 505 · 188
chen, lucia: 914 – 4 · 144
Chen, Michael: 230 · 159, 722 · 204
Chen, Peng-Sheng: 405 · 144
Chen, Stephen Y.: 2302 · 114
Cheng, Victor: 924 – 5 · 151, 924 – 7 · 151
cherukupalli, Raghu: 2311 · 166
Cheung, Anson: 2644 · 107
Chevalier, Bernard: 2500 – 13 · 137, 2503 – 13 · 146, 407 · 181
Chhatriwalla, Adnan: 2510 – 15 · 140, 2501 – 8 · 137, 2511 – 13 · 147
Chicos, Alexandru B.: 406 · 154
Chieffo, Alaide: 2202 · 161, 2503 · 145, 2625 · 177
Chien, Kenneth: 309 · 211
Childs, Susan: 113 · 193
Chin, Derek: 2314 · 189
Chin, Michael T.: 405 · 144
Chinnaiyan, Kavitha: 924 – 5 · 151, 924 – 7 · 151
Chipkin, Stuart: 911 – 9 · 143
Chiribiri, Amedeo: 908 – 3 · 110
Chisholm, Robert: 2644 · 107
Chiswell, Karen: 921 – 5 · 150
Chitwood, W. Randolph: 504 · 193, 674 · 182
Cho, Ae Shin: 917 – 4 · 148
Cho, Hyang Hee: 917 – 4 · 148
Cho, Jinman: 2608 · 119
Cho, Myeong Chan: 2505 – 14 · 139
Cho, Myeong-Chan: 917 – 4 · 148
Choi, Andrew: 744b · 170
Choi, Byoung Geol: 2505 – 12 · 139
Choi, Cheol Ung: 2505 – 12 · 139
Choi, Donghoon: 2508 – 9 · 139, 2644 · 107
Choi, Jin-Ho: 2504 – 13 · 138
Choi, Seung Cheol: 405 · 144
Choi, Seung-Hyuk: 2504 – 13 · 138
Chou, Eric: 308 · 210
Choudhury, Anirban: 2505 – 6 · 138
Choudhury, Lubna: 233 · 163
Chow, Benjamin: 924 – 7 · 151
Chow, Benjamin J.: 924 – 5 · 151
Chow, Benjamin J. W.: 696 · 185
Chow, Marcus W.: 407 · 181
Chowdhary, Saqib: 304 · 143
Chris, Feindel: 2644 · 107
Christenson, Robert: 905 – 4 · 109
Christiansen, Evald: 2506 – 11 · 146
Christie, Catherine: 235 · 164
Christman, Karen L.: 627 · 127
Chronos, Nicolas A. F.: 633 · 129
Chrysohoou, Christine: 931 – 3 · 113
Chu, Victor: 2644 · 107
Chua, Terrance: 905 – 8 · 109
Chugh, Atul: 908 – 8 · 110
Chugh, Sumeet: 691 · 184, 702 · 196
Chung, Eugene: 922 – 5 · 150
Chung, Eugene H.: 688 · 182
Chung, Mina: 243 · 184, 904 – 4 · 141, 922 – 7 · 150
Churchwell, Keith B.: 684 · 180
Cigarroa, Joaquin: 629 · 128, 910 · 111
CIMADEVILLA, Claire: 915 – 7 · 145
Clack, Lucy: 2645 · 120
Claessen, Bimmer E.: 2502 · 119
Clair, Daniel G.: 2637 · 195
Clark, Michael G.: 731 · 142
Clarkson, Priscilla M.: 911 – 9 · 143
Clayton, Tim: 2501 – 10 · 137
Clegg, Stacey D.: 2507 – 9 · 146
Cleland, John G. F.: 207 · 116
Clement-Guinaudeau, Stephanie: 406 · 154
Clever, Yvonne P.: 2509 – 7 · 147
Clouse, Melvin: 909 – 8 · 111
Clyne, Christopher: 919 – 5 · 149
Coelho-Filho, Otavio: 922 – 3 · 150
Cogle, Christopher: 300 · 112
Cohen, David: 2510 – 15 · 140, 2511 – 13 · 147
Cohen, David J.: 2636 · 195, 665 · 167, 503 · 188, 928 · 153
Cohen, Howard: 2510 – 13 · 140
Cohen, Marc: 623 · 126
Cohen, Mauricio G.: 2122 · 183
Cohen, Meryl: 724 · 209
Cohen-Solal, Alain: 680 · 179
Cohn, Lawrence H.: 401 · 124
Colan, Steven: 901 – 5 · 114
Cole, Stephanie M.: 911 – 9 · 143
Collier, Kevin: 2502 – 7 · 119
Collins, Tyrone J.: 2623 · 166
Colombo, Antonio: 2504 – 11 · 138, 2644 · 107, 400 · 106, 404 · 199
Comerota, Anthony J.: 2607 · 115, 2631 · 183, 2637 · 195
Comhair, Suzy: 912 – 8 · 142
Connolly, Stuart: 904 – 5 · 141, 904 – 7 · 141
Connor, Jean A.: 616 · 122
Conrad, Gibby: 907 – 5 · 142
Conrad, Michael J.: 905 – 7 · 109
Contant, Charles: 916 – 8 · 140
Conte, Michael S.: 2613 · 126, 2623 · 166
Conti, C. Richard: 214 · 122
Cook, E. Francis: 925 – 4 · 152
Cook, Earl Francis: 925 – 5 · 152
Cook, Stephen C.: 679 · 179
Cook, Thomas: 407 · 181
Cooke, Blaire: 923 – 4 · 151
Cooper, Christopher J.: 2627 · 177
Cooper, Leslie T.: 240 · 179, 720 · 203, 925 – 3 · 152
Cooper-Dehoff, Rhonda M.: 733 · 114
Cooper-DeHoff, Rhonda M.: 629 · 128, 663 · 165, 698 · 186, 731 · 142
Copeland, Hannah: 408 · 187
Copeland, Jack: 408 · 187
Coppens, Michiel: 904 – 5 · 141
Corcos, Thierry: 2627 · 178
Cormier, Bertrand: 2500 – 13 · 137, 407 · 181
ACC.12 Final Program 221
Last Name, First Name: Session # · Page #
ACC.12 • Author Index
Cornel, J.H.: 903 – 8 · 108
CORONARY Study Investigators: 305 · 181
Corrado, Domenico: 603 · 113
Corriveau, Nicole: 913 – 6 · 143
Corso, Paul: 2500 – 15 · 137, 2507 – 15 · 147
Corvaja, Nicola: 2310 · 156
Coselli, Joseph S.: 260 · 211
Costa, Jr., J. Ribamar: 2504 – 11 · 138
Costa, José de Ribamar: 2506 – 15 · 146
Costa, Marco A.: 2111 · 177, 2639 · 202, 2201 · 119, 2303 · 115
Costa, Ricardo: 2506 – 15 · 146
Costa, Ricardo A.: 2504 – 11 · 138
Costa, Salvatore: 256 · 204, 612 · 118, 814 · 164
Costantini, Costantino: 2309 · 156
Costanza, Salvatore: 906 – 5 · 110
Costanzo, Maria Rosa: 617 · 122
Côté, Mélanie: 915 – 6 · 145
Cotter, Gadi: 680 · 179
Cotts, William: 2315 · 189
Courchesne, Paul: 905 – 3 · 109
Coutinho, Thais: 407 · 181
Cowart, Pam: 922 – 5 · 150
Cowger, Jennifer: 694 · 185
Cox, David: 2501 – 10 · 137, 2501 – 14 · 138, 2501 – 16 · 138
Cox, David A.: 604 · 115, 2309 · 156
Coylewright, Megan: 744b · 170
Crawford, Michael H.: 308 · 210, 920 · 149
Crawford, Thomas: 918 – 3 · 148
Crawford, Thomas C.: 713 · 199
Crean, Andrew: 925 – 4 · 152, 925 – 5 · 152
Cremers, Bodo: 2509 – 7 · 147
Cribier, G. Alain: 2606 · 115, 2203 · 194, 305 · 181
Crispino, Caroline: 923 – 4 · 151
Cristea, Ecaterina: 916 – 4 · 140, 2501 – 14 · 138, 2501 – 16 · 138, 2508 – 15 · 139, 304 · 143
Cross, Russell R.: 901 – 7 · 114
Crossley, George H.: 243 · 184, 614 · 121
Crowley, Kevin: 916 – 8 · 140
Cueff, Caroline: 915 – 7 · 145
Cui, Lianqun: 2645 · 120
Cuisset, Thomas: 739 · 211
Cummings, Jennifer E.: 716 · 201
Cuni, Rezarta: 2503 – 9 · 146
Curb, J D.: 904 – 4 · 141
Currier, Jesse: 917 · 148
Curtis, Anne: 904 – 4 · 141
Curtis, Anne B.: 207 · 116, 239 · 178
Curtis, Jeptha P.: 919 – 4 · 149
Cury, Ricardo C.: 696 · 185
Cushman, William C.: 631 · 128
Cutlip, Donald: 2645 · 120
Cuttica, Michael: 249 · 198
D’Agostino, Ralph B.: 700 · 186, 308 · 210
D’Elia, Emilia E.: 914 – 6 · 144
Dager, William: 623 · 126
Dagogo-Jack, Samuel: 711 · 199, 711 · 199
Dai, Dadi (David): 928 – 5 · 154
Dal-Bianco, Jacob: 406 · 154
Damal, Kavitha: 918 – 6 · 148
Damelou, Anastasia: 903 – 7 · 108
Damiano, Ralph J.: 1607 · 205, 509 · 190
Damman, Peter: 2502 – 13 · 119
Damp, Julie: 204 · 110, 695 · 185
Danciu, Sorin: 2303 · 115
Dandel, Michael: 921 – 7 · 150
Daneault, Benoit: 2500 – 11 · 137, 2507 – 11 · 146
Dangas, George: 2508 – 6 · 139, 2501 – 6 · 137, 2501 – 10 · 137, 308 · 210
Dangas, George D.: 2627 · 178, 2632 · 184, 2638 · 196, 646 · 155, 2644 · 107, 304 · 143, 510 · 193, 745 · 203
Daniels, Curtis J.: 202 · 108, 668 · 168
Danik, Jacqueline S.: 911 – 6 · 143
Danik, Stephan: 922 – 3 · 150
Danoff, Ann: 2505 – 10 · 139
Darbar, Dawood: 702 · 196
Darst, Jeffrey: 692 · 184
Datta, Saurabh: 907 – 8 · 142
Daubeney, Piers E. F.: 692 · 184
Daubert, James: 919 – 6 · 149
Daubert, James P.: 704 · 196, 690 · 184
Dauerman, Harold L.: 2624 · 167, 722 · 204, 2305 · 125
Daugherty, Stacie L.: 245 · 185, 928 – 6 · 154
Davendralingam, Natasha: 908 – 4 · 110
Davidson, Brian: 909 – 4 · 110
Davidson, Charles J.: 2201 · 119, 2310 · 156
Davidson, Karina: 910 – 5 · 111
Davidson, Michael: 911 – 10 · 143
Davidson, Michael H.: 611 · 117
Davidson, William R.: 668 · 168, 920 · 149
Davies, Justin E.: 923 – 6 · 152
Davis, David: 106 · 123
Davis, Suresh: 2311 · 166
Davlouros, Periklis: 903 – 4 · 108, 903 – 7 · 108
Dawkins, Keith: 2506 – 7 · 146, 2506 – 13 · 146, 910 – 4 · 111
Dawn, Buddhadeb: 932 – 4 · 155
de Belder, Mark A.: 508 · 191
de Bruyne, Bernard: 2503 – 13 · 146, 916 – 4 · 140
De Bruyne, Bernard: 2508 – 7 · 139, 2511 – 7 · 147
De Carlo, Carlotta: 2644 · 107
De Caterina, Raffaele: 904 – 9 · 141
De Cecco, Carlo Nicola: 925 – 4 · 152, 925 – 5 · 152
De Ferranti, Sarah: 247 · 196
de la Torre Hernandez, Jose: 2625 · 177, 2504 – 15 · 138
de Lemos, James: 913 – 7 · 143
De Lemos, James A.: 653 · 162, 710 · 198, 1605 · 171, 911 · 142
De Marco, Teresa: 649 · 159, 705 · 196
De Michelis, Nathalie: 907 – 8 · 142
De Schutter, Alban: 927 – 5 · 153
de Vries, Antoine: 906 – 3 · 109
de Vries, Ton: 910 – 4 · 111
de Waha, Antoinette: 2645 · 120
de Waha, Suzanne: 902 – 8 · 108
de Winter, Robbert: 2502 – 13 · 119
Dearani, Joseph A.: 2615 · 148, 625 · 127, 661 · 164
Dec, G. William: 680 · 179
Decker, Carole: 2501 – 8 · 137
Deedwania, Prakash C.: 207 · 116
Deering, Thomas F.: 690 · 184
DeFilippi, Christopher: 905 – 6 · 109
DeFilippi, Christopher R.: 905 – 4 · 109
Degertekin, Muzaffer: 2639 · 202, 518 · 189
Dehmer, Gregory J.: 2104 · 165
Deitelzweig, Steven: 913 – 5 · 143
Del Nido, Pedro: 724 · 209
DeLa Rochellière, Robert: 2510 – 9 · 139
Delafontaine, Patrice: 916 – 6 · 140
Delago, Augustin: 924 – 5 · 151
DeLago, Augustin: 924 – 7 · 151
Delaney, Joseph: 924 – 4 · 151
Delaney, Joseph A.: 930 – 7 · 155
DeLarochellière, Robert: 2644 · 107, 915 – 6 · 145
Delewi, Ronak: 2502 – 13 · 119, 918 – 4 · 148
Delgado, Juan: 517 · 191
Delgado, Victoria: 2618 · 161, 922 – 8 · 150
Deliargyris, Efthymios: 2501 – 10 · 137
Della Rocca, Domenico G.: 906 – 4 · 109
Delli Fraine, Jami: 928 – 7 · 154
Dello Russo, Antonio: 925 – 8 · 152
Deluca, Carlos: 2310 · 156
DeMaria, Anthony N.: 610 · 117, 633 · 129, 111 · 159, 400 · 106, 740 · 204
Dembrink, Jan Henk: 304 · 143
DeNofrio, David: 213 · 122, 641 · 157
DePuey, III, E. Gordon: 658 · 163, 708 · 197
Dery, Jean-Pierre: 2510 – 9 · 139, 2624 · 167, 903 – 8 · 108
Dery, Ugo: 2510 – 9 · 139
Desai, Akshay S.: 732 · 109, 234 · 163, 718 · 202, 517 · 191, 806 · 123, 921 · 150
Desai, Milind Y.: 648 · 159, 619 · 122, 2612 · 125
Desai, Shashank: 694 · 185
Desch, Steffen: 902 – 8 · 108
DeSilva, Kalpa: 2645 · 120
Deswal, Anita: 203 · 109
DeVarennes, Benoit: 2644 · 107
Devendra, Ganesh: 920 – 6 · 149
Dewey, Marc: 909 – 8 · 111
Dewey, Todd M.: 246 · 187, 2606 · 115, 1607 · 205, 2102 · 160
Dey, Damini: 924 – 5 · 151
222 GO for ACC.12!
Last Name, First Name: Session # · Page #
Author Index • ACC.12
Dhar, Ritesh: 223 · 142
Di Biase, Luigi: 677 · 178, 925 – 8 · 152
Di Carli, Marcelo: 910 – 3 · 111
Di Carli, Marcelo F.: 223 · 142
Di Mario, Carlo: 916 – 5 · 140, 2505 · 138, 923 – 6 · 152
Diamond, Robin: 248 · 198
Dias, Clapton: 923 – 4 · 151
Dib, Nabil: 610 · 117, 618 · 121
DiCarlo, Lorenzo: 911 – 10 · 143
Dickerson, Jennifer: 204 · 110
Dieter, Robert S.: 2305 · 125
Dietz, Harry: 908 – 8 · 110
Dill, Karin: 619 · 122
Diller, Gerhard-Paul: 920 – 5 · 149, 920 – 8 · 149
Dilsizian, Vasken: 619 · 122, 658 · 163, 708 · 197
Dimas, Alexios P.: 2510 · 139
Dimitriadis, K.: 926 – 8 · 153
Dimopoulos, Konstantinos: 920 – 5 · 149
Ding, Jingzhong: 927 –3 · 153
Dion, Robert: 652 · 160
DiSciascio, Germano: 2511 · 147
DiScipio, Anthony: 260 · 211
Dixon, Simon: 2508 – 11 · 139
Dixon, Simon R.: 2639 · 202, 2121 · 177, 2315 · 189
Djousse, Luc: 905 – 5 · 109
Dobesh, Paul: 734 · 116
Dodson, John A.: 919 – 4 · 149
Doevendans, P.: 926 – 5 · 153
Dogan, Ozgen: 2506 · 146
Doh, Joon Hyung: 2303 · 115
Doherty, Caroline L.: 2104 · 165
Dohi, Tomoharu: 2311 · 166
Donzeau-Gouge, Patrick: 2500 – 13 · 137
Donzeau-Gouge, Patrik: 407 · 181
Dorange, Cecile: 2503 – 11 · 146, 2503 – 13 · 146
Dorbala, Sharmila: 223 · 142, 910 – 3 · 111
Dorian, Paul: 904 – 5 · 141
Dörner, Jonas: 917 – 3 · 148
Dote, Yoko: 2309 · 156
Douglas, Pamela: 915 – 5 · 145
Douglas, Pamela S.: 644 · 158, 710 · 198, 107A · 125
Dovellini, Emilio Vincenzo: 903 – 6 · 108
Downey, William: 2502 – 7 · 119
Doyle, Daniel: 2644 · 107
Doyle, Daniel: 915 – 6 · 145
Doyle, Mark: 918 – 5 · 148
Drachman, Douglas E.: 2610 · 120, 2627 · 177, 2637 · 195, 734 · 116, 737 · 169, 812 · 158, 825 · 202
Drazner, Mark H.: 922 · 150
Dressler, Ovidiu: 2508 – 15 · 139, 916 – 4 · 140
Drozda, Joseph P.: 710 · 198
Du, Wei: 408 · 187
Du-Russel-Weston, Jean: 913 – 6 · 143
Dubin, Anne M.: 603 · 113
Dudek, Dariusz: 2503 – 15 · 146
Duess, Mai-Ann: 405 · 144
Duffy, Peter: 2501 – 14 · 138, 2501 – 16 · 138
Dumesnil, Jean: 2644 · 107
Dumesnil, Jean G.: 238 · 171, 256 · 204
Dumont, Eric: 2644 · 107, 915 – 6 · 145
Dumonteil, Nicolas: 2500 · 137
Dunlap, Stephanie: 921 – 4 · 150
Dunn, Steven P.: 733 · 114
Dunning, Allison: 924 – 5 · 151, 924 – 7 · 151
Dupont, Matthias: 912 – 7 · 142
Duprez, Daniel A.: 727 · 210, 406 · 154
Dusek, Jeffery: 741 · 187
Dutka, David: 923 – 7 · 152
Duvernoy, Claire S.: 245 · 185
Dvir, Danny: 2500 – 15 · 137, 2507 – 15 · 147
Dweck, Marc R.: 407 · 181
Dworkin, Lance: 2627 · 177
Dzavik, Vladimir: 2505 – 6 · 138
Eagle, Kim: 2511 – 15 · 147, 913 – 6 · 143, 931 – 8 · 113
Eagle, Kim A.: 231 · 162, 713 · 199, 107A · 125
Eagle, Taylor F.: 913 – 6 · 143
Earing, Michael: 202 · 108, 625 · 127
Easton, J. Donald: 904 – 9 · 141
Ebeid, Makram R.: 506 · 191
Ebell, Wolfram: 921 – 7 · 150
Eberle, Balthasar: 2606 · 115
Economy, Katherine: 679 · 179, 920 – 7 · 149
Edelmann, Frank: 921 – 8 · 150
Edwards, Brooks: 234 · 163
Edwards, Fred: 308 · 210, 915 – 5 · 145
Egidy Assenza, Gabriele: 920 – 7 · 149
Ehle, Gregory: 710 · 198
Eick, Christian: 926 – 6 · 153
Eikelboom, John: 206 · 116, 904 – 5 · 141, 904 – 7 · 141
Einhorn, Bryce: 2510 – 13 · 140
Einstein, Andrew J.: 927 – 4 · 153
Eisenberg, Mark: 920 – 4 · 149
Eitel, Ingo: 902 – 8 · 108
El Etriby, Adel: 746 · 105
El-Omar, Magdi: 304 · 143
Elasfar, Abdelfatah A.: 515 · 193
Elashoff, Michael: 924 – 6 · 151
Elashoff, Michael R.: 923 – 8 · 152
Elbal, Luis: 2509 – 9 · 147
Elhmidi, Yacine: 2507 – 13 · 147
Elkayam, Uri: 695 · 185, 720 · 203, 738 · 181
Ellenbogen, Kenneth A.: 201 · 108, 232 · 162
Elliott, Andrea: 912 – 5 · 142
Elliott, Perry M.: 253 · 203, 648 · 159
Elliott, William: 663 · 165
Ellis, Stephen: 2502 – 11 · 119, 300 · 112, 923 – 8 · 152
Ellis, Stephen G.: 2309 · 156, 2502 · 119, 503 · 188
Elmariah, Sammy: 2308 · 156, 2310 · 156, 2314 · 189, 930 – 7 · 155, 902 – 6 · 108
Elnagar, Amro: 2505 – 12 · 139
Eltchaninoff, Hélène: 2502 – 9 · 119
Eltchaninoff, Helene: 2606 · 115, 2636 · 195
Emanuelsson, Hakan: 902 – 7 · 108
Emert, Jamie: 928 – 7 · 154
Emery, Maurice: 923 – 4 · 151
Emmanuel, Noel: 914 – 7 · 144
Engstrom-Koch, Krysthel: 744a · 170
Enriquez-Sarano, Maurice: 246 · 187, 2609 · 120, 2640 · 200, 612 · 118, 632 · 129, 674 · 182, 814 · 164, 915 – 3 · 145
Entrikin, Daniel: 305 · 181
Epstein, Andrew E.: 201 · 108, 239 · 178, 703 · 196, 716 · 201, 655 · 163
Epstein, Laurence M.: 624 · 126
Erb, Blair D.: 219 · 128, 244 · 185, 601 · 112, 609 · 117, 710 · 198
Erbel, Raimund: 924 – 4 · 151
Erbel, Raimund A.: 2632 · 184, 507 · 191
Ergene, Oktay: 518 · 189
Erlinge, David: 902 – 4 · 107
Erol, Cetin: 904 – 9 · 141
Ertl, Georg: 507 · 191
Erwin, Phillip: 931 – 7 · 113
Eryazici, Paula d.: 2303 · 115
Erzurum, Serpil C.: 912 – 8 · 142
Escalante, Jose Luis: 906 – 5 · 110
Escaned, Javier: 923 – 6 · 152
Escarcega, Orlando: 507 · 191
Esler, Murray: 926 – 3 · 153
Esler, Murray D.: 926 – 4 · 153
Estep, Jerry: 643 · 158
Estes, N. A. M.: 239 · 178
Evangelista, Artur: 908 – 8 · 110
EVEREST II Investigators: 930 – 4 · 155
Everett, Brendan: 911 – 4 · 143
Everitt, Melanie: 901 – 5 · 114
Exner, Derek V.: 232 · 162, 651 · 160
Ezekowitz, Justin: 904 – 9 · 141
Ezekowitz, Michael M.: 206 · 116, 654 · 162, 677 · 178, 739 · 211
Fadol, Anceta: 642 · 157
Fahy, Martin: 2506 – 9 · 146, 2511 – 7 · 147, 2501 – 6 · 137
Falk, Rodney: 257 · 209, 720 · 203
Falk, Rodney H.: 744b · 170
Fall, Khady: 2309 · 156
Fang, James C.: 203 · 109, 234 · 163, 801 · 105, 807 · 124
Fang, Weiyi: 2645 · 120
Fantana, Gregory P.: 2626 · 177
Farasat, Morteza: 744b · 170
Farge, Arnaud: 2500 – 13 · 137, 407 · 181
Farha, Samar: 912 – 8 · 142
ACC.12 Final Program 223
Last Name, First Name: Session # · Page #
ACC.12 • Author Index
Farhat, Naim: 916 – 4 · 140
Farmer, Jill: 608 · 116
Farooq, Vasim: 910 – 4 · 111, 2503 – 13 · 146
Faruqui, Azhar: 514 · 194
Fasules, James W.: 301 · 157, 650 · 153
Favarato, Desiderio: 911 – 8 · 143
Favero, Luca: 2510 – 11 · 140
Faxon, David P.: 903 · 108
Fearon, William: 923 – 9 · 152, 2508 – 7 · 139
Fearon, William F.: 2113 · 194, 2627 · 178, 2201 · 119
Fedele, Francesco: 2644 · 107
Fedson, Savitri: 670 · 168
Feigenbaum, Harvey: 107A · 125
Feiring, Andrew J.: 2623 · 166, 2642 · 201
Feit, Frederick: 2501 – 10 · 137, 931 – 5 · 113
Feldman, Dmitriy: 928 – 4 · 154
Feldman, Dmitriy N.: 2502 · 119
Feldman, Ted: 2131 · 160, 2203 · 194, 2609 · 120, 2640 · 200, 2644 · 107, 681 · 179, 930 – 4 · 155
Felker, G. Michael: 641 · 157, 617 · 122, 626 · 127
Fenrich, Arnold: 914 – 5 · 144
Ferdinand, Keith C.: 237 · 169, 645 · 158
Ference, Brian A.: 306 · 186, 910 – 6 · 111
Feres, Fausto: 2504 – 11 · 138
Fernandez Diaz, Jose A.: 2504 – 15 · 138
Fernandez-Aviles, Francisco: 916 – 5 · 140
Fernandez-Santos, Mª Eugenia: 906 – 5 · 110
Ferrand, Anne-Catherine: 306 · 186
Fifer, Michael A.: 2612 · 125
Figulla, Hans R.: 2645 · 120, 915 – 4 · 145
Fineberg, Tabitha: 106 · 123
Fitzgerald, Peter: 2645 · 120
Fiuzat, Mona: 921 – 5 · 150
Flack, John: 306 · 186, 910 – 6 · 111
Flaker, Greg C.: 654 · 162, 904 – 7 · 141
Flamm, Scott: 908 – 5 · 110, 920 – 6 · 149
Flato, Uri: 304 · 143
Fleck, Desiree A.: 114 · 210
Fleg, Jerome: 308 · 210
Fleischmann, Dominik: 2635 · 195
Fleischmann, Kirsten E.: 644 · 158
Fletcher, Alison M.: 407 · 181
Fletcher, Barbara: 699 · 186, 701 · 193
Fletcher, Gerald: 701 · 193
Fletcher, Gerald F.: 651 · 160
Flores, Demetrio R.: 407 · 181
Fogel, Richard I.: 654 · 162, 666 · 167, 677 · 178
Foley, David: 902 – 4 · 107
Fonarow, Gregg: 921 – 5 · 150
Fonarow, Gregg C.: 217 · 127, 617 · 122, 717 · 202, 2121 · 177
Fonger, James: 633 · 129
Foody, Joanne M.: 601 · 112, 629 · 128
for the PARTNER Trial Investigators: 2500 – 7 · 137, 2500 – 9 · 137, 305 · 181
Forfia, Paul: 254 · 203, 649 · 159
Forfia, Paul R.: 705 · 196
Forman, Daniel: 929 – 6 · 154
Forman, Daniel E.: 651 · 160, 674 · 182
Formisano, Francesco: 925 – 4 · 152, 925 – 5 · 152
Foster, Elyse: 2622 · 166, 612 · 118, 738 · 181, 930 – 4 · 155
Fox, James: 2511 – 15 · 147
Fox, Keith A. A.: 200 · 107, 2634 · 190
Frackelton, Edward C.: 916 – 8 · 140
Frame, Alissa A.: 405 · 144
francis, darrel: 923 – 6 · 152
Francis, Sanjeev A.: 228 · 157
Francisco, Fernandez-Aviles: 906 – 5 · 110
Franklin, Barry: 929 – 7 · 154
Franklin, Barry A.: 701 · 193
Franklin, Leonardo F.: 906 – 4 · 109
Franklin, Stanley S.: 230 · 159, 727 · 210
Franklin, Wayne J.: 202 · 108
Frantz, Robert P.: 249 · 198
Franzen, Olaf: 2622 · 166, 2640 · 200, 930 – 3 · 155
Freed, Benjamin: 2308 · 156
Freeman, Andrew M.: 601 · 112, 720 · 203
Freeman, Rosario: 237 · 169, 809 · 128, 908 · 110
French, William J.: 2306 · 125
Friedman, Mark: 408 · 187
Friedman, Paul A.: 715 · 201, 715 · 201
Friedrich, Matthias: 228 · 157, 605 · 116
Froehlich, James: 931 – 8 · 113
Froehlich, James B.: 687 · 180, 722 · 204, 727 · 210, 931 · 113
Frost, Kim A.: 914 – 5 · 144
Fu, Guosheng: 2645 · 120
Fuernau, Georg: 902 – 8 · 108
Fujii, Kenichi: 2639 · 202
Fujii, Kenshi: 2303 · 115
Fujimoto, Hajime: 2309 · 156
Fujita, Masashi: 2311 · 166
Fujita, Tsutomu: 2504 – 7 · 138
Fujiwara, Toshiki: 909 – 7 · 111
Furlan, Anthony: 2614 · 140
Fuster, Valentin: 613 · 121, 622 · 123, 713 · 199, 726 · 210, 107A · 125, 400 · 106, 403 · 170, 902 – 6 · 108, 930 – 7 · 155
Gaasch, William H.: 635 · 141
Gafoor, Sameer A.: 744a · 170
Galantowicz, Mark E.: 252 · 201
Galappatthy, Gamini: 2313 · 189
Galassi, Alfredo R.: 2621 · 162
Galati, Anastasia: 903 – 4 · 108, 903 – 7 · 108
Gallardo, Arsenio: 2504 – 15 · 138
Galloway, James M.: 713 · 199
Galper, Benjamin Z.: 927 – 4 · 153
Gan, Li-ming: 902 – 7 · 108
Ganz, Peter: 622 · 123
Gao, Bing: 923 – 4 · 151
Garasic, Joseph M.: 2627 · 177
garbarz, eric: 930 – 5 · 155
Garber, Alan M.: 903 – 5 · 108
Garcia, Ernest V.: 708 · 197
Garcia, Eva M.: 914 – 5 · 144
Garcia, Hector: 910 – 4 · 111
Garcia, Hector M.: 2645 · 120
Garcia, Joel A.: 2629 · 183
Garcia, Lawrence A.: 2633 · 189
Garcia, Mario J.: 744a · 170, 228 · 157, 233 · 163, 638 · 151, 683 · 180, 251 · 199
Garcia Camarero, Tamara: 2504 – 15 · 138
Garcia del Blanco, Bruno: 2504 – 15 · 138
Garcia-Alberola, Arcadio: 726 · 210
Gardin, Julius: 927 – 7 · 153
Gardin, Julius M.: 218 · 127
Garot, Philippe: 2500 – 13 · 137, 2502 – 9 · 119, 407 · 181
GArot, Philippe: 926 – 7 · 153
Garrand, Amanda: 921 – 4 · 150
Garratt, Kirk: 308 · 210
Garrido, Gregorio: 906 – 5 · 110
Garry, Daniel J.: 681 · 179
Garvey, J.: 2502 – 7 · 119
Gaspar-Hernandez, Jorge: 513 · 190
Gassdorf, Johannes: 2645 · 120
Gates-Striby, Linda: 600 · 112, 630 · 128
Gati, Sabiha: 914 – 7 · 144
Gatsonis, Constantine: 305 · 181
Gatzoulis, Michael: 920 – 5 · 149, 920 – 8 · 149
Gavin, Laurence: 305 · 181
Gawaz, Meinrad: 926 – 6 · 153
Gaynor, J. William: 901 – 6 · 114
Gazelle, Scott: 308 · 210
Gaztanaga, Juan: 2310 · 156
Gbadebo, T. David: 664 · 165
Ge, Junbo: 2645 · 120
Ge, Lei: 2645 · 120
Gee, Adrian: 300 · 112
Genereux, Philippe: 2500 – 7 · 137, 2500 – 9 · 137, 2500 – 11 · 137, 2507 – 11 · 146
Gentile, Federico: 691 · 184
George, Isaac: 2500 – 11 · 137, 2507 – 11 · 146
George, Richard T.: 214 · 122, 218 · 127
Gerber, Thomas C.: 305 · 181
Gerckens, Ulrich: 2644 · 107
German Transcatheter Aortic ValveInterventions-Registry Investigators: 915 – 4 · 145
Gersh, Bernard: 2501 – 6 · 137, 2501 – 10 · 137, 904 – 9 · 141
Gersh, Bernard J.: 222 · 141, 645 · 158, 661 · 164, 308 · 210, 737 · 169
Gershlick, Anthony: 902 · 107
Gertz, Morie: 257 · 209
Gertz, Zachary: 2609 · 120
224 GO for ACC.12!
Last Name, First Name: Session # · Page #
Author Index • ACC.12
Geva, Tal: 241 · 179, 920 – 7 · 149
Ghali, Jalal: 921 – 4 · 150
Ghali, Jalal K.: 225 · 150
Ghanem, Alexander: 917 – 3 · 148
Ghani, Saqib: 914 – 7 · 144, 914 – 4 · 144
Ghazzal, Ziyad: 746 · 105
Gheorghiade, Mihai: 626 · 127
Ghoshhajra, Brian: 922 – 3 · 150
Gialafos, Elias: 931 – 3 · 113
Gialde, Elizabeth: 2501 – 8 · 137
Gianguzzi, Robert: 684 · 180
Giannarelli, Chiara: 902 – 6 · 108
Gibbons, Raymond J.: 628 · 127
Gibbs, John: 923 – 4 · 151
Gibson, C. Michael: 2617 · 156, 2638 · 196, 613 · 121, 1605 · 171, 2501 – 10 · 137, 304 · 143, 305 · 181, 925 – 4 · 152, 925 – 5 · 152
Gilbert, Edward: 922 – 5 · 150
Gilchrist, Ian C.: 2624 · 167, 2305 · 125
Giles, Thomas D.: 631 · 128, 663 · 165
Gillam, Linda D.: 707 · 197, 507 · 191
Gillespie, Mathew: 634 · 141, 678 · 178
Gillis, Anne M.: 654 · 162, 666 · 167, 904 · 141, 904 – 3 · 141
Gimeno, Federico: 2504 – 15 · 138
Ginsburg, Geoffrey S.: 602 · 113, 671 · 168
Gitt, Anselm K.: 910 – 8 · 111
Giugliano, Robert P.: 629 · 128, 916-3· 140
Gkizas, Spyridon: 2314 · 189
Gleeton, Onil: 2510 – 9 · 139
Glick, Danielle: 905 – 4 · 109
Gloviczki, Peter: 2613 · 126
Glower, Donald: 930 – 4 · 155
Gnall, Eric: 912 – 4 · 142
Godlewski, Jan: 304 · 143
Goehler, Alexander: 308 · 210
Goel, Kashish: 927 – 6 · 153
Goessl, Mario: 231 · 162
Gogas, Bill D.: 2503 – 13 · 146
Goitein, Orly: 924 – 3 · 151
Goktekin, Omer: 518 · 189
Gold, Michael R.: 704 · 196, 243 · 184
Goldbarg, Seth E.: 744b · 170
Goldberg, Anne C.: 730 · 170
Goldberg, Caren: 913 – 6 · 143
Goldberg, Lee R.: 517 · 191, 660 · 164
Goldberg, Sheldon: 2645 · 120
Goldberg, Steven L.: 2630 · 183, 2131 · 160
Goldberger, Jeffrey J.: 406 · 154, 929 – 5 · 154
Goldhaber, Samuel Z.: 2607 · 115, 107A · 125, 264 · 187, 747 · 209
Goldstein, James: 2508 – 11 · 139
Goldstein, James A.: 2121 · 177
Goldstein, Steven: 2500 – 15 · 137, 2507 – 15 · 147, 915 – 8 · 145
Gollob, Michael H.: 691 · 184
Gomberg-Maitland, Mardi: 249 · 198
Gomes, Antoinette: 908 – 8 · 110
Gomez, Millie: 924 – 7 · 151
Goodlin, Sarah J.: 225 · 150
Goodman, Shaun: 916 – 5 · 140
Goodman, Shaun G.: 653 · 162
Gorcsan, John: 220 · 129, 907 – 7 · 142, 922 – 6 · 150
Gorelick, Phillip B.: 727 · 210
Gornik, Heather: 931 – 8 · 113
Gornik, Heather L.: 264 · 187
Goryo, Yutaka: 2309 · 156
Gottdiener, John: 905 – 4 · 109, 905 – 5 · 109
Gottdiener, John S.: 905 – 6 · 109
Gottlieb, Ilan: 909 – 8 · 111
Grady, Kathleen: 694 · 185
Graham, Dionne: 920 – 7 · 149
Graham, Eric M.: 901 – 4 · 114
Graham, John: 913 – 5 · 143, 916 – 5 · 140
Graham, Jr., Thomas P.: 920 – 3 · 149
Granada, Juan: 2503 · 145, 2505 – 8 · 138
Grando-Ting, Jennifer: 805 · 123
Granger, Christopher: 904 – 9 · 141
Granger, Christopher B.: 739 · 211
Gransar, Heidi: 924 – 5 · 151
Grantham, James A.: 2621 · 162, 2302 · 114, 505 · 188
Grapsas, Nikolaos: 903 – 4 · 108
Grasso, Francesco: 901 – 3 · 114
Grau-Sepulveda, Maria V.: 308 · 210
Gray, Bruce: 931 – 8 · 113
Gray, Huon: 404 · 199, 508 · 191, 740 · 204, 746 · 105
Gray, William A.: 2613 · 126, 2631 · 183, 2311 · 166, 502 · 188, 743 · 129
Grayburn, Paul: 930 – 4 · 155
Grayburn, Paul A.: 204 · 110, 697 · 185, 220 · 129
Greason, Kevin: 238 · 171, 246 · 187, 927 – 6 · 153
Green, Joseph S.: 106 · 123
Green, Philip: 2500 – 11 · 137
Greenbaum, Adam B.: 2111 · 177
Greenberg, Barry H.: 635 · 141
Greenspahn, Bruce: 2315 · 189
Gregg, Anthony: 679 · 179
Greif, Martin: 909 – 6 · 111
Griffin, Brian: 907 – 5 · 142
Griffin, Brian P.: 612 · 118
Griffith, Bartley P.: 681 · 179
Griffith, John L.: 308 · 210
Grigioni, Francesco: 723 · 204
Grimaldi, Adam: 911 – 9 · 143
Grimm, Richard: 907 – 5 · 142
Grines, Cindy L.: 211 · 121, 606 · 116
Grise, Mark: 931 – 8 · 113
Grossbard, Joseph: 911 – 4 · 143
Grossman, P. M.: 932 – 5 · 155
Grover, Frederick: 308 · 210
Grover, Frederick L.: 107A · 125, 674 · 182
Gruner, Christiane: 925 – 4 · 152, 925 – 5 · 152
Gu, Xiaokui: 931 – 8 · 113
Guagliumi, Giulio: 2501 – 6 · 137, 2508 – 15 · 139
Guagliumi, Giulio G.: 2303 · 115
Guang, Xuefeng: 2645 · 120
Guarneri, Erminia: 741 · 187
Guazzi, Marco: 929 – 6 · 154
Guchelaar, Henk-Jan: 917 – 5 · 148
Guerrero, James: 914 – 5 · 144
Guerrero, Luis: 406 · 154
Guglielmotti, Angelo: 2644 · 107
Guglin, Maya E.: 207 · 116, 617 · 122, 680 · 179, 718 · 202, 811 · 158, 905 · 109
Guimaraes, Helio: 304 · 143
Guiry, Michael: 2102 · 160
Gulati, Ankur: 908 – 4 · 110
Gulati, Martha: 255 · 204, 620 · 123, 929 – 8 · 154
Gulseth, Michael: 735 · 122
Guo, Ning: 2625 · 177
Gupta, Kamal: 932 – 4 · 155
Gupta, Sanjaya: 918 – 3 · 148
gupta, saurabh k.: 2310 · 156
Gura, Melanie T.: 736 · 125, 243 · 184, 716 · 201
Gurbel, Paul: 2501 – 12 · 137
Gurbel, Paul A.: 2111 · 177, 2617 · 156, 2643 · 201, 604 · 115
Gurm, Hitinder: 932 – 5 · 155, 2511 – 15 · 147
Gurm, Hitinder S.: 408 · 187, 515 · 193, 721 · 204
Gurm, Roopa: 913 – 6 · 143
Gurvitz, Michelle: 920 – 4 · 149, 202 · 108
Gustafson, Gregory: 744b · 170
Gustavson, Susan: 931 – 7 · 113
Gutierrez, Antonio: 928 – 3 · 153
Gutman, Einat: 924 – 3 · 151
Gutteridge, Daniel: 2301 · 114
Guyton, Robert A.: 305 · 181
Gwon, Hyeon-Cheol: 2504 – 13 · 138, 623 · 126
Ha, Jinyong: 2508 – 9 · 139
Haack-Sørensen, Mandana: 923 – 5 · 151
Haas, Tammy: 925 – 4 · 152, 925 – 5 · 152
Haber, Robert: 2502 – 7 · 119
Habib, Gilbert: 251 · 199
Hachamovitch, Rory: 407 · 181, 218 · 127, 644 · 158, 908 – 5 · 110
Hadamitzky, Martin: 924 – 5 · 151, 924 – 7 · 151
Hagege, Albert A.: 612 · 118
Hahalis, George: 903 – 4 · 108, 903 – 7 · 108
Hahn, Joo-Yong: 2504 – 13 · 138
Hahn, Rebecca: 2500 – 11 · 137, 2507 – 11 · 146
Hahn, Rebecca T.: 2618 · 161, 2622 · 166, 2629 · 183, 643 · 158, 2203 · 194, 2507 – 6 · 146
Hakonarson, Hakon: 916 – 8 · 140
Halkati, Prabhu: 2310 · 156, 2313 · 189
ACC.12 Final Program 225
Last Name, First Name: Session # · Page #
ACC.12 • Author Index
Halkati, Prabhu C.: 2314 · 189
Halkos, Michael E.: 2302 · 114
Hall, Jack: 2506 – 13 · 146
Hall, Jennifer L.: 602 · 113, 671 · 168
Halliburton, Sandra: 696 · 185
Halperin, Jonathan: 930 – 7 · 155
Halperin, Jonathan L.: 735 · 122, 264 · 187, 743 · 129, 747 · 209
halvorsen, Sigrun: 916 – 5 · 140
Hamburg, Naomi: 743 · 129
Hamburg, Naomi M.: 405 · 144
Hamirani, Yasmin: 930 – 7 · 155
Hammill, Stephen C.: 677 · 178, 919 – 4 · 149
Han, Eric: 2310 · 156
Han, Seongwoo: 2505 – 12 · 139
Han, Yaling: 505 · 188
han, zhigang: 916 – 7 · 140
Handberg, Eileen M.: 906 – 4 · 109, 731 · 142, 112 · 180, 237 · 169
Hannan, Edward: 910 – 7 · 111
Hanotin, Corinne: 306 · 186, 911 – 5 · 143
Hansen, Knud: 2506 – 11 · 146
Hanzel, George S.: 2630 · 183
Harahsheh, Ashraf: 901 – 7 · 114
Hare, Joshua M.: 240 · 179
Hargrove, Clark: 632 · 129
Harold, John G.: 609 · 117, 508 · 191, 607 · 116, 738 · 181, 742 · 186
Harrild, David M.: 667 · 167
Harrington, Robert A.: 2641 · 200, 639 · 156, 700 · 186, 107 · 124, 107A · 125, 304 · 143, 639 · 156, 712 · 199
Hart, Robert: 904 – 7 · 141, 904 – 5 · 141
Hart, Stephen A.: 920 – 6 · 149
Harvey, James: 2303 · 115
Hasan, Rani K.: 909 – 8 · 111
Hasenfuss, Gerd: 921 – 8 · 150
Hashimoto, Yukihiro: 2309 · 156
Hassanein, Mahmoud: 746 · 105
Hastings, Jeffrey: 261 · 171
Hatzopoulos, Antonis: 300 · 112
Hauser, Robert G.: 201 · 108, 215 · 123, 919 – 7 · 149
Hauser, Thomas: 308 · 210, 925 – 4 · 152, 925 – 5 · 152
Hausleiter, Joerg: 924 – 5 · 151, 924 – 7 · 151, 930 – 3 · 155
Havranek, Edward P.: 713 · 199
Hawkey, Marian: 238 · 171, 2102 · 160
Hawwa, Nael: 2301 · 114
Hayashida, Kentaro: 2500 – 13 · 137, 407 · 181
Hayden, Douglas: 308 · 210
Hayes, David L.: 201 · 108, 614 · 121, 624 · 126
He, Qing: 2645 · 120
Heath, R. Terry: 226 · 152
Hecht, Harvey S.: 214 · 122, 628 · 127
Hedstrom, Erik: 908 – 3 · 110
Heidenreich, Paul A.: 217 · 127, 239 · 178
Heit, John: 264 · 187
Heitner, Stephen: 2313 · 189
Held, Aaron: 405 · 144
Held, Maria: 2606 · 115
Hellenbrand, William E.: 2615 · 148
Heller, Gary V.: 658 · 163
Hendel, Robert C.: 214 · 122
Henderson, Robert A.: 508 · 191
Henriques, José: 2502 – 13 · 119
Henriques, Jose P.: 2502 · 119, 676 · 178, 676 · 178
Henry, Timothy: 2501 – 14 · 138, 2501 – 16 · 138, 300 · 112, 928 – 7 · 154
Henry, Timothy D.: 2112 · 182, 2638 · 196, 613 · 121, 604 · 115
Henzlova, Milena J.: 708 · 197
Heo, Jung Ho: 2503 – 13 · 146
Hermiller, James B.: 2203 · 194, 2309 · 156
Hermiller, Jr., James B.: 2112 · 182, 2626 · 177
Hernandez, Adrian F.: 224 · 143
Hernandez, Felipe: 2504 – 15 · 138
Herrmann, Howard C.: 2131 · 160, 2202 · 161, 2203 · 194
Hershberger, Ray E.: 236 · 169
Herweg, Bengt: 207 · 116
Hetzer, Roland: 921 – 7 · 150
Hewins, Benjamin: 908 – 4 · 110
Hickey, Edward: 901 – 3 · 114
Higuchi, Koji: 918 – 6 · 148
Hijazi, Ziyad M.: 2615 · 148, 2630 · 183, 2132 · 195, 2132 · 195, 2313 · 189
Hill, Alexander: 2507 – 13 · 147
Hill, Alexander J.: 407 · 181
Hill, Joseph A.: 109 · 128, 710 · 198
Himbert, Dominique: 930 – 5 · 155
Hines, Jerome L.: 226 · 152, 621 · 123
Hirsch, Alan T.: 675 · 169
Hirsch, Alexander: 918 – 4 · 148
Hirsch, Glenn A.: 902 · 107
Hirshfeld, John W.: 2609 · 120, 2306 · 125, 2310 · 156
Hlatky, Mark: 903 – 5 · 108
Hlatky, Mark A.: 671 · 168
Ho, Jennifer: 905 – 3 · 109
Ho, Kalon: 928 – 5 · 154
Ho, Kalon K.L.: 687 · 180
Hochman, Judith S.: 221 · 140, 107A · 125
Hod, Hanoch: 924 – 3 · 151
Hodgson, John M.: 2625 · 177, 2639 · 202, 2201 · 119, 2303 · 115
Hodkinson, Emily: 919 – 8 · 149
Hoercher, Katherine J.: 717 · 202
Hoffmann, Udo: 308 · 210
Hogan, Shea E.: 932 – 5 · 155
Hohnloser, Stefan: 904 – 9 · 141
Hohnloser, Stefan H.: 703 · 196
Höke, Ulas: 922 – 8 · 150
Holbrook, Monika: 405 · 144
Hollander, Judd: 231 · 162, 305 · 181
Hollis, Bruce W.: 901 – 4 · 114
Holmes, David R.: 107A · 125, 300 · 112, 302 · 165, 309 · 211, 504 · 193, 744a · 170, 746 · 105
Holmes, Jr., David R.: 2101 · 156, 300 · 112, 309 · 211, 606 · 116, 610 · 117, 674 · 182, 710 · 198, 723 · 204
Holzer, Ralf: 616 · 122, 901 · 114, 901 – 8 · 114
Hombach, Vinzenz: 903 – 3 · 108
Honda, Yasuhiro: 2611 · 125
Hong, Moon Hwa: 917 – 4 · 148
Hong, Mun K.: 511 · 188
Hong, Myeong-Ki: 2508 – 9 · 139, 2644 · 107, 511 · 188
Hong, Soon Jun: 405 · 144
Hong, Susie: 925 – 5 · 152
Hong-Zohlman, Susie N.: 925 – 4 · 152
Honjo, Osami: 901 – 3 · 114
Hoole, Stephen: 923 – 7 · 152
Hoosain, Jamael: 2310 · 156
Hopkins, L. Nelson: 2618 · 161
Hord, Edward: 903 – 8 · 108
Horie, Minoru: 405 · 144
Horii, Manabu: 917 – 8 · 148
Horlick, Eric: 2644 · 107
Horowitz, John: 904 – 9 · 141
Horwich, Tamara: 718 · 202
Hosseini Khalili, Alireza: 744a · 170
Hou, Jingbo: 916 – 7 · 140, 2611 · 125, 909 – 5 · 111
Hough, Stacyann S.: 929 – 4 · 154
Houghtaling, Penny: 2502 – 11 · 119
House, John: 2510 – 7 · 139, 2510 – 15 · 140, 2511 – 13 · 147
Hovasse, Thomas: 2500 – 13 · 137, 407 · 181
Hsich, Eileen: 925 – 7 · 152
Hu, Dayi: 505 · 188, 505 · 188, 686 · 180
Hu, Sining: 909 – 5 · 111
huang, henry: 925 – 6 · 152
Huber, Ken: 2614 · 140
Huber, Kurt: 903 – 8 · 108
Hudson, Michael P.: 817 · 169
Hueb, Whady: 911 – 8 · 143
Hughes, Alun: 923 – 6 · 152
Hughes, Suzanne: 601 · 112, 699 · 186
Humphrey, Angela: 2502 – 7 · 119
Humpl, Tilman: 901 – 3 · 114
Hundley, Greg: 908 – 8 · 110
Hundley, W. G.: 218 · 127, 719 · 202
Hung, Judy W.: 220 · 129, 672 · 168, 682 · 179, 697 · 185, 707 · 197
Hunt, Sharon: 669 · 168
Huo, Yong: 685 · 180
Hussain, Shazia: 908 – 3 · 110
Hutchings, Jennifer Y.: 914 – 5 · 144
Hutter, Adolph: 914 – 8 · 144
Hutter, Adolph M.: 261 · 171, 910 · 111, 929 – 4 · 154
Hwang, Jin-Yong: 2501 – 12 · 137
226 GO for ACC.12!
Last Name, First Name: Session # · Page #
Author Index • ACC.12
Hwang, Seok-Jae: 2501 – 12 · 137
Hylek, Elaine: 904 – 9 · 141
Hynes, Brian: 2308 · 156
Iazzo, Paul A.: 407 · 181
Igarashi, Yasumi: 2504 – 7 · 138
Ignacio Amat-Santos, Ignacio: 915 – 6 · 145
Igo, Stephen: 907 – 8 · 142
Iida, Osamu: 2311 · 166
iida, Osamu: 931 – 4 · 113, 931 – 6 · 113
Ijichi, Takeshi: 2503 – 7 · 145
Ikari, Yuji: 2503 – 7 · 145
Ilg, Karl: 918 – 3 · 148
Ilkay, Erdogan: 518 · 189
Ilustre, Joanne: 2315 · 189
Im, sung il: 2505 – 12 · 139
IMMEDIATE Trial Investigators: 308 · 210
Inaba, Yoichi: 909 – 4 · 110
Indermuehle, Andreas: 908 – 3 · 110
Indik, Julia H.: 640 · 157, 747 · 209, 808 · 124, 904 · 141
Ing, Frank: 901 – 8 · 114
Ing, Frank F.: 678 · 178
Inglessis, Ignacio: 2308 · 156, 2310 · 156, 2314 · 189
Iobst, William: 109 · 128
Ionescu-Ittu, Raluca: 920 – 4 · 149
Irimpen, Anand: 916 – 6 · 140
Ishida, Masaki: 908 – 3 · 110
Ishigami, Kenichi: 917 – 8 · 148
Ishihara, Takayuki: 2311 · 166
Ishimori, Hiroshi: 2504 – 9 · 138
Ishizawar, David: 912 – 5 · 142
Ismail, Tevfik F.: 908 – 4 · 110
Isojima, Takuya: 2309 · 156
ISSUE-3 investigators: 306 · 186
Itchhaporia, Dipti: 621 · 123, 509 · 190, 685 · 180
Ito, Matthew K.: 736 · 125
Ito, Shigenori: 2305 · 125
Iung, Bernard: 251 · 199, 930 – 5 · 155, 723 · 204, 915 – 7 · 145
Iwabuchi, Masashi: 2302 · 114
Iwai, Sei: 615 · 121
Iwakura, Katsuomi: 2303 · 115
Iwama, Hajime: 2309 · 156
Iwamura, Toshiharu: 909 – 7 · 111
Ix, Joachim: 905 – 5 · 109
Iyer, Sriram S.: 743 · 129
Jabbour, Andrew: 908 – 4 · 110
Jaber, Weal A.: 407 · 181
Jackson, Elizabeth: 913 – 6 · 143
Jackson, Elizabeth A.: 701 · 193, 698 · 186, 730 · 170, 803 · 118, 822 · 198, 927 · 153
Jackson, Greg: 922 – 7 · 150
Jackson, Marcia J.: 103 · 117, 106 · 123, 109 · 128
Jackson, Matthew S.: 907 – 8 · 142
Jacob, Howard: 671 · 168
Jacob, Jasmine R.: 2310 · 156
Jacobs, Alice K.: 2638 · 196, 653 · 162, 308 · 210, 675 · 169
Jacobshagen, Claudius: 921 – 8 · 150
Jacques, Frederic: 901 – 3 · 114
Jaff, Michael: 931 – 8 · 113
Jaff, Michael R.: 2613 · 126, 2613 · 126, 646 · 155, 825 · 202, 932 – 3 · 155
Jaffe, Allan S.: 659 · 163, 728 · 209
Jafri, Haseeb: 911 – 7 · 143
Jahangir, Arshad: 733 · 114
Jain, Sandeep: 922 – 6 · 150
Jain, Sandeep K.: 706 · 197
Jakubowski, Joe: 902 – 4 · 107
Jakubowski, Joseph: 902 – 6 · 108
Jalbert, Jessica: 922 – 4 · 150
Jama, Abdi A.: 406 · 154
Jamal, Syed Z.: 514 · 194, 514 · 194
Jamerson, Kenneth A.: 237 · 169, 631 · 128
James, Stefan: 902 – 4 · 107
James, Stefan K.: 1605 · 171, 623 · 126, 653 · 162, 721 · 204
Jamis-Dow, Carlos: 305 · 181
Janel, Lee: 2644 · 107
Jang, Ik-Kyung: 2608 · 119, 2611 · 125, 909 – 5 · 111, 916 – 7 · 140
Jang, Yangsoo: 2508 – 9 · 139, 2644 · 107
Janiak, Florian: 2645 · 120
Januzzi, Jr., James L.: 641 · 157, 728 · 209
Jarolim, Petr: 905 – 7 · 109
Jaskie, Suzette: 244 · 185, 621 · 123
Jassal, Davinder: 642 · 157
Javaheri, Shahrokh: 718 · 202
Jeevanandam, Valluvan: 2308 · 156
Jeevanantham, Vinodh: 932 – 4 · 155
Jefferies, John: 901 – 5 · 114
Jefferies, John L.: 301 · 157
Jeffries, Brad: 922 – 5 · 150
Jelnin, Vladimir: 2510 – 13 · 140
Jenkins, James S.: 2627 · 177
Jenkins, Kathy: 901 – 8 · 114
Jenkins, Kathy J.: 616 · 122, 402 · 162
Jennings, Lisa K.: 903 – 8 · 108
Jensen, Lisette: 2608 · 119
Jensen, Lisette Okkels: 2506 – 11 · 146
Jeong, Han Saem: 405 · 144
Jeong, Jin-Ok: 2504 – 13 · 138
Jeong, Myung Ho: 917 – 4 · 148, 2505 – 14 · 139, 511 · 188
Jeong, Young-Hoon: 2501 – 12 · 137
Jerosch-Herold, Michael: 922 – 3 · 150
Jeroudi, Ahmad M.: 744a · 170
Jessen, Michael: 629 · 128
Jessup, Mariell: 213 · 122
Jha, Ashish K.: 913 – 4 · 143
Jia, Haibo: 909 – 5 · 111, 916 – 7 · 140
Jianping, Li: 685 · 180
Jimenez Navarro, Manuel: 2504 – 15 · 138
Jing, Yonghua: 913 – 5 · 143
Jneid, Hani: 925 – 6 · 152
Jockel, Heinz Karl: 924 – 4 · 151
Johnson, Andrea: 924 – 6 · 151
Johnson, Paula: 245 · 185
Jollis, James G.: 204 · 110
Jolly, Sanjit S.: 2624 · 167, 2641 · 200
Jonasson, Jenny: 902 – 7 · 108
Jonathon, Leipsic: 2618 · 161
Joner, Michael: 2503 – 9 · 146
Jones, Charlotte: 407 · 181
Jones, Robert H.: 606 · 116
Jones, Thomas K.: 252 · 201
Jorgensen, Erik: 923 – 5 · 151
Joseph, Emmerich: 904 – 8 · 141
Joshi, Nikhil V.: 407 · 181
Joynt, Karen: 913 – 4 · 143
Juan, Gaibor C.: 2310 · 156
Judd, Suzanne: 910 – 5 · 111
Judge, Daniel P.: 234 · 163
Jukema, Johan: 917 – 5 · 148
Juni, Peter: 665 · 167, 2645 · 120
Junker, Anders: 2506 – 11 · 146
Justino, Henri: 634 · 141, 637 · 149
Kadish, Alan H.: 702 · 196
Kahn, Joel: 306 · 186
Kaji, Shuichiro: 909 – 7 · 111
Kala, Petr: 923 – 9 · 152
Kalahasti, Vidyasagar: 920 – 6 · 149
Kalil-Filho, Roberto: 911 – 8 · 143
Kallinen, Linda: 919 – 7 · 149
Kalra, Ankur: 2313 · 189
Kalsch, Hagen: 924 – 4 · 151
Kaltenbach, Lisa: 928 – 4 · 154, 928 – 8 · 154
Kaltoft, Anne: 2506 – 11 · 146
Kandzari, David: 2506 – 7 · 146
Kandzari, David E.: 2627 · 178, 604 · 115, 2202 · 161, 2302 · 114, 2504 – 6 · 138, 511 · 188
Kang, Hyun-Jae: 304 · 143
Kang, Soo-Jin: 2645 · 120, 2611 · 125, 2625 · 177, 2608 · 119
Kang, Wan Seok: 917 – 4 · 148
Kanter, Joshua: 634 · 141, 637 · 149
Kanter, Kirk: 725 · 209
Kantor, Paul F.: 901 – 5 · 114
Kanwal, Sunil: 2309 · 156
Kao, David P.: 925 – 7 · 152
Kapadia, Samir: 2303 · 115, 2308 · 156
Kapadia, Samir R.: 2630 · 183, 2635 · 195, 2203 · 194, 2314 · 189, 2626 · 177
Kaplan, Aaron V.: 238 · 171
ACC.12 Final Program 227
Last Name, First Name: Session # · Page #
ACC.12 • Author Index
Kapoor, Deepak: 2302 · 114
Kappetein, A.: 910 – 4 · 111
Kar, biswajit: 2315 · 189
Kar, Saibal: 2114 · 194, 2131 · 160, 2132 · 195, 2132 · 195, 220 · 129, 2203 · 194, 2622 · 166, 652 · 160
Kara, Tomas: 406 · 154
Karapetyan, Anush K.: 917 – 7 · 148
Karas, Maria G.: 905 – 5 · 109
Karas, Richard: 911 – 7 · 143
Karas, Richard H.: 611 · 117
Karlsberg, Ronald P.: 696 · 185, 740 · 204
Karmpaliotis, Dimitrios: 505 · 188
Karwatowska-Prokopczuk, Ewa: 921 – 8 · 150
Kashyap, Sangeeta: 306 · 186
Kassimis, George: 903 – 7 · 108
Kastrati, Adnan: 2503 – 9 · 146, 2645 · 120
Kastrup, Jens: 923 – 5 · 151
Kataoka, Yu: 2303 · 115
Kates, Andrew M.: 730 · 170, 822 · 198
Kato, Keiji: 917 – 8 · 148
Kato, Koji: 916 – 7 · 140
Katoh, Yoshihiro: 2509 – 13 · 147
Katsouli, Anthi: 912 – 5 · 142
Katus, Hugo A.: 2511 · 147
Katz, Jason N.: 263 · 170
Kaufman, Beth: 901 – 5 · 114, 901 – 6 · 114
Kaufmann, Beat: 909 – 4 · 110
Kaufmann, Philipp: 924 – 7 · 151
Kaul, Sanjay: 744b · 170, 2614 · 140, 604 · 115, 639 · 156, 665 · 167, 700 · 186, 712 · 199
Kaul, Sanjiv: 628 · 127
Kautzner, Josef: 905 – 7 · 109
Kawata, Hiroyuki: 917 – 8 · 148
Kayani, Waleed: 925 – 6 · 152
Kazi, Dhruv: 903 – 5 · 108
Keadle, Justin: 911 – 9 · 143
Kealey, Angela: 695 · 185
kedhi, elvin: 2506 – 9 · 146
Keeley, Ellen: 923 · 151
Kelly, Christopher: 2511 – 7 · 147
Kelsey, Anita M.: 744b · 170
Kemme, Michiel: 918 – 4 · 148
Kempny, Aleksander: 920 – 5 · 149, 920 – 8 · 149
kennedy, kevin: 2501 – 8 · 137, 2510 – 15 · 140, 2511 – 13 · 147, 932 – 7 · 155
Kennedy, Kevin F.: 2511 – 11 · 147
Kennett, Jerry D.: 650 · 153
Kereiakes, Dean: 2506 – 9 · 146, 306 · 186
Kereiakes, Dean J.: 2634 · 190, 646 · 155, 2506 – 7 · 146, 2202 · 161
Kern, Karl B.: 263 · 170
Kern, Morton J.: 2609 · 120, 107A · 125, 2122 · 183, 2303 · 115, 821 · 197
kesari, kavitha: 2301 · 114
Kesarwani, Manoj: 744b · 170
Khairy, Paul: 668 · 168, 506 · 191
Khalique, Omar: 907 – 4 · 142
Khan, Fakhar Z.: 716 · 201
Khann, Amber D.: 406 · 154
Khaw, Ban-An: 642 · 157
Khera, Amit: 711 · 199, 729 · 203
Kholmovski, Eugene: 918 – 6 · 148, 918 – 8 · 148
Khumri, Taiyeb M.: 2301 · 114
Kiernan, Michael: 2502 – 11 · 119
Kilner, Philip: 920 – 8 · 149
Kim, Brian H.: 405 · 144
Kim, Byeong-Keuk: 2508 – 9 · 139, 2644 · 107
Kim, Chong Jin: 2505 – 14 · 139
Kim, Donghan: 2505 – 14 · 139
Kim, Eung Ju: 2505 – 12 · 139
Kim, Henry: 918 – 3 · 148
Kim, Hyo Soo: 304 · 143
Kim, Hyo-Soo: 2504 – 13 · 138
Kim, Hyun-Sook: 2508 – 7 · 139
Kim, Hyung-Kwan: 930 – 8 · 155
Kim, Je Sang: 405 · 144
Kim, Jeong Sook: 917 – 4 · 148
Kim, Ji-Hyun: 930 – 8 · 155
Kim, Jin Won: 2505 – 12 · 139
Kim, Jong-Ho: 405 · 144
Kim, Jung-Sun: 2508 – 9 · 139
Kim, Kyung-Hee: 930 – 8 · 155
Kim, Luke: 928 – 4 · 154
Kim, Michael C.: 676 · 178, 511 · 188
Kim, Raymond J.: 233 · 163, 605 · 116
Kim, Soo Hyun: 931 – 8 · 113, 932 · 155
Kim, Soo Joong: 916 – 7 · 140
Kim, Sunghee: 928 – 6 · 154
Kim, Sunwon: 2505 – 12 · 139
Kim, Won-Jang: 2645 · 120
Kim, Yong Sook: 917 – 4 · 148
Kim, Yong-Jin: 930 – 8 · 155
Kim, Young Jo: 2505 – 14 · 139
Kim, Young-Hak: 2645 · 120
Kim, Young-Tae: 2645 · 120
Kim, Yuli: 920 – 6 · 149
Kimmelstiel, Carey: 2506 – 7 · 146
Kimmelstiel, Carey D.: 230 · 159, 2612 · 125
Kimura, Takeshi: 2509 – 13 · 147
King, Lamin: 2503 – 9 · 146
King, Richard: 928 – 7 · 154
King, Spencer B.: 610 · 117, 610 · 117, 111 · 159, 2121 · 177
Kingery, Joanna: 913 – 8 · 143
Kini, Annapoorna S.: 2508 – 6 · 139, 676 · 178
Kioufis, Stamatios: 931 – 3 · 113
Kirby, Ruth: 308 · 210
Kirma, Cevat: 518 · 189
Kirtane, Ajay: 2500 – 11 · 137
Kirtane, Ajay J.: 2113 · 194, 604 · 115, 613 · 121, 665 · 167, 1605 · 171, 821 · 197, 2501 – 14 · 138, 2501 – 16 · 138, 2201 · 119
Kirwanj, John: 306 · 186
Kitzman, Dalane: 905 – 6 · 109
Kizer, Jorge: 905 – 5 · 109
Klarich, Kyle W.: 812 · 158, 110 · 129
Kleiman, Neal S.: 2617 · 156, 2121 · 177, 2202 · 161, 2306 · 125
Klein, Allan L.: 208 · 116, 672 · 168
Klein, Lloyd: 308 · 210
Klein, Lloyd W.: 2502 · 119
Kliger, Chad: 931 – 5 · 113, 2630 · 183, 2510 – 13 · 140
Kligfield, Paul: 929 · 154
Kline-Rogers, Eva: 913 – 6 · 143, 931 – 8 · 113
Kline-Rogers, Eva M.: 713 · 199, 721 · 204
Kluge, Matthew A.: 405 · 144
Knap, Malgorzata: 930 – 6 · 155
Knight, Bradley P.: 615 · 121
Ko, Young-Guk: 2508 – 9 · 139, 2644 · 107
Kobashigawa, Jon A.: 670 · 168
Koch, Karel T.: 2502 – 13 · 119
Kociol, Robb D.: 656 · 163
Kodali, Susheel: 2112 · 182, 2618 · 161, 2626 · 177, 2131 · 160, 2500 – 7 · 137, 2500 – 9 · 137, 2500 – 11 · 137, 2507 – 11 · 146
Kodali, Susheel K.: 305 · 181
Kodama, Alessandra: 304 · 143
Kodoth, Vivek: 919 – 8 · 149
Kohl, III, Harold W.: 914 – 5 · 144
Kohli, Payal: 902 – 5 · 108
Kolluri, Raghu: 2607 · 115, 2616 · 156
Kolm, Paul: 308 · 210
Komajda, Michel: 738 · 181
Konecny, Tomas: 406 · 154
Konen, Eli: 924 – 3 · 151
Konstam, Marvin A.: 103 · 117, 635 · 141, 710 · 198, 110 · 129
Kontos, Michael C.: 628 · 127
Koo, Bon Kwon: 2639 · 202
Koo, Bon-Kwon: 304 · 143
Koolen, Jacques: 2503 – 13 · 146
Kop, Willem: 905 – 6 · 109
Koren, Michael: 306 · 186
Kornowski, Ran: 2501 – 6 · 137
Kosiborod, Mikhail: 711 · 199, 2511 – 11 · 147
Koss, Elana: 2507 – 11 · 146
Kostis, William J.: 2608 · 119
Kotha, Jayaprakash: 903 – 8 · 108
Kothari, Shyam S.: 2310 · 156
Kotowycz, Mark A.: 2505 – 6 · 138
Kotrc, Martin: 905 – 7 · 109
Kott, Andrew E.: 2315 · 189
Kottam, Anupama: 2306 · 125
Kovac, Jan: 2314 · 189, 2500 · 137, 2511 · 147, 2644 · 107, 723 · 204
228 GO for ACC.12!
Last Name, First Name: Session # · Page #
Author Index • ACC.12
Kovacic, Jason: 2508 – 6 · 139
Kovacs, Adrienne H.: 679 · 179
Kovacs, Richard: 913 – 8 · 143
Kovacs, Richard J.: 710 · 198, 261 · 171
Kowal, Robert C.: 212 · 121
Kowalchuk, Glen: 2502 – 7 · 119
Kowey, Peter: 206 · 116, 1603 · 172
Kozan, Omer: 518 · 189
Krahn, Andrew D.: 640 · 157, 816 · 166
Kraitchman, Dara: 719 · 202
Kramer, Christopher M.: 644 · 158
Krasuski, Richard: 920 – 6 · 149
Kraus, William E.: 923 – 8 · 152
Kremers, Mark S.: 239 · 178
Kren, Stefan: 906 – 5 · 110
Kreutzer, Jacqueline: 637 · 149
Krieger, Eric V.: 202 · 108
Krishna, Vamsi: 200 · 107
Krishnaswamy, Amar: 2308 · 156, 2629 · 183, 210 · 118
Kronenberg, Marvin: 300 · 112
Kronmal, Richard: 924 – 4 · 151, 930 – 7 · 155
Kronzon, Itzhak: 2510 – 13 · 140, 2619 · 161
Kruck, Irmtraut: 738 · 181
Krucoff, Mitchell W.: 633 · 129, 689 · 184
Kruisselbrink, Teresa: 236 · 169
Krum, Henry: 926 – 3 · 153, 663 · 165, 926 – 4 · 153
Krumholz, Harlan M.: 224 · 143, 717 · 202
Kuehl, Karen S.: 725 · 209
Kugelmass, Aaron D.: 510 · 193, 746 · 105
Kugler, John: 667 · 167
Kukucka, Marian: 921 – 7 · 150
Kullo, Iftikhar J.: 407 · 181
Kumar, Gautam: 2309 · 156, 744a · 170
Kurata, Mie: 932 – 6 · 155
Kurita, Takashi: 501 · 190
Kuvin, Jeffrey T.: 103 · 117, 106 · 123, 109 · 128, 730 · 170, 812 · 158
Kwak, Choong Hwan: 2501 – 12 · 137
Kwok, Bernard: 905 – 8 · 109
Kwolek, Christopher J.: 2623 · 166
Kwon, Deborah: 908 – 5 · 110
Kwon, Hyuck-Moon: 2644 · 107
Kwon, Jin-Sook: 917 – 4 · 148
Kwong, Raymond: 922 – 3 · 150
Kwong, Raymond Y. K.: 257 · 209, 605 · 116
Ky, Bonnie: 642 · 157
Kydd, Anna: 923 – 7 · 152
LaBounty, Troy: 924 – 5 · 151
LaBounty, Troy M.: 924 – 7 · 151
Lacomis, Joan: 305 · 181
Lacour-Gayet, Francois G.: 724 · 209
Ladd, Mark E.: 918 – 7 · 148
Laham, Roger J.: 221 · 140
Lahoti, Ankush: 912 – 4 · 142
Lahr, Brian: 927 – 6 · 153
Lai, Dejian: 300 · 112
Laird, John R.: 2311 · 166, 2613 · 126, 502 · 188
Lakdawala, Neal: 720 · 203
Lakshminarayan, Kamakshi: 904 – 4 · 141
Lamendola, Cindy: 699 · 186
Lamour, Jacqueline: 901 – 5 · 114
Lampert, Rachel: 919 – 4 · 149
Lampert, Rachel J.: 914 · 144
Lamy, Andre: 305 · 181
Lander, Matthew: 912 – 5 · 142
Landzberg, Michael: 662 · 164, 920 – 7 · 149
Landzberg, Michael J.: 2615 · 148, 668 · 168, 107A · 125, 2132 · 195
Lanfear, David E.: 826 · 203
Lang, Peter: 725 · 209
Lang, Roberto: 2308 · 156
Lang, Roberto M.: 682 · 179, 697 · 185, 407 · 181
Langabeer, James R.: 928 – 7 · 154
Lange, Richard A.: 508 · 191, 709 · 197
Lange, Rudiger: 2507 – 13 · 147
Lansky, Alexandra: 916 – 4 · 140, 923 – 8 · 152, 924 – 6 · 151
Lansky, Alexandra J.: 653 · 162, 2508 · 138
Lantin-Hermoso, M. Regina: 805 · 123
Lanza, Gregory M.: 259 · 210
Laranjeira, Ligia: 304 · 143
Lardo, Albert C.: 259 · 210
Larose, Eric: 2510 – 9 · 139, 915 – 6 · 145
Larson, Joseph: 904 – 4 · 141
larson, martin: 905 – 3 · 109
Lasala, John M.: 2638 · 196, 676 · 178, 2202 · 161, 2313 · 189
Lassen, Jens: 2506 – 11 · 146
Latson, Larry A.: 2313 · 189, 518 · 189
Lattouf, Omar M.: 746 · 105
Lau, Ernest: 919 – 8 · 149
Lau, Joe: 931 – 7 · 113
Lau, Yee How: 905 – 8 · 109
Lauck, Sandra: 2102 · 160
Lauer, Michael S.: 651 · 160, 929 – 3 · 154
Lauten, Alexander: 915 – 4 · 145
Lavie, Carl: 927 – 5 · 153
Lavigne, Paul M.: 911 – 7 · 143
Lawler, Patrick: 920 – 4 · 149
Lawless, Christine E.: 262 · 187
Lawrence, Silvana M.: 914 – 5 · 144
Laynez Carnicero, Ana: 2507 – 15 · 147
Layug, Beth: 921 – 8 · 150
Le May, Michel R.: 916 – 5 · 140
Leaming, James: 305 · 181
Lee, Byron K.: 824 · 200
Lee, Cheol Whan: 2645 · 120
Lee, Daniel C.: 719 · 202
Lee, Hang: 916 – 7 · 140, 308 · 210
Lee, John H.: 932 – 7 · 155
Lee, Jong-Young: 2645 · 120
Lee, Junsoo Alex: 915 – 8 · 145
Lee, Kerry: 656 · 163
Lee, Ki Hong: 2505 – 14 · 139
Lee, Randall J.: 201 · 108
Lee, Raymond: 905 – 8 · 109
Lee, Seung-Pyo: 930 – 8 · 155
Lee, Seung-Whan: 2645 · 120
Leesar, Massoud A.: 2625 · 177
Lefèvre, Thierry: 2500 – 13 · 137
Lefevre, Thierry: 2502 – 9 · 119, 407 · 181, 926 – 7 · 153, 2112 · 182, 2624 · 167
Leier, Carl V.: 680 · 179
Leipsic, Jonathon: 2203 · 194, 2618 · 161
Leiva Pons, Jose Luis: 513 · 190
Lemos, Pedro A.: 503 · 188
Lenihan, Daniel J.: 642 · 157
Leon, Martin: 2500 – 7 · 137, 2500 – 9 · 137, 2500 – 11 · 137, 2507 – 11 · 146, 2645 · 120, 305 · 181
Leon, Martin B.: 2606 · 115, 2635 · 195, 2636 · 195, 652 · 160, 2500 – 6 · 137, 309 · 211, 511 · 188, 674 · 182
Leor, Jonathan: 746 · 105
lepera, mario: 909 – 3 · 110
Lerakis, Stamatios: 2618 · 161, 2635 · 195
Lerman, Jorge: 516 · 192
Leschke, Matthias: 2509 – 9 · 147
Lesser, John: 925 – 4 · 152, 925 – 5 · 152
Lesser, John R.: 218 · 127
lettieri, corrado: 2644 · 107
Lever, Harry M.: 253 · 203, 648 · 159
Levi, Daniel S.: 2615 · 148
Levine, Glenn: 675 · 169
Levine, Paul A.: 614 · 121
Levine, Robert A.: 406 · 154, 697 · 185
Levit, Aaron D.: 405 · 144
Levy, Daniel: 905 – 3 · 109
Levy, Samuel: 2644 · 107
Levy, Wayne: 922 – 5 · 150
Lewin, Jack: 610 · 117, 687 · 180, 710 · 198, 404 · 199, 505 · 188, 647 · 159, 650 · 153, 685 · 180, 742 · 186
Lewin, Mark B.: 252 · 201, 802 · 111, 301 · 157, 301 · 157
Lewis, Gregory: 914 – 8 · 144
Lewis, Gregory D.: 254 · 203, 649 · 159, 705 · 196, 929 – 4 · 154
Lewis, William R.: 601 · 112, 690 · 184
Li, Hui: 2645 · 120
Li, Wei: 920 – 8 · 149, 920 – 5 · 149
Li, Yat Wa: 907 – 4 · 142
Li, Yigang: 2645 · 120
Liberman, Henry: 2302 · 114
Lichstein, Edgar: 408 · 187
Lichtenstein, Samuel: 2644 · 107
ACC.12 Final Program 229
Last Name, First Name: Session # · Page #
ACC.12 • Author Index
Lieber, Elizabeth: 2502 – 11 · 119
Lieu, Hsiao: 923 – 8 · 152
Lim, D. S.: 2114 · 194
Lim, Do-Sun: 405 · 144
Lim, Hong Euy: 2505 – 12 · 139
Lim, Michael J.: 2625 · 177, 2629 · 183, 2122 · 183
Lima, Joao: 908 – 8 · 110, 909 – 8 · 111
Lima, Joao A. C.: 214 · 122, 218 · 127, 641 · 157
Limaye, Atul: 2508 – 6 · 139
Limbruno, Ugo: 2644 · 107
Lin, Fay: 924 – 5 · 151, 924 – 7 · 151
Lin, Grace: 242 · 182
Lin, Jay: 913 – 5 · 143
Lin, Kimberly: 901 – 6 · 114
Lincoff, A.: 2501 – 10 · 137
Lincoff, A. M.: 2301 · 114, 2306 · 125, 2643 · 201
Lindahl, Bertil: 653 · 162
Lindenfeld, Joann: 925 – 7 · 152
Linderbaum, Jane A.: 689 · 184, 731 · 142
Lindner, Jonathan: 909 – 4 · 110
Lindner, Jonathan R.: 907 – 3 · 142
Lindsay, Bruce: 922 – 7 · 150
Lindsay, Bruce D.: 239 · 178
Ling, Lee Fong: 407 · 181
Link, Mark S.: 688 · 182
Linke, Axel: 2644 · 107
Liodakis, Emmanouil: 920 – 5 · 149
Lioy, Ernesto: 2644 · 107
Lip, Gregory: 904 – 5 · 141, 904 – 7 · 141
Lipshultz, Steven: 901 – 5 · 114
Litt, Harold: 305 · 181
Little, Stephen: 907 – 8 · 142
Little, Stephen H.: 707 · 197, 814 · 164
Little, William: 203 · 109, 229 · 159
Liu, Bin: 2645 · 120
Liu, Chia Ying: 908 – 8 · 110
Liu, Christopher: 614 · 121
Liu, Chunyu: 905 – 3 · 109
Liu, Huiliang: 2645 · 120
Liu, Peter P.: 240 · 179
Liu, Shizhen: 907 – 8 · 142
Liu, Ya Ni: 909 – 4 · 110
liu, yang: 906 – 8 · 110
Llacer, Angel: 908 – 6 · 110
Llanos, Alexander: 2308 · 156, 2310 · 156
Lloyd-Jones, Donald: 905 – 6 · 109
Lock, James E.: 678 · 178, 692 · 184
Locke, Amy: 235 · 164
Logan, Julie A.: 2105 · 171, 2105 · 171
Lomasney, Jon: 2315 · 189
Lombardi, William L.: 2112 · 182, 2621 · 162, 505 · 188
Long, Janet B.: 255 · 204, 736 · 125
Lopes, Renato: 304 · 143
Lopes, Renato D.: 904 – 9 · 141
Lopez, Leo: 724 · 209
López, Mª Pilar: 908 – 6 · 110
Lopez-Candales, Angel: 912 – 5 · 142
Lorin, Jeffrey: 2505 – 10 · 139
Losordo, Douglas W.: 2623 · 166, 618 · 121
Lotan, Chaim: 510 · 193, 746 · 105, 746 · 105
Louvard, Yves: 2502 – 9 · 119, 926 – 7 · 153
Love, Charles J.: 690 · 184
Lowery, Robert: 744b · 170
Loyalka, Pranav: 2314 · 189
Lu, Chengzhi: 2645 · 120
Lubos, Edith: 930 – 6 · 155
Lubs, Daniel: 930 – 6 · 155
Lucisano, Luigi: 2644 · 107
Luke, William: 259 · 210
Lumley, Matthew: 2645 · 120
Lundgrin, Erika: 912 – 8 · 142
Luo, Yanting: 927 – 7 · 153
Lurz, Philipp: 902 – 8 · 108
Lyass, Asya: 905 – 3 · 109
Lyden, Sean: 2613 · 126
Ma, Genshan: 2645 · 120
Ma, Yitong: 2645 · 120
Maalouf, Joseph: 251 · 199, 504 · 193, 674 · 182, 915 · 145
MacDougall, Diane: 911 – 10 · 143
Mace, Pamela: 931 – 8 · 113
MacFadyen, Jean: 911 – 4 · 143, 911 – 6 · 143
Mack, Michael: 2500 – 7 · 137, 2500 – 9 · 137, 305 · 181
Mack, Michael J.: 2122 · 183, 2131 · 160, 2636 · 195, 606 · 116, 737 · 169, 309 · 211
MacLeod, Rob: 918 – 6 · 148, 918 – 8 · 148
MacRae, Calum A.: 236 · 169
Madan, Mina: 916 – 5 · 140
Madan, Pankaj: 913 – 7 · 143
Madden, Sean: 2508 – 13 · 139
Madder, Ryan: 2610 · 120, 2508 – 11 · 139
Maddox, Thomas M.: 209 · 117, 219 · 128, 721 · 204, 913 · 143
Maeda, Mika: 909 – 7 · 111
Maehara, Akiko: 2303 · 115, 2508 – 15 · 139, 2511 – 7 · 147, 2625 · 177, 2629 · 183, 304 · 143, 916 – 4 · 140
Maeng, Michael: 2506 – 11 · 146
Magalski, Anthony: 262 · 187
Maganti, K: 208 · 116
Mahaffey, Kenneth: 903 – 8 · 108
Mahajan, Nitin: 306 · 186, 910 – 6 · 111
Mahfoud, Felix: 926 – 3 · 153
Mahle, William: 693 · 185
Mahmarian, John J.: 708 · 197
Mahmud, Ehtisham: 2627 · 177
Mai, Xingchen: 2505 – 10 · 139
Maier, Lars: 921 – 8 · 150
Maisano, Francesco: 930 – 3 · 155, 612 · 118
Makenbaeva, Dinara: 913 – 5 · 143
Makiyama, Takeru: 405 · 144
Makkar, Raj R.: 2609 · 120, 2626 · 177, 2202 · 161, 2308 · 156
Makris, George: 903 – 7 · 108
Maldonado, Galo: 2506 – 15 · 146
Malenka, David J.: 723 · 204
Malik, Iqbal: 923 – 6 · 152
Malik, Marek: 702 · 196
Mallorie, Amy: 908 – 4 · 110
Manankil, Marian: 2303 · 115
Mancini, Donna M.: 669 · 168
Mancone, Massimo: 2644 · 107
Mancuso, J. Jacob: 234 · 163, 259 · 210
Mandapaka, Sangeeta: 2305 · 125
Mandras, Stacy: 912 · 142
Manito, Nicolas: 517 · 191
Mankad, Rekha: 620 · 123
Mankad, Sunil V.: 229 · 159, 258 · 210, 632 · 129, 697 · 185, 815 · 165
Mann, Douglas L.: 710 · 198, 656 · 163, 746 · 105
Mann, Tift: 2624 · 167, 2305 · 125
Manning, Warren: 925 – 4 · 152, 925 – 5 · 152
Manoharan, Ganesh: 2203 · 194, 2500 · 137, 2635 · 195
Manoukian, Steven V.: 2641 · 200
Mansour, M. A.: 932 – 5 · 155
Manthripragada, Gopi: 2305 · 125
Mantzoros, Christos S.: 905 – 5 · 109
Maranan, Leandro: 2510 – 13 · 140
Maranhão, Raul C.: 911 – 8 · 143
Marban, Eduardo: 300 · 112, 618 · 121
Marchlinski, Francis E.: 706 · 197, 715 · 201
Marek, Josef: 907 – 7 · 142
Marek, Joseph C.: 688 · 182
Marelli, Ariane: 920 – 4 · 149
Margenet, Alain: 2502 – 9 · 119
Margey, Ronan: 2308 · 156, 2310 · 156, 2314 · 189
Margulies, Janice: 911 – 10 · 143
Marine, Joseph E.: 703 · 196, 826 · 203
Marinos, Georgios: 931 – 3 · 113
Markl, Michael: 719 · 202
Markovic, Sinisa: 903 – 3 · 108
Markowitz, Steven M.: 703 · 196
Maron, Barry: 925 – 4 · 152, 925 – 5 · 152
Maron, Barry J.: 253 · 203, 619 · 122, 262 · 187, 262 · 187, 914 – 3 · 144
Maron, Martin: 925 – 4 · 152, 925 – 5 · 152
Maron, Martin S.: 253 · 203, 648 · 159, 661 · 164
Marrouche, Nassir: 918 – 6 · 148
Marrouche, Nassir F.: 918 – 8 · 148
Marshall, J.: 2505 – 8 · 138
Marso, Steven: 2501 – 8 · 137, 2510 – 7 · 139, 2510 – 15 · 140, 916 – 4 · 140
Marso, Steven P.: 2641 · 200, 711 · 199, 510 · 193, 2511 – 13 · 147
Martin, Daniel: 300 · 112
230 GO for ACC.12!
Last Name, First Name: Session # · Page #
Author Index • ACC.12
Martin, Gerard: 616 · 122, 901 – 7 · 114
Martin, Gerard R.: 402 · 162, 506 · 191, 901 – 8 · 114
Martin, Joseph: 2303 · 115
Martin, Victoria: 2504 – 15 · 138
Martinez, Matthew W.: 253 · 203, 648 · 159, 816 · 166
Martinez-Sanchez, Carlos R.: 513 · 190
Martucci, Giussepe: 2644 · 107
Marwick, Thomas: 907 – 5 · 142, 908 – 5 · 110
Marwick, Thomas H.: 407 · 181, 682 · 179
marzullo, marco: 909 – 3 · 110
Mascette, Alice M.: 656 · 163
Maseri, Attilio: 404 · 199
masi, filippo: 909 – 3 · 110
Masotti, Monica: 2504 – 15 · 138
Masoudi, Frederick: 2511 – 11 · 147, 928 – 5 · 154, 928 – 6 · 154
Masoudi, Frederick A.: 205 · 112, 712 · 199, 515 · 193
Massaro, Joseph: 930 – 4 · 155, 2645 · 120
Massaro, Joseph M.: 308 · 210
Massberg, Steffen: 2645 · 120
Massie, Barry M.: 669 · 168, 680 · 179, 921 · 150, 921 – 3 · 150
Masuyama, Tohru: 501 · 190
Matesanz, Rafael: 906 – 5 · 110
Matetzky, Shlomi: 924 – 3 · 151
Matheny, Michael: 2511 – 11 · 147
Mather, Paul J.: 694 · 185
Mathew, Samuel K.: 509 · 190
Mathiasen, Anders B.: 923 – 5 · 151
Mathier, Michael: 912 – 5 · 142
Mathier, Michael A.: 249 · 198, 649 · 159, 912 – 3 · 142
matsubara, Tetsuo: 2504 – 7 · 138
Matsuda, Takehisa: 2509 – 15 · 147
Matsumoto, Alan: 931 – 8 · 113
Matsumoto, Daisuke: 2503 – 7 · 145
Mattos, Luiz A.: 503 · 188
Mauri, Laura: 2645 · 120, 2617 · 156, 2103 · 165, 2511 · 147, 930 – 4 · 155
Mavronasiou, Eleni: 903 – 7 · 108
May, David C.: 219 · 128
Mayer, John: 308 · 210
Mayet, Jamil: 923 – 6 · 152
Maytin, Melanie: 2502 – 11 · 119
Mazzaferri, Ernest: 2501 – 14 · 138, 2501 – 16 · 138
Mazzitelli, Domenico: 2507 – 13 · 147
McAllister, Todd: 627 · 127
McBane, Robert: 931 – 8 · 113
McBride, Patrick E.: 227 · 152
McCarter, Robert: 901 – 7 · 114
McCarthy, Patrick M.: 242 · 182, 258 · 210, 697 · 185, 632 · 129
McClelland, Robyn: 924 – 4 · 151
McClurken, James B.: 659 · 163
McCormick, Liam M.: 923 – 7 · 152
McCullough, Peter A.: 711 · 199
McDaniel, Michael C.: 2303 · 115
McElhinney, Doff B.: 2615 · 148, 634 · 141
mcelwee, sam: 2306 · 125
McEneaney, David: 919 – 8 · 149
McGlothlin, Dana: 249 · 198
McGowan, Jr, Francis X.: 901 – 4 · 114
McGrew, Frank: 921 – 4 · 150
McGuire, Darren K.: 645 · 158
McKay, Charles: 308 · 210
McKenna, William: 236 · 169, 253 · 203, 661 · 164
McKenney, James: 306 · 186, 911 – 5 · 143
McKillop, Graham: 407 · 181
McLaughlin, Vallerie V.: 705 · 196, 254 · 203
McLean, Rhondalyn: 645 · 158
McMullan, Paul: 263 · 170
McMurtry, M. Sean: 2607 · 115
McNally, Elizabeth: 671 · 168
McNamara, Dennis M.: 605 · 116, 635 · 141, 695 · 185, 664 · 165
Mcnitt, Scott: 919 – 5 · 149
McNitt, Scott: 919 – 6 · 149
McPherson, John: 2511 – 7 · 147, 916 – 4 · 140, 923 – 8 · 152, 924 – 6 · 151
McPherson, John A.: 806 · 123, 811 · 158, 819 · 192, 263 · 170
Meadows, Jeffrey: 2615 · 148
Mega, Jessica: 916 – 8 · 140
Mehdipour, Mahshid: 308 · 210
Mehra, Mandeep R.: 655 · 163
Mehran, Roxana: 200 · 107, 2634 · 190, 2641 · 200, 622 · 123, 2501 – 6 · 137, 2501 – 10 · 137, 2501 – 14 · 138, 2501 – 16 · 138, 2502 – 15 · 119, 2508 – 15 · 139
Mehrotra, Praveen: 2310 · 156
Mehta, Laxmi S.: 241 · 179, 245 · 185
Mehta, Rajendra: 408 · 187
Mehta, Sameer: 676 · 178
Mehta, Shamir R.: 903 · 108
Meier, Bernhard: 2645 · 120
Melenovsky, Vojtech: 905 – 7 · 109
meliga, emanuele: 2315 · 189
Mell, MD, Matthew W.: 903 – 5 · 108
Menard, Matthew T.: 2620 · 161, 2623 · 166
Mendes, Lisa A.: 710 · 198
Mendiz, Oscar A.: 502 · 188
Meng, Lingbo: 916 – 7 · 140
Menon, Venu: 2502 – 11 · 119, 916 · 140
Mentz, Robert J.: 744a · 170, 921 – 5 · 150
Meredith, Ian: 2506 – 7 · 146, 2506 – 13 · 146
Merrill, Michael F.: 113 · 193
Mertens, Luc: 693 · 185
Messenger, John: 2510 – 15 · 140, 2511 – 11 · 147, 308 · 210, 928 – 5 · 154, 928 – 6 · 154
Messenger, John C.: 510 · 193
Messer, Joseph V.: 659 · 163
Messerli, Franz H.: 250 · 198
Messika-Zeitoun, David: 238 · 171, 246 · 187, 915 · 145, 915 – 7 · 145, 930 – 5 · 155
Metkus, Thomas S.: 2314 · 189
Metzger, Christopher: 2505 – 8 · 138
Metzger, D. Christopher: 304 · 143, 2620 · 161, 2631 · 183
Metzger, David: 2501 – 14 · 138, 2501 – 16 · 138
Meuwissen, Martijn: 2502 – 13 · 119
Mewada, Abhishek: 306 · 186
Michael, Tesfaldet T.: 2302 · 114
Michelena, Hector I.: 260 · 211, 723 · 204
Michifumi, Tokuda: 922 – 3 · 150
Michos, Erin: 235 · 164, 698 · 186
Mieres, Jennifer H.: 237 · 169, 245 · 185, 255 · 204
Mietus-Snyder, Michele: 746 · 105
Mikati, Issam A.: 643 · 158, 682 · 179, 809 · 128, 908 · 110
Mikell, Frank L.: 630 · 128
Mila, Rafael: 923 – 6 · 152
Milani, Richard: 927 – 5 · 153
Millar, Lynne: 914 – 7 · 144
Miller, Alan: 921 – 4 · 150
Miller, Alan B.: 922 – 5 · 150
Miller, Amy Leigh: 107 · 124, 209 · 117
Miller, Chadwick: 305 · 181
Miller, D. Craig: 2636 · 195, 2500 – 7 · 137, 2500 – 9 · 137, 305 · 181
Miller, Denise: 2502 – 7 · 119
Miller, Fletcher A.: 204 · 110
Miller, John M.: 737·[page
Miller, Julie: 909 – 8 · 111
Miller, Leslie W.: 669 · 168
Miller, Todd D.: 651 · 160
Mills, Nicholas L.: 407 · 181
Mills, Rebecca: 2510 – 7 · 139, 2511 – 13 · 147
Min, James: 924 – 7 · 151
Min, James K.: 231 · 162, 683 · 180, 2507 · 146, 740 · 204, 924 – 5 · 151
Minissian, Margo B.: 112 · 180, 710 · 198
Mintz, Gary: 2508 – 15 · 139, 2511 – 7 · 147, 916 – 4 · 140
Mintz, Gary S.: 2201 · 119, 2201 · 119, 309 · 211, 646 · 155
Minutello, Robert: 928 – 4 · 154
Miquel-Hebert, Karine: 2503 – 11 · 146, 2503 – 13 · 146
Mira, Vera: 304 · 143
Mirowska, Karolina K.: 306 · 186
Mirro, Michael J.: 630 · 128, 647 · 159
Mishkel, Gregory J.: 2607 · 115, 2610 · 120
Mistry, Kshitij P.: 616 · 122
Mistry, Niraj: 908 – 4 · 110
Mitchell, Justin: 2315 · 189
Miyashita, Yusuke: 931 – 4 · 113, 931 – 6 · 113
Miyazaki, Shunichi: 501 · 190, 501 · 190
Mizuguchi, Yukio: 2301 · 114
Moat, Neil E.: 2636 · 195
Moccetti, Tiziano: 903 – 8 · 108
Moceri, Pamela: 920 – 5 · 149
ACC.12 Final Program 231
Last Name, First Name: Session # · Page #
ACC.12 • Author Index
Modi, Kalgi A.: 695 · 185
Moebius-Winkler, Sven: 2509 – 9 · 147
Moebus, Susanne: 924 – 4 · 151
Moeller, Chaim: 408 · 187
Moga, Michael-Alice: 901 – 3 · 114
Mohammed, Selma: 649 · 159
Mohan, Puneet: 904 – 9 · 141
Mohanty, Prasant: 925 – 8 · 152
Mohanty, Sanghamitra: 925 – 8 · 152
Möhlenkamp, Stefan: 924 – 4 · 151
Mohler, III, Emile R.: 825 · 202
Mok, Michael: 915 – 6 · 145
Moliterno, David: 903 – 8 · 108
Moliterno, David J.: 2201 · 119, 2301 · 114, 2509 · 147, 2617 · 156, 2634 · 190, 623 · 126, 2103 · 165
Möllmann, Helge: 2506 – 13 · 146
Monaghan, Mark J.: 2606 · 115
Monmeneu, JVicente: 908 – 6 · 110
Montalescot, Gilles: 2643 · 201, 623 · 126, 1605 · 171, 304 · 143
Mooney, Michael R.: 263 · 170
Moore, John: 901 – 8 · 114
Moore, Johnn W. M.: 2615 · 148
Mooss, Aryan: 744b · 170
Mor-Avi, Victor: 407 · 181
Mora, Samia: 911 – 4 · 143
Morady, Fred: 918 – 3 · 148
Morales, David: 625 · 127
Moravec, Christine: 906 – 7 · 110
Moreira, Adriana: 2506 – 15 · 146
Morel, Marie-angèle: 910 – 4 · 111
Morell, Victor O.: 724 · 209
Morelli, Peter: 247 · 196
Moreno, Pedro: 2508 – 6 · 139
Moreu, Jose: 2504 – 15 · 138
Moriarty, Patrick M.: 729 · 203
Morice, Marie Claude: 926 – 7 · 153
Morice, Marie-Claude: 2500 – 13 · 137, 2502 – 9 · 119, 407 · 181
Morillo, Carlos A.: 640 · 157
Morris, Andrew J.: 917 – 7 · 148
Morrison, Lauren M.: 2505 – 6 · 138
Morrow, David: 902 – 3 · 107, 905 – 7 · 109, 916 – 8 · 140
Morrow, David A.: 300 · 112, 508 · 191
Morrow, William R.: 252 · 201
Morton, Geraint: 908 – 3 · 110
Moscona, John: 916 – 6 · 140
Moser, Marvin: 230 · 159
Moses, Jeffrey: 2500 – 7 · 137, 2500 – 9 · 137, 2500 – 11 · 137, 2505 – 8 · 138, 2507 – 11 · 146, 305 · 181
Moses, Jeffrey W.: 2621 · 162
Moshkevich, Solomon: 903 – 5 · 108
Moskovits, Norbert: 408 · 187
Moss, Arthur: 919 – 5 · 149, 919 – 6 · 149
Moss, Arthur J.: 222 · 141, 655 · 163, 691 · 184
Moss, Richard: 906 – 8 · 110
Moss, Robert R.: 2635 · 195
Mostashari, Farzad: 647 · 159
Mota, Luiz: 304 · 143
Motz, Wolfgang: 2509 – 9 · 147
Mountis, Maria: 906 – 7 · 110
Mousa, Tarek M.: 744b · 170
Moussa, Issam: 308 · 210
Moussa, Issam D.: 2511 · 147
Moustakakis, Emmanuel N.: 744b · 170
Movahed, Mohammad R.: 2305 · 125
Moye, Lem: 300 · 112
Mueller, Gisela: 918 – 3 · 148
Mugnolo, Antonio: 2510 – 11 · 140
Mukamal, Kenneth J.: 905 – 5 · 109
Mukherjee, Debabrata: 408 · 187, 665 · 167, 689 · 184, 689 · 184
Mullens, Wilfried: 912 – 7 · 142
Muller, James: 2508 – 13 · 139
Mulvagh, Sharon: 929 – 8 · 154
Mulvagh, Sharon L.: 620 · 123
Munir, Khan: 932 – 5 · 155
Munshi, Kartik: 916 – 6 · 140
Muntner, Paul: 910 – 5 · 111
Murali, Srinivas: 705 · 196
Muramatsu, Toshiya: 2504 – 7 · 138, 2504 – 9 · 138
Murphy, Daniel J.: 252 · 201, 402 · 162
Murphy, Joseph G.: 113 · 193
Murphy, Ryan M.: 929 – 4 · 154
Murphy, Sabina: 902 – 3 · 107, 902 – 5 · 108
Murray, Sarah S.: 2644 · 107
Murthy, Venkatesh: 910 – 3 · 111
Mushlin, Alvin I.: 928 – 8 · 154
Muthappan, Palaniappan: 2511 – 15 · 147
Muthuchamy, Mariappan: 906 – 8 · 110
Muto, Makoto: 2504 – 7 · 138
Myerburg, Robert: 703 · 196, 703 · 196
Myers, Jonathan N.: 929 – 6 · 154
Mylotte, Darren: 2502 – 9 · 119, 407 · 181, 926 – 7 · 153
Na, Jin Oh: 2505 – 12 · 139
Naccarelli, Gerald V.: 206 · 116, 706 · 197
Nadamanee, Koonlawee: 691 · 184
Nagai, Hiroyuki: 2303 · 115
Nagavalli, Sravanthi: 932 – 4 · 155
Nagel, Eike: 908 – 3 · 110
Nagueh, Sherif F.: 2618 · 161, 619 · 122, 638 · 151
nagurney, john: 308 · 210
Naidu, Srihari: 2310 · 156
Naidu, Srihari S.: 2122 · 183, 2315 · 189, 2612 · 125
Naik, Sunil: 2309 · 156
Naito, Masaki: 2309 · 156
Najm, Hani: 515 · 193, 746 · 105
Nakagawa, Yoshihisa: 2509 – 13 · 147
Nakamura, Shigeru: 2504 – 7 · 138
Nakamura, Sunao: 2505 – 16 · 139
Nakanishi, Rine: 924 – 5 · 151
Nakatani, Shimpei: 2303 · 115
Nakazawa, Gaku: 2503 – 7 · 145, 2611 · 125
Nanda, Navin C.: 509 · 190
Nanjundappa, Aravinda: 2305 · 125, 2311 · 166, 2607 · 115, 2642 · 201
Nanto, Kiyonori: 931 – 4 · 113
Naofumi, Doi: 2309 · 156
Narasimhan, Calambur: 509 · 190
Narula, Jagat: 111 · 159, 2121 · 177
Nasir, Khurram: 696 · 185, 924 – 4 · 151, 927 –3 · 153, 930 – 7 · 155
Nasseri, Boris A.: 921 – 7 · 150
Natale, Andrea: 716 · 201, 212 · 121, 925 – 8 · 152
Natarajan, Madhu: 2644 · 107
Nath, Jayant: 932 – 4 · 155
Nathan, Sandeep: 2308 · 156
Natsuaki, Masahiro: 2509 – 13 · 147
Naya, Masanao: 910 – 3 · 111
Nazif, Tamim: 211 · 121
Neilan, Tomas G.: 922 – 3 · 150
Neish, Steven R.: 802 · 111
Nelson Worel, Jane: 701 · 193
Neumann, Franz-Josef: 739 · 211, 2501 – 14 · 138, 2501 – 16 · 138
Neunteuff, Thomas D: 304 · 143
Neville, Susan: 922 – 5 · 150
Newburger, Jane: 247 · 196, 107A · 125
Newby, David: 714 · 199
Newby, David E.: 407 · 181, 740 · 204
Newby, L. Kristin: 728 · 209
Newman, Jonathan: 904 – 4 · 141
Newton, Roger: 911 – 10 · 143
Ng, Jason: 406 · 154, 929 – 5 · 154
nguyen, can: 2510 – 9 · 139
Nicholas, Michael: 2311 · 166
Nicholls, Stephen: 2303 · 115
Nichols, Len: 687 · 180
Nickenig, Georg: 917 – 3 · 148
Nihoyannopoulos, Petros: 745 · 203
Niinuma, Hiroyuki: 909 – 8 · 111
Nijveldt, Robin: 918 – 4 · 148
Nikas, Dimitrios: 2510 – 11 · 140
Nikolsky, Eugenia: 2505 · 138
Nishimura, Rick A.: 103 · 117, 256 · 204, 258 · 210, 619 · 122, 710 · 198, 107A · 125, 309 · 211, 744a · 170, 801 · 105
Nissen, Steven: 306 · 186
Nissen, Steven E.: 215 · 123, 107A · 125
Nkomo, Vuyisile: 210 · 118, 220 · 129, 930 · 155
Nobuyoshi, Masakiyo: 2302 · 114
Noel, Bernard: 2510 – 9 · 139
Noheria, Amit: 744b · 170
232 GO for ACC.12!
Last Name, First Name: Session # · Page #
Author Index • ACC.12
Nohria, Anju: 626 · 127
Nombela-Franco, Luis: 915 – 6 · 145
Noohi Bezanjani, Feridoun: 746 · 105
Nordbeck, Peter: 918 – 7 · 148
Normand, Sharon-Lise T.: 700 · 186
Novak, Jan: 406 · 154
Novo, Salvatore: 706 · 197
Nugent, Alan W.: 692 · 184
Nunez, Julio: 908 – 6 · 110
Nuyles, Michael: 2311 · 166
Nyberg, Fredrik: 911 – 6 · 143
Nylander, Sven: 902 – 7 · 108
O’Brien, Kevin: 930 – 7 · 155
O’Brien, Sean: 308 · 210, 915 – 5 · 145, 928 – 5 · 154
O’Connell, John B.: 2122 · 183
O’Connor, Christopher: 921 – 5 · 150
O’Donoghue, Susan: 744b · 170
O’Gara, Patrick T.: 103 · 117, 260 · 211, 712 · 199, 107A · 125, 305 · 181, 309 · 211, 503 · 188, 675 · 169, 744a · 170, 801 · 105
O’Neill, Blair J.: 504 · 193
O’Neill, Brian P.: 2121 · 177, 2505 · 138
O’Neill, William W.: 213 · 122, 2643 · 201, 604 · 115, 2315 · 189
O’Riordan, Martin: 603 · 113
Ochala, Andrzej: 304 · 143
Ochiai, Masahiko: 2621 · 162
Oderich, Gustavo: 2613 · 126
Oechslin, Erwin N.: 725 · 209
Oetgen, William J.: 219 · 128, 607 · 116
Ofili, Elizabeth: 686 · 180, 656 · 163
Ogawa, Hisao: 2505 – 16 · 139
Ogle, James: 2314 · 189
Oh, Dong Joo: 2505 – 12 · 139
Oh, Jae K.: 208 · 116, 229 · 159, 714 · 199
Ohman, Erik M.: 2638 · 196, 2315 · 189, 304 · 143
Oieru, Dan: 924 – 3 · 151
Oikawa, Yuji: 2621 · 162
Oikonomou, Evangelos: 931 – 3 · 113
Okamoto, Shin: 2311 · 166
OKAMURA, ATSUNORI: 2504 – 7 · 138, 2303 · 115
Okubagzi, Petros: 915 – 8 · 145
Oldroyd, Keith: 2506 – 13 · 146, 923 – 9 · 152
Olin, Jeffrey: 931 – 7 · 113
Olin, Jeffrey W.: 2610 · 120, 931 – 8 · 113
Oliveira, Ricardo: 929 – 6 · 154
Oliver-McNeil, Sandra M.: 112 · 180, 2104 · 165
Olivotto, Iacopo: 925 – 4 · 152, 925 – 5 · 152
Olshansky, Brian: 914 · 144
Ommen, Steve R.: 256 · 204, 607 · 116, 607 · 116, 619 · 122, 648 · 159, 661 · 164, 801 · 105, 807 · 124
Onishi, Tetsuari: 907 – 7 · 142
Onishi, Toshinari: 907 – 7 · 142
Onsea, Kevin: 926 – 5 · 153
Onuma, Yoshinobu: 2503 – 11 · 146
Oparil, Suzanne: 926 · 153, 631 · 128, 250 · 198
Opitz, Anke: 2507 – 13 · 147
Opitz, Christian: 2509 – 9 · 147
Oral, Elif: 235 · 164, 711 · 199
Orav, Endel: 901 – 5 · 114
Orban, Marek: 406 · 154
Oren, Ron M.: 921 – 4 · 150
Ormiston, John: 2503 – 13 · 146
Ormiston, John A.: 2611 · 125, 2632 · 184, 2202 · 161
Ornish, Dean: 698 · 186
Orsinelli, David: 204 · 110
Oshinski, John N.: 406 · 154
Osten, Mark: 2505 – 6 · 138, 2644 · 107
Otake, Hiromasa: 2503 – 7 · 145
Otto, Catherine M.: 714 · 199, 258 · 210
Otto, Sylvia: 2645 · 120
Ou, Narith: 732 · 109
Oudiz, Ronald J.: 254 · 203
Overgaard, Chris: 2505 – 6 · 138
Overholser, Brian: 913 – 8 · 143
Owens, Douglas K.: 903 – 5 · 108
Ozaki, Yukio: 2639 · 202
Ozkan, Mehmet: 518 · 189
Pacchioni, Andrea: 2510 – 11 · 140
Pack, Quinn: 929 – 8 · 154
Pack, Quinn R.: 927 – 6 · 153
Packer, Douglas L.: 666 · 167
Packer, Milton: 722 · 204
Pagani, Francis D.: 213 · 122
Page, Richard L.: 666 · 167
Page, II, Robert L.: 225 · 150, 736 · 125
Pahl, Elfriede: 901 – 5 · 114
Palacios, Igor: 2308 · 156, 2310 · 156
Palacios, Igor F.: 2630 · 183, 2635 · 195, 2310 · 156, 238 · 171
Palma-Davis, LaVaughn: 913 – 6 · 143
Palmieri, Bruno: 2506 – 15 · 146
Pancholy, Samir B.: 2510 · 139
Paniagua de Decoud, Maria: 516 · 192
Papadakis, Michael: 914 – 4 · 144, 914 – 7 · 144
Papademetriou, Vasilios: 926 – 8 · 153
Papageorgiou, Nikolaos: 931 – 3 · 113
Papavassiliou, Athanasios G.: 931 – 3 · 113
Papp, Andrea: 910 – 8 · 111
Pappagianopoulos, Paul P.: 929 – 4 · 154
Pappas, Christos: 903 – 4 · 108
Paradis, Jean-Michel: 2500 – 11 · 137, 2507 – 11 · 146
Parharidis, George: 745 · 203
Paridon, Stephen: 901 – 6 · 114
Parikh, Manish A.: 2201 · 119, 2202 · 161, 2509 · 147
Parikh, Sahil A.: 2633 · 189
Parise, Helen: 665 · 167, 2501 – 6 · 137, 2501 – 14 · 138, 2501 – 16 · 138, 2502 – 15 · 119, 2506 – 9 · 146, 304 · 143, 665 · 167
Park, Chang Gyu: 2505 – 12 · 139
Park, Chong H.: 744b · 170
Park, Duk-Woo: 2645 · 120, 646 · 155, 511 · 188
Park, Euljoon: 926 – 8 · 153
Park, Hyo Eun: 930 – 8 · 155
Park, Jae Hyoung: 405 · 144
Park, Jae-Hyeong: 912 – 8 · 142
Park, Ji Young: 2505 – 12 · 139
Park, Jong-Seon: 2504 – 13 · 138
Park, Kyung Woo: 304 · 143
Park, Margaret: 912 – 8 · 142
Park, Myung H.: 705 · 196
Park, Seong-Wook: 2645 · 120, 2645 · 120
Park, Seung-Jung: 2645 · 120, 2202 · 161, 511 · 188
Park, Yonghwi: 2501 – 12 · 137
Parker, Beth A.: 911 – 9 · 143
Parodi, Juan Carlos: 502 · 188
Parra, David: 732 · 109, 733 · 114, 734 · 116, 735 · 122, 736 · 125
Pasquet, Agnès: 260 · 211
Passeri, Jonathan: 2308 · 156, 2310 · 156
Patange, Amit: 408 · 187
Patel, Amit R.: 407 · 181
Patel, Dharmendrakumar: 927 – 5 · 153
Patel, Hamang M.: 662 · 164
Patel, Kavita: 650 · 153
Patel, Manesh R.: 205 · 112, 2643 · 201
Patel, Nainesh C.: 263 · 170
Patel, Rikesh: 2313 · 189
Patel, Uptal: 2511 – 11 · 147
Patrick, Jonathan: 2306 · 125
Patrick-Lake, Bray: 601 · 112
Patted, Suresh: 2314 · 189
Patted, Suresh V.: 2310 · 156, 2313 · 189
Patterson, Cam: 405 · 144
Patterson, J. Herbert: 921 – 4 · 150
Patton, Kristen K.: 736 · 125, 918 · 148, 820 · 192
Paul, Jonathan: 2308 · 156
Paul, Sara: 217 · 127, 717 · 202
Peberdy, Mary Ann: 929 – 6 · 154
Pedrazzini, Giovanni: 930 – 3 · 155
Pehlivanoglu, Seckin: 518 · 189
Pelargonio, Gemma: 925 – 8 · 152
Pelchovitz, Daniel J.: 406 · 154
Pellegrini, Cara: 690 · 184
Pellegrini, Gian: 407 · 181
Pelliccia, Antonio: 262 · 187, 262 · 187
Pellikka, Patricia A.: 407 · 181, 643 · 158, 657 · 163
Pelosi, Frank: 2122 · 183
Pena, Tino: 2607 · 115, 2616 · 156
Penaloza, Dante: 726 · 210
Pencina, Michael: 700 · 186, 905 – 3 · 109
ACC.12 Final Program 233
Last Name, First Name: Session # · Page #
ACC.12 • Author Index
Peng, Szu-Po: 913 – 7 · 143
Penn, Marc: 300 · 112
Pennacchi, Mauro: 2644 · 107
Pennell, Dudley: 908 – 4 · 110
Pennell, Dudley J.: 920 – 8 · 149, 740 · 204
Penzo, Carlo: 2510 – 11 · 140
Pepine, Carl: 620 · 123, 300 · 112
Pepine, Carl J.: 906 – 4 · 109
Perera, Divaka: 2645 · 120, 908 – 3 · 110
Perez, Marco: 904 – 4 · 141
Perin, Emerson C.: 300 · 112
Peruga, Jan Z.: 2501 – 6 · 137
Pescatello, Linda S.: 911 – 9 · 143
Petersen, John W.: 906 – 4 · 109
Peterson, Eric: 664 · 165, 304 · 143, 308 · 210, 913 – 7 · 143
Peterson, Eric D.: 721 · 204
peterson, eric D.: 915 – 5 · 145
Peterson, Eric D.: 513 · 190, 928 – 5 · 154
Peterson, Mark: 2644 · 107
Pettersen, Michael: 408 · 187
Pfeffer, Marc: 704 · 196
Philippon, François: 915 – 6 · 145
Phillips, Matthew: 244 · 185, 244 · 185, 621 · 123
Phillips, Tierney: 2644 · 107
Piana, Robert N.: 600 · 112
Piazza, Nicolo: 2507 – 13 · 147, 2618 · 161, 2131 · 160
Pibarot, Philippe: 915 – 6 · 145, 707 · 197, 2644 · 107
Picard, Michael: 914 – 8 · 144
Picard, Michael H.: 657 · 163
Pichard, Augusto: 2606 · 115, 2635 · 195, 2203 · 194, 2308 · 156, 2500 – 15 · 137, 2507 – 15 · 147, 2635 · 195, 915 – 8 · 145
Piek, Jan: 2502 – 13 · 119, 918 – 4 · 148
Pieper, Petronella G.: 738 · 181
Pierard, Luc: 242 · 182, 256 · 204
Pierucci, Daniela: 2644 · 107
Pijls, Nico: 923 – 9 · 152, 2508 – 7 · 139
Pijnappels, Daniël: 906 – 3 · 109
Pilote, Louise: 920 – 4 · 149
Pina, Ileana: 921 – 4 · 150
Pina, Ileana L.: 217 · 127, 224 · 143, 237 · 169, 641 · 157
Pineiro, Daniel: 726 · 210
Pinney, Sean P.: 670 · 168
Pinto, Duane S.: 2111 · 177, 613 · 121, 1605 · 171
Piscione, Federico: 916 – 5 · 140
Pislaru, Sorin: 251 · 199
Pitsavos, Christos: 931 – 3 · 113
Pitt, Bertram: 107A · 125, 921 – 6 · 150
Placentino, Filippo: 2644 · 107
Plakomyti, Theodora E.: 903 – 4 · 108
Plana, Juan C.: 2122 · 183
Plutzky, Jorge: 306 · 186
Pocock, Stuart: 665 · 167, 2501 – 10 · 137
Poerner, Tudor C.: 2645 · 120
Poggio, Daniele: 914 – 6 · 144
Polk, Donna: 911 – 9 · 143
Polk, Donna M.: 709 · 197, 729 · 203, 730 · 170
Pollice, Paolo: 909 – 3 · 110
Poole, Jeanne E.: 216 · 126, 243 · 184
Pope, James H.: 308 · 210
Popma, Jeffrey: 2506 – 7 · 146, 2509 – 11 · 147, 2645 · 120, 308 · 210
Popma, Jeffrey J.: 2114 · 194, 2635 · 195, 2309 · 156
Popovic, Zoran: 908 – 5 · 110
Porter, Thomas R.: 672 · 168
Porvasnik, Stacy L.: 906 – 4 · 109
Posteraro, III, Anthony F.: 744b · 170
Postley, John: 927 – 7 · 153
Pothier, Claire: 306 · 186
Powell, Alex: 2623 · 166
Powell, Andrew: 693 · 185
Powell, Brian: 212 · 121, 815 · 165
Prabhakaran, Dorairaj: 742 · 186
Prager, Richard L.: 721 · 204
Prakash, Ashwin: 693 · 185
Prasad, Sanjay: 719 · 202, 908 – 4 · 110
Pratap, T.: 2306 · 125
Price, Matthew J.: 2617 · 156, 2627 · 178, 2644 · 107, 2132 · 195, 2202 · 161, 2506 – 6 · 146
Primitivo, Stefano Giuseppe: 909 – 3 · 110
Prince, Martin: 908 – 8 · 110
Proulx, Guy: 2510 – 9 · 139
Providencia, Luis: 903 – 8 · 108
Prystowsky, Eric N.: 615 · 121, 654 · 162, 501 · 190
Pump, Agnes: 925 – 8 · 152
Puri, Rishi: 2303 · 115
Puskas, John: 2302 · 114
Pyo, Robert: 2504 · 138
Pyrgakis, Vlassios N.: 745 · 203
Pyxaras, Stelios: 923 – 9 · 152
Qian, Juying: 2645 · 120
Qin, Yongwen: 2645 · 120
Quagliara, Donato: 909 – 3 · 110
Quaife, Robert: 2507 – 9 · 146
Quick, Harald H.: 918 – 7 · 148
Quinones, Miguel A.: 516 · 192
Quyyumi, Arshed A.: 406 · 154
Rab, Syed: 2303 · 115
Rab, Syed T.: 2306 · 125, 2315 · 189
Raber, Lorenz: 910 – 4 · 111
Raby, Khether E.: 205 · 112
Radtke, Wolfgang A. K.: 2615 · 148
Radu, Maria: 2503 – 13 · 146
Raff, Gilbert: 924 – 5 · 151, 628 · 127, 924 – 7 · 151
Rahimi, Farnoosh: 308 · 210
Rahimtoola, Shahbudin H.: 514 · 194, 659 · 163
Raichlen, Joel: 2508 – 13 · 139
Raiszadeh, Farbod: 744a · 170
Raj, Satish: 640 · 157
Rajagopal, Sudarshan: 744a · 170
Rajagopalan, Navin: 705 · 196
Rajagopalan, Sanjay: 406 · 154
Rajamannan, Nalini M.: 714 · 199
Rakowski, Harry: 925 – 4 · 152, 925 – 5 · 152
Ram, C. Venkata S.: 727 · 210
Ramachandran, Vasan: 905 – 3 · 109
Raman, Subha V.: 241 · 179, 228 · 157
Ramanathan, Kodangudi: 925 – 6 · 152
Ramani, Gautam V.: 912 · 142
Ramani, Ravi: 670 · 168
Ramee, Stephen R.: 2637 · 195, 2500 · 137
Ramires, Jose: 911 – 8 · 143
Ramkisoensing, Arti: 906 – 3 · 109
Ramstad, Anders: 113 · 193
Ranjan, Ravi: 918 – 8 · 148
Rao, Seshu: 2501 – 8 · 137
Rao, Sunil: 2510 – 9 · 139, 2510 – 15 · 140, 928 – 3 · 153, 928 – 6 · 154
Rao, Sunil V.: 109 · 128, 2111 · 177, 2113 · 194, 2624 · 167, 2634 · 190, 604 · 115, 639 · 156, 1605 · 171, 813 · 164
Rapezzi, Claudio: 925 – 5 · 152, 925 – 4 · 152
Rapoza, Richard: 2503 – 13 · 146
Rashwan, Magdy: 506 · 191
Rasmusson, Kismet: 217 · 127, 695 · 185
Raspanti, Silvia: 903 – 6 · 108
Rassi, Andrew: 2502 – 11 · 119
Ratajczak, Mariusz Z.: 917 – 7 · 148
Ravkilde, Jan: 2506 – 11 · 146
Ray, Carolyn: 744b · 170
Razavi, Mahmood K.: 2607 · 115
Read, Philip: 923 – 7 · 152
Reardon, Michael: 2203 · 194
Redberg, Rita: 928 – 8 · 154
Redberg, Rita F.: 644 · 158, 709 · 197
Reddy, M, Sahadev T.: 918 – 5 · 148
Redfield, Margaret M.: 203 · 109, 656 · 163, 107A · 125
Redheuil, Alban: 908 – 8 · 110
Redington, Andrew: 901 – 3 · 114
Redwood, Simon: 2645 · 120
reed, matthew: 914 – 4 · 144
Reed, Timm: 2103 · 165
Reeder, Guy: 406 · 154
Regar, Evelyn: 2503 – 13 · 146, 2611 · 125
Reiffel, James A.: 677 · 178
Reilly, John P.: 214 · 122, 823 · 200
Reimers, Bernhard: 2507 · 146, 2510 – 11 · 140
Reisman, Mark: 2131 · 160, 2132 · 195, 2505 – 8 · 138
Rene, A. Garvey: 2500 – 11 · 137
Resar, Jon: 2314 · 189
Resnic, Frederic S.: 215 · 123
Reuter, David: 633 · 129
234 GO for ACC.12!
Last Name, First Name: Session # · Page #
Author Index • ACC.12
Rexrode, Kathryn: 904 – 4 · 141
Rezende, Paulo C.: 911 – 8 · 143
Rha, Seung-Woon: 2504 – 13 · 138, 2505 – 12 · 139
Rhee, Ceron: 903 – 5 · 108
Rhodes, Denise A.: 2104 · 165
Rhodes, John F.: 634 · 141, 637 · 149, 518 · 189
Rhodes, Jonathan: 261 · 171
Rich, Michael: 924 – 8 · 151
Rich, Michael W.: 225 · 150, 722 · 204
Richardson, Caroline: 701 · 193
Richardson, Hamish: 407 · 181
Richman, Joshua: 910 – 5 · 111
Rickard, Jack: 922 – 7 · 150
Ricotta, John J.: 2613 · 126
Ridker, Paul: 911 – 4 · 143, 911 – 6 · 143
Riggs, Lisa A.: 2103 · 165
Rigolin, Vera H.: 242 · 182, 707 · 197
Rihal, Charanjit S.: 104 · 117, 211 · 121, 504 · 193, 518 · 189, 200 · 107, 2630 · 183
Rinaldi, Michael: 2501 – 14 · 138, 2501 – 16 · 138, 2502 – 7 · 119
Rinehart, Sarah: 924 – 6 · 151
Rinfret, Stephane: 2510 – 9 · 139
Ringel, Richard: 901 – 8 · 114
Ritter, Oliver: 918 – 7 · 148
Ritzenthaler, Laura: 308 · 210
Rivero, Fernando: 2504 – 15 · 138
Rizas, Konstantinos: 926 – 6 · 153
Rizzo, Caterina: 909 – 3 · 110
Robbers, Lourens: 918 – 4 · 148
Roberts, Michael: 919 – 8 · 149
Roberts, Robert: 602 · 113
Robinson, Jennifer: 227 · 152, 729 · 203
Robinson, Thompson: 727 · 210
Rocha-Singh, Krishna J.: 2610 · 120, 2642 · 201
Rochitte, Carlos: 909 – 8 · 111
Rodes-Cabau, Josep: 2644 · 107, 251 · 199, 2510 – 9 · 139, 2606 · 115, 2626 · 177, 504 · 193, 723 · 204
Rodés-Cabau, Josep: 915 – 6 · 145
Rodgers, George P.: 914 – 5 · 144
Rodgers, Jo E.: 732 · 109
Rodrigo, Maria E.: 2306 · 125
Rodriguez, Carlos J.: 664 · 165
Rodriguez, L. Leonardo: 907 – 5 · 142
Rodríguez-Abella, Hugo: 906 – 5 · 110
Roe, Matthew: 913 – 7 · 143, 928 – 8 · 154
Roe, Matthew T.: 653 · 162
Roffi, Marco: 2631 · 183, 2633 · 189
Rogers, Frances A.: 662 · 164
Rogers, Jason H.: 2619 · 161, 2510 · 139, 2610 · 120
Rogers, Joseph G.: 694 · 185
Rohatgi, Anand: 826 · 203
Rokos, Ivan: 613 · 121, 604 · 115
Romano, Mauro: 2500 – 13 · 137, 407 · 181
Rome, Eric: 904 – 6 · 141
Rome, Jonathan: 901 – 8 · 114
Romeo, Francesco: 906 – 4 · 109, 706 · 197
Rorick, Tyrus: 903 – 8 · 108
Roselli, Eric: 2619 · 161, 2626 · 177
Rosenberg, Steven: 923 – 8 · 152, 924 – 6 · 151
Rosenfield, Kenneth: 2616 · 156, 2631 · 183, 2310 · 156
Rosenson, Robert S.: 730 · 170
Rosenzweig, James L.: 405 · 144
Rossano, Joseph W.: 901 – 6 · 114
Roth, Eli M.: 911 – 5 · 143
Rothman, Andrew: 922 – 4 · 150
Rottbauer, Wolfgang: 903 – 3 · 108, 908 – 7 · 110
Roubin, Gary S.: 2637 · 195
Rouleau, Jacques: 2510 – 9 · 139
Rowin, Ethan: 925 – 4 · 152, 925 – 5 · 152
Roy, Denis: 207 · 116
Roy, Louis: 2510 – 9 · 139
Roy, Melanie: 2510 – 9 · 139
Rozehnal, John: 905 – 7 · 109
Rozenman, Yoseph: 510 · 193
Rubin, Jeffrey: 932 – 5 · 155
Rubio, Agustin E.: 247 · 196
Rudd, James H.: 407 · 181
Ruderman, Neil B.: 405 · 144
Rudolph, Volker: 930 – 6 · 155
Rudski, Lawrence G.: 241 · 179, 638 · 151
Ruff, Christian T.: 916 – 8 · 140
Ruge, Hendrik: 2507 – 13 · 147
Ruggiero, II, Nicholas J.: 2623 · 166
Ruiz, Carlos: 2510 – 13 · 140, 901 – 8 · 114
Ruiz, Carlos E.: 2630 · 183, 2132 · 195, 2314 · 189
Rumoroso, Jose R.: 2504 – 15 · 138
Rumsfeld, John: 2511 – 11 · 147, 928 – 3 · 153
Rumsfeld, John S.: 209 · 117, 515 · 193, 913 · 143, 913 – 3 · 143
Rundback, John: 2616 · 156
Rusconi, Paolo: 901 – 5 · 114
Russell, Raymond R.: 642 · 157
Russo, Andrea M.: 216 · 126, 239 · 178
Russo, Cesare: 907 – 4 · 142
Russo, Mark: 2308 · 156
Russo, Robert J.: 2625 · 177, 2629 · 183
Ruthazer, Robin: 308 · 210
Ryan, Thomas: 907 – 8 · 142
Ryan, Thomas J.: 657 · 163, 737 · 169
Rychik, Jack: 725 · 209
Saba, Samir: 907 – 7 · 142, 922 – 6 · 150
Sabatine, Marc: 916 – 8 · 140
Sabatine, Marc S.: 2617 · 156, 407 · 181, 739 · 211
Sabbah, Hani N.: 746 · 105
Sable, Craig A.: 725 · 209
Saccà, Salvatore: 2510 – 11 · 140
Saeed, Wajeeha: 912 – 4 · 142
Safford, Monika: 910 – 5 · 111
Safirstein, Jordan: 695 · 185
Safley, David: 2511 – 13 · 147
Safley, David M.: 2510 – 7 · 139
Saia, Theresa A.: 616 · 122
Saidi, Arwa S.: 667 · 167
Saito, Yoshihiko: 917 – 8 · 148
Sakai, Koyu: 2302 · 114
Sakamoto, Yasunari: 2504 – 9 · 138
Saksena, Sanjeev: 509 · 190
Sakwa, Marc P.: 929 – 7 · 154
Salamon, Jason: 912 – 4 · 142
Salcedo, Ernesto: 2507 – 9 · 146
Salisbury, Adam: 2511 – 13 · 147
Salman, Nabia: 912 – 6 · 142
Saltik, Levent: 518 · 189
Salustri, Alessandro: 746 · 105
Salvatella, Neus: 2504 – 15 · 138
Samady, Habib: 2608 · 119, 2639 · 202
Sanborn, Timothy A.: 2624 · 167, 2502 · 119
Sanchez, Pedro L.: 916 – 5 · 140
Sanchez, Pedro L: 906 – 5 · 110
Sanchez-Recalde, Angel: 2504 – 15 · 138
Sanchis, Juan: 908 – 6 · 110
Sanders, Stephen: 692 · 184
Sandhu, Amneet: 408 · 187
Sangli, Chithra: 930 – 4 · 155
Sanidas, Elias: 2508 · 139
Sanoski, Cynthia: 736 · 125
Santangeli, Pasquale: 925 – 8 · 152
Santarelli, Pietro: 925 – 8 · 152
Santini, Alberto: 903 – 6 · 108
Santoro, Daniela: 909 – 3 · 110
Santos-Gallego, Carlos: 902 – 6 · 108
Santucci, Eliana: 304 · 143
Sanz, Javier: 726 · 210
Sarafin, Jennifer: 2502 – 7 · 119
Sardar, Rizwan: 912 – 4 · 142
SARDELLA, GENNARO: 2644 · 107
Sardella, Gennaro: 2506 · 146
Saric, Muhamed: 707 · 197
Sarsam, Sinan: 918 – 3 · 148
Satler, Lowell: 2308 · 156, 2500 – 15 · 137, 2507 – 15 · 147, 915 – 8 · 145
Sato, Kei: 931 – 6 · 113, 2311 · 166
Saudye, Hammad: 2315 · 189
Sauer, William: 918 – 3 · 148
Sauer, William H.: 216 · 126
Sawyer, Douglas: 405 · 144
Saxena, Anita: 2310 · 156
Saxon, Leslie A.: 212 · 121
Saxonhouse, Sherry: 803 · 118, 810 · 128, 820 · 192
Scantlebury, Dawn: 744a · 170
ACC.12 Final Program 235
Last Name, First Name: Session # · Page #
ACC.12 • Author Index
Schafer, Ulrich: 930 – 3 · 155
Schainfeld, Robert: 2607 · 115, 2616 · 156, 2633 · 189
Schalij, Martin: 906 – 3 · 109, 917 – 5 · 148
Schauer, Philip R.: 306 · 186
Schauwecker, Peter: 903 – 3 · 108
Scheinman, Melvin M.: 615 · 121
Schelbert, Erik: 228 · 157
Scheller, Bruno: 2509 – 7 · 147, 2509 – 9 · 147, 916 – 5 · 140
Scherillo, Marino: 706 · 197
Scheurer, Mark: 634 · 141
Schiller, Nelson B.: 241 · 179
Schillinger, Wolfgang: 930 – 3 · 155
Schlaich, Markus: 926 – 3 · 153, 926 – 4 · 153
Schlüter, Michael: 930 – 6 · 155
Schmieder, Roland: 926 – 4 · 153
Schnell, Susan: 2102 · 160
Schoenfeld, David: 308 · 210
Schoenfeld, Mark H.: 614 · 121
Schoenhagen, Paul: 2635 · 195
Schomig, Albert: 2503 – 9 · 146
Schotborgh, Carl: 2502 – 13 · 119
Schreier, Jenna: 920 – 7 · 149
Schrezenmeier, Hubert: 903 – 3 · 108
Schroyer, Michael K.: 609 · 117, 684 · 180
Schuler, Gerhard: 902 – 8 · 108
Schuller, Joseph: 918 – 3 · 148
Schulman, Steven: 2314 · 189
Schultheiss, Hans Peter: 240 · 179
Schultz, Gregory: 906 – 4 · 109
Schuster, Andreas: 908 – 3 · 110
Schwartz, Allan: 2203 · 194, 2308 · 156, 2500 · 137
Schwartz, Robert S.: 923 – 8 · 152
Schwartz, Steven: 901 – 3 · 114
Schwartz, Todd: 921 – 4 · 150
Schwartzman, David: 907 – 7 · 142
Schwarz, Klaus: 903 – 3 · 108
Sciagrà, Roberto: 903 – 6 · 108
Scirica, Benjamin: 902 – 3 · 107, 916 – 8 · 140
Scirica, Benjamin M.: 604 · 115
Seale, Anna: 692 · 184
Seder, David: 263 · 170
Sedlis, Steven: 2505 – 10 · 139
Seeger, John: 922 – 4 · 150
Segev, Amit: 510 · 193, 924 – 3 · 151
Segovia, Javier: 517 · 191
Segre, Alexandre: 911 – 8 · 143
Segrest, Wendy: 928 – 7 · 154
Seldin, David C.: 257 · 209
Seliger, Stephen: 905 – 4 · 109, 905 – 6 · 109
Selim, Samy: 917 – 7 · 148
Selker, Harry P.: 308 · 210
Selvanayagam, Joseph: 257 · 209
Semigran, Marc J.: 257 · 209, 649 · 159, 2122 · 183, 905 · 109
Sen, Sayan: 923 – 6 · 152
Senapathi, Murali K.: 744b · 170
Senges, Jochen: 910 – 8 · 111, 915 – 4 · 145
Seo, Hong-Seog: 2505 – 12 · 139
Sera, Fusako: 2311 · 166
Serruys, Patrick: 916 – 4 · 140, 2506 – 9 · 146, 2511 – 7 · 147, 2645 · 120, 910 – 4 · 111
Serruys, Patrick W.: 2503 – 11 · 146, 2606 · 115, 2632 · 184, 2503 · 145, 2503 – 6 · 145, 2503 – 13 · 146
Seslar, Stephen P.: 667 · 167
Sethi, Nishant: 744b · 170
Sethi, Sanjum S.: 931 – 7 · 113
Setoguchi, Soko: 922 – 4 · 150
Seung, Ki-Bae: 511 · 188
Seyfarth, Melchior: 221 · 140
Sezer, Murat: 518 · 189
Shaban, Nada: 744a · 170
Shaban, Nada M.: 744b · 170
Shaddy, Robert: 901 – 6 · 114
Shah, Atman P.: 2308 · 156
Shah, Bindi K.: 615 · 121, 810 · 128, 813 · 164, 824 · 200
Shah, Binita: 2505 – 10 · 139, 931 – 5 · 113
Shah, Dipan J.: 719 · 202, 924 · 151
Shah, Moneal: 918 – 5 · 148
Shah, Nidhi: 408 · 187
Shah, Prediman K.: 221 · 140, 403 · 170, 611 · 117
Shah, Rashmee: 903 – 5 · 108
Shah, Ravi: 922 – 3 · 150
Shah, Sangeeta B.: 809 · 128
Shahian, David: 308 · 210
Shalaby, Alaa A.: 624 · 126
Shalev, Aryeh: 510 · 193
Shankar, Adurthy A.: 2306 · 125
Shannon, Francis L.: 929 – 7 · 154
Shara, Nawar: 904 – 4 · 141
Share, David: 2511 – 15 · 147
Sharifi, Mohsen: 308 · 210, 2616 · 156, 2633 · 189
Sharma, Aditya M.: 264 · 187
Sharma, Amit: 2311 · 166
Sharma, Mala: 907 – 4 · 142
Sharma, Samin: 2508 – 6 · 139
Sharma, Samin K.: 2504 · 138
Sharma, Sanjay: 262 · 187, 914 – 4 · 144, 914 – 7 · 144
Sharp, Jacqueline: 912 – 8 · 142
Shaw, Leslee: 924 – 7 · 151
Shaw, Leslee J.: 255 · 204, 620 · 123, 628 · 127, 408 · 187, 924 – 5 · 151
Shaw, Richard: 308 · 210
Shaywitz, Adam: 923 – 4 · 151
Sheehan, Patricia R.: 308 · 210
Shehadeh, Waseem: 912 – 6 · 142
Sheikh, Nabeel: 914 – 7 · 144, 914 – 4 · 144
Sheldon, Robert S.: 640 · 157
Shelton, Marc E.: 226 · 152, 512 · 192, 659 · 163
Shemin, Richard J.: 674 · 182
Shen, Win-Kuang: 677 · 178
Shenouda, Sherene M.: 405 · 144
Shepard, Charles: 252 · 201
Sherman, Warren: 689 · 184, 2309 · 156
Sherrid, Mark V.: 661 · 164
Sherwood, Matthew W.: 913 – 7 · 143
Shestakovska, Olga: 904 – 5 · 141
Shewan, Cynthia M.: 308 · 210
Shim, Eun-Bo: 2645 · 120
Shimbo, Daichi: 910 – 5 · 111
Shimizu, Wataru: 405 · 144
Shin, Dong-Ho: 2508 – 9 · 139, 2644 · 107
Shinke, Toshiro: 2503 – 7 · 145
Shirali, Girish S.: 301 · 157, 693 · 185
Shishehbor, Mehdi: 2502 – 11 · 119
Shishehbor, Mehdi H.: 2620 · 161, 2311 · 166, 2510 · 139, 502 · 188, 808 · 124, 823 · 200
Shite, Junya: 2503 – 7 · 145
Shivkumar, Kalyanam: 715 · 201
Shrivastava, Rakesh: 932 – 4 · 155
Shullo, Michael: 670 · 168
Shunk, Kendrick A.: 2629 · 183
Shuvy, Mony: 510 · 193
Siasos, Gerasimos: 931 – 3 · 113
Sibbing, Dirk: 1605 · 171
Sicari, Rosa: 672 · 168
Siddiqui, Danish: 2306 · 125
Siegel, Robert J.: 210 · 118, 2622 · 166, 2635 · 195
Siegel, Stephen A.: 688 · 182
Sievert, Horst: 930 – 3 · 155, 2619 · 161, 2630 · 183, 2132 · 195, 2132 · 195, 739 · 211
Sigwart, Ulrich: 253 · 203, 2612 · 125
Silber, Sigmund: 2632 · 184, 2201 · 119
Silversides, Candice: 679 · 179
Silvestry, Frank E.: 2609 · 120, 2622 · 166, 2622 · 166, 2131 · 160, 507 · 191, 643 · 158
Silvestry, Scott: 229 · 159, 922 · 150
Sim, David: 905 – 8 · 109
Sim, Kui-Hian: 512 · 192
Sim, Ling Ling: 905 – 8 · 109
Simari, Robert: 300 · 112
Simon, Jean-Philippe: 2509 – 9 · 147
Simon, Marc A.: 705 · 196
Simonton, Charles: 2506 – 9 · 146
Simprini, Lauren: 2306 · 125, 924 – 8 · 151
Simpson, Iain A.: 508 · 191
Simpson, Kathleen: 911 – 9 · 143
Singh, Anvesha: 2314 · 189
Singh, Harjit: 305 · 181
Singh, Jagmeet: 655 · 163
Singh, Tania: 915 – 8 · 145
Sinno, Mohamad: 918 – 3 · 148
Sinusas, Albert J.: 708 · 197
Siqueira, Dimytri: 2504 – 11 · 138
236 GO for ACC.12!
Last Name, First Name: Session # · Page #
Author Index • ACC.12
Siscovick, David: 905 – 5 · 109
Sivaram, Chittur A.: 710 · 198, 103 · 117, 106 · 123, 109 · 128, 710 · 198
Sivasubramanian, Ramakrishnan: 2310 · 156
Skarlatos, Sonia: 300 · 112
Skarlatos, Sonia I.: 710 · 198
Skelding, Kimberly A.: 2501 · 137
Skrocki, Laura: 308 · 210
Slater, James: 931 – 5 · 113
Slawnych, Mike: 603 · 113
Small, David: 902 – 6 · 108
Smedira, Nicholas G.: 2612 · 125
Smirnakis, Karen: 923 – 4 · 151
Smith, Brian: 923 – 4 · 151
Smith, Craig: 2500 – 7 · 137, 2500 – 9 · 137, 2500 – 11 · 137, 2507 – 11 · 146, 305 · 181
Smith, Cydni: 913 – 6 · 143
Smith, Dean: 408 · 187, 2511 – 15 · 147
Smith, James L.: 2508 – 11 · 139, 929 – 7 · 154
Smith, Peter K.: 675 · 169
Smith, Peter N.: 824 · 200
Smith, Jr., Sidney: 622 · 123, 699 · 186
Smits, Nicole C.: 405 · 144
Smits, Pieter: 2506 – 9 · 146
Smolensky, Alexander V.: 406 · 154
Smyth, Susan: 903 – 8 · 108, 917 – 7 · 148
Snyder, Brad: 305 · 181
Sobhy Aly, Mohamed: 506 · 191, 746 · 105
Sobotka, Paul: 926 – 3 · 153, 926 – 4 · 153
Sobotka, Paul A.: 2620 · 161
Soeda, Tsunenari: 917 – 8 · 148
Soendergaard, Lars: 930 – 3 · 155
Soga, Yoshimitsu: 2311 · 166, 931 – 4 · 113, 931 – 6 · 113
Sohn, Dae Won: 930 – 8 · 155
Solinas, Emilia: 2509 · 147
Solomon, Allen: 904 – 4 · 141
Solomon, Curtis: 2301 · 114
Solomon, Scott: 921 – 6 · 150
Solomon, Scott D.: 704 · 196, 641 · 157
Soman, Prem: 909 · 110
Somers, Virend K.: 406 · 154
Somerville, Jane: 400 · 106, 402 · 162
Song, Haegeun: 2645 · 120
Song, Pil Sang: 2504 – 13 · 138
Song, Young Bin: 2504 – 13 · 138
Sood, Nitesh: 919 – 5 · 149
Sood, Poornima: 2506 – 9 · 146
Sorajja, Paul: 253 · 203, 2630 · 183, 648 · 159, 661 · 164, 2121 · 177, 803 · 118, 817 · 169, 819 · 192
Sorour, Khaled: 506 · 191
Sosnovik, David E.: 719 · 202
Soucier, Richard: 744a · 170
Sousa, Amanda: 2504 – 11 · 138, 2506 – 15 · 146
Sousa, J Eduardo: 2506 – 15 · 146
Sousa, J. Eduardo: 2504 – 11 · 138
Specchia, Giuseppe: 914 – 6 · 144
Speight, Martina: 2102 · 160, 2105 · 171
Spencer, Kirk T.: 672 · 168, 107 · 124
Spertus, John: 2501 – 8 · 137, 2511 – 11 · 147, 2511 – 13 · 147, 928 – 8 · 154
Spertus, John A.: 107A · 125
Spiering, Wilko: 926 – 5 · 153
Spinler, Sarah A.: 623 · 126, 734 · 116
Spirito, Paolo: 925 – 4 · 152, 925 – 5 · 152
Spragg, David: 704 · 196
Sprandel, Marília C.: 911 – 8 · 143
Squires, Ray: 927 – 6 · 153
Sreekanth, Sowmya: 2309 · 156
Srivastav, Sudesh: 916 – 6 · 140
Stables, Rod: 2645 · 120
Stacey, Richard: 908 – 8 · 110
Staico, Rodolfo: 2504 – 11 · 138
Stamm, Christof: 921 – 7 · 150
Stanislawski, Maggie: 928 – 3 · 153
STAR-Study-Group: 910 – 8 · 111
Starling, Randall: 906 – 7 · 110, 908 – 5 · 110
Starling, Randall C.: 669 · 168, 694 · 185
Steaban, Robin: 684 · 180
Stecy, Peter: 2303 · 115
Stefanadis, C.: 926 – 8 · 153
Stefanadis, Christodoulos: 931 – 3 · 113, 2509 · 147
Stefanick, Marcia L.: 904 – 4 · 141
Stefanini, Giulio: 2645 · 120
Steg, Philippe G.: 304 · 143
Stegic, Jasminka: 2102 · 160
Stehlik, Josef: 670 · 168
Stein, Evan: 911 – 5 · 143, 923 – 4 · 151
Stein, Evan A.: 729 · 203, 306 · 186
Stein, James H.: 227 · 152
Steinberg, Jonathan S.: 704 · 196, 716 · 201
Stella, Pieter: 926 – 5 · 153
Stevens, Steven M.: 221 · 140
Stevenson, Lynne: 922 – 4 · 150
Stevenson, Lynne W.: 744b · 170, 669 · 168, 107A · 125
Stevenson, William: 922 – 3 · 150
Stevenson, William G.: 715 · 201
Stewart, Garrick: 922 – 4 · 150
Stewart, William J.: 242 · 182, 2618 · 161
Steyerberg, Ewout W.: 910 – 4 · 111
Stio, Rocco: 2644 · 107
Stone, Gregg: 2501 – 6 · 137, 2501 – 10 · 137, 2501 – 14 · 138, 2501 – 16 · 138, 2502 – 15 · 119, 2506 – 7 · 146, 2506 – 9 · 146, 2508 – 15 · 139, 2511 – 7 · 147, 916 – 4 · 140
Stone, Gregg W.: 2632 · 184, 2640 · 200, 604 · 115, 622 · 123, 623 · 126, 646 · 155, 404 · 199, 2506 – 13 · 146, 304 · 143
Stone, Neil: 911 · 142, 227 · 152, 235 · 164, 227 · 152
Storey, Robert: 903 – 8 · 108
Stout, Karen K.: 625 · 127, 668 · 168, 802 · 111, 805 · 123
Strony, John: 903 – 8 · 108
Stuart, Leilani: 928 – 7 · 154
Stuckey, Thomas: 2501 – 14 · 138, 2501 – 16 · 138
Stuckey, Thomas D.: 104 · 117
Subacius, Haris: 929 – 5 · 154
Subherwal, Sumeet: 928 – 6 · 154
Sudhir, Krishnan: 2506 – 9 · 146
Suematsu, Nobuhiro: 931 – 4 · 113, 931 – 6 · 113
Sueta, Carla: 921 – 4 · 150
Sugeng, Lissa: 407 · 181
Sulistio, Melanie S.: 261 · 171
Sullivan, Suzanne: 406 · 154
Sundt, Thoralf: 107A · 125, 652 · 160
Sundt, Thoralf M.: 210 · 118
Sung, Ji-Hee: 917 – 8 · 148
Sunkara, Manjula: 917 – 7 · 148
Superko, Robert: 602 · 113
Suri, Rakesh: 612 · 118
Suryanarayana, Prakash Goutham: 408 · 187
Suzuki, Kenji: 931 – 4 · 113, 931 – 6 · 113
Suzuki, Megumi: 2309 · 156
Svensson, Lars: 2500 – 7 · 137, 2500 – 9 · 137, 305 · 181
Svensson, Lars G.: 2619 · 161, 2636 · 195
Swaminathan, Rajesh V.: 928 – 4 · 154
Swan, Christopher H.: 744a · 170
Swart, Michael: 910 – 4 · 111
Sweeny, Joseph: 2508 – 6 · 139
Sweet, Wendy: 906 – 7 · 110
Sweitzer, Nancy K.: 720 · 203
Syed, Mushabbar A.: 818 · 169
Systrom, David M.: 929 – 4 · 154
Szeto, Wilson Y.: 2626 · 177
Szklo, Moyses: 927 –3 · 153
Tabata, Yasuhiko: 917 – 8 · 148
Tabit, Corey E.: 405 · 144
Tada, Tomohisa: 2503 – 9 · 146
Tadros, Peter: 932 – 4 · 155
Taggart, David: 2202 · 161
Tahirkheli, Naeem: 923 – 8 · 152
Tajik, A. Jamil: 309 · 211
Takabatake, Shu: 2509 – 15 · 147
Takahashi, Masato: 247 · 196
Takano, Masamichi: 2611 · 125
Takemoto, Yasuhiro: 917 – 8 · 148
Takimura, Hideyuki: 2504 – 9 · 138
Talajic, Mario: 666 · 167
Talameh, Jasmine: 921 – 4 · 150
Tamburino, Corrado: 2202 · 161, 2302 · 114, 2505 · 138, 2644 · 107
Tamita, Koichi: 909 – 7 · 111
Tan, Mary: 916 – 5 · 140
Tan, Ru-San: 905 – 8 · 109
ACC.12 Final Program 237
Last Name, First Name: Session # · Page #
ACC.12 • Author Index
Tanajura, Luiz F.: 2504 – 11 · 138
Tang, Jifei: 2645 · 120
Tang, Wai Hong: 906 – 7 · 110, 912 – 7 · 142, 912 – 8 · 142, 922 – 7 · 150
Tang, Wai Hong W.: 617 · 122, 626 · 127
Tani, Lloyd Y.: 247 · 196, 301 · 157
Tansuphaswadikul, Sudaratana: 2505 – 16 · 139
Tantry, Udaya: 2501 – 12 · 137
Tarbine, Sergio G.: 2309 · 156
TASMC Cardiology: 406 · 154
Tatsis, I.: 926 – 8 · 153
Tawakol, Ahmed A.: 743 · 129
Taylor, Allen: 915 – 8 · 145, 924 – 8 · 151
Taylor, Allen J.: 611 · 117, 815 · 165, 927 – 8 · 153
Taylor, Doris: 906 – 5 · 110, 300 · 112
Taylor, Michael D.: 605 · 116
Taylor, Sarah N.: 901 – 4 · 114
Taylor, William R.: 406 · 154
Tazaki, Junichi: 931 – 4 · 113, 931 – 6 · 113
Tazarourte, Karim: 2502 – 9 · 119
Tcheng, James E.: 2306 · 125, 647 · 159, 660 · 164
Tedrow, Usha: 922 – 3 · 150
Teerlink, John: 922 – 5 · 150
Teerlink, John R.: 626 · 127
Teirstein, Paul: 2506 – 7 · 146, 2506 – 13 · 146
Teirstein, Paul S.: 2309 · 156
Teixido, Gisela: 908 – 8 · 110
Tek, Chankevin: 918 – 6 · 148
Templin, Barry: 2511 – 7 · 147, 916 – 4 · 140
Ten Berg, Jurrien: 902 – 4 · 107
Tenuta, Marcos: 304 · 143
Teoh, Kevin: 2644 · 107
Terashima, Mitsuyasu: 2611 · 125
Terzic, Andre: 618 · 121
Teuteberg, Jeffrey: 213 · 122, 694 · 185
Texter, John: 909 – 8 · 111
Textor, Stephen: 2610 · 120, 663 · 165
Thavendiranathan, Paaladinesh: 907 – 8 · 142
Thayssen, Per: 2506 – 11 · 146
the ABSORB B investigators: 2503 – 11 · 146
Thébert, Dominique: 2502 – 9 · 119
Theodoropoulos, Konstantinos C.: 903 – 7 · 108
Therrien, Judith: 667 · 167
Thibault, Bernard: 232 · 162
Thiele, Holger: 221 · 140, 689 · 184, 902 – 8 · 108
Thomas, Gregory: 903 – 8 · 108, 924 – 6 · 151
Thomas, Gregory S.: 673 · 169
Thomas, James: 300 · 112, 912 – 8 · 142
Thomas, James D.: 638 · 151, 638 · 151
thomas, Lecompte: 904 – 8 · 141
Thomas, Martyn: 2645 · 120
Thomas, Randal: 927 – 6 · 153
Thomas, Susan: 306 · 186
Thomopoulos, C.: 926 – 8 · 153
Thompson, Chris R.: 2644 · 107
Thompson, Joseph J.: 603 · 113
Thompson, Lauren: 928 – 6 · 154
Thompson, Paul: 911 – 9 · 143
Thompson, Paul D.: 688 · 182, 746 · 105
Thourani, Vinod H.: 2203 · 194
Thuesen, Leif: 2503 – 13 · 146, 721 · 204, 2506 – 11 · 146
Tian, JinWei: 909 – 5 · 111
Tighe, Dennis: 744b · 170
Tighe, Dennis A.: 241 · 179
Tijssen, Jan: 2502 – 13 · 119
Tilsted, Hans-Henrik: 2506 – 11 · 146
Timmers, Gregory D.: 673 · 169, 673 · 169
Tisch, Rebecca: 2644 · 107
Tisdale, James: 913 – 8 · 143, 736 · 125
Tison, Geoffrey H.: 927 –3 · 153
Tiwari, Sumit: 916 – 6 · 140
Tobis, Jonathan M.: 2614 · 140, 2639 · 202, 2614 · 140
Toggweiler, Stefan: 2644 · 107
Tomaselli, Gordon: 710 · 198
Tomberli, Benedetta: 925 – 4 · 152, 925 – 5 · 152
Tompkins, Christine: 624 · 126, 919 – 6 · 149
Tong, Carl W.: 906 – 8 · 110
Tonino, Pim: 923 – 9 · 152, 2508 – 7 · 139
Topalian, Simon: 2313 · 189
Topilsky, Yan: 242 · 182
Topol, Eric: 2644 · 107, 923 – 8 · 152
Torguson, Rebecca: 915 – 8 · 145, 2500 – 15 · 137, 2507 – 15 · 147
Torii, Sho: 2503 – 7 · 145
Torner, James C.: 904 – 4 · 141
Torre-Amione, Guillermo: 240 · 179
Tousoulis, Dimitris: 931 – 3 · 113
Towbin, Jeffrey: 901 – 5 · 114
Towbin, Jeffrey A.: 222 · 141, 240 · 179, 107A · 125, 301 · 157, 301 · 157, 301 · 157, 671 · 168
Tracy, Russell: 905 – 5 · 109
Traverse, Jay: 300 · 112
Travin, Mark I.: 658 · 163, 708 · 197
Tremmel, Jennifer: 2508 – 7 · 139
Tresukosol, Damras: 2505 – 16 · 139
Tricoci, Pierluigi: 903 – 8 · 108
Troughton, Richard W.: 680 · 179
Troxel, David B.: 248 · 198
Trujillo, Tate N.: 913 – 8 · 143
Truong, Quynh: 308 · 210
Trupp, Robin: 217 · 127
Tsai, Thomas: 2511 – 11 · 147, 928 – 3 · 153, 928 – 6 · 154
Tsai, Thomas T.: 209 · 117, 2641 · 200
Tsang, Teresa S. M.: 638 · 151
Tsang, Wendy: 407 · 181
Tsiachris, D.: 926 – 8 · 153
Tsigkas, Grigorios: 903 – 4 · 108, 903 – 7 · 108
Tsioufis, Konstantinos P.: 926 – 8 · 153
Tsubokawa, Toshinari: 2509 – 15 · 147
Tsuchikane, Etsuo: 2621 · 162, 2504 · 138, 2504 – 7 · 138
Tsukahara, Reiko: 2504 – 9 · 138
Tu, Thomas: 2113 · 194, 2113 · 194
Turi, Zoltan G.: 2609 · 120, 2624 · 167, 2310 · 156, 2510 – 6 · 139, 821 · 197
Turker, Isik: 405 · 144
Turpie, Alexander G.: 304 · 143
Tuzcu, E. Murat: 2606 · 115, 646 · 155, 1607 · 205, 2303 · 115, 2308 · 156, 2500 – 7 · 137, 2500 – 9 · 137, 305 · 181, 309 · 211, 518 · 189
Tweddell, James S.: 724 · 209, 402 · 162
Uber, Patricia: 203 · 109
Uber, Patricia A.: 925 · 152
Udayachalerm, Wasan: 2505 – 16 · 139
Udell, Jacob: 902 – 5 · 108
Udelson, James: 308 · 210, 925 – 4 · 152, 925 – 5 · 152
Udelson, James E.: 658 · 163, 641 · 157, 308 · 210
Uebing, Anselm: 920 – 8 · 149
Uematsu, Masaaki: 931 – 6 · 113, 2311 · 166
Uemura, Shiro: 917 – 8 · 148
Uesugi, Yoshiko: 917 – 8 · 148
Ueyama, Takeshi: 405 · 144
Ulveling, Kyle G.: 744b · 170
Underwood, S. Richard: 740 · 204, 740 · 204
Unger, Barbara T.: 263 · 170
Unterseeh, Thierry: 926 – 7 · 153
Urena, Marina: 915 – 6 · 145
Uretsky, Seth: 233 · 163
Ussia, Gian Paolo: 930 – 3 · 155
Utsunomiya, Daisuke: 924 – 8 · 151
Uy, Stephen: 923 – 4 · 151
Vahanian, Alex: 915 – 7 · 145, 930 – 5 · 155
Valente, Anne Marie: 920 – 7 · 149, 252 · 201, 668 · 168, 806 · 123, 920 – 7 · 149
Valenti, Renato: 903 – 6 · 108
Valentine, C. Michael: 244 · 185, 621 · 123, 684 · 180, 104 · 117
Valentini, Rudolph: 408 · 187
Valgimigli, Marco: 910 – 4 · 111, 2644 · 107, 903 – 8 · 108
Valika, Ali: 2315 · 189
Van Arsdell, Glen: 901 – 3 · 114
Van Bakel, Adrian: 921 – 4 · 150
van Beek, Edwin J.: 407 · 181
Van Belle, Eric: 2507 · 146
van de Hoef, Tim P.: 2502 – 13 · 119
Van de Werf, Frans J.: 308 · 210
Van der Heyden, Jan: 2631 · 183
van der Hoeven, B. L.: 917 – 5 · 148
Van Der Laan, Anja: 918 – 4 · 148
van der Vleuten, Pieter: 918 – 4 · 148
Van Eyk, Jennifer: 671 · 168, 602 · 113
van Geuns, Robert Jan M.: 2503 – 13 · 146
van Nierkerk, Nicolene: 914 – 4 · 144
van Rossum, Albert: 918 – 4 · 148
238 GO for ACC.12!
Last Name, First Name: Session # · Page #
Author Index • ACC.12
Vanerio, Gabriel: 726 · 210
Vannan, Mani: 907 – 8 · 142
Varadarajan, Padmini: 110 · 129
Vardeny, Orly: 921 – 6 · 150
Varghese, Mithun J.: 2310 · 156
Varleta, Paola: 516 · 192
Varma, Niraj: 614 · 121, 717 · 202, 922 – 7 · 150
Varosy, Paul: 919 – 4 · 149
Varosy, Paul D.: 205 · 112, 215 · 123, 515 · 193, 928 · 153
Vavere, Andrea: 909 – 8 · 111
Veer, Marcel v.: 923 – 9 · 152
Velazquez, Eric J.: 681 · 179, 682 · 179, 924 · 151
Veldtman, Gruschen R.: 725 · 209
Velez, Mauricio: 229 · 159
Velianou, James L.: 2644 · 107
Ventura, Hector O.: 686 · 180, 720 · 203, 516 · 192, 664 · 165
Vercel, Mark: 2311 · 166
Verdejo, Juan P.: 513 · 190
Verdini, Daniel J.: 922 – 3 · 150
Verdino, Ralph J.: 702 · 196, 716 · 201, 804 · 118, 810 · 128
Vergouwe, Yvonne: 910 – 4 · 111
Verheugt, Freek W.A.: 211 · 121
Verheye, Stefan: 2506 – 7 · 146, 2511 – 7 · 147
Verloop, Willemien: 926 – 5 · 153
Verma, Atul: 615 · 121
Verrier, Richard L.: 702 · 196
Verrill, Thomas A.: 929 – 7 · 154
Versaci, Francesco: 2510 – 11 · 140
Verschuren, Jeffrey J.: 917 – 5 · 148
Vetrovec, George: 2505 – 8 · 138
Vetrovec, George W.: 2501 · 137
Victor, Elivane: 304 · 143
Victor, Ronald G.: 250 · 198, 631 · 128
Vidaillet, Humberto: 904 – 6 · 141
Vido, Diane: 918 – 5 · 148
Vidovich, Mladen: 928 – 3 · 153
Vij, Kamal: 918 – 8 · 148
Vijayakumar, Sathya: 918 – 8 · 148
Vijayaraghvan, Krishnaswami: 686 · 180, 686 · 180
Viles-Gonzalez, Juan: 902 – 6 · 108
Villines, Todd: 924 – 5 · 151, 924 – 7 · 151, 927 – 8 · 153
Vincent, Robert: 901 – 8 · 114
Vinereanu, Dragos: 904 – 9 · 141
Virani, Salim: 925 – 6 · 152
Virani, Salim S.: 227 · 152
Virmani, Renu: 2611 · 125, 2632 · 184, 622 · 123
Viswanathan, Mohan N.: 744b · 170
Vita, Joseph A.: 405 · 144, 622 · 123
Vlachojannis, Georgios: 2501 – 10 · 137
Vlachojannis, Georgios J.: 2501 – 6 · 137
Vlahakes, Gus: 2310 · 156
Vlahakes, Gus J.: 2121 · 177
Vogel, Robert: 688 · 182
Volpe, Massimo: 920 – 7 · 149
von Scheidt, Fabian: 903 – 3 · 108
von Ziegler, Franz: 909 – 6 · 111
Vongpatanasin, Wanpen: 250 · 198, 629 · 128, 663 · 165
Vora, Amit: 509 · 190
Vorchheimer, David: 902 – 6 · 108
Voros, Szilard: 923 – 8 · 152, 924 – 6 · 151, 683 · 180, 2608 · 119, 2639 · 202
Voskuil, Michiel: 926 – 5 · 153
Vrancx, Pascal: 910 – 4 · 111
Wachter, Rolf: 921 – 8 · 150
Wage, Ricardo: 908 – 4 · 110
Wagner, Henrik: 902 – 4 · 107
Wagner, William: 627 · 127
Waites, Thad: 302 · 165
Waksman, Ron: 2308 · 156, 2500 – 15 · 137, 2503 · 145, 2505 – 8 · 138, 2507 – 15 · 147, 2632 · 184, 2645 · 120, 503 · 188, 915 – 8 · 145, 923 – 8 · 152
Waldo, Albert L.: 677 · 178, 107A · 125
Wallentin, Lars: 2643 · 201, 639 · 156, 747 · 209, 904 – 9 · 141
Walpole, Howard T.: 621 · 123, 226 · 152
Walsh, Edward P.: 667 · 167
Walsh, Joseph: 2315 · 189
Walsh, Mary N.: 224 · 143, 245 · 185, 601 · 112
Walther, Thomas: 2619 · 161
Wan Ahmad, Wan Azman: 512 · 192
Wang, Andrew: 714 · 199, 808 · 124
Wang, Francis: 914 – 8 · 144
Wang, Paul: 919 – 6 · 149
Wang, Paul J.: 919 · 149
Wang, Thomas: 914 – 8 · 144
Wang, Thomas J.: 635 · 141
Wang, Tracy: 209 · 117, 722 · 204, 913 – 7 · 143, 928 – 4 · 154
Wang, Y. Claire: 927 – 4 · 153
Wang, Yongfei: 919 – 4 · 149
Wang, Zuyue: 2500 – 15 · 137, 2507 – 15 · 147, 915 – 8 · 145
Warber, Sara: 698 · 186
Ward, R. Parker: 644 · 158, 672 · 168
Ware, Stephanie: 901 – 5 · 114
Warnes, Carole A.: 679 · 179, 107A · 125, 402 · 162, 402 · 162, 608 · 116
Washam, Jeffrey: 722 · 204
Washington, Reginald L.: 603 · 113
Wasserman, Scott: 923 – 4 · 151
Wassertheil-Smoller, Sylvia: 904 – 4 · 141
Watanabe, Tetsuya: 2311 · 166
Wate, Prateek S.: 906 – 4 · 109
Watson, Karol E.: 736 · 125, 306 · 186, 664 · 165
Watta, Matteo: 405 · 144
Watts, James A.: 2122 · 183
Wazni, Oussama M.: 810 · 128
Weaver, W. Douglas: 928 – 5 · 154
Webb, Gary D.: 202 · 108
Webb, John: 2500 – 7 · 137, 2500 – 9 · 137, 2644 · 107, 305 · 181
Webb, John G.: 2619 · 161, 2308 · 156
Webber, Steven: 901 – 5 · 114
Wei, Xufeng: 906 – 6 · 110
Weigold, William Guy: 924 – 8 · 151, 2629 · 183, 683 · 180, 915 – 8 · 145
Weinberg, Paul M.: 724 · 209
Weiner, Rory: 2310 · 156
Weiner, Rory B.: 914 – 8 · 144, 929 – 4 · 154
Weiner, Scott: 308 · 210
Weinert, Lynn: 407 · 181
Weintraub, Andrew R.: 250 · 198
Weintraub, William S.: 308 · 210, 2505 · 138, 622 · 123
Weiss, Jocelyn: 308 · 210
Weissman, Gaby: 744b · 170, 915 – 8 · 145, 924 – 8 · 151
Weissman, Neil: 930 – 4 · 155
Weissman, Neil J.: 2608 · 119, 2629 · 183, 672 · 168, 657 · 163
Weisz, Giora: 2505 – 8 · 138, 2501 – 14 · 138, 2501 – 16 · 138, 2511 – 7 · 147, 2645 · 120, 639 · 156, 916 – 4 · 140
Weitz, Jeffrey I.: 264 · 187
Welch, Terrence D.: 744b · 170
Wenaweser, Peter: 2644 · 107
Wenger, Nanette K.: 255 · 204, 709 · 197, 1602 · 130, 742 · 186, 746 · 105
Wertz, Jonathon: 912 – 5 · 142
Wessels, Judith A.: 917 – 5 · 148
West, Erin: 929 – 6 · 154
West, Lori: 625 · 127
Westcott, R. Jeffrey: 660 · 164
Westernout, Cynthia M.: 916 – 5 · 140
Wharton, J. Marcus: 207 · 116
White, Audrey: 407 · 181
White, C. Michael: 911 – 9 · 143
White, Charles: 308 · 210
White, Christopher: 932 – 7 · 155
White, Christopher J.: 2627 · 177, 2631 · 183, 2311 · 166
White, Harvey D.: 2617 · 156
White, Patrick J.: 673 · 169
White, William B.: 663 · 165
Whitlow, Patrick: 2502 – 11 · 119
Whitlow, Patrick L.: 2627 · 178, 2302 · 114, 2621 · 162
Wicky, Stephan: 2616 · 156
Wiederkehr, Daniel: 913 – 5 · 143
Wiegers, Susan E.: 907 · 142
Wiesneth, Markus: 903 – 3 · 108
Wilber, David J.: 715 · 201
Wilde, Arthur A.: 691 · 184
Wiley, Jose: 2313 · 189
Wiley, Mark: 932 – 4 · 155
Wilkinson, James: 901 – 5 · 114
Wilkoff, Bruce: 904 – 4 · 141, 922 – 7 · 150
Wilkoff, Bruce L.: 205 · 112, 232 · 162, 690 · 184
ACC.12 Final Program 239
Last Name, First Name: Session # · Page #
ACC.12 • Author Index
Willenberg, Bradley J.: 906 – 4 · 109
Willerson, James: 300 · 112
Williams, Amy W.: 645 · 158
Williams, Eric S.: 109 · 128, 710 · 198, 737 · 169
Williams, Kim: 306 · 186
Williams, Kim A.: 658 · 163
Williams, Lauren: 922 – 4 · 150
Williams, Mathew: 2203 · 194, 2500 – 7 · 137, 2500 – 9 · 137, 2500 – 11 · 137, 2507 – 11 · 146, 2619 · 161
Williams, MIchelle C.: 407 · 181
Williams, Roberta G.: 402 · 162
Williams, M, Ronald: 918 – 5 · 148
Wilson, B. Hadley: 2502 – 7 · 119, 104 · 117
Wilson, Carol: 919 – 8 · 149
Winchester, David E.: 113 · 193
Windecker, Stefan: 2503 – 13 · 146
Windecker, Stephan: 2645 · 120, 910 – 4 · 111
Windle, John R.: 647 · 159
Wingate, Suzanne J.: 220 · 129, 225 · 150
Winitsky, Steve: 618 · 121
Winston, Stuart: 501 · 190
Winters, Kenneth: 902 – 4 · 107
Witt, Nils: 923 – 9 · 152
Wittfeldt, Ann: 902 – 7 · 108
Witzenbichler, Bernhard: 2501 – 6 · 137, 2501 – 14 · 138, 2501 – 16 · 138, 2508 – 15 · 139, 304 · 143
Wiviott, Stephen: 308 · 210, 902 – 3 · 107, 902 – 5 · 108, 913 – 7 · 143
Wiviott, Stephen D.: 623 · 126, 709 · 197, 1605 · 171, 659 · 163, 826 · 203
Woehrle, Jochen: 2502 – 15 · 119, 2509 – 9 · 147, 903 – 3 · 108, 908 – 7 · 110
Wohns, David: 2104 · 165, 2511 – 15 · 147
Wöhrle, Jochen: 689 · 184
Wojdyla, Daniel: 921 – 5 · 150
Wolf, Bethany: 901 – 4 · 114
Wolff, Steven: 304 · 143
Wolski, Kathy: 306 · 186
Wong, Michael J.: 235 · 164
Wong, Nathan: 927 – 7 · 153
Wong, Shing-Chiu: 2624 · 167, 2634 · 190
Wood, David: 2644 · 107
Wood, Malissa J.: 235 · 164, 261 · 171
Woodard, Pamela: 308 · 210
Woody, Walter: 928 – 3 · 153
Worle, Jochen: 2643 · 201
Wright, Janet S.: 742 · 186
Wright, Scott: 215 · 123, 687 · 180, 712 · 199
Wroblewski, Heather: 913 – 8 · 143
Wu, Chuntao: 910 – 7 · 111
Wu, Colin: 908 – 8 · 110
Wu, Xin: 906 – 8 · 110
Wu, Yuping: 912 – 7 · 142
Wunderlich, Nina: 2630 · 183, 2640 · 200
Wylie-Sears, Jill: 406 · 154
Wyman, Janet F.: 2101 · 156, 2102 · 160
Xanthopoulou, Ioanna: 903 – 4 · 108, 903 – 7 · 108
Xiang, Meixiang: 2645 · 120
Xie, Aris: 909 – 4 · 110
Xing, Lei: 916 – 7 · 140
Xu, Ke: 916 – 4 · 140, 2511 – 7 · 147
Yacoub, Magdi H.: 401 · 124, 506 · 191, 627 · 127, 400 · 106
Yadav, Jay: 922 – 5 · 150
Yadav, Jay S.: 2637 · 195, 633 · 129
Yadav, Neha: 744b · 170
Yakubov, Steven J.: 2132 · 195, 2606 · 115
Yakushiji, Tadayuki: 2508 – 15 · 139
Yamagishi, Masakazu: 2509 – 15 · 147
Yamane, Masahisa: 2504 – 7 · 138
Yamaoka, Terutoshi: 931 – 4 · 113, 931 – 6 · 113
Yamawaki, Masahiro: 2504 – 9 · 138
Yamrozik, June: 918 – 5 · 148
Yan, Andrew: 916 – 5 · 140
Yancy, Clyde W.: 237 · 169, 107A · 125
Yang, Hongqiu: 904 – 9 · 141
Yang, Jeong Hoon: 2504 – 13 · 138
Yang, Shuang: 916 – 7 · 140
Yang, YueJin: 505 · 188
Ye, Jian: 2644 · 107
Ye, Siqin: 910 – 5 · 111
Yeh, Edward T.: 642 · 157
Yeh, Robert W.: 209 · 117, 215 · 123, 700 · 186
Yeo, Hans: 2505 – 16 · 139
Yetman, Angela T.: 202 · 108
Yeung, Alan: 2645 · 120
Yeung, Alan C.: 2608 · 119, 2201 · 119
Yeung, Hubert: 407 · 181
Yingchoncharoen, Teerapat: 907 – 5 · 142
Yonetsu, Tiashi: 916 – 7 · 140
Yong, Andy: 2508 – 7 · 139
Yoo, Wonsuk: 306 · 186, 910 – 6 · 111
Yoon, Jung H.: 511 · 188
Yoon, Jung-Han: 2644 · 107
Yoon, Sung-Cheol: 2645 · 120
Yoshida, Takayuki: 2305 · 125
Yoshikawa, Ayako: 2503 – 7 · 145
Yoshikawa, Junichi: 909 – 7 · 111
Yu, Bo: 909 – 5 · 111
Yu, Cheol Woong: 2504 – 13 · 138
Yu, Jennifer: 2501 – 10 · 137
Yue, Qi: 909 – 4 · 110
Yundai, Chen: 685 · 180
Yusuf, Salim: 206 · 116, 665 · 167, 686 · 180, 700 · 186, 904 – 5 · 141, 904 – 7 · 141
Zafar, M. Urooj: 902 – 6 · 108
Zafrir, Barak: 912 – 6 · 142
Zahger, Doron: 916 · 140
Zahn, Ralf: 910 – 8 · 111, 915 – 4 · 145
Zaidi, Abbas: 914 – 7 · 144
Zaidi, Abbas: 914 – 4 · 144
Zajarias, Alan: 258 · 210, 2619 · 161, 646 · 155, 819 · 192
Zakroysky, Pearl: 308 · 210
Zaman, Khan S.: 514 · 194
Zambahari, Robaayah: 512 · 192
Zannad, Faiez: 921 – 6 · 150
Zareba, Wojciech: 704 · 196, 919 – 6 · 149
Zaromitidou, Marina: 931 – 3 · 113
Zaverio, Ruggeri M.: 909 – 4 · 110
Zazula, Ana: 304 · 143
Zeiher, Andreas M.: 618 · 121, 2506 · 146, 300 · 112
Zellers, Paul: 2315 · 189
Zeymer, Uwe: 910 – 8 · 111
Zhang, Dadong: 2645 · 120
Zhang, Shaosong: 909 – 5 · 111, 916 – 7 · 140
Zhang, Zhen: 916 – 4 · 140
Zhang, Zheng: 2645 · 120
Zhang, Zugui: 308 · 210
Zhao, David: 300 · 112
Zhao, Dong: 685 · 180, 685 · 180
Zhao, Songyang: 910 – 7 · 111
Zhao, Yan: 909 – 4 · 110
Zhao, Yue: 915 – 5 · 145
Zhong, Liang: 905 – 8 · 109
Zhou, Chunmei: 902 – 4 · 107
Zhou, Yujie: 2645 · 120, 685 · 180
Ziada, Khaled: 917 – 7 · 148
Ziada, Khaled M.: 2627 · 178
Zidar, James P.: 2642 · 201
Zieman, Susan: 905 – 5 · 109
Ziffer, Jack A.: 696 · 185
Zijlstra, Felix: 918 – 4 · 148
Zile, Michael R.: 635 · 141
Zipes, Douglas P.: 646 · 155, 746 · 105
Zisimos, Konstantinos: 931 – 3 · 113
Zoghbi, William A.: 652 · 160, 507 · 191, 742 · 186, 746 · 105
Zolty, Ronald: 912 – 4 · 142
Zuba-Surma, Ewa K.: 917 – 7 · 148
Zuckerman, Bram D.: 633 · 129
Zuern, Christine: 926 – 6 · 153
Zugwitz, Daša: 2645 · 120
Zwicke, Dianne L.: 662 · 164
Zyblewski, Sinai: 901 – 4 · 114
Zynda, Todd K.: 2121 · 177
The American College of Cardiology Proudly Welcomes the Newest
Physician Members of the CardioSurve Panel for 2012
©2012 American College of Cardiology. T1105
CardioSurve is a select panel of ACC members who provide important insights and perspectives on the issues that affect today’s cardiovascular professionals and assist the College in listening closely to the “voice of U.S. cardiologists.”
For more on CardioSurve and to learn about the newest panelists, visit CardioSource.org/CardioSurve.
TM
Visit ACC Central, Booth #10027
Help Shape the Future of CardioSmart (and win a free iPad!)� e ACC is re-launching CardioSmart, and we want your input. � e new CardioSmart will provide tools to improve the patient-clinician relationship.
If you’re a practicing clinician, come and tell us what you need. It only takes � ve minutes. We’ll give you a token of our appreciation and enter you in a drawing to win an iPad!
CARD-1023626-0000 01/12
See how the data connects with your practice.
Bring it all together at BOOTH 14008
Please pick up your complimentary medically relevant customized poster and informative CD.
vytorin.com zetia.com